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Pathogenicity and Virulence of Trueperella pyogenes: A Review
Reprinted from: Int. J. Mol. Sci. 2019, 20, 2737, doi:10.3390/ijms20112737 . . . . . . . . . . . . . . 289
Mónica Galocha, Pedro Pais, Mafalda Cavalheiro, Diana Pereira, Romeu Viana 
and Miguel C. Teixeira
Divergent Approaches to Virulence in C. albicans and C. glabrata: Two Sides of the Same Coin
Reprinted from: Int. J. Mol. Sci. 2019, 20, 2345, doi:10.3390/ijms20092345 . . . . . . . . . . . . . . 323
Tiago Pita, Joana R. Feliciano and Jorge H. Leitão
Small Noncoding Regulatory RNAs from Pseudomonas aeruginosa and
Burkholderia cepacia Complex
Reprinted from: Int. J. Mol. Sci. 2018, 19, 3759, doi:10.3390/ijms19123759 . . . . . . . . . . . . . . 349
Daniel Hatlem, Thomas Trunk, Dirk Linke and Jack C. Leo
Catching a SPY: Using the SpyCatcher-SpyTag and Related Systems for Labeling and Localizing
Bacterial Proteins
Reprinted from: Int. J. Mol. Sci. 2019, 20, 2129, doi:10.3390/ijms20092129 . . . . . . . . . . . . . . 371
vi
About the Editor
Jorge H. Leitão, Ph.D., is associate professor at the scientific and pedagogical area of Biological
Sciences of the Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa,
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Microbial virulence factors encompass a wide range of molecules produced by pathogenic
microorganisms, enhancing their ability to evade their host defenses and cause disease. This broad
definition comprises secreted products such as toxins, enzymes, exopolysaccharides, as well as cell
surface structures such as capsules, lipopolysaccharides, glyco- and lipoproteins. Intracellular changes
in metabolic regulatory networks, governed by protein sensors/regulators and non-coding regulatory
RNAs are also known to contribute to virulence. Furthermore, some secreted microbial products have
the ability to enter the host cell and manipulate their machinery, contributing to the success of the
infection. The knowledge, at the molecular level, of the biology of microbial pathogens and their
virulence factors is central in the development of novel therapeutic molecules and strategies to combat
microbial infections. This is of particular importance in the present days with the worldwide emergence
of microbes resistant to available antimicrobials, as well as of novel pathogens such as the SARS-CoV-2
responsible for the present pandemics. Advances in recent years in molecular biology, genomics
and post-genomics technologies, and bioinformatics contributed to the molecular identification and
functional analyses of a wide range of microbial virulence factors. The Special Issue of IJMS focused
on virulence factors and their regulatory networks from microbes such as bacteria, viruses, fungi,
and parasites, as well as on the description of innovative experimental techniques to characterize
microbial virulence factors. A total of 18 papers was published in this Special Issue. The collection
comprises state of the art papers on virulence factors and mechanisms from a wide range of bacterial
and fungal pathogens for humans, animals, and plants, thus reflecting the impact of microorganisms
in health and economic human activities and the importance of the topic.
Due to their impact on human health, bacterial pathogens that cause infections in humans have
received a higher attention, with Escherichia coli as one of the most studied bacteria. Pokharel et al.
investigated the roles played by the recently described serine Protease Autotransporters (SPATE) TagB,
TagC, and Sha of E. coli on urinary infections using a 5637 bladder epithelial cell line [1]. Members of the
SPATE family owe their proteolytic activity to the serine protease catalytic triad composed of an aspartic
acid, a serine, and a histidine residue. Evidence is presented showing that the three SPATE proteins
are internalized by bladder epithelial cells, leading to alterations of actin cytoskeleton distribution.
Results presented indicate that Sha and TagC degrade mucin and gelatin, respectively [1]. The
mutation analysis of the serine catalytic site showed that secretion of the three proteins is not affected,
but impaired their entry into epithelial cells, affecting their cytotoxicity and proteolytic activity [1].
The presence of genes related to virulence factors including adhesins, siderophores, protectines or
invasins, and involved in allantoin metabolism were investigated among 32 non-E. coli Enterobacterales
isolates obtained from the feces of 20 healthy adults [2]. Similar studies analyzed virulent NECE strains
from patients with an ongoing infection, and not commensal NECE from healthy subjects as in the
present study [2]. Isolates were taxonomically characterized by 16S RNA sequencing and MALDI-TOF
MS analysis, and profiled by pulsed-field gel electrophoresis. The genus Klebsiella was found as the
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most represented, followed by Enterobacter and Citrobacter [2]. The isolates were further characterized
concerning the presence in their genomes of genes encoding selected virulence factors, as well as
their phenotypes related to biofilm formation and resistance to a selection of antibiotics. Results point
out that the isolates do not encompass particularly virulent strains and in most of the cases were
susceptible to antibiotics [2].
Yang et al. investigated the role of the Salmonella enterica serovar Typhimurium (ST) pdxB-usg-
truA-dedA operon on intracellular survival using deletion mutants constructed with the λ-Red
recombination technology [3]. The Salmonella genus comprises several facultative intracellular
pathogens capable of infecting both human and animal hosts. The ST deletion mutants was investigated
in J774A.1 macrophage cells. The deletion mutants ΔpdxB, Δusg, and ΔtruA exhibited reduced
replication abilities compared to ST and the deletion mutant ΔdedA. The pdxB-usg-truA-dedA operon is
shown to contribute to ST virulence in mice, and to resistance to oxidative stress [3].
Aeromonas hydrophila is an aquatic Gram-negative bacterium, capable of causing serious and
lethal infections to a wide range of hosts, including fish, birds, amphibians, reptiles, and mammals [4].
Dong et al. described the identification and functional characterization of the LahS global regulator of
A. hydrophila [4]. LahS was identified after the screening of a Tn5-derived library of 947 A. hydrophila
mutants for reduced hemolytic activity. The LysR family transcriptional regulator family member
LahS was found to play a role in biofilm formation, motility, antibacterial activity, resistance to
oxidative stress, and proteolytic activity, as well as essential for A. hydrophila virulence to zebrafish [4].
The comparative proteomics analysis performed by the authors confirmed the role of the protein as a
global regulator in A. hydrophila [4].
Bacteria of the Dickeya genus comprise plant pathogens that affect crops such as potatoes. In order
to succeed when infecting their hosts, Dickeya secrete several proteins with plant cell wall degrading
activities, including pectinases, cellulases, and proteases [5]. To investigate the role played by the
protease Lon on D. solani pathogenicity towards potato, Figaj et al. used a λ-Red-derived protocol
to construct a lon deletion mutant [5]. Results presented indicate that the Lon protein plays a role in
protecting the bacterium to high ionic and temperature stresses, affecting the activity of pectate lyases,
the organism motility, and delaying the onset of infection symptoms in the potato host [5].
The plant pathogen Candidatus Phytoplasma mali is the causal agent of apple proliferation disease,
that affects apple production in Northern Italy [6]. Phytoplasma are biotrophic, obligate plant and insect
bacterial symbionts, with a biphasic life cycle comprising reproduction in phloem-feeding insects
and in plants [6]. The paper of Mittelberger et al. focused on the effector protein PME2 (Protein in
Malus Expressed 2), expressed by P. mali when infecting apples [6]. The in silico analysis of the PME2
protein sequence performed revealed that the protein has features of effector proteins of Gram-positive
bacteria, with a predicted final localization at the cytoplasm or nucleus of the host [6]. Two main
protein variants, PME2ST PME2AT, were found associated in infected apple trees from Italy and
Germany. Using protein variants tagged with GFP, both variants were found to translocate to the
nucleus of Nicotiana spp. protoplasts. A better understanding of the molecular mechanisms used by
P. mali to manipulate its host will rely on genomics analysis, since no genetic manipulation is presently
available for these organisms [6].
The necrotrophic fungal pathogen Sclerotinia sclerotiorum (Lib.) de Bary infects a wide range of
plants causing devastating agricultural losses. The organism forms a typical structure named sclerotia
when vegetative hyphae gather to form a hardened multicellular structure important in its development
and pathogenesis, and that under favorable conditions germinate leading to vegetative hyphae or
apothecia that will initiate novel disease cycles by producing ascospores [7]. Li et al. used a proteomics
approach based on 2D gels followed by spot isolation and protein identification by MALDI-TOF to
identify proteins differentially expressed between a wild-type strain and a deletion mutant on the gene
SsNsd1 encoding a type IVb GATA zinc finger transcription factor [7]. Although the gene encoding
SsNsd1 was found as expressed at low levels during the hyphae stage, the mutant is unable to form
the compound appressoria. The authors were able to identify a total of 40 proteins as differentially
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expressed, 17 with predicted functions and 23 as hypothetical proteins [7]. The authors emphasize the
utility of the approach used to identify important proteins involved in the SsNsd1-mediated formation
of appressorium.
In addition to other factors, the success of pathogens rely on cell-cell communication. Bacterial outer
membrane vesicles (OMV) are recognized as an efficient means of bacteria-bacteria and bacteria-host
communication, not only intra-species, but also interspecies [8]. Despite the lack of data on a possible
role played by OMVs in bacterial-yeast communication, Roszkowiak et al. investigated the role played
by Moraxella catarrhalis OMVs on the susceptibility of selected bacterial and fungal pathogens to the
cationic peptide polymyxin B, and to the serum complement [9]. Using OMVs from M. catarrhalis strain
6, the authors found that these OMVs conferred protection against the cationic peptide polymyxin
B to the non-typeable Haemophilus influenzae, Pseudomonas aeruginosa, and Acinetobacter baumannii.
Furthermore, OMVs also protected serum-sensitive non-typeable H. influenza and promoted the
growth of the serum-resistant P. aeruginosa and A. baumannii against the complement [9]. In addition,
the results presented also show that OMVs facilitate the formation of hyphae by the pathogenic yeast
Candida albicans, promoting its virulence [9]. As stated by the authors, this work might pave the way to
uncover additional roles played by OMVs-dependent interactions in multispecies communities [9].
The RNA chaperone Hfq is a master regulator of gene expression in bacteria, mediating the
interaction of small noncoding RNAs with their mRNA targets, including those related to virulence in
Gram-negative bacteria [10]. Dienstbier et al. performed an integrated Omics comparative analysis
of the Hfq regulon in the Bordetella pertussis human pathogen, responsible for respiratory tract
infections, in particular of a whooping cough [11]. Based on the use of RNAseq, and gene ontology
analysis, genes significantly upregulated in the hfq mutant fall into categories including “Translation”,
“Regulation of transcription”, and “Transmembrane transport”, while genes downregulated fall
in the categories “Transmembrane transport”, “Iron–sulfur cluster assembly”, “Oxido-reduction
process”, “Pathogenesis”, and “Protein secretion by the type III secretion system” [11]. Correlations of
transcriptome, proteome, and secretome datasets are also presented [11]. Results presented corroborate
the central role played by Hfq on the physiology and pathogenicity of B. pertussis [11].
In their brief report, Maisetta et al. performed the ex vivo evaluation of the bactericidal activity
of combinations of the semi synthetic antimicrobial peptide lin-SB056-1 in combination with EDTA
(Ethylenediaminetetraacetic acid) against endogenous P. aeruginosa present in the sputum from patients
suffering from primary ciliary dyskinesia (PCD) [12]. The authors observed that the peptide and EDTA
were almost inactive against PCD sputum endogenous P. aeruginosa when used alone, but exhibited
a significant synergistic killing effect with a sputum sample-dependent efficacy [12]. EDTA, but not
lin-SB056-1, was found to inhibit biofilm formation and the production of virulence factors including
alginate, pyocyanin, and the metalloprotease LasA [12].
Various bacterial species have evolved various strategies to invade, survive, and multiply
intracellularly in host cells. The paper of Denzer et al. presents an updated review of the mechanisms
used by bacteria to invade the host cell, to manipulate their biochemical and gene expression machinery,
and to multiply and escape from the host cell [13]. The authors present a thorough review of
mechanisms used by intracellular pathogens, including the highjack of host immune defenses to
enter into the host cell. Central attention is given to the various mechanism used to manipulate gene
expression, including histone modification, control of host DNA methylation patterns, sabotage of
host long non-coding RNAs, interfering with the host RNA transcription and translation, as well as
with host protein stability [13]. The importance of the detailed molecular knowledge of pathogenesis
mechanisms to the development of strategies to combat bacterial infections is highlighted [13].
The functions of grimelysin of Serratia grimesii and protealysin of Serratia proteamaculans that
use actin as a substrate and promote bacterial invasion was reviewed by Khaitlina et al. [14].
The Serratia genus comprises facultative pathogens able to cause nosocomial infections or infections
in immunocompromised patients, but nosocomial infections by S. grimesii or S. proteamaculans are
low [14]. The paper focused on the discovery, properties and substrate specificity of the two proteases,
3
Int. J. Mol. Sci. 2020, 21, 5320
their high specificity towards actin, and discussed their contribution to the invasiveness of Serratia,
although further knowledge of the bacterium virulence factors and the cellular response mechanisms
is required to fully understand the mechanism of Serratia invasion of the host cell [14].
The virulence factors that the bacteria use to cross the blood-brain barrier and cause meningitis is
reviewed by Herold et al. [15]. Meningitis remains a worldwide problem often associated with fatalities
and severe sequelae. After reviewing important traits of the central nervous system barriers to bacterial
entrance, the authors review the various stages of the virulence processes of bacterial meningitis,
including the processes of attachment and invasion, the routes used to enter the central nervous system,
and the general mechanisms used to survive intracellularly [15]. The roles played by virulence factors
produced by bacteria when crossing the central nervous system is also addressed, followed by the
review of the specific traits of bacterial species more commonly associated with meningitis [15].
Coagulase-negative Staphylococci are a broad group of skin commensals that emerged as major
nosocomial pathogens, with the species S. epidermidis, S. haemolyticus, S. saprophyticus, S. capitis,
and S. lugdunensis as the most frequent pathogens [16]. In their paper, Argemi et al. reviewed the
recent progress achieved in the pathogenomics of these species, based on published work supported by
whole-genome data deposited in public databases [16]. As stated by the authors, the ever increasing
amount of data available at the genomic, molecular, and clinical levels is expected to enhance the
development of innovative approaches to characterize the pathogenicity of this bacterial group
of pathogens [16].
Bacteria of the Trueperella pyogenes species are considered as belonging to the microbiota of
animals skin and mucous membranes of the upper respiratory and urogenital tracts, but it is also
an important opportunistic pathogen to animals, leading to important economic losses [17]. In their
paper, Rzewuska et al. reviewed the taxonomy of the species, their pathogenicity to animals, and the
various diseases associated, as well as their possible involvement in zoonotic infections, as well as
the reservoirs and routes of transmission and infections [17]. The authors also present a thorough
review of the main virulence factors used by the organism, including pyolysin, fimbriae, extracellular
matrix-binding proteins, neuraminidases, and ability to form biofilms [17]. The availability of
complete genome sequences and a better knowledge of T. pyogenes virulence factors, transmission
routes, and epidemiology of infections is expected to lead to the development of effective vaccines,
with particular hope deposited on DNA vaccines [17].
Candidiasis are on the rise worldwide, with Candida albicans and Candida glabrata as the more
prevalent etiologic agents of these fungal diseases [18]. The paper by Galocha et al. thoroughly
reviewed the distinct strategies used by the two Candida species to successfully cause human infections,
starting by the adhesion and ability to form biofilms [18]. While C. albicans is dimorphic, growing as
yeast or pseudohyphae, C. glabrata cannot undergo hyphal differentiation. As a consequence, C. albicans
relies on the production of proteolytic enzymes and hyphal penetration to invade the host cell, while
C. glabrata is thought to invade host cells by inducing endocytosis [18]. The authors extensively review
the distinct mechanisms used by the two pathogenic to evade the host immune system, and succeed as
pathogens. The detailed knowledge of the virulence mechanisms is critical to develop therapies that
specifically target virulence traits of these two pathogenic yeasts [18].
Bacterial small non-coding regulatory RNAs (sRNAs) have emerged over the last decade as key
regulators of post-transcriptional regulators of gene expression, being involved in a wide range of
cellular processes, including bacterial virulence [19]. In their review, Pita et al. updated knowledge
on sRNAs from two pathogens associated with respiratory infections and lung function decline of
patients suffering from Cystic Fibrosis, P. aeruginosa and bacteria of the so-called Burkholderia cepacia
complex (Bcc) [20]. As stated by the authors, the knowledge on P. aeruginosa sRNAs is far more
extensive than from bacteria of the Bcc. After reviewing the main molecular characteristics of bacterial
RNAs and their modes of action, including the role played by Hfq as a mediator of RNA-RNA
interactions, the authors detail the description of the roles played by P. aeruginosa sRNAs known for
their involvement in virulence traits of the bacterium. Despite the shorter information on Bcc sRNAs,
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the authors make a brief description of known sRNAs from Bcc [19]. The identification and functional
characterization of additional sRNAs from these two pathogens will certainly enlighten our knowledge
on their virulence traits.
The development of new tools to investigate microbial pathogenesis, at the molecular and cellular
level, is of keen importance to comprehend how the microorganism can invade the host and cause
infection. The paper from Hatlem et al. reviewed the basic molecular traits and applications
of the SpyCatcher-SpyTag system, originally developed as a method for protein ligation [20].
The system consists of a modified domain of the SpyCatcher surface protein from Streptococcus
pyogenes that recognizes the cognate SpyTag peptidic sequence composed of 13 amino acid residues [20].
Upon recognition, a covalent isopeptide bond is formed between a lysine side chain of the SpyCatcher
and an aspartate of the SpyTag [20]. The authors describe in detail the fundamentals of the system and
of related variants, emphasizing their uses in molecular studies of microbial virulence factors, surface
proteins, membrane dynamics, as well as in the development of vaccines [20].
Microorganisms employ a wide array of virulence factors to successfully thrive and flourish
with their hosts, leading this interaction to the development of infections that can often be fatal.
The molecular knowledge of the virulence traits, associated with the recent availability of genomics
data and bioinformatics tools for the more frequent human pathogens, is expected to lead in the near
future of novel molecules and strategies to battle infectious diseases.
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Abstract: TagB, TagC (tandem autotransporter genes B and C), and Sha (Serine-protease hemagglutinin
autotransporter) are recently described members of the SPATE (serine protease autotransporters of
Enterobacteriaceae) family. These SPATEs can cause cytopathic effects on bladder cells and contribute
to urinary tract infection in a mouse model. Bladder epithelial cells form an important barrier in
the urinary tract. Some SPATEs produced by pathogenic E. coli are known to breach the bladder
epithelium. The capacity of these newly described SPATEs to alter bladder epithelial cells and the
role of the serine protease active site were investigated. All three SPATE proteins were internalized
by bladder epithelial cells and altered the distribution of actin cytoskeleton. Sha and TagC were also
shown to degrade mucin and gelatin respectively. Inactivation of the serine catalytic site in each of
these SPATEs did not affect secretion of the SPATEs from bacterial cells, but abrogated entry into
epithelial cells, cytotoxicity, and proteolytic activity. Thus, our results show that the serine catalytic
triad of these proteins is required for internalization in host cells, actin disruption, and degradation of
host substrates such as mucin and gelatin.
Keywords: SPATEs; UTIs; cytotoxicity; serine proteases; 5637 bladder cells; mucin; gelatin; actin
1. Introduction
Urinary tract infections (UTIs) present a broad range of symptoms and include urosepsis, pyelonephritis
(or upper UTI, with infection in the kidney), and cystitis (or lower UTI, with bacteria infecting the bladder) [1,2].
Uropathogenic Escherichia coli (UPEC) is the main cause of community-acquired UTIs (about 80–90%) [3],
and the ability of UPEC to establish a UTI is due to the expression of a variety of virulence factors. These
factors include type 1 and P fimbriae (pili), flagella, capsular polysaccharides, iron acquisition systems,
and toxins including hemolysin, cytotoxic necrotizing factor (CNF), and serine protease autotransporters of
Enterobacteriaceae (SPATEs) [4].
The bladder urothelium constitutes a physical barrier to ascending urinary tract infections [5].
UPEC can produce toxins that damage bladder tissue and can lead to release of host nutrients and
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counter host defenses and innate immunity. A pore-forming toxin HlyA, can lyse erythrocytes and
nucleated host cells [6], induce apoptosis [7], promote exfoliation of bladder epithelial cells and cause
extensive uroepithelial damage [8–11]. Another UPEC toxin, cytotoxic necrotizing factor 1 (CNF1),
has been reported to mediate bacterial entry into host epithelial cells [12], induce apoptotic death of
bladder epithelial cells [13], and potentially promote bladder cell exfoliation [13]. SPATEs such as Sat,
Pic, and Vat were also shown to affect bladder or kidney epithelial cells [14–16].
An important step to understand the role of SPATEs in UPEC pathogenesis is to elucidate molecular
mechanisms underlying their effect on the bladder epithelium and during urinary tract colonization.
The proteolytic activity of SPATEs is mediated by a serine protease catalytic triad of aspartic acid (D), serine (S),
and histidine (H), wherein serine is the nucleophile, and aspartic acid interacts with histidine [17]. Mutations
within the catalytic triad have been shown to abolish proteolytic activity in a number of SPATEs [15,17–19].
Recently, members of our group identified three new SPATEs: TagB, TagC (tandem autotransporter
genes B and C), and Sha (Serine-protease hemagglutinin autotransporter) in some strains of extra-intestinal
pathogenic E. coli (ExPEC). In ExPEC strain QT598, tagB and tagC are tandemly encoded on a genomic
island, and were present in 10% of UTI isolates and 4.7% of avian pathogenic E. coli (APEC) that we
screened [20]. Further, Sha, which is encoded on a virulence plasmid in strain QT598 was present in
1% of UTI isolates and 20% of avian pathogenic E. coli [20]. The tagBC genes are also present in the
genomes of sequenced UPEC strains such as multidrug-resistant CTX-M-15-producing ST131 isolate E. coli
JJ1886 (Accession number CP006784), E. coli CI5 (Accession number CP011018), and multidrug-resistant
uropathogenic E. coli strain NA114 (Accession number CP002797.2). When cloned into E. coli K-12, TagB,
TagC, and Sha mediated autoaggregation, hemagglutination, and adherence to human HEK 293 renal and
5637 bladder cell lines, but did not contribute significantly to biofilm production [20]. Further, TagB and
TagC exhibited cytopathic effects on the bladder epithelial cell line [20]. Following transurethral infection
of CBA/J mice with a tagBC mutant or sha mutant, no significant difference in colonization was observed.
However, the competitive fitness of a mutant derivative lacking all of the SPATEs present in QT598 was
significantly lower in the kidney [20].
The purpose of this report was to more fully investigate the effects of the TagB, TagC, and Sha
SPATEs on the 5637 bladder epithelial cell line focusing on the actin cytoskeleton. We also investigated
potential entry of SPATE proteins within these bladder epithelial cells and whether they demonstrate
mucinase or gelatinase activity.
2. Results
2.1. Processing and Secretion of TagB, TagC, and Sha Is Independent of the Serine Protease Motif
To evaluate the importance of the serine protease motif for processing and secretion of three
novel SPATEs, we generated variant proteins of TagB, TagC, and Sha lacking the serine catalytic site.
Plasmids expressing TagB, TagC, or Sha [20] were used as the templates for construction of site-directed
mutant clones where the serine site was substituted for an alanine at residue S255, S252, and S258
respectively (Figures S1 and S2). Each of these three plasmids expressing mutant SPATEs, produced
a high-molecular-weight protein (>100 kDa) in culture supernatants that corresponded to the expected
size of the native protein, and also lacked breakdown products that are present in samples containing
native SPATEs that exhibit some autoproteolytic activity (Figure 1A, asterisks). This demonstrated that
the serine protease motif is not necessary for SPATE secretion and release from bacterial cells.
To further localize each of the SPATEs expressed from plasmids in E. coli BL21 on the bacterial cell
surface, we used immunogold labeling and transmission electron microscopy. Polyclonal antibodies
against the entire secreted Vat SPATE [20] were used as they were shown to strongly cross-react and
recognize conserved epitopes of the other SPATEs. Thus, we used these polyclonal “SPATE antibodies”
for the detection of other SPATEs in our experiments.
E. coli BL21 pBCsk+ expressing TagB, TagC, and Sha were immunogold-labeled (Figure 1B–D);
demonstrating localization of these SPATEs on the bacterial surface, as well as release into culture
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supernatant. The inset depicts the heavily concentrated proteins on the bacterial surface that appears
to cluster around each other and produce fiber-like aggregates on the cell surface (white chevron,
Figure 1B–D). E. coli BL21 bacteria containing only the empty plasmid vector were not labeled
after immunogold labeling with anti-SPATE antibodies and secondary anti-rabbit immunoglobulin
conjugated to 10-nm gold particles (Figure 1E).
Figure 1. (A) Silver stained SDS-PAGE analysis of concentrated supernatants of E. coli BL21 expressing
SPATE proteins. Filtered supernatants from clones expressing TagB, TagC, and Sha or the variant TagB
S255A, TagC S252A, and Sha S258A proteins were concentrated through Amicon filters with a 50 kDa cutoff.
Samples containing 5 μg of protein were migrated and stained with silver stain. (B–E) Immunogold Electron
Microscopy (EM) of SPATEs (Serine protease autotransporters of Enterobacteriaceae) localized to the outer
membrane and extracellular medium. Immunogold-TEM micrographs of SPATEs using SPATE-specific
antiserum. Bacteria were cultured to 0.6 OD600nm in Luria-Bertani medium. E. coli BL21 pBCsk+ expressing
TagB (B), TagC (C), and Sha (D) labelled with immunogold particles. (E) E. coli BL21 pBcsk+ (vector only
control) shows no immunogold staining. Insets represents boxed areas of higher magnification showing
clustering of SPATE proteins. All images were acquired at ×17,000 magnification; scale bars represent 1 μm,
and 0.5 μm (Insets).
2.2. The Serine Catalytic Motif of SPATEs Is Not Required for Autoaggregation or Hemagglutination Activity
To determine if the serine catalytic site of each of the three SPATEs is involved in autoaggregation
or hemagglutination activity, we tested these phenotypes with our mutant SPATEs as described in [20].
Macroscopic analysis of autoaggregation of E. coli BL21 expressing TagB S255A, TagC S252A, or Sha
S258A showed that bacterial cells settled at the bottom of the tube under static incubation similar to
their respective native protein-expressing clones. The percentage of reduction in turbidity is given as
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a percentage of the initial OD600 value and was similar for both mutant and native proteins (Figure 2).
The reduction in turbidity of the negative control E. coli BL21 pBCsk+was significantly lower compared
to clones expressing TagB, TagC, Sha, or AIDA-1 (positive control) (Figure 2). AIDA-1 (Adhesin
Involved in Diffuse Adherence) of E. coli is a characterized self-associating autotransporter protein
which mediates bacterial cell–cell interactions and autoaggregation [21].
These results show that inactivation of the serine catalytic site in each SPATE does not affect
autoaggregation. It is therefore likely that other motifs or residues present in these proteins contribute
to autoaggregation of bacterial cells.
Figure 2. The autoaggregation phenotype is independent of the serine protease motif. Clones of E. coli
BL21 expressing TagB, TagC, Sha, or their respective serine-site mutants were grown 18 h and adjusted
to an OD600 of 1.5 and left to rest at 4 ◦C. Samples were taken at 1 cm from the top surface of the
cultures after 3 h to determine the change in OD600. Assays were performed in triplicate, and the rate of
autoaggregation was determined by the mean decrease in OD600nm after 3 h. E. coli BL21 pBCsk+ vector
without insert (empty vector) was used as a negative control and the AIDA-1 autotransporter was the
positive control for autoaggregation. Error bars represent standard errors of the means (*** p < 0.001
compared to empty vector using one-way ANOVA).
Likewise, Sha S258A showed similar hemagglutination of human blood as reported previously
for the Sha native protein [20]. When cloned in the hemagglutination negative E. coli strain ORN172,
there was no hemagglutination activity for either the native or mutant TagB or TagC proteins. In addition
to autoaggregation and hemagglutination activity, the adherence capability of the serine catalytic site
mutants of the SPATEs to 5637 human bladder epithelial cells was not affected (Figure S3). Hence, loss of
the serine catalytic site did not affect autoaggregation, adherence, or hemagglutination phenotypes
associated with each of the SPATEs compared to the native proteins.
2.3. Cytopathic Effect of TagB and TagC Requires the Serine Protease Motif
To assess the role of the serine protease motif for the cytopathic effect of SPATEs, extracts of
supernatants of the different SPATEs (30 μg of protein per well) were incubated with human bladder
epithelial cell line 5637 for 5h. Then the cells were fixed, stained with Giemsa stain, and observed
by light microscopy. Cytopathic changes (dissolution in cytoplasm, enlargement of the nucleus
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with vacuoles) observed under the microscope for TagB and TagC (Figure 3A) were absent from
cells treated with either TagB or TagC proteins lacking the serine protease active site. In addition,
no significant morphological changes were observed with cells treated with either Sha or the mutant,
Sha S258A, protein. No cytopathic effect was observed after treatment of cells with concentrated
filtered supernatant from E. coli BL21 pBCsk+ (empty vector) or media alone (Figure 3A). To examine
this cytopathic effect quantitatively, we measured lactate dehydogenase (LDH) release from epithelial
cells incubated with each of SPATEs or their respective catalytic site mutant proteins. There was release
of LDH after 5 h upon exposure of cells to TagB or TagC. However, the catalytic site mutant proteins
did not release LDH from cells (Figure 3B). Further, no LDH release was detected from cells treated
with either Sha or its catalytic site mutant variant (Figure 3B), indicating that cytotoxicity to human
bladder epithelial cells by TagB and TagC was dependent on the serine protease catalytic site.
Figure 3. The serine catalytic site is necessary for the cytopathic effect of TagB and TagC. (A) Concentrated
supernatants containing 30 μg of protein per well derived from E. coli BL21 clones expressing TagB, TagC,
Sha, or their respective serine mutant variant proteins were incubated with monolayers of the 5637 human
bladder epithelial cell line for 5 h at 37 ◦C. Cytopathic effects (white triangle) were absent in cells treated with
the serine catalytic site mutant variants of TagB or TagC. The empty vector (pBCsk+) without insert was
used as a negative control. The scale bar represents 20 μm. (B) Cytotoxicity measured by LDH release from
5637 human bladder cells after incubation with supernatant filtrates of different clones (30 μg of protein per
well) at 37 ◦C for 5 h. Empty vector (pBCsk+) was used as a negative control and maximum LDH release
(positive control) was determined by treatment with lysis solution. Data are the means of three independent
experiments, and error bars represent the standard errors of the means. Significant differences between lysis
caused by native and mutant SPATEs were determined using Student’s t-test with *** p < 0.001.
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2.4. Exposure to TagB, TagC, or Sha Alters Actin Distribution in Bladder Epithelial Cells
Based on the cellular changes seen with bladder epithelial cells after exposure to TagB and
TagC, we hypothesized that TagB and TagC could alter the distribution of cytoskeletal components
such as actin, with actin being one of the most abundant intracellular proteins in the eukaryotic cell.
So, to examine the effect on F-actin cytoskeleton organization, 5637 bladder cells were incubated
with native and mutant TagB, TagC, or Sha (30 μg of protein per well) for 5 h at 37 ◦C, stained
with fluorescently labeled phalloidin, and then observed under confocal microscopy. Cells treated
with the supernatant extract from the empty vector containing clone were uniform, smooth-edged,
and contained clearly visible actin stress fibers (yellow triangle) and strong actin staining around the
cell (Figure 4A). By contrast, bladder cells treated with TagB showed reduced actin stress fibers and
less actin staining (Figure 4A). Bladder cells treated with TagC, also had a pronounced effect on the
cytoskeleton as demonstrated by the absence of actin stress fibers and reduced levels of actin staining.
Sha treated cells showed a loss of actin stress fibers and the presence of punctate patterns of actin
within the cytoplasm of the cells (yellow arrowheads, Figure 4A). By contrast, the TagB, TagC, and Sha
mutants lacking the serine protease catalytic sites demonstrated no changes in the actin cytoskeleton
and had actin stress fibers similar to negative control cells, indicating that the serine protease activity of
these SPATEs mediates the changes in actin distribution within bladder cells. To quantify the level of
phalloidin binding, we measured the staining intensity and distribution of fluorescence of phalloidin
around each cell using ImageJ software [22]. Fluorescence intensity for cells was calculated using the
channel for actin staining. In comparison with the negative control (empty vector), the density of
F-actin staining was significantly lower in cells treated with TagB, TagC, or Sha. Cells treated with the
serine catalytic site mutant proteins, demonstrated F-actin staining that was greater when compared to
cells treated with the native SPATE proteins (Figure 4B). Overall, these results demonstrate that these
SPATEs alter the cytoskeleton and reduce the distribution of actin in bladder epithelial cells.
Figure 4. Cont.
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Figure 4. Effects of TagB, TagC, and Sha on the actin cytoskeleton of bladder epithelial cells is
serine-protease-motif dependent. (A) Concentrated supernatant extracts (30 μg of protein per well)
from E. coli BL21 clones expressing TagB, TagC, or Sha and their respective serine catalytic site mutants
were incubated with monolayers of human bladder (5637) epithelial cells for 5 h at 37 ◦C. After incubation,
cells were fixed and permeabilized. Actin was stained with fluorescently labeled phalloidin (green)
and the nucleus was stained by DAPI (blue). Cells treated with the filtered supernatant of E. coli BL21
pBCsk+without insert (empty vector) were used as a negative control. Slides were observed by confocal
microscopy. Inset images from the left panels are magnified in the panels to the right. Bars represent
10 μm. (B) Quantitative analysis of fluorescence intensity of F-actin. Analysis of fluorescent intensity
was done at the original magnification by measuring the mean gray value with ImageJ software [22]
with an n value of at least 10 cells. Data values represent the mean ± SEM of at least three independent
experiments. (* p < 0.05, ** p < 0.01, *** p < 0.001 one-way ANOVA with multiple comparisons).
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2.5. SPATE Entry into Bladder Epithelial Cells Is Dependent on the Serine Protease Active Site
We previously showed that TagB and TagC demonstrated cytotoxicity as measured by lactate
dehydrogenase (LDH) release from epithelial cells within 5 h [20]. This toxicity could be due to the
interaction of the SPATEs with targets inside host cells. So, to gain insight into the potential internalization
of these SPATEs, we employed immunofluorescence labeling of proteins followed by visualization using
confocal or immunogold electron microscopy. Firstly, confocal Z-sections (optical slices) of 5637 bladder
cells treated with SPATEs were examined to determine if SPATEs were translocated within cells. After 5 h of
incubation, TagB, TagC, and Sha (red color) were found within cells as evidenced by cell sectioning analysis
(Figure 5A). By contrast, the serine active-site mutant variants were unable to enter epithelial cells and were
not detected (absence of red staining) (Figure 5A), suggesting that serine protease activity is needed for the
entry of SPATEs within cells. Interestingly, TagB within cells also co-localized with actin (green color) in the
outer border of the cell (Figure 5A). Further, cells incubated with serine mutant variants of SPATEs did not
enter cells, and these cells also produced actin stress fibers (Figure 5).
Figure 5. Cont.
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Figure 5. Intracellular localization of TagB, TagC, and Sha determined by confocal microscopy.
(A) Z-stack imaging showing the localization of TagB, TagC, and Sha and their respective serine
active site mutant variants during interaction with 5637 bladder epithelial cells after 5 h of incubation.
SPATEs were detected by Alexa Fluor 594 (white arrowheads, red fluorescence) using anti-mouse
secondary antibody and actin was stained by Alexa Fluor 488- phalloidin (green fluorescence). Images
are displayed in a 3D section view with large Z-sections in the X-Y direction (R), Z-projection in the
X–Z direction (P), and Z-projection in the Y–Z direction (Q). The green and red lines in R indicate the
orthogonal planes of the X–Z and Y–Z projection. For each selected section, the signal was gathered
from a span of 5 μm. Scale bar: 10 μm (B) Quantitative analysis of fluorescence intensity of F-actin in
the cells treated with native or mutant SPATEs. Analysis of fluorescence intensity was done in green
channel by measuring the mean gray value on ImageJ. Data represent the mean ± SEM of at least three
independent experiments. Significant differences between fluorescence intensity of each native and
mutant SPATE treated cell was determined using Student’s t-test with ** p < 0.01, *** p < 0.001.
Analysis of thin-sections of SPATE-treated cells using immunogold staining and transmission
electron microscopy (TEM) also confirmed the intracellular localization of all three SPATEs within
cells. TagB and Sha were found in the cytoplasm, whereas TagC was present in the nucleus (Figure 6).
However, in multiple independent experiments, we failed to detect the presence of serine mutant
variants of TagB, TagC, or Sha within cells. The serine catalytic-site mutant proteins when visualized
were almost exclusively observed on the extracellular surface of cells as seen in cells treated with TagB
S255A (Figure 6D).
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Figure 6. Transmission electron micrographs of 5637 bladder cells showing internalized SPATEs,
immunolabelled with 10-nm-diameter gold particles after 5 h of incubation. Gold particles are
highlighted with red triangles. (A) TagB is principally located in the cytoplasm (CP). (B) For Tag C,
gold particles were associated with the nucleus (N) and cytoplasm (CP). (C) Sha was located mainly in
the cytoplasm (CP). (D) For the serine mutant variants of TagB, TagC, and Sha, gold particles were
only localized on the extracellular surface of cells (red box). Only the TagB S255A mutant protein
localization is shown. Cell membrane (CM), Cytoplasm (CP), Nuclear Membrane (NM), Nucleus (N),
Nucleolus (NC) Bars, 1 μm.
2.6. Sha Exhibits Serine Protease-Dependent Mucinase Activity
Epithelial cell damage caused by SPATEs was shown to require protease activity, and some
other SPATEs were previously shown to demonstrate activity against host proteins such as mucin or
gelatin [18,23]. Further, we also tested for mucinase activity, since two of the novel SPATEs identified
in APEC QT598, Sha and TagB [20], belong to the class 2 SPATE family whose members have been
shown to demonstrate mucinolytic activity. Clones of E. coli BL21 expressing each of the SPATEs were
grown on agar plates containing 0.5% porcine gastric mucin for 24 h at 37 ◦C, followed by amido
black-staining. Plates containing clones growing on discs expressing Sha revealed clear zones of mucin
lysis (Figure 7A) and the lysis zone produced by Sha was intermediate when compared to clones
expressing either Tsh (positive control) or Vat. Mucin containing plates had a clearing zone with
a diameter of 3.9 ± 0.1 cm after exposure to Sha expressing bacteria, which was less than following
exposure to Tsh expressing cells (4.2 ± 0.1 cm), but more than following exposure to Vat expressing
cells (3.7 ± 0.2 cm). By contrast, TagB and TagC were mucinase-negative as evidenced by the absence
of any clearing zones (Figure 7B). Further, the critical role of the serine catalytic site of Sha for mucinase
activity was demonstrated with the clone expressing Sha S258A, which did not produce a zone of
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mucin lysis (Figure 7B). The clone containing only the empty vector (negative control) did not grow
well in the presence of mucin and also demonstrated no clearing zone. When mucin was treated
with culture filtrates of SPATE proteins (Figure 7C), it was not degraded by either TagB, TagC, or in
the negative control (empty vector). Sha as well as Tsh and Vat degraded mucin, whereas the serine
protease mutant of Sha, Sha S258A, did not. Hence, the serine catalytic site of Sha is required for
mucinase activity.
Figure 7. Sha demonstrates serine-protease dependent mucinase activity, but not TagB nor TagC.
Mucinase activity was tested in a medium containing 1.5% agarose and 0.5% porcine gastric mucin.
Filter discs inoculated with clones containing the empty vector, expressing Sha, Vat, Tsh, (A) TagB,
TagC, or Sha S258A (B) were placed on the agar surface and incubated overnight at 37 ◦C. Mucin lysis
zones were visualized by staining with 0.1% amido-black in 3.5 M acetic acid for 15 min, followed by
destaining with 5% acetic acid and 0.5% glycerol for 6 h to overnight. (C) Zones of 0.5% porcine gastric
mucin hydrolysis are visible in the stacking region of the SDS-PAGE gel (boxed area), concentrated
supernatant extracts of SPATEs (5 μg of protein per well) were incubated at 37 ◦C for 48 h with mucin
prior to migration. The gel was stained with a PAS glycoprotein staining kit.
2.7. TagC Exhibits Serine Protease-Dependent Gelatinase Activity
Some SPATEs were previously reported to degrade extracellular matrix proteins such as collagen
and gelatin [23]. We previously demonstrated that TagB, TagC, and Sha could mediate increased
adherence to chicken fibroblasts [20], which are cells that are associated with connective tissues and
produce extracellular matrix proteins such as collagen. The hydrolyzed form of collagen—gelatin was
used as a substrate to test for potential gelatinase activity from supernatant extracts containing SPATEs.
Culture supernatant filtrate from Pseudomonas aeruginosa was used as a positive control, since it is
known to demonstrate gelatinase activity [24]. Samples were incubated with 1% bovine gelatin for 48 h
at 37 ◦C. Culture filtrates containing TagC as well as other SPATEs EspC, Tsh, and Vat demonstrated
gelatinase activity (Figure 8A). By contrast, neither TagB nor Sha demonstrated gelatinase activity,
since high-molecular-weight bands, indicating intact gelatin, remained after exposure to these SPATEs.
Further, gelatinase activity from TagC was shown to be dependent on the serine protease motif,
since the E. coli clone expressing a serine active site mutant protein, TagC S252A, did not generate
a hydrolysis zone on medium containing 1% gelatin, whereas the TagC expressing clone did exhibit
a hydrolysis zone (Figure 8B).
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Figure 8. TagC demonstrates serine-protease dependent gelatinase activity, but not TagB nor Sha.
(A) Zones of 1% bovine skin gelatin hydrolysis are visible in the stacking region of the SDS-PAGE gel
(boxed area), concentrated supernatant extracts of SPATEs (5 μg of protein per well) were incubated at
37 ◦C for 48 h prior to migration. (B) Gelatinase activity of TagC was tested in a medium containing
1.5% agarose and 1% bovine skin gelatin. The disc inoculated with a clone expressing TagC or its serine
catalytic site mutant variant, TagC S252A, were inoculated on the agar surface and were incubated for
48 h at 37 ◦C. Zones of gelatin lysis were visualized by staining with 0.1% amido-black in 3.5 M acetic
acid for 15 min, followed by destaining with 5% acetic acid and 0.5% glycerol for 6 h.
3. Discussion
Colonization of the bladder is vital for UTI pathogenesis and UPEC deploys an array of virulence
factors to infect and colonize the bladder, including secreted toxins [25]. Hemolysin A [8,9], UpxA
(TosA) [26], cytotoxic necrotizing factor-1 (CNF-1) [27,28], and a variety of SPATEs (serine-protease
autotransporters of Enterobacteriaceae) [29] are known toxins of host cells that are produced by
some UPEC strains. The recent identification of new members of the SPATEs family present in
some pathogenic E. coli and their cytotoxic activity on bladder cell lines [20], led us to further
investigate mechanisms underlying the cytotoxic and proteolytic activity of the TagB, TagC, and Sha
SPATEs on an established human urinary bladder cell line [30,31] and other properties of these
virulence-associated proteins.
TagB, TagC, and Sha proteins demonstrated autoaggregating activity, and also promoted adherence
of E. coli strain BL21 to the human HEK 293 renal and 5637 bladder human cell lines. Further, Sha
also contributed to increased biofilm production [20]. SPATEs present on the bacterial surface are
likely to contribute to the autoaggregation phenomenon. (Figure 1A). TagB and TagC also exhibited
cytopathic effects on the bladder epithelial cell line. Further, we also previously determined that
proteolytic activity of these SPATEs was strongly inhibited upon addition of serine protease inhibitor
(PMSF), providing evidence for the importance of the serine protease motif in the activity of these
SPATEs [20]. To further investigate the role of the serine protease activity, we generated catalytic
site mutants of these three SPATEs. It is of note that the serine protease consensus motif (GDSGS) is
conserved among different members of SPATEs [20,32–35]. Importantly, loss of the serine active site
did not affect the processing or secretion of the SPATE proteins into the extracellular milieu (Figure 1A).
Further, loss of the serine active site also eliminated any autoproteolytic activity (Figure 1A). Similarly,
autoproteolytic activity has also been reported for other SPATEs including EspP, Sat, Pic [36], and for
AspA autotransporter from Neisseria meningitidis [37]. Thus, from our results, it is clear that the
processing of the passenger domain across the bacterial surface and autocatalytic activities of the TagB,
TagC, and Sha is independent of the proteolytic serine site.
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We investigated the role of the serine catalytic site of TagB, TagC, and Sha in autoaggregation or
hemagglutination, as either SPATE protease activity on the bacterial or host cell surfaces could have
possibly mediated these phenotypes. For instance, cleavage could have led to certain domains within
the protein, leading to exposure of hydrophobic sites which could promote aggregation [38]. However,
the serine protease site was not required for TagB, TagC, or Sha-mediated aggregation (Figure 2).
These results indicate that other specific SPATE structural domains are likely to be responsible for
aggregation. However, importantly, the autoaggregation phenotype is not a generalized phenotype
of SPATEs, since in previous experiments, both the Tsh and Vat SPATEs did not demonstrate any
autoaggregation phenotype [20]. Currently, the molecular mechanism of autoaggregation of TagB, TagC,
and Sha is unknown. Unlike the three SPATEs described herein, loss of the active site serine of the Hap
adhesin, a Haemophilus influenzae serine protease autotransporter, abrogated autoproteolytic processing
leading to retention of this AT protein on the bacterial cell surface [39]. In fact, the increase in Hap
present on the bacterial surface also increased aggregation, formation of microcolonies, and adherence
of H. influenzae to host cells [40]. With regards to hemagglutination activity of the Sha protein, the serine
active site was also dispensable. We found that Sha S258A hemagglutinated human blood with
a similar titer to the native Sha protein. Similarly, a Tsh S259A variant protein was also able to bind to
avian erythrocytes, turkey hemoglobin, collagen IV, fibronectin, and laminin [41]. Considering that
the TagB S255A, TagC S252A, and Sha S258A variant SPATEs all retained the respective phenotypes
present in the native SPATE proteins, this suggests that, despite lacking catalytic activity, that these
variants are likely to have maintained a properly folded conformation.
In contrast to adherence or aggregation phenotypes, the presence of a serine protease motif was
clearly required for cytotoxicity and entry of the SPATE proteins into bladder epithelial cells. In this
study, the TagB S255A and TagC S252A mutant proteins were no longer cytopathic. Our results are
similar to those described for other SPATEs [15,41,42] which have demonstrated a key role for the
serine active site with regards to any native proteolytic or cytopathic activity of SPATEs on protein
substrates or host cells.
Since TagC shares 60% identity/74% similarity with another SPATE, EspC, a non-LEE-encoded
enterotoxin of enteropathogenic E. coli (EPEC) which causes cytotoxic effects and cleavage of cytoskeletal
actin-associated protein [43]; we explored potential cellular targets in relation to the cytopathic effect
observed in bladder epithelial cells. Following treatment with either TagB, TagC, or Sha, reorganization
of the cytoskeleton and loss of actin stress fibers were seen in bladder epithelial cells (Figure 4).
The effect of TagC was severe with faint staining remaining for actin compared to TagB interaction
with cells. Exposure to Sha caused punctate localization of actin within the cytoplasm. Diminished
actin staining and the formation of punctate actin accumulation suggests that each of these SPATEs
are targeting the actin cytoskeleton or other cellular targets that lead to modifications in actin fiber
formation or distribution within bladder cells. As expected, alterations in actin distribution were
absent from bladder cells exposed to the serine catalytic site mutant variant proteins TagB S255A, TagC
S252A, or Sha S258A, confirming the critical cytopathic role of serine protease activity.
Many pathogens exploit host actin for various stages of infection, including cellular invasion,
intracellular replication, and dissemination by different mechanisms [44,45]. Specifically, during UTIs,
UPEC utilizes the Rho family GTPase member Rac1 to mediate actin polymerization for E. coli bladder
epithelial cell invasion [46]. It has been well documented that there is a relation between intracellular
growth of UPEC in the bladder epithelium and the host F-actin cytoskeleton [47]. Based on the
observation of actin rearrangement observed in bladder cells, it is also possible that the TagB, TagC,
and Sha SPATEs might also contribute to UPEC invasion of the bladder epithelium, as these proteases
may promote adhesion and loss of integrity of the protective epithelial barrier which could increase
bacterial entry into epithelial cells as well as increase entry and systemic spread of the bacteria to other
tissue sites during infection.
Before reaching the epithelial cell surface in the urinary tract, bacteria must cross the protective
mucus layer that is coated with mucin [48]. Mucin serves as a primary antibacterial defense in the
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bladder and contributes to host innate defense by providing a barrier and by trapping bacteria [49].
Many pathogens can invade or reduce the viscosity of mucin by cleaving it [50–52]. Certain SPATEs,
belonging to the Class 2 family, including Pic [18,53], PicC of Citrobacter rodentium [53], and Tsh,
demonstrate mucinase activity [54]. We, therefore, tested whether any of the three novel SPATEs were
mucinolytic, and only Sha was identified as a mucinase (Figure 7). The zone of mucinolytic activity of
Sha was intermediate when compared to Vat and Tsh and, as has been shown for Pic [18], the serine
catalytic site of Sha was required for mucinase activity. From this standpoint, it is interesting to note
that in strain QT598, 3 of the 5 SPATEs (Tsh, Vat, and Sha) demonstrate mucinase activity [20] which
might facilitate bacterial colonization by degrading mucus to overcome the mucous barrier at the
interface of epithelial surfaces. TagC was also shown to degrade gelatin, which is the hydrolyzed
form of collagen, although this activity was absent from Sha and TagB. Collagen is an abundant and
ubiquitous extracellular matrix protein that forms an essential component of connective tissues [55].
From this standpoint, the TagC protease may contribute to tissue invasion and systemic spread of
ExPEC by degradation of extracellular matrix proteins. As expected, the activity of TagC on gelatin
was also dependent on the active serine catalytic site. Similarly, Pic [23] also demonstrated gelatinase
activity that required an active serine catalytic site.
Previous reports have described different mechanisms of internalization of SPATEs and types of
cytoskeletal damage in various epithelial cells in vitro. The Pet SPATE from enteroaggregative E. coli
(EAEC) is internalized by a retrograde trafficking pathway [56] through the Pet host cell receptor,
cytokeratin 8 [57]. Once internalized, Pet causes loss of actin stress fibers due to the breakdown of
spectrin [58,59]. Internalization of EspC by EPEC requires the type 3 secretion system [60] and leads
to cleavage of cytoskeletal proteins [43]. Sat is secreted by UPEC, enters the cell by an unknown
mechanism, and localizes to the cytoskeletal fraction of fodrin/spectrin and integrin present within
bladder and kidney epithelial cells [15]. In the present report, we have demonstrated that TagB, TagC,
and Sha are also internalized in bladder epithelial cells by a mechanism that requires an active serine
catalytic domain. We used confocal Z-sections to verify the intracellular localization of the SPATEs
within human bladder epithelial cells. Of note, we observed the internalization of TagB, TagC, and Sha
within bladder cells after 5 h and this was concomitant with diminished fluorescence staining of actin
in the vicinity of the localized SPATEs. This observation was pronounced following exposure to TagB,
and TagB was shown to be closely associated with actin. Furthermore, to confirm the internalization of
SPATEs within bladder epithelial cells, we carried out immunogold TEM of cross-sections of cells to
demonstrate SPATE proteins within epithelial cells. TEM demonstrated localization of TagB and Sha in
the cytoplasm, whereas TagC targeted the nucleus. We speculate that, since TagC has previously been
shown to promote nuclear enlargement [20], TagC may alter nuclear targets and elicit a significant
increase in nuclear size. The entry of these SPATEs into host bladder cells does not require a type
3 secretion mechanism since it is absent from E. coli QT598 and E. coli BL21, and SPATE proteins
from bacterial supernatants entered bladder epithelial cells directly. Future studies will elucidate
the cytoplasmic or nucleo-cytoplasmic shuttling pathways that mediate the entry and trafficking of
these three SPATEs. Importantly, the serine catalytic site was required for cell entry and cytotoxicity
of all three SPATEs, since serine protease active site mutants were unable to enter cells or cause any
cytopathic effects, further demonstrating a critical role for the serine catalytic site of these SPATEs.
Taken together, the TagB, TagC, and Sha SPATE proteins mediate multiple activities. These include
adhesion, aggregation, cytopathic effects, mucinase and gelatinase activities that may collectively
contribute to different stages of bacterial infection including initial colonization, invasion of host
epithelia, and an increased potential for systemic infection.
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4. Materials and Methods
4.1. Ethics Statement
This study was performed in accordance with the ethical standards of the University of Quebec, INRS.
A protocol for obtaining biological samples from human blood donors was reviewed and approved by the
ethics committee—Comité d’éthique en recherche (CER 19-507, approved November 19, 2019) of INRS.
4.2. Bacterial Strains, Plasmids, and Growth Conditions
E. coli clones expressing TagB, TagC, or Sha were described previously [20]. All DNA constructs
were transformed into E. coli strain BL21 or the type 1 fimbriae fim-negative E. coli strain ORN172.
Strains were grown at 37 ◦C on solid or liquid Luria-Bertani medium (Alpha Bioscience, Baltimore,
MD, USA) supplemented with the appropriate antibiotics when required at concentrations of 100 μg/mL
ampicillin, 30 μg/mL chloramphenicol, or 50 μg/mL of kanamycin. Strains, plasmids, and primers are
listed in Table 1.
Table 1. Strains and plasmids used in this study.
Strains Characteristic(s) Reference
QT598 APEC O1: K1, serum resistant [61]
ORN172 thr-1 leuB thi-1Δ (argF-lac)U169 xyl-7 ara-13 mtl-2 gal-6 rpsLtonA2 supE44Δ (fimBEACDFGH)::Km pilG1 [62]
BL21 fhuA2 [lon] ompT gal [dcm] ΔhsdS New England Biolabs
QT1603 HB101 with AIDA-1 operon [63]
QT4767 ORN172/pIJ553 (Expressing sha)
[20]
QT5194 BL21/pIJ548 (Expressing tagB)
QT5195 BL21/pIJ549 (Expressing tagC)
QT5197 BL21/pIJ550 (Expressing espC)
QT5198 ORN172/pIJ548 (Expressing tagB)
QT5199 ORN172/pIJ549 (Expressing tagC)
QT5431 BL21/pIJ551 (Expressing vat)
QT5432 BL21/pIJ552 (Expressing tsh)
QT5433 BL21/pIJ553 (Expressing sha)
QT5437 BL21 + pIJ554 (Expressing tagB S255A) This study
QT5438 BL21 + pIJ555 (Expressing tagC S252A) This study
QT5439 BL21 + pIJ556 (Expressing sha S258A) This study
QT5598 ORN172 + pIJ554 (Expressing tagB S255A) This study
QT5599 ORN172 + pIJ555 (Expressing tagC S252A) This study
QT5600 ORN172 + pIJ556 (Expressing sha S258A) This study
QT3046 Pseudomonas aeruginosa PA14 Eric Déziel, INRS
Plasmids
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Table 1. Cont.







pIJ554 pBCsk+::tagB S255A This study
pIJ555 pBCsk+::tagC S252A This study
pIJ556 pBCsk+::sha S258A This study
4.3. Site-Directed Mutagenesis
Site-directed mutagenesis was performed using the Q5® Site-Directed Mutagenesis kit as specified
by the manufacturer. pIJ548, pIJ544, and pIJ553 were used as a template for the construction of the serine
catalytic site mutants TagB S255A (pIJ554), TagC S252A (pIJ555), and Sha S258A (pIJ556) at 25 to 50 ng
per reaction with 10 pmol of each of the complementary primers. Primers used to generate the single
point mutation substituting alanine for serine for TagB were 5′-TCCCGGTGACGCCGGCTCTCCT-3′
and 5′-GTACCGTAGGTTGAGAGTG-3′; TagC were 5′-AGGAGGAGACGCCGGTTCCGGA-3′ and
5′-GTCACTTCATTATAAAATCCACC-3′; and Sha were 5′-GGCTGGTGATGCCGGTTCTCCGC-3′
and 5′-TCACCATAGATCGGTAATAC-3′. Following mutagenesis, all constructs were verified by
sequencing at the proteomics platform of the Institut de Recherche en Immunologie et en Cancérologie
(IRIC) of the Université de Montréal (Montréal, QC, Canada).
4.4. Recombinant Protein and Antibody Preparation
Expression and purification of SPATE proteins from concentrated filtered culture supernatant
fractions were obtained as described previously [20] and the extract was checked by silver staining
before each assay. Antibodies against ~ 112 kDa Vat protein were used to generate a Vat-specific rabbit
polyclonal antibody, according to a standard protocol [64] (Laboratorio de Biología Celular y Tisular,
Departamento de Morfología, Universidad Autónoma de Aguascalientes (UAA), Aguascalientes,
Mexico). Since SPATE proteins contain some highly conserved epitopes, anti-Vat antibodies were
used to detect and label each of the SPATE proteins. The alignment of the passenger domain of
Vat with TagB, TagC, and Sha share identities of 39%, 30%, 56%, respectively. Specific epitopes are
not established but Vat-antibodies demonstrate multiple conserved residues (Figure S4) and strong
immune cross-reactivity. Cross-reactivity of antibodies raised against other SPATEs have also been
reported. Antibodies raised against Pet protein (45% identity with EspC and 60 gaps) cross-reacted
with EspC [65]. Likewise in the supernatant of CFT073, anti-Pic (44% identity with Vat and 76 gaps)
antibodies were used to detect Vat and PicU SPATEs [66]. Polyclonal antisera adsorption was done by
incubating the filtered supernatant of E. coli BL21 pBCsk+without insert with a 1:50 dilution of the Vat
polyclonal antiserum for 1 h at room temperature under mild agitation followed by centrifugation at
2000× g for 5 min at 4 ◦C.
4.5. Autoaggregation and Hemagglutination Tests
Autoaggregation of bacterial cells was measured by a settling assay as performed previously [20].
The sedimentation of 10 mL of each culture of E. coli BL21 cells expressing native or serine active
site mutant SPATEs were adjusted to an OD600nm 1.5 from an overnight culture grown at 37 ◦C in
liquid Luria-Bertani medium. Then, they were monitored for a reduction in turbidity from the top of
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the tube which was left at 4 ◦C for 3 h. The reduction of turbidity was plotted as a ratio against the
initial turbidity.
For hemagglutination assays, human blood cells (RBCs) were washed and resuspended in PBS at
a final concentration of 3% using a protocol adapted from [67]. The E. coli fim-negative K-12 strain
ORN172 expressing either native or serine active site mutant SPATEs was grown overnight at 37 ◦C in
Luria-Bertani medium, harvested and adjusted to an optical density (O.D.600nm) of 60. Suspensions
were serially diluted in 96-well round-bottom plates containing 20 μL of PBS mixed with 20 μL of 3%
red blood cells and incubated for 30 min at 4 ◦C.
4.6. Epithelial Cell Culture
The 5637 bladder epithelial cell line was routinely cultured in RPMI 1640 medium (Thermo Fisher
Scientific) supplemented with 10% heat-inactivated FBS at 37 ◦C in humidified 5% CO2, and 2 × 105
cells/well were seeded into eight-well chamber slides (Thermo Fisher Scientific, Waltham, MA, USA)
and allowed to grow to 75% confluence.
To determine cytopathic effects on bladder cells, a final concentration of 30 μg/mL of native
SPATEs or the serine catalytic site mutants were added directly to monolayers and incubated for 5 h in
RPMI 1640 medium at 37 ◦C with 5% CO2. Cells were then washed twice with PBS (phosphate-buffered
saline), fixed with 70% methanol, and stained with Giemsa stain. Cell morphology was analyzed at
a magnification of ×20 with standard bright-field light microscopy. For the lactate dehydrogenase assay,
supernatant from cells treated with native or mutant SPATEs were collected and the release of LDH
in cell culture supernatants were quantified by using the CytoTox 96® Non-Radioactive Cytotoxicity
Assay kit (Promega, Madison, WI, USA). Maximum LDH release (positive control) was determined by
adding lysis solution (provided in the kit) to the non-infected cells.
For fluorescence actin-staining and immunostaining assays, cells were fixed with 3.0%–4.0%
formaldehyde in PBS, washed, permeabilized by addition of 0.1% Triton X-100-PBS, stained with
0.05 μg of Alexa Fluor 488-phalloidin/mL (AAT Bioquest, Sunnyvale, CA, USA) at 37 ◦C for 1 h and
counterstained with ProLong Gold/DAPI antifade reagent (Invitrogen, Carlsbad, CA, USA). After image
acquisition using confocal microscope, the actin staining intensity was quantified by measuring mean
gray value (mean pixel intensity) in ImageJ (https://imagej.nih.gov/ij/) [22]. The cells of interest as well
as background with no fluorescence were selected manually to analyze the areas integrated intensities
and mean gray value. The value was then corrected and total fluorescence (CTF) was calculated
as CTF = Integrated Density – (Area of selected cell X Mean fluorescence of background readings).
The averaged corrected mean gray value was used to generate relative quantitative comparison of
fluorescence intensity.
SPATE protein localization in bladder cells was detected by immunofluorescence. Treated cells
were fixed, permeabilized, and incubated with blocking solution (PBS with 5% BSA) for 1 h at 37 ◦C.
Samples were then incubated with rabbit anti-SPATE polyclonal antibodies (UAA, Mexico) for 2 h at 37
◦C. This was followed by incubation with secondary antibody Alexa Fluor 594-labeled goat anti-rabbit
IgG antibody (Thermo Fisher Scientific, Waltham, MA, USA). Samples were mounted and imaged with
the 60X objective of an LSM780 confocal microscope (Carl Zeiss microscopy Gmbh, Jena, Germany).
Images were processed with ZEN 2012 software (Carl Zeiss microscopy Gmbh, Jena, Germany).
4.7. Electron Microscopy
Immunogold labeling of bacteria was carried out by culturing E. coli BL21 expressing different
SPATEs in Luria-Bertani medium supplemented with 30 μg/mL chloramphenicol for 5 h. Bacterial
suspensions (50 μL) were spotted on nickel-coated TEM grids. After 15 min, liquid was wicked away
with bibulous paper and blocked with drops of PBS containing 1% ovalbumin for 15 min. A blocking
solution was exchanged with a drop of SPATE antiserum diluted 1:100 in PBS. After 15 min, excess fluid
was wicked away with bibulous paper and exchanged for PBS containing 1% ovalbumin drops for
5 min. The wash was repeated and then incubated in suitable goat anti-rabbit IgG (H+L), Alexa
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Fluor 488–10 nm colloidal gold secondary antibodies (Thermo Fisher Scientific, Waltham, MA, USA)
diluted 1:250 in incubation solution. After 15 min, grids were washed twice with PBS drops and rinsed
twice with distilled water. Grids were dried with bibulous paper and imaged on a Philips CM-100
transmission electron microscope.
For immunogold labeling of epithelial cell thin sections, cells were fixed in 0.1% glutaraldehyde
+ 4% paraformaldehyde in cocodylate buffer at pH 7.2, and post-fixed in 1.3% osmium tetroxide in
collidine buffer. After dehydration by successive passages through 25, 50, 75, and 95% solutions of
acetone in water (for 15–30 min each) samples were immersed for 16–18 h in SPURR: acetone (1:1).
Samples were then embedded in BEEM capsules using SPURR resin with the ELR-4221 kit (Polysciences
Inc, Warrington, PA, USA) followed by placing the capsules at 60–65 ◦C for 20–30 h to polymerize the
resin. After resin polymerization, samples were cut using an ultramicrotome (Ultratome) and were
put onto Formvar and carbon covered-copper 200-mesh grids treated with sodium metaperiodate
and were blocked with 1% BSA in PBS. Grids were then incubated with primary antibodies, washed,
and incubated with goat anti-rabbit IgG (H+L), Alexa Fluor 488–10 nm colloidal gold secondary
antibodies (Thermo Fisher Scientific, Waltham, MA, USA). After washing, samples were contrasted
with uranyl acetate and lead citrate and subsequently visualized using a Philips EM 300 transmission
electron microscope.
4.8. Cleavage of Protein Substrates
For mucinase activity, cultures of E. coli BL21 expressing SPATEs were incubated for 24 h at 37 ◦C
on a medium containing 1.5% agarose and 0.5% porcine gastric mucin (Sigma-Aldrich, St. Louis,
MI, USA). Plates were subsequently stained with 0.1% amido-black in 3.5 M acetic acid for 15 min,
followed by destaining with 5% acetic acid and 0.5% glycerol for 6 h to overnight. Zones of mucin lysis
were visualized as discolored halos around colonies. For the Periodic Acid Schiff (PAS) assay to detect
mucin degradation [53], 5 μg of each SPATE protein were incubated with 5 μg of 0.5% porcine gastric
mucin (Sigma-Aldrich) in 30 μL of MOPS buffer and incubated for 48 h at 37 ◦C. Treated samples were
electrophoresed on an 8% SDS-PAGE gel and the gel staining was developed using a colorimetric
Pierce™ Glycoprotein Staining kit (ThermoFisher Scientific, Waltham, MA, USA).
For gelatinase activity, 5 μg of each SPATE protein were incubated with 5 μg of bovine skin gelatin
(Sigma-Aldrich, St. Louis, MI, USA) in 30 μL of MOPS buffer and incubated for 48 h at 37 ◦C. Samples
were then boiled with Laemmli sample buffer, were electrophoresed on an 8% SDS-PAGE gel and then
resolved by Coomassie blue staining. In addition, gelatinase activity was also tested by growing the
clones on agar plates containing 1.5% agarose and 1% bovine skin gelatin for 48 h at 37 ◦C. Plates were
subsequently stained with 0.1% amido-black in 3.5 M acetic acid for 15 min, followed by destaining
with 5% acetic acid and 0.5% glycerol for 6 h to overnight. Zones of gelatin lysis consist of discolored
halos around colonies.
4.9. Statistical Analysis
Experimental data were expressed as a mean ± standard error of the mean (SEM) in each
group. The means of groups were combined and analyzed by a two-tailed Student t-test for pairwise
comparisons and analysis of variance (ANOVA) to compare means of more than two populations.
A p value of <0.05 was considered statistically significant. All data were analyzed with the Graph Pad
Prism 7 software (GraphPad Software, San Diego, CA, USA).
5. Conclusions
In conclusion, TagB, TagC, and Sha are novel SPATEs that demonstrate different proteolytic
activities on different substrates as well as distinct cytopathic effects on bladder epithelial cells.
Additional molecular in vitro and in vivo studies are in progress in an effort to understand the link
between protease activity of the TagB, TagC, and Sha SPATEs and how these proteases disrupt or
alter the actin cytoskeleton during ExPEC infections. It will be of further interest to also investigate
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their potential interactions with other host cells or extracellular matrix proteins, and determine how
these relatively large proteins (generally greater than 100 kDa) manage to enter host cells through
serine protease activity and what specific trafficking pathways may be involved in their localization or
association with specific cellular compartments.
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Abbreviations
AIDA-I Adhesin involved in diffuse adherence
ANOVA Analysis of variance
APEC Avian pathogenic E. coli
CNF1 Cytotoxic necrotizing factor 1
DAPI 4′,6-Diamidino-2-phenylindole
EAEC Enteroaggregative E. coli
EPEC Enteropathogenic E. coli
ExPEC Extra-intestinal pathogenic E. coli
LDH Lactate dehydrogenase





SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
SPATEs Serine protease autotransporters of Enterobacteriaceae
TEM Transmission electron microscopy
UPEC Uropathogenic Escherichia coli
UTIs Urinary tract infections
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Abstract: Non-Escherichia coli Enterobacterales (NECE) can colonize the human gut and may present
virulence determinants and phenotypes that represent severe heath concerns. Most information
is available for virulent NECE strains, isolated from patients with an ongoing infection, while the
commensal NECE population of healthy subjects is understudied. In this study, 32 NECE
strains were isolated from the feces of 20 healthy adults. 16S rRNA gene sequencing and mass
spectrometry attributed the isolates to Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae,
Enterobacter aerogenes, Enterobacter kobei, Citrobacter freundii, Citrobacter amalonaticus, Cronobacter sp.,
and Hafnia alvei, Morganella morganii, and Serratia liquefaciens. Multiplex PCR revealed that
K. pneumoniae harbored virulence genes for adhesins (mrkD, ycfM, and kpn) and enterobactin (entB)
and, in one case, also for yersiniabactin (ybtS, irp1, irp2, and fyuA). Virulence genes were less numerous
in the other NECE species. Biofilm formation was spread across all the species, while curli and
cellulose were mainly produced by Citrobacter and Enterobacter. Among the most common antibiotics,
amoxicillin-clavulanic acid was the sole against which resistance was observed, only Klebsiella strains
being susceptible. The NECE inhabiting the intestine of healthy subjects have traits that may pose
a health threat, taking into account the possibility of horizontal gene transfer.
Keywords: Enterobacterales; Klebsiella; Enterobacter; Citrobacter; virulence; antibiotic resistance; biofilm
1. Introduction
Important enteric pathogens belong to Enterobacterales, a bacterial order within the phylum
Proteobacteria. This order encompasses permanent colonizers of the human gut that, in healthy
conditions, constitute minor bacterial components of the microbiota. Opportunistic Enterobacterales
can persist as gut commensals without inducing any infections, as long as the microbiota is balanced and
Int. J. Mol. Sci. 2020, 21, 1847; doi:10.3390/ijms21051847 www.mdpi.com/journal/ijms31
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the complex and dense bacterial community prevents their overgrowth. A bloom of Enterobacterales
may occur as a result of disturbance of the microbiota, yielding pathogen-mediated infections and
triggering inflammatory host responses.
Escherichia coli is the most studied among the Enterobacterales with regards to the traits that
differentiate commensalism and pathogenicity. It normally colonizes the intestine but comprises both
harmless commensals and different pathogenic variants that may instigate infections in the gut or in
other tissues [1,2]. Virulent strains of E. coli isolated from infected patients attracted most research
interest [3,4], but also fecal isolates from healthy subjects and environmental strains are the target of
increasing attention, aiming to determine the pathogenic potential of a wider biodiversity reservoir [5,6].
Many non-E. coli Enterobacterales (hereinafter referred to as NECE) that can colonize the gut
(e.g., Klebsiella, Enterobacter, Citrobacter, and Serratia) also present traits that can confer them virulence and
pathogenicity or phenotypes that may result in severe heath concern, such as multidrug resistance [7–10].
The greatest efforts have been carried out to describe virulent strains, generally isolated from patients
with an ongoing infection, while the pathogenic potential of NECE inhabiting the gut of healthy
subjects has not been thoroughly investigated with genetic and phenotypic analysis, except for some
genera [9]. The research herein presented aims to fill this gap, providing a genotypic and phenotypic
description of the NECE population isolated from the feces of 20 healthy adults, and to complement
a previous study that described the E. coli population of the same cohort of subjects [5]. A set of 32
NECE strains was isolated, taxonomically classified, subjected to PFGE genotyping, and described
in terms of the genotypic determinants and phenotypic traits that may confer on them potential
pathogenicity or invasiveness.
Information on the genes associated to virulence is detailed especially for Klebsiella spp., where
a number of genes associated to harmful traits were identified, such as those encoding adhesins,
siderophores (e.g., enterobactin, aerobactin, yersiniabactin), protectines, or invasins (responsible
for mucoid phenotype and invasiveness), and involved in allantoin metabolism [7,11]. For other
NECE genera, such as Enterobacter, Cronobacter, and Citrobacter, the knowledge of the genetic
determinants associated to virulence and invasiveness is less comprehensive and, with few exceptions
(e.g., Citrobacter koseri), mainly acquired from better characterized pathogens [12–15].
In addition to fimbrial and afimbrial adhesins, the production of surface cellulose structures and
curli favors the adhesion of Enterobacterales and can exert a significant role in enteric biofilm-related
infections [16,17]. Although not directly involved in pathogenic mechanisms, the acquisition of
multiple antibiotic resistances favors the success of opportunistic Enterobacterales pathogens in
invasion, survival, and spread, severely complicating the containment and treatment of infections [9,18].
Therefore, the occurrence of drug resistant bacteria within a commensal population and the possibility
to exchange genetic material by horizontal gene transfer may represent a major health concern.
In the present study, multiplex PCR assays were utilized to screen the NECE, isolated from the
feces of healthy subjects, for the presence of 17 main virulence genes associated to those of Klebsiella
and E. coli [19–21]. From the point of view of the phenotype, the isolates were characterized for the
ability to form biofilm and to yield curli and surface cellulose, were screened for the susceptibility
to the most common antibiotics and for the ability to act as recipients in conjugation experiments,
and biochemical tests were performed to compare the metabolic profile.
2. Results
2.1. Counting and Isolation of NECE
The selective differential medium HiCrome Coliform Agar (HCCA) was utilized to count and
isolate E. coli [5] and NECE from fecal samples of 20 healthy adults. Total counts in HCCA ranged
from 4.6 × 105 to 2.2 × 108 cfu/g (Figure 1). Blue colonies attributed to E. coli overcounted the pink ones
attributed to NECE in all the samples except V11 (Figure 1; Supplementary Figure S1). NECE ranged
between < 104 and 1.3 × 108 cfu/g and, except in V11, accounted for a minority of total Enterobacterales
32
Int. J. Mol. Sci. 2020, 21, 1847
(NECE + E. coli), the 75th percentile being the 5.7% (Figure 1). In some cases, NECE were not recovered,
being outnumbered by E. coli. Spearman’s rank correlation analysis excluded any significant correlation
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Figure 1. Counts of Escherichia coli and non-Escherichia coli Enterobacterales (NECE), enumerated onto
HiCrome Coliform Agar (HCCA) plates. (a) Percentage of colonies attributed to E. coli (blue shades)
and NECE (pink shades) in the feces of 20 subjects. For each subject, different shades indicate
different biotypes according to enterobacterial repetitive intergenic consensus-PCR (ERIC-PCR) and
random amplification of polymorphic DNA-PCR (RAPD-PCR) fingerprinting. The total count of
Enterobacterales (E. coli +NECE) is reported in the top margin. (b) Distribution of the percentage of
NECE colonies. The median (dashed line), the 25th and 75th percentiles (colored box), the 10th and
90th percentiles (whiskers), and outliers (*) are indicated.
2.2. Taxonomic Attribution and PFGE Genotyping
The isolates putatively attributed to NECE were clustered in 32 different biotypes utilizing ERIC-PCR
(enterobacterial repetitive intergenic consensus-PCR) and RAPD-PCR (random amplification of polymorphic
DNA-PCR) fingerprinting. A representative isolate of each biotype was assigned a taxonomic designation
utilizing 16S rRNA gene sequencing and MALDI-TOF MS (Supplementary Table S1). The genus Klebsiella
was the most represented (14/32), with the species K. pneumoniae (10 strains) and Klebsiella oxytoca (4) found
in seven and three fecal samples, respectively. The genus Enterobacter was represented by eight strains
belonging to Enterobacter cloacae (6), Enterobacter aerogenes, and Enterobacter kobei (1 strain each). Other strains
belonged to Citrobacter (4 to Citrobacter freundii and 1 to Citrobacter amalonaticus), Cronobacter sp. (2), and to
Hafnia alvei, Morganella morganii, and Serratia liquefaciens (1 strain each).
PFGE highlighted a wide diversity of the NECE isolates, which did not cluster according to the
taxonomic attribution (Figure 2).
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Figure 2. XbaI-PFGE pattern of NECE strains: unweighted pair group method with arithmetic means
(UPGMA) dendrogram derived from Dice’s coefficients, calculated based on the band profile. Strains
are colored based on their MALDI-TOF MS taxonomic attribution.
2.3. Virulence Genotyping
PCR was used to investigate 17 virulence genes encoding adhesins (fimH1, mrkD, kpn, and ycfM),
siderophores (enterobactin, entB; aerobactin, iutA; yersiniabactin, irp-1, irp2, ybtS, fyuA; catechols
receptor, iroN; and other, kfu), protectines or invasins (K2, magA, rmpA, and traT), and involved in
allantoin metabolism (allS).
Most strains of K. pneumoniae harbored the mrkD, ycfM, and kpn encoding adhesins and entB
encoding enterobactin (Figure 3). Only K. pneumoniae 11.55 was positive to the main virulence genes
involved in the synthesis of Yersinia siderophore, including ybtS (encoding for the synthase), irp1 and
irp2 (for regulatory proteins), and fyuA (for the siderophore receptor). irp2 was also detected in most of
the other strains of K. pneumoniae although they lacked the counterpart ybtS. All the K. pneumoniae
strains were negative to the genes K2, magA, and rmpA associated with hypermucoid phenotype and
invasivity, except for K. pneumoniae 01.49 that was positive to K2. Similarly, other virulence genes, such
as allS, kfu, and iutA occurred only once among the tested strains.
The strains of K. oxytoca harbored entB (three out of four isolates) but were negative to most of the
other virulence genes. A sole strain harbored ytbS. Most of Cronobacter and Enterobacter isolates were
characterized by the presence of the gene irp2 but never harbored ybtS or other Yersinia siderophore
genes. A few strains were positive to mrkD or entB.
The strains ascribed to Citrobacter, H. alvei, and M. morganii were negative to those virulence genes
whose presence could not be excluded by primer-blast search. The strain of S. liquefaciens was positive
to ytbS.
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Figure 3. PCR assay of the NECE isolates for the presence of virulence genes. Colors: red, positive
amplification; green, negative amplification; grey, PCR analysis not performed since the gene was
putatively absent based on a primer-blast search.
2.4. Biofilm Formation and Production of Curli and Cellulose
NECE strains were tested for biofilm formation in minimal and rich media (M9 and LBWS,
respectively; Supplementary Figure S2). The vast majority of the strains (26 out of 32), belonging to all
the species except E. aerogenes, H. alvei, and M. morganii, formed biofilm in M9 (Figure 4; Supplementary
Figure S2). Biofilm formation was less frequent in LBWS, being observed only in 10 strains of K. oxytoca,
K. pneumoniae, and S. liquefaciens. The extent of biofilm production was always less abundant in the
rich medium compared to M9 (p < 0.05).
Extracellular cellulose was detected in most of Citrobacter and Enterobacter strains, in five strains
of K. pneumoniae and two out of four of K. oxytoca, in H. alvei and in S. liquefaciens. Curli were produced
by nearly all Citrobacter, Cronobacter, and Enterobacter strains and by one isolate belonging to K. oxytoca.
The isolates of H. alvei and M. morganii were also positive to curli. The strains belonging to Citrobacter,
E. cloacae, H. alvei, and K. oxytoca 19.49 produced both cellulose and curli.
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Figure 4. Phenotypic characterization of NECE isolates: biofilm formation in LBWS and M9 media,
curli and cellulose production, conjugation, and antibiotic resistance. Colors: red, positive; green,
negative. For antibiotics: red, resistant; green, susceptible, yellow, intermediate. Antibiotics: amikacin
(AMK), amoxicillin–clavulanic acid (AMC), cefotaxime (CTX), ceftazidime (CAZ), ciprofloxacin (CIP),
gentamicin (GEN), piperacillin-tazobactam (PZT), and trimethoprim-sulfamethoxazole (SXT).
2.5. Conjugation
The strains were challenged as conjugation recipients for receiving pOX38: Cm plasmid from E. coli
N4i. Only two strains of K. pneumoniae, and single strains of Cronobacter and Citrobacter amalonaticus
succeeded in plasmid acquisition (Figure 4).
2.6. Antibiotic Resistance
Phenotypic susceptibility to amikacin, amoxicillin–clavulanic acid, cefotaxime, ceftazidime,
ciprofloxacin, gentamicin, piperacillin-tazobactam, and trimethoprim-sulfamethoxazole was assayed.
Amoxicillin-clavulanic acid was the sole antibiotic against which few isolates presented some resistance,
with all the strains of Enterobacter, Citrobacter, Cronobacter, H. alvei, M. morganii, and S. liquefaciens being
resistant. All the 14 biotypes of Klebsiella spp. were sensitive to the whole set of tested antibiotics,
with the exception of K. pneumoniae 11.71 that was partially resistant to amoxicillin–clavulanic
acid, presenting a minimum inhibitory concentration (MIC) intermediate between resistance and
susceptibility thresholds.
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2.7. Biochemical Characterization
The fermentation of substrates and some distinctive enzymatic reactions and metabolic routes
were assayed utilizing the API 20 E system (Figure 5). Generally, the NECE strains were positive to
β-galactosidase. Most strains were capable of utilizing citrate, glucose, mannose, inositol, sorbitol,
rhamnose, sucrose, melibiose, amygdalin, and arabinose. The main exceptions were M. morganii that
could utilize only glucose, H. alvei that fermented a restricted number of sugars, and some Citrobacter,
Cronobacter, and Enterobacter strains that exhibited specific substrate preferences. The majority of the
isolates produced either lysine decarboxylase (Klebsiella) or ornithine decarboxylase (Cronobacter and
Enterobacter). Urease was characteristic of Klebsiella, while arginine dihydrolase was found in most
Enterobacter, Citrobacter, and Cronobacter. Acetoin was produced by Cronobacter, Enterobacter, Hafnia,
and Klebsiella. Indole was produced by K. oxytoca and by few other strains, H2S by two strains of
Citrobacter freundii. Only S. liquefaciens was positive to gelatinase. All the strains except M. morganii
and S. liquefaciens exhibited denitrifying activity, in most cases yielding nitrite. Nitrate reduction to N2
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Figure 5. Biochemical reaction profiles of NECE isolates in the API 20 E assay: β-galactosidase (ONPG),
arginine dihydrolase (ADH), lysine decarboxylase (LDC), ornithine decarboxylase (ODC), citrate
utilization (CIT), production of hydrogen sulfide (H2S), urease (URE), tryptophan deaminase (TDA),
indole (Kovac’s test, IND), acetoin (Voges-Proskauer test, VP), gelatinase (GEL), fermentation of glucose
(GLU), mannitol (MAN), inositol (INO), sorbitol (SOR), rhamnose (RHA), sucrose (SAC), melibiose
(MEL), amygdalin (AMY), arabinose (ARA), and reduction of nitrates to nitrites (N2O) or nitrogen (N2,
tested only in case of negative N2O). Colors: red, positive; green, negative.
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3. Discussion
Thirty-two NECE strains were isolated from the feces of 20 healthy adults that did not present any
dysbiosis, and thus as members of a relatively balanced gut microbiota. The load of Enterobacterales
was in the order of millions or tens of millions per gram of feces, with a sole exception where they
reached the magnitude of 108. NECE represented a small population of Enterobacterales, with E. coli
being on average 20 times more abundant, and a minor component of the whole microbiota, being less
than 0.1%. The genus Klebsiella, which is ubiquitous in nature, colonizing humans, animals, and plants,
and frequently detected in waters, sewages, and soils, was the most represented, encompassing 14 of
the 32 strains. K. pneumoniae, the most frequently isolated species (10 strains), was present in 7 out of
20 fecal samples, in accordance to the 35% of healthy adults from which it was isolated in a pioneering
study [22].
K. pneumoniae encompasses opportunistic pathogens that can cause human infections in lungs,
urinary tract, and bloodstreams, mostly to hospitalized and/or immunocompromised patients [23,24].
Virulence of K. pneumoniae is associated to the presence of capsule and pili, to the production of
lipopolysaccharides and siderophores, to allantoin utilization, and to iron uptake systems, efflux
pumps, and type VI secretion systems [7]. Surface molecules, such as capsular polysaccharides and
lipopolysaccharides, are some of the major virulence factors that Klebsiella use to protect itself from
the host innate immune apparatus. Furthermore, the capability to compete for iron has a pivotal role
to the establishment of the infection. The genes involved in iron assimilation are generally clustered
in pathogenicity islands, large chromosomal regions that were likely acquired by horizontal transfer.
Virulence genetic determinants can be located both in the core or in the accessory genome [7], the former
also including metabolic genes required for some species to cause disease.
Among the 10 K. pneumoniae isolates, all but one strain harbored entB, encoding a common
catecholate siderophore located in the core genome, and mrkD, involved in the synthesis of type 3 pili
that promote adherence to the surfaces [19]. The genes encoding other adhesins, such as ycfM and
kpn were detected in nine and five strains, respectively. Only two K. pneumoniae strains were positive
to the yersiniabactin gene ybtS, a common virulence factor associated with human infections [25,26],
and one of the two also harbored irp1. These genes are involved in the synthesis of the siderophore
yersiniabactin by virulent Yersinia strains, which harbor them within the high-pathogenicity island
(HPI). HPI is widely distributed among members of the order Enterobacterales, including E. coli,
K. pneumoniae, Citrobacter spp., Salmonella enterica, Serratia liquefaciens, and Enterobacter spp. [27,28].
In addition, irp2, another marker of HPI, was detected in the majority of the strains of K. pneumonia
and E. cloacae, albeit they lacked the counterpart ybtS.
Although Enterobacterales are normally present as a low fraction of commensal bacteria in
the healthy gut, their numbers can increase in the inflamed gut, and take advantage over other
commensals [29]. Siderophores are major contributors of exploitative competition, since iron is
an essential nutrient present in very low amounts in the gut and may play a role in virulence. Overall,
K. pneumoniae 11.55 was the strain equipped with the broadest set of virulence genes involved in
iron metabolism, including those encoding enterobactin (entB), yersiniabactin (irp1, irp2, and ybtS),
and, the sole strain among the 32 isolates, also the Yersinia siderophore receptor (fyuA).
In agreement with their commensal behavior, none of the K. pneumoniae strains were positive for
the two genes associated with invasive infections, i.e., the mucoviscosity-associated gene magA and the
regulator of mucoid phenotype rmpA [30,31], that are associated with a hypervirulent and hypermucoid
phenotype. In our isolates, the presence of other genetic determinants of virulence was sporadic or
quite rare. In the gut of the healthy host, the Enterobacterales resides in the outer loose mucus layer,
separated from the epithelial mono-cell barrier by an inner dense mucin coat [32]. During the infection,
they penetrate the mucus layer, interact with the epithelial cells, and may breach the mucosal barrier.
In case these enterobacteria strains reach other tissues, biofilm formation may act as a fitness factor
concurring to pathogenesis [33]. Adhesion factors and extracellular matrix components are involved in
formation of biofilms [34]. All but one strain produced biofilm in minimal medium M9, whereas this
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phenotype was less frequent when growth occurred in the rich medium LBWS. The higher extent of
biofilm formation in M9 is consistent with the fact that this mineral medium is more challenging for
these bacteria. Extracellular cellulose structures, determined in five strains, were consistent with the
capability to form biofilm on both media. Curli were found in a sole strain that presented also cellulose
structures (19.58 CA) and produced biofilm on both the substrates.
Based on genetic and functional features, some K. pneumoniae isolates present a higher potential
to cause infections, albeit they are present at low charge in the microbiota of healthy hosts. The link
between colonization and infection by K. pneumoniae in hospitalized patients has been demonstrated,
with robust evidence that their own microbiota is the main source of the infective strains [35,36].
Thus, potentially more virulent K. pneumoniae strains may take advantage of critical conditions,
becoming responsible for nosocomial infections [37].
The isolates of K. oxytoca, another prominent pathogen that may be involved in diseases and
life-threatening infections [38,39], generally encoded the siderophore gene entB, but were negative
to most of the other virulence genes. A sole strain harbored the gene encoding the yersiniabactin
siderophore. Biofilm production was a general feature of the K. oxytoca strains, regardless of the
presence of curli or cellulose structures.
Similar considerations are valid for the other NECE strains herein described, belonging to genera
that may have clinical relevance, such as Enterobacter, Citrobacter, and Cronobacter. The isolates were
generally capable of forming biofilm and producing curli and cellulose and were negative for most
virulence genes. However, unlike Klebsiella that shares many virulence genes with E. coli, the genetic
determinants of virulence of these genera have not been fully disclosed.
In this study emerged that NECE isolates from feces of healthy subjects are still quite susceptible
to most of the antibiotics. This is important, since any treatment of opportunistic outbreaks of
NECE (e.g., in case nosocomial infections) requires antibiotics, but resistance developments would
seriously curb the therapeutic options [40]. All the isolates of Klebsiella were sensitive to the whole
set of tested antibiotics. Amoxicillin-clavulanic acid was the sole antibiotic against which was
detected some resistance: the strains ascribed to the genus Enterobacter and the isolates belonging
to Citrobacter, Cronobacter, Hafnia alvei, Morganella morganii, and Serratia liquefaciens were all resistant
to this combination of antibiotics. Interestingly, Enterobacterales presented the highest increase in
terms of relative abundance in a short-term amoxicillin-clavulanic acid treatment in healthy adults [41].
Some genera belonging to this family, such as Enterobacter and Citrobacter, are recognized as intrinsically
resistant [42], and may take advantage to this antibiotic treatment. In general, the profile of resistance
was independent by the subject of the fecal sample, but two clusters encompassing sensitive or resistant
strains were sharply differentiated by taxonomy.
PFGE genotyping was carried out to evaluate the genetic similarity among the bacterial isolates
of this study and highlighted a wide dispersion of the strains, regardless their taxonomic attribution
and phylogenetic relationships. The spreading of the strains regardless of species or genera may be
attributed to the presence of plasmids, the horizontal acquisition of additional genes from diverse
species of Enterobacterales, and to the exchange of mobile elements that rapidly integrate and promote
DNA shuffling, in agreement with the capability of some strains to accept DNA by conjugation from
E. coli as a donor. However, the biochemical profiling mostly clustered the strains in species (data not
shown), confirming that energy production and conservation, and lipid, amino acid, and nucleotide
metabolism are part of the conserved reactome, despite the genome plasticity.
The Enterobacterales encountered in this study are generally recognized as opportunistic
pathogens, with some potential capability to cause disease, on the basis of predicted virulence
factors. Except for K. pneumoniae hypervirulent strains, NECE virulence seems more associated to the
host features than to the strain traits. According to the similar results obtained for the E. coli isolated
from the same cohort of healthy subjects, the absence of antibiotic resistance for most of the tested
antibiotics does not pose a serious challenge for infection control. This highlights the stratification
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of antibiotic resistance distribution among healthy and hospitalized/diseased subjects, with NECE
associated risk increasing with both illness and antibiotic therapy.
4. Materials and Methods
4.1. Isolation and Enumeration of Enterobacterales
Fresh fecal samples were collected from 20 healthy adult subjects who gave written informed
consent regarding their participation in the study in accordance with the protocol approved by the local
research ethics committee (reference number: 974/2019/SPER-UNIMO-ENTEROPOP; Comitato etico
dell’Area Vasta Emilia Nord, Italy). The subjects—10 males and 10 females aged 35 to 45, following
a western omnivore diet, and who had not been treated with prebiotics and/or probiotics for 1 month
and antibiotics for 3 months—were enrolled among the employees of the University of Modena and
Reggio Emilia and their relatives and were not in relationship with the researchers.
Feces were homogenized (10% w/v) in isotonic Buffered Peptone Water (Sigma, Steinheim,
Germany), then serial dilutions were spread onto plates of HiCrome Coliform Agar (HCCA, Sigma)
and incubated at 37 ◦C. The medium differentiates E. coli (blue colonies) from NECE (salmon to red).
For each subject, up to 48 colonies of putative NECE were picked and clustered into biotypes with
ERIC-PCR [43] and RAPD-PCR [44] fingerprint presenting Pearson’s similarity > 75%.
4.2. PFGE Genotyping
PFGE was performed according to PulseNet protocol (http://www.cdc.gov/pulsenet/PDF/ecoli-
shigella-salmonella-pfge-protocol-508c.pdf). The genomic DNA was digested with 50 U of XbaI at
37 ◦C for 3 h. Fragments were resolved in a CHEF-DRIII apparatus (Bio-Rad, Hercules, CA, USA)
using counter-clamped homogeneous electric field electrophoresis (24 h at 6.0 V/cm; initial switch
time, 2.2 s; final switch time, 54.2 s). The run was digitally captured and analyzed with GelCompare
II 6.0 software (Applied Maths NV, Sint-Martens-Latem, Belgium). Dice coefficient was computed
to evaluate similarity between band profiles (position tolerance, 1%; optimization, 1%) and to derive
an UPGMA dendrogram (unweighted pair group method with arithmetic means). Strains were
ascribed to the same pulsotype if PFGE profile possessed >85% similarity.
4.3. Taxonomic Attribution
A strain for each biotype was taxonomically characterized by partial sequencing of the 16S rRNA
gene sequencing, utilizing primers targeting the V1-V3 portion. Primer sequences and PCR conditions
were set up according to Raimondi et al. [45]. The sequences, obtained from a service provider (Eurofins
Genomics, Ebersberg, Germany), were compared to those in SILVA SSU database utilizing SINA
Aligner v1.2.11 (https://www.arb-silva.de/aligner/).
In addition, the MALDI-TOF MS-based biotyping was carried using the MALDI Biotyper 3.1
system (Bruker Daltonics, Bremen, Germany). Sample preparation for MALDI-TOF MS was performed
as previously described with minor modifications [46]. Briefly, colonies of fresh overnight culture
were placed on a MALDI sample slide (Bruker Daltonics) and dried at room temperature. The sample
was then overlaid with 1 μL of matrix solution (α-cyano-4-hydroxycinnamic acid in 50% acetonitrile
and 2.5% trifluoroacetic acid) and dried at room temperature. A MALDI-TOF MS measurement was
performed with a Bruker MicroFlex MALDI-TOF MS (Bruker Daltonics) using FlexControl software
and a Escherichia coli DH5α protein extract (Bruker Daltonics) was placed on the calibration spot of
the sample slide for external calibration. Spectra collected in the positive-ion mode within a mass
range of 2000–20,000 Da were analyzed using a Bruker Biotyper (Bruker Daltonics) automation control
and the Bruker Biotyper 3.1 software and library (a database with 5627 entries). High confidence
species identification was accepted, if the log(score) was ≥2.00, low confidence species identification
log(score) values (≥1.70 and <2.00) were accepted if the three best matches showed the same species
name. Any results with log(score)<1.70 were considered as an unacceptable identification.
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4.4. Profiling of Virulence Genes
All the isolates were screened by multiplex-PCR for the genes associated to 17 virulence factors:
allS, entB, fimH, fyuA, iroN, irp1, irp2, iutA, K2, kfu, kpn, magA, mrkD, rmpA, traT, ybtS, and ycfM.
Primer sequences and amplification conditions were set up according to El Fertas-Aissani et al. [19],
Compain et al. [20], and Johnson et al. [21]. In order to assess the possibility to obtain the amplicon
in the different NECEs species, a search with the primer-blast tool (https://www.ncbi.nlm.nih.gov/
tools/primer-blast/) was performed for all the set of primers developed for K. pneumoniae and E. coli.
The result of PCR amplification was reported only for the species in which the annealing and the
possibility to yield an amplicon were predicted.
4.5. Biofilm and Phenotype Assays
Biofilm formation was quantified with crystal violet in the microtiter assay described in [47].
Two growth media were compared: Luria Bertani without salt (LBWS) and M9 (BD Difco, Sparks, MD,
USA) containing 4 g/L glucose and 0.25 g/L yeast extract. Strains exhibiting a specific biofilm formation
(i.e., the ratio between crystal violet absorbance at 570 nm and culture turbidity at 600 nm) > 1. The data
herein reported are the means of three independent experiments, each carried out in triplicate.
The strains were screened for curli and cellulose production utilizing LBWS agar plates
supplemented with the appropriate stain [48]. Red colonies in Congo red-supplemented plates
were considered positive to curli. Colonies in calcofluor white-supplemented plates that emitted
fluorescence due to UV exposure (315–400 nm) were considered positive to cellulose.
4.6. Solid Mating Conjugation Experiments
The strains were screened as recipients in conjugation experiments with the donor E. coli N4i
pOX38:Cm (N4i: EcN immE7 Gmr; pOX38:Cm: Tra+ RepFIA+ Cmr) [5]. The donor and the recipient
strains were cultured and put in contact onto LB plates under the conditions described in [5]. HCCA
and HCCA with 20 μg/mL chloramphenicol were utilized to differentiate recipient, transconjugant,
and donor colonies [5].
4.7. Antibiotic Susceptibility
The strains were tested for antimicrobial susceptibility with a Vitek2 semi-automated system
(bioMerieux, Marcy-l’Étoile, France). Minimum inhibitory concentrations (MICs) were interpreted
according to EUCAST (European Committee on Antimicrobial Susceptibility Testing—www.eucast.org)
and susceptibility (S) or resistance (R) were defined based on the following thresholds (mg/L): amikacin,
S < 8 and R > 16; amoxicillin/clavulanic acid, S < 8 and R > 8; cefotaxime, S < 8 and R > 2; ceftazidime,
S < 8 and R > 8; ciprofloxacin, S < 0.5 and R > 1; gentamicin, S < 2 and R > 4; piperacillin + tazobactam,
S < 8 and R > 16; trimethoprim/sulfamethoxazole, S < 40 and R > 80.
4.8. Biochemical Characterization
The strains were tested for distinctive enzymatic reactions and metabolic routes utilizing API 20 E
test system (bioMerieux, France), according to the manufacturer’s instructions.
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Abbreviations
NECE non-E. coli Enterobacterales
HCCA HiCrome Coliform Agar
MALDI-TOF MS Matrix-assisted laser desorption ionization–time of flight mass spectrometry
ERIC Enterobacterial repetitive intergenic consensus
RAPD Random Amplification of Polymorphic DNA
UPGMA Unweighted pair group method with arithmetic means
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Amaretti, A.; Rossi, M. Antibiotic resistance, virulence factors, phenotyping, and genotyping of E. coli isolated
from the feces of healthy subjects. Microorganisms 2019, 7, 251. [CrossRef]
6. Sarowska, J.; Futoma-Koloch, B.; Jama-Kmiecik, A.; Frej-Madrzak, M.; Ksiazczyk, M.; Bugla-Ploskonska, G.;
Choroszy-Krol, I. Virulence factors, prevalence and potential transmission of extraintestinal pathogenic
Escherichia coli isolated from different sources: Recent reports. Gut Pathog. 2019, 11, 10. [CrossRef]
7. Martin, R.M.; Bachman, M.A. Colonization, Infection, and the accessory genome of Klebsiella pneumoniae.
Front. Cell. Infect. Microbiol. 2018, 8, 4. [CrossRef]
8. Davin-Regli, A.; Pagès, J.M. Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens
confronting antibiotic treatment. Front. Microbiol. 2015, 6, 392. [CrossRef]
9. Liu, L.; Chen, D.; Liu, L.; Lan, R.; Hao, S.; Jin, W.; Sun, H.; Wang, Y.; Liang, Y.; Xu, J. Genetic diversity,
multidrug resistance, and virulence of Citrobacter freundii from diarrheal patients and healthy individuals.
Front. Cell. Infect. Microbiol. 2018, 8, 233. [CrossRef]
10. Gajdács, M.; Urbán, E. Resistance Trends and epidemiology of citrobacter-enterobacter-serratia in urinary
tract infections of inpatients and outpatients (RECESUTI): A 10-year survey. Medicina (Kaunas) 2019, 55, 285.
[CrossRef]
11. Lee, C.R.; Lee, J.H.; Park, K.S.; Jeon, J.H.; Kim, Y.B.; Cha, C.J.; Jeong, B.C.; Lee, S.H. Antimicrobial resistance of
hypervirulent Klebsiella pneumoniae: Epidemiology, hypervirulence-associated determinants, and resistance
mechanisms. Front. Cell. Infect. Microbiol. 2017, 7, 483. [CrossRef] [PubMed]
12. Azevedo, P.A.A.; Furlan, J.P.R.; Oliveira-Silva, M.; Nakamura-Silva, R.; Gomes, C.N.; Costa, K.R.C.; Stehling, E.G.;
Pitondo-Silva, A. Detection of virulence and β-lactamase encoding genes in Enterobacter aerogenes and
Enterobacter cloacae clinical isolates from Brazil. Braz. J. Microbiol. 2018, 49 (Suppl. 1), 224–228. [CrossRef]
[PubMed]
13. Mokracka, J.; Koczura, R.; Kaznowski, A. Yersiniabactin and other siderophores produced by clinical isolates
of Enterobacter spp. and Citrobacter spp. FEMS Immunol. Med. Microbiol. 2004, 40, 51–55. [CrossRef]
14. Yuan, C.; Yin, Z.; Wang, J.; Qian, C.; Wei, Y.; Zhang, S.; Jiang, L.; Liu, B. Comparative genomic analysis of
Citrobacter and key genes essential for the pathogenicity of Citrobacter koseri. Front. Microbiol. 2019, 10, 2774.
[CrossRef]
15. Cruz, A.; Xicohtencatl-Cortes, J.; González-Pedrajo, B.; Bobadilla, M.; Eslava, C.; Rosas, I. Virulence traits in
Cronobacter species isolated from different sources. Can. J. Microbiol. 2011, 57, 735–744. [CrossRef]
16. Zogaj, X.; Bokranz, W.; Nimtz, M.; Römling, U. Production of cellulose and curli fimbriae by members of the
family Enterobacteriaceae isolated from the human gastrointestinal tract. Infect. Immun. 2003, 71, 4151–4158.
[CrossRef]
42
Int. J. Mol. Sci. 2020, 21, 1847
17. Tursi, S.A.; Tükel, Ç. Curli-containing enteric biofilms inside and out: Matrix composition, immune
recognition, and disease implications. Microbiol. Mol. Biol. Rev. 2018, 82. [CrossRef]
18. Partridge, S.R. Resistance mechanisms in Enterobacteriaceae. Pathology 2015, 47, 276–284. [CrossRef]
19. El Fertas-Aissani, R.; Messai, Y.; Alouache, S.; Bakour, R. Virulence profiles and antibiotic susceptibility
patterns of Klebsiella pneumoniae strains isolated from different clinical specimens. Pathol. Biol. (Paris) 2013,
61, 209–216. [CrossRef]
20. Compain, F.; Babosan, A.; Brisse, S.; Genel, N.; Audo, J.; Ailloud, F.; Kassis-Chikhani, N.; Arlet, G.; Decré, D.
Multiplex PCR for detection of seven virulence factors and K1/K2 capsular serotypes of Klebsiella pneumoniae.
J. Clin. Microbiol. 2014, 52, 4377–4380. [CrossRef]
21. Johnson, J.R.; Porter, S.; Johnston, B.; Kuskowski, M.A.; Spurbeck, R.R.; Mobley, H.L.; Williamson, D.A. Host
characteristics and bacterial traits predict experimental virulence for Escherichia coli bloodstream isolates
from patients with urosepsis. Open Forum Infect. Dis. 2015, 2. [CrossRef] [PubMed]
22. Davis, T.J.; Matsen, J.M. Prevalence and characteristics of Klebsiella species: Relation to association with
a hospital environment. J. Infect. Dis. 1974, 130, 402–405. [CrossRef] [PubMed]
23. Lau, H.Y.; Huffnagle, G.B.; Moore, T.A. Host and microbiota factors that control Klebsiella pneumoniae mucosal
colonization in mice. Microbes Infect. 2008, 10, 1283–1290. [CrossRef] [PubMed]
24. Magill, S.S.; Edwards, J.R.; Bamberg, W.; Beldavs, Z.G.; Dumyati, G.; Kainer, M.A.; Lynfield, R.; Maloney, M.;
McAllister-Hollod, L.; Nadle, J.; et al. Multistate point-prevalence survey of health care-associated infections.
N. Engl. J. Med. 2014, 370, 1198–1208. [CrossRef]
25. Lan, Y.; Zhou, M.; Jian, Z.; Yan, Q.; Wang, S.; Liu, W. Prevalence of pks gene cluster and characteristics of
Klebsiella pneumoniae-induced bloodstream infections. J. Clin. Lab. Anal. 2019, 33, e22838. [CrossRef]
26. Lawlor, M.S.; O’connor, C.; Miller, V.L. Yersiniabactin is a virulence factor for Klebsiella pneumoniae during
pulmonary infection. Infect. Immun. 2007, 75, 1463–1472. [CrossRef]
27. Schubert, S.; Cuenca, S.; Fischer, D.; Heesemann, J. High-pathogenicity island of Yersinia pestis in
Enterobacteriaceae isolated from blood cultures and urine samples: Prevalence and functional expression.
J. Infect. Dis. 2000, 182, 1268–1271. [CrossRef]
28. Schubert, S.; Rakin, A.; Heesemann, J. The Yersinia high-pathogenicity island (HPI): Evolutionary and
functional aspects. Int. J. Med. Microbiol. 2004, 294, 83–94. [CrossRef]
29. Raffatellu, M. Learning from bacterial competition in the host to develop antimicrobials. Nat. Med. 2018, 24,
1097–1103. [CrossRef]
30. Fang, C.T.; Chuang, Y.P.; Shun, C.T.; Chang, S.C.; Wang, J.T. A novel virulence gene in Klebsiella pneumoniae
strains causing primary liver abscess and septic metastatic complications. J. Exp. Med. 2004, 199, 697–705.
[CrossRef]
31. Yu, W.L.; Ko, W.C.; Cheng, K.C.; Lee, H.C.; Ke, D.S.; Lee, C.C.; Fung, C.P.; Chuang, Y.C. Association between
rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan. Clin. Infect. Dis.
2006, 42, 1351–1358. [CrossRef] [PubMed]
32. Johansson, M.E.; Sjovall, H.; Hansson, G.C. The gastrointestinal mucus system in health and disease.
Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 352–361. [CrossRef] [PubMed]
33. Flores-Mireles, A.L.; Walker, J.N.; Caparon, M.; Hultgren, S.J. Urinary tract infections: Epidemiology,
mechanisms of infection and treatment options. Nat. Rev. Microbiol. 2015, 13, 269–284. [CrossRef] [PubMed]
34. Hobley, L.; Harkins, C.; MacPhee, C.E.; Stanley-Wall, N.R. Giving structure to the biofilm matrix: An overview
of individual strategies and emerging common themes. FEMS Microbiol. Rev. 2015, 39, 649–669. [CrossRef]
[PubMed]
35. Martin, R.M.; Cao, J.; Brisse, S.; Passet, V.; Wu, W.; Zhao, L.; Malani, P.N.; Rao, K.; Bachman, M.A. Molecular
epidemiology of colonizing and infecting isolates of Klebsiella pneumoniae. mSphere 2016, 1. [CrossRef]
[PubMed]
36. Gorrie, C.L.; Mirceta, M.; Wick, R.R.; Edwards, D.J.; Thomson, N.R.; Strugnell, R.A.; Pratt, N.F.; Garlick, J.S.;
Watson, K.M.; Pilcher, D.V.; et al. Gastrointestinal carriage is a major reservoir of Klebsiella pneumoniae
infection in intensive care patients. Clin. Infect. Dis. 2017, 65, 208–215. [CrossRef] [PubMed]
37. Gajdács, M.; Bátori, Z.; Ábrók, M.; Lázár, A.; Burián, K. Characterization of resistance in gram-negative
urinary isolates using existing and novel indicators of clinical relevance: A 10-year data analysis. Life (Basel)
2020, 10, 16. [CrossRef]
43
Int. J. Mol. Sci. 2020, 21, 1847
38. Carrie, C.; Walewski, V.; Levy, C.; Alexandre, C.; Baleine, J.; Charreton, C.; Coche-Monier, B.; Caeymaex, L.;
Lageix, F.; Lorrot, M.; et al. Klebsiella pneumoniae and Klebsiella oxytoca meningitis in infants. Epidemiological
and clinical features. Arch. Pediatr. 2019, 26, 12–15. [CrossRef]
39. Pötgens, S.A.; Brossel, H.; Sboarina, M.; Catry, E.; Cani, P.D.; Neyrinck, A.M.; Delzenne, N.M.; Bindels, L.B.
Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal
dysfunction. Sci. Rep. 2018, 8, 12321. [CrossRef]
40. Gajdács, M.; Ábrók, M.; Lázár, A.; Burián, K. Comparative epidemiology and resistance trends of common
urinary pathogens in a tertiary-care hospital: A 10-year surveillance study. Medicina (Kaunas) 2019, 55, 356.
[CrossRef]
41. MacPherson, C.W.; Mathieu, O.; Tremblay, J.; Champagne, J.; Nantel, A.; Girard, S.A.; Tompkins, T.A.
Gut bacterial microbiota and its resistome rapidly recover to basal state levels after short-term
amoxicillin-clavulanic acid treatment in healthy adults. Sci. Rep. 2018, 8, 11192. [CrossRef] [PubMed]
42. Leclercq, R.; Cantón, R.; Brown, D.F.; Giske, C.G.; Heisig, P.; MacGowan, A.P.; Mouton, J.W.; Nordmann, P.;
Rodloff, A.C.; Rossolini, G.M.; et al. EUCAST expert rules in antimicrobial susceptibility testing.
Clin. Microbiol. Infect. 2013, 19, 141–160. [CrossRef] [PubMed]
43. Wilson, L.A.; Sharp, P.M. Enterobacterial repetitive intergenic consensus (ERIC) sequences in Escherichia coli:
Evolution and implications for ERIC-PCR. Mol. Biol. Evol. 2006, 23, 1156–1168. [CrossRef] [PubMed]
44. Quartieri, A.; Simone, M.; Gozzoli, C.; Popovic, M.; D’Auria, G.; Amaretti, A.; Raimondi, S.; Rossi, M.
Comparison of culture-dependent and independent approaches to characterize fecal bifidobacteria and
lactobacilli. Anaerobe 2016, 38, 130–137. [CrossRef]
45. Raimondi, S.; Luciani, R.; Sirangelo, T.M.; Amaretti, A.; Leonardi, A.; Ulrici, A.; Foca, G.; D’Auria, G.;
Moya, A.; Zuliani, V.; et al. Microbiota of sliced cooked ham packaged in modified atmosphere throughout
the shelf life: Microbiota of sliced cooked ham in MAP. Int. J. Food Microbiol. 2019, 16, 200–208. [CrossRef]
46. Mencacci, A.; Monari, C.; Leli, C.; Merlini, L.; De Carolis, E.; Vella, A.; Cacioni, M.; Buzi, S.; Nardelli, E.;
Bistoni, F.; et al. Typing of nosocomial outbreaks of Acinetobacter baumannii by use of matrix-assisted laser
desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 2013, 51, 603–606. [CrossRef]
47. Sicard, J.F.; Vogeleer, P.; Le Bihan, G.; Rodriguez Olivera, Y.; Beaudry, F.; Jacques, M.; Harel, J.
N-Acetyl-glucosamine influences the biofilm formation of Escherichia coli. Gut Pathog. 2018, 22, 10–26.
[CrossRef]
48. Vogeleer, P.; Tremblay, Y.D.N.; Jubelin, G.; Jacques, M.; Harel, J. Biofilm-forming abilities of shiga toxin-producing
Escherichia coli isolates associated with human infections. Appl. Environ. Microbiol. 2015, 28, 1448–1458. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
44
 International Journal of 
Molecular Sciences
Article
Relation of the pdxB-usg-truA-dedA Operon and the
truA Gene to the Intracellular Survival of
Salmonella enterica Serovar Typhimurium
Xiaowen Yang 1,2,3, Jiawei Wang 1, Ziyan Feng 1, Xiangjian Zhang 4, Xiangguo Wang 1,* and
Qingmin Wu 2,*
1 Animal Science and Technology College, Beijing University of Agriculture, Beijing 102206, China;
yangxiaowen@icdc.cn (X.Y.); wangjiawei20190110@gmail.com (J.W.); zy.feng0215@gmail.com (Z.F.)
2 Key Laboratory of Animal Epidemiology and Zoonosis of the Ministry of Agriculture, College of Veterinary
Medicine, China Agricultural University, Beijing 100193, China
3 State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for
Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and
Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
4 Tianjin Xiqing District Animal Husbandry and Aquatic Industry Development Service Center,
Tianjin 300380, China; zhangxiangjian2019@gmail.com
* Correspondence: xiangguo731@bua.edu.cn (X.W.); wuqm@cau.edu.cn (Q.W.);
Tel./Fax: +86-10-8079-3721 (X.W.); +86-10-6273-3901 (Q.W.)
Received: 17 December 2018; Accepted: 15 January 2019; Published: 17 January 2019
Abstract: Salmonella is the genus of Gram-negative, facultative intracellular pathogens that have
the ability to infect large numbers of animal or human hosts. The S. enterica usg gene is associated
with intracellular survival based on ortholog screening and identification. In this study, the λ-Red
recombination system was used to construct gene deletion strains and to investigate whether the
identified operon was related to intracellular survival. The pdxB-usg-truA-dedA operon enhanced the
intracellular survival of S. enterica by resisting the oxidative environment and the usg and truA gene
expression was induced by H2O2. Moreover, the genes in this operon (except for dedA) contributed to
virulence in mice. These findings indicate that the pdxB-usg-truA-dedA operon functions in resistance
to oxidative environments during intracellular survival and is required for in vivo S. enterica virulence.
This study provides insight toward a better understand of the characteristics of intracellular pathogens
and explores the gene modules involved in their intracellular survival.
Keywords: usg; truA; Salmonella enterica serovar Typhimurium; oxidative stress; intracellular survival
1. Introduction
Salmonella is a genus of Gram-negative and facultative intracellular pathogens that consists of
a large group of genetically similar organisms with the ability to infect many animal and human
hosts [1]. In 2005, the Salmonella genus was divided into S. bongori and S. enterica species [2]. Salmonella
spp. are the second most common causative-agents of gastrointestinal infections in humans, after
Campylobacter spp. [3]. Some Salmonella serovars cause large outbreaks of gastroenteritis associated
with contaminated meat and produced or processed food [4].
A previous study found that the S. enterica usg gene was associated with intracellular survival
based on ortholog screening and identification [5]. Because the complemented STΔusg/p-usg and
wild type strains showed significant variation in the infection assay, our lab suggested that the usg
gene was located in an operon with other genes. Operon prediction for the S. enterica strain LT2 whole
genome sequence [6] found that the pdxB, usg, truA and dedA genes were located in the same operon.
The promoter of this operon was located upstream of the pdxB gene (http://www.softberry.com/berry.
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phtml?topic=bprom&group=programs&subgroup=gfindb; accessed on 2 May 2018). Based on the
genome annotation, the pdxB gene encodes 4-phosphoerythronate dehydrogenase, which is associated
with de novo vitamin B6 biosynthesis [7]; the usg gene encodes putative aspartate-semialdehyde
dehydrogenase, truA encodes RNA pseudouridine (38–40) synthase, and the dedA gene encodes a
hypothetical protein.
In this study, the λ-Red recombination system was used to construct gene deletion strains and
investigate whether the identified operon was related to intracellular survival. Furthermore, this study
investigated the possible functions of the genes in the operon and assessed their roles in the virulence
of S. enterica.
2. Results
2.1. The pdxB-usg-truA-dedA Operon Is Required for Intracellular Survival of S. enterica
The predicted operon showed that the pdxB, usg, truA and dedA genes were transcribed in the
same direction, indicating that these genes may have co-transcription. The primers were used to
amplify the cDNA of the upstream and downstream genes and the intergenic regions, and the DNA
and RNA were used as controls. The results revealed that the genes in the operon were co-transcribed.
The above results indicate that the operon contains four genes: pdxB, usg, truA and dedA (Figure 1).
The expression of each gene, using RT-PCR, showed that the genes in the operon had no effect on other
genes in the lysogeny broth (LB) medium.
Figure 1. Analysis of co-transcription detection in the operon. Note: “+” means there was a fragment,
“−” means there was no fragment. Lane 1 was a DNA marker, lanes 2, 5 and 8 were amplified using
genome DNA; lanes 3, 6 and 9 were amplified using total RNA; lanes 4, 7 and 10 were amplified
using cDNA.
The pdxB, usg, truA and dedA genes were located in the same operon and deletion strains for these
genes were constructed using the λ-Red recombination system. The intracellular survival of the gene
deletion strains was assessed using J774A.1 macrophage cells (Figure 2). At 12 and 24 h post-infection,
the cells infected with the STΔpdxB, STΔusg and STΔtruA strains showed lower bacterial loads than
the cells infected with the ST and STΔdedA strains (p < 0.01) (Figure 2A,B). The STΔpdxB, STΔusg
and STΔtruA strains had reduced replication abilities inside the J774A.1 macrophages and, therefore,
exhibited reduced virulence in vitro. However, the STΔdedA strain did not show reduced replication.
Subsequently, the complemented gene plasmids were electroporated into all of the gene deletion
mutants. As shown in Figure 2C,D, the STΔpdxB strains electroporated with the recombinant plasmids
p-pdxB and p-usg showed significant differences in bacterial loads (p < 0.001), whereas the STΔpdxB
strains electroporated with the recombinant plasmid p-truA had almost the same bacterial loads in the
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macrophages. Similar results were found for the other complemented strains. These results indicated
that the truA gene played a key role related to intracellular survival in this operon.
Figure 2. Intracellular survival of the operon gene deletion mutants and complemented strains in
macrophages. (A) The infection process in J774A.1 macrophages by the strains was observed under a
microscope at 12 h post-infection (40×). “Light” indicates that the cells were observed under natural
light, and “Green” indicates that the cells were under a fluorescence microscope. (B) Bacterial loads of
the gene deletion strains at 12 and 24 h post inoculation. (C,D) Bacterial loads of the complemented
strains with different plasmids at 12 and 24 h post-inoculation. ** p < 0.01, *** p < 0.001.
In summary, these results showed that all genes in this operon, except for the dedA gene, confirmed
that S. enterica has the ability to survive in macrophages and that the truA gene played a key role in
this function.
2.2. The pdxB-usg-truA-dedA Operon Contributes to Virulence in Mice
Ten mice were intraperitoneally inoculated with a dose of 105 Colony-Forming Units (CFU) of the
STΔpdxB, STΔusg, STΔtruA, STΔdedA and wild type strains. The animals did not survive more than
seven days after intraperitoneal inoculation with the wild type strain and not more than nine days
post-inoculation with STΔdedA. The mice in the group inoculated with STΔpdxB did not survive more
than 15 days. Conversely, the survival rates of the groups inoculated with STΔusg and STΔtruA were
both 80% at 24 days post-inoculation (Figure 3A).
Five infected mice from each group were randomly selected at 6, 12, and 18 days post-inoculation.
Their spleens were removed to assess the bacterial loads (Figure 3B). At six days post-inoculation,
the bacterial loads were significantly lower for the gene deletion strains than for the wild type strain
and a large reduction (above 2-log) in the spleen bacterial load was observed in the mice inoculated
with STΔusg and STΔtruA compared to the mice infected with the wild type strains. At 12 days
post-inoculation, the spleen bacterial load increased in the mice inoculated with STΔpdxB, which
was similar to the load measured in the mice inoculated with the wild type strain at six days. The
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bacterial loads of the mice inoculated with STΔusg and STΔtruA reduced slowly (Figure 3B). The
results showed that usg and truA contributed to virulence in mice, which was consistent with the cell
infection assay results.
Figure 3. Survival of the gene deletion mutant and wild type strains in mice. (A) Survival curves
of the gene deletion and wild type strains. (B) Bacterial loads of the spleens at six, 12, and 18 days
post-inoculation with the gene deletion and wild type strains. *** p < 0.001.
2.3. The usg and truA Expression Levels Were Higher in the Oxidative Environment
The expression levels of genes in the operon were evaluated in the gene deletion and wild
type strains in the routine growth medium and under oxidative conditions (Figure 4). As shown in
Figure 3A, pdxB, usg, truA and dedA expression was induced in the wild type strain by H2O2 and was
significantly higher in the samples treated with H2O2 than in the untreated controls (Figure 4A).
Figure 4. Gene expression levels in the bacterial strains. (A) Gene expression levels in the wild type
strain under oxidative conditions. (B) Gene expression levels in wild type and gene deletion strains
under oxidative conditions. *** p < 0.001.
Under oxidative conditions, the usg, truA and dedA genes were barely expressed when pdxB
was deleted compared with the expression levels in the wild type strain. The pdxB gene expression
levels were similar in the usg, truA and dedA gene deletion strains. When dedA was deleted, the
expression levels of the other genes were not significantly different from the expression levels in the
wild type strain. When usg was deleted, truA expression was induced by oxidative conditions and
truA expression was significantly higher in these strains compared with the wild type strain. Usg
expression also significantly increased when truA was deleted (Figure 4B).
2.4. The pdxB-usg-truA-dedA Operon Contributed to Resistance to Oxidative Conditions
The growth characteristics of the gene deletion and parent strains were determined in an LB
medium. No significant variations were observed between the gene deletion and wild type strains
(Figure 5A). These results suggested that the genes in the operon did not affect the in vitro growth of
Salmonella spp. at normal temperatures. Under oxidative conditions, all of the strains grew slowly for
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the first 2 h. After 6 h, the growth of the wild type and STΔdedA strains reached the plateau phase
(Figure 3B). At this time, the STΔpdxB strain was in the logarithmic phase, and the STΔusg and STΔtruA
strains had barely replicated. At 10 h post-infection, the STΔusg and STΔtruA strains began to replicate,















Figure 5. Growth characteristics of the gene deletion and complemented strains in the lysogeny
broth (LB) medium and under oxidative conditions. (A) Growth characteristics of the gene deletion
strains in the LB medium. (B) Growth characteristics of the gene deletion strains under oxidative
conditions. (C) Growth characteristics of the strains complemented with the p-truA plasmid in the
LB medium. (D) Growth characteristics of the strains complemented with p-truA plasmid under
oxidative conditions.
The growth characteristics and oxidative resistance were also assessed for the STΔpdxB/p-truA,
STΔusg/p-truA and STΔtruA/p-truA strains, which were complemented strains with the same
recombinant p-truA plasmid (Figure 3C,D). These strains had characteristics similar to the wild
type, even under oxidative conditions. All of the results suggested that the operon (except for the
dedA gene) contributed to a resistance to oxidative conditions promoted the survival of S. enterica
in macrophages.
3. Discussion
S. enterica is a common facultative intracellular pathogen. The main pathway used by
macrophages to eliminate invading pathogens are endocytosis and digestion. S. enterica can exploit
multiple aspects of host defenses to promote its replication in the host after adaptation to a variety
of harsh environments, such as oxidative conditions [8]. A previous study found that the usg gene
was related to intracellular survival and that the pdxB, usg, truA and dedA genes were located in
the same operon. Another study found that pdxB was related to intracellular survival in S. enterica.
This study found that a pdxB mutant strain was sensitive to oxidative conditions and reduced the
bacterial load in macrophages. Another study found that pdxB in E. coli and Pseudomonas aeruginosa
contained tightly bound NAD+ and/or NADH [7,9,10] and that the nucleotide-binding domains
of pdxB were homologous to the corresponding domains of D-3-phosphoglycerate dehydrogenase
(PGDHs) from E. coli and Mycobacterium tuberculosis [7]. Because orthologs usually have conserved
biological structures and functions [11,12], the results of this study suggest that pdxB in S. enterica has
the same function. The usg and truA genes had similar results in the cell assay, similar expression levels
under oxidative conditions, and inhibited TNF-α and IL-1β expression in macrophages. One study
used random insertions of TnphoA-132 and found that truA was one target of glyoxal [13]. Another
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study showed that truA was associated with resistance to quinoxaline 1, 4-dioxides (QdNOs) in E. coli,
which have been used in animals as antimicrobial agents and growth promoters for decades [14]. The
results showed that usg and truA were related to intracellular survival. Although the dedA gene was in
the same operon as the other genes, no effect on intracellular survival was observed for this gene.
There were many genes related to intracellular survival via oxidative resistance. The sodA gene
deletion strain resulted in a slightly reduced growth rate, low SOD activity, increased susceptibility to
reactive oxygen species and chicken serum, and no effect on the motility of the wild type strain [15].
One study found that three catalases (KatE, KatG, and KatN) and two alkyl hydroperoxide reductases
(AhpC and TsaA) were related to oxidative resistance using silico genome analysis and gene deletion
methods [16]. Large-scale profiling of Salmonella protein expression was performed under H2O2
treatment. The results showed that the abundance of 116 proteins were altered significantly among
1600 quantified proteins and that iron acquisition systems were induced to promote bacterial survival
under oxidative stress [17]. Macrophages play important roles in the phagocytosis of pathogens
and antigen presentation. Macrophages are immediately activated after phagocytosing pathogens,
resulting in a variety of bactericidal mechanisms. These mechanisms include both oxidative and
non-oxidative bactericidal mechanisms [8,18]. These poor survival environments lead Salmonella
spp. to secrete effectors and generate a replicative compartment known as the Salmonella-containing
vacuole (SCV). This study showed that genes in this operon (except for the dedA gene) conferred
S. enterica with the ability to survive in macrophages and that the truA gene played a key role. The usg
and truA expression levels were increased under oxidative treatment. All of these results suggested
that this operon enhanced the intracellular survival of S. enterica by increasing resistance to oxidative
environments and that truA played a key role in this function.
Operons are polycistronic clusters of genes transcribed from a promoter at the 5′ end of the
cluster [19]. Several operons reportedly related to virulence have been identified in S. enterica [20–24].
Typically, genes in the same operon have similar functions and interact with each other. The amino
acid sequences pdxB, usg, truA and dedA were uploaded to the STRING database [25] to predict
protein–protein interactions. Usg and truA had the highest combined association score (0.935).
Co-expression of usg and truA orthologs was also found in Acinetobacter sp. ADP1 and Pseudomonas
aeruginosa. The combined association score of dedA was lower than the association scores for the other
genes and no co-expression of dedA orthologs had been found to date. The results of our study are
similar to our predictions.
4. Materials and Methods
4.1. Ethics Statement
All animal research was approved by the Beijing Association for Science and Technology. The
approval ID is SYXK (Beijing) 2015–0028 (Validity period: 22 September 2015 to 22 September 2020),
and the animal research complied with the Beijing Laboratory Animal Welfare and Ethics guidelines
of the Beijing Administration Committee of Laboratory Animals.
4.2. Bacterial Strains and Media
All of the bacterial strains and plasmids used in this study are listed in Table 1. The S. typhimurium
and E. coli strains, including the parental strain and the derived mutants, were routinely grown or
incubated in an LB medium. Antibiotics were added at the following concentrations when required:
ampicillin, 100 mg/L and chloramphenicol, 34 mg/L. All bacterial strains were frozen at −80 ◦C with
15–20% (v/v) glycerol.
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Table 1. Strains and plasmids used in this study.
Strains or Plasmids Description/Purpose Source or Reference
Strains
S. typhimurium ATCC14028 (ST) Wild type (WT) Guangdong Culture Collection Center
STΔpdxB ΔpdxB mutant of ST by the λ-Red recombination system This study
STΔusg Δusg mutant of ST by the λ-Red recombination system Our lab
STΔtruA ΔtruA mutant of ST by the λ-Red recombination system This study
STΔdedA ΔdedA mutant of ST by the λ-Red recombination system This study
STΔpdxB/p-pdxB STΔpdxB harboring the pBR322-pdxB plasmid, complement strains This study
STΔpdxB/p-usg STΔpdxB harboring the pBR322-usg plasmid, complement strains This study
STΔpdxB/p-truA STΔpdxB harboring the pBR322-truA plasmid, complement strains This study
STΔusg/p-pdxB STΔusg harboring the pBR322-pdxB plasmid, complement strains This study
STΔusg/p-usg STΔusg harboring the pBR322-usg plasmid, complement strains Our lab
STΔusg/p-truA STΔusg harboring the pBR322-truA plasmid, complement strains This study
STΔtruA/p-pdxB STΔtruA harboring the pBR322-pdxB plasmid, complement strains This study
STΔtruA/p-usg STΔtruA harboring the pBR322-usg plasmid, complement strains This study
STΔtruA/p-truA STΔtruA harboring the pBR322-truA plasmid, complement strains This study
DH5α For cloning Takara
Plasmids
pKD3, pKD46 and pCP20 λ-Red recombination system Datsenko and Wanner, 2000 [26]
pBR322 For constructed complement strains Virulent laboratory
p-pdxB pdxB of ST product cloned into pBR322 for complementation assay This study
p-usg usg of ST product cloned into pBR322 for complementation assay Our lab
p-truA truA of ST product cloned into pBR322 for complementation assay This study
4.3. Mice
BALB/c mice (aged 4 to 6 weeks) were purchased from the Weitong Lihua Laboratory Animal
Services Center (Beijing, China), and bred in individually ventilated cage rack systems. All
experiments involving animals followed the regulations of the Beijing Administration Office for
Laboratory Animals.
4.4. Construction of Gene Deletion and Complemented Gene Deletion Mutant Strains
Deletion mutants and their complemented mutants were constructed for all genes in the
operon. Gene deletion mutants were constructed using the λ-Red recombination system. After
sequencing confirmation, the recombinant plasmids with the coding regions and their promoters
were subsequently electroporated into every gene deletion mutant to complement the gene function.
The complemented strains were selected from an LB medium containing ampicillin. The primers are
shown in Table S1. The gene deletion and complemented gene deletion mutants were confirmed by
PCR amplification and sequencing.
Total RNA was extracted from all strains using TRIzol (Invitrogen, Inc., Carlsbad, CA, USA)
according to the manufacturer’s instructions and treated with DNase (TaKaRa Bio, Inc., Dalian,
China) before reverse transcription to remove DNA contamination. Total RNA was dissolved in
diethypyrocarbonate (DEPC)-treated water, and the concentration and purity of the total RNA were
estimated by reading the absorbance at 260 and 280 nm, respectively. cDNA was synthesized using
the Prime ScriptTM RT Reagent Kit (TaKaRa Bio, Inc., Dalian, China), according to the manufacturer’s
instructions. The reverse transcription product was stored at −20 ◦C. PCR was performed with the
primers shown in Table S1 to evaluate gene expression.
To determine if the genes in the operon were co-transcribed, the intergenic regions of genes were
amplified by RT-PCR [27]. The RNA of the parental strain was extracted and cDNA was synthesized by
reverse transcription using the method descibed before. The gene spacers were amplified using primers
(Table S1) while the wild strain genomic DNA and RNA were used as controls. The amplification
system and conditions were the same as before.
4.5. Cell Infection Assay
To investigate the intracellular survival of the strains, infection assays were performed using
J774A.1 murine macrophages (Key Laboratory of Animal Epidemiology and Zoonosis of the Ministry
of Agriculture, Beijing, China). The cells were cultured in 24-well plates and infected with each strain
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at a multiplicity of infection (MOI) of 10 CFU. Then, the infected plates were centrifuged at 1000 rpm
for 5 min at room temperature and incubated at 37 ◦C in an atmosphere containing 5% (v/v) CO2.
After 20 min, the cells were washed three times with phosphate buffered solution (PBS) and incubated
in a medium containing gentamycin (50 μg/mL) at 37 ◦C under 5% CO2 until the end of the infection
period. At 12 and 24 h post infection (p.i.), the cells were washed and lysed, and the numbers of
bacteria exhibiting intracellular survival were determined through serial dilution and plating on an
LB medium.
The pBR322 plasmid encoding the green fluorescent protein (GFP) was transferred into the parent
and gene deletion strains using the electroporation method. Recombinant clones were selected from
the LB medium containing ampicillin. Then, infection assays were performed as described above.
After 12 h of incubation, the macrophages were washed three times with PBS. Infection of the J774A.1
macrophages by the strains was observed under a fluorescence microscope (Olympus, Tokyo, Japan).
4.6. Growth Characteristics and Oxidative Resistance Assay
The in vitro growth analysis of the deletion mutants and complemented strains was described
previously. An oxidative resistance assay was performed as follows. One colony of each strain was
inoculated into 3 mL of LB or LB with ampicillin medium and cultured overnight at 37 ◦C with shaking
at 200 rpm. Subsequently the cultures were adjusted to the same concentration (OD600 ≈ 1.0) and a
50 μL sample of each strain was inoculated into 5 mL of an LB or LB with ampicillin medium. Then,
30% H2O2 was add to the liquid medium (final concentration 4.4 mM) [28] to provide an oxidative
environment. The cultures were incubated at 37 ◦C with shaking at 200 rpm, and the OD600 value was
determined every 2 h using a BioTek microplate reader (Gene Company Limited, Hong Kong, China).
4.7. Gene Expression Levels in an Oxidative Environment
The gene expression levels under oxidative treatment were assessed by real-time PCR (RT-PCR).
One colony of the gene deletion and parent strain was inoculated into 3 mL of LB medium and cultured
overnight at 37 ◦C with shaking. The cultures were adjusted to the same concentration (OD600 ≈ 1.0).
A 50 μL sample of each strain was inoculated into 5 mL of LB medium and LB medium with H2O2.
Total RNA was extracted from all strains, and cDNAs were obtained as described above. The cDNA
samples were subjected to quantitative RT-PCR using the SYBR® Premix Ex TaqTM II Kit (TaKaRa Bio,
Inc., Dalian, China). Each PCR reaction consisted of 2 μL of cDNA, 0.8 μL of each primer (10 μM), 10 μL
of SYBR®Premix Ex TaqTM II, and 20 μL RNase-free water. The cycling conditions were a denaturation
step, at 95 ◦C for 10 min, followed by 40 cycles of 95 ◦C for 10 s and 60 ◦C for 20 s. The specificity of
the RT-PCR products was confirmed using a melting curve analysis. These reactions were repeated in
triplicate for every sample as technical replicates. Gene mRNA quantification was performed using
the 2−ΔΔCt method to analyze the expression levels. The 16S rRNA expression level in S. enterica was
used as a reference to normalize all values. The results presented in this study represent the averages
from at least three separate experiments.
4.8. Virulence in BALB/c Mice
There were two experiments. The first experiment concerned the survival of the mice. Ten mice
were intraperitoneally inoculated with a dose of 105 CFU of the gene deletion and wild type strains in
100 μL of phosphate-buffered saline (PBS) [29]; the control group included five mice intraperitoneally
inoculated with 100 μL of PBS. The survival of the mice was observed over the next 24 days. The
second experiment was the virulence of the gene deletion strains. Based on survival time, five mice
were intraperitoneally inoculated with the same dose of the gene deletion and wild type strains. Five
infected mice from each group were randomly selected at 6, 12, and 18 days post-inoculation. At each
time point, the spleens were removed and homogenized individually in an aseptic manner in 1 mL of
PBS and then serially diluted to isolate the bacteria. The results are presented as the mean number of
CFU per spleen± the standard deviation (SD) in each group.
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4.9. Statistical Analysis
The statistical analyses of the data, including the data from the growth curve analysis, cell
infection study, oxidative resistance assay and virulence experiments, were performed using IBM
SPSS Statistics version 23 (IBM, Armonk, New York, NY, USA, https://www.ibm.com/analytics/data-
science/predictive-analytics/spss-statistical-software). A p value < 0.05 obtained through one-way
analysis of variance (ANOVA) was considered significant. All graphics were drawn with GraphPad
Prism 5 (GraphPad Software, La jolla, CA, USA, https://www.graphpad.com/).
5. Conclusions
In conclusion, this study used the λ-Red recombination system to construct gene deletion strains
and determine whether the identified operon was related to intracellular survival. Except for the dedA
gene, all of the genes in this operon confirmed the ability of S. enterica to survive in macrophages, and
the truA gene played a key role in resistance to oxidative conditions. Moreover, the genes in this operon
(except for dedA) contributed to virulence in mice. These findings indicate that the pdxB-usg-truA-dedA
operon functions in resistance to oxidative environments and contributes to intracellular survival;
moreover, the operon is required for the virulence of S. enterica in vivo. In this study, clues were
examined to gain a better understanding of the characteristics of intracellular pathogens and to explore
the gene modules involved in the intracellular survival of intracellular pathogens.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/2/
380/s1.
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Abstract: Aeromonas hydrophila is an important aquatic microorganism that can cause fish hemorrhagic
septicemia. In this study, we identified a novel LysR family transcriptional regulator (LahS) in the
A. hydrophila Chinese epidemic strain NJ-35 from a library of 947 mutant strains. The deletion of
lahS caused bacteria to exhibit significantly decreased hemolytic activity, motility, biofilm formation,
protease production, and anti-bacterial competition ability when compared to the wild-type strain.
In addition, the determination of the fifty percent lethal dose (LD50) in zebrafish demonstrated that
the lahS deletion mutant (ΔlahS) was highly attenuated in virulence, with an approximately 200-fold
increase in LD50 observed as compared with that of the wild-type strain. However, the ΔlahS strain
exhibited significantly increased antioxidant activity (six-fold). Label-free quantitative proteome
analysis resulted in the identification of 34 differentially expressed proteins in the ΔlahS strain.
The differentially expressed proteins were involved in flagellum assembly, metabolism, redox
reactions, and cell density induction. The data indicated that LahS might act as a global regulator to
directly or indirectly regulate various biological processes in A. hydrophila NJ-35, contributing to a
greater understanding the pathogenic mechanisms of A. hydrophila.
Keywords: Aeromonas hydrophila; LysR-family; ΔlahS; global regulator; virulence
1. Introduction
Aeromonas hydrophila is a gram-negative bacterium that is widely distributed in various aquatic
environments, such as rivers, lakes, and swamps. In addition, A. hydrophila has a diverse host range,
which includes fish, birds, amphibians, reptiles, and mammals [1]. Motile aeromonas septicemia
(MAS) caused by this bacterium has caused serious damage to the aquaculture industry. In recent
years, this bacterium has also been confirmed as an important pathogen of various human diseases,
including diarrhea, sepsis, necrotizing fasciitis, meningitis, and hemolytic uremic syndrome [2,3].
A. hydrophila has a variety of factors that are associated with virulence, such as exotoxins, S-layers,
extracellular enzymes and secretion systems [4]. Of these factors, hemolytic molecules may contribute
to the reddening skin and systemic hemorrhagic septicemia; symptoms that are observed in diseased
fish infected with A. hydrophila, and have been defined as one of the major virulence markers of this
bacterium [5].
The expression of virulence factors in response to changes in environmental conditions is
especially important for pathogenic bacteria, and this process is commonly governed by a complex
network of regulatory elements [6]. Histone-like nucleoid structuring protein (H-NS) has been
reported as a negative regulator of hemolytic activity by acting as a repressor of hemolysin gene
Int. J. Mol. Sci. 2018, 19, 2709; doi:10.3390/ijms19092709 www.mdpi.com/journal/ijms55
Int. J. Mol. Sci. 2018, 19, 2709
expression in Vibrio anguillarum [7]. Sigma factor RpoE controls the development of hemolytic
activity and virulence in Vibrio harveyi [8]. A transcriptional regulator of the MarR family, Eha,
is required for the bacterial infection and the transcriptional regulation of important virulence factors
in Edwardsiella tarda, including those that are associated with hemolytic activity [9]. Recently, the LysR
family of transcriptional regulators (LTTRs), which is a well-characterized group of transcriptional
regulators, has been shown to be global transcriptional regulators in a variety of bacteria [10,11].
LTTRs can regulate a diverse set of genes, such as those involved in metabolism, pilus synthesis,
biofilm formation, antioxidant activity, acid resistance, toxin production, and drug efflux [12–17].
More often than not, LTTRs indirectly affect the expression of virulence factors by regulating
virulence-related transcriptional regulators. For example, LrhA in enterohemorrhagic Escherichia coli
positively regulates the expression of LEE genes by the regulation of their master regulators PchA and
PchB [18]. The LysR family transcription factor LeuO in Vibrio cholerae regulates the transcription of the
CarRS two-component regulatory system to control almEFG expression, which contributes to cationic
antimicrobial peptide (CAMP) resistance by glycosylation of lipid A [19]. In Haemophilus parasuis,
approximately 500 differentially expressed genes were identified, resulting from the deletion of
oxyR, and these genes were involved in various biological processes [20]. Despite the importance of
LTTRs, very little information is currently available regarding their regulation of virulence factors in
A. hydrophila.
To identify the factors responsible for the hemolytic activity of A. hydrophila, in this study,
we individually screened for reduced hemolytic ability in a Tn5-derived library of mutants that
were previously generated by our group [21]. Interestingly, we identified a LysR-type transcriptional
regulator (LahS) in A. hydrophila NJ-35. Our study showed that, in addition to hemolytic activity, LahS
positively regulates a variety of virulence factors, including motility, biofilm formation, and protease
activity, and it is involved in the anti-bacterial competition ability and virulence of this bacterium. This
is the first study to evaluate the role of LahS in virulence and environmental adaptation in A. hydrophila,
the results of which are of great importance in gaining a better understanding of the pathogenesis of
this bacterium.
2. Results
2.1. Isolation of Transposon Mutants with Reduced Hemolytic Activity
Among 947 random EZ-Tn5 transposon mutants, a total of six mutants were identified as having
reduced hemolytic activity (Figure 1). The EZ-Tn5 chromosomal insertion sites of the six mutants
were analyzed by Tail-PCR, followed by BLASTn searches and sequence analyses. The data revealed
that the six hemolysis-associated genes that were identified in this study included those encoding for
PTS alpha-glucoside transporter subunit IIBC, a LysR family transcriptional regulator, an AraC family
transcriptional regulator, and three hypothetical proteins (Table 1).
Table 1. Characteristics of the hemolysis-reduced mutants screened by transposon mutant library.
Mutant Locus Tag Insertion Site/Gene Length (bp) a Function b
M80 U876_21575 2/480 hypothetical protein
M211 U876_23300 125/1587 PTS alpha-glucoside transporter subunit IIBC
M228 U876_22535 102/246 hypothetical protein
M307 U876_10550 440/909 LysR family transcriptional regulator
M402 U876_02250 330/516 hypothetical protein
M705 U876_01475 711/857 Arac family transcriptional regulator
a Insertion sites were identified using Tail-PCR and sequence analysis. b Putative functions were obtained from the
NCBI BLAST online server [22].
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Figure 1. Hemolytic activity of the mutants compared to the wild-type strain. A total of six mutants
were identified based on their hemolytic activities. * p < 0.05 or ** p < 0.01.
2.2. Effect of the LysR-type Transcriptional Regulator on A. hydrophila Hemolytic Activity
As shown in Figure 1, the M307 mutant exhibited decreased hemolytic activity. A sequence
analysis of this strain revealed that the EZ-Tn5-disrupted in this strain encodes a protein belonging
to LTTRs. This newly identified gene was designated as lahS. The open reading frame (ORF) of lahS
is 909 bp, which encodes a hypothetical 34 kDa protein consisting of 302 amino acid (aa) residues.
Secondary structure analysis showed that LahS protein has a conserved N-terminal DNA-binding
helix–turn–helix (HTH) motif, which is located at amino acids 5–64 from N terminus (Figure 2A).
In addition, there is a LysR substrate binding region that is located at amino acids 87–293, which has
the ability to affect the binding capability of this protein. The two domains are connected via a long
flexible linker helix that is involved in the oligomerization of the proteins (Figure 2B). The predicted
three-dimensional (3D) structure of LahS showed that there are two α/β regulatory domains (RD1 and
RD2) in the LysR substrate binding region, which are connected by two crossover regions (Figure 2B).
To verify whether the hemolytic phenotype of the M307 mutant was due to lahS inactivation,
we constructed lahS mutant and complemented strains via homologous recombination. Similar to the
M307 mutant, the lahS deletion mutant showed decreased hemolytic activity, and the hemolytic activity
in the complemented strain CΔlahS was restored to wild-type levels (Figure 3A). Through a BLAST
analysis, lahS homologs were identified within the genomes of several Aeromonas species, including
Aeromonas salmonicida strain A527 (89%), Aeromonas veronii strain TH0426 (83%), Aeromonas caviae strain
8LM (83%), and Aeromonas schubertii strain WL1483 (72%). Additionally, the transcription levels of
both the upstream and the downstream genes, which encode an oxidoreductase and C4-dicarboxylate
ABC transporter, respectively (Figure 3B), showed no significant differences between the ΔlahS and
wild-type strains (Supplementary Figure S1). This finding indicated that the lahS mutation had no
polar effect on the transcription of adjacent genes. Collectively, our findings indicate that LahS is a
newly identified regulator of hemolytic activity in A. hydrophila NJ-35, and homologs of this regulator
are present in a number of Aeromonas species.
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Figure 2. Structure of LahS protein. (A) Secondary structure of LysR family transcriptional regulator
(LahS) protein. The N-terminal helix–turn–helix (HTH) domain and the LysR-substrate binding region
were predicted using simple modular architecture research tool (SMART) software [23]. Rectangular
box, α-helix; arrowheaded box, β-strand. (B) Predicted three-dimensional (3D) structure of LahS
protein. The predicted maps were constructed with the SWISS-MODEL software [24]. Domains were
shown in the corresponding position with the same colour coding, as in Figure 2A.
 
Figure 3. The lahS gene was involved in hemolytic activity of A. hydrophila. (A) Hemolytic activity of
the wild-type and lahS mutant strains. A. hydrophila strains were grown overnight in Luria Bertani
broth (LB) medium at 28 ◦C, after which 100 μL of supernatants were added to 1% sheep blood for 1 h
at 37 ◦C. Hemolytic activity was expressed as the values measured at OD540. * p < 0.05. (B) Schematic
diagram of the EZ-Tn5 transposon insertion in the lahS gene. The gene cluster shows the location of the
lahS gene in the NJ-35 genome. The red rectangle shows the transposon insertion site in lahS.
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2.3. LahS Is Involved in Biofilm Formation of A. hydrophila NJ-35
CLSM analysis of the A. hydrophila NJ-35 wild-type, ΔlahS, and CΔlahS strains showed that
wild-type strain and CΔlahS exhibited abundant biofilm formation, while the biofilm formation
phenotype of the ΔlahS mutant is poor when compared to that of the wild-type strain (Figure 4A).
This is consistent with our crystal violet staining results at 24 h. The ability of ΔlahS mutant to form
biofilms was significantly decreased (by 38.8%) as compared to the wild-type strain (p < 0.01), whereas
the biofilm formation was restored to the wild-type level in the CΔlahS strain (Figure 4B). These data
indicate that the transcriptional regulator LahS may directly or indirectly regulate biofilm formation of
A. hydrophila.
Figure 4. Biofilm formation of the wild-type and lahS mutant strains. (A) CLSM images of biofilms of
the wild-type and lahS mutant strains. The viable cells exhibit green fluorescence. (B) Biofilm formation
was measured by crystal violet staining using 96-well plates and was expressed as the values measured
at OD595. The data are presented as the means ± SEM from three independent experiments. ** p < 0.01.
2.4. LahS Influences Motility in A. hydrophila NJ-35
The swimming motility of A. hydrophila was measured by examining the distance cells migrated
from the center to the periphery of the plate. As shown in Figure 5, migration diameters of 12.4 ± 0.6
and 8.4 ± 0.5 mm were measured for the wild-type and ΔlahS mutant strains, respectively, indicating
that the swimming motility of the ΔlahS mutant was significantly decreased when compared with
that of the wild-type strain. The motility phenotype was partially restored in the CΔlahS strain. This
finding indicates that LahS contributes to the motility of A. hydrophila NJ-35.
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Figure 5. Motility of the wild-type and lahS mutant strains. Swimming ability was observed after
culturing strains at 28 ◦C for 48 h on 0.3% Luria Bertani broth (LB) agar plates. The migration diameters
were measured to assess the motility. The results are presented as the means ± SEM from three
independent replicates. ** p < 0.01.
2.5. LahS Contributes to the Antibacterial Activity of A. hydrophila NJ-35
To determine whether the transcriptional regulator LahS influences the antibacterial ability of
A. hydrophila NJ-35, we carried out growth competition experiments by co-culturing A. hydrophila
strains with E. coli BL21. The A. hydrophila strains were ampicillin resistant, and the E. coli BL21 strain
contained the plasmid pET-28a (+), which confers kanamycin resistance to allow for the selection of
viable E. coli BL21 cells. As shown in Figure 6, co-culturing of E. coli BL21 with ΔlahS mutant showed
about a six-fold rise in colony-forming unit (CFU) when compared to E. coli that was co-cultured
with the wild-type strain (p < 0.05). The antibacterial capacity of the ΔlahS mutant was restored after
complementing with lahS gene.
Figure 6. Competition ability of the wild-type and lahS mutant strains. (A) The image of competition
ability is shown on Luria Bertani broth (LB) agar plate. (B) Quantification analysis of competition
ability of the wild-type and lahS mutant strains. The respective bacterial strains were cultured together
at a ratio of 1:1. The competition capability of A. hydrophila strains against E. coli BL21 was defined as
the amount of observed E. coli survival after antagonism. Data are presented as the means ± SEM of
three independent experiments. * p < 0.05.
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2.6. LahS Plays a Role in the Resistance of A. hydrophila NJ-35 to Oxidative Stress
The antioxidant abilities of A. hydrophila strains were determined by treating each strain with
H2O2. As shown in Figure 7, the ΔlahS mutant was hyposensitive to H2O2 as compared with the
wild-type strain (p < 0.001). The viable cell number of the ΔlahS mutant was six-fold higher than that
of the wild-type strain. This anti-oxidation ability was partially restored in the CΔlahS strain. This
result suggested that disruption of lahS enhanced the antioxidant capacity of A. hydrophila NJ-35.
Figure 7. Oxidative stress resistance of the wild-type and lahS mutant strains. The effect of hydrogen
peroxide on cell viability was examined to investigate the role of lahS in the resistance of A. hydrophila
to oxidative stress. The H2O2 resistance levels were expressed as the colony-forming unit (CFU) of
the viable A. hydrophila after treatment with H2O2. Data are presented as the means ± SEM of three
independent experiments. *** p < 0.001.
2.7. Deletion of lahS Reduced the Protease Activity of A. hydrophila NJ-35
The culture supernatants of A. hydrophila strains were used to test for the presence of protease
activity. The results in Figure 8 show that the ΔlahS mutant was significantly reduced for the production
of protease (0.295 ± 0.013) as compared with that observed in the wild-type strain (0.409 ± 0.025)
(p < 0.05). The protease activity was partially restored in the complemented strain CΔlahS. The result
suggested that the lahS gene was involved in the protease activity of A. hydrophila NJ-35.
Figure 8. Protease activity of the wild-type and lahS mutant strains. The protease activity was detected
using azocasein as a protease substrate and was measured at OD440. Data are presented as the means
± SEM of three independent experiments. * p < 0.05.
2.8. LahS Is Essential for the Virulence of A. hydrophila in Zebrafish
To determine whether the lahS gene affected bacterial virulence, the LD50 values of the wild type
and lahS mutant strains were compared while using zebrafish. The LD50 of A. hydrophila NJ-35 was
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8.84 × 102 CFU, and all the fish were dead within three days. However, the lahS mutant had a LD50 of
more than 105 CFU (Figure 9). Most of the dying fish showed typical clinical signs of hemorrhagic
septicemia. Colonies of A. hydrophila were recovered from all dead fish, and no evident external lesions
were observed in the surviving fish.
Figure 9. LD50 values of the wild-type and lahS mutant strains in zebrafish. The zebrafish were
intraperitoneally (i.p.) injected with 10-fold serially diluted bacterial suspensions. The control group
was i.p. injected with sterile phosphate buffered saline (PBS) only. The results are presented as the
means ± SEM from three independent replicates. ** p < 0.01.
2.9. Comparative Proteomic Analysis
When considering that LahS functions as a transcriptional regulator, we investigated the
differentially expressed profiles of the wild-type and the lahS mutant strains while using a label-free
mass spectrometry method. The comparative proteomic analysis showed that a total of 2051 proteins
matched to the Universal Protein Resource (UniProt). Thirty-four proteins were differentially expressed
(change of > 1.5-fold) between the lahS mutant and wild type strain, including 10 upregulated and
24 downregulated proteins. A complete list of the names or locus tags of the 34 proteins is shown in
Table 2.
To identify the relationship between the 34 different proteins, a hierarchical clustering method
based on Pearson’s correlation of variances was applied while using R studio. Figure 10A shows
the hierarchical clustering of the 34 identified proteins, where an increasing color intensity indicates
increasing protein expression levels. To further understand the functions of these identified proteins,
we classified 34 differential proteins by Gene Ontology (GO) categories, including cellular component
(CC), molecular function (MF), and biological process (BP) (Figure 10B). According to the analysis
of CCs, the majority of the proteins were involved in cell projection and flagellum. According to the
analysis of BPs, the primary functions were cellular detoxification and antioxygenation. According
to the analysis of MFs, the assayed proteins regulated by LahS could be classified into six categories,
as follows: heme binding, tetrapyrole binding, antioxidant activity, catalase activity, peroxidase activity,
and oxidoreductase activity. In addition, to determine the accuracy of the mass spectrometry results,
14 of these 34 genes (six of the upregulated genes and eight of the downregulated genes) were randomly
selected for further verification by qRT-PCR, the results of which showed that the quantitative PCR
results were consistent with the proteomic data (Figure 10C).
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Table 2. Differentially expressed proteins in lahS mutant compared to the wild type strain.
Locus Tag Predicted Function Fold Change
Up-regulated proteins
U876_17600 Hypothetical protein 28.34991961
U876_01465 Catalase 11.31448355
U876_16540 Peroxidase 2.09906885
U876_04415 Cytochrome C biogenesis protein CcsA 2.043010753
U876_04895 Triose-phosphate isomerase 2.939215876
U876_07195 Fructose-6-phosphate aldolase 2.67060636
U876_05460 Penicillin-sensitive transpeptidase 6.074663579
U876_13305 Transcriptional regulator 2.236916529
U876_10585 Prolyl-tRNA synthetase 2.143335753
U876_23535 Chromosome partitioning protein ParA 2.1254663
Down-regulated proteins
U876_07270 Flagellar hook protein FlgE 0.123192009
U876_16245 Flagellar hook-length control protein FliK 0.396639518
U876_07265 Flagellar hook capping protein FlgD 0.446402163
U876_14260 Flagellar hook-associated protein FliD 0.49944046
U876_14545 Phospho-2-dehydro-3-deoxyheptonate aldolase 0.021640145
U876_09970 Phospho-2-dehydro-3-deoxyheptonate aldolasee 0.067411226
U876_11610 LuxR family transcriptional regulator 0.279023788
U876_07335 Fis family transcriptional regulator 0.366104356
U876_14125 Glycine cleavage system protein T 0.014741915
U876_08310 Hypothetical protein 0.22058777
U876_14865 Cytochrome C 0.243506128
U876_17595 Hydroxylamine reductase 0.267712471
U876_13425 Thioredoxin reductase 0.280916369
U876_14870 Nitrate reductase 0.304735753
U876_22700 YeeE/YedE family protein 0.381751269
U876_14250 Hypothetical protein 0.401170621
U876_07930 Cytochrome c biogenesis protein CcmH 0.426902415
U876_15300 Hypothetical protein 0.43795805
U876_13000 Methionine gamma-lyase 0.448173659
U876_01200 Cytochrome C 0.45592439
U876_16185 RNA polymerase sigma 70 0.457438622
U876_16300 Peptidase C80 0.481165879
U876_01650 Single-stranded DNA-binding protein 0.487195726
U876_09765 Electron transporter HydN 0.494528201
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Figure 10. Label-free quantitative proteomics analysis of differentially expressed proteins between
the wild-type and lahS mutant strains. (A) Heat map of the 34 identified proteins. Up- and
down-regulated proteins are indicated in shades of green (increased) and red (decreased), respectively.
(B) Gene Ontology (GO) classification of differentially expressed proteins. The differentially expressed
proteins are grouped into three hierarchically structured terms: biological process, cellular component,
and molecular function. (C) Relative mRNA expression levels of 14 genes coding the differentially
expressed proteins in lahS mutant and wild-type strains. The results were expressed as n-fold increases
with respect to the control. Data are presented as the means ± SEM from three independent experiments.
* p < 0.05, ** p < 0.01 or *** p < 0.001.
3. Discussion
Hemolytic molecules are the major contributors to the hemorrhagic septicemia that is characteristic
of A. hydrophila infections in fish, although this bacterium uses a variety of virulence factors [5].
However, prior to this study, little was known regarding the regulation of these hemolytic factors
in this bacterium. In the present study, we identified a novel hemolysis-associated regulator (LahS)
in A. hydrophila that belongs to the LTTRs. Interestingly, we observed that the LahS participated in
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different biological activities in this pathogen, including motility, biofilm formation, environmental
adaptability, and virulence.
To investigate the global impact of the lahS deletion on protein expression in A. hydrophila NJ-35,
we performed a label-free quantification analysis between the ΔlahS and wild-type strains. From this
analysis, it was observed that LahS regulated the expression of a series of proteins that were involved
in a wide range of biological processes, including oxidative stress, transcriptional regulation, DNA
replication, and metabolism. LTTRs have been reported to regulate motility in many bacteria, but the
molecular mechanisms are different in different strains. For example, LeuO in V. cholerae O1 modulates
motility by cooperating with the nucleoid-associated protein H-NS to repress vieSAB transcription [25].
In E. coli, LrhA controls the transcription of flagellar, motility, and chemotaxis genes by regulating
the expression of the master regulator FlhDC [26]. In this study, 34 proteins were observed to
be differentially expressed in the lahS mutant as compared to the wild-type strain. Among the
downregulated proteins, four proteins are involved in flagellin formation, including FlgE, FliK, FlgD,
and FliD. In addition, the expression of ORF (U876_07335), which is 94% identical to FlrA from
A. hydrophila AH-3 by a BLASTp analysis, was downregulated in the lahS mutant. FlrABC is known as
the polar flagellum master regulator of a four-step hierarchical for the expression of flagellar genes in
A. hydrophila [27]. Therefore, we speculate that LahS may control motility by positively regulating the
expression of FlrABC.
Bacterial biofilm formation has been divided into three stages: the planktonic stage, the monolayer
stage and the biofilm stage [28]. The transition between different stages is initiated by various
environmental signals through the action of specific transcription factors. In V. cholerae, LeuO regulates
the transition from the monolayer to the biofilm stage by the modulation of exopolysaccharide VPS gene
transcription [29]. In addition to stage-specific regulatory functions, certain members of LysR family
have roles in biofilm formation through a combination of direct and indirect regulation. For example,
OxyR from H. parasuis regulates the DNA-binding transcriptional regulator FabR, which is directly
involved in biofilm formation, as well as some membrane-related genes that are indirectly related to
biofilm formation, such as an outer membrane assembly protein and an outer-membrane lipoprotein
carrier protein [20]. In the present study, no proteins that are directly related to biofilm formation
were identified among the differentially expressed proteins between the ΔlahS and wild-type strains,
but RNA polymerase sigma 70 (σ70), which has been reported to participate in the biofilm formation
process [30], was observed to be downregulated. This led to us to speculate that deletion of lahS
might downregulate the expression of the σ70 gene, which in turn, leads to a decrease in biofilm
formation. In addition, a previous study confirmed that flagellar genes were actively transcribed
during the planktonic stage, and motility and chemotaxis were important for the initiation of bacterial
biofilm formation [31]. Therefore, there is another possibility that the reduction in motility may affect
biofilm accumulation.
It is particularly noteworthy that we observed that the inactivation of lahS resulted in a significant
downregulation of a LuxR family transcriptional regulator. LuxR regulators are key players in
quorum sensing (QS), which coordinates the expression of a variety of genes, including those encoding
virulence factors, motility, and biofilm formation [32]. Our previous study showed that the LuxR-type
response regulator, AhyR, contributes to exoprotease and hemolysin production and the virulence of
A. hydrophila [33]. In the present study, LahS was observed to be involved in motility, biofilm formation,
interbacterial competition, hemolytic and proteolytic activities and virulence in zebrafish. All of
these findings led us to speculate that the diverse role exhibited by LahS in A. hydrophila virulence
might be achieved by upregulating the expression of a LuxR regulator. This speculation is further
strengthened by a recent study that was conducted by Gao et al. [34], which indicated that a LysR-type
transcriptional regulator (VqsA) is an important QS regulator in Vibrio alginolyticus and it plays essential
roles in QS-regulated phenotypes, such as type VI secretion system 2 (T6SS2)-dependent interbacterial
competition, biofilm formation, exotoxin production, and in vivo virulence. In this regard, it will be
interesting to elucidate whether a correlation between LahS and QS exists in A. hydrophila.
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Members of the LysR family have been widely reported to participate in regulating the antioxidant
capacity and environmental adaptability, of which OxyR is the most thoroughly studied [35–37]. OxyR
controls oxidative stress by acting as an activator [38] or a repressor [39] for defensive factors, such as
catalase. In this study, the inactivation of lahS resulted in a substantial increase in the expression level
of the catalases (U876_01465), which might partly explain the phenomenon that antioxidant capacity
of the lahS-deleted strain was significantly higher than that of the wild-type strain.
In conclusion, our data suggest that the hemolysis-associated regulator LahS is positively involved
in motility, biofilm formation, protease production, anti-bacterial competition ability, and virulence,
but it negatively regulates the antioxidant capacity in A. hydrophila. The comparative proteomic
analysis revealed that LahS directly or indirectly controls the expression of 34 proteins involved in
flagellar assembly, cellular metabolism, oxidative stress, and environmental adaptability. It will be
interesting to further examine the roles of LahS in virulence expression in A. hydrophila and to explore
whether interfering with its function is an effective way to defend against this bacterial infection.
4. Materials and Methods
4.1. Strains, Plasmids and Growth Conditions
The bacterial strains and plasmids that were used in this study are listed in Table 3. A. hydrophila
NJ-35, which belongs to the ST251 clonal group, was isolated from diseased cultured crucian carp
in the Jiangsu province of China in 2010 [40]. The genome sequence of A. hydrophila NJ-35 has been
published in GenBank (accession number CP006870). A. hydrophila and E. coli were cultured in Luria
Bertani broth (LB) at 28 and 37 ◦C, respectively. When necessary, chloramphenicol (Cm) (Sigma Louis,
MO, USA), kanamycin (Kan) (Sigma), or ampicillin (Amp) (Sigma) were added to the medium.
Table 3. Bacterial strains and plasmids used in this study.
Strain or Plasmid Description a Source or Reference
Strains
NJ-35 Wild-type, isolated from diseased crucian carp, in China Collected in our laboratory
SM10 E. coli strain, λpir+, Kanr [41]
BL21 E. coli strain, F−, ompT, hsdS (rB−mB−), gal, dcm (DE3) Invitrogen
ΔlahS lahS deletion mutant from NJ-35 This study
CΔlahS ΔlahS complemented with pMMB-lahS This study
Plasmid
pET 28a (+) Kanr, F1 origin Novagen
pYAK1 R6K-ori suicide vector, SacB+, Cmr [42]
pYAK1-lahS pYAK1 carrying the flanking sequence of lahS, Cmr This study
pMMB207 Low-copy-number vector, Cmr [43]
pMMB-lahS Plasmid pMMB207 carrying the complete ORF of lahS This study
a Characteristics of strains or plasmids. Kanr, kanamycin resistant; Cmr, chloramphenicol resistant.
4.2. Screening Transposon Insertion Mutants for Hemolytic Activity
A library containing 947 random EZ-Tn5 transposon mutants based on A. hydrophila NJ-35 was
previously constructed in our laboratory [21]. All the mutants were assayed for hemolytic activity,
as described previously [44], with some minor modifications. Briefly, A. hydrophila strains were grown
overnight in LB medium at 28 ◦C, diluted to an optical density of 0.2 at 600 nm (OD600), and pelleted by
centrifugation at 10,000× g for 10 min. Next, the supernatants were filter-sterilized while using 0.22-μm
(pore-size) membrane filters, and 100 μL of supernatant was double ratio diluted and dispensed into
96-well polystyrene plates. Subsequently, 100 μL of 1% sheep blood was added to each well and mixed
completely. The plates were incubated for 1 h at 37 ◦C without agitation, followed by an overnight
incubation at 4 ◦C. The plates were centrifuged at 1000× g for 10 min, after which 100-μL aliquots of
supernatants were transferred into a new 96-well polystyrene plate. The OD540 was monitored while
using a spectrophotometer (BIO-RAD, Hercules, CA, USA).
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4.3. Identification of Insertion Sites by Tail-PCR
The insertion sites of the EZ-Tn5 in the chromosome of A. hydrophila NJ-35 were identified by
Tail-PCR. The primers that were used in this study are listed in Supplementary Table S1. Six specific
primer pairs (SP1–SP6) were designed to amplify the DNA sequence from either end of the transposon.
Degenerate primers AD1 to AD6 were paired with SP1 to SP6, respectively, to amplify the flanking
sequences of the inserted EZ-Tn5. The detailed operation of the Tail-PCR was performed, as previously
described [21]. After Tail-PCR, the specific products were gel purified and sequenced. The BLASTn
program was used to compare the DNA sequence with the genome of the reference strain NJ-35 to
confirm the sequences flanking the EZ-Tn5.
4.4. Construction of a lahS Mutant and Complemented Strains
The lahS deletion mutant strain was constructed, as previously described [42]. Briefly, two
flanking regions of the target gene were amplified and ligated by PCR using two sets of primer
pairs, lahS-1/lahS-2 and lahS-3/lahS-4 (Table 4). Next, the fusion fragment was generated with the
primer pair lahS-1/lahS-4 and then was inserted into pYAK1 and transformed into E. coli SM10 [41].
The recombination vector from the donor E. coli SM10 strain was conjugated into the recipient
A. hydrophila NJ-35 strain. LB agar plates containing 100 μg/mL Amp and 34 μg/mL Cm were
used to select for isolates in which the plasmid had integrated into the chromosome via recombination.
The positive colonies were inoculated into LB broth supplemented with 20% sucrose to induce a second
crossover event, and aliquots of this culture were subsequently spread onto LB agar plates containing
20% sucrose to generate the deletion of mutants. The lahS mutant was confirmed by sequencing the
deleted region and flanking DNA in the mutated strain.








The complemented ΔlahS strain was constructed using the shuttle plasmid pMMB207 [43].
The complete lahS gene and its putative promoter and terminator regions were amplified using
the primer pair lahS-C-F/R and then ligated into the pMMB207 vector. The recombinant plasmid
pMMB207-lahS was transformed into the ΔlahS mutant strain by bacterial conjugation to generate the
complemented strain CΔlahS, which was verified by PCR.
4.5. Biofilm Formation Assay
To compare the biofilm formation ability of strains NJ-35 and ΔlahS, confocal laser scanning
microscopy (CLSM) was performed to analyze the three-dimensional architecture of biofilms as
previously described [45]. Briefly, the stationary phase bacterial cultures were adjusted to an OD600 of
1.0 and then diluted 1:1000 in LB medium. Two milliliters of these dilutions were subsequently added
into each well of 6-well plate containing pre-sterilized microscopic glass slides for biofilm growth.
After incubating at 28 ◦C for 24 h to allow for biofilm development, the glass slides were carefully
washed with phosphate buffered saline (PBS) to remove the planktonic cells. Next, 20 μL of fluorescein
diacetate (FDA, Sigma, Louis, MO, USA) was added to each glass slide, which were then protected
from light for 20 min. The slides were then observed by CLSM (Carl Zeiss LSM700, Oberkochen,
Germany) to observe the biofilms using an argon laser. Seven random spots were measured for each of
the three replicate glass slides. The image stacks were recorded under identical conditions (i.e., similar
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area and vertical resolution). Sterilized glass slides incubated with fresh LB medium were used as a
control group.
Biofilm formation was also quantitatively measured by crystal violet staining, as previously
described [46]. A. hydrophila strains were grown to an OD600 of 0.6–0.8 in LB broth at 28 ◦C and
then diluted to an OD600 of 0.1. Next, 200-μL aliquots of suspensions (1:100 dilution in fresh LB)
were dispensed into 96-well polystyrene plates, which were incubated at 28 ◦C for 24 h without
shaking. The medium was decanted, and the wells were washed three times with sterile PBS. Next,
the bacterial cells were fixed with 200 μL of methanol for 15 min, after which they were air dried at
room temperature. After drying, 200 μL of a crystal violet solution (1% w/v) was added to each well
and the cells were stained for 10 min. The wells were then rinsed with ddH2O to remove the unbound
crystal violet. The bound crystal violet was solubilized using 95% ethanol for 10 min, and the optical
density was measured at OD595. The assay was performed in three independent experiments.
4.6. Motility Assay
The swimming motility assay was performed using 0.3% agar plates, as previously described [47].
A. hydrophila strains were grown to the log phase in LB broth at 28 ◦C, and 1 μL of each culture (5 × 108
CFU/mL bacteria) was stabbed into motility assay agar plates. The plates were incubated at 28 ◦C
for 48 h, after which motility was assessed by measuring the migration diameter of the bacterial cells.
The assay was performed in three independent experiments.
4.7. Anti-Bacterial Competition Assay
The E. coli inhibition assay was performed as previously described with some modifications [48].
A. hydrophila and E. coli BL21 strains grown to an OD600 of 1.0 and then were concentrated 10 times.
Cells were mixed at a ratio of 1:1, spotted onto 0.22-μm sterile filters on LB plates, and incubated at
28 ◦C for 3 h. E. coli BL21 cells that were mixed with equal volume of LB media was used as a control.
Then, the spots were serially diluted in 1 mL LB medium, and the survival E. coli was quantified by
serial dilution in LB and visualized on LB plates containing kanamycin. The assay was performed in
three replicates.
4.8. Oxidative Stress Resistance Test
For oxidative stress tests, 4 mM H2O2 was freshly prepared before each experiment and was
filter-sterilized using 0.22-μm (pore-size) membrane filters. Log-phase cultures were normalized to
an OD600 of 0.5. Next, 400-μL aliquots were added to 100 μL H2O2 and the mixtures were incubated
at 28 ◦C for 1 h. The oxidation was terminated with 2000 U of catalase for 10 min. The number of
viable A. hydrophila was counted via serial dilution of the suspensions and plating on LB agar plates.
The assay was performed in three independent experiments.
4.9. Protease Activity
A. hydrophila strains were grown overnight in LB medium at 28 ◦C and the OD600 values were
normalized to 2.0 with fresh LB medium. Next, the cells were pelleted by centrifugation at 10,000× g
for 10 min, and the supernatants were then filter-sterilized using 0.22-μm (pore-size) membrane
filters. Subsequently, 250-μL aliquots of supernatants were added to 250 μL of 0.5% (w/v) azocasein in
50 mM Tris-HCl (pH 8.0) and then incubated at 37 ◦C for 2 h. After incubating, 500 μL of 10% (w/v)
trichloroacetic acid (TCA) was added and the mixture was incubated on ice for 30 min. The cells were
then pelleted by centrifugation at 10,000× g for 10 min, and 500 μL of the supernatants were added to
500 μL NaOH. The azodye was measured at OD440.
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4.10. Determination of LD50 in Zebrafish
The animal experiment was carried out in accordance with the animal welfare standards and
guidelines of the Animal Welfare Council of China and was approved by the Ethical Committee for
Animal Experiments of Nanjing Agricultural University, China [permit number: SYXK (SU).2017-0007].
Zebrafish were supplied by the Pearl River Fishery Research Institute, Chinese Academic of Fishery
Science. The animal-challenge experiment was performed according to a previous study [49].
Log-phase bacteria were washed three times with sterile PBS and the suspensions were serially
tenfold diluted from 5 × 102 to 5 × 107 CFU/mL. Ten zebrafish per group were intraperitoneally (i.p.)
injected with 20 μL of the suspensions in PBS. An additional 10 zebrafish were injected with 20 μL of
sterile PBS as the negative control. Mortality was recorded for seven days, and the LD50 values were
calculated by the method of Reed and Muench [50].
4.11. Comparative Proteomic Analysis
A. hydrophila strains were grown overnight in LB broth at 28 ◦C, after which the bacterial cells
were washed three times with PBS and then resuspended in lysis buffer. The bacterial suspensions
were then ruptured by sonication at 4 ◦C and centrifuged (12,000× g, 30 min, 4 ◦C) to collect the
supernatants. Next, 10% (w/v) TCA was added to the supernatants, which were incubated in ice-cold
water for 30 min. The supernatants were centrifuged at 12,000× g for 10 min and then washed three
times with ice-cold acetone. The proteins were harvested by centrifugation at 12,000× g for 10 min and
analyzed using a label free mass spectrometry method. For quantitative proteomics analysis, 200 μg
samples were digested with trypsin (1:50 w/w; Sigma Louis, MO, USA) at 37 ◦C for 24 h. Peptide
mixtures were fractionated by nano-liquid chromatography and analyzed by mass spectrometry (MS).
MS data were searched against uniprot_Aeromonas_hydrophila_27500_20170605.fasta (27,500 total
entries, downloaded 5 June 2017). The identified proteins were analyzed by GO categories, KEGG
enrichment, and clustering analyses.
4.12. Quantitative Reverse Transcription-PCR (qRT-PCR)
To validate the proteomic results, we used qRT-PCR to measure the transcription levels of
randomly selected genes. The primer pairs used in this assay are shown in Supplementary Table S2.
Total RNA was isolated using an E.Z.N.A. bacterial RNA isolation kit (Omega, Beijing, China). cDNA
synthesis was performed while using a PrimeScript RT reagent kit (TaKaRa, Dalian, China). qRT-PCR
was performed to quantify each target transcript using a QuantiTect SYBR green PCR kit (Qiagen,
Valencia, CA, USA). The constitutively expressed recA gene was chosen as a reference gene for qRT-PCR,
and the 2−ΔΔCt method was used as previously described [51].
4.13. Statistical Analysis
Statistical analyses were performed while using GraphPad Prism 6. Student’s t test was used
for examining the differences between the wild-type and mutant strains. p values of <0.05 were
considered significant.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/19/9/
2709/s1. Figure S1: Fold difference in mRNA level; Table S1: Primers used for Tail-PCR; Table S2: Primers used
for qRT-PCR.
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Abstract: The Lon protein is a protease implicated in the virulence of many pathogenic bacteria,
including some plant pathogens. However, little is known about the role of Lon in bacteria from genus
Dickeya. This group of bacteria includes important potato pathogens, with the most aggressive species,
D. solani. To determine the importance of Lon for pathogenicity and response to stress conditions of
bacteria, we constructed a D. solani Δlon strain. The mutant bacteria showed increased sensitivity
to certain stress conditions, in particular osmotic and high-temperature stresses. Furthermore,
qPCR analysis showed an increased expression of the lon gene in D. solani under these conditions.
The deletion of the lon gene resulted in decreased motility, lower activity of secreted pectinolytic
enzymes and finally delayed onset of blackleg symptoms in the potato plants. In the Δlon cells,
the altered levels of several proteins, including virulence factors and proteins associated with
virulence, were detected by means of Sequential Window Acquisition of All Theoretical Mass Spectra
(SWATH-MS) analysis. These included components of the type III secretion system and proteins
involved in bacterial motility. Our results indicate that Lon protease is important for D. solani to
withstand stressful conditions and effectively invade the potato plant.
Keywords: protease Lon; Dickeya solani; plant pathogen; virulence factors; motility; type III secretion
system; pathogenicity; resistance to stress; lon expression; pectinolytic enzymes
1. Introduction
Bacteria from the genus Dickeya, together with Pectobacterium, are classified as soft rot
Pectobacteriaceae (SRP) [1]. They cause diseases of many economically important plants leading to
significant financial losses all over the world [2,3]. Dickeya solani was first identified in 2005 and since
then it has spread in Europe reducing yields of its primary host, potato [4,5]. Dickeya solani turned out
to be a well-adapted and very successful pathogen, and due to its better adaptation in many regions, it
has displaced another common potato pathogen, Dickeya dianthicola. Briefly, D. solani can infect the
host plant with as little as 10 cells per tuber and has a broader temperature spectrum for infection
compared to other SRP species [2]. SRP causes two types of plant diseases: blackleg and soft rot
characterized by the blackening and wilting of a plant stem or tuber rot, respectively [5]. No effective
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methods to combat these pathogens have been developed so far [5]. The virulence factors that are
primarily involved in the development of the disease symptoms caused by D. solani are plant cell
wall degrading enzymes (PCWDE). This group of proteins encompasses pectinases, cellulases and
proteases, whose joint action leads to maceration of plant tissues. Pectinases and cellulases are secreted
via the type II secretion system (T2SS) and proteases are secreted via the type I secretion system (T1SS).
However, an effective infection process requires also an array of other virulence determinants. These
include the ability to actively move (motility) toward wounded tissue (chemotaxis), production of
antioxidants, siderophores, secreted effectors and, finally, cellular factors that provide survival under
unfavorable environmental conditions inside the host plant. Dickeya enters the plant via wounds or
natural openings, and then it can penetrate the apoplast. There, the type III secretion system (T3SS),
an essential virulence factor, is activated (reviewed in [6]). It consists of a pillus apparatus, so-called
injectisome, connecting bacterial and plant cell cytoplasm [7] to directly inject effector proteins into
the host. The effectors frequently manipulate host signaling pathways to disable the plant’s defense
systems to enable successful infection (reviewed in [8]).
For proper functioning of the cell, it is necessary to maintain its homeostasis, which is especially
problematic under stressful conditions. Pathogenic bacteria are frequently exposed to unfavorable
conditions, both in the host and during transmission between the hosts. In their life cycle, Dickeya may
encounter several types of stress. These include changes in temperature and pH, exposure to oxidants,
as well as osmotically active compounds [6]. All the stressors mentioned above can cause protein
damage. To maintain cellular proteostasis, a dedicated set of proteins, termed protein quality control
system (PQCS), is employed. It includes proteases and chaperones, that, among others, protect the cell
against the accumulation of harmful protein aggregates and participate in regulatory proteolysis [9,10].
Lon and ClpP are two major cytoplasmic proteases, responsible for 70–80% of the ATP-dependent
proteolysis in the cytosol [11]. Lon degrades aberrant proteins, which can arise in the cell not only as a
consequence of stress but also under physiological conditions. Additionally, native proteins with the
degradation tags (in general nonpolar amino acids exposed to the solvent) can undergo proteolysis by
the Lon protease. Lon regulates many important cellular processes through the degradation of relevant
substrates. For example, in Escherichia coli, cell division and synthesis of capsular polysaccharide
are regulated by proteolysis of the cell division inhibitor SulA and transcription regulator RcsA,
respectively [12,13]. Moreover, in various bacteria, functions of Lon can be implicated in such processes
as motility, DNA replication, sporulation and, finally, pathogenicity [14].
Lon is crucial for virulence of many animal and plant pathogenic bacteria [8,14]. The lon mutant
of Brucella abortus displayed decreased pathogenicity in BALB/c mice, however only at an early stage
of infection [15]. The more pronounced effect was observed in the case of Salmonella enterica serovar
Typhimurium lon mutants, which were highly attenuated in mice [16]. Pseudomonas aeruginosa Lon
protease is necessary for effective bacterial infection in the mouse acute lung and amoeba model [17].
Agrobacterium tumefaciens depleted of a functional lon gene was unable to induce tumors in Kalanchoe
diagremontiana [18]. The lon mutants of Pseudomonas syringae pv. phaseolicola and P. syringae pv. tomato,
in turn, showed reduced disease symptoms in bean and tomato models, respectively [19].
To determine the role of the Lon protein in D. solani, we constructed a D. solani Δlon strain using a
modified lambda red recombination protocol. This allowed us to provide an insight into the functions
played by Lon in D. solani pathogenicity and growth under stressful conditions.
2. Results
2.1. Construction of the D. solani IPO 2222 Δlon and the Complemented D. solani IPO 2222 Δlon/lon Strains
A lon deletion mutant of D. solani was constructed using the gene doctoring method, a modified
protocol for lambda red recombination dedicated to the pathogenic bacterial strains. The gene encoding
the Lon protease was substituted with the kanamycin resistance cassette, amplified from the pDOC-K
plasmid. We confirmed the deletion of lon by three independent methods: (1) detection of the lon
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sequence on the D. solani chromosome by PCR using the primers complementary to the sequences
flanking the lon gene; (2) detection of the lon transcript by real-time PCR; (3) immunodetection of the
Lon protein using the anti-E. coli Lon rabbit antibodies. As can be seen in Figure 1, the lon gene and its
product were not found in the strain D. solani IPO 2222 Δlon but were present in the WT parental strain.
Figure 1. Confirmation of successful deletion of the lon gene in D. solani IPO 2222: (A) PCR analysis of
genomic DNA isolated from the D. solani WT (wild type) and Δlon mutant. The lon gene was replaced
by a 1000 bp smaller kanamycin resistance gene. Δlon1 and Δlon2 denote two independent clones
(B) immunodetection using the anti-Lon E. coli primary antibodies. (C) The qPCR analysis with the
use of the lon gene-specific primers revealed that no cDNA amplification product was created within
50 cycles.
Single-copy complementation in the genome of the D. solani Δlon strain was obtained using
the E. coli MFD (Mu-free donor) pir conjugation strain. Immediately after the end of the lon gene, a
marker gene encoding a pink Scarlett fluorescent protein was inserted. We confirmed the Δlon/lon
complementation at the gene and protein level (Figure S1).
A lack of the lon gene did not affect the growth of bacteria at the standard in vitro conditions
(LB medium, 30 ◦C), as judged from the growth curves. The growth rates of the Δlon, Δlon/lon and
WT D. solani cultures were comparable (Figure 2). Similar growth patterns of the Δlon and WT strains
have significantly facilitated the normalization of bacterial cultures in terms of age and cell density for
subsequent stress sensitivity and pathogenicity tests.
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Figure 2. Growth of D. solani Δlon. Curves were determined with the use of a plate reader at 30 ◦C.
OD595 (optical density (595 nm)) values in LB medium were averaged for four replicates.
2.2. The Expression of the lon Gene is Upregulated under Certain Stressful Conditions
Under stress, a cell activates a variety of defense mechanisms that are manifested by increased
expression of the key protective proteins [20–22]. To check the importance of Lon in the stress response,
we performed the qPCR analysis to measure levels of transcription of the lon gene. We chose the
common stressors, possible to affect D. solani during saprophytic and pathogenic life cycle: elevated
temperature, nonionic and ionic osmotica, acidic pH and oxidants [23].
We found that transcription of lon was significantly upregulated in the exponentially growing
bacteria under stressful conditions such as hyper osmosis, acidic pH and high temperature (Figure 3).
The most pronounced effect was exerted by acidic pH and elevated temperature (over three log2 fold
increase). A milder effect was caused by the presence of a nonionic osmoticum, sucrose (over two
log2 fold increase). In contrast, the expression of the lon gene did not change significantly in cells in
the stationary phase of growth. The exception was the upregulation (over 5.5 log2 fold increase) of
the lon gene expression in cells treated with acidic pH. Interestingly, the changes in the lon transcript
level upon treatment with ionic osmoticum, NaCl, were pronounced regardless of the growth phase,
although they were not statistically significant (Figure 3). In contrast, oxidative stress did not affect
the transcription of lon (Figure 3). Hence, the Lon protease is rather not a component of the oxidation
response in D. solani.
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Figure 3. The relative log2 fold change of the expression levels of the lon gene in the D. solani cells
under stressful conditions analyzed by qPCR. The data correspond to the means ± S.D. of three
different samples, including three technical replicates. A red horizontal line indicates a relative two-fold
increase in expression level. * indicates statistically significant (95% confidence interval) fold change in
expression level according to the REST 2009 software.
2.3. Lon Protease Plays a Protective Role under Ionic and High-Temperature Stresses
Knowing that expression of lon is upregulated in cells in response to stress, we decided to check if
the presence of the Lon protease in the cell is necessary for bacterial growth in the presence of selected
stressors. Bacteria were exposed to the following stressful conditions: elevated temperature, ionic and
nonionic osmotic shock, oxidative stress and low pH. We found that D. solani Δlon was characterized
by a decreased ability to form single colonies under three of five tested conditions. In particular,
elevated temperature and presence of the nonionic osmoticum, sucrose, reduced viable cell counts by
five and three orders of magnitude, respectively. Moreover, the Δlon mutant colonies were very small
under both tested conditions. The reintroduction of the lon gene into the D. solani Δlon chromosome
restored the wild-type phenotype of bacteria (Figure 4A). Hence, the strong phenotype of the mutant
strain resulted from the lack of the Lon protease and not from putative additional suppressor mutations.
The pronounced effect was also noticed under ionic osmotic stress: addition of NaCl resulted in a
three-log reduction of cell counts of the Δlon mutant with respect to the WT or complemented Δlon/lon
strain (Figure 4A). Acidic pH and oxidative stress affected all strains similarly (Figure 4A,B).
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Figure 4. Growth of D. solani Δlon under stressful conditions. (A) Overnight grown cultures were
serially diluted and spotted on the LA (Luria Agar) agar plates, agar plates supplemented with 0.6 M
sucrose or 0.3 M NaCl or on the LA medium adjusted to pH 5.0 when indicated. Bacteria grown on
the LA agar plates at 30 ◦C refer to control. Disk diffusion assay with 1% hydrogen peroxide. As a
negative control, sterile water was used (B). All plates were incubated at 30 ◦C except for the elevated
temperature stress (39 ◦C).
2.4. Deletion of the lon Gene Delays the Onset of the Infection Symptoms
To test the importance of the Lon protease for pathogenicity of D. solani, we performed in vivo
infection of the potato plants under greenhouse conditions. This kind of experiment shows the ability
of bacteria to invade plants through the root system and produce blackleg symptoms. Although the
deletion of the lon gene did not significantly reduce the occurrence of disease, an obvious delay in
the development of the disease symptoms was observed. On the seventh day postinfection, only 30%
of the potato plants treated with the Δlon mutant bacteria showed blackleg symptoms, compared to
75% of symptomatic plants infected with WT D. solani. On the 17th day, the differences were much
less pronounced, with 55% and 75% of symptomatic plants infected with Δlon and WT D. solani,
respectively (Figure 5).
To evaluate the effects of the Δlon mutation on the ability of bacteria to macerate plant tissues,
we used three models: potato tubers and leaves of chicory and Chinese cabbage. In no case did we
observe differences in the degree of tissue maceration (Figure S2).
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Figure 5. Pathogenicity of D. solani Δlon in the whole potato plant model. Potato plants cv. Vineta were
infected with WT and lon mutant strains. After 7 and 17 days of incubation at room temperature with a
16/8 photoperiod, the number of plants with blackleg symptoms was counted. Four plants watered
with Ringer buffer represented a negative control. The number of infected plants with WT and Δlon
mutant was 16 for each strain.
2.5. The Deletion of lon Affects the Activity of Secreted Pectate Lyases
PCWDEs are the virulence factors that are directly responsible for the manifestation of disease
symptoms. To check if altered pathogenicity of D. solani Δlon results from changes in the level or
activity of the enzymes that degrade the plant cell wall, we measured the activity of pectate lyases
(major pectic enzymes), cellulases and proteases secreted from the mutant and WT D. solani cells.
The enzymatic activity was assayed using PGA, modified cellulose CMC and casein, which are
commonly used substrates for pectinases, cellulases and proteases, respectively. In the case of D. solani
Δlon, the secreted pectate lyase activity was 85% lower than that of the WT strain (Figure 6A). However,
the activities of the remaining hydrolytic enzymes were not affected by the lon mutation (Figure 6B,C).
The level of other secreted virulence factors, siderophores, also remained unchanged (Figure 6D).
Figure 6. The activity of secreted virulence factors. (A) Pectinase activity was assayed as described in
the Methods section with PGA as a substrate at 30 ◦C. ** p < 0.01 (t-test), n = 5. (B) Cellulases were
assayed on M63Y with CMC. Seven microliters of bacterial cultures (108 CFU/mL) were spotted on
the medium and incubated for 72 h. Plates were stained with 2% Congo red solution. (C) To monitor
protease activity, 7 μL of bacterial cultures (108 CFU/mL) were spotted onto LA with skimmed milk and
incubated for 48 h. (D) Siderophore activity was determined by spotting 10 μL of supernatant from
overnight grown bacteria cultures onto chrome azurol S-agar plates. The picture was taken after 1 h of
incubation at 30 ◦C. The experiments (B–D) were performed at least five times. The representative
results are shown.
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2.6. Lon Protease is Essential for Efficient Motility
Motility is one of the key factors for a successful invasion of the plant host. To determine if
the observed delay of the blackleg symptoms development in the potato plants infected by D. solani
Δlon can be associated with altered bacterial motility, we examined two types of motility, swimming
and swarming. While both types rely on the rotation of flagella, swimming is characteristic for an
individual cell and is enhanced by chemotaxis. In contrast, swarming is common for a group of
bacteria [24]. Indeed, the lack of Lon resulted in the altered motile phenotype of bacteria. The mutated
strain showed considerable reduction in the swarm (Figure 7A) and 30% reduced swimming motility
in the presence of galactose as a chemotactic agent (Figure 7B).
Figure 7. Swarming and swimming motility of D. solani Δlon. (A) Representative pictures of bacteria
swarming on 0.8% TSA after 12 h incubation at 30 ◦C. The experiments were performed at least five
times. (B) Swimming was examined in a 0.3% MMA medium for 24 h at 30 ◦C. The diameter of the
bacteria spreading area was measured. Presented data represent values for 5 biological replicates.
*** p < 0.001 level (t-test).
2.7. Comparison of Proteomic Profiles of the D. solani Δlon and WT Cells under Physiological and
Stressful Conditions
To gain more detailed insight into the properties of the Δlon mutant cells, we compared the
proteomes of the mutant and WT strains under physiological, as well as stress conditions, by the
means of SWATH-MS (Sequential Window Acquisition of All Theoretical Mass Spectra) analysis.
SWATH-MS is an advanced analysis method of proteomic data, recommended for quantification of
identified peptides. It allows quantitative comparison of protein levels between different species or
treatments due to the construction of a peptide spectral library [25].
It is well known that treatment with severe stressful agents can cause abnormal changes in the
level of individual macromolecules [20] so we decided to subject the lon mutant to a rather mild
stress—a short incubation at 40 ◦C.
The analysis identified a total of 635 proteins, for which at least two peptides per protein were
quantified (Table S1). Deletion of the lon gene induced global changes in the D. solani proteome.
We narrowed the number of differentially expressed proteins by applying the following cut-off
criteria: p < 0.05, as well as fold changes below 0.5 or above 2.0. This resulted in 38 proteins with
altered abundance in Δlon compared to WT under physiological conditions and 60 proteins under
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stress conditions. Hence, the changes in the mutant proteome were more pronounced following the
temperature shift than under control conditions, which may reflect the increased need for the Lon
function during stress. In particular, the deletion of the lon gene resulted in upregulation of 17 or 41
proteins and downregulation of 13 or 19 proteins under physiological or stress conditions, respectively.
Of these, 28 proteins shared a similar pattern of expression under both tested conditions (Figure 8A).
We grouped differentially expressed proteins into eight categories, depending on their
physiological functions (Table 1). These include involvement in motility, iron metabolism,
stress response, transport, general metabolism, transcription/translation, virulence and others.
Percentage of proteins representing particular groups differs between control and induced conditions,
however, the most abundant class encompasses proteins associated with general cell metabolism
(Figure 8B). Consistent data were obtained for proteins involved in bacterial motility, namely all of them
were repressed in Δlon compared to WT. Among them, we identified flagellin, a structural component
of bacterial flagella, and proteins responsible for chemotaxis (CheW, a positive regulator of CheA
protein activity and CheA, signal transduction histidine kinase CheA). On the contrary, deletion of lon
caused an increase in the cellular content of a group of proteins associated with virulence. They are
all engaged in the T3SS and include hairpins, HrpN, a homolog of HrpW (Various polyols ABC
transporter, permease component 2), as well as HrpA, Hrp pili protein. Deletion of lon differentially
affected levels of proteins related to iron metabolism. We observed the upregulation of the proteins
involved in the Fe-S cluster assembly (ISCU) and biosynthesis of achromobactin siderophore. However,
the level of proteins involved in the synthesis of another siderophore, enterobactin, was decreased
(for example isochorismate synthase enterobactin siderophore). The mutant strain was characterized
by an increased content of several proteins engaged in transcription and translation. Among them,
we could distinguish ribosomal proteins (50S ribosomal protein L27 and L7/L12), transcription factors
(CytR, DksA) and RNA-binding protein Hfq. We obtained a similar trend regarding stress-related
proteins, like ClpP protease and cold shock response proteins (CspE and CspG). A total of 77% of
proteins associated with transport activity were downregulated, including histidine ABC transporter
and efflux pump membrane transporter. The group named “others” comprises uncharacterized
proteins or polypeptides which were not assigned to any other category. Among them, we identified
putative membrane protein A0A2K8W3L1_9GAMM whose expression was increased more than
100-fold under both tested conditions. Protein blast indicated very close homology to periplasmic
ComEA from many bacterial species, with the closest homology (100% coverage, 99% identity) to
Dickeya fangzhongdai. ComEA is essential for DNA uptake in naturally competent bacteria, like Bacillus
subtilis [26]. In Δlon, we also observed an increased cellular level of S-ribosylhomocysteine lyase,
which is associated with quorum sensing.
Figure 8. Number (A) and percentage (B) of proteins whose expression level was changed in the Δlon
mutant under physiological and heat shock conditions. Data are categorized into 8 groups depending
on the protein function. Physiological and heat shock conditions refer to temperatures 30 ◦C and
40 ◦C, respectively.
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3. Discussion
For successful infection, a pathogen must have the capability to enter the host, overcome the
host defense systems, acquire nutrients, multiply and disseminate. All these stages are associated
with constant exposure to a variety of potentially harmful conditions, both in and outside the host.
Hence, successful pathogens should have well-developed virulence mechanisms but also efficient
stress response systems. Proteolytic enzymes were shown to play numerous crucial roles in bacterial
virulence. They can directly act as virulence factors, but also can contribute to virulence by regulating
the production of virulence factors and/or as components of protein quality control systems to provide
cellular proteostasis. One of the latter cases is the Lon protease which is indispensable for stress
tolerance and virulence of many bacterial species causing infectious diseases.
Our work showed that the Lon protease is necessary for the bacterium D. solani to resist exposure
to stress, including ionic- and nonionic osmotic stress, as well as high temperature. This finding is in
agreement with data obtained for other bacterial species. Lon has a well-documented role in bacterial
viability under heat and salt stress [14]. In E. coli, expression of the lon gene depends on sigma32 (RpoH)
transcription factor [27,28], activated under heat shock and osmotic stress [29,30]. High temperature
stimulates expression of lon in E. coli [31] and Francisella tularensis LSV [32]. Ionic osmotic stress is
responsible for the elevated level of lon expression in B. subtilis and Dickeya dadantii [33]. Consistently,
in D. solani, lon expression was significantly elevated in exponentially growing bacteria following
exposure to elevated temperature; a positive trend was also observed in case of salt stress. Heat shock
is more harmful to bacteria in the logarithmic than the stationary growth phase [34], which may explain
stronger stimulation of the lon gene in the logarithmically growing cells. Higher demand for Lon,
suggested by the upregulation of lon under certain stress conditions, can explain reduced growth of
the Δlon bacteria under thermal and osmotic stress. Additionally, the elevated level of stress-related
proteins in proteomes of bacteria treated with 40 ◦C, revealed by the SWATH-MS analysis, indicates the
higher stress level in the mutant cells than the WT. Increased expression of RecA and protease HtpX
suggests a higher frequency of DNA damage and probably impaired integration of membrane proteins,
respectively, according to data published for E. coli [35,36]. Finally, the increase in the abundance of
the second important cytosolic protease, ClpP, in the deletion strain, reveals the essential role of Lon
protease in the quality control proteolysis in the cytoplasm. Most probably, ClpP takes over some of
the Lon functions. However, it should be noted that the Δlon strain showed a temperature-sensitive
(TS) phenotype, so ClpP cannot substitute for Lon under heat shock conditions.
To our surprise, the Δlon mutants were particularly vulnerable to treatment with sucrose. Nonionic
osmotic agents, like sucrose, are considered less harmful for a cell than the ionic ones, (e.g., NaCl) [37].
We did not find data regarding the relationship between Lon and the response to osmotic stress caused
by high sucrose in any bacterial species. Hence, this important function of Lon in resistance to nonionic
osmotic stress needs to be elucidated. Although the expression of lon was strongly upregulated in the
response of D. solani to low pH, we did not observe differences of growth between the mutant and WT
strains. Possibly, the ClpP protease or other component of the protein quality control system takes over
the duties of Lon under this type of stress. The involvement of the Lon protease in resistance to acidic
stress is rather poorly investigated across different bacterial species. In E. coli, Lon is responsible for the
degradation of the activator of acidic resistance, GadE, playing a role in the termination of the stress
response [38]. Additionally, S. enterica serovar Typhimurium requires this protease to successfully
cope with low pH [16]; however, the precise mechanism was not provided. Interestingly, the closely
related species, D. dadantii, showed repression of lon expression in the low pH medium (although
not statistically significant) [33], which is opposite to our findings. This may reflect interspecies
differences but also certain differences in experimental design. As with D. dadantii [33], in D. solani
the expression of lon was not affected by oxidative stress-induced with hydrogen peroxide. Hence,
in Dickeya, the oxidation response most probably involves other components of PQCS.
Production of functional virulence factors is frequently dependent on specific proteolytic activity
in the cell [39,40]. To verify the involvement of Lon in D. solani virulence, we checked the activity of
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the most abundant secreted virulence factors. We found that activity of the extracellular pectinases
was reduced in the case of Δlon mutant. Pectinases constitute a heterogeneous group of proteins.
They differ in substrate specificity, abundance and role in virulence but all are secreted via T2SS [41].
At least 10 pectinases produced by D. solani have been identified so far [41]. The commonly used tests
(including the one used in this work) measure a total pectinase activity and do not allow to distinguish
between the individual pectinases. Analysis of the Δlon and WT D. solani proteomes did not reveal
differences in the cellular content of pectinases. However, we do not know if these proteins were
efficiently transported outside the cell. As this is the first report of the function of Lon in the soft rot
bacteria, there is no information regarding the relationship between Lon and PCWDE. No literature
data is indicating the possibility of regulating the T2SS transport system by Lon. Moreover, the activity
of extracellular cellulases, also T2SS dependent, remained unchanged in the lon mutant. Hence, the
involvement of Lon in the regulation of T2SS is unlikely. Thus, further research is needed to clarify the
Lon-dependent protease regulation of the secreted pectinase activity.
We did not observe any changes in the production of siderophores, although the lack of Lon
protease lowered the abundance of several proteins engaged in iron metabolism. A higher level of
proteins with function in iron-sulfur (Fe-S) protein biogenesis (IscU, ErpA) in the deletion strain may
indicate them as potential substrates for the Lon protease. That is true in Saccharomyces cerevisiae,
where a Lon homolog, Pim1, degrades Isu, a homolog of IscU [42]. The increase in the amount of
the negative transcriptional regulator Fur is very interesting. Whether it is degraded by Lon is not
known and no such Lon function was found in other bacteria. Almost a 10-fold increase of the Fur
level in Δlon may explain the decreased amount of certain Fur-dependent proteins involved in the
synthesis of siderophores (e.g., enterobactin synthetase component F in E. coli [43]. On the other hand,
the other enzymes from the siderophore biogenesis pathway were upregulated (like achromobactin
biosynthesis protein AcsD), presumably compensating for the downregulated components to maintain
iron homeostasis in the mutant cells.
A lack of Lon exerted a significant impact on the mobility of D. solani. We demonstrated that the
cells deprived of Lon showed impaired swarming and swimming motility. This can be explained by
the reduced levels of flagellin and positive regulators of chemotaxis in D. solani Δlon, as revealed by
the proteomic analysis. Depending on the bacterial species, the effects of the lon mutations on bacterial
motility may be radically different. On one hand, the lon mutation can cause stimulation of motility.
Good examples are Proteus mirabilis and B. subtilis, in which lon mutants showed better swarming [44,45].
In these bacteria, Lon degrades master activators of flagellin biogenesis- FlhD and SwrA, respectively.
Hence, in the lon backgrounds, these activators became stabilized, leading to a hypermotile phenotype.
In contrast, the lon mutant of Erwinia amylovora was characterized by a nonswarming phenotype [46].
In E. amylovora, a mutation in the lon gene resulted in the accumulation of RcsA/RcsB that negatively
regulates transcription of flhD, the master regulator of flagellar biosynthesis. Finally, a lack of Lon may
not affect bacterial motility at all, as shown for S. entrica serovar Typhimuirum [47]. The results obtained
in this work suggest an indirect role of Lon in the motility of D. solani, analogous to that of E. amylovora
Lon, as the flhD gene is present in D. solani genome and the lon mutant was characterized by a decreased
flagellin content. Interestingly, D. solani Δlon was characterized by the two-fold increased level of the
CytR transcription factor, which in Pectobacterium carotovorum positively stimulates genes associated
with motility: fldH, fliA, fliC and motA [48]. However, the increased content of the CytR protein in
D. solani Δlon obviously was not sufficient to compensate for the other Δlon -dependent effects that lead
to a reduced flagellin and chemotaxis protein levels, or CytR is not involved in regulation of motility in
D. solani.
The phenotypes of D. solani Δlon reported in this work suggested that the presence of Lon may be
necessary for efficient infection of the potato plant. Indeed, we found that the process of development
of blackleg symptoms in the plants infected with the mutant strain was markedly delayed in respect to
infection with the WT D. solani. On the other hand, Lon was not essential for the maceration of plant
tissues in vitro. Both types of infection tests differ fundamentally in terms of the availability of plant
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tissues for bacteria. In the whole plant model, the bacteria were placed in the soil, from where they
must have got into the wounded tissue, in this case, roots. In this context, the motility and chemotaxis
toward chemical signals (e.g., jasmonic acid) are crucial. Consequently, the nonmotile mutant strains
are characterized by a lack or reduced virulence, as they may encounter severe problems with entering
and/or spreading in the host [49]. In the slice or leaf model, bacteria were spotted directly into the
wounded tissue, so chemotaxis and motility were less important. In the tissue model, the basis of
infection’s success lies in the production of PCWDE, iron homeostasis, and bacterial fitness under
pH, oxidative and osmotic stresses (reviewed in [6]). As we did not observe any difference in the
degree of maceration of the tuber or leaf tissues between the WT and mutant strains, we assumed that
Lon was not essential for bacterial survival in the plant under experimental conditions. The secreted
pectinase activity of the Δlon mutant was reduced but was still enough for efficient plant maceration.
Hence, we concluded that the observed delay in the potato plant infection process was most probably
due to reduced motility of the Δlon strain.
Lon is known to be engaged in the regulation of T3SS, however, the particular effects of lon
mutations are species-dependent. In P. aeruginosa and Yersinia, the deletion of the lon gene results in the
downregulation of T3SS [17,50]. However, the opposite effect was demonstrated in E. amylovora and
P. syringae [46,51]. We found that in D. solani, Lon negatively affected the level of proteins associated with
the type III secretion system: HrpN and a homolog of HrpW as well as HrpA (structural protein of T3SS
pillus). These results are consistent with data obtained for E. amylovora and P. syringae. In these bacteria,
Lon indirectly downregulates transcription of hrpL gene coding for HrpL, the RNA polymerase sigma
factor, which is necessary for the initiation of transcription of T3SS genes. In P. syringae and E. amylovora
this is mediated via degradation of the transcriptional activators of the hrpL gene, HrpR and HrpS,
respectively [46,51]. In addition, Lon also indirectly regulates HrpS levels through RcsA proteolysis
in the E. amylovora cells. RcsA is a component of RcsA/RcsB regulatory complex, which activates
transcription of the hrpS gene [46]. Finally, Lon of E. amylovora degrades HrpA [46], which may also
be true in the case of D. solani, as we observed an elevated level of this protein in the mutant strain.
Interestingly, in E. coli, the Lon substrates, CspG and CspE proteins, positively regulate the rcsA
expression [52]. In the D. solani Δ lon strain, CspG and CspE were upregulated. It cannot be ruled out
that they can also be degraded by the Lon protease, which would additionally suppress the expression
of T3SS.
In addition to the IscU, HrpA and CspG/E proteins discussed above, the proteome analysis
revealed one more potential substrate for the D. solani Lon protease. We observed elevated levels of
the RNA-binding protein Hfq, which is a known substrate for Lon in P. aeruginosa [53]. Fernandez and
colleagues [53] suggested that the accumulation of Hfq can contribute to reduced motility of the lon
strain. In the case of D. solani, these findings need verification.
The most pronounced effect of the lon deletion was observed in the case of the protein
A0A2K8W3L1_9GAMM, a homolog of ComEA, whose level was more than 100-fold higher in
Δlon. ComEA is necessary for natural cell competence. However, D. solani was not reported to exhibit
natural competence. Moreover, the calcium chloride transformation method of D. solani is highly
inefficient and D. solani spp. genomes lack in general large plasmids [54]. Interestingly, in Vibrio cholerae
comEA expression is activated by the transcriptional regulator CytR [55]. We also observed an increased
level of CytR in the deletion strain, which may be the reason for the upregulation of the ComEA protein.
However, the relationship between CytR and Lon protease requires further investigation.
Finally, SWATH-MS analysis revealed that the deletion of lon affected the balance among proteins
involved in cellular metabolism and transport. This is not surprising as the housekeeping proteases,
in general, regulate metabolic activities [56] and this is also true for Lon [14].
In light of the data presented in this work, the Lon protease is a protein that plays very important
roles in D. solani physiology, both under physiological and stressful conditions. Lon was shown to be
required for the full virulence of D. solani in the whole plant model. Lower pathogenicity of the Δlon
bacteria may result from impaired expression/activity of certain virulence factors, including motility
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and secreted pectinases, but also from decreased ability to withstand stressful conditions. To our
knowledge, this is the first report that describes the function of the Lon protein in the bacterial species
from the SRP group.
4. Materials and Methods
4.1. Materials
Restriction enzymes and dNTPs were purchased from EURx (EURx Sp. z o.o., Gdańsk, r, Poland);
PrimeSTAR GXL polymerase for construction of deletion strain from Takara Bio Inc. (Shiga, Japan);
T4 DNA ligase, T5 Exonuclease and Phusion High-Fidelity polymerase from New England Biolabs
(USA) and reagents for media and buffers from Sigma-Aldrich (Saint-Louis, MI, USA), and Chempur
(Piekary Śląskie, Poland). Oligonucleotides were synthesized by Eurofines Scientific (Luxembourg,
Luxembourg) or Sigma-Aldrich (Saint Louis, MI, USA).
4.2. Bacterial Growth Conditions
Bacterial strains and plasmids used in this study are listed in Table 2. Bacteria were grown in
the minimal medium M63Y (0.1 M KH2PO4, 15 mM (NH4)2SO4, 9 μM FeSO4, 1 mM MgSO4, 1 mg/L
vitamin B1 and 0.3% glycerol, pH = 7.0) [57], LB broth (1% tryptone, 0.5% yeast extract, 1% NaCl) or
SOC (2% tryptone, 0.5% yeast extract, 10 mM NaCl, 20 mM glucose, 2.5 mM KCl, 10 mM MgSO4) with
shaking at 30 ◦C, unless indicated otherwise. For all analyses, overnight cultures were diluted 1:50
with M63Y or LB and cultured for the next 16 h until they reached the early stationary growth phase.
Then, they were used in experiments or diluted again 1:50 with M63Y and grown for 4.5 h to reach a
midexponential phase. The overnight D. solani Δ lon cultures were grown in the medium supplemented
with kanamycin (0.1 mM); the cultures directly subjected to experiments were devoid of the antibiotic
to provide comparable growth conditions of all bacterial strains.
Table 2. Bacterial strains and plasmids used in this study.
Strain Genotype Reference or Source
Escherichia coli DH5α
F– ϕ80lacZΔM15 Δ(lacZYA-argF)U169
recA1 endA1 hsdR17(rK–, mK+) phoA
supE44 λ– thi-1 gyrA96 relA1
[58]
Escherichia coli DH5α pir
sup E44 ΔlacU169 (ΦlacZΔM15) recA1
endA1 hsdR17 thi-1 gyrA96, relA1 λpir
phage lysogen
[59]





Dickeya solani IPO 2222 WT [61]
D. solani IPO 2222 Δlon Δlon This work
D. solani IPO 2222 Δlon/lon Δlon/lon This work
Plasmids Feature Reference or Source
pDOC-C pEX100T, Sce1 -Sce1 sacB AmpR [62]
pDOC-K pEX100T, Sce1-KanR -Sce1 sacB AmpR [62]
pACBSCE I-Sce1 λ-Red CmR [62]
pDFDOC-C-lon pDOC-C Sce1-KanR-Sce1 This work
pRE112 pRE107 cmR sacB [63]
pmScarlet pMB1 ori mScarlet AmpR [64]
pLonScar pRE112 lon mScarlet This work
Please define all abbreviations in table footer, if appropriate.
Growth curves were determined with the use of the EnSpire plate reader (PerkinElmer, Waltham,
MA, USA) in a 24-well nontreated plate (#702011 Wuxi NEST Biotechnology Co., Ltd., Wuxi, China).
Overnight grown cultures were diluted 1:50 with LB medium to a final volume of 1 mL. Bacteria were
grown with orbital shaking (120 rpm) and OD595 measurements were taken every hour. Growth was
monitored for 20 h at 30 ◦C. The final OD values were averaged for four biological replicates.
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To induce stress, 4 μL aliquots of 10-fold serial dilutions of the stationary bacterial cultures in
Ringer buffer (147 mM NaCl, 4 mM KCl, 2.24 mM CaCl2 × 2H2O) were spotted onto the LA agar plates
(LB broth with 1.5% agar, control conditions and temperature stress), LA agar plates supplemented
with 0.6 M sucrose (nonionic osmotic stress) or 0.3 M NaCl (ionic osmotic stress), or adjusted with
malic acid to pH 5.0 and incubated for 20–48 h at 30 ◦C or 39 ◦C (heat shock). The Agar disk diffusion
method was used to study the susceptibility of bacteria to oxidative stress. One-hundred microliters of
overnight culture diluted 100 times was spread onto the LA medium. A sterile disk (6mm) of Whatman
1M paper was placed on an LA plate and then 8 μL of 1% hydrogen peroxide solution was spotted on
it. The water-soaked disk served as a negative control. Plates were incubated at 30 ◦C for 24 h.
To analyze gene expression, the WT strain grown in M63Y to the midexponential or early stationary
phase was subjected to the selected stress conditions for 15 min [33]. Briefly, NaCl and sucrose were
added to the cultures to a final concentration of 0.3 M and 0.32 M, respectively. The shift of temperature
was obtained by incubation of bacteria for 15 min in a water bath at 37 ◦C or 40 ◦C with shaking. As a
control, bacteria grown in the absence of a stressor at 30 ◦C were used. To stabilize mRNA, a cold
solution of 5% acid phenol (BioShop Canada Inc., Ontario, Canada), in 99.9% ethanol was added to the
bacterial culture at the 1:9 ratio and bacteria were immediately put on ice.
4.3. Construction of the lon Deletion Strain
The deletion of the lon gene from the D. solani chromosome was performed according to gene
doctoring protocol [62]. Briefly, primers with homology to the upstream/ downstream regions of
the kanamycin resistance cassette from pDOC-K plasmid and 40 bp flanking region of the lon gene
were designed (Table 3). Restriction sites for XhoI and KpnI were added at 5′ end of lonkan L and
lonkan R primers, respectively. PCR reaction was performed with pDOC-K as a template. The PCR
product and pDOC-C plasmid were digested with XhoI and KpnI restriction enzymes, then the PCR
product was cloned into the backbone of pDOC-C, generating pDFDOC-C-lon. Plasmid pABSCE
and pDFDOC-C-lon were electroporated into D. solani cells and the transformants were selected for
resistance to chloramphenicol and ampicillin. The proper recombinants were selected based on a lack
of ability to grow on a medium with 8% filtrated sucrose, as the pDFDOC-C-lon plasmid contains the
sacB gene. To check this, 1 mL portions of LB medium with 0.5% glucose and appropriate antibiotics
were inoculated with single colonies and incubated with shaking at 30 ◦C for 4 h. The culture was
centrifuged (1167× g, 2 min), pellet resuspended in 1 mL LB medium supplemented with 0.1–2%
arabinose and incubated at 30 ◦C with shaking until turbid. Bacteria were spotted on the LA plates
supplemented with 8% sucrose (sterilized by filtration) and kanamycin and in parallel on LA with
kanamycin. Next, the colonies that did not grow on the sucrose plates were tested for pDFDOC-C-lon
and pABSCE plasmid loss by the selection of bacteria unable to grow on ampicillin and chloramphenicol.
PCR with primers homologous to the flanking region of a lon gene (Table 3) was performed to confirm
the deletion of the lon gene.
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4.4. Single-Copy Complementation
Complementation strain was obtained by reintroduction of the WT lon gene into its native locus
on the chromosome in the D. solani Δlon cells using conjugation strain E. coli MFD pir, according to [60].
To do this, a plasmid containing the WT lon gene with the mScarlet gene coding for a fluorescent pink
protein as a marker was obtained by the Gibson assembly approach. Briefly, four insert fragments were
amplified (Table 3) and mixed with the allelic exchange pRE112 vector cut with the SmaI restriction
enzyme, and reaction mix [65]. pRE112 carries the sacB marker gene and chloramphenicol resistance
gene. The total amount of DNA in the reaction was 150 ng.
The resulting reaction product was transformed into E. Coli DH5α pir and the subsequently
isolated plasmid was named pLonScar. The pLonScar plasmid was introduced into E. coli MFD pir
in the presence of 0.3 mM diaminopimelic acid (DAP, Sigma-Aldrich, Saint Louis, MI, USA) in the
medium to allow the growth of bacteria [60]. The overnight cultures of E. coli MFD pir (pLonScar)
and D. solani Δlon were mixed in a 3:1 ratio (total volume 800 μL) and centrifuged (1677× g, 2 min).
The pellet was suspended in 30 μL of LB and spotted on an acetate cellulose filter placed on the
LA solid medium supplemented with chloramphenicol but without DAP to eliminate E. Coli MFD
pir. After 24 h incubation at 30 ◦C, bacteria were recovered by shaking the filter in 1 mL M63Y.
Bacteria were spotted onto the LA agar plates with chloramphenicol. Then, individual colonies
were tested for loss of the pRE112 plasmid. Briefly, cultures in the middle logarithmic growth
phase were serially diluted and spread on LA without NaCl but supplemented with 10% of 0.22 μL
filtered sucrose. Only cultures unable to grow on medium with sucrose were subjected for further
verification. Ultimately, pink colonies sensitive to chloramphenicol and kanamycin were considered as
true recombinants.
4.5. Plasmid and Genomic DNA Purification
Genomic and plasmid DNA were isolated using Genomic Mini (A&A Biotechnology, Gdynia,
Poland) and Plasmid Mini (A&A Biotechnology, Poland) kits, respectively, according to the
manufacturer’s protocols.
4.6. Preparation of Electrocompetent Cells and Electroporation
50 mL of SOC medium was inoculated with an overnight culture of D. solani at a 1:50 ratio.
Bacteria were grown until OD595 of 0.45–0.5. The culture was centrifuged (7 min, 5063× g, 20 ◦C),
pellet resuspended in 50 mL of deionized water, mixed thoroughly and forwarded to centrifugation
(8 min, 5872× g, 20 ◦C). The cells were suspended in 25 mL of deionized water, mixed and centrifuged
again (as above). The supernatant was precisely discarded, bacteria suspended in 1 mL of deionized
water and split into 60 μL portions. Then, the cells were immediately used for electroporation [66].
Briefly, up to 50 ng of DNA was mixed with electrocompetent cells and transferred to 0.1 cm gap
electroporation cuvettes (room temperature) for electroporation (1.25 kV). The bacterial suspension
was diluted with 1 mL of SOC medium and incubated for up to 3 h for recovery. The 100 μL aliquots
and the remaining bacteria (after 1 min 1677× g centrifugation and resuspension in 100 μL SOC) were
plated onto the LA solid medium supplemented with an appropriate antibiotic and incubated for
24–36 h at 30 ◦C.
4.7. In Vivo Infection of the Potato Plants
The pot grown potato plants were obtained from sprouts. Briefly, the potato tubers of cultivar
Vineta, obtained locally in Gdańsk, Poland, were stored in the dark until the development of sprouts
(app. 3–4 months). Sprouts of a length of ca. 5 cm were carefully removed from tubers, planted into
7 cm square pots with potting soil (COMPO SANA ca 50% less weight) and placed on the windowsill
for rooting and shoot development. After approximately two weeks, the rooted green plants were
transferred to the humid growth chamber and grown under the white fluorescent light (48 × 5 W,
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Mars Hydro Reflector 48 with 16:8 h light: dark photoperiod). The potato plants at least 10 cm high
were subjected to pathogenicity tests. Four overnight cultures of WT and four of D. solani Δlon grown in
LB medium were diluted with Ringer buffer to OD595 ~0.125, corresponding to 108 CFU/mL. The roots
of each potato plant were wounded with the scalpel about 2 cm from the stem. Plants were watered
with 30 mL of bacterial suspensions and left for an hour. Then, the filtrate was discarded. Each bacterial
culture was used to infect 4 plants. As a negative control, four plants treated with Ringer buffer were
used. The experiment was carried out for 17 days and the percentage of plants with blackleg symptoms
was estimated.
4.8. Pathogenicity on Potato Tubers, Chicory and Chinese Cabbage Leaves.
CFU/mL of each overnight bacterial culture was normalized to 108 with Ringer buffer and
then 10-fold serially diluted. Potato tubers were sterilized with a 10% bleach solution for 20 min,
then submitted to three washes with sterile deionized water for 20 min each. The tubers were cut
into 1 cm thick potato slices; in each slice, a little hole was pierced with a sterile pipette tip. Chicory
and Chinese cabbage leaves were washed with sterilized deionized water and incised with a sterile
scalpel. Ten-microliter aliquots of bacterial culture of 107 CFU/mL were spotted onto the plant material.
Ringer buffer was used as a negative control. The infection assays were performed in the humid
boxes, at 30 ◦C for up to two days: one day for Chinese cabbage, two days for chicory leaves and for
potato slices.
4.9. Determination of Motility
For swimming, a single bacterial colony (five replicates per strain) was inoculated into the semisolid
agar plate with 0.3% MMA medium (40 mM K2HPO4, 22 mM KH2PO4, 0.41 mM MgSO4 × 7H2O,
0.3% agar) supplemented with 1 mM galactose. The plates were incubated under aerobic conditions at
30 ◦C for 48 h. The diameter of the bacterial spreading area was measured.
To monitor swarming motility, a single bacterial colony (five replicates per strain) was inoculated
into the plate with 0.5% TSA (tryptone soy broth) medium (Oxoid, Basingstoke, UK) supplemented
with 0.5% agar). Plates were incubated under aerobic conditions at 30 ◦C for 12 h. Both tests were
repeated two times.
4.10. Determination of Secreted PCWDE Activity
The measurement of pectinolytic activity was performed as described in [67]. Briefly, bacteria
were cultured in the M63Y medium until an early stationary phase and centrifuged (13,148× g,
2 min). Then, 260 μL aliquots of supernatant were diluted with equal volumes of distilled water.
Briefly, 500 μL samples of the diluted supernatant were mixed with 1.5 mL of PGA (polygalacturonic
acid, Sigma-Aldrich, Saint Louis, MI, USA) buffer (100 mM Tris–HCl (pH 8.5), 0.35 mM CaCl2 and
0.24% sodium polygalacturonate) warmed up to 30 ◦C. The reaction consisting in the formation
of unsaturated products from polygalacturonate [68] was monitored spectrophotometrically by
measurement of increase of absorbance at 232 nm for 2 min, every 30 s. Absorbance values obtained
for PGA buffer were subtracted from values obtained for unsaturated product. The spectrophotometer
was calibrated with distilled water. Pectynolytic activity was presented as ΔA235/min/mL/OD595.
The experiment was repeated two times for each strain with at least three replicates.
The extracellular cellulase activity was assayed as described in [69]. Briefly, bacteria grown in the
M63Y medium to the stationary phase were diluted with Ringer buffer to 108 CFU/mL. Seven-microliter
aliquots of bacterial cultures were spotted on the agar plates with carboxymethyl cellulose CMC (M63Y
medium supplemented with 1.5% agar and 1% CMC). The plates were incubated at 30 ◦C for 48 h and
then subjected to staining with 2% Congo red solution for 20 min. The diameters of the arisen halo
were measured. The experiment was repeated two times for each strain with five replicates.
To measure the extracellular protease activity, bacteria cultivated in the M63Y medium to the
stationary phase were diluted with Ringer buffer to 108 CFU/mL. Seven-microliter aliquots of bacterial
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cultures were spotted on the milk agar plates (the LA medium supplemented with 5% skimmed milk).
Plates were incubated at 30 ◦C for 48 h and the diameters of the arisen halo were measured. Each strain
was tested two times with five replicates.
4.11. Siderophore Activity Assay
Ten-microliter aliquots of supernatants from the stationary cultures (grown in M63Y medium
for 16 h) were spotted on the chrome azurol S-agar plates [70]. To prepare the chrome azurol S-agar
medium the following solutions were prepared: (1) main medium, (2) 10% deferrated casamino acids
(CAS), (3) 0.1 M CaCl2, (4) filtered 1 mM FeCl3 × 6H2O in 10 mM HCl, (5) CTAB (cetrimonium bromide,
Sigma-Aldrich, Saint Louis, MI, USA). To prepare the main medium solution the components, KH2PO4
(3 g), NaCl (0.5 g), NH4Cl (1.0 g), MgSO4 × 7H2O (0.2 g), sucrose (4.0 g) and agar (15.0 g), were
dissolved in 850 mL of 0.5 M Tris–HCl, pH 6.8 and sterilized. The deferrated casamino acids were
prepared by the removal of ferrous ions with 3% 8-hydroxyquinoline in chloroform. The sterilized
main solution was supplemented by 30 mL of 10% deferrated casamino acids, 10 mL of 0.1 M CaCl2,
50 mL of 0.08 mM CAS, 10 mL of 1 mM filtered FeCl3 × 6H2O in 10 mM HCl and 40 mL of 2 mM CTAB
(CAS, FeCl3 and CTAB were mixed before adding to solution). Plates were incubated at 30 ◦C for 1 h
and the intensity and diameter of the orange halo were compared. The experiment was performed two
times for five replicates for each strain.
4.12. RNA Extraction
Bacterial RNA was extracted using the Total RNA Mini Plus RNA extraction kit (A&A
Biotechnology, Gdynia, Poland) according to the manufacturer’s instructions. The quantity and
quality of the RNA samples were confirmed by measurement of absorbance at 260 nm and evaluation
of A260/A280 (~2) and A260/A230 (>2) ratios, and by agarose gel electrophoresis. Samples of 5 μg of
RNA were subjected to DNase treatment (A&A Biotechnology, Poland) by incubation of 20 μL reaction
mixtures in the presence of DNase (1U/μL) at 37 ◦C for 25 min followed by incubation at 75 ◦C for
10 min. The samples served as a template for the reverse transcription reaction.
4.13. Reverse Transcription
cDNA was transcribed from 1.5 μg of RNA with the use of RevertAid First Strand cDNA Synthesis
Kit (Thermo Fisher Scientific, Waltham, Massachusetts, USA), according to manufacturer’s protocol.
Obligatory step of denaturation of RNA with random hexamer primers mixture at 65 ◦C for 5 min
was added.
4.14. Quantitative Real-Time PCR (qPCR)
qPCR analysis was performed as described in [23]. Briefly, diluted cDNA samples in a 1:2 ratio
were used as qPCR templates. The qPCR reactions were carried out using the LightCycler 96 instrument
(Roche Diagnostics, Rotkreuz, Switzerland). Primer3 software was used to design primers [71] (Table 4).
Ten-fold dilution series of genomic DNA templates isolated from D. solani IPO 2222 were used to
estimate the amplification efficiency of each pair of primers. qPCR reaction was carried out with
FastStart Essential DNA Green Master (Roche Diagnostics, Rotkreuz, Switzerland). A 20 μL qPCR
reaction mixture contained 0.5 μL of cDNA, 3–4.5 pmol of forward and reverse primers, 10 μL of PCR
Mix. Thermal cycling parameters were as follows: preincubation at 95 ◦C for 5 min; 35–50 cycles
of amplification and quantitation at 95 ◦C for 15 s, 62 ◦C for 20 s and 72 ◦C for 16 s. At the end
of each cycle, melting curve analysis was performed (95 ◦C for 10 s, 65 ◦C for 60 s and 97 ◦C for
1 s). All qPCR reactions were performed for three biological replicates, with three technical repeats,
negative no template control (NTC) and no-reverse transcriptase (NRT) controls. Cq (quantification
cycle) values were averaged. The 16s rRNA gene was selected for normalization as it showed stability
under all tested conditions. Pfaffl-ΔΔCT method with correction for PCR efficiency was used for the
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determination of the relative expression of the lon gene [72]. Statistical analysis was performed with
the use of REST2009 software (v. 2009, Qiagen, Hilden, Germany) [73,74].














GCTTCTTTCTGTG 111 1.97 1.0 0.3
16S rRNA GCTCGTGTTGTGAAATGTTGGGTT
GCAGTCTCCCT
TGAGTTCCCAC 94 1.96 1.0 0.225
4.15. Protein Electrophoresis and Immunodetection
SDS page electrophoresis and Western blotting were performed as described in [75,76].
Then, 7.5% polyacrylamide gels were used. Briefly, the Lon protein was detected with the anti-Escherichia
coli Lon rabbit antibodies (#40219-T24, Sino Biological Inc., Beijing, China) at dilution 1:2000 followed
by incubation with HRP conjugated secondary anti-rabbit antibodies (#31462 Thermo Fisher) diluted
1:50,000. Chemiluminescent signal was developed using a luminol/ p-coumaric acid (Carl Roth GmbH
+ Co. KG) mix (4 mL of 1.41 mM luminol, 400 μL of 6.7 mM p-coumaric acid in DMSO, 4 μL of 30%
H2O2) and was recorded by Azure Biosystems c600 (Dublin, California, USA) imaging system.
4.16. Sample Preparation for Mass Spectrometry
The stationary growth phase cultures of D. solani cultivated in M63Y were subjected to
high-temperature stress. Briefly, the cultures were transferred from 30 ◦C to 40 ◦C and incubated
for 30 min with shaking. For control conditions, bacteria were cultivated at 30 ◦C. Five biological
replicates of each strain were pooled and centrifuged (7000× g, 2 min). The pellets were lysed with
the solution containing 4% SDS, 100 mM Tris/HCl pH 7.6, 0.1 M DTT (lysis solution) and incubated
at 95 ◦C for 10 min. After cooling, cold acetone was added to the solution to precipitate the released
proteins. The samples were incubated at -20 ◦C for about 2 h and then centrifuged for 20 min 20,000× g.
The supernatant was decanted and the precipitate dried. The pellet was then dissolved in 8 M urea in
0.1 M Tris/HCl pH 8.5 [77].
4.17. Protein Digestion
First, the protein concentration was measured by measuring absorbance at 280 nm (MultiskanTM
Thermo, Waltham, Massachusetts, USA) using the μDrop plate. Digestion was carried out according
to the standard Filter Aided Sample Preparation (FASP) procedure [77]. Then, 100 μg of protein
was used for each digestion and the procedure was carried out using microcons with 10 kDa mass
cut-offmembrane. Generated tryptic peptides were desalted with StageTips according to the protocol
described by Rappsilber [78]. For each desalting step, 10 μg of the peptide was taken and desalted on
StageTip containing three layers of 3 M Empore C18 exchange disks.
4.18. Liquid Chromatography and Mass Spectrometry
LC-MS/MS analysis was performed with the use of a Triple TOF 5600+mass spectrometer (SCIEX
Framingham, MA) coupled with the Ekspert MicroLC 200 Plus System (Eksigent, Redwood City,
California, USA). All chromatographic separations were performed on the ChromXP C18CL column
(3 μm, 120 Å, 150 × 0.3 mm). The chromatographic gradient for each IDA and SWATH runs was
3.5–20% B (solvent A 0% aqueous solution 0.1% formic acid, solvent B 100% acetonitrile 0.1% formic
acid) in 60 min. The whole system was controlled by the SCIEX Analyst TF 1.7.1 software (version
1.7.1, Framingham, MA, USA).
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4.19. SWATH Mass Spectrometry Experiments
All samples were acquired in triplicates. Experiments were performed in a looped product
ion mode.
A set of 25 transmission windows (variable wide) was constructed and covered the precursor
mass range of 400–1200 m/z. The collision energy for each window was calculated for +2 to +5 charged
ions centered upon the window with a spread of two. The SWATH-MS1 survey scan was acquired in
high sensitivity mode in the range of 400–1200 Da in the beginning of each cycle with the accumulation
time of 50 ms, and SWATH-MS/MS spectra were collected from 100 to 1800 m/z followed by 40 ms
accumulation time high sensitivity product ion scans, which resulted in the total cycle time of 1.11 s.
4.20. Data Analysis
Database search was performed with ProteinPilot 4.5 software (Sciex, v.4.5 AB, Framingham,
MA, USA) using the Paragon algorithm against the UNIPROT Dickeya solani database with an automated
false discovery rate, and standard parameters [79,80]. Next, a spectral library was created with the
group file data processing in PeakView v. 2.2 (Sciex), with parameters as described in detail by
Lewandowska [79]. Files from SWATH experiments for each sample were downloaded to PeakView
(Sciex, v.2.2, Framingham, MA, USA) software and processed with the previously established library.
Resulting data were exported to the .xml file and exported to Marker View software. All data
were normalized using total area sums (TAS) approach, grouped as wild type and tested samples
and t-test was performed. Samples were compared to each other, coefficient of variation (CV%)
was calculated, and proteins with a p-value lower than 0.05 with fold change 2 were considered as
differentially expressed in examined samples. The mass spectrometry proteomics data have been
deposited to the ProteomeXchange Consortium via the PRIDE [81] partner repository with the dataset
identifier PXD018297.
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Abbreviations
CAS casamino acids








PCWDE plant cell wall degrading enzymes
PQCS protein quality control system
SRP soft rot Pectobacteriaceae
SWATH-MS Sequential Window Acquisition of All Theoretical Mass Spectra
T1SS type I secretion system
T2SS type II secretion system
T3SS type III secretion system
WT wild-type
References
1. Adeolu, M.; Alnajar, S.; Naushad, S.; S Gupta, R. Genome-based phylogeny and taxonomy of the
“Enterobacteriales”: Proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae,
Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae
fam. nov., and Budviciaceae fam. nov. Int. J. Syst. Evol. Microbiol. 2016, 66, 5575–5599. [PubMed]
2. Toth, I.K.; Saddler, G.; Hélias, V.; Van Der Wolf, J.M.; Lojkowska, E.; Pirhonen, M.; Lahkim, L.T.; Elphinstone, J.
Dickeya species: An emerging problem for potato production in Europe. Plant Pathol. 2011, 60, 385–399.
[CrossRef]
3. Mansfield, J.; Genin, S.; Magori, S.; Citovsky, V.; Sriariyanun, M.; Ronald, P.; Dow, M.; Verdier, V.; Beer, S.V.;
Machado, M.A.; et al. Top 10 plant pathogenic bacteria in molecular plant pathology. Mol. Plant Pathol.
2012, 13, 614–629. [CrossRef] [PubMed]
4. Sławiak, M.; Van Beckhoven, J.R.C.M.; Speksnijder, A.; Czajkowski, R.; Grabe, G.; Van Der Wolf, J.M.
Biochemical and genetical analysis reveal a new clade of biovar 3 Dickeya spp. strains isolated from potato
in Europe. Eur. J. Plant Pathol. 2009, 125, 245–261. [CrossRef]
5. Czajkowski, R.; Perombelon, M.C.M.; Van Veen, J.A.; Van Der Wolf, J.M. Control of blackleg and tuber soft
rot of potato caused by Pectobacterium and Dickeya species: A review. Plant Pathol. 2011, 60, 999–1013.
[CrossRef]
6. Reverchon, S.; Nasser, W. Dickeyaecology, environment sensing and regulation of virulence programme.
Environ. Microbiol. Rep. 2013, 5, 622–636. [CrossRef]
7. Wagner, S.; Grin, I.; Malmsheimer, S.; Singh, N.; E Torres-Vargas, C.; Westerhausen, S. Bacterial type III
secretion systems: A complex device for the delivery of bacterial effector proteins into eukaryotic host cells.
FEMS Microbiol. Lett. 2018, 365, 365. [CrossRef]
8. Figaj, D.; Ambroziak, P.; Przepiora, T.; Skorko-Glonek, J. The Role of Proteases in the Virulence of Plant
Pathogenic Bacteria. Int. J. Mol. Sci. 2019, 20, 672. [CrossRef]
9. Flanagan, J.M.; Bewley, M.C. Protein quality control in bacterial cells: Integrated networks of chaperones
and ATP-dependent proteases. Genet. Eng. (N.Y.) 2002, 24, 17–47.
10. Ventura, S.; Villaverde, A. Protein quality in bacterial inclusion bodies. Trends Biotechnol. 2006, 24, 179–185.
[CrossRef]
11. Maurizi, M.R. Proteases and protein degradation inEscherichia coli. Cell. Mol. Life Sci. 1992, 48, 178–201.
[CrossRef] [PubMed]
12. Schoemaker, J.M.; Gayda, R.C.; Markovitz, A. Regulation of cell division in Escherichia coli: SOS induction
and cellular location of the sulA protein, a key to lon-associated filamentation and death. J. Bacteriol.
1984, 158, 551–561. [CrossRef] [PubMed]
98
Int. J. Mol. Sci. 2020, 21, 3687
13. Torres-Cabassa, A.S.; Gottesman, S. Capsule synthesis in Escherichia coli K-12 is regulated by proteolysis.
J. Bacteriol. 1987, 169, 981–989. [CrossRef] [PubMed]
14. Tsilibaris, V.; Maenhaut-Michel, G.; Van Melderen, L. Biological roles of the Lon ATP-dependent protease.
Res. Microbiol. 2006, 157, 701–713. [CrossRef] [PubMed]
15. Robertson, G.T.; Kovach, M.E.; Allen, C.A.; Ficht, T.A.; Roop, R.M. The Brucella abortus Lon functions as a
generalized stress response protease and is required for wild-type virulence in BALB/c mice. Mol. Microbiol.
2002, 35, 577–588. [CrossRef] [PubMed]
16. Takaya, A.; Suzuki, M.; Matsui, H.; Tomoyasu, T.; Sashinami, H.; Nakane, A.; Yamamoto, T. Lon,
a Stress-Induced ATP-Dependent Protease, Is Critically Important for Systemic Salmonella enterica Serovar
Typhimurium Infection of Mice. Infect. Immun. 2003, 71, 690–696. [CrossRef] [PubMed]
17. Breidenstein, E.B.M.; Janot, L.; Strehmel, J.; Fernández, L.; Taylor, P.K.; Kukavica-Ibrulj, I.; Gellatly, S.;
Levesque, R.C.; Overhage, J.; Hancock, R.E. The Lon Protease Is Essential for Full Virulence in Pseudomonas
aeruginosa. PLoS ONE 2012, 7, e49123. [CrossRef]
18. Su, S. Lon protease of the -proteobacterium Agrobacterium tumefaciens is required for normal growth,
cellular morphology and full virulence. Microbiology 2006, 152, 1197–1207. [CrossRef]
19. Lan, L.; Deng, X.; Xiao, Y.; Zhou, J.-M.; Tang, X. Mutation of Lon Protease Differentially Affects the
Expression ofPseudomonas syringaeType III Secretion System Genes in Rich and Minimal Media and
Reduces Pathogenicity. Mol. Plant Microbe Interact. 2007, 20, 682–696. [CrossRef]
20. Guo, M.; Gross, C.A. Stress-induced remodeling of the bacterial proteome. Curr. Boil. 2014, 24, R424–R434.
[CrossRef]
21. Ron, E.Z. Bacterial Stress Response. In The Prokaryotes: Prokaryotic Physiology and Biochemistry; Rosenberg, E.,
DeLong, E.F., Lory, S., Stackebrandt, E., Thompson, F., Eds.; Springer: Berlin/Heidelberg, Germany, 2013;
pp. 589–603. ISBN 978-3-642-30141-4.
22. Gottesman, S. Trouble is coming: Signaling pathways that regulate general stress responses in bacteria.
J. Boil. Chem. 2019, 294, 11685–11700. [CrossRef] [PubMed]
23. Przepiora, T.; Figaj, D.; Radzinska, M.; Apanowicz, M.; Sieradzka, M.; Ambroziak, P.;
Hugouvieux-Cotte-Pattat, N.; Lojkowska, E.; Skorko-Glonek, J. Effects of stressful physico-chemical factors
on the fitness of the plant pathogenic bacterium Dickeya solani. Eur. J. Plant Pathol. 2019, 156, 519–535.
[CrossRef]
24. Kearns, D.B. A field guide to bacterial swarming motility. Nat. Rev. Genet. 2010, 8, 634–644. [CrossRef]
[PubMed]
25. Ludwig, C.; Gillet, L.C.; Rosenberger, G.; Amon, S.; Collins, B.C.; Aebersold, R. Data-independent
acquisition-based SWATH - MS for quantitative proteomics: A tutorial. Mol. Syst. Boil. 2018, 14, e8126.
[CrossRef]
26. Inamine, G.S.; Dubnau, D. ComEA, a Bacillus subtilis integral membrane protein required for genetic
transformation, is needed for both DNA binding and transport. J. Bacteriol. 1995, 177, 3045–3051. [CrossRef]
27. Goff, S.A.; Casson, L.P.; Goldberg, A.L. Heat shock regulatory gene htpR influences rates of protein
degradation and expression of the lon gene in Escherichia coli. Proc. Natl. Acad. Sci. USA 1984, 81, 6647–6651.
[CrossRef]
28. Grossman, A.D.; Erickson, J.W.; Gross, C.A. The htpR gene product of E. coli is a sigma factor for heat-shock
promoters. Cell 1984, 38, 383–390. [CrossRef]
29. Grossman, A.D.; Straus, D.B.; A Walter, W.; A Gross, C. Sigma 32 synthesis can regulate the synthesis of heat
shock proteins in Escherichia coli. Genes Dev. 1987, 1, 179–184. [CrossRef]
30. Bianchi, A.A.; Baneyx, F. Hyperosmotic shock induces the σ32 and σE stress regulons of Escherichia coli.
Mol. Microbiol. 1999, 34, 1029–1038. [CrossRef]
31. Richmond, C.S. Genome-wide expression profiling in Escherichia coli K-12. Nucleic Acids Res.
1999, 27, 3821–3835. [CrossRef]
32. He, L.; Nair, M.K.M.; Chen, Y.; Liu, X.; Zhang, M.; Hazlett, K.R.O.; Deng, H.; Zhang, J.-R. The Protease
Locus of Francisella tularensis LVS Is Required for Stress Tolerance and Infection in the Mammalian Host.
Infect. Immun. 2016, 84, 1387–1402. [CrossRef]
33. Jiang, X.; Zghidi-Abouzid, O.; Oger-Desfeux, C.; Hommais, F.; Greliche, N.; Muskhelishvili, G.; Nasser, W.;
Reverchon, S.; Xuejiao, J.; Ouafa, Z.; et al. Global transcriptional response of Dickeya dadantii to environmental
stimuli relevant to the plant infection. Environ. Microbiol. 2016, 18, 3651–3672. [CrossRef] [PubMed]
99
Int. J. Mol. Sci. 2020, 21, 3687
34. Cebrián, G.; Condón, S.; Mañas, P. Physiology of the Inactivation of Vegetative Bacteria by Thermal Treatments:
Mode of Action, Influence of Environmental Factors and Inactivation Kinetics. Foods 2017, 6, 107. [CrossRef]
[PubMed]
35. Witkin, E. RecA protein in the SOS response: Milestones and mysteries. Biochimie 1991, 73, 133–141.
[CrossRef]
36. Sakoh, M.; Ito, K.; Akiyama, Y. Proteolytic Activity of HtpX, a Membrane-bound and Stress-controlled
Protease fromEscherichia coli. J. Boil. Chem. 2005, 280, 33305–33310. [CrossRef] [PubMed]
37. Shabala, L.; Bowman, J.P.; Brown, J.; Ross, T.; McMeekin, T.; Shabala, S. Ion transport and osmotic adjustment
inEscherichia coliin response to ionic and non-ionic osmotica. Environ. Microbiol. 2009, 11, 137–148.
[CrossRef] [PubMed]
38. Heuveling, J.; Possling, A.; Hengge, R. A role for Lon protease in the control of the acid resistance genes of
Escherichia coli. Mol. Microbiol. 2008, 69, 534–547. [CrossRef]
39. Ingmer, H.; Brøndsted, L. Proteases in bacterial pathogenesis. Res. Microbiol. 2009, 160, 704–710. [CrossRef]
40. Frees, D.; Brøndsted, L.; Ingmer, H. Bacterial Proteases and Virulence. Membr. Biog. 2013, 66, 161–192.
41. Hugouvieux-Cotte-Pattat, N.; Condemine, G.; Shevchik, V. Bacterial pectate lyases, structural and functional
diversity. Environ. Microbiol. Rep. 2014, 6, 427–440. [CrossRef]
42. Ciesielski, S.J.; Schilke, B.; Marszalek, J.; Craig, E. Protection of scaffold protein Isu from degradation by the
Lon protease Pim1 as a component of Fe–S cluster biogenesis regulation. Mol. Boil. Cell 2016, 27, 1060–1068.
[CrossRef] [PubMed]
43. Hunt, M.D.; Pettis, G.S.; A McIntosh, M. Promoter and operator determinants for fur-mediated iron regulation
in the bidirectional fepA-fes control region of the Escherichia coli enterobactin gene system. J. Bacteriol.
1994, 176, 3944–3955. [CrossRef] [PubMed]
44. Clemmer, K.M.; Rather, P.N. The Lon protease regulates swarming motility and virulence gene expression in
Proteus mirabilis. J. Med. Microbiol. 2008, 57, 931–937. [CrossRef] [PubMed]
45. Mukherjee, S.; Bree, A.C.; Liu, J.; Patrick, J.E.; Chien, P.; Kearns, D.B. Adaptor-mediated Lon proteolysis
restricts Bacillus subtilis hyperflagellation. Proc. Natl. Acad. Sci. USA 2014, 112, 250–255. [CrossRef]
[PubMed]
46. Lee, J.H.; Ancona, V.; Zhao, Y. Lon protease modulates virulence traits in Erwinia amylovora by
direct monitoring of major regulators and indirectly through the Rcs and Gac-Csr regulatory systems.
Mol. Plant Pathol. 2017, 19, 827–840. [CrossRef]
47. Takaya, A.; Tomoyasu, T.; Tokumitsu, A.; Morioka, M.; Yamamoto, T. The ATP-Dependent Lon Protease
of Salmonella enterica Serovar Typhimurium Regulates Invasion and Expression of Genes Carried on
Salmonella Pathogenicity Island 1. J. Bacteriol. 2002, 184, 224–232. [CrossRef]
48. Haque, M.M.; Oliver, M.H.; Nahar, K.; Alam, M.Z.; Hirata, H.; Tsuyumu, S. CytR Homolog of Pectobacterium
carotovorum subsp. carotovorum Controls Air-Liquid Biofilm Formation by Regulating Multiple Genes
Involved in Cellulose Production, c-di-GMP Signaling, Motility, and Type III Secretion System in Response
to Nutritional and Environmental Signals. Front. Microbiol. 2017, 8.
49. Josenhans, C.; Suerbaum, S. The role of motility as a virulence factor in bacteria. Int. J. Med. Microbiol.
2002, 291, 605–614. [CrossRef]
50. Jackson, M.W.; Silva-Herzog, E.; Plano, G.V. The ATP-dependent ClpXP and Lon proteases regulate expression
of the Yersinia pestis type III secretion system via regulated proteolysis of YmoA, a small histone-like protein.
Mol. Microbiol. 2004, 54, 1364–1378. [CrossRef]
51. Bretz, J.; Losada, L.; Lisboa, K.; Hutcheson, S.W. Lon protease functions as a negative regulator of type III
protein secretion in Pseudomonas syringae. Mol. Microbiol. 2002, 45, 397–409. [CrossRef]
52. Ventrice, C. Functional Characterization of the csp Homologs of E. coli K-12. Electronic Theses and
Dissertations. Master’s Thesis, Duquesne University, Pittsburgh, PA, USA, 2004.
53. Fernández, L.; Breidenstein, E.B.M.; Taylor, P.K.; Bains, M.; De La Fuente-Núñez, C.; Fang, Y.; Foster, L.J.;
Hancock, R.E. Interconnection of post-transcriptional regulation: The RNA-binding protein Hfq is a novel
target of the Lon protease in Pseudomonas aeruginosa. Sci. Rep. 2016, 6, 26811. [CrossRef] [PubMed]
54. Golanowska, M. Characterization of Dickeya solani strains and identification of bacterial and plant signals
involved in induction of virulence. In Microbiology and Parasitology; INSA de Lyon: Lyon, France, 2015.
100
Int. J. Mol. Sci. 2020, 21, 3687
55. Antonova, E.S.; Bernardy, E.; Hammer, B.K. Natural competence in Vibrio cholerae is controlled
by a nucleoside scavenging response that requires CytR?dependent anti?activation. Mol. Microbiol.
2012, 86, 1215–1231. [CrossRef] [PubMed]
56. Porankiewicz, J.; Wang, J.; Clarke, A.K. New insights into the ATP-dependent Clp protease: Escherichia coli
and beyond. Mol. Microbiol. 1999, 32, 449–458. [CrossRef] [PubMed]
57. Miller, J.H. A Short Course in Bacterial Genetics: Handbook; Cold Spring Harbor Laboratory Press: Cold Spring
Harbor, NY, USA, 1992; ISBN 978-0-87969-349-7.
58. Hanahan, D. Studies on transformation of Escherichia coli with plasmids. J. Mol. Boil. 1983, 166, 557–580.
[CrossRef]
59. Platt, R.; Drescher, C.; Park, S.-K.; Phillips, G.J. Genetic System for Reversible Integration of DNA Constructs
and lacZ Gene Fusions into the Escherichia coli Chromosome. Plasmid 2000, 43, 12–23. [CrossRef]
60. Ferrières, L.; Hémery, G.; Nham, T.; Guérout, A.-M.; Mazel, D.; Beloin, C.; Ghigo, J.-M. Silent Mischief:
Bacteriophage Mu Insertions Contaminate Products of Escherichia coli Random Mutagenesis Performed
Using Suicidal Transposon Delivery Plasmids Mobilized by Broad-Host-Range RP4 Conjugative Machinery.
J. Bacteriol. 2010, 192, 6418–6427. [CrossRef]
61. Van Der Wolf, J.M.; Nijhuis, E.H.; Kowalewska, M.J.; Saddler, G.S.; Parkinson, N.; Elphinstone, J.G.;
Pritchard, L.; Toth, I.K.; Lojkowska, E.; Potrykus, M.; et al. Dickeya solani sp. nov., a pectinolytic
plant-pathogenic bacterium isolated from potato (Solanum tuberosum). Int. J. Syst. Evol. Microbiol.
2014, 64, 768–774. [CrossRef]
62. Lee, D.J.; Bingle, L.E.; Heurlier, K.; Pallen, M.J.; Penn, C.W.; Busby, S.; Hobman, J. Gene doctoring: A method
for recombineering in laboratory and pathogenic Escherichia coli strains. BMC Microbiol. 2009, 9, 252.
[CrossRef]
63. Edwards, R.A.; Keller, L.H.; Schifferli, D.M. Improved allelic exchange vectors and their use to analyze 987P
fimbria gene expression. Gene 1998, 207, 149–157. [CrossRef]
64. Stukenberg, D.; (Zentrum für Synthetische Mikrobiologie, Marburg, Germany). Personal communication, 2019.
65. Isothermal Reaction (Gibson Assembly) Master Mix. Cold Spring Harb. Protoc. 2017, 2017, 090019.
66. Tu, Q.; Yin, J.; Fu, J.; Herrmann, J.; Li, Y.-Z.; Yin, Y.; Stewart, A.F.; Müller, R.; Zhang, Y. Room temperature
electrocompetent bacterial cells improve DNA transformation and recombineering efficiency. Sci. Rep.
2016, 6, 24648. [CrossRef] [PubMed]
67. Collmer, A.; Ried, J.L.; Mount, M.S. Assay methods for pectic enzymes. In Methods in Enzymology; Elsevier BV:
Amsterdam, The Netherlands, 1988; Volume 161, pp. 329–335.
68. Tardy, F.; Nasser, W.; Robert-Baudouy, J.; Hugouvieux-Cotte-Pattat, N. Comparative analysis of the five
major Erwinia chrysanthemi pectate lyases: Enzyme characteristics and potential inhibitors. J. Bacteriol.
1997, 179, 2503–2511. [CrossRef] [PubMed]
69. Andro, T.; Chambost, J.P.; Kotoujansky, A.; Cattaneo, J.; Bertheau, Y.; Barras, F.; Van Gijsegem, F.;
Coleno, A. Mutants of Erwinia chrysanthemi defective in secretion of pectinase and cellulase. J. Bacteriol.
1984, 160, 1199–1203. [CrossRef] [PubMed]
70. Schwyn, B.; Neilands, J. Universal chemical assay for the detection and determination of siderophores.
Anal. Biochem. 1987, 160, 47–56. [CrossRef]
71. Primer3 Input (Version 0.4.0). Available online: http://bioinfo.ut.ee/primer3-0.4.0/ (accessed on 31 March 2020).
72. Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res.
2001, 29, 45. [CrossRef] [PubMed]
73. Pfaffl, M.W. Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis
of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30, 36. [CrossRef]
74. REST-BioInformatics in Real-Time PCR. Available online: http://rest.gene-quantification.info/ (accessed on
31 March 2020).
75. Laemmli, U.K. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature
1970, 227, 680–685. [CrossRef]
76. Oberfelder, R. Detection of proteins on filters by enzymatic method. In Methods in Nonradioactive Detection;
Howard, G.C., Ed.; Appleton & Lange: Norwalk, CT, USA, 1993; pp. 83–85. ISBN 978-0-8385-6946-7.
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Abstract: Effector proteins play an important role in the virulence of plant pathogens such as
phytoplasma, which are the causative agents of hundreds of different plant diseases. The plant hosts
comprise economically relevant crops such as apples (Malus × domestica), which can be infected by
‘Candidatus Phytoplasma mali’ (P. mali), a highly genetically dynamic plant pathogen. As the result of
the genetic and functional analyses in this study, a new putative P. mali effector protein was revealed.
The so-called “Protein in Malus Expressed 2” (PME2), which is expressed in apples during P. mali
infection but not in the insect vector, shows regional genetic differences. In a heterologous expression
assay using Nicotiana benthamiana and Nicotiana occidentalis mesophyll protoplasts, translocation
of both PME2 variants in the cell nucleus was observed. Overexpression of the effector protein
affected cell integrity in Nicotiana spp. protoplasts, indicating a potential role of this protein in
pathogenic virulence. Interestingly, the two genetic variants of PME2 differ regarding their potential
to manipulate cell integrity. However, the exact function of PME2 during disease manifestation and
symptom development remains to be further elucidated. Aside from the first description of the
function of a novel effector of P. mali, the results of this study underline the necessity for a more
comprehensive description and understanding of the genetic diversity of P. mali as an indispensable
basis for a functional understanding of apple proliferation disease.
Keywords: phytoplasma; effector protein; apple; pathogenicity; virulence; apple proliferation
1. Introduction
Phytoplasma are small, biotrophic bacteria that cause hundreds of different plant diseases and
are involved in their infection cycle not only in plant hosts, but also in insect vectors. ’Candidatus
Phytoplasma mali’ (P. mali), the causal agent of apple proliferation (AP) disease, has caused significant
economic losses in apple production in Northern Italy (one of Europe’s main production areas) in
the last decades [1]. Phytoplasma are obligate plant and insect symbionts that exhibit a biphasic life
cycle comprising reproduction in certain phloem-feeding insects as well as in plants [2,3]. Within their
plant host, phytoplasma colonize the phloem. By ingestion of phloem sap, insect vectors acquire the
phytoplasma, with the colonization of those insects enabling the transmission of the pathogen between
host plants [3,4]. Although several concepts of phytoplasma effector biology were able to be unraveled
for the ’Candidatus Phytoplasma asteris’ strain Aster Yellow Witches’ Broom (AY-WB) in the model plant
Arabidopsis thaliana [5–12], the understanding of effector-driven changes induced by P. mali remain
limited. Genetic and functional homologues of AY-WB phytoplasma protein SAP11 could be identified
in P. mali [10,13]. Recently a novel effector was described that exhibits E3 Ubiquitin ligase function and
affects the plant’s basal defense [14]. Furthermore, the immunodominant membrane protein Imp of
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P. mali was shown not to be involved in symptom development but is considered to play a role during
plant colonization [15]. A role of phytoplasmal HflB proteases and an AAA+ ATPase in AP virulence
has been hypothesized but not yet clarified [16–18]. P. mali encodes genes for a Sec-dependent protein
secretion system, whereas genes encoding components of other secretion systems, such as the type
three secretion system, are mainly lacking [19,20]. Secreted phytoplasma proteins may directly interact
with cellular host components and thus manipulate the cell’s metabolism [3]. Potential effector proteins
may thus be identified by the presence of a characteristic N-terminal secretion signal.
The aim of this study was to characterize the function of the phytoplasmal “Protein in Malus
Expressed 2” (PME2) from P. mali that exhibits genetic features indicating that it acts as an effector
protein in plants. To unravel PME2s potential role as an effector, this study analyzed (1) whether it is
genetically conserved; (2) whether it is expressed during infection; (3) where it is translocated within
the plant cell; and (4) if it induces morphological changes within the expressing plant cells.
To address these questions, we analyzed the expression of PME2 in P. mali-infected
Malus × domestica leaf and root tissue, and in infected Cacopsylla picta (i.e., insect species transmitting
P. mali). In infected Malus × domestica we found two distinct genetic variants of pme2. In addition,
heterologous overexpression of PME2 in mesophyll protoplasts of Nicotiana spp. was used to gain
insights into the subcellular localization of PME2 as well as its effects on plant cell integrity. These data
were complemented by the expression of PME2 in yeast. With the data presented here, the first steps
into unraveling the molecular mechanism of PME2 function were taken, but further experiments in the
future will be indispensable.
2. Results
2.1. In Silico Analysis of PME2 Indicates Effector Potential
Bioinformatic analysis of conserved hypothetical proteins encoded in the P. mali genome [19]
revealed that CAP18323.1, encoded by the gene atp_00136, contains interesting features that might
confer effector function. Neural networks and hidden Markov prediction models (Transmembrane
Helices Hidden Markov Model; TMHMM) were applied to analyze CAP18323.1 for the presence of a
signal peptide and the presence of transmembrane regions (SignalP v. 3.0 [21], TMHMM [22]). Since
phytoplasma phylogenetically belong to Gram-positive bacteria [3], a prediction algorithm trained on
this bacterial group was applied. The N-terminal amino acid-stretch 1–31 contains a signal peptide that
is supposed to confer Sec-dependent secretion of the protein (Figure 1). Further transmembrane regions
were not predicted, indicating that CAP18323.1 is not inserted in a membrane. Upon translation,
N-terminal signal peptides are cleaved [23]. At the C-terminal part of CAP18323.1 an importin
α/β-dependent nuclear localization site (NLS) and a nuclear export signal (NES) were predicted [24,25].
The absence of transmembrane regions in the mature protein, the predicted localization in the plant
cytoplasma or the nucleus (WoLF PSORT, [26]), and the small size of about 16 kDa (Analysis Tool on
the ExPASy Server, [27]) indicate that CAP18323.1 may exhibit an effector function (Figure 1).
2.2. Atp_00136 (Pme2) is Expressed in P. Mali-Infected Malus × Domestica but not in the Insect Vector
C. Picta
Subsequently, it was analyzed whether atp_00136 was expressed in apple trees infected with P. mali.
Leaf and root samples of P. mali-infected and non-infected Malus × domestica cv. “Golden Delicious”
trees were taken in May and October. Expression of atp_00136 was analyzed with atp_00136-specific
primers and Malus × domestica cDNA derived from mRNA. Expression of atp_00136 was confirmed in
P. mali-infected leaf and root tissue by the detection of distinct amplicons at the expected size in the
respective samples (Figure 2).
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Figure 1. Results of the in silico analysis. Sequence analysis of atp_00136 revealed the presence of
an N-terminal signal peptide (indicated in red), as well as a nuclear localization signal (NLS), and a
C-terminal nuclear export signal (NES), both indicated in green. Graphs were generated with Geneious
Prime 2018 version 11.1.4.
Figure 2. Expression of pme2 (CAP18323.1) in ’Candidatus Phytoplasma mali’ (P. mali)-infected
Malus × domestica. Transcripts of pme2 were detected by PCR using cDNA from Malus × domestica
infected with P. mali. A discrete band of the size indicative for the pme2 transcript was detected in
P. mali-infected (Pm+) but not in non-infected (Pm–) leaves and roots harvested in October. DNA
derived from an infected Malus× domestica served as a positive control (pc) and water as the non-template
control (ntc).
Using quantitative PCR (qPCR) the expression levels of atp_00136 and P. mali in the samples
were quantified. The results show that atp_00136 is only expressed in tissue colonized by P. mali
(Table 1). Since identified expressed genes were named in a chronological manner, atp_00136 was
named “Protein in Malus Expressed 2” (pme2) based on the general recommendations for bacterial
gene nomenclature [28].
To analyze if pme2 was expressed in the transmitting insect vectors during infection, three
P. mali-infected C. picta individuals were analyzed for the expression of the potential effector. In the
RNA/cDNA of all infected individuals, P. mali-specific transcripts of the ribosomal protein rpl22 were
detected, but expression of pme2 was not detectable.
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Table 1. Detection of atp_00136 in cDNA samples from infected and non-infected leaf tissue from
May and October 2011. In May phytoplasma were only detectable in the roots but not in the leaves.
atp_00136 was only detectable in P. mali-infected and colonized tissue. Cq values are given as the mean
value of three repeated qPCR runs.
Month Status Pool cDNA Integrity (tip41) Phytoplasma (16S) atp_00136
May non-infected 1 26.38 N/A N/A
2 26.38 N/A N/A
Oct non-infected 3 26.58 N/A N/A
2 26.59 N/A N/A
3 26.58 N/A N/A
May infected 1 26.56 N/A N/A
2 26.53 N/A N/A
3 26.61 N/A N/A
Oct infected 1 26.71 23.67 28.00
2 26.44 23.18 27.66
3 26.48 23.34 28.34
2.3. Genetic Variability of Pme2
Cloned amplicon sequencing revealed that the prevalent variant of pme2 from infected trees in
South Tyrol (North-East Italy) differs compared to the pme2 sequence of the P. mali AT strain from
Germany [19]. In a total of 20 samples from naturally infected apple trees in the regions Burggraviato
and Val Venosta, a prevalent, conserved sequence of pme2 was identified (pme2ST; accession number
MN224214). This conserved variant exhibits a single nucleotide polymorphism (SNP) in the sequence
stretch before the NLS, and two SNPs within and one SNP after the NLS compared to the AT strain
(Figure 3). All four SNPs in the pme2ST variant lead to nonsynonymous missense substitutions at the
protein level as compared to the pme2 sequence published previously [19] (pme2AT). The NLS of pme2ST
has a slightly higher prediction score than the NLS of pme2AT. The most striking difference between
pme2AT and pme2ST is a stretch of 120 bp in pme2ST which is absent in pme2AT. This stretch is a partial
duplication of a fragment also present in pme2AT (Figure 3). In three Malus × domestica samples, a very
sporadic sequence of pme2 could be detected that did not contain the pme2ST characteristic sequence
duplication but showed strong sequence similarity to pme2AT. The sporadic sequence contains six
SNPs at positions 218 (A > T), 220 (A > G), 322 (A > G), 331 (A > C), 344 (C < T), and 427 (T > G)
that lead to nonsynonymous missense mutations (accession number MN224215) compared to pme2AT.
However, in the trees in which these very sporadic pme2 sequences were found, pme2ST could also be
detected, indicating the presence of a mixed population of different P. mali strains.
Figure 3. Sequence comparison of PME2ST and PME2AT. The protein variants (a) PME2AT and (b)
PME2ST contain the same N-terminal signal peptide sequence (red). PME2ST (b) contains a duplicated
amino acid stretch (the replicative sequences 1 and 2; marked in blue) of a partial sequence also present
in PME2AT (a). Both variants show slight differences in and directly before the nuclear localization
signal sequences (NLS, green). The nuclear export signal sequence (NES, green) is identical in both
protein variants. Amino acid differences of PME2ST to the PME2AT variant are shown in black, whereas
similarities are shown in grey. Graphs were generated with Geneious Prime 2018 version 11.1.4.
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2.4. PME2ST and PME2AT Translocate to the Nucleus of Nicotiana spp. Protoplasts
To identify the subcellular localization of the PME2 protein in the plant cell, mesophyll protoplasts
of Nicotiana occidentalis and N. benthamiana were transformed, with expression vectors coding for
PME2AT and PME2ST tagged with GFP or mCherry-fluorescent protein to allow subcellular tracking.
The N-terminal signal part was not considered for these studies, since it is removed from the processed,
mature CAP18323.1 protein. N. occidentalis and N. benthamiana can be infected with P. mali. Upon
infection, both Nicotiana species show disease-specific symptoms and are thus appropriate model
plants for P. mali effector studies [15,29]. Confocal microscopy analysis revealed that overexpressed
PME2AT and PME2ST are translocated to the nucleus of Nicotiana spp. protoplasts. This translocation
was independent of the used tag and Nicotiana species (Figure 4 and Figures S1–S3). The in vivo results
therefore confirm the in silico prediction that PME2ST and PME2AT are translocated to the nucleus of
potential host cells.
 
Figure 4. PME2ST and PME2AT are translocated to the nucleus of mesophyll protoplasts. Mesophyll
protoplasts of Nicotiana benthamiana were transformed with the plasmid pGGZ001 encoding C-terminal
GFP-tagged PME2ST (first column), PME2AT (second column), GFP N-terminally fused to a NLS
sequence (third column), or GFP only as a control for nuclear localization (fourth column). Expression
of the transgenes was under the control of a 35S promoter. The upper panel shows autofluorescence of
chloroplasts (Chl), the second panel the signal derived from the GFP, and the third panel the bright
field image and the last panel an overlay of all images (merged). Microscopic analysis was performed
with a Zeiss LSM 800. Corresponding images after expression of mCherry-tagged PME2 and of use of
Nicotiana occidentalis mesophyll protoplasts are presented in Figures S1–S3. Bars represent 20 μm.
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A leaf infiltration assay using Agrobacterium strain EHA105 transformed with PME2 encoding
expression vectors did not result in detectable expression or phenotypic alterations of either PME2AT
or PME2ST in both Nicotiana species. Nonetheless, positive controls expressing the fluorophore tag
only and leaves infiltrated with the P. mali SAP11-like effector protein ATP_00189 [13] as control
showed strong signals (Figure S5), indicating that PME2 expression might be somehow blocked or is
immediately degraded by the plant.
2.5. PME2ST but not PME2AT Affect Cell Integrity of Nicotiana spp. Protoplasts
Protoplasts transformed with the PME2ST expression vector often showed shrinkage, and only
about 50% of the N. benthamiana protoplasts were viable 20 h post-transformation compared to the
transformation control expressing the fluorophore only or a GFP with NLS (Figure 5a). The shrunk
cells lysed and only the remaining cell debris was microscopically detectable (Figure 4). The effect
on protoplast integrity was observed in protoplasts expressing PME2ST:GFP and PME2ST:mCherry,
and thus was independent of the fluorophore used as a tag for microscopic analyses. Similar results
were obtained using N. occidentalis as the heterologous PME2ST expression system. The mCherry-tagged
PME2ST induced a weak but significant reduction of viability in N. occidentalis protoplasts (Figure 5b).
The GFP-tagged PME2ST showed the same tendency but to a stronger extent, i.e., it reduced cell
viability by about 50%, which is similar to the effect seen in N. benthamiana protoplasts. Cell viability
stain with fluorescein diacetate (FDA) showed similar results, i.e., that N. benthamiana protoplasts
transformed with the PME2ST-expressing vector showed a significantly reduced viability (Figure 6).
Shrunk cells were positive for propidium iodide (PI) staining (Figure S4), indicating that these cells
were dead.
Figure 5. PME2ST overexpression reduces viability of (a) N. benthamiana and (b) N. occidentalis mesophyll
protoplasts. For each assay, 20,000 mesophyll protoplasts were transformed with the plasmid pGGZ001
encoding PME2ST, PME2AT (tagged with GFP or mCherry), the GFP-tagged control for nuclear
localization (NLS), or the mCherry tag (tag only) and viable protoplasts were counted. Overexpression
of the transgenes was under the control of a 35S promoter. Data represent the mean viability +/–
SE of 3–4 independent experiments. The respective control (NLS or tag only) was set at 1 to allow
comparison between different experiments. Differences between the groups were determined applying
a one way-ANOVA analysis. Significant differences (p < 0.05) between groups are indicated with an
asterisk (*).
Interestingly, PME2AT did not have an effect on protoplast integrity in N. benthamiana nor in N.
occidentalis protoplasts (Figure 5).
2.6. A Yeast Two-Hybrid Screen Was Unsuitable for the Elucidation of PME2ST Function
Upon expression of PME2ST, the yeast reporter strain Saccharomyces cerevisiae NMY51 showed
several macroscopic aberrations in colony growth (Figure 7a). However, at the microscopic level
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when visualizing the yeast cell wall with calcofluor white, no phenotypic differences between yeast
cells expressing PME2AT, PME2ST, and empty bait vector pLexA-N could be detected (Figure 7b).
Considering the effect of mere PME2ST expression on growth of the yeast reporter strain, the relevance
of any identified interaction in a yeast two-hybrid screen remains highly questionable and the assay
was therefore not performed.
Figure 6. PME2ST overexpression reduces viability of N. benthamiana mesophyll protoplasts. Mesophyll
protoplasts were transformed with the plasmid pGGZ001 encoding mCherry-tagged PME2ST (PMEST)
or the mCherry tag only (mCherry) and stained with fluorescein diacetate (FDA) to detect viable
cells. Data represent the mean percentage of FDA-positive stained cells +/– SE (n = 3). The statistical
difference between the two groups was determined by using a Student’s t-test and is indicated with an
asterisk (*p < 0.05).
 
Figure 7. PME2ST overexpression in the yeast reporter strain NMY51 leads to macroscopic aberrations.
Saccharomyces cerevisiae strain NMY51 was transformed with the yeast two-hybrid (Y2H) bait vector
pLexA-N, which encodes tryptophan auxotrophy, expressing PME2AT, PME2ST, or the empty vector
only, and drop-plated onto SD-trp plates. In comparison to the empty pLexA-N vector and the vector
expressing PMEAT, colonies expressing PMEST showed reduced growth and remained white (a). Yeast
cells stained with calcofluor white did not show any phenotypic differences on single-cell level (b).
Calcofluor white fluorescence was visualized on a confocal microscope (LSM 800, Carl Zeiss AG,
Oberkochen, Germany).
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3. Discussion
The results of this study show that PME2ST (a variant of CAP18323.1 previously annotated as
“conserved hypothetical protein”) affects plant cell integrity. Based on our findings and the definition
that effectors are secreted pathogen proteins altering host-cell structure and function [30], we propose
defining PME2 as a phytoplasmal effector. Interestingly, two different variants of PME2 were identified
and both variants translocate to the nucleus of plant cells, but only the newly described regional
variant PME2ST subsequently affects protoplast integrity. The small size of about (at a maximum)
21 kDa (PME2ST: 21 kDa and PME2AT: 16 kDa; both considering the mature protein without the signal
peptide) indicates that PME2 can be translocated from the phloem and target adjacent tissues or be
distributed systemically in the plant [3]. Subcellular localization using microscopy requires the use of
fluorescent tags that are attached to the protein of interest. Tagging can affect subcellular localization
of the protein; however, we used two different tags (GFP and mCherry) to analyze whether tagging
influences the target localization. In cells expressing the tag only, a localization of the fluorescent
signal in the cytoplasm could be observed. PME2 was localized only in the nucleus and since no
signal was visible in other cell compartments, it can be assumed that the observed localization is
effector-mediated (see also [31]). Only protoplasts transformed with PME2ST showed significant cell
disruption as indirectly quantified by counting the remaining viable cells and FDA staining of the
protoplasts. Shrunk cells were positive for the PI stain but did not show a GFP signal. The lack of the
GFP-signal might be caused by a disruption of the nucleus, protein degradation, and/or leakage of the
signal into the surrounding medium. Cells expressing PME2ST were intact, indicating that the effector
either exhibits a dose-dependent or delayed effect on cell integrity.
Both variants of PME2 contain an N-terminal signal peptide, a nuclear localization signal (NLS),
and a nuclear export signal (NES). It is a common feature of nuclear proteins to contain both NLS and
NES and these signals coordinate the translocation of the protein between nucleus and cytoplasm [32].
Nuclear targeting of proteins containing a classical NLS is mediated by the importin α/β heterodimer
through NLS-dependent binding to the importin α subunit and importin β–mediated attachment to
the nuclear pore complex [33,34]. The SNPs in the NLS region of PME2ST lead to a (slightly) higher
sequence-based NLS prediction; thus, the differences might show a stronger translocation to the
nucleus. The NES signal (which indicates that shuttling of PME2 between nucleus and cytoplasm might
occur) is the same in both variants. Even though nucleocytoplasmic distribution is predicted, PME2
was only detected in the nucleus. Many proteins containing NLS and NES appear to be localized in the
nucleus because the rate of import to the nucleus is higher than the rate of export to the cytoplasm [35].
It remains thus unclear if PME2 is strictly limited to the nucleus or if a constant shuttling between
nucleus and cytosol occurs.
Bacterial effectors that translocate to the nucleus, the so-called nuclear effectors, can affect master
switches of the host immune machinery or alter host transcription to the benefit of the pathogen [31].
Effectors from different phytoplasma species target plant–host transcription factors or affect gene
expression on the transcriptional level to alter the host metabolism to their own benefit [4,12,13,36,37].
However, none of these effectors have yet been reported to exhibit such detrimental effects during in
planta expression. The effector protein BR1 of the phloem colonizing squash leaf curl geminivirus
shuttles between the cytoplasm and the nucleus of protoplasts [38]. Upon binding to the second
movement protein BL1, BR1 shuttles to the cytoplasma [39] and the concerted action between BR1 and
BL1 mediates cell-to-cell movement of the virus within the phloem and to adjacent cells [35,38,40,41].
To unravel BR1 function it was necessary to identify its interaction partner, a general approach to
investigate effector function. Yeast two-hybrid (Y2H) screens have been successfully applied to
determine phytoplasmal effector targets on the molecular level [10,13]. These screens allow the
screening of a protein of interest (effector) against a library containing hundreds of thousands of
different potential interaction partners of a certain host species [42,43]. Successful interaction is
monitored by a genetic reporter system that complements certain auxotrophies in the recombinant
yeast reporter strain. However, a Y2H with PME2ST is not suitable since PME2ST expression strongly
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affected the Y2H yeast reporter strain. This effect on yeast cells further supports the finding that PME2ST
exhibits a strong effect not only on plant, but also on yeast cells, even though the latter do not have
relevance as phytoplasma host cells. Since PME2ST exhibits such a strong effect on the expressing host
and non-host cells, alternative approaches must be applied to unravel its molecular function. Nicotiana
spp. leaf infiltration assays with recombinant Agrobacterium strains expressing PME2 failed. It remains
furthermore elusive as to whether PME2 exhibits effects on the host plant phenotype. Considering
the PME2ST effects on protoplasts it can be assumed that a systemic overexpression would lead to
overwhelming deleterious effects in transgenic plants that express this effector. The results show that
PME2 is expressed in roots and leaves of infected Malus × domestica, but not in infected individuals of
its insect vector C. picta, underlining the hypothesis that PME2 plays a role as an effector protein in
plant cells. However, it needs further clarification if expression is fine-tuned in a tempo-spatial manner
in the plant host.
A neatly coordinated and local expression during infection might have very local effects and might
not lead to cell disruption as seen in heterologous overexpression experiments. It is hypothesized
that phytoplasma are able to degrade plant cell walls or generate holes in plant cell membranes to
expedite cell-to-cell effector translocation [4]. Infection with P. mali induces cytochemical modifications
and injuries of the affected phloem cells [44,45]. It is speculated that plasma membrane integrity is
affected by until-now unknown P. mali effector(s) and that plasma membrane disruption is involved
in the observed phloem damage induced by virulent P. mali strains [45]. However, since molecular
indications are lacking, interpretation of the mode of PME2 action remains speculative. Subsequent
approaches to analyze PME2 function should comprise assays that do not depend on functional
living cells.
Since PME2 is translocated to the nucleus it is possible that it directly targets the host DNA by
mimicking DNA regulatory elements, such as transcription factors or repressors. Some plant pathogen
effectors bind host DNA and thus modulate gene expression [46,47]. An example of these effectors are
TAL effectors of the plant pathogen Xanthomonas. TAL effectors bind promoter elements and regulate
plant host expression to the benefit of the pathogen [48–51]. The effector AvrBs3 of Xanthomonas
translocates to the nucleus where it acts as a transcription factor and affects the size of mesophyll
cells [52]. Bioinformatic prediction and sequence comparison did not indicate that PME2 has similarity
with currently known transcription factors or other gene expression regulating factors in plants.
Both P. mali strains from which the two different PME2 variants were derived cause infection and
typical disease symptoms in Malus × domestica. Thus, the effect of PME2ST on cell integrity seems to
be dispensable for infection and symptom development but might affect strain virulence. However,
a direct comparison between the two strains regarding their virulence is missing. It might also be
possible that another effector of P. mali strain AT (unknown at the time of this research), mimics and
thus complements the function that PME2AT is lacking.
Some P. mali strains strongly differ regarding their virulence potential in Malus × domestica and
several studies addressed the genetic identification of virulence factors or certain genetic determinants
that account for these differences [17,18,53–55]. Since phytoplasma cannot be genetically manipulated,
determining the importance of an effector during infection often involves tortuous experimental
paths. In this study we provide the first characterization of the P. mali effector PME2 and its effect on
cells of potential plant hosts. We report an interesting difference between two variants of PME2 that
occur in Italy and Germany, claiming that further full genomic sequence analysis is required to better
understand how P. mali manipulates its host on the molecular level.
4. Materials and Methods
4.1. Verification of Pme2 Expression in Malus × Domestica and C. Picta
For the verification of pme2 expression by PCR in infected apple root and leaf samples RNA was
extracted from the plant tissue as described in [13]. Extracted RNA was subjected to DNase treatment
111
Int. J. Mol. Sci. 2019, 20, 4613
using DNAfree Turbo reagent (Ambion, Austin, TX, USA) and cDNA synthesis was performed using
the SuperScript™ VILO™ cDNA Synthesis Kit (Invitrogen, Waltham, MA, USA). The generated
cDNA was diluted 1:200 in nuclease free water and cDNA integrity was checked in all samples
by performing a control PCR targeting the house-keeping gene transcript putative tip41-like family
(transcript identifier: Mdo.1349) using the primers 5’-ACATGCCGGAGATGGTGTTTGG-3’ (forward)
and 5’-ACTTCCAGAGTACGGCGTTGTG-3’ (reverse). Contamination with genomic DNA was
checked by performing a PCR with primers amplifying a fragment within the non-coding region trnL of
chloroplast DNA using the primers B49317 and A49855 [56]. No DNA contamination was detected in any
of the cDNA samples, and the amplification of the putative tip41-like transcript fragment was positive,
thus confirming the integrity of the generated cDNA. PCR reactions to verify pme2 expression were set
up in a total reaction volume of 10 μL, using 2 μL of diluted cDNA (1:200) as template, 0.05 μL GoTaq®
DNA Polymerase (Promega, Madison, WI, USA), 2 μL of 5X Green GoTaq® Reaction Buffer (Promega,
Madison, WI, USA), 0.2 μL dNTP-mix (40 mM), 1 μL of forward primer ATP00136_forw_EcoRI
(10 μM, 5’-CCCCCCGAATTCATGTTTCAATTTAAAAAAAATTTA-3’), and 1 μL of reverse primer
ATP00136_rev_SalI (10 μM, 5’-CCCCCCGTCGACATTATTACTGTTGAGGTTTAA-3’). Cycling
conditions were applied as follows: 95 ◦C for 5 min followed by 40 cycles of 95 ◦C
for 1 min, 44.9 ◦C for 1 min, 72 ◦C for 1 min, and a final elongation step at 72 ◦C
for 5 min. PCR products were visualized on 1% agarose gel. Additionally, pme2
expression level was detected by qPCR based on SYBR-Green chemistry using the primer
pair ATP00136_GW_fwd (5’-CACCATGACGAAAAATGATCCAACAAA-3’)/ATP00136_nostopp_rev
(5’-CTGTTGAGGTTTAAAACAT-3’) in a total reaction volume of 20 μL using 4.0 μL of diluted
cDNA (1:200) as a template together with 10.0 μL 2× SYBR FAST qPCR Kit Master Mix (Kapa
Biosystems/αmann-La Roche, Basel, Switzerland), 1.0 μL of each primer (10 μM), and 4.0 μL of nuclease
free water. qPCR conditions were as follows: an initial denaturation step at 95 ◦C for 20 s followed by
34 cycles of 95 ◦C for 3 s and 60 ◦C for 30 s and a melting curve ramp from 65 to 95 ◦C, at increments of
0.5 ◦C every 5 s (CFX384 Touch Real-Time PCR Detection System; BioRad, Hercules, CA, USA). Data
analysis was performed using the CFX ManagerTM software (BioRad, Hercules, CA, USA).
To control whether pme2 is expressed in infected individuals of the insect vector C. picta, RNA
of six potentially infected and two uninfected F1 individuals was extracted with the ZR Tissue &
Insect RNA MicroPrepTM kit (ZymoResearch, Irvine, CA, USA) according to the manufacturer’s
instructions. Extracted RNA was subjected to DNase treatment using DNAfree Turbo reagent (Ambion,
Austin, TX, USA) and RNA integrity was controlled with an RNA ScreenTape on a TapeStation 2200
(both Agilent, Santa Clara, CA, USA). cDNA was synthesized with the iScriptTM cDNA Synthesis Kit
(BioRad, Hercules, CA, USA). Together with the cDNA synthesis a control was performed lacking
the reverse transcriptase (-RT). Here, 2 μL of diluted cDNA (1:200) were used as template in a total
qPCR reaction volume of 10 μL, together with 5 μL 2× SYBR FAST qPCR Kit Master Mix (Kapa
Biosystems/Hoffmann-La Roche, Basel, Switzerland), 2 μL of nuclease free water, and 0.5 μL of forward
and reverse primer (10 μM). The primer combination qPSY-WG-F and qPSY-WG-R, targeting the
species-specific wingless gene [57], was used to determine cDNA integrity. P. mali infection was
detected in three of the six individuals with primer pair rpAP15f-mod and rpAP15r3, targeting the
ribosomal protein gene rpl22 [58]. Pme2 expression was checked with primer pair ATP00136_GW_fwd
and ATP00136_nostopp_rev using the same qPCR conditions as described for the qPCR detection in
Malus × domestica leaf samples.
4.2. Amplification, Subcloning, and Sequencing of atp_00136
DNA was purified from leaves from P. mali infected Malus x domestica cv Golden Delicious
trees (10 trees from Burggraviato and 10 trees from Val Venosta) using the DNeasy Plant Mini kit
(Qiagen, Hilden, Germany) following the manufacturer’s instructions. DNA was diluted 1:10 in
water and 2 μL template were used in a total PCR reaction volume of 50 μL as follows: atp_00136
was amplified using 0.02 U/μL Phusion High-Fidelity DNA Polymerase (Thermo Fisher Scientific,
112
Int. J. Mol. Sci. 2019, 20, 4613
Waltham, MA, USA) using HF-buffer supplied by the manufacturer, 400 μM dNTPs, and 0.5 μM
of each primer (forward: 5’-CCCCCCGAATTCATGTTTCAATTTAAAAAAAATTTA-3’; reverse:
5’-CCCCCCGTCGACATTATTACTGTTGAGGTTTAA-3’). DNA was denatured at 98 ◦C for 30 s
followed by 30 cycles of denaturation for 10 s at 98 ◦C, amplification for 30 s at 49.3 ◦C, and elongation
at 72 ◦C for 30 s. The PCR was finalized by a terminal elongation step at 72 ◦C for 5 min. The PCR
product was purified using the Illustra GFX PCR DNA and Gel Band Purification Kit (GE Healthcare,
Chicago, IL, USA) and 1 μg of purified PCR product was digested with 4 U EcoRI and SalI following
the manufacturer’s instructions (Thermo Fisher Scientific, Waltham, MA, USA), ligated into equally
digested pUC19 using T4-Ligase (Thermo Fisher Scientific, Waltham, MA, USA) and transformed into
MegaX DH10B™ T1R cells (Life Technologies, Carlsbad, CA, USA). At least five clones from each tree
were sequenced with pUC19 specific primers (GATC Biotech, Constance, Germany) and analyzed to
see different variants of the gene indicating a mixed infection.
4.3. Subcloning of Pme2 into GreenGate Expression Vectors
The genes pme2ST and pme2AT were subcloned into the GreenGate-entry
module pGGC000 [59] using the primer pair ATP00136pP_CBsaI_fw
(5’-AACAGGTCTCAGGCTCCATGACGAAAAATGATCCAACAAA-3’) and ATP00136pP_DBsaI_rv
(5’-AACAGGTCTCACTGACTGTTGAGGTTTAAAACAT-3’). Using different components from the
GreenGate-kit plant, transformation constructs coding for pme2AT-linker-GFP or pme2AT-linker-mCherry
and pme2ST-linker-GFP or pme2ST-linker-mCherry, driven by the 35S promoter and flanked at the
3’-end by the RBCS terminator, including kanamycin as the plant resistance marker, were designed.
The following modules were assembled by GreenGate reaction in a total volume of 15 μL: 150 ng
pGGA004 (35S), 150 ng pGGB003 (B-dummy), 150 ng pGGC000-pme2AT or pGGC00-pme2ST, 150 ng
pGGD001 (linker-GFP) or pGGD003 (linker-mCherry), 150 ng pGGE001 (RBCS), 150 ng pGGF007
(pNOS:KanR:tNOS), and 100 ng pGGZ001 (empty destination vector). Subsequently, 1.5 μL 10×
CutSmart Buffer (New England Biolab, Ipswich, MA, USA), 1.5 μL ATP (10 mM), 1.0 μL T4 DNA
Ligase (5 u/μL) (Thermo Fisher Scientific, Waltham, MA, USA), and 1.0 μL BsaI-HF®v2 (20,000 u/mL)
(New England Biolab, Ipswich, MA, USA) were added to the module mixture, and 30 cycles of 2 min
at 37 ◦C and 2 min at 16 ◦C each, followed by 50 ◦C for 5 min and 80 ◦C for 5 min were performed.
Subsequently, 5 μL of the reaction mixture were used for heat-shock transformation of ccdB-sensitive
One Shot® TOP10 chemically competent Escherichia coli (Invitrogen, Carlsbad, CA, USA). For the
assembly of positive controls, the modules pGGC012 (GFP-NLS) or pGGC014 (GFP) or pGGC015
(mCherry) were used instead of the above mentioned pGGC000 modules. The correct assembly of
the plant transformation constructs was confirmed by sequencing. Plasmid-DNA for protoplast
transformation was obtained as described elsewhere [60], using the NucleoSnap® Plasmid Midi
preparation kit (Macherey-Nagel, Düren, Germany) and PEG precipitation.
4.4. Protoplast Isolation and Transformation
Protoplasts of N. benthamiana and N. occidentalis were isolated from four- to five-week-old plants,
cultivated under long photoperiod conditions (16 h/8 h, 24 ◦C/22 ◦C, 70% rH) and transformed as
described in [60] using 10 μg plasmid-DNA per 20,000 protoplasts. After 18 h, at least 100 protoplasts of
each transformation were checked for the occurrence of GFP or mCherry-fluorescence using a confocal
laser scanning microscope (LSM800, Zeiss, Oberkochen, Germany) with an excitation wavelength of
488 nm for GFP and 561 nm for mCherry. The detection wavelength of GFP was set between 410 nm
and 575 nm and of mCherry between 575 nm and 650 nm. Autofluorescence of chlorophyll was
detected between 650 nm and 700 nm. After 20 h the number of intact protoplasts/mL was determined
by counting in a Fuchs-Rosenthal chamber. Protoplast transformation and viability determination was
repeated independently four times.
Only experiments in which at least 20% of the protoplasts in the control setup were viable after
transformation were considered for further evaluation. Significant outliers were removed from the
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data set using the GraphPad QuickCalcs Outlier calculator online tool (https://www.graphpad.com/
quickcalcs/Grubbs1.cfm; status of information 16th September 2019). Greisser Greenhouse correction on
raw data and one-way-ANOVA with a Tukey Posttest were performed to analyze statistical differences
between groups (GraphPad Prism 7.01., GraphPad Software, San Diego, CA, USA). To allow a better
visual comparison, data were normalized to each respective control, which was set to 1.
Additionally, protoplast viability was visualized by propidium iodide (PI) and counted by
fluorescein diacetate (FDA) staining in three independent repetitions. For the first, 20 μL of protoplasts
transformed with GFP tagged expression vectors were mixed with 20 μL of PI solution (10 μg/mL PI in
0.65 M mannitol). FDA staining was done according to [61] using 20 μL of protoplasts transformed
with either mCherry tagged PME2AT expression vectors or a vector expressing only mCherry and
20 μL of FDA solution (0.1 mg/mL FDA in 0.65 M mannitol). Fluorescence of PI, mCherry, and GFP
was recorded using a LSM800 confocal laser scanning microscope (Zeiss, Oberkochen, Germany) with
excitation and detection wavelengths for GFP and mCherry as described above and for PI excitation at
561 nm and detection between 560 nm and 640 nm.
4.5. Nicotiana spp. Leaf Infiltration
For subcellular localization of PME2, the two GreenGate expression vectors, as well as GFP and
GFP-NLS expression vectors as positive controls, were subcloned by electroporation into Agrobacterium
tumefaciens strain EHA105. As an additional control, we subcloned a GreenGate expression vector
expressing the SAP11-like P. mali effector protein ATP_00189 [13] with an N-terminal fused GFP tag
into A. tumefaciens strain EHA105. The transgenic A. tumefaciens clones were cultured for 2 days
at 28 ◦C in liquid selective LB medium. Subsequently, 0.5 OD/mL were resuspended in infiltration
medium (10 mM MgCl2, 10 mM MES, 200 μM acetosyringone, pH 5.7) and infiltrated with a blunt
syringe into leaves from four- to five-week-old N. occidentalis and N. benthamiana. Fluorescence was
recorded after 48 h and 72 h using the confocal laser scanning microscope (LSM800, Zeiss, Oberkochen,
Germany) with excitation for GFP at 488 nm and detection between 410 nm and 546 nm and excitation
for mCherry at 561 nm and detection between 562 and 624 nm.
4.6. Expression in Yeast
For a potential Y2H, pme2AT and pme2ST were subcloned into bait-vector pLexA-N as
described in [13,62] with primer pair ATP00136_forw_EcoRI/ATP00136_rev_SalI. The bait-plasmids
pLexA-N-pme2ST and pLexA-N-pme2AT were transformed into S. cerevisiae strain NMY51. Growth
aberrations of yeast colonies on selective SD-trp plates were observed and recorded by photographing.
For calcofluor white staining, yeast cells were grown overnight in SD-trp liquid media.
Subsequently, 2 mL of the overnight culture were centrifuged, supernatant removed, and the cells
resuspended in clear phosphate-buffered saline (PBS) buffer. Then, 10 μL of a 5 mM calcofluor white
solution (Biotium, Fremont, California) were added to the cell suspension and incubated for 20 min
at room temperature. The yeast cell wall was visualized by a confocal laser scanning microscope
(LSM800, Zeiss, Oberkochen, Germany) with excitation at 405 nm and detection wavelength between
400 nm and 560 nm.
5. Conclusions
In this study we identified and characterized the novel P. mali effector protein PME2.
This effector contains an NLS and an NES sequence and translocates to the nucleus of N. benthamiana
mesophyll protoplasts. Two naturally occurring genetic variants of PME2, namely PME2ST and
PME2AT, differ regarding their ability to induce cellular modifications in yeast and plant cells.
When overexpressed, the variant PME2ST affects yeast growth and reduces the viability of Nicotiana
spp. mesophyll protoplasts. These findings indicate that PME2 might play a role for P. mali virulence
in plants. Despite the similarities between both PME2 variants, this effect was not observed in yeast or
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protoplasts expressing PME2AT. The results of our study show for the first time that a phytoplasmal
effector causes detrimental effects when overexpressed in protoplasts.
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Abstract: Sclerotinia sclerotiorum (Lib.) de Bary is a devastating necrotrophic fungal pathogen
attacking a broad range of agricultural crops. In this study, although the transcript accumulation
of SsNsd1, a GATA-type IVb transcription factor, was much lower during the vegetative hyphae
stage, its mutants completely abolished the development of compound appressoria. To further
elucidate how SsNsd1 influenced the appressorium formation, we conducted proteomics-based
analysis of the wild-type and ΔSsNsd1 mutant by two-dimensional electrophoresis (2-DE). A total
number of 43 differentially expressed proteins (≥3-fold change) were observed. Of them, 77% were
downregulated, whereas 14% were upregulated. Four protein spots fully disappeared in the mutants.
Further, we evaluated these protein sequences by mass spectrometry analysis of the peptide mass
and obtained functionally annotated 40 proteins, among which only 17 proteins (38%) were identified
to have known functions including energy production, metabolism, protein fate, stress response,
cellular organization, and cell growth and division. However, the remaining 23 proteins (56%) were
characterized as hypothetical proteins among which four proteins (17%) were predicted to contain the
signal peptides. In conclusion, the differentially expressed proteins identified in this study shed light
on the ΔSsNsd1 mutant-mediated appressorium deficiency and can be used in future investigations
to better understand the signaling mechanisms of SsNsd1 in S. sclerotiorum.
Keywords: Sclerotinia sclerotiorum; SsNsd1; compound appressorium; two-dimensional
electrophoresis; proteomics analysis; differential expression proteins
1. Introduction
Sclerotinia sclerotiorum (Lib.) de Bary is a destructive and hard-to-control plant necrotrophic fungal
pathogen on a broad range of agricultural crops [1,2]. Developmentally, vegetative hyphae gathered
together forming hardened, multicellular sclerotia enclosed by a melanized rind layer, which plays
an important role in the development and pathogenesis of S. sclerotiorum [3,4]. Under suitable
environmental conditions, sclerotia germinate to form vegetative hyphae or apothecia, and the latter
release numerous ascospores that initiate new disease cycles [5]. Mycelia from sclerotia or ascospores
can directly infect the plant tissues by forming compound appressoria (also known as infection
cushions) from modified hyphae [2,4] or enter the plant tissue through open stomata by secreting
oxalic acid [6]. Therefore, a better understanding of the developmental mechanism of appressorium is
also critical to the control of this important plant disease.
The formation of compound appressoria in S. sclerotiorum has been reported to require a contact
stimulus [7]. Prior to penetration, the tips of hyphae become swollen and extensively branched, and
then form modified, multicellular, and melanin-rich compound appressoria [8,9]. The tip of compound
appressorium could penetrate the host epidermis and form vesicles of bulbous [8]. Some events are
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consistent with this development process, such as the production and accumulation of oxalic acid
(OA), cell wall-degrading enzymes (CWDE), and effector proteins, which contribute to S. sclerotiorum
pathogenesis in myriad ways [9–14]. However, despite these important findings, the detailed molecular
mechanism underpinning the development and formation of compound appressoria in S. sclerotiorum
is still largely unclear.
In the past years, many genetic factors have already been characterized to be essential for
appressoria development in S. sclerotiorum. The disruption of the oxalic acid biosynthesis gene
(Ssoah1) promotes the compound appressorium development; however, the disruption of Sspks13 only
eliminates the pigmentation of the compound appressorium without attenuating its infection and
pathogenicity potential [2]. Significant accumulation of the oxalate decarboxylase (OxDC) gene Ss-odc2
occurs during the compound appressorium development, and ΔSs-odc2 mutants were found to have
less effective compound appressorium differentiation [11]. In addition, the secretory proteins Ss-Rhs1
and Ss-Caf1 were highly expressed during the hyphal infection process, whereas the silenced strains
had decreased appressoria formation [9,15]. Furthermore, Ss-ggt1 (γ-glutamyl transpeptidase gene),
sac1 (cAMP pathway adenylatecyclase gene), and rgb1 (type-2A phosphoprotein phosphatase (PP2A) B
regulatory subunit gene) have also been identified to be associated with the development of compound
appressoria [16–18]. Recently, the type IV GATA zinc finger transcription factor SsNsd1, orthologous to
the Aspergillus nidulans NsdD (never in sexual development) proteins and Botrytis cinerea BcLTF1 [19],
was reported to regulate asexual–sexual development and appressoria formation [4]. Its knockout
mutants were defective in the transition from hyphae to compound appressorium formation, resulting
in a loss of infection-dependent pathogenicity on healthy hosts [4]. However, the signal pathway by
which the SsNsd1 regulates the development and pathogenicity remains to be further elucidated.
Life sciences have been deeply influenced by the “omics” technologies in last decade, including
genomics, transcriptomics, proteomics, and metabolomics, aiming at a global perspective on
biological systems [20]. Proteomics strategies, such as the two-dimensional gel electrophoresis (2-DE)
approaches, have been confirmed as efficient, rapid, and powerful means to identify proteins (or
genes) followed by mass spectrometry, and matrix-assisted laser desorption/ionization (MALDI) [21].
Large-scale analyses of proteins by 2-DE have been conducted in a number of organisms, such
as animals [22], plants [23], yeast [24], and fungi [25,26], which contributes considerably to our
understanding of gene functions in the postgenomic era. However, the development and application
of such methods in the filamentous plant-pathogenic fungus S. sclerotiorum have not yet been reported.
Modern agriculture faces a huge challenge in the prevention from the diseases caused by
S. sclerotiorum. The transcription factor SsNsd1 was characterized to be essential for appressoria
development in our previous study [4]. The possibility to control plant diseases by suppressing the
compound appressorium formation would eliminate initial infections. Here, we used the SsNsd1
knockout mutant (ΔSsNsd1) to confirm the loss-of-function nature in compound appressorium
development and conducted proteomics analysis by 2-DE. Using comparative proteomics analysis of
the ΔSsNsd1 mutant and the wild-type S. sclerotiorum, we attempted to identify the ΔSsNsd1-mediated
differentially expressed proteins combined with peptide mass spectrometry analysis, which would
contribute significantly to the SsNsd1-mediated compound appressorium formation.
2. Results
2.1. Phylogenetic Analysis of SsNsd1 and Other GATA-Type Proteins
In this study, similar proteins of SsNsd1 and other GATA-type proteins of S. sclerotiorum were
searched from Botrytis cinerea, Fusarium oxysporum, Magnaporthe oryzae, and Aspergillus oryzae by BLAST.
The homolog of SsNsd1 was obtained only from the B. cinerea. However, all other GATA-type proteins
had homologs in B. cinerea, F. oxysporum, M. oryzae, and A. oryzae. Phylogenetic analysis of the putative
amino acid sequence of these GATA-type proteins showed their genetic relationship in different fungi
(Figure 1A). Coincidently, the GATA-type proteins of S. sclerotiorum were closely related to B. cinerea.
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Besides, two forms of the type IV zinc finger motif (IVa and IVb) are also depicted in Figure 1A based
on the residue loops. Most of the clades contained all five sequences from S. sclerotiorum, B. cinerea,
F. oxysporum, M. oryzae, and A. oryzae. However, the SS1G_03775 and its homologs were separated as
shown by the pink color clade. One branch was also separated from the clade of the SS1G_03252 and
its homologs, which might be due to the poor similarity in different fungi.
Figure 1. Phylogenetic analysis and transcription expression of SsNsd1 and other proteins containing
GATA-type DNA domains in S. sclerotiorum. (A) Phylogenetic analysis of the amino acid sequences
of SsNsd1 (SS1G_10366) and other GATA-type proteins in pathogenic fungi (S. sclerotiorum, B. cinerea,
F. oxysporum, M. oryzae, and A. oryzae). A phylogenetic tree was generated by MAGE using the
neighbor-joining method. The nine GATA-type proteins were separated by using a different branch
color. (B) Hierarchical cluster of GATA-type genes and two histone genes in transcript abundance from
three developments stages (hyphae, sclerotia, and apothecia) of S. sclerotiorum. Each gene is represented
by a single row of colored boxes, and a single column indicates different development stages. The gene
transcription abundance was evaluated by the fragments per kilobase of exon per million mapped
fragments (FPKM) value. (C) The transcription level of SsNsd1, Histone H2A, and Histone H3 genes at
the hyphae developmental stage. The expression level of SsNsd1 gene was significantly different from
those of the histone genes (n = 3; ** p < 0.01).
2.2. Transcript Accumulation of SsNsd1 and Other GATA-Type Proteins
Digital gene expression (DGE) analysis based on FPKM values was performed using the
transcriptomes during three the developmental stages of S. sclerotiorum (Figure 1B). The transcript
accumulation in the GATA-type proteins was lower than those of the histone genes (histone H3 and
histone H2A). Only the SS1G_03252 protein showed a little higher transcript accumulation in the
hyphae development stage, whereas most of the other GATA-type proteins displayed low contents
with FPKM values ranging from 1.3 to 64 in all three development stages. Obviously, the SS1G_08523
and SS1G_09784 proteins were extremely low abundant with FPKM values under 10 in all three
development stages.
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As one of the GATA-type proteins, the varied expression patterns of SsNsd1 were previously
examined and compared across developmental stages [4]. In this study, to further determine
the regulation mechanism of the Ssnsd1 expression, we obtained its expression profile in the
vegetative hyphae development stage (Figure 1C). The transcript accumulation of the SsNsd1 gene was
significantly lower than those of the histone genes (histone H2A or histone H3) during the vegetative
mycelial growth prior to the compound appressorium formation. SsNsd1 was expressed at the lowest
level (FPKM value of 39.6), however, Histone H2A was expressed higher (FPKM value of 171.8).
Moreover, Histone H3 (FPKM value of 3337.3) displayed the highest expression level, indicating its
predominant role, usually as a housekeeping gene. Overall, the transcript accumulation of SsNsd1 and
other GATA-type proteins were exceedingly low in the development stages of S. sclerotiorum.
2.3. ΔSsNsd1 Mutant Suppressed Compound Appressorium Formation
Although SsNsd1 exhibited a low expression level during the hyphae development, it still
played a crucial role in appressorium development (Figure 2). Phenotypically, the ΔSsNsd1 mutant
had inhibited normal production of pigmented compound appressoria from the vegetative hyphae,
as established by paraffin film assays (Figure 2A). In determining whether ΔSsNsd1 affected the
compound appressorium formation or only the pigmentation, normal compound appressorium and
penetration (invasive mycelium) were observed microscopically only on onion epidermal strips
inoculated with the wild type (WT) strain (Figure 2B), but not on the ΔSsNsd1 mutant strain. The WT
strain could colonize onion cells, but no invasive mycelium was observed from ΔSsNsd1 mutants
(Figure 2C). Thus, SsNsd1 abolished the compound appressoria formation from the modified hyphae,
resulting in the penetration-dependent loss of pathogenicity.
Figure 2. The defective compound appressoria of ΔSsNsd1 mutant strain led to a loss of penetration
into unwounded onion tissue. (A) Pigmented compound appressoria of wild type (WT) were observed
on parafilm. Pictures were taken four days after transfer (DAT) of 5-mm-diameter mycelial plugs
to parafilm. (B) Penetration assays with the WT on onion epidermal strips. Invasion mycelium
(penetration) of WT strain on onion epidermal strips was observed by light microscopy two days
after inoculation (DAI). (C) Penetration assays with the ΔSsNsd1 strain on onion epidermal strips at 2
DAI. No invasion mycelium was observed on onion epidermal strips inoculated by ΔSsNsd1 strain.
(D) Penetration assays with the WT and the ΔSsNsd1 mutant on onion epidermal strips at 4 DAI.
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2.4. Diagram of the Identification of Differential Proteins
In this study on S. sclerotiorum, we applied the 2-DE technology. A diagram illustrating the
approach of the determination of the proteomics changes is presented in Figure 3. In this diagram,
the comprehensive protocol is described by individual steps of the application of this technique, i.e.,
sample preparation and solubilization, isoelectric focusing (IEF) in IPG strips, running SDS-PAGE
gels, image analysis, differential spots identification and mass spectrometry (MS) analysis, and
bioinformatic prediction.
Figure 3. Schematic diagram illustrating the process of identifying the changes of proteomics between
the ΔSsNsd1 mutant and wild type (WT) during the compound appressorium formation. Generally,
tissue samples with different phenotypes were subjected to protein extraction and SDS-PAGE test.
Then the proteomics profiles were analyzed by two-dimensional gel electrophoresis (2-DE) to obtain
the differential expression spots, which were further identified by mass spectrometry (MS) of the
peptides and bioinformatics analyses (2-DE, two-dimensional gel electrophoresis; IEF, isoelectric
focusing; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis).
2.5. Protein Extraction from Enriched Compound Appressoria
The cellophane induced the formation of abundant compound appressoria from the modified
hyphae, which were observed macroscopically when the WT was cultured on cellophane (Figure 4A).
No pigmentation was observed due to the lack of compound appressoria when ΔSsNsd1 were
cultured on cellophane (Figure 4A). Thus, this was an effective method to provide enriched compound
appressoria tissue with simple sample collection, which was ideally suited for protein extraction.
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Figure 4. Protein extraction and SDS-PAGE test of accumulated compound appressoria tissue induced
on cellophane. (A) Induction assay for compound appressoria development on potato dextrose agar
(PDA) overlaid with cellophane at 3 DAI. (B) Quantification of protein concentration, which was
enriched by three different extraction methods: lysate, trichloroacetic acid (TCA)/acetone precipitation,
and polyethylene glycol PEG method (n = 3; ** p < 0.01). (C) Quality detection of proteomics by
SDS-PAGE to optimize the method for protein extraction.
To optimize the best protein extraction method for 2-DE separation, we compared the
concentration and quality of the extracted proteins using the three different methods. The highest
concentration of protein was extracted by the use of the lysate as compared with those extracted by
trichloroacetic acid (TCA)/acetone or polyethylene glycol (PEG) precipitation (Figure 4B); however, the
quality of this protein, established by the SDS-PAGE test, was extremely poor (Figure 4C). In contrast,
the protein extracted by further TCA/acetone or PEG precipitation exhibited clearer bands, but that
extracted by TCA/acetone precipitation was at a higher concentration; the best result was obtained
using the SDS-PAGE test (Figure 4C). Furthermore, the 2-DE clearly showed protein spots aggregation
and transparent background (Figure 5). Thus, the protein extraction with further TCA-acetone
precipitation could lay a foundation for a novel approach in comparative proteomics analysis by
2-DE technology in S. sclerotiorum.
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Figure 5. Silver nitrate-stained 2-DE gel image of the WT and ΔSsNsd1 strains. The proteins were
extracted from the accumulated compound appressoria tissue induced by cellophane. The numbers
and arrows correspond to the identified differential expression proteins (≥3-fold change) for further
MS analysis of the peptides.
2.6. Identification of the Differential Protein Spots by 2-DE Analysis
The proteins extracted from the WT and ΔSsNsd1 culture on cellophane were separated by
2-DE (Figure 5). In this figure, 2-DE displayed well-visible protein spot aggregation and transparent
background, while few nonspecific bands or foreign matters were observed. Using three biological
replicates for both the wild-type and mutant strains, the clear 2-DE images were compared and
analyzed by ImageMaster™ 2D Platinum 6.0 software. More than 2660 protein spots were detected
reproducibly on each 2-DE gel image for the WT and ΔSsNsd1 mutant, within the pH range of 4 to
10 and with relative molecular masses of 8 to 80 kDa. However, only 43 protein spots exhibited
changes in the differential abundance (more than three-fold) between the WT and the ΔSsNsd1 mutant,
which are marked with arrows and numbers in Figure 5. Among these selected differential protein
spots, 33 protein spots were downregulated, six proteins spots were upregulated, and four proteins
spots disappeared in the ΔSsNsd1 strain compared to the wild type (Figure 6A). Subsequently,
all differential expression proteins were excised and subjected to MALDI-TOF analysis.
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Figure 6. Analysis and evaluation of differentially expressed proteins. (A) Differential expression
analysis of the identified protein spots in the ΔSsNsd1 mutant compared to the WT strain. (B) Functional
categories of differential expression proteins after MS identification and functional annotation.
The percentage corresponds to the proportion of the annotated proteins in the classification. (C) The
population distribution of the protein size evaluated by the amino acid count of the predicted proteins.
(D) The signal peptide was predicted by running amino acid sequences of predicted hypothetical
proteins on the SignalP server.
2.7. Prediction and Characteristics of the Identified Proteins
After prediction and functional annotation of these excised proteins, 40 proteins were identified.
Of them, 17 proteins (38%) were predicted with the known functions (Table 1), and other 23 homologous
to unnamed or predicted proteins were collectively designated as “hypothetical proteins”, accounting
for 56% (Table 2). However, three proteins (spots 7, 13, and 23) were not identified by MALDI for
unknown reason, which were designated as “uncharacterized” (6%). The predicted known functional
categories (38%) were further sorted into six functional categories, including energy production (18%),
metabolisms (7%), protein fate (5%), stress responses (4%), cellular organization (2%), and cell growth
and division (2%) (Figure 6B).
In addition to providing functional categories, the global view of the protein sizes was also
evaluated by the numbers of the amino acids (Figure 6C). Based on the function annotation, they
were divided into hypothetical and annotated proteins. Then, the distribution of their protein size
was similar to that of 262 and 247 amino acids, respectively (Figure 6C). Furthermore, we predicted
the signal peptide among these hypothetical proteins to obtain additional insights into the putative
functions of the hypothetical proteins (Figure 6D, Table 2). Four proteins (17.4%) were predicted to
contain the N-terminal signal peptide, which indicated they might be potential secretory proteins
during the compound appressorium formation.
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Table 1. List of the differential expression proteins identified as function known proteins.
Spot a Protein Name b Locus c Accession No. d Score e PM f Cov g
01↓ nucleoside diphosphate kinase gi/156063126 XP_001597486.1 360 6 44
03↓ nuclear transport factor 2 gi/156052963 XP_001592408.1 364 4 34
04↓ 60 s ribosomal protein L23 gi/154703604 EDO03343.1 85 6 47
08↓ ubiquitin-conjugating enzyme E2 gi/156042748 XP_001587931.1 141 5 48
09↓ nucleoside diphosphate kinase gi/156063126 XP_001597485.1 130 8 74
12↓ peptidyl-prolyl cis-trans isomerase gi/156054872 XP_001593362.1 532 9 53
16↓ peptidyl-prolyl cis-trans isomerase B gi/156042834 XP_001587974.1 583 10 37
17↓ nucleoside diphosphate kinase gi/156063126 XP_001597485.1 281 5 39
18↓ eukaryotic translation initiationfactor 5A-1 gi/156063512 XP_001597678.1 97 2 44
25↓ peptidyl-prolyl cis-trans isomerase gi/156054872 XP_001593362.1 620 12 57
26↓ elongation factor 1-beta gi/156053087 XP_001592470.1 107 2 31
28↓ 60 s ribosomal protein L23 gi/154703604 EDO03343.1 59 2 62
29↑ peptidyl-prolyl cis-trans isomerase gi/156054872 XP_001593362.1 406 8 46
30↓ GTP-binding nuclear proteinGSP1/Ran gi/156057585 XP_001594716.1 215 7 47
32- SCF complex subunit Skp1 gi/156065065 XP_001598454.1 603 13 69
35↓ citrate synthase,mitochondrial precursor gi/156063018 XP_001597431.1 104 9 42
39↓ peptidyl-prolyl cis-trans isomerase gi/156054872 XP_001593362.1 498 11 51
a: The number of identified protein spots was showed on the two-dimensional gel electrophoresis (2-DE) image;
The identified function known proteins were shown in this table; b: Protein name searched by locus tag in NCBI
result; c: Locus tag number in NCBI annotation; d: Accession number in NCBI; e: Mascot score (threshold score
> 50); f: Peptide count; g: Percent sequence coverage (%); ↓: expression level of proteins was down-regulated
in the mutant; ↑: expression level of protein was up-regulated in the mutant; -: protein spot was disappeared in
the mutant.
Table 2. List of the differential expression proteins identified as hypothetical proteins.
Spot a Protein Name b Locus c Accession No. d Score e PM f SignalP g
02↓ hypothetical proteins SS1G_05791 gi|156053886 412 6 No
05- hypothetical proteins SS1G_08534 gi|156049655 147 5 No
06↓ hypothetical proteins SS1G_02967 gi|156061643 1090 16 Yes
10↓ hypothetical proteins SS1G_13380 gi|156033320 329 7 No
11↓ hypothetical proteins SS1G_10490 gi|156044772 136 5 No
14↑ hypothetical proteins SS1G_05792 gi|156053888 404 6 No
15↓ hypothetical proteins SS1G_03527 gi|156059030 58 3 No
19↓ hypothetical proteins SS1G_03843 gi|156059662 545 10 No
20↓ hypothetical proteins SS1G_06246 gi|156054796 143 4 No
21↓ hypothetical proteins SS1G_06246 gi|156054796 658 10 No
22↓ hypothetical proteins SS1G_11818 gi|156039363 1040 14 Yes
24↑ hypothetical proteins SS1G_04923 gi|156055144 199 5 Yes
27- hypothetical proteins SS1G_09167 gi|156045782 46 7 No
31↓ hypothetical proteins SS1G_02387 gi|156060497 237 5 No
33↓ hypothetical proteins SS1G_06394 gi|156052457 389 4 No
34↓ hypothetical proteins SS1G_02266 gi|156060255 1510 32 Yes
36↑ hypothetical proteins SS1G_03994 gi|156056527 61 5 No
37↓ hypothetical proteins SS1G_12818 gi|156036260 383 8 No
38↓ hypothetical proteins SS1G_14285 gi|156031009 491 8 No
40↓ hypothetical proteins SS1G_03527 gi|156059030 421 11 No
41↑ hypothetical proteins SS1G_08260 gi|156049107 57 2 No
42↑ hypothetical proteins SS1G_06959 gi|156051104 155 4 No
43- hypothetical proteins SS1G_06561 gi|156052787 186 3 No
a: The number of identified protein spots was showed on the 2-DE gel image; The hypothetical proteins were
shown in this table; b: Protein name searched by locus tag in NCBI result; c: Locus tag number in NCBI annotation;
d: Accession number in NCBI; e: Mascot score (threshold score > 50); f: Peptide count; g: Signal peptide predicted
(Yes or No); ↓: expression level of protein was down-regulated in the mutant; ↑: expression level of protein was
up-regulated in the mutant; -: protein spot was disappeared in the mutant.
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2.8. Functional Analysis of Annotated Proteins
The 2-DE approach provided a powerful proteomic screening tool to identify the initial candidate
differentially expressed proteins. We evaluated these predicted proteins after functional annotation
and identified 17 proteins to be functionally known, representing 10 nonredundant unique proteins
(Table 1). The fact that identical proteins were available in different protein spots might have been due
to the protein modification or other unclear reasons as analyzed in the discussion section.
Here, we provide information concerning the analysis of the predicted functionally known
proteins. Nucleoside diphosphate kinase (NDPK) (spots 1, 9, and 17) usually possesses kinase activity
exerted by direct response to the G-protein signaling or indirect catalytic GDP–GTP exchange activity,
which also plays a major role in the synthesis of nucleoside triphosphates [27–29]. The eukaryotic
translation initiation factor 5A-1 (eIF5A-1; spot 18) is involved in the protein fate pathway [30],
which activates the 60 s subunits combination, assists in the conformational changes of the 80 s
subunits, and participates in the intracellular part; proteins associate with ribosomes cyclically during
the elongation phase of the protein synthesis [31]. The elongation factor 1-β (spot 26) plays a central
role in the elongation step in eukaryotic protein biosynthesis [32]. The 60 s ribosomal protein L23
(Spot 4) is usually involved in cell growth; its expression was decreased in the mutant (Table 1).
Ribosomal protein is involved in regulating gene transcription, translation, and regulation of cell
proliferation, differentiation, apoptosis, etc. [33].
The nuclear transport factor 2 (spot 3) mediates the nucleus introduction of GDP-bound RAN
(ras-related nuclear) from the cytoplasm, which is of great significance in the cargo receptor-mediated
nucleocytoplasmic transport [34]. The GTP-binding nuclear protein (spot 30) is also known as the
GDP-bound RAN, which is involved in the nucleocytoplasmic transport processes, nuclear envelope
formation, and mitotic spindle formation [35].
The predicted ubiquitin-conjugating (UBC) enzyme E2 (spot 8) belongs to the ubiquitin
pathway enzymes, which are involved in protein degradation in eukaryotic cells [36]. The SCF
(Skp1/Cul1/F-box) complex submit Skp1 (spot 32) is involved in the assembly of protein complex
and joins in ubiquitin depending on the protein catabolism process [37]. Peptidyl-prolyl cis-trans
isomerase (spots 12, 25, 16, and 39) was downregulated, whereas spot 29 was upregulated
(Table 1). Peptidyl-prolyl cis-trans isomerase regulates the mitosis-related protease in the cell cycle
by protein phosphorylation of the substrate proteins [38] or through other mechanisms such as the
ubiquitin-mediated proteasomal degradation [39].
Citrate synthase (spot 35) is localized in the mitochondrial matrix and catalyzes the condensation
reaction from acetyl coenzyme A (CoA) and oxaloacetate to form the six-carbon citrate [40]. Oxalic acid
biogenesis is realized through the hydrolysis of oxaloacetate, which is a key pathogenicity factor
accumulated during the compound appressorium development [10].
The functional analysis of the predicted differential proteins was mainly based on the evidence
in mammalian, plant, or yeast cells. However, the proteins displayed their important role on the cell
proliferation, differentiation, protein synthesis and degradation, protein transport and modification,
etc., which might determine they function as a complex regulatory network during the compound
appressorium formation in S. sclerotiorum.
3. Discussion
Novel strategies for prevention and control of the devastating plant pathogenic fungus
S. sclerotiorum have been intensively investigated [5]. However, still no effective method has been
discovered to control the diseases caused by this pathogen. Compound appressoria are formed
unless penetration occurs directly via stomata, which could be one of the key targets for disease
control. The GATA-family transcription factors are involved in several essential aspects of the life
cycle of M. oryzae, especially in the regulation of appressorium development and sporulation [41].
In S. sclerotiorum, the GATA-type transcription factors SsSFH1 and SsNsd1 were recently reported
to be involved in the development of compound appressoria [4,42]. Here, phylogenetic analysis was
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performed, and transcription accumulation of all the predicted GATA-type proteins was detected.
Importantly, even the transcription accumulation of SsNsd1 in the vegetative hyphae was significantly
higher than that during the sclerotium and apothecium developmental stages [4]. The transcript
accumulation remained at a much lower level even during vegetative mycelial growth, compared
to that of the histone genes (Figure 1C). The SsNsd1 gene knockout strain was defective in the
development of appressorium, and no penetration was observed into unwounded onion epidermal
cells (Figure 2), which confirmed the findings of a previous study [4]. In general, NsdD or
its orthologous gene is involved in providing a regulatory balance between asexual and sexual
development in ascomycete fungi (e.g., the development of perithecia, fruiting body, conidia, or
sclerotia) [43–45]. In addition, NsdD is also involved in pathogenicity. The Δbclft1 mutants of B. cinerea
exhibited only a postpenetration virulence defect without causing significant defects in the compound
appressorium development; however, the S. sclerotiorum ΔSsnsd1 mutant was essentially reversed
as established earlier [4]. Due to the particularly different infection defects between B. cinerea and
S. sclerotiorum, in the present study, we focused on the compound appressorium deficiency phenotype
and the biological role of SsNsd1, aiming to find the key target of appressorium formation-related
genes that would enable the control of this pathogen.
The proteomics analysis as an evaluation of the final level of gene expression started out
with techniques based on 2-DE and extended its reach by the use of MS-based techniques that
have been increasingly employed in recent years [20]. Although alternative technologies, such as
multidimensional protein identification technology (MudPIT), or arrays, have already emerged, thus
far, there is no technology that matches 2-DE in its capability to realize routine parallel expression
profiling of large mixtures [46]. Furthermore, 2-DE combined with the identification by MS is
currently the major approach utilized in most of the undergoing proteome projects to develop a global
understanding of the living cell [46]. Compared to the quantitative analysis based on MALDI-TOF
techniques, LC–MS is currently in an early stage considering limitations, such as the availability of
software, algorithms, etc. [20]. MALDI-TOF is already widely used in fungal proteome research,
such as that in yeast [24], A. fumigatus [25], and Cryomyces antarcticus [26]. Therefore, we applied
the 2-DE technology and MALDI-TOF mass spectrometry in this project to investigate the plant
pathogenic fungus S. sclerotiorum using proteomics analysis for identification of differentially expressed
proteins during the compound appressorium formation (Figure 3). Using suitable equipment and
experienced laboratory personnel, this system approach can quickly perform the identification of
functional proteins.
The 2-DE technology combined with IPGs has already conquered most limitations of carrier
ampholyte-based 2-DE with in the respect of reproducibility, handling, resolution, and separation [47].
The efforts to develop the 2-DE technology further have been concentrated on improved
solubilization/separation of hydrophobic proteins, show of low abundance, and more reliable
quantitation by fluorescent dye technologies in recent years [46]. Despite the obvious advantages of the
2-DE technology, high quality proteins samples are always the bottleneck and precondition to the 2-DE
project approach. As the 2-DE was firstly applied in S. sclerotiorum, we provided an optimal method
for sample preparation after comparing three different pathways for protein extraction (Figure 4).
By SDS-PAGE test, the protein extracted by further TCA/acetone precipitation and PEG methods
has a better quality and could be used for 2-DE analysis. Both TCA/acetone and PEG methods are
useful for minimizing protein degradation and removing interfering compounds, such as salt or
polyphenols [48]. However, the amount of protein extracted by the PEG method is difficult to meet
the requirements of 2-DE as established based on our results and those of a previous study [49]. In a
comprehensive analysis, the TCA/acetone method displayed its advantages and was found to be the
best method for protein extraction, which was consistent with the findings of a previous examination
on another fungus, A. fumigatus [50]. Furthermore, in the 2-DE analysis, we achieved the separation of
as many protein spots as needed on the gel, which was a prerequisite for the computerized analysis
(Figure 5). In addition, a clear peptide mass spectrum was finally obtained by extraction of the
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different expressed protein spots, which laid the foundation of further research on SsNsd1-mediated
differentially expressed proteins.
The development of the compound appressoria involves several distinct stages [9] and is tightly
regulated by numerous genetic factors. In the present study, a total of 43 differentially expressed
proteins were identified with significantly differential expression changes (≥3-fold) by computer
analysis (Figures 5 and 6). Most of them were downregulated, which indicated that the SsNsd1
transcript factor might positively regulate them. SsNsd1 might exert a reverse role in the signal
pathway of the upregulated protein spots. By MS analysis of peptides and functional annotation,
these functionally known proteins were predicted to be involved into energy production, metabolism,
protein fate, stress response, cellular organization, and cell growth and division. However, attention
had to be paid to the hypothetical proteins as they contained the signal peptide. The secretion and
accumulation of effector proteins are usually coincident with the appressorium formation process,
which contributes to S. sclerotiorum pathogenesis [9,15]. Therefore, these newly identified four proteins
might have the effector protein role during the compound appressoria formation, but this notion needs
to be further studied (Table 2). Overall, the differentially expressed proteins were finally obtained
from the ΔSsNsd1 mutant, which might play an important role during the compound appressorium
formation. Furthermore, losing the capacity to produce compound appressorium could also lead to
defective sclerotium development, which is a key factor in the disease cycle of S. sclerotiorum, such as
the mutation of Ss-ggt1 (a γ-glutamyltranspeptidase gene) [16], sac1 (a cAMP pathway adenylatecyclase
gene) [17], and rgb1 (a type-2A phosphoprotein phosphatase (PP2A) B regulatory subunit gene) [18].
Therefore, these identified differential expression proteins were important gene resources involved in
the development of S. sclerotiorum, which might be associated with the formation of both compound
appressoria and sclerotia.
Last but not the least, a section on how to evaluate the 2-DE and the identified differential proteins
is included here. After 2-DE, each protein could be theoretically resolved at a unique isoelectric
point/molecular size coordinate [51]. Although hundreds of protein spots were also separated on
the gel, omission of partial differential proteins can always occur due to unfavorable experimental
factors, such as incomplete precipitation and/or dissolution of proteins [48], loss of sample during gel
entry, inefficiency transfer of the protein from the first to the second dimension, loss of protein during
staining [20], and truly absent spots from the samples [52]. In addition, some spots from 2-DE might
result multiple protein identification, however, only the first identified protein with best protein score
and most peptide counts was accepted for further study. Moreover, attention had also to be paid to
the identical proteins (listed in Table 1), such as the nucleoside diphosphate kinase, peptidyl-prolyl
cis-trans isomerase, and the 60 s ribosomal protein. Post-translational protein modifications affect
the isoelectric point and, therefore, the focusing behavior of the protein in the first dimension [23],
which could lead to the presence of identical proteins in different locations (i.e., spot 25 and spot 29;
spot 4 and spot 28) (Table 1 and Figure 5). Post-translational modifications by fatty acid acylation,
glycosylation, methylation, acetylation, or phosphorylation largely modulate the activity of most
eukaryote proteins [53,54]. For example, certain signaling pathways were found to consist of series of
phosphorylation and dephosphorylation events, which defined directionality and allowed different
levels of feedback regulation [55]. In addition, the incomplete and insensitive separation can also lead
to the appearance of identical proteins in different locations. Besides, attention is to be paid to the
silver staining, as Coomassie brilliant blue was used in most of the 2-DE staining [56]. The silver
staining has a low dynamic range, which has been criticized for the quantitative analyses of spots.
However, the silver staining has very high sensitivity, which allows for a detection of very low protein
amounts [20]; the improved and advanced image processing method could become feasible in better
quantification of protein spots [57]. Besides, to obtain more data of the exact protein abundance,
only the differential proteins with ≥3-fold changes were accepted for further study in this research.
Therefore, the 2-DE technology of gradual optimization, further analysis of protein modifications,
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and other proteomic analysis methods are still needed to employ, which would present formidable
challenges but generate indispensable insight into biological functions in S. sclerotiorum.
4. Materials and Methods
4.1. Fungal Strains and Culture Conditions
The wild-type (WT) S. sclerotiorum isolate 1980 and its derived mutant ΔSsNsd1 were used in this
study based on our previous reports [4]. The strains were routinely grown on potato dextrose agar
(PDA) at normal room conditions. The WT and ΔSsNsd1 stocks were stocked as dry sclerotia or as
desiccated mycelia-colonized filter paper at −20 ◦C.
4.2. Phylogenetic Analysis of SsNsd1 and Other GATA-Type Proteins
From the genome of S. sclerotiorum, nine proteins are predicted to containing GATA-type DNA
domains: SS1G_1036, SS1G_11953, SS1G_12238, SS1G_03252, SS1G_08523, SS1G_05040, SS1G_09784,
SS1G_03775, and SS1G_01151 [4,42]. The BLASTX program at NCBI (http://www.ncbi.nlm.nih.
gov/) was employed to search for the homologs of the sequence of the SsNsd1 (SS1G_1036) and
other GATA-type proteins from pathogenic fungi (Botrytis cinerea, Fusarium oxysporum, Magnaporthe
oryzae, and Aspergillus oryzae). The phylogenetic tree was generated using neighbor-joining method
in MEGA5 [58]. Prediction of protein zinc finger domain was performed to classify the different
categories. Most fungal GATA factors contain a single zinc finger domain, which can be divided into
two distinct categories: the 17-residue loops (CX2CX17CX2C; zinc finger type IVa) and the 18-residue
loops (CX2CX18CX2C; zinc finger type IVb) [59,60].
4.3. Digital Gene Expression of SsNsd1 and Other GATA-Type Proteins
The transcription accumulation of SsNsd1 from three different developmental stages (hyphae,
sclerotia, and apothecia) has been characterized by qRT-PCR [4]. To further study the gene
expression patterns of SsNsd1 prior to compound appressorium development, we profiled gene
expression patterns in S. sclerotiorum from hyphae, sclerotia, and apothecia through RNA-seq approach.
The transcription level of SsNsd1 and other GATA-type proteins were quantified using the fragments
per kilobase of exon per million mapped fragments (FPKM) method [61]. The FPKM means were
generated from three technical replicate samples. The FPKM values of histone H3 (SS1G_09608.3)
and histone H2A (SS1G_02052) were used as endogenous control for quantitative comparison with
SsNsd1 and other GATA-type protein genes. Hierarchical clustering was performed using the MeV
program [62]. Clustering was based on the average of FPKM values.
4.4. Compound Appressorium Assays
Deficiency of compound appressoria was observed macroscopically by placing the freshly
colonized mycelial agar plugs (5-mm diameter) on parafilm due to the presence of pigmented
appressoria surrounding the agar plug [2]. Yellow onions were purchased from a local grocery
store, and the onion epidermal strips were used for inoculation with a colonized PDA agar plug for
observing the penetration of compound appressorium using light microscopy. For the enrichment of
compound appressoria, colonized agar was cultured on PDA medium covered with cellophane and
grown at a temperature of 22 to 25 ◦C as reported previously [2].
4.5. Two-Dimensional Gel Electrophoresis (2-DE) Strategy in This Study
The 2-DE combines isoelectric focusing separation based on isoelectric point of protein in the
first dimension and sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (SDS-PAGE) to
separate the complex mixtures of proteins according to the molecular size in the second dimension [23].
The Combined with identification by mass spectrometry (MS), 2-DE is currently the major method used
in the majority of the ongoing proteome projects [46]. Besides, 2-DE gels are easy to handle and could
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be produced in a highly parallelized way. Furthermore, the corresponding software has also reached a
level that allows for routine bioinformatic analysis. Meanwhile, in the presence of a suitable laboratory
equipment and experienced personnel, analysis of samples can be theoretically completed through
this approach with investments of time and efforts that are much smaller than those needed for the
laboratory work [20]. Thus, these mature and coherent techniques are well-suited for comparative
proteomics analysis of ΔSsNsd1 mutant-mediated appressoria deficiency in S. sclerotiorum. In detail,
tissues derived from two different strains, WT and ΔSsNsd1, were harvested, and the proteome was
enriched and solubilized. The protein mixture was then applied to a “first dimension” gel strip
that separated the proteins based on isoelectric focusing (IEF) in IPG strips. Next, the IPG strip
was subjected to equilibration and running of multiple “second dimension” SDS–PAGE gels, where
proteins were finally separated by their molecular charge and molecular size. After staining, the visual
protein spots were recorded and analyzed by sophisticated software. Then, the differential protein
spots were excised for MS analysis. Finally, the differential proteins were subjected to functional
annotation and prediction analysis.
4.6. Protein Extraction and Optimization
The enriched compound appressoria on the cellophane were harvested and frozen in liquid
nitrogen, and then ground to a fine powder for protein extraction. To optimize the method for protein
extraction from S. sclerotiorum and separate the protein by 2-DE, during the compound appressoria
production, the protein was extracted by direct lysate and further TCA/acetone or PEG precipitation
methods. For the lysate method [63], 0.1 g powdered sample was suspended in 300 μL of precooled
lysate (7 M urea, 2 M thiourea, 2% (w/v) 3-[(3-Cholamidopropyl)dimethylammonio]propanesulfonate
(CHAPS), 20 mM Tris-HCl, and 20 mM dithiothreitol), then vortexed for 30 s and centrifuged at
15,000× g rpm for 10 min at 4 ◦C. The supernatant was further centrifuged at 15,000× g rpm for
30 min. Approximately 250 μL of the supernatant was taken as the crude protein solution and
stored in a freezer at −80 ◦C. For further precipitation by trichloroacetic acid (TCA)/acetone [64],
80 μL of crude protein solution was suspended in 5 mL of cold TCA/acetone (10% TCA, 0.07%
β-Mercaptoethanol (ME) in acetone) and mixed for 30 s, then precipitated at −20 ◦C for 2 h. Further,
the precipitate was centrifuged at 15,000× g rpm for 15 min at 4 ◦C. Then, the supernatant was
discarded, and the pellet washed three times with 800 μL of cold acetone and finally centrifuged at
15,000× g rpm for 15 min at 4 ◦C. Next, the pellet was desiccated using a vacuum dryer and stored at
−80 ◦C. For the PEG precipitation [65], 80 μL of crude protein solution was suspended using 40% PEG
solution for 30 s and then precipitated at −20 ◦C for 2 h. Further, the pellet was washed with 800 μL
of cold acetone and desiccated, as described above. The final protein was resuspended in 80 μL of
rehydration buffer (7 M urea, 2 M thiourea, 4% (w/v) CHAPS, 0.002% (w/v) bromophenol blue, 2%
(v/v) Bio-Lyte, and 20 mM dithiothreitol). The concentration of the dissolved protein solution was
determined according to the method of Bradford [66]. Then, the results were compared by routine
SDS-PAGE test to optimize the method for protein extraction, and the extracted protein with the best
quality was further separated by 2-DE for image analysis.
4.7. The 2-DE Assay and Image Analysis
Comparative 2-DE was performed using a EttanTM IPGphor apparatus (GE Healthcare, Pittsburgh,
PA, USA) for isoelectric focusing (IEF; first dimension), and an EttanTM DALTsix (GE Healthcare) for
the second dimension according to the manufacturer’s instructions [48] and the protocol described
in a previous report [56]. For IEF, 300 μg hydrated protein was loaded on immobilized pH gradient
(IPG) strips (18 cm length, pH 3.0–10.0). The following IEF steps were used: 500 V for 1 h, 1000 V
for 1 h, 4000 V for 1 h, 8000 V for 1 h with a linear gradient, holding at 8000 V until a total of at least
40,000 Vh was reached, then holding at 500 V for 20 h. After the strips were balanced twice, the second
dimension was performed with 12% SDS-PAGE gel, and the total proteins were stained before further
analysis. The stained gel image was captured with an Image Master LabScan (GE Healthcare), and the
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images were analyzed using the ImageMasterTM 2D Platinum 6.0 software (GE Healthcare) for spot
detection, gel matching, and statistical analysis of the spots [56]. The image analysis remains one of
the most labor-intensive parts of the 2-DE approach. In brief, triplicate images from three independent
gels for the WT and mutant were obtained, while the normalization of the gels was carried out by the
sum of the spot densities on each gel to compare the spots. The abundance of the individual protein
spots was determined as vol.%. To identify the protein spots, the silver staining method was applied to
the prepared gels. Silver nitrate was added to the solution before use, and then it was quickly admixed
into the dyeing tray. The tray was then covered with an opaque cloth to reduce the decomposition of
the silver nitrate utilized.
After visualization by staining and gel image analysis, protein spots with at least 3-fold spot
volume ratio change (p < 0.05) were excised and subjected to mass spectrometry sequence analysis
combined with database comparison. Statistical comparisons were conducted using the one-way
ANOVA with the Tukey’s HSD test.
4.8. MALDI-TOF Analysis and Prediction of Differential Proteins
In this study, the spots showing statistically significant changes were cut out from the preparative
gels and washed twice with ultrapure water. Then, the protein spots were destained with 50%
acetonitrile (ACN) in 25 mM NH4HCO3. After removing the destaining buffer, the gel pieces
were lyophilized and rehydrated in 30 μL of 50 mM NH4HCO3 containing 50 ng trypsin (Promega,
Madison, WI, USA) at 37 ◦C overnight. The supernatant of the resulting peptides was washed with
0.1% trifluoroacetic acid (TFA) in 67% ACN. Extracts were pooled and lyophilized for MS analysis.
The MS spectra were obtained using an ABI 4800 MALDI-TOF/MS-MS Proteomics Analyzer (Applied
Biosystems, Foster City, CA, USA) as previously described [56]. The positive ion reflector (2 kV
accelerating voltage) with 1000 laser shots per spectrum and automatic data acquisition modes were
used for data collection, and the TOF spectra were collected over the mass range within 800–4000 Da
with a signal-to-noise ratio minimum set to 10 and a local noise window width of m/z 250. A maximum
of 10 precursors per spot with a minimum signal/noise ratio of 50 were selected for data-dependent
MS/MS analysis.
Then, the resultant MS and MS/MS spectra data were analyzed with the GPS Explorer software
(Version 2.0, Applied Biosystems). The database search was performed on the Mascot server (http:
//www.matrixscience.com) by searching the NCBInr (nonredundant protein sequence) database
of S. sclerotiorum (http://www.ncbi.nlm.nih.gov/) to identify the proteins. The other important
parameters were set as follows trypsin cleavage, two missed cleavage allowed, carbamidomethylation
set as fixed modification, oxidation of methionine allowed as variable modification, monoisotopic
precursor mass, precursor ion mass tolerance set to ±100 ppm, and fragment mass tolerance set
to ±0.5 Da. The protein was correctly identified if a sufficient number of peptides were matched
with a high score to a protein in the database. Only the significant hits with a protein score of 100%
and the highest peptide counts were recorded and analyzed. Then the predicted protein sequences
that matched the sequences in the NCBInr database were further analyzed for functional category
denomination [56,62]. Prediction of the signal peptide was done using the online SignalP 4.1 Server
(http://www.cbs.dtu.dk/services/SignalP/).
4.9. Data Analysis
All graphs were exported by the GraphPad Prism 6 software (La Jolla, CA, USA).
Statistical comparisons were done using the one-way ANOVA with the Tukey’s HSD (Honestly
Significant Difference) test in the PASW Statistics 18 (SPSS Inc., Chicago, IL, USA).
5. Conclusions
In this study, we combined TCA/acetone precipitation for protein extraction, 2-DE, and peptide
mass analysis to develop a fast and simple method for studying the proteomics changes of ΔSsNsd1
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mutant during compound appressorium formation. In our approach the results from 2-DE gel
analysis are put into a larger context by combining spot data with functional annotations to explore the
SsNsd1-mediated compound appressoria formation. Visualizing results, such as differential expression,
functional categories, and predicted effector proteins makes it possible to gain new insights from the
data accumulated by the “omics” technologies. Thus, this system approach can be effectively used to
identify important candidate proteins in response to the SsNsd1-mediated appressorium formation,
but it will require subsequent, more detailed studies to determine the precise role of the differentially
expressed proteins.
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Abstract: The virulence of bacterial outer membrane vesicles (OMVs) contributes to innate microbial
defense. Limited data report their role in interspecies reactions. There are no data about the relevance
of OMVs in bacterial-yeast communication. We hypothesized that model Moraxella catarrhalis OMVs
may orchestrate the susceptibility of pathogenic bacteria and yeasts to cationic peptides (polymyxin B)
and serum complement. Using growth kinetic curve and time-kill assay we found that OMVs protect
Candida albicans against polymyxin B-dependent fungicidal action in combination with fluconazole.
We showed that OMVs preserve the virulent filamentous phenotype of yeasts in the presence of
both antifungal drugs. We demonstrated that bacteria including Haemophilus influenza, Acinetobacter
baumannii, and Pseudomonas aeruginosa coincubated with OMVs are protected against membrane
targeting agents. The high susceptibility of OMV-associated bacteria to polymyxin B excluded
the direct way of protection, suggesting rather the fusion mechanisms. High-performance liquid
chromatography-ultraviolet spectroscopy (HPLC-UV) and zeta-potential measurement revealed a
high sequestration capacity (up to 95%) of OMVs against model cationic peptide accompanied by
an increase in surface electrical charge. We presented the first experimental evidence that bacterial
OMVs by sequestering of cationic peptides may protect pathogenic yeast against combined action of
antifungal drugs. Our findings identify OMVs as important inter-kingdom players.
Keywords: outer membrane vesicles (OMVs); Candida albicans; antimicrobial peptides; complement;
interspecies interactions; inter-kingdom protection; fungicidal activity; fluconazole; hyphae
1. Introduction
In the environment, different microbial populations, including bacteria and fungi, co-exist.
Mixed microbial populations are also a common feature in many diseases. Hence, understanding
which factors may be potentially important players in interspecies dynamics of growth and to what
degree these dynamics are mediated by the host is very important. Among these factors are outer
membrane vesicles (OMVs) of Gram-negative bacteria classified recently as secretion system type
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zero [1]. These proteoliposomal nanoparticles released from the cell play an important role in bacterial
physiology and pathogenesis. During pathogenesis, they enhance cellular adherence, cause biofilm
formation, and induce apoptosis or inflammation [2–4]. Furthermore, DNA-containing OMVs, through
horizontal gene transfer, are important in interspecies communication as well as in host–pathogen
interactions [5]. OMVs contribute also to innate bacterial defense through β-lactamase content or
trapping and degrading the membrane-active peptides [6–10]. Accordingly, the involvement of OMVs
in resistance to antibiotics with various modes of action is growing [11]. Both offensive and defensive
functions of OMVs have been reported. In line with this, OMVs can deliver bactericidal toxins or
enzymes to other bacteria. Lytic activities have been documented for OMVs derived from Pseudomonas
aeruginosa or Myxococcus xanthus [12–14]. On the other hand, for example, M. catarrhalis OMVs
carrying β-lactamases confer protection to M. catarrhalis and Streptococcus pneumoniae against β-lactam
antibiotics [15]. Likewise, OMVs from β-lactam-resistant E.coli can protect β-lactam-susceptible E.coli
and fully rescue them from β-lactam antibiotic-induced growth inhibition [16]. Several earlier studies
have shown that OMVs are involved in the trapping of antimicrobials, thus providing protection
among bacteria, essentially in intraspecies systems [6,8,17]. Nevertheless, limited data are available on
the relevance of this phenomenon in various interspecies populations. Among mixed populations,
the degree of OMV-dependent protection of individual partners can be completely different. One of
the factors that may influence this is the physicochemical nature of the vesicle itself. It includes both
the intrinsic antimicrobial binding capacity, which is the result of inherited or acquired resistance [18]
but also the ability of vesicle, based on physicochemical properties, to interact with other target
cells. There are several factors responsible for the latter phenomenon including electric charge and
hydrophobicity of a cellular surface [19,20]. The metabolic activity of OMV-producing bacteria also
seems to have a significant impact on this issue. For example, for P. aeruginosa it was reported
that variation in physicochemical properties was dependent on growth phase (exponential versus
stationary), influencing, therefore, the cell association activity [19]. All aforementioned characteristics
of OMVs indicate the significant degree of selectivity in OMV–cell interactions. Therefore, considering
variety of microbial populations, the question of which bacteria are and which are not protected against
membrane-active agents is still very ambiguous. It is also of great importance to ask whether this
protection can go beyond the protection against only bacteria, affecting pathogens from other kingdoms
such as fungi. Hence, it is of interest to investigate the protective potency of OMVs in the light of their
specificity to react with a target cell. In the present study, we used our well-characterized OMVs from
Moraxella catarrhalis Mc6 [4,21] as model vesicles and characterized their protective potential against
model membrane-active agents in various interspecies combinations. First, we examined the protective
activity of OMVs in bacterial intra- and interspecies systems and mode of observed protection, showing
by HPLC-UV, zeta potential measurement, and o-nitrophenyl-β-D-galactopyranoside ONPG-based
permeabilization assay, highly effective sequestration. Next, we examined the protective potential of
OMVs in the bacterial-yeast inter-kingdom system. As far as we know, our study is the first report
that OMVs can protect Candida albicans against antifungals drugs. Finally, we investigated whether
OMVs-dependent protection is a signature of only free vesicles or those associated with the cell.
2. Results
2.1. Mc6 OMVs Characteristics
As shown in transmission electron microscopy (TEM) image, the diameters of outer membrane
vesicles from M. catarrhalis 6 had 30–200 nm (Figure 1a). The results of measurements of OMV
particle size/zeta potential are shown in Figure 1b. The protein and lipooligosaccharide (LOS)
components of OMVs are shown in Figure 1c,d, respectively. As we documented previously [21],
the pivotal outer membrane proteins packaged in these vesicles were OmpCD, OmpE, UspA1
(ubiquitous surface protein A1, Hag/MID (Moraxella immunoglobulin D-binding protein), CopB, MhuA
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(hemoglobin-binding protein), TbpA (transferrin-binding protein A), TbpB (transferrin-binding protein
B), LbpB (lactoferrin-binding protein B), OMP M35, and MipA (structural protein).
Figure 1. Physical characterization of outer membrane vesicles (OMVs) released from Mc6 cells:
(a) TEM image of OMVs, vesicles are indicated by arrows (magnification, ×50,000); (b) the size
distribution by volume and the zeta potential of vesicles, as assessed by the Zeta-sizer; each experiment
was performed in triplicate; (c) the respresentative proteinogram of 12% SDS-PAGE electrophoresis
of OMVs; the protein profiles were visualized using Coomassie staining; (d) the representative 10%
SDS-PAGE electrophoresis of lipooligosaccharide (LOS)-OMVs visualized by silver staining.
2.2. M. catarrhalis OMVs Passively Protect Cross-Pathogens against Polymyxin B-Dependent Killing
Polymyxin B (PB) was used as a model of cationic peptide. In our study, using 4-h time-kill assay,
the minimal bactericidal concentrations (MBC) of PB against 5 × 105–106 cfu/mL of prominent human
pathogens, including nontypeable Haemophilus influenzae, Pseudomonas aeruginosa, and Acinetobacter
baumannii, was in the range 0.5–5 μg/mL, and caused killing effect within 2 h (Figure 2a). When
pathogenic bacteria were incubated with a bactericidal concentration of PB in combination with
20 μg/mL OMVs from Mc6, the bacteria showed active growth in contrast to the antibiotic alone, which
remained at the level of control. Up to 10 times lower concentrations of OMVs had no effect or the
effect was negligible. The amount of OMVs that was required to achieve complete protection against
respiratory pathogens referred to 20 μg/mL. The higher concentrations of vesicles did not intensify
the growth.
2.3. OMVs Protect Serum-Sensitive Strains and Accelerate Growth of Serum-Resistant Strains against
Complement
To define the influence of OMVs on the survival of cross-pathogens in the presence of active
serum (NHS), the 4 h complement bactericidal assays were performed (Figure 2b). Of the three
studied cross-pathogens, only nontypeable H. influenzae appeared to be serum-sensitive. Two others,
A. baumannii and P. aeruginosa, were serum-resistant. The resistant strains showed either 100% survival
or only a slight decrease (within one order) after 4 h of incubation in 50% or 75% NHS. Nontypeable
H. influenzae strains were sensitive to NHS-dependent killing with a reduction of cfu/mL in the range
of six orders after 30 min of incubation (NTHi3) or 120 min of incubation (NTHi6) in the presence of
25% or 50% serum, respectively, compared to the initial inoculum. These strains co-incubated with
NHS and 20 μg/mL of OMVs exhibited a time-dependent increase in survival, which was similar to
growth of control incubated in the presence of heat-inactivated serum (HiNHS).
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Figure 2. Mc6 OMVs protect bacteria from other species against polymxin B-dependent and human
complement-dependent bactericidal activity: (a) Polymyxin B-dependent killing; (b) human serum
(NHS) complement-dependent killing. Bacteria from log phase were incubated for 4 h in the presence
of indicated concentrations of membrane-targeting agents alone or along with OMVs and plated in 0,
30, 120, and 240 min. Data are expressed as mean cfu/mL ± SD from three independent experiments
performed in triplicate.
A. baumannii incubated only in the presence of active NHS was slightly killed by the lytic
complement action within 4 h, whereas after parallel exposure to OMVs, its growth was at the level of
HiNHS control. P. aeruginosa was highly resistant to 75% action of serum, thus co-incubation with
OMVs did not change the growth dynamics (data not shown). When control bacteria were incubated
in the presence of heat-inactivated NHS, neither killing nor other growth alterations were observed
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for any of the tested strains, indicating that observed lysis was complement-dependent. Overall,
these findings indicate that OMVs efficiently protect serum-sensitive gram-negative pathogens against
complement action while accelerating the growth of moderately serum-resistant strains.
2.4. Mc 6 OMVs Passively Protect Pathogenic Yeasts against Polymyxin B-Dependent Fungicidal Effect in
Combination with Fluconazole
It has been previously reported that the antifungal effect of polymyxin B combined with fluconazole
can be synergistic or potentiated [22]. We therefore initially examined the sensitivity of Candida albicans
to combined action of both drugs. Our results showed, that for ~105 cfu/mL of this yeast, the MIC50
for fluconazole (FLC) and MIC100 for polymyxin B (PB) were, respectively, 1 μg/mL and 128 μg/mL.
Next, based on checkerboard assay, we assessed the growth of C. albicans incubated with polymyxin B
alone, fluconazole alone, or their combinations at various concentrations. The results revealed that
polymyxin B at concentrations much lower than MIC (1/8 MIC and 1/16 MIC) exerts a potent antifungal
effect against C. albicans when combined with 1 μg/mL (MIC50) of FLC (Figure 3a).
Figure 3. OMVs protect yeast against synergistic fungicidal activity of polymyxin B in combination
with fluconazole: (a) Synergistic activities determined by checkerboard assay; (b) time-kill assay;
(c) 24 h growth-curve kinetics for C. albicans incubated with drug alone and drug in combinations with
or without OMVs. The kinetics were measured using Varioskan™ LUX reader with measurements at
1 h intervals. The data for experiments (a,b) show means ± SD from two independent experiments
carried out in triplicate; the data for experiment (c) show mean values from two independent repetitions
carried out in duplicate; for better readability, SDs were not included.
Next, using time-kill assay we showed that after 24 h of incubation, the combinations of FLC1-PB8
and FLC1-PB16 (μg/mL) are fungicidal, which was expressed by one order and by two orders of
143
Int. J. Mol. Sci. 2019, 20, 5577
decrease in viability, respectively (Figure 3b). In the presence of OMVs, this fungicidal action of both
drugs was significantly abolished or weakened in comparison to action of a single drug and depending
on PB concentration used. This protective effect of Mc6 OMVs against C. albicans was also confirmed in
bacterial growth kinetics (Figure 3c). By estimating the profiles of Candida growth, as a result of every
hour measurements carried out for 24 h at 37 ◦C, we have documented that the OMVs added to both
aforementioned drug combinations abolished their inhibitory effect on Candida growth rate. Thus, the
Candida growth in the presence of OMVs remained at the level for a single compound. Collectively,
these results indicate that OMVs protect C. albicans from PB-dependent fungicidal effect in combination
with fluconazole.
2.5. Mc6 OMVs Passively Enhance the Virulence of Pathogenic Yeasts Facilitating the Formation of Filaments
It was documented that azole drugs are necessary both during growth and induction step to
have an effect on transition yeast-to hyphae in C. albicans [23]. The presence of FLC in the decreased
range between 1–0.125 μg/mL both during growth and induction step caused considerable inhibition
of hyphal growth (data not shown). Therefore, to determine the effects of fluconazole in combination
with polymyxin B on hyphal growth, the yeasts were initially preincubacted overnight at 37 ◦C with
1/16 MIC of FLC (0.0625 μg/mL). During the 2 h induction of hyphal growth in the presence of 10%
fetal bovine serum, 1/16 MIC of FLC was added together with 1/8, 1/16, and 1/32 MIC of PB in the
presence of absence of 20 μg/mL of OMVs. Figure 4a,b shows that the number of hyphal cells, shown
by the ratio of cells in yeast form compared to that with formed filaments after 2 h of incubation,
decreases as the concentration of polymyxin B increases. Under the tested conditions, the combinations
FLC0.0625-PB8 and FLC0.0625-PB16 (μg/mL) showed almost complete inhibitory activity against the
formation of hyphae. FLC0.0625-PB4 had also clear inhibitory effect on yeast-to-hyphae transition in
comparison to FLC alone. The presence of 20 μg/mL OMVs in all tested drug combinations caused
a significant increase in the percentage of hyphae-forming cells (Figure 4b), probably as a result of
neutralizing PB-dependent potentiating effect of FLC. Furthermore, the increase in yeast-to-hyphal
transition was accompanied by a significant extension of filaments (Figure 4c). In summary, these
results indicate that in the presence of Mc6 OMVs, the inhibiting effect of FLC and PB, at concentrations
significantly lower than MICs, on the formation of filaments is abolished. It shows that in the presence
of OMVs, C. albicans may retain the virulent filamentous phenotype in the presence of both antifungal
drugs, thus increasing its virulence.
2.6. OMV-Dependent Protection against PB and Complement is the Result of PB Sequestration on Free OMVs
To study how efficiently PB is neutralized by Mc6 OMVs, various biological and biochemical
methods were used. Initially, a decrease of free PB was confirmed indirectly using E.coli ML35p mutant
with constitutive β-galactosidase expression (Figure 5a).
In the experiment, different concentrations of Mc6 OMVs were introduced into the system
containing E. coli ML-35p mutant at a concentration of ~106 cfu/mL and PB at a concentration of
5 μg/mL. By measuring the quantitative intracellular influx and hydrolysis of ONPG (β-galactosidase
substrate), as a result of membrane permeabilization, we showed that OMV-dependent protection was
dose-dependent and that PB was very quickly depleted from the environment in the presence of at
least 20 μg/mL OMVs leading to a decrease in peptide activity (Figure 5a).
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Figure 4. Effect of OMVs on filamentous growth of C. albicans: Yeast cells were preincubated overnight
with 1/16 MIC of FLC (0.0625 μg/mL) without shaking and then, after washing, were incubated at OD
= 0.4 in 0.4 mL of hyphae inducing medium (10% FBS in PBS) in 24-well microtiter plates with shaking
(130 rpm) for 2 h at 37 ◦C in the presence of 0.0625 μg/mL FLC, indicated concentrations of PB, and with
or without 20 μg/mL of OMVs. Three independent experiments were performed. (a) The filamentation
was monitored under inverted microscope using 40× objective (Zeiss) and images were recorded. Scale
bars = 100 μm. (b) The number of hyphal cells versus yeast cells was determined using ImageJ software.
The pool of yeast cells contains yeasts and yeasts whose germ tubes did not exceed 10 μm. The data
represent the mean values calculated for ≥ 200 cells for each of the eight tested options. (c) Box and
Whisker plots of hyphal length: Minimal and maximal values, median, quartiles Q1 and Q3. Statistical
analysis was performed by one-way ANOVA (* p < 0.05, ** p < 0.01).
Next, to directly confirm the role of OMVs in PB sequestration, we determined zeta potential,
showing that the initially moderately negative zeta potential of intact OMVs was immediately and
significantly neutralized by addition of at least 50 μg/mL of PB, in a concentration-dependent and
diluent-dependent manner leading to membrane depolarization (Table 1). The presented results of
alteration in Zeta potentials were similar after 30 min and 60 min incubation at 37 ◦C (data not shown).
Finally, to quantitatively assess the magnitude of PB sequestration by OMVs, the residual free PB
content remaining after ultrafiltration of OMV-PB complexes was measured using HPLC-UV. Figure 6
shows the chromatograms of recovered by ultrafiltration PB that was preincubated for 30 min either
alone or with OMVs. The loss of PB following incubation with OMVs at 5 μg/mL and 20 μg/mL was
almost 60% (p < 0.001) and over 96% (p < 0.001), respectively, in reference to standard PB (Table 2).
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Figure 5. OMVs block the permeabilizing activity of membrane targeting agents. Change in E. coli
ML-35p membrane permeability was assayed by a time-dependent influx of ONPG in the presence
of membrane-targeting agents and different concentrations of Mc6 OMVs. Bacteria at log phase
(~106 cfu/mL) were incubated on microplate at 37 ◦C for 120 min in the presence of indicated
concentrations of OMVs together with (a) polymyxin B (PB) and (b) normal human serum (NHS). The
absorbance was measured at indicated time points. The results are shown as mean ± SD from at least
three independent experiments performed in duplicate.
Table 1. Alteration in Zeta potential of OMVs treated with polymyxin B.







20 μg/mL OMVs (control) −22.5 ± 1.05 20 μg/mL OMVs (control) −24.7 ± 0.76
20 μg/mL OMVs + 5 μg/mL PB −21.2 ± 1.06 20 μg/mL OMVs + 5 μg/mL PB −25.9 ± 0.97
20 μg/mL OMVs + 50 μg/mL PB −16.5 ± 0.76 * 20 μg/mL OMVs + 50 μg/mL PB −9.6 ± 0.35 *
20 μg/mL OMVs + 250 μg/mL PB −10.1 ± 0.46 * 20 μg/mL OMVs + 250 μg/mL PB −1.17 ± 0.14 *
*-p < 0.001 in reference to control as determined by one-way ANOVA.
Collectively, our results demonstrate that PB is quickly and effectively depleted from the
environment via OMV-dependent sequestration.
Similar experiments with E.coli ML35p mutant were performed with human active serum (NHS).
Similar to PB, the strong permeabilizing potency of membrane attack complex (MAC), present in 10%
human serum, against E.coli ML35p was considerably decreased or even dumped as the concentration
of OMVs increased (Figure 5b). It suggests that by deposition of complement components on the
OMV surface, vesicles trigger MAC formation away from target bacteria and thus protect them from
MAC-mediated lysis. Accordingly, based on the quantitative formation of soluble non-proteolytic
membrane attack complex (SC5b-9), we demonstrated that the Mc6 OMVs activate human serum
complement in a concentration-dependent manner (Figure S1).
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Figure 6. The HPLC spectra of polymyxin B incubated alone or along with OMVs. Chromatograms
of (a) 50 μg/mL solution of polymyxin B, (b) 50 μg/mL of PB after treatment with 5 μg/mL of Mc6
OMVs, (c) 50 μg/mL of PB after treatment with 20 μg/mL of Mc6 OMVs. Samples were prepared as
described in Materials and Method section. HPLC analyses were performed with Macherey–Nagel
Nucleodur C18 Isis column. UV-detection at 215 nm. Double peak with Tr = 3.8 min corresponds
mainly to polymyxin PB2 and PB3, and double peak with Tr= 7 min corresponds to polymyxin PB1 and
PB1-I. The representative chromatograms are shown.
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Table 2. Magnitude of PB sequestration on M. catarrhalis OMVs.
Treatment PB2 (μg/mL) PB1 (μg/mL) PB2 + PB1 (μg/mL)
Standard PB 14.38 ± 0.48 17.45 ± 3.58 31.83 ± 3.47
PB after treatment with 5 μg/mL OMVs 7.76 ± 1.01 5.19 ± 1.05 13.67 ± 1.33 *
PB after treatment with 20 μg/mL OMVs 0.96 ± 0.42 0.06 ± 0.01 1.02 ± 0.42 *
The PB content was measured by HPLC-UV method as described in material and methods. The results are expressed
as mean ± SD. * p < 0.001 in reference to standard PB as determined by one-way ANOVA.
2.7. OMVs Associated with Bacteria do not Protect against PB
To answer the question of whether Mc6 OMVs protect bacteria against the membrane-active agent
by sequestration only indirectly, being far from the bacterial surface or through the direct shield of
these cells, we determined the association capability of OMVs using flow cytometry. We used 4-times
higher concentration of OMVs (80 μg/mL) to make sure that the entire cell population could be covered
(Figure S2). We found that Mc6 OMVs incubated with studied strains strongly interacted within 30 min
with the parental strain as well as with other strains from Moraxella species. After this time, more than
93% of measured events were fluorescent, indicating that FITC-labelled OMVs were associated with
unlabeled bacteria. No increase in fluorescence was observed when Mc6 OMVs were incubated even
up to 2 h with bacteria from other species indicating the complete lack of association (Figure 7a,b).
These results indicate that OMVs released by M. catarrhalis associated only in intraspecies but not in
interspecies tested systems, pointing to the specificity of this reaction. To verify whether the covering
of M. catarrhalis with OMVs is another mode of protection against PB, 4 h time-kill assays (Figure 7c,d),
as well as 24 h real-time bacterial growth kinetics (Figure 7e,f) were carried out on OMV-associated
and not associated cells in the presence and absence of PB.
Not in the line with expectation, the results showed that for M. catarrhalis associated and not
associated with OMVs, the lethal effect of PB occurred after 4 h (Figure 7c) and 2 h (Figure 7d),
respectively. It indicates that the association does not ensure longer protection but only delays the
bactericidal effect. The lack of protection was confirmed in growth kinetic experiments documenting
that PB-dependent growth inhibition for OMV-associated M. catarrhalis and non-associated control
was comparable and preserved for 24 h of incubation (Figure 7e). In the case of bacteria incubated in
the presence of free OMVs and PB, the OMV-dependent protection is assured for ~7 h being on the
level of control growth. Some modest and stable level of protection is maintained for 24 h (Figure 7f).
Compared to the growth profiles of OMV-associated and non-associated M. catarrhalis, it was shown
that the interaction with vesicles weakens the growth dynamics of the former. Overall, the results
are evidence that OMVs associated with bacteria do not protect against PB, assuming of course that
the bacterial cell is completely shielded by them. Consequently, it suggests the active fusion between
OMVs and target cell membrane rather than only surface association.
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Figure 7. Mc6 OMVs highly associated with bacteria do not protect against polymyxin B-dependent
killing. (a) Flow cytometry analysis of fluorescein isothiocyanate (FITC)-labelled OMVs associated
with intraspecies bacteria (upper panel) and not associated with interspecies bacteria (lower panel),
The fluorescence intensities of OMV-associated bacteria are shown as black histograms whereas control
bacteria as dotted histograms. Representative plots are shown. (b) Quantification of bacteria associated
with FITC-labelled OMVs. Data are expressed as mean fluorescent intensity (MFI) ± SD from three
independent experiments performed in duplicates. (c) Bactericidal activity of polymyxin B against
M. catarrhalis after association with OMVs. (d) Bactericidal activity of polymyxin B against M. catarrhalis
incubated with free OMVs. (e) 24 h growth-curve kinetics for M. catarrhalis after association with OMVs.
(f) 24 h growth-curve kinetics for M. catarrhalis incubated with free OMVs. The kinetics was measured
using Varioskan™ LUX reader with measurements at 30 min intervals. In experiments (c,d) results
are shown as mean ± SD from at least two independent experiments. In experiments (e,f) results are
shown as mean from at least three independent experiments performed at duplicate and for better
readability, SDs were not included.
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3. Discussion
Bacteria and yeasts employ a variety of means to protect their envelopes against harmful
environmental factors. Some of these factors cause membrane permeabilization, while others can
inhibit the synthesis of cellular membrane components affecting the physical properties of the
membrane [24,25]. The common strategy of bacteria to avoid membrane targeting factors is to
overcome the negative charges of their surface envelope [24,26]. Alternatively, bacteria can release
OMVs that act as extracellular decoys for some antimicrobials.
In this study, we report that OMVs may serve as a model of passive interspecies protection of
prominent pathogenic bacteria but also pathogenic yeasts. While documenting the lethal effect, we
showed that free OMVs block both the bactericidal action of peptide antibiotic polymyxin B and the
lytic activity of complement. By quantitative measurement of alteration in electric charge on the OMV
surface treated with PB as well as free PB determination by HPLC, we showed that 20 μg/mL of OMVs
that had a significant protective effect against interspecies microorganisms caused almost complete
depletion of this model cationic antimicrobial agent after co-incubation, thus indicating the immediate
sequestration of the peptide on free OMVs. Accordingly, in similar experiments, we showed that OMVs
inhibit serum lytic activity against prone pathogens, indicating that by deposition of complement
components on the OMV surface, vesicles trigger MAC (SC5b-9) formation away from target bacteria
and thus protect them from MAC-mediated lysis. The intensity of OMV-dependent complement
activation in vitro was correlated with the number of free vesicles in the environment. Therefore, it is
possible that any fluctuation in the number of released vesicles may positively or negatively influence
complement activation of this potent innate mechanism.
Next, using the PB-dependent model, we investigated whether OMVs-dependent protection is a
signature of only free vesicles or those associated with the cell. Using flow cytometry, we documented
that the association of OMVs with bacterial cells may be very potent and species-specific, influencing the
cell sensitivity to antimicrobial compound. Our vesicles were able to associate only with representatives
of M. catarrhalis species while they did not work in interspecies systems. By evidencing the lethal effect
of cell-associated OMVs exposed to polymyxin B, we showed that OMVs do not protect against AMPs
this way, suggesting a fusion between OMVs and OM rather than only shielding. It is tempting to
speculate that the specificity of interaction between OMVs and recipient cell is somehow pivotal in
its sensitization at least to AMPs. We are therefore in agreement with Tashiro et al. that elucidating
the selectivity in OMV-cell interaction is critical for an improved understanding of the outcome of
this reaction. On the other hand, it has been documented that interactions with OMVs for some
cross-pathogens can be specific, less specific, or not specific at all [27]. Thus, the OMV-dependent
interplay may contribute to the generation of synergistic or antagonistic interactions between pathogens,
resulting in more or less harmful outcomes for the host.
Next, we address the question of whether OMV-dependent trapping of cationic antimicrobials can
protect pathogens from other kingdoms such as fungi of the species C. albicans. Polymyxins alone are
effective against C. albicans only at relatively high concentrations [28]. Azoles including fluconazole
are common antifungal drugs [29]. They affect the integrity of fungal membranes, altering their
morphology and inhibiting growth [30,31]. It has been reported that quinolone and other antibiotics
may augment the anti-candidal activity of azole and polyene agents [32]. Previous research also
documented that PB in lower concentrations exerts a potent antifungal effect when combined with
fluconazole [22,33]. Therefore, the elimination of the antibiotic from these systems by means of
OMVs should decrease the fungus susceptibility to fluconazole. To test this hypothesis, we incubated
C. albicans in the presence of both drugs and OMVs using FLC at MIC50 (1 μg/mL) and PB in the
range much lower than MIC (1/8–1/16). To our knowledge, for the first time, we have provided
evidence that bacterial OMVs can inhibit the fungicidal action of certain combined antifungal agents
that are effective against pathogenic yeasts. Next, we documented that sub-MIC concentrations of FLC
(1/16) and PB (in the range of 1/8–1/32) applied together weakened or almost completely inhibited the
yeast-to-hyphae transition. Furthermore, in the presence of OMVs, the filamentous phenotype was
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considerably recovered and even strengthened despite exposure to both drugs. It is a very undesirable
action of OMVs, since filamentation increases the virulence of C. albicans, which in hyphae form is
more invasive and can attach in a higher number to epithelial cells than yeast and pseudohyphae
forms [34,35]. Using analogies to the role of OMVs contributing to the sequestration of PB, it is
tempting to speculate that the same mechanism of action exists in this case. Collectively, both of the
aforementioned activities of bacterial vesicles seem to render C. albicans less vulnerable to destruction.
The documented inter-kingdom OMV-based mutualistic relationship between bacteria and yeasts are,
to our knowledge, a novel phenomenon. Therefore, its importance for more complex in vitro and
in vivo conditions, as well as pathophysiology, remains to be clarified.
The complex Candida–bacteria interactions are not a rare occurrence and may have an important
impact on the human disease by causing e.g., the faster biofilm growth or Candida-dependent induction
of antimicrobial resistance of Staphylococci [36,37]. Sometimes, the results investigating cross-kingdom
polymicrobial interactions are very contradictory even for the same microbial components. It was
shown that direct or indirect (by released soluble molecules) contact of P. aeruginosa or A. baumannii with
C. albicans or other fungi may lead to the killing of yeast [38,39]. It can also decrease fungal filamentation,
biofilm formation, and conidia biomass [40]. The synergistic collaboration between the two pathogens
was also documented. For example, the pre-colonization with C. albicans, which compromises
the immune system, facilitates the emergence of A. baumannii pneumonia [41]. The interactions
between microbes are not only affected by the specific combination of microorganisms, but also by
the environment such as immunological milieu. Therefore, bacterial OMVs shape the behavior of
neighboring microbes and the overall outcome of their interplay for the host. Due to the limited
antifungal arsenal, the synergistic effect of PB and fluconazole or human broad-spectrum AMP
lactoferrin with amphotericin B or fluconazole, which increases the activity of the antifungals against
Candida spp, could be an alternative for treatment [22,42]. Likewise, AMPs such as defensins or
gramicidin have shown to be a promising alternative to the current antimycotic and antibacterial
therapies [43–45]. Furthermore, AMPs display a lower propensity to develop resistance than do
conventional antibiotics [45]. In light of our research, however, these promising strategies should
consider the unfavorable role of OMVs as a trap for host cationic peptides in mixed bacterial and
bacterial–fungal infections. Our results may also have a meaning in medical microbiology. Because
AMPs are already used in topical nasal antimicrobials in the treatment of nasal or paranasal cavity
infections (sinusitis, maxillary, otitis media) [46,47], it is conceivable that abundantly produced OMVs,
by very efficient AMP sequestration, may decrease the pharmacokinetics of these compounds.
Another important issue of our results is the number of OMVs needed to show biological
activity. In general, the information about the number of OMVs produced in vivo is still very limited.
Although OMV production in the course of infection has been documented [48], the magnitude of
this production was not given. During the in vitro part of this study, however, the biologically active
concentration of OMVs was 5 μg/mL per 103 cfu/mL. In our study, 20 μg/mL of OMVs was protective
against 106 cfu/mL, indicating that OMV amounts used in our study are rational and may resemble the
infectious condition.Furthermore, there is many data on how different stress factors may induce bacterial
hypervesiculation incuding temperature stress [49], oxidative stress [50], hyperosmotic stress [49],
or antibiotic stress [51]. So far, the correlation between OMVs production and pathophysiology of a
specific disease was proven both in animal sepsis-like inflammation models [52–54] and in a patient
with fatal meningococcal septicaemia [55]. Based on these aforementioned examples, the OMVs
concentrations, which seems to be clinically relevant, are in the range 5–20 μg/mL.
Overall, our results on the protective and somehow deleterious for pathogens role of OMVs,
in the bacteria–bacteria and bacteria–yeast interspecies systems, underline the enormous potential
of these nanostructures as accelerating factors in case of various mixed infections. Furthermore,
the OMV-dependent mode of actions may serve as a model of passive resistance of gram-negative
bacteria not only to antimicrobials, but also to humoral defense components, which operate to disrupt
cell membrane. Likewise, for dimorphic yeasts, the ability of OMVs to sequester membrane active
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compounds that augment the antifungal activity of azoles may have an important impact on Candida
virulence. This work may serve as an important basis for further evaluation of OMVs-dependent
interactions within pathogenic bacterial-fungal communities. Our results indicate that OMVs are
important players in interspecies and cross-kingdom microbial interactions.
4. Materials and Methods
4.1. Materials
4.1.1. Reagents
BHI (Brain Heart Infusion, OXOID, Basingstoke, UK) ); TSB (Tryptone Soya Broth, OXOID,
Hampshire, England); TSA (Tryptone Soya Agar, OXOID, Hampshire, England), Bradford
reagent (Protein Assay Dye Reagent Concentrate, Bio-Rad, München, Germany); β-nicotinoamide
adenine dinucleotide hydrate (NAD, Sigma-Aldrich, Steinheim, Germany); fluconazole (FLC,
Sigma-Aldrich, Poznan, Poland), hemin (Sigma-Aldrich, St. Louis, MO, USA); polymyxin B sulfate
salt (PB, Sigma-Aldrich, Denmark); fluorescein isothiocyanate (FITC, ThermoScientific, Rockford, IL,
USA); Hank’s Buffer with Ca2+, Mg2+ (HBSS, PAN Biotech, UK); RPMI 1640 (Lonza, Walkersville, MD,
USA); o-nitrophenyl-β-D-galactopyranoside (ONPG, Sigma, Steinheim Germany), heat inactivated
(56 ◦C, 1 h) FBS (Fetal bovine serum, Gibco Life Technologies, Grand Island, NY, USA).). HPLC
chemicals: Acetonitrile (Sigma, München, Germany) for separation was HPLC far UV/gradient grade
(J. T. Baker, Avantor™ Performance Material); 32 mM Na2SO4 solution for chromatographic usage
was prepared with 4.5 g anhydrous sodium sulfate (POCh, Avantor™ Performance Material, Gliwice,
Poland) and MiliQ (ultrapure water made with Simplicity UV Water Purification System, Merck
Millipore, Saint-Quentin, France).
4.1.2. Microbial Strains and Growth Condition
The following microbial strains were used: Moraxella catarrhalis (Mc5, Mc6, Mc8), nontypeable
Haemophilus influenzae (NTHi3, NTHi6), Acinetobacter baumannii (ATCC 19606), Pseudomonas aeruginosa
(PAO1), Candida albicans (Ca1), mutant of Escherichia coli ML-35p, a lactose permease-deficient strain
with constitutive cytoplasmic β-galactosidase. All strains were from the collection of our Institute.
M. catarrhalis strains were grown on Columbia agar plates or BHI broth. NTHi strains were grown on
chocolate agar plates or in BHI broth supplemented with hemin and NAD at final concentrations of
15 μg/mL each. Moraxella and Haemophilus strains were cultivated at 37 ◦C with 5% CO2. A. baumannii;
E. coli ML-35p and P. aeruginosa were routinely cultured in TSB medium at 37 ◦C. C. albicans was
cultured in yeast extract-peptone-glucose (YPG) in 37 ◦C.
4.2. Methods
4.2.1. Outer Membrane Vesicles Isolation
Outer membrane vesicles (OMVs) isolation was performed as described previously [21].
The protein concentartions of purified OMVs preparations was determined by Bradford assay)
and the quality of OMVs preparation was confirmed in 12% SDS-PAGE.
4.2.2. Time-Kill Assay
For testing PB or human serum (NHS) activity, the log-phase bacterial suspension
(5 × 105–106 cfu/mL) was incubated with or without PB (in the range 0.5–5 μg/mL) or NHS (in the
range 25%–75%) with the presence or absence of free OMVs (2 μg/mL or 20 μg/mL) in the final volume
of 200 μL 1% medium (w/v). The experiments were performed from 0 to 240 min and the 10 μL aliquots
of 10-time diluted bacterial suspensions were plated in triplicate on appropriate agar plates at 0, 30, 120,
and 240 min time points. The colony counts and cfu/mL were calculated the next day. The controls for
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NHS contained heat-inactivated serum (HiNHS), (56 ◦C, 30 min). The bactericidal activity of PB or NHS
was expressed in each time point as cfu/mL in reference to cfu/mL in time 0. Analogous experiments
with bacteria associated and non-associated with OMVs (20 μg/mL or 80 μg/mL) in the presence of PB
(5 μg/mL) were performed. Analogous experiments for selected combinations of antifungals were
carried out for C. albicans except that: (i) Initial inoculum was ~2 × 105–5 × 105 cfu/mL, (ii) tested
antimicrobials were PB (8 μg/mL or 16 μg/mL) and fluconazole (1 μg/mL), (iii) the medium was 0.5%
YPG (w/v), and (iv) incubation lasts 24 h. All microbicidal assays were performed at least two times
in triplicate.
4.2.3. Growth Kinetics Assay
All growth kinetics experiments were performed on the flat-bottomed 96-well microplates (NUNC,
Denmark) at 37 ◦C in volume 200 μL. Dynamic of growth was measured using Varioskan™ LUX reader
with measurements at 30 min intervals for bacteria at 106 cfu/mL diluted (final concentration) in 1%
BHI (w/v) and 60 min intervals for yeast at 105 cfu/mL (final concentration.) diluted in 0.5% YPG.
OMV-associated bacteria preparation: 0.5 mL of ~108 cfu/mL exponentially growing bacteria
were washed by centrifugation with HBSS Ca2+ Mg2+ and resuspended in 100 μL OMVs (20 μg/mL
or 80 μg/mL) in Eppendorf tube. Association was performed for 30 min at 37 ◦C with gentle mixing.
Thereafter, all samples were washed with HBSS Ca2+, Mg2 by centrifugation (8000 rpm, 10 min, 4 ◦C)
to remove free OMVs particles, diluted to 2 × 106 cfu/mL with HBSS Ca2+, Mg2, and used in growth
kinetics assay.
4.2.4. Checkerboard Microdilution Assay
The microdilution assay was performed on flat-bottom microplate according to the CLSI (formerly
NCCLS) standard [56] except that the initial inoculum for C. albicans was ~105 cfu/mL and cells were
incubated at 37 ◦C without shaking. Synergy/growth potentiation was tested by the checkerboard
method including a two-dimensional array of serial concentrations of both drugs. The fluconazole was
used in concentrations 1–64 μg/mL whereas polymyxin B in concentrations 1–128 μg/mL. Wells without
drugs or yeast inoculation were included as positive and negative controls, respectively. The MIC100 of
polymyxin B and the MIC50 of fluconazole was defined as the lowest drug concentration that caused a
decrease in absorbance of 100% and 50%, respectively, compared to control in drug-free medium.
4.2.5. Induction of Filamentation
Before the induction of filamentation, C. albicans cells were preincubated overnight in YPG
supplemented with sub-MIC concentration of FLC at 37 ◦C without shaking. To induce hyphal
transition, the suspensions of C. albicans (OD = 0.4) were treated with 10% heat inactivated FBS in PBS
for 2 h at 37 ◦C in 24-well flat-bottom microplates (NUNC) in volume 0.4 mL, in the presence of sub-MIC
concentrations of FLC (1/16) and PB (range 1/8–1/32) and with shaking (130 rpm). The samples were
observed under inverted microscope Zeiss Axio Vert. A1 with objective Zeiss LD A-Plan (40 × /0.55 Ph1).
The images wer recorded using Industrial Digital Camera 5.1 MP 1 /2.5”. The assessment of cell
morphology and the length (μm) of hyphae was performed using ImageJ software.
4.2.6. Membrane Permeability Assay with ONPG
To assess the polymyxin B sequestration by M. catarrhalis OMVs in vitro, the time-dependent
decrease of permeabilizing activity of this peptide against E. coli ML-35p with constitutive
β-galactosidase activity was measured using the ONPG-mediated β-galactosidase microplate assay as
previously described [57]. The final bacterial suspension (~106 cfu/mL) in 10 mM sodium phosphate
NaPB (pH 7.4) were incubated in the flat-bottom 96-well microplates (NUNC, Denmark) with 5μg/mL of
PB in the presence of OMVs at concentration range 1–20μg/mL and with 3 mM ONPG asβ-galactosidase
substrate in the final volume of 150 μL. Microplates were incubated at 37 ◦C for 1.5 h and optical
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densities at λ = 405 nm were measured every 15 min (spectrophotometer ASYS). All the assays were
performed at least 3 times in duplicates.
4.2.7. Complement Activation
This method was described previously [58]. To assess complement activation by M. catarrhalis
OMVs in vitro, the various concentrations of OMVs (1–20 μg/mL) were pretreated with active normal
human serum (NHS) at a volume ratio 1:9 and the soluble terminal complement complex SC5b-9 was
measured using ELISA kit according to manufacturer’s instructions (Quidel Corporation, San Diego,
USA). Unstimulated NHS served as negative controls.
4.2.8. OMV Association Assay and Flow Cytometry
OMVs labeling: Initially, OMVs (80 μg/mL) in PBS were concentrated using 50 kDa Vivaspin
centrifugal concentrators (Amicon ultra, Millipore) at 14,000 × g for 10 min at 4 ◦C to remove PBS.
The collected OMVs were reconstituted with 500 μL of 0.05 M carbonate/bicarbonate buffer (pH 9.5)
and washed by centrifugation on vivaspin as described before. The collected OMVs at concentration
80 μg/mL were labeled with 1 mg/mL FITC at carbonate/bicarbonate buffer for 30 min at 37 ◦C with
gentle mixing in the dark. The remaining fluorochrome was rinsed of 3 times with a 500 μL of cold
carbonate/biscarbonate buffer each time, using 50 kDa Vivaspin. The final FITC-labelled OMVs were
resuspended in Hank’s buffer Ca2+, Mg2+ at original concentration.
OMVs association with bacteria: 1 mL of each fresh bacterial culture corresponding to OD550 = 0.2
was centrifuged and subsequently washed with 1 mL of HBSS Ca2+, Mg2+ (8000× g, 10 min, 4 ◦C).
The pellet was resuspended in 200 μL of OMV-FITC conjugate (80 μg/mL OMVs) and incubated for
30 min at 37 ◦C with gentle mixing in the dark. Afterward, samples were washed with HBSS Ca2+Mg2
by centrifugation (8000× g, 10 min, 4 ◦C) to remove free OMVs particles and finally resuspended in
200 μL of HBSS Ca2+ Mg2.
Flow cytometric analysis: To detect bacterial cells associated with FITC-labeled OMVs flow
cytometry analysis was performed using GUAVA® easyCyte flow cytometer (Millipore, Seattle, WA,
USA). Before analysis, the samples were diluted 1:100 to obtain approximately 1–5 × 105 cell/mL in
HBSS Ca2+Mg2+. Fluorescence intensity of bacterial cells associated with OMVs was analyzed for green
fluorescence in the FL1 channel, by collecting 5000 events. Data were expressed as mean fluorescence
intensity (MFI). Data analysis was performed using InCyte Merck Guava software (Millipore, Hayward,
CA, USA).
4.2.9. Estimation of Zeta Potential
The Zeta potential of OMVs was measured at room temperature (25 ◦C) by a Zetasizer Nano-ZS
90 (Malvern, UK). The instrument was equipped with a Helium–Neon laser (633 nm) as a source of
light. The detection angle of Zetasizer at aqueous media was 173◦. Considering the influence of factors
such as conductivity (salt concentration) or pH of the solution on the Zeta potential, to minimize
their influence, all Zeta potential measurements were performed with 10 mM NaPB buffer (pH 7.4) or
in MiliQ.
4.2.10. HPLC-UV System and Method
HPLC chromatography of polymyxin B was performed as described previously [26,59]. The HPLC
system consisted of a Water’s 2695 Solvent Manager System with a built-in autosampler and 100 μL
sample loop connected to Waters 2996 Photodiode Array Detector. Data collection and peaks integration
were realized by computer with Water’s Empower 3 Chromatography Data Software. The separation
developed with the use of a Macherey-Nagel EC Nucleodur C18 Isis column (50 mm, 4.6 mm ID with
1.8 μm beads) with Hypersil Gold aQ 5 μm (10 mm × 4.6 mm ID) guard precolumn. The mobile phase
consisted of 22% acetonitrile and 78% of 32 mM Na2SO4 in water (pH 3.2 achieved with H2SO4) in
isocratic separation mode. Eluent flow 0.75 mL/min and detection realized with a UV detector at
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215 nm. Column and sample temperature were respectively 30 ◦C and 5 ◦C; separation run time
was 15 min. The injection volume was 50 μL. The calibration curve was in the range of 1.56 μg/mL
to 100 μg/mL prepared with 10 mg/mL standard stock solution of polymyxin B sulfate salt. Each
concentration was injected twice daily for precision into 3 or 2 independent samples, and between day
eight samples. The linearity of the method was in a range from 6.25 to 100 μg/mL with 16% of the
average coefficient of variation (CV%) for the sum of peaks, and with a coefficient of determination
R2 = 0.997. Since the major constituents of polymyxin B are B1 and B2 [59], (polymyxin B sulfate
certificate of analysis, Sigma-Aldrich), these two components were analyzed altogether.
To quantify the results, the relative concentration was calculated as the mean PB concentration of
sample/mean PB of control × 100%. Results were expressed as mean ± SD.
Sample preparation: 200 μL of reaction mixtures containing OMVs (5 μg/mL or 20 μg/mL) and PB
(50 μg/mL) or PB alone (50 μg/mL) were incubated for 30 min at 37 ◦C with gentle mixing. The samples
were ultrafiltrated using 50 kDa vivaspin centrifugal concentrators (Amicon ultra, Merck Millipore,
Cork, Ireland) at 14 000× g for 15 min at RT to remove OMVs. The filtrate was collected and stored at
−20 ◦C until use. Tested and control samples were processed identically.
4.2.11. LOS-OMVs Electrophoresis
The concentration of lipooligosaccharide (LOS) from Mc6 OMVs was determined based on the
purpald assay [60]. Diluted samples were solubilized in Laemmli sample buffer and heated at 100 ◦C
for 5 min. Proteinase K (20 mg mL−1) was added per 20 mg of OMV proteins and incubated in a heating
block at 60◦C for 1 h. The presence of LOS in proteinase K-treated OMV samples was analyzed by
dodecylosulfate gel electrophoresis. The 15 μL of samples were applied to the Glycine-SDS-PAGE (10%)
gel path, corresponding to 5 μg LOS. Electrophoresis was carried during 2.5 h at a constant voltage
of 80 V at 4 ◦C. The gel was fixed for 1 h at room temperature using a fixing solution (EtOH: Acetic
Acid: MiliQ: 40:5:55); POCH, Gliwice, Poland) The fixed gel was stored overnight at 4 ◦C. MiliQ was
exchanged for fresh before visualization using a modified Tsai and Frasch [61] silver staining protocol.
4.2.12. TEM
The OMVs preparation for TEM was described previously [4]. OMVs were visualized by standard
negative staining using a formvar copper grid (Christine Gröpl Electronenmikroskopie, Tulln, Austria)
and 2% (w/v) aqueous solution of uranyl acetate. The OMVs were imaged with a TEM operating at an
acceleration voltage of 150 kV (Hitachi H-800, Japan).
4.2.13. Statistical Analysis
The data were expressed as the mean ± SD, and analyzed for the significant difference by one-way
ANOVA or Kruskal–Wallis ANOVA rang using the Statistica (version 13.1) software (StatSoft, Krakow,
Poland) Differences were considered statistically significant if p < 0.05.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/22/
5577/s1.
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with input from J.R.; D.A., J.R., G.G. reviewed and edited the manuscript. D.A., wrote the revised version of the
manuscript; Z.D.-K. and D.A. acquired funding. This work is a part of the PhD thesis by J.R.
Funding: This study was supported by research grants of University of Wroclaw (1016/S/IGiM/T-20).
Conflicts of Interest: The authors declare no conflict of interest.
155
Int. J. Mol. Sci. 2019, 20, 5577
Abbreviations
AMP Antimicrobial peptide
FBS Fetal bovine serum
FLC Fluconazole
HiNHS Heat-inactivated normal human serum
LOS Lipooligosaccharide
MIC Minimal inhibitory concentration
NHS Normal human serum
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Abstract: Bordetella pertussis is a Gram-negative strictly human pathogen of the respiratory tract
and the etiological agent of whooping cough (pertussis). Previously, we have shown that RNA
chaperone Hfq is required for virulence of B. pertussis. Furthermore, microarray analysis revealed
that a large number of genes are affected by the lack of Hfq. This study represents the first attempt
to characterize the Hfq regulon in bacterial pathogen using an integrative omics approach. Gene
expression profiles were analyzed by RNA-seq and protein amounts in cell-associated and cell-free
fractions were determined by LC-MS/MS technique. Comparative analysis of transcriptomic and
proteomic data revealed solid correlation (r2 = 0.4) considering the role of Hfq in post-transcriptional
control of gene expression. Importantly, our study confirms and further enlightens the role of Hfq
in pathogenicity of B. pertussis as it shows that Δhfq strain displays strongly impaired secretion of
substrates of Type III secretion system (T3SS) and substantially reduced resistance to serum killing.
On the other hand, significantly increased production of proteins implicated in transport of important
metabolites and essential nutrients observed in the mutant seems to compensate for the physiological
defect introduced by the deletion of the hfq gene.
Keywords: Bordetella pertussis; Hfq; omics analysis; T3SS; serum resistance; solute-binding proteins
1. Introduction
Bordetella pertussis is a Gram-negative strictly human pathogen of the respiratory tract and the
etiological agent of whooping cough (pertussis) [1]. This highly contagious disease is especially severe
in infants and remains a major cause of infant mortality and morbidity worldwide, predominantly in
developing countries [2]. Furthermore, pertussis incidence is currently on the rise in industrialized
countries with highly vaccinated populations [3,4]. While there are several reasons for this
phenomenon [5], there are two major disease-related factors contributing to recent increase in pertussis
cases: short-lived immunity induced by current acellular vaccines and pathogen adaptation leading to
escape from the immunity by antigenic variation [6–8]. The global reemergence of pertussis clearly
suggests that we need to widen our understanding of the molecular mechanisms underlying the
pathogenesis of B. pertussis [9,10]. In many pathogenic bacteria the RNA chaperone Hfq and small
non-coding regulatory RNAs (sRNAs) emerged as critical players in posttranscriptional regulation
of virulence and physiological fitness [11–13]. The Hfq protein forms ring-shaped hexamers that
possess several RNA binding sites that allow for simultaneous interaction with both sRNA and mRNA
molecules and stabilization of their interactions [14–16]. Besides its role in facilitation and stabilization
Int. J. Mol. Sci. 2019, 20, 3073; doi:10.3390/ijms20123073 www.mdpi.com/journal/ijms161
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of RNA duplexes, Hfq can actively remodel the structure of RNAs and also increase the stability of
sRNAs [14,16,17].
Recently we have shown that Hfq is required for virulence of B. pertussis as the Δhfq mutant was
affected both in its ability to efficiently multiply and persist in mouse lungs as well as in its capacity to
cause a lethal infection in mouse [18]. Furthermore, our global DNA microarray-based transcriptomic
profiling of the hfq mutant suggested that Hfq protein significantly affects expression of more than
10% annotated genes [19]. Nevertheless, despite the high sensitivity, transcriptomic profiling does not
capture post-transcriptional and post-translational modifications that affect the amounts of produced
proteins. On the other hand, mass spectrometry-based proteomics lacks the sensitivity to detect low
abundant proteins. Therefore, integrative analysis of both transcriptomic and proteomic datasets
enables a more complete understanding of studied biological processes [20,21]. First studies based on
such an approach revealed that the overlap between the outcomes of transcriptomic and proteomic
analyses is not extensive irrespective of the organism [22–24]. This discrepancy was attributed in part
to technological limitations of applied procedures and in part to inherent biological complexity of
transcription and translation processes [25,26]. Especially, factors linked to translational efficiency,
such as codon usage bias, strength and accessibility of ribosome binding site, secondary structure and
stability of the transcript, and post-transcriptional activity of the regulatory proteins, contribute to
poor correlation between determined transcript and protein levels [20,27–29]
Hfq is a key player in post-transcriptional control of gene expression in Gram-negative bacteria and
therefore, its biological activities should in principle weaken the correlation between the gene expression
and protein synthesis profiles. Recently, an integrative analysis of Hfq-specific transcriptomic and
proteomic profiles based on high-throughput RNA-seq and LC-MS/MS technologies was performed
in soil bacterium Pseudomonas fluorescence. It showed that such a multiomics approach allows for
dissection of discrete contributions of Hfq to gene regulation at different levels [30]. Therefore, we were
interested to perform such a comparative analysis in human pathogen to elucidate the Hfq-related
variations at both transcriptomic and proteomic levels per se and also to decipher how the changes
in gene expression profiles translate into protein production in B. pertussis. Our results indicate that
considering the role of Hfq in the post-transcriptional control of gene expression, the correlation
between transcriptome and proteome is relatively high. Furthermore, our data corroborate and further
clarify the necessity of Hfq for physiological fitness and pathogenicity of B. pertussis.
2. Results
2.1. Identification of the Hfq Regulon by RNA-seq
Samples of total RNA isolated from biological triplicates of B. pertussis Tohama I strain and
its isogenic Δhfq strain cultures were analyzed by RNA-seq. RNA-seq analysis yielded on average
16 million reads, which were mapped to the B. pertussis genome. The comparison of global expression
profiles showed that biological replicates of either wt or Δhfq cells are highly uniform and thereby
reproducible (Figure 1A). Principal component analysis (PCA) revealed that samples from wt strain
and hfq mutant clustered separately along principal component 1 (94%) reflecting global changes in
gene expression profiles resulting from deletion of the hfq gene (Figure 1B).
Differential expression (DE) analysis identified 653 significantly modulated B. pertussis genes
(|log2FC| > 1; q < 0.05) including 40 non-coding RNAs and 11 transfer RNA genes (Table S1). Among
the DE genes, 281 genes were downregulated and 372 upregulated in the Δhfq strain. Remarkably,
56 genes (8.3% of all DE genes) encoding the components of ATP-binding cassette transport system
were significantly up- or downregulated in the mutant. In agreement with our previous microarray
study, the expression of several genes within the type III secretion (T3SS) bcs/btr locus including bsp22,
bopN, bopB, and bopD was substantially decreased in the mutant. Genes involved in iron–sulfur cluster
protein biogenesis (iscU, iscA, iscS) were also highly downregulated in the hfq mutant. Among the
genes displaying increased expression in the hfq mutant were those coding for ribosomal proteins,
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amino acid biosynthesis and transport, and, surprisingly, genes encoding pertussis toxin subunits and
its secretion apparatus (ptx/ptl locus).
Figure 1. Clustering of transcriptomic data. (A) Heat map showing hierarchical clustering of
the Euclidean sample-to-sample distance between transcriptomic profiles of wt and Δhfq mutant.
(B) Principal component analysis was applied to transcriptomic profiles of the wt strain (blue circles)
and Δhfq mutant (red circles). Each dot represents an independent biological replicate.
To get better insight into the functional profiles of Hfq-dependent genes we performed gene
ontology (GO) enrichment analysis using all DE genes. GO term analysis revealed that genes belonging
to several biological processes were significantly enriched in both up- and downregulated gene sets.
As shown in Figure 2A, within the set of genes which were significantly upregulated in the hfq mutant,
categories such as “Translation”, “Regulation of transcription”, and “Transmembrane transport” were
highly enriched. On the other side, genes belonging to “Transmembrane transport”, “Iron–sulfur
cluster assembly”, “Oxido-reduction process”, “Pathogenesis”, and “Protein secretion by the type III
secretion system” terms were enriched among the transcripts which were significantly downregulated
in the hfq mutant (Figure 2B). Apparently, GO term analysis of the DE genes recapitulated many of the
observations from our previous studies [19].
 
Figure 2. Gene ontology (GO) term analysis of genes significantly downregulated (A) or upregulated
(B) in the Δhfq mutant. Significantly enriched terms from the domain ‘Biological processes’ and their
catenations are summarized and visualized by REVIGO as an interactive graph. Circle size encodes
number of genes associated with respective category and red shades encode the significance level of
the enrichment.
2.2. The Effect of Hfq on Proteome and Secretome Composition of B. pertussis
LC-MS/MS analysis of the B. pertussis proteome and secretome identified 1631 and 733 proteins,
respectively, whose label-free quantification (LFQ) intensities passed our detection criteria. Principal
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component analysis of both datasets revealed that protein profiles identified in samples of the wt strain
clustered separately from those of the Δhfq strain (Figure 3).
Figure 3. Principal component analysis (PCA) of proteomic samples. PCA was applied to protein profiles
of the wt strain (blue circles) and Δhfq mutant (red circles) determined in corresponding cell-associated
(A) or secreted (B) protein fractions. Each dot represents an independent biological replicate.
For pellet proteins, the production of 489 proteins was found to be significantly modulated
between wt and hfq mutant strains (Table S2). The abundance of 219 proteins was higher in the mutant
including 19 “ON” proteins which were not detected in the wt strain. Among this set of proteins,
GO terms such as “Cell cycle”, “Peptidoglycan synthesis”, and “Aromatic amino acid metabolism”
were significantly enriched (Figure 4A). On the other hand, 270 proteins displayed significantly higher
LFQ intensities in the wt strain including 10 “OFF” proteins which, in contrast to the wt samples, were
not detected in the mutant. GO term analysis revealed that biological processes such as “Proteolysis”,
“Ion transport”, “Pathogenesis”, and “Protein secretion by the type III secretion system” were enriched
among this group of proteins (Figure 4B).
As for the secreted fraction (Table S3), abundance of 114 proteins was higher in the mutant
(including six “ON” proteins) and these proteins clustered into categories such as “Transmembrane
transport”, “Cell adhesion”, and “Amino acid transport” (Figure 4C). On the other hand, 445 proteins
displayed significantly higher LFQ intensities in the wt strain (including 136 “OFF” proteins). The GO
term analysis of these differentially secreted proteins identified rather broad variety of processes
including “Transmembrane transport”, “Proteolysis”, “Response to oxidative stress”, “Protein secretion
by the type III secretion system”, and several processes linked to translation and amino acid biosynthesis
(Figure 4D).
Among the proteins with highly increased abundance in the hfq mutant in both proteome and
secretome datasets were prevalently members of various transporters including tripartite tricarboxylate
transporters (TTT) (BP2066, BP3501, and BP1358), ABC transporters (BP2090, BP2352, and BP0663) and
tripartite ATP-independent periplasmic transporters [31] (BP1487 and BP1489), lipoprotein BP2271,
adhesin FhaS and all five pertussis toxin subunits. Of note, genes encoding these overproduced
proteins also belonged to the set of the most upregulated genes in the mutant strain (Table 1).
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Figure 4. GO term enrichment analysis of genes either significantly upregulated (A,C) or downregulated
(B,D) in the Δhfq cells and Δhfq culture supernatants, respectively. Biological processes significantly
enriched for genes belonging to corresponding functional category are shown as an interactive
graph. Significantly enriched terms from the domain “Biological processes” and their catenations
are summarized and visualized by REVIGO. Circle size encodes number of genes associated with
respective categories, red shades encode the significance level of the enrichment.
Table 1. List of genes showing consistently increased RNA and protein abundance in the hfq mutant.
Gene RNA-seq1 Proteome1 Secretome1 Function
BP1358 4.18 3.93 2.78 TTT transporter
BP1487 4.34 2.92 1.65 TRAP transporter
BP1489 3.48 2.06 ND TRAP transporter
BP2066 2.64 ON 8.80 TTT transporter
BP2090 1.92 ON 4.40 ABC transporter
BP2271 5.05 9.75 3.98 lipoprotein
BP2352 3.58 4.50 1.90 TRAP transporter
BP2667 2.11 6.47 5.72 adhesin FhaS
BP2692 1.51 2.10 1.90 ABC transporter
BP3501 3.36 4.86 ON TTT transporter
BP3783 1.50 1.62 1.05 pertussis toxin subunit A
BP3784 1.80 1.14 1.04 pertussis toxin subunit B
BP3785 1.47 1.57 0.81 pertussis toxin subunit D
BP3786 1.14 ND 1.60 pertussis toxin subunit E
BP3787 1.49 1.76 1.26 pertussis toxin subunit C
1 Log2FC values of Δhfq/wt comparison are shown for RNA-seq and proteomic analyses. Values which did not pass
the statistical significance are shown in italics. ND: not determined in both strains in the respective analysis. ON:
protein was not detected in the wt strain within the corresponding fraction.
A substantial number of proteins displayed significantly diminished levels in the hfq mutant in
both proteomic analyses. The largest group of such proteins belonged to T3SS structural components
and its secreted substrates. Among the 20 proteins displaying the most decreased abundance in the
Δhfq cells were nine T3SS-specific proteins. Likewise, in the supernatant fraction, amounts of Bsp22 and
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BopD proteins were dramatically reduced (log2FC < −9) while BopC, Bcr4, BopB and BopN proteins
could not be detected (Table 2).
Table 2. List of T3SS genes showing consistently decreased RNA and protein abundance in the
hfq mutant.
Gene Name RNA-seq1 Proteome1 Secretome1
BP0500 bopC −0.69 −1.19 OFF
BP2248 bscJ −1.58 −2.16 ND
BP2250 bcr4 −1.81 −2.75 OFF
BP2251 bcrH2 −1.58 −1.44 ND
BP2252 bopB −1.89 −2.23 OFF
BP2253 bopD −1.85 −1.83 −9.95
BP2254 bcrH1 −1.26 −0.96 OFF
BP2256 bsp22 −1.22 −1.76 -9.13
BP2257 bopN −0.85 −1.71 OFF
1 Log2FC values of Δhfq/wt comparison are shown for RNA-seq and proteomic analyses. Values that did not pass
the statistical significance are shown in italics. ND: not determined in both strains in the respective analysis. OFF:
protein was not detected in the Δhfq strain within the corresponding fraction.
Noticeably, one of the virulence factors displaying consistently reduced expression, production
and secretion in the hfq mutant was the autotransporter Vag8. The Vag8 protein binds and recruits C1
esterase inhibitor and thereby inhibits complement activity and contributes to serum resistance [32–34].
Therefore, we asked whether the reduced production of Vag8 factor would compromise the capacity of
the Δhfq strain to evade complement-mediated killing. When compared to recent isolates, Tohama
I strain exhibits high susceptibility to serum killing [34], nevertheless, in line with our assumption,
the survival of the hfq mutant (0.06% ± 0.01%) was dramatically decreased when compared to the wt
strain (1.36% ± 0.38%) (Figure 5).
Figure 5. Serum killing assay of Δhfq and Tohama I strains. Serum resistance is expressed as percentage
of wt (white bar) and Δhfq (grey bar) cells that survived upon incubation with 10% human serum when
compared to controls (bacteria incubated with heat-inactivated serum). The error bars represent the
standard deviation of the mean obtained from three biological replicates (*, p < 0.001). The result is
representative of three independent experiments.
2.3. Correlation between Transcriptome, Proteome and Secretome Datasets
Considering previous reports, the correlation between RNA-seq and LC-MS/MS analysis of
cell-associated proteins was relatively high (r2 = 0.40, p-value 1.2 × 10−174) with 148 proteins displaying
same trend in abundance as corresponding genes in transcriptomic profiling (Figure 6A). As shown in
Figure 6B, the concordance of RNA-seq data with secretome analysis was much less positive (r2 = 0.24,
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p-value 7.4 × 10−34) with only 80 proteins showing similar trend between both analyses. Of note,
among genes showing strong correlation with both proteomic datasets were those encoding the T3SS
apparatus, pertussis toxin and its transport machinery, ABC, TRAP, and TTT transporters and other
proteins involved in the primary metabolism. Apparently, highly modulated genes showed better
correlation with abundance of corresponding proteins than those for which the expression was changed
only slightly above the thresholds of significance.
 
Figure 6. Correlation analysis between transcriptomic and proteomic datasets. (A) Scatterplots
representing the pairwise comparisons of Δhfq/wt log2 ratios between transcriptome and either
proteome (left) or secretome (right). Only the genes for which levels of corresponding proteins were
reliably detected by label-free quantification were used for correlation analysis. Red dots depict genes
which are significantly deregulated in both datasets (p-value < 0.05, |log2FC| > 1). Line depicts the best
fit as predicted by linear regression. (B) Venn diagrams showing the number of differentially expressed
genes and proteins and the overlap between each dataset. Left: comparison of transcriptome and
proteome. Right: comparison of transcriptome and secretome. Zero values indicate intersections which
can not materialize (i.e., being up- and downregulated in the same dataset).
3. Discussion
In this study we present first integrative omics analysis of the Hfq regulon in the human pathogen.
Our study had several objectives: (a) to corroborate the outcomes of our previous transcriptomic study,
(b) identify novel targets of Hfq-specific regulatory activities using high-throughput omics techniques,
and (c) compare and evaluate the general effects caused by an important post-transcriptional regulator
at the level of transcriptome, proteome, and secretome. Compared to microarray profiling (368 protein
coding differentially expressed (DE) genes), the differential expression RNA sequencing identified
almost two-fold higher number of deregulated genes (602 protein coding DE genes) in the hfq mutant.
This finding is not surprising considering the higher sensitivity and reproducibility of the RNA-seq
method compared to DNA microarray technique [35,36].
Our data are in line with previous studies reporting modest correlation between transcriptomic
and proteomic analyses. Nevertheless, considering the role of Hfq in the post-transcriptional control of
gene expression, the correlation coefficient between transcriptome and proteome is relatively high
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when compared to other studies [22,23,37]. The comparison of RNA-seq with secretome analysis
output yielded lower correlation values. This finding can possibly result from “contamination” of
bacterial culture supernatants with abundant cytosolic proteins such as components of transcriptional
and translational machineries. We speculate that these proteins were released from lysed cells during
cultivation and sample preparation and therefore their levels do not correspond to changes in gene
expression profiles between wt and Δhfq strains.
Importantly, we corroborated several Hfq-specific effects on gene expression profiles which were
seen in our previous microarray study [19]. We recapitulated the strong requirement of Hfq chaperone
for T3SS functionality as the expression of T3SS genes and production as well as secretion of T3SS
components were significantly reduced in the hfq mutant. Especially the differences observed in culture
supernatants were enormous (more than two orders of magnitude). Several regulators were shown to
play a role in control of T3SS activity in B. pertussis, including BvgAS two-component system and BtrAS
regulatory circuit [38,39]. The response regulator BvgA activates the expression of an extracytoplasmic
function sigma factor btrS (BP2234) as well as of btrU, btrV, and btrW genes [40]. While BtrS was
shown to be required for efficient transcription of the bsc locus encoding the T3SS injectisome, BtrU,
BtrV, and BtrW regulatory proteins encoded within the btr locus are required for secretion through the
T3SS apparatus. Recently, a secreted antagonist of BtrS factor called BtrA (BP2233) exerting negative
control over the expression of Bordetella T3SS genes was reported [39,41]. Secretion of the BtrA inhibitor
reactivates BtrS and, consequently, activates the expression of the T3SS genes [39]. Nevertheless, we
did not observe any significant changes in expression of the btrAS regulatory node. Moreover, BtrA
protein could be detected only in the pellets and its levels were decreased in the mutant (log2FC of
−0.53). Apparently, the reduced expression, production and in particular secretion of T3SS components
observed in the hfq mutant are independent of btrAS circuit. Relatively high LFQ intensities of T3SS
secreted substrates detected in the wt strain were rather surprising. B. pertussis Tohama I represents a
laboratory-adapted strain and was suggested to lose its ability to secrete T3SS components during
long-term in vitro passaging [40,42,43]. Nevertheless, the capacity to secrete T3SS substrates in Tohama
I can be regained upon contact with the host [19,43] or under nutrient limitation [44,45]. We did not use
iron- or glutamate-limited media in our experiments and cells were collected in mid exponential phase
of growth. Nevertheless, we cannot completely rule out the possibility that our cultures were partially
nutrient-limited at the time of harvest. Of note, when compared to Hfq-specific effects at transcriptional
and translational levels, the massive differences in protein abundances seen in culture supernatants
suggest that Hfq is indirectly required for efficient secretion process through the T3SS apparatus.
In line with our previous reports, expression and production of autotransporter Vag8, a major
player in complement evasion [32–34], was significantly reduced in the hfq mutant. In support, the hfq
mutant displayed strongly reduced resistance to serum killing. Increased serum sensitivity of the hfq
mutant was described also in Neisseria meningitidis [46]. We assume that this phenotype can be ascribed
to reduced production of the Vag8 protein, as the amounts of BrkA, FhaB, and BapC factors reported to
be involved in diversion of complement-mediated killing [47–49] were comparable (BrkA) or even
higher in the mutant (FhaB). BapC autotransporter was not detected by proteomics and expression of
bapC gene was increased in the mutant.
Similarly to several other hfq-deficient bacteria, the Δhfq strain of B. pertussis displays growth
deficit. Based on the results of our microarray study we hypothesized that hfq mutant of B. pertussis
compensates the slower growth with increased production of translation machinery components and
proteins involved in transport of nutrients [19]. In support, our current study reveals that the most
upregulated genes and corresponding proteins found in the hfq mutant are represented predominantly
by different types of transport proteins, namely, TTT, TRAP, and ABC transporter families. These
solute-binding protein-dependent transporters allow uptake even at very low concentrations of
ligands [50]. Interestingly, TTT family transporter genes called “Bug” genes (Bordetella uptake genes)
are highly overrepresented in the B. pertussis genome as they encode 81 functional TTT proteins [51].
While ligands for majority of these proteins are unknown, crystal structures of BugD and BugE proteins
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identified their ligands as aspartate and glutamate, respectively [52,53]. Intriguingly, expression of
ptx/ptl locus and, consequently, production and secretion of pertussis toxin subunits was significantly
increased in the hfq mutant. In the light of reduced virulence of the mutant and the importance of this
toxin for B. pertussis pathogenicity [54] it is rather surprising observation which may be conceived as
compensatory response to the lack of Hfq.
With regard to observed high impact of hfq deletion on gene expression profiles it is of particular
interest that abundance of at least 16 transcriptional regulators and five alternative sigma factors
was significantly modulated in the hfq mutant. These results are in line with already described
roles of Hfq in expression of alternative sigma factors [55–58] and suggest that similarly to other
bacteria, a substantial part of the Hfq-specific effects seen in B. pertussis represents indirect regulation.
For example, the expression and production of the iron transport repressor Fur is increased in the hfq
mutant of B. pertussis and, consequently, the expression of several genes responsible for iron delivery
was decreased in the mutant. One of the surprising results of this study was the relatively low impact
of Hfq on abundance of non-coding RNAs. Recently we have identified small non-coding RNA RgtA
that is involved in the regulation of the transport of glutamate, a key metabolite in the B. pertussis
physiology and the abundance of which in the hfq mutant was strongly reduced [59]. Nevertheless,
our data indicate that only 40 non-coding transcripts out of the recently identified 400 candidate
sRNAs [60] changed their levels in the absence of Hfq. Similarly, integrative analysis of Hfq regulon in
P. fluorescence identified only four ncRNAs out of 87 whose abundance was dependent on Hfq [30].
Thus, in the light of observed extensive changes in transcriptomic and proteomic profiles observed in
B. pertussis, the relatively small impact on sRNA levels suggests that Hfq exerts some of its regulatory
activities in the sRNA-independent fashion or does not substantially contribute to sRNA stability in
B. pertussis.
Collectively, this study reveals that impact of Hfq on the gene and protein expression profiles in
B. pertussis is very profound. The Hfq regulon is comprised of hundreds of genes/proteins making
almost 20 % of its genome and covering broad variety of genes and their products involved in different
cellular processes. Obviously, these pleiotropic effects associated with loss of Hfq in B. pertussis
cannot be completely ascribed to its role in posttranscriptional circuits but instead may be related to
other global regulators that are themselves targets of Hfq regulation such as transcriptional factors.
We assume that several observed effects are linked to impaired growth of the mutant. Especially
increased production of proteins implicated in transport of metabolites and essential elements seems
to compensate for the physiological defect introduced by deletion of the hfq gene. Finally, our study
corroborated and further clarified the necessity of Hfq for physiological fitness and pathogenicity
of B. pertussis. It will be of our primary interest to characterize the exact mechanism rendering the
production and secretion of T3SS components strongly dependent on Hfq. Furthermore, we are
currently characterizing function of several identified Hfq-dependent sRNAs in the physiology of
B. pertussis.
4. Materials and Methods
4.1. Bacterial Strains and Growth Conditions
The Bordetella pertussis Tohama I strain [61] and its isogenic hfq deletion mutant were grown
on Bordet-Gengou agar (BGA) plates supplemented with 15% sheep blood for 3 to 4 days at 37 ◦C.
For liquid cultures, bacteria were grown in Stainer–Scholte (SS) medium [62] supplemented with
0.1% cyclodextrin and 0.5% casamino acids (Difco) at 37 ◦C. To harvest samples for RNA and protein
isolation, the B. pertussis cells were grown overnight in SS medium to mid exponential phase of growth
(OD600 ≈ 1.0). Three independent cultivation experiments were performed to collect three biological
replicates for each of both strains for RNA and protein isolation.
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4.2. RNA Isolation
Total RNA was isolated using TRI Reagent (Sigma, Darmstadt, Germany) according to
manufacturer’s protocol. Removal of DNA was achieved by treatment of samples with TURBO
DNA-free kit (Thermo Fisher Scientific). RNA quality and quantity was determined by agarose gel
electrophoresis and using the Nanodrop 2000 machine (Thermo, Carlsbad, CA, USA). Furthermore,
the RNA quality was assessed at sequencing facility (Vienna Biocenter Core Facility, NGS unit) on an
Agilent 2100 Bioanalyzer device. All samples displayed RNA integrity numbers higher than 9.
4.3. Library Preparation and Deep Sequencing
Ribosomal RNA was depleted with the Ribo-Zero rRNA Removal Kit for Bacteria (Illumina, San
Diego, CA, USA). Libraries were prepared using NEBNext® Ultra™ II DNA Library Prep Kit for
Illumina and sequenced on an Illumina HiSeq 2500 platform using HiSeqV4 chemistry with single-end
50-base-pair reads at the Vienna Biocenter Core Facilities Next Generation Sequencing unit. Reads
were demultiplexed and quality trimming and adapter removal from the reads was performed using
trimmomatic [63]. After quality control and adapter clipping, the reads were mapped to B. pertussis
Tohama I reference genome using segemehl [64] with default parameters. Reads per gene counts were
deduced with htseq-count with default parameters [65]. Differential gene expression analysis was
performed with DESeq2 [66]. Genes with a |log2 fold change| > 1 and a q-value (p-value adjusted for
multiple testing correction by the method of Benjamini and Hochberg [67]) < 0.05 were considered as
significantly deregulated. RNA-seq data from the sequencing runs were deposited at the European
Nucleotide Archive (ENA) under project accession number PRJEB32623.
4.4. Protein Isolation and Sample Preparation for Proteomics
Cultures of B. pertussis were pelleted by centrifugation (10,000× g, 4 ◦C, 10 min) to separate
cell pellets and culture supernatants. Cells were resuspended in TEAB digestion buffer (100 mM
Triethylammonium bicarbonate, pH 8.5, 2% sodium deoxycholate) and lysed by sonication. For analysis
of supernatant fractions, supernatants were filtered through 0.22-μm filters and precipitated with 10%
(w/v) trichloracetic acid (Sigma) overnight at 4 ◦C. Precipitated proteins were collected by centrifugation
(14,000× g, 4 ◦C, 20 min), washed with 80% acetone (w/v) and finally dissolved in TEAB digestion
buffer. Protein concentrations were determined using BCA protein assay kit (Thermo Fischer Scientific)
and 20 μg of protein per sample were used for protein analysis. Cysteines were reduced with M
Tris(2-carboxyethyl)phosphine (60 ◦C for 60 min) and blocked with 1M methyl methanethiosulfonate
(10 min, room temperature). Samples were digested with trypsin (trypsin to protein ratio 1:20) at
37 ◦C overnight. Digestion of samples was stopped by addition of trifluoracetic acid (Sigma) to a final
concentration of 1% (v/v). SDC was removed by extraction with ethylacetate [68] and peptides were
desalted on C18 column (Michrom Bio, Auburn, CA, USA).
4.5. Label-Free Proteomic Analysis by LC-MS/MS
A nanoreversed phase column (EASY-Spray column, 50 cm × 75 μm ID, PepMap C18, 2 μm
particles, 100 Å pore size) was used for LC-MS analysis. Mobile phase buffer A was composed of
water and 0.1% formic acid. Mobile phase B was composed of acetonitrile and 0.1% formic acid.
Samples were loaded onto the trap column (Acclaim PepMap300, C18, 5 μm, 300 Å wide pore, 300 μm
× 5 mm) at a flow rate of 15 μL/min. Loading buffer was composed of water, 2% acetonitrile, and 0.1%
trifluoroacetic acid. Peptides were eluted with gradient of B phase ranging from 4% to 35% over 60 min
at a flow rate of 300 nL/min. Eluting peptide cations were converted to gas-phase ions by electrospray
ionization and analyzed on a Thermo Orbitrap Fusion (Q-OT-qIT, Thermo Fischer). Survey scans of
peptide precursors from 350 to 1400 m/z were performed at 12 resolution (at 200 m/z) with a 5 × 105
ion count target. Tandem MS (MS2) was performed by isolation within 1.5-Th window with the
quadrupole, HCD fragmentation with normalized collision energy of 30, and rapid scan MS analysis in
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the ion trap. The MS2 ion count target value was set to 104 and the maximal injection time was 35 ms.
Only those precursors with charge state 2–6 were sampled for MS2. The dynamic exclusion duration
was set to 45 s with a 10 ppm tolerance around the selected precursor and its isotopes. Monoisotopic
precursor selection was turned on. The instrument was run in top speed mode with 2 s cycles [69].
Raw data were imported into MaxQuant software (version 1.5.3.8) [70] for identification and
label-free quantification of proteins. The false discovery rate (FDR) was set to 1% for peptides and
minimum specific length of seven amino acids. The Andromeda search engine [71] was used for the
MS/MS spectra search against the Uniprot Bordetella pertussis database (downloaded on November
2016), containing 3258 entries. Enzyme specificity was set as C-terminal to Arg and Lys, also allowing
cleavage at proline bonds and a maximum of two missed cleavages. Dithiomethylation of cysteine
was selected as fixed modification and N- terminal protein acetylation and methionine oxidation
as variable modifications. The “match between runs” feature of MaxQuant was used to transfer
identifications to other LC-MS/MS runs based on their masses and retention time (maximum deviation
0.7 min) and this was also used in quantification experiments. Protein abundance was calculated from
obtained label-free protein intensities using the MaxLFQ algorithm described recently [72]. Proteins
with less than four MS/MS spectral counts were removed from the analysis. Statistics and data
interpretation were performed using Perseus 1.6.1.3 software [73]. The normalized label free intensities
were compared between wt and hfq mutant and each abundance ratio was tested for significance with
two-group t-test (p-value < 0.05). The p-values were further adjusted for multiple testing correction to
control the false discovery rate at cut off of 0.05 using the permutation test (number of randomization
250). Proteins with corrected p-value (q-value) < 0.05 were considered as significantly modulated.
For downstream analyses (e.g., GO term enrichment) only proteins which were detected by at least
two unique peptides in at least two of the three biological replicates were considered. Proteins for
which label free intensities were not obtained in any of the replicates of either the wt or the Δhfq strain
were considered as significantly modulated and defined as “ON/OFF”. The proteomics data were
deposited to the ProteomeXchange Consortium via the PRIDE [74] partner repository with the dataset
identifier PXD013953.
4.6. GO Term Enrichment Analysis
To gain a comprehensive functional annotation of the reference genome, gene ontology (GO)
terms per gene were deduced using blast2go [75]. For the GO term enrichment analysis significantly
deregulated genes from the transcriptome and proteome analysis were split into up- and downregulated
genes and each gene set was analyzed separately. Each GO term which is associated with more than
one gene in the gene set was tested for enrichment in the gene set compared to the whole transcriptome,
applying a Fisher’s exact test. Afterwards, determined p-values were corrected for multiple testing
by the method of Benjamini and Hochberg [67]. Enriched GO terms were further summarized and
visualized by Revigo [76].
4.7. Transcriptome–Proteome Correlation Analyses
To correlate the effect of hfq gene deletion on the transcript and protein abundance globally, the
log2FC of all genes the products of which were reliably detected (see Chapter 4.5) by the label-free
quantification were compared. To this end, the ‘lm’ function from R was used to fit a linear model
between these two datasets. Since the relative errors in log2FC measurements can be expected to be
higher for genes with higher p-value, each data point was weighted in the course of model fitting
by 1 - q-value where q-value represents the geometric mean of the q-values of the proteome and the
transcriptome analysis.
4.8. Serum Killing Assay
Overnight-grown bacterial cultures were diluted in SS medium to 5 × 106 bacteria/ml of culture
and supplemented either with intact or heat-inactivated (56 ◦C, 30 min) 10% human serum (Sigma No).
171
Int. J. Mol. Sci. 2019, 20, 3073
Cells were incubated in parallel in the presence of both type of sera for 60 min at 37 ◦C in orbital
incubator. Then the bactericidal activity was terminated by addition of 10 mM EDTA, serial dilutions
of bacterial samples were plated onto BG agar and colony-forming units (CFU) were counted to assess
bacterial survival. Survival was calculated as a percentage of CFU obtained from cultures treated
with intact serum compared to CFUs from cultures treated with heat-inactivated serum (control, 100%
survival). Mann–Whitney test was applied to assay the statistical significance of observed differences
in sensitivity to serum killing.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/12/
3073/s1.
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FDR False discovery rate
TEAB Triethylammonium bicarbonate
EDTA Ethylenediamine tetra-acetic acid
CFU Colony forming unit
DE Differential expression
TTT Tripartite tricarboxylate transporters
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Abstract: In primary ciliary dyskinesia (PCD) patients, Pseudomonas aeruginosa is a major opportunistic
pathogen, frequently involved in chronic infections of the lower airways. Infections by this
bacterial species correlates with a worsening clinical prognosis and recalcitrance to currently
available therapeutics. The antimicrobial peptide, lin-SB056-1, in combination with the cation
chelator ethylenediaminetetraacetic acid (EDTA), was previously demonstrated to be bactericidal
against P. aeruginosa in an artificial sputum medium. The purpose of this study was to validate
the anti-P. aeruginosa activity of such a combination in PCD sputum and to evaluate the in vitro
anti-virulence effects of EDTA. In combination with EDTA, lin-SB056-1 was able to significantly reduce
the load of endogenous P. aeruginosa ex vivo in the sputum of PCD patients. In addition, EDTA
markedly reduced the production of relevant bacterial virulence factors (e.g., pyocyanin, proteases,
LasA) in vitro by two representative mucoid strains of P. aeruginosa isolated from the sputum of PCD
patients. These results indicate that the lin-SB056-1/EDTA combination may exert a dual antimicrobial
and anti-virulence action against P. aeruginosa, suggesting a therapeutic potential against chronic
airway infections sustained by this bacterium.
Keywords: antimicrobial peptide; EDTA; Pseudomonas aeruginosa; primary ciliary dyskinesia;
virulence factor; anti-virulence; sputum; chronic infection
1. Introduction
Primary ciliary dyskinesia (PCD) is an autosomal recessive disorder characterized by abnormal
ciliary ultrastructure and function leading to impaired mucociliary clearance and recurrent respiratory
infections [1]. Although Haemophilus influenzae is the pathogen most commonly isolated from patients
with PCD until adolescence/early adulthood, in adult PCD patients, P. aeruginosa plays a major
role, especially after the age of 30 [1]. Accordingly, a negative correlation between the abundance of
P. aeruginosa in the airways of these patients and lung function has been reported [2,3]. The pathogenesis
of P. aeruginosa infection is at least partially attributable to its ability to synthesize and secrete a number
of virulence factors (e.g., pyoverdine, pyocyanin, proteases) and to form biofilms, in which bacterial
cells are embedded in an alginate extracellular matrix [4]. Despite intensive antibiotic therapy, once the
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patients are stably colonized by P. aeruginosa, the eradication of the bacterium is rarely achieved [1,5].
Therefore, there is a critical need for novel antimicrobial drugs that can effectively lower P. aeruginosa
load in the challenging environment of PCD lung.
Over the last decades, antimicrobial peptides (AMPs) have been intensively investigated as
potential antibiotics against multidrug-resistant bacteria [6]. Most AMPs are cationic molecules with
an amphipathic structure that selectively target bacterial membranes via electrostatic forces. In contrast
to standard antibiotics, AMPs are generally effective against both quiescent and actively growing
bacteria, display rapid killing kinetics, and demonstrate low propensity to select resistant mutants
in vitro [7,8]. On the other hand, AMPs may display a reduction in their antibacterial potency in the
presence of complex biological fluids such as sputum, plasma, or saliva due to the high concentration
of salt found in these fluids and/or the presence of anionic proteins and host or bacterial proteases that
may neutralize their activity [9,10].
As observed in cystic fibrosis (CF) lungs, the biofilm mode of growth of bacteria together
with the lung mucus viscosity reduces the effectiveness of conventional antibiotic therapy in PCD
patients [11]. Thus, the usage of adjuvants has been proposed to improve the diffusion of antimicrobials
through the mucus and the biofilm matrix and facilitate the targeting of bacterial cells [12]. Previous
studies have shown that the divalent cation chelator ethylenediaminetetraacetic acid (EDTA) can
destabilize the biofilm structure by interfering with the ionic attractive forces among the biofilm
matrix components [13,14]. EDTA is prescribed in a number of clinical conditions demonstrating high
tolerability (up to 2 g once a week, intravenously injected) and efficacy [15]. Recently, we demonstrated
that the optimized semi-synthetic antimicrobial peptide lin-SB056-1 in combination with EDTA is
able to exert a synergistic bactericidal effect against P. aeruginosa in an artificial sputum medium
resembling CF sputum [16]. Similarities and differences between CF and PDC sputum have been
reported. For instance, while both diseases seem to be associated with a similar degree of airways
neutrophilia, the concentration of interleukin-8 in sputum is higher in PCD than in CF patients, while
neutrophil elastase activity is lower in PCD compared with CF [17]. In order to evaluate the therapeutic
potential of the lin-SB056-1/EDTA combination in PCD, in this study, we evaluated its bactericidal
activity ex vivo, against endogenous P. aeruginosa in the sputum from PCD patients. Importantly,
the ex vivo sputum mimics, with good approximation, the lung environment, as it contains both
host and bacterial components, including bronchial mucus contaminated by saliva, serum proteins,
inflammatory mediators, desquamated epithelial cells, and pathogenic bacteria, as well as bacteria
from the normal flora [18].
Previous reports have demonstrated the involvement of different cations (i.e., calcium, magnesium,
and zinc) either in the regulation of gene expression or in the production and processing of virulence
factors in P. aeruginosa [19,20]. Thus, herein, we also evaluated the ability of EDTA to reduce the
production of relevant virulence factors of P. aeruginosa (e.g., pyoverdin, pyocyanin, proteases, biofilm
production). Overall, the results obtained demonstrated that the lin-SB056-1/EDTA combination is able
to significantly reduce P. aeruginosa load ex vivo and that EDTA is highly active in suppressing the
production of relevant bacterial virulence factors, suggesting a dual antibacterial and anti-virulence
potential of the combination.
2. Results
2.1. Killing Activity of lin-SB056-1 in Combination with Ethylenediaminetetraacetic Acid (EDTA) against
Endogenous P. aeruginosa
P. aeruginosa strains were isolated from the sputum of six PCD patients known to be chronically
infected with the bacterium. All the strains displayed a mucoid phenotype and different antibiotic
susceptibility profiles (Supplementary Table S1).
Diluted sputum (5-fold) from each patient was incubated for 1.5 h with the peptide at 25 μg/mL,
alone or in combination with EDTA (0.625 or 1.25 mM), and the colony forming unit (CFU) number
of P. aeruginosa surviving the treatment was detected. During the incubation time, endogenous
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P. aeruginosa did not grow in PCD sputum. While the peptide and EDTA were almost inactive
when used alone, their combination exerted a significant synergistic killing effect against endogenous
P. aeruginosa, although with different efficacy depending on the sputum sample (Figure 1). When
compared to the corresponding controls, the reduction in CFU number caused by the combination
ranged from approximately 0.3 Log-units (50% reduction, grey dot) to 3 Log-units (99.9% reduction,







Figure 1. Antibacterial activity of peptide lin-SB056-1, ethylenediaminetetraacetic acid (EDTA), and both
in combination against endogenous P. aeruginosa in primary ciliary dyskinesia (PCD) sputum. The effect
of lin-SB056-1 and/or EDTA after 1.5 h of incubation in six diluted (1:5) sputum samples was assessed
against endogenous P. aeruginosa strains (PaM1 to PaM6) by colony forming unit (CFU) counting.
Lin-SB056-1 was tested at 25 μg/mL in combination with 0.625 mM EDTA against PaM1 and PaM5
strains (triangles), and with 1.25 mM EDTA against PaM2, PaM3, PaM4, and PaM6 strains (dots).
Control (CTRL): bacteria incubated in diluted sputum only. Individual sputum samples are identified
with different colors. Results represent the mean of 6 sputa done in duplicate. Error bars indicate the
standard error of the mean. ** p < 0.01, *** p < 0.001 (one-way analysis of variance (ANOVA) followed
by the Tukey–Kramer post-hoc test).
2.2. Effects of EDTA and lin-SB056-1 on Virulence Factors’ Production by P. aeruginosa PaM1 and PaM5
Preliminary experiments indicated that PaM1and PaM5 strains are able to produce high levels of
most of the virulence factors analyzed; therefore, these strains were selected to evaluate the effect of
sub-inhibitory concentrations of EDTA on virulence factors’ production. To this aim, we first evaluated
the susceptibility of PaM1 and PaM5 strains to EDTA in liquid medium, in terms of minimum inhibitory
concentration (MIC). A concentration of 1.25 mM EDTA was able to inhibit visible bacterial growth
(MIC), while the concentrations of 0.075 and 0.15 mM were sub-inhibitory and therefore, were selected
for the subsequent experiments.
Pyocyanin is a greenish pigment secreted by P. aeruginosa that enhances the inflammatory response
and causes tissue damage in the host [21]. As shown in Figure 2a, EDTA at the concentrations of
0.075 and 0.15 mM, highly inhibited pyocyanin production by the PaM1 strain at 72 h (by 62% and
70%, respectively) as compared to the untreated cells. Regarding the PaM5 strain, which was a low
pyocyanin producer (Figure 2b), EDTA at both concentrations caused a reduction of approximately
40% in the production of such pigment, although the difference did not reach statistical significance
compared to the untreated cells.
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P. aeruginosa produces and secretes a number of proteases, such as LasA, elastase B (LasB), protease
IV, and alkaline protease, which are considered important virulence factors as they damage host tissues
and interfere with host antibacterial defense mechanisms [22]. The total proteolytic activity of PaM1
was completely abolished in the presence of either 0.075 or 0.15 mM EDTA (Figure 2a). Similarly,
EDTA significantly reduced the proteolytic activity of the PaM5 strain but only at the concentration of
0.15 mM (Figure 2b).
LasA is a zinc-dependent metalloprotease secreted by P. aeruginosa. It exhibits a staphylolytic
activity, enhances the elastolytic activity of LasB in vivo, and induces shedding of syndecans, a family
of cell surface heparan sulfate proteoglycans, from host cell surfaces [23]. LasA activity of both the
PaM1 and PaM5 strains was significantly inhibited in the presence of 0.075 and 0.15 mM EDTA,
with a reduction of approximately 70% and 80%, as compared to the untreated control, respectively
(Figure 2a,b). Further experiments were undertaken in order to evaluate whether the reduction of
LasA activity was ascribable to the inhibition of protease synthesis or, rather, to the inhibition of the
enzyme activity due to zinc chelation by EDTA (Figure S1). To this aim, the assessment of the PaM1
staphylolytic activity was performed in the presence of exogenously added zinc (0.1 mM ZnSO4).
When ZnSO4 was added directly in the enzyme assay, at the end of the incubation period (72 h), no
significant increase in LasA activity was observed, suggesting that the low levels of LasA activity
detected in the presence of EDTA were likely due to inhibition of protein synthesis and not to the
chelation of the enzyme cofactor. In contrast, when ZnSO4 was added at the beginning of the incubation
of PaM1 with EDTA, LasA activity was restored (Supplementary Figure S1), indicating that the excess
of zinc could overcome the inhibitory effect of EDTA. Overall, these data suggest that EDTA may act by
interfering with the expression/procession of LasA protease by PaM1 strain rather than by sequestering
the zinc cofactor.
Pyoverdin is a chelator involved in iron binding and cellular uptake in a low-iron environment [24].
EDTA at both concentrations tested did not reduce the level of pyoverdin in culture supernatants of
both P. aeruginosa strains (Figure 2a,b).
Studies on mucoid P. aeruginosa isolates have shown that alginate plays a critical role in biofilm
establishment and persistence by protecting bacteria against antibiotics and phagocytosis [25,26].
Although EDTA did not inhibit the production of alginate in culture supernatants of both strains
(Figure 2a,b), it was able to significantly reduce the viscosity of PaM1 culture supernatants at both
concentrations tested (Figure 2a).
Finally, EDTA was tested for its antibiofilm activity against the PaM1 strain. A reduction of
40% and 57% in PaM1 biofilm formation was observed in the presence of 0.075 and 0.15 mM EDTA,
respectively (Figure 2a).
The impact of lin-SB056-1 on the production of virulence factors by PaM1 and PaM5 strains was
also evaluated. As reported in Table S2, the peptide at sub-inhibiting concentrations did not reduce the
production of any of the virulence factors analyzed for both bacterial strains tested.
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Figure 2. Effects of EDTA on virulence factor production by (a) PaM1 and (b) PaM5 strains. PaM1
and PaM5 cultures were incubated at 37 ◦C in the presence or absence of EDTA for 72 h. Following
incubation, OD600 was measured prior the quantification of the virulence factors in culture supernatants
(see the Materials and Methods Section for details). Values obtained were normalized by multiplying
them by the ratio between OD600 of the control/OD600 of the corresponding EDTA-treated samples and
reported as mean +/- SEM of three independent experiments. CTRL: bacteria incubated without EDTA;
* p < 0.05, ** p < 0.01 (one-way ANOVA followed by the Tukey–Kramer post-hoc test).
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3. Discussion
Similar to CF patients, eradication of chronic P. aeruginosa infection in PCD lungs is hardly
obtained, and the reduction of bacterial density during chronic colonization or exacerbations is often
the aim of the antimicrobial therapy [3]. In previous studies, we have shown that the combination of
lin-SB056-1/EDTA possesses antimicrobial activity against P. aeruginosa in artificial sputum medium
and prevents P. aeruginosa biofilm formation in an in vivo-like three-dimensional (3D) lung epithelial
cell model [16,27]. Despite resembling the airway mucus, artificial sputum media normally behave
like Newtonian fluids lacking many of the intramolecular interactions and covalent cross-links that
give respiratory secretions their viscoelastic characteristic [28]. Furthermore, the genotype and
physiological state of P. aeruginosa cells found in vivo may significantly differ from those of bacteria
grown in laboratory media [29]. Hence, in this study, we sought to validate the anti-pseudomonal
activity of the lin-SB056-1/EDTA combination in conditions more closely resembling the environment
found in vivo. To this aim efficacy of the combination was tested ex vivo, against endogenous
P. aeruginosa in the sputum of PCD patients. Differently from artificial sputum medium, patients’
sputum contains host/bacterial components such as cell-derived factors, normal flora, inflammatory
mediators, proteases, or peptidases that may exert an additional inhibitory effect on the peptide’s
activity. Nevertheless, herein, we showed that the combination of lin-SB056-1 and EDTA at sub-active
and non-cytotoxic concentrations [16,27] determined a significant reduction in P. aeruginosa load
in sputa of PCD chronically infected patients, despite certain differences in the level of reduction
among different sputum samples being observed. Such differences are not surprising considering that
inter-patient variables (e.g., clinical stage and severity of lung infection, bacterial load, sputum sample
composition, and consistency) were not standardized in our experiments, in the attempt to mimic
conditions found during the actual antimicrobial therapy. The mechanisms of the synergistic effect
of EDTA on the peptide’s activity might be multiple. Due to the chelation of divalent cations from
their binding sites in lipopolysaccharide (LPS), EDTA may destabilize the bacterial outer membrane,
thus increasing the permeability to lin-SB056-1 molecules and their interaction with the bacterial
membranes. In addition, at least part of the synergistic effect observed in sputum could be ascribed to
the ability of EDTA to reduce sputum viscosity, thus favoring peptide diffusion [16]. Finally, EDTA
could also neutralize the inhibitory effect of sputum on the peptide’s activity, sequestering cations that
may interfere with the electrostatic interactions of the peptide with bacterial surface [9,10]. The possible
use of EDTA in the treatment of pulmonary infections and its safety as an adjuvant has been highlighted
in previous in vivo studies [30,31]. For instance, Liu and coworkers demonstrated, in the guinea pig
model, that EDTA (30 mg/kg intraperitoneally injected) plus ciprofloxacin (4 μg/mL administered by
inhalation) significantly reduced the P. aeruginosa CFU number per gram of lung tissue as compared to
the single treatment groups [31].
Interestingly, the results obtained in this study clearly demonstrated that EDTA could not only
favor the activity of lin-SB056-1 in ex vivo conditions, but could also reduce in vitro, at sub-inhibitory
concentrations, the production of several P. aeruginosa virulence factors (i.e., pyocyanin, total protease
and LasA), which are known to play a crucial role in the pathogenesis of P. aeruginosa infections.
The action of EDTA as an anti-virulence molecule could be ascribed to its capacity of binding divalent
cations, many of which are critical for the expression/processing of virulence factors of P. aeruginosa.
In particular, the reduction of pyocyanin observed in the presence of EDTA is in line with previous
reports demonstrating a positive correlation between calcium levels and the expression of proteins
involved in the pathway of pyocyanin biosynthesis [32]. Analogously, the reduction of proteases
by EDTA is in agreement with previous observations reporting that zinc ions are important for the
efficient production and processing of different proteases, such as LasA, LasB, and protease IV [19,33].
On the contrary, EDTA did not inhibit pyoverdin production, in agreement with the observation
that neither calcium nor magnesium enhances pyoverdin production [34,35]. Interestingly, although
EDTA did not inhibit alginate production, it was able to markedly reduce the viscosity of culture
supernatants of the PaM1 strain. It can be hypothesized that this effect may be due to the sequestration
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of calcium ions that are crucial for alginate cross-linking [36]. A similar mechanism may be involved
in the ability of EDTA to reduce the formation of PaM1 biofilm, confirming previous observations
in which EDTA significantly reduced biofilm formation by a mucoid strain of P. aeruginosa either
in vitro or in a guinea-pig model of lung infection [31]. Overall, the ability of EDTA to reduce the
accumulation and/or activity of important virulence factors might contribute to limit the pathogenicity
of P. aeruginosa.
In conclusion, in the present study, we demonstrated that the lin-SB056-1/EDTA combination is
able to significantly reduce P. aeruginosa load in PCD sputum, and that EDTA decreases the production
of relevant virulence factors of mucoid P. aeruginosa in vitro. Such results suggest a dual antimicrobial
and anti-virulence effect of the lin-SB056-1/EDTA combination and highlight the possible use of EDTA
as an adjuvant in the treatment of chronic P. aeruginosa lung infections.
4. Materials and Methods
4.1. Sputum Collection and Treatment
The sputum samples were collected by spontaneous expectoration from six PCD patients
following informed consent. The study was conducted in accordance with the Declaration of Helsinki,
and the protocol was approved by the Ethics Committee of Pisa (Protocol number 62532, 11.06.2016).
PCD patients included in this study (median age: 34 years) were chronically infected by P. aeruginosa
and characterized by frequent relapses of infection. A volume of 0.5–1 mL of sputum was collected
from each patient after interruption (at least 14 days) of the antibiotic therapy regimen. For easier
handling of the samples, the dense and sticky sputa were diluted five-fold in sodium phosphate buffer
10 mM, pH 7.4 (SPB). Samples were plated on cetrimide (Sigma Aldrich, Saint Louis, MO, USA) and
MacConkey (Oxoid Basingstoke, Hampshire, UK agar to confirm the presence of P. aeruginosa and
assess the mucoid phenotype of the colonies, respectively.
4.2. Peptide and EDTA Solutions
Lin-SB056-1 peptide (KWKIRVRLSA-NH2) was purchased from Peptide Protein Research, Ltd.
(Fareham, UK) with a purity of 98%. EDTA (disodium salt) was obtained from Sigma-Aldrich. A stock
solution of disodium-EDTA (0.5 M) was prepared in milli-Q water by adjusting the pH to 8.0 with
NaOH (Sigma-Aldrich). The stock solution was then diluted in milli-Q water to obtain a working
solution of 50 mM that was sterilized and stored at 4 ◦C.
4.3. Susceptibility Testing
Identification and susceptibility testing of P. aeruginosa strains isolated from sputum samples
(PaM1, PaM2, PaM3, PaM4, PAM5, PaM6) were performed by MALDI-TOF (Bruker Daltonics, Bremen,
Germany) and VITEK 2 automatic instruments (BioMerieux, Lyon, France), respectively (Table S1).
Determination of minimum inhibitory concentration (MIC) of EDTA towards PaM1 and PaM5 strains
was performed according to the standard microdilution method in Muller–Hinton broth (Oxoid) [37].
The MIC was defined as the lowest concentration of EDTA that completely inhibited visible growth of
bacteria after 24 h of incubation.
4.4. Bactericidal Assay in Patients’ Sputum
An aliquot of each PCD sputum was serially diluted and plated on selective cetrimide agar,
to assess the CFU number of endogenous P. aeruginosa at time 0. After that, a volume of 90 μL of
diluted (1:5) sputum of each patient was incubated with sub-bactericidal concentrations of peptide and
EDTA, used alone or in combination, for 1.5 h at 37 ◦C. Following incubation, samples were serially
diluted and plated on selective cetrimide agar for assessing the P. aeruginosa CFU number.
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4.5. Assays for Evaluation of Virulence Factors in Culture Supernatants
Colonies of mucoid strains PaM1 and PaM5 grown on MacConkey agar were suspended in Luria
Bertani (LB) broth (Sigma-Aldrich) to obtain an OD600 of 0.1. Cultures were incubated in the presence
or in the absence of EDTA (0.075 or 0.15 mM) in static conditions at 37 ◦C for 72 h. Following incubation,
the OD600 of the cultures was determined to account for bacterial density. After that, cultures were
centrifuged at 10,000× g for 20 min at room temperature and culture supernatants were used for the
quantification of virulence factors. The same protocol was followed to evaluate the eventual effects of
linSB056-1 on the production of virulence factors. To this aim, the peptide was added to PaM1 and
PaM5 cultures at the concentration of 6.25 μg/mL and 12.5 μg/mL that were sub-inhibitory for both
bacterial strains.
Pyocyanin was extracted from cell-free supernatants with subsequent exposure to chloroform and
0.2 N hydrochloric acid (Sigma-Aldrich) and quantified at OD520 nm, as previously described [38].
Total proteolytic activity was determined using a modified skim milk assay [39]. Briefly, culture
supernatants of PaM1 and PaM5 strains (0.5 mL) were incubated with 0.5 mL skim milk (Sigma-Aldrich)
(1.25%) at 37 ◦C for 30 min and turbidity was measured at OD600 nm. The decrement in turbidity due
to proteolytic activity was expressed as ΔA/min/mL.
Secreted LasA of P. aeruginosa has a staphylolytic activity, i.e., it causes a decrement in the OD600
of a culture of Staphylococcus aureus. LasA activity was assessed by evaluating the ability of cell-free
supernatants from P. aeruginosa exposed or not exposed to EDTA to lyse boiled cells (intact) of S. aureus
American Type Culture Collection (ATCC) 33591 and expressed as ΔA/min/mL [40]. Due to the role of
zinc as a cofactor of LasA, in some experiments, the staphylolytic activity in the presence of EDTA was
evaluated by adding 0.1 mM ZnSO4 (Sigma-Aldrich) to the enzyme assay.
Pyoverdin was quantified by measuring the OD400 of cell-free supernatants [41].
The quantification of alginate was performed by carbazole-borate assay according to Heidari et
al. [42]. Shear viscosity of culture supernatants was assessed by rheometric measurement at 25 ◦C,
applying a shear stress of 1 Pa/s on 150 μl of supernatant using a gap between the rheometer plates of
52 μm (Rheometer Scientific RM500, Reologica Instruments AB, Lund, Sweden).
The value obtained for each virulence factor was multiplied by the ratio OD600 of the control/OD600
of the sample, to normalize for small differences in the culture densities between the controls and the
EDTA-exposed samples after 72 h of incubation.
4.6. Biofilm Inhibition Assay
P. aeruginosa PaM1 grown in tryptone soy broth (TSB) for 48 h at 37 ◦C was diluted 1:20 in TSB
supplemented with 0.25 mM CaCl2. Bacterial suspensions were inoculated into flat-bottom polystyrene
96-well microplates (Corning Costar, Lowell, MA, USA) in the absence (negative control) or in the
presence of EDTA at sub-inhibiting concentrations (0.075 and 0.15 mM). Microplates were incubated
statically at 37 ◦C for 48 h and biofilm biomass was estimated by crystal violet (CV) (Sigma-Aldrich)
staining assay, as previously described [43].
4.7. Statistical Analysis
Data reported in Figure 1 represent the mean of 6 experiments done in duplicate. Figure 2 and
Supplementary Figure S1 depict the data obtained from three independent experiments, while Table S2
reports the mean of two independent experiments. Differences between mean values of groups were
evaluated by one-way analysis of variance (ANOVA) followed by the Tukey–Kramer post-hoc test.
A p-value < 0.05 was considered statistically significant. Data analysis was performed with GraphPad
In Stat (GraphPad Software, La Jolla, CA, USA).
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Supplementary Materials: Supplementary Materials can be found at http://www.mdpi.com/1422-0067/21/1/69/s1.
Table S1: Patients’ information, colony phenotype, and resistance profile of P. aeruginosa strains isolated from PDC
sputum; Table S2: Effects of lin-SB056-1 on the production of virulence factors by PaM1 and PaM5 strains; Figure
S1: Effect of exogenously added Zinc on LasA staphylolytic activity of PaM1 strain in the presence of EDTA.
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Abstract: Bacteria evolved many strategies to survive and persist within host cells. Secretion of
bacterial effectors enables bacteria not only to enter the host cell but also to manipulate host gene
expression to circumvent clearance by the host immune response. Some effectors were also shown to
evade the nucleus to manipulate epigenetic processes as well as transcription and mRNA procession
and are therefore classified as nucleomodulins. Others were shown to interfere downstream with gene
expression at the level of mRNA stability, favoring either mRNA stabilization or mRNA degradation,
translation or protein stability, including mechanisms of protein activation and degradation. Finally,
manipulation of innate immune signaling and nutrient supply creates a replicative niche that enables
bacterial intracellular persistence and survival. In this review, we want to highlight the divergent
strategies applied by intracellular bacteria to evade host immune responses through subversion of
host gene expression via bacterial effectors. Since these virulence proteins mimic host cell enzymes or
own novel enzymatic functions, characterizing their properties could help to understand the complex
interactions between host and pathogen during infections. Additionally, these insights could propose
potential targets for medical therapy.
Keywords: virulence factors; bacteria; host-pathogen interaction; gene expression; immune response;
manipulation; inflammation; persistence; replicative niche
1. Introduction
Successful defence against extracellular and intracellular bacteria primarily relies on the ability of
innate immune cells to sense present bacteria followed by activation of the adequate matching immune
response. The identification of bacteria is enabled by a broad array of pathogen recognition receptors
(PRRs), which recognize extensively conserved pathogen-associated molecular patterns (PAMPs) as
nucleid acids, cell wall components and proteins from viruses, bacteria, fungi and parasites [1]. Toll like
receptors (TLRs) and NOD-like receptors (NLRs) represent the two major classes of PRRs, acting at the
cell surface or in the cytoplasm, respectively [2]. After activation, PRRs induce multiple signalling
pathways aiming at the expression of proinflammatory cytokines, which regulate the innate immune
response. The most prominent pathways involved are mediated by mitogen-activated protein kinases
(MAPKs) or nuclear factor-κB (NF-κB), which are initiated by path-specific adapter proteins and
transferred by downstream phosphorylation cascades [3]. Interestingly, all pathways can synergize to
guarantee a specific and appropriate immune response for the present pathogen. This is enabled by the
high diversity of PRRs, PAMPs and PRR adapter proteins and their numerous ways to be combined
during innate immune response [1,4].
The immune response has to be tightly controlled to ensure a clearance of the bacteria but also
to prevent tissue damage and necrosis as result of sepsis. There are several levels to influence the
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expression of inflammatory genes. A first level of interference is changing of the DNA’s structure
on the chromatin level. Epigenetic modulation enables remodelling of the chromatin to transfer
heterochromatin into euchromatin allowing transcription or vice versa [5–7]. In addition, the affinity
of promotors and other regulatory DNA sequences for RNA polymerases and transcription factors
(TFs) can be influenced by cytosine or adenine methylation. To induce transcription, TFs and RNA
polymerases are recruited to target genes, a step that represents another level to regulate gene expression.
Only a minor portion (fewer than 2%) of genes is transcribed into mRNAs, instead the majority is
transferred into so called non-coding RNAs (ncRNAs). The long ncRNAs (lncRNAs) as well as some
classes of short ncRNAs are also involved in epigenetic regulations but its most studied group, the
miRNAs (microRNA), are mostly involved in RNA destruction [8].
Another point for interference with gene expression is during processing of mRNAs, which
includes 5′ capping, alternative splicing and polyadenylation [9,10]. Primary ncRNAs can be processed
by the protein complex DICER (eukaryotic ribonucleases) to generate miRNAs, which can negatively
regulate expression of its primary transcript. To guarantee proper cell function, mRNAs need to be
degraded after a certain time frame; the RNA stability is, therefore, another switch to modify gene
expression. Polyadenylation and 5′capping prolongs RNA stability but several enzymes are able to
decap the 5′cap and to remove the polyadenyl tail of the RNA leaving an unprotected mRNA [11–13].
Nevertheless, these structures are crucial for translation initiation and can gain enough time for the
mRNA to be translated. This represents a further step for interference with gene expression, as there
is the need of several factors to induce and prolong translation [14]. Translation initialisation factors
have to be recruited leading to ribosome assembly and binding of the first amino acid loaded tRNA
(transfer RNA). To keep translation ongoing, elongation factors and ATP (Adenosine triphosphate)
have to be present. The nascent protein chain then needs to fold into its physiological form to be
active [15,16]. Therefore, protein-folding and activation catalysed by different chaperones is another
important step during gene expression and is also tightly controlled. Finally, a last step to regulate gene
expression is represented by the stability and degradation of, in some cases misfolded, proteins [17,18].
An overview of the steps during host gene expression targeted by bacterial pathogens, as well as the
bacteria involved, is given in Figure 1.
Host cells fight bacteria with a proinflammatory cytokine response, lysosomal degradation,
autophatic clearance and activation of the unfolded protein response, which in the end can lead to
apoptosis [19]. Bacteria can hijack all these defence mechanisms by interfering with the host’s gene
expression at any level. For that purpose, bacteria express several virulence factors, the so-called
effectors. These proteins are able to mimic host enzymes, thereby manipulating the host response
following invasion favouring intracellular survival, persistence and spreading. Since proteins and
enzymes of signal transduction pathways are involved in all defence mechanisms, they are a favoured
target of effector proteins [19]. It is worth noting that other virulence proteins own novel enzymatic
functions, which allow them to enter the nucleus and directly induce gene expression or repression.
Therefore, these bacterial effectors are termed nucleomodulins [20,21]. In the following we will present
an overview on the manipulation of host gene expression at different levels by nucleomodulins and
other bacterial effectors.
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Figure 1. Steps of host gene expression manipulated by bacterial pathogens. The figure provides
an overview over the main steps of gene expression that are indicated at the left side (I-VI). The numbers
in the scheme highlight distinct characteristic processes that are part of each gene expression level and
are listed in the legend at the right side. Different bacterial pathogens (indicated at the right) have
been described to target the distinct steps and processes during host gene expression to their favor.
For detailed information please refer to the text of this review.
2. Bacterial Virulence Factors Manipulating Host Gene Expression
2.1. Epigenetic Control of Gene Expression
The expression of genes is dependent on their accessibility for RNA polymerase II (RNA Pol II)
and TFs. As approximately 147 base pairs of the DNA are wrapped around histone octamers build
by the subunits H2A, H2B, H3 and H4 as well as the scaffold protein H1 to form the nucleosome,
those sequences are protected from transcription [5–7]. Therefore, the packaging of the nucleosomes
defines the chromatin state into euchromatin and heterochromatin enabling transcription or blocking
it. In order to react properly to a certain stimulus, the chromatin state can be remodeled to give
access to the required genes, a process called nuclear remodeling or histone modification. Enzymes
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posttranslationally modify the amino acids at the N-termini of the histone proteins (called histone tails)
by acetylation, phosphorylation, methylation and ubiquitination in a reversible manner to modify the
interaction between neighbored nucleosomes favoring an open or closed chromatin state [19,20,22].
Nucleosomes are then allowed to slide along the chromatin fiber in an ATP-dependent manner, to
give access to the DNA sequence. This reveals the dual function of chromatin, to provide a natural
scaffold and being part of an essential regulatory signaling network processing the incoming data to
create a special transient biological output [23]. On top, established posttranslational modifications
(PTMs) can be maintained beyond the initial signal and cell divisions inheriting cell type specific gene
expression enabling cell lineage specification and cellular identity [23–25].
The enzymes responsible for the modulation of the histone tails are divided into “writers,” which
attach the chemical units, “readers,” which recognize and translate them by recruitment of activating
or repressing factors and “erasers,” which remove the modifications. The resulting “epigenetic
code” is highly dynamic, as each established modification influences the addition or removement of
other modifications that in turn influence the own stability and persistence. Moreover, epigenetic
mechanisms represent the missing link between more or less stable gene expression and the impact of
environmental factors on gene expression that can also cause diseases as cancer [5,26,27]. Therefore,
these enzymes represent a central role in the regulation of immune responses as alterations in their
activity and expression profiles leading to global changes in the histone modification pattern have
been detected as cause of several chronic immune diseases as asthma, chronic obstructive pulmonary
disease, colitis, systemic lupus erythematosus and rheumatoid arthritis [28,29].
Additionally, the DNA can be methylated at cytosine or adenosine residues converting them
into methyl-cytosine or methyl-adenosine to cause transcriptional repression [30]. Hypermethylation
dominantly occurs at CpG islands, cytosine-guanine rich regions at promotor regions, disrupting TFs
and RNA polymerase binding to DNA or recruiting other co-repressors. A hypermethylated gene,
that was not methylated before is therefore, not suitable for transcription and with the recruitment
of further silencing-factors, will finally be silenced. This kind of modification is thought to provide
a stable gene silencing that can be inherited to the next generation of cells [31,32].
Moving away from the old definition of epigenetics as hereditable stable changes at chromatin and
DNA without changing its sequence, modern opinion changed towards a highly dynamic and reversible
mechanism of gene regulation also enabling short term adaptions to changing environments [30].
As consequence, regulation through ncRNAs are also included to the epigenetic regulatory repertoire
that can be classified according to their length into short ncRNAs (<200 nucleotides), which include
miRNAs or long ncRNAs (>200 nucleotides) [33].
2.1.1. Manipulation at the Level of Histone Modifications
After recognition of bacterial presence by PRRs, signaling cascades activate proinflammatory
cytokine expression. To improve accessibility of TFs, such as NF-κB, to the promoters of inflammatory
response genes, an activating histone modification as phosphorylation of Serine 10 on histone H3
(H3S10) is established, which itself is mediated by MAPK signalling. It has been shown, that the
virulence factor LPS alone is able to induce a global increase of H3S10 leading to promotion of gene
expression proving the high sensitivity of the immune reaction [34].
Recent studies revealed that bacteria directly interfere with a host’s histone modifications to
dampen the expression of proinflammatory cytokines by the secretion of effectors. Presence of
Listeria monocytogenes induces phosphorylation of H3S10 but the bacterium is able to remove this
activating phosphorylation within short time [35–38]. The secreted virulence factor Listeriolysin (LLO)
mediates this mechanism and is also responsible for a global deacetylation of H3 and H4. Other
bacteria, as Clostridium perfringens or Streptococcus pneumoniae, produce toxins, such as perfringolysin
and pneumolysin, respectively, that belong to the same family as LLO and show also a similar effect
on H3S10 phosphorylation [36]. The decreased levels of phosphorylated H3S10 and acetylated H4
at proinflammatory genes resulted in transcriptional downregulation thereby damping the immune
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response. As this observation is only dependent on the membrane-binding ability of LLO, it is most
likely that LLO modulates the signal transduction to induce alterations in the histone modification
pattern [36].
Like L. monocytogenes, Shigella flexneri is also able to inhibit H3S10 phosphorylation by secretion
of phosphothreonine lyase effector OspF, which dephosphorylates MAPKs as p38 or ERK resulting
in attenuated NF-κB binding at promotors of inflammatory genes [39]. Together with OspB, another
effector of Shigella, OspF, interacts with the human retinoblastoma protein Rb that is capable of binding
several chromatin-remodeling factors [40,41]. In this constellation, Shigella adjusts the chromatin
structure at specific genes to downregulate host innate immunity.
L. monocytogenes owns another effector, which induces deacetylation on lysine 18 of histone H3
(H3K18). Thereby, Internalin B (InlB) activates the host histone deacetylase sirtuin 2 (SIRT 2), leading to
repression of transcriptional start sites through occupation by SIRT 2 and following downregulation of
the immune response, which could be attenuated by SIRT 2 inhibition [42]. The listerial virulence factor
LntA enters the nucleus after infection of epithelial cells targeting the chromatin silencing complex
component BAHD1. Together with heterochromatin protein 1 (HP1), methylated DNA-binding protein
1 (MBD1), histone deacetylases (HDAC1/2) and the KRAB-associated protein 1 (KAP1/TRIM28) that
are involved in heterochromatin formation, BADH1 targets interferon-stimulated genes (ISG) for
silencing by binding to their promotors [43,44]. This is inhibited by LntA, which is thought to promote
chromatin-unwinding and as consequence upregulation of ISG by histone H3 acetylation. The exact
mechanisms, how BAHD1 is recruited to its targets and how LntA interferes with this process has still
to be investigated [21].
Another prominent histone modification is the methylation or demethylation of lysine residues,
mediated by histone N-lysine methyltransferase (HKMT) or histone demethylases (HDM), respectively.
Several bacteria express HKMT effectors, which enable them to directly interfere with host gene
regulation as they are mimics of host chromatin modifiers. As there are many HKMT homologues
in the repertoire of bacterial effectors described this mechanism seems to be a successful strategy to
subvert host gene expression [45]. The nuclear effector (NUE), is secreted by Chlamydia trachomatis via
a type III secretion system (T3SS) to enable its localization to the nucleus, where it might methylate H2B,
H3 and H4. The homologous effectors RomA and LegAS4 secreted by Legionella pneumophila Paris and
L. pneumophila Philadelphia Lp02 strains, respectively, methylate H3 to alter host transcription but target
different residues [45,46]. RomA represses global transcription by methylation of histone 3 lysine 14
(H3K14), a modification that is known to compete with the activating acetylation of H3K14 [46]. Contrary
to RomA, LegAS4 increases transcription of ribosomal RNA genes (rRNA) through methylation of
histone 3 lysine 4 (H3K4) but if this modification is mediated by LegAS4 alone it is not clear yet [45].
Interestingly all described bacterial methyltransferases own a conserved SET (Suppressor of variegation,
Enhancer of zeste and Trithorax) domain, which uses a S-adenosyl-l-methionine (SAM) methyl donor to
catalyze methyl group attachment to lysine residues [45,47]. One example is the effector BtSET, secreted
by Burkholderia thailandensis that localizes to the nucleolus to methylate histone H3K4 promoting
transcription of rRNA genes. Some effectors are capable of more unusual modifications, for example,
the effector BaSET identified in Bacillus anthracis trimethylates histone H1 but none of the core histones.
This effector represses the expression of NF-κB target genes after transient overexpression in mammalian
cells and its deletion results in the loss of virulence [45–47].
Another modification, which differs from the known mechanisms of histone modification,
is represented by dimethylation of histone 3 on arginine 42 (H3R42me2), a residue critical for DNA
entry/exit from the nucleosome and not located at the histone N-termini. This modification is involved
in the regulation of ROS (reactive oxygen species) production, which represents a crucial host defense
mechanism against bacterial pathogens [48]. Mycobacterium tuberculosis represses genes involved in
ROS production by secreting Rv1988, a methytransferase able to establish H3R42me2 to increase
survival in host macrophages [48]. An overview of bacteria and their effectors that are secreted to
induce histone modifications is given in Table 1.
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Influencing the expression of histone modifying enzymes is another possibility to affect histone
modifications in favor of bacterial survival (see Table 2). Modulation of the histone deacetylase HDAC1
appears to be most targeted by pathogens, to manipulate the key acetylation system enabling protection
against eradication. Infection with Anaplasma phagocytophilum, an intracellular pathogen causing
human granulocytic anaplasmosis, causes upregulation of HDAC1 leading to a globally increased
HDAC activity [56]. The recruitment of HDAC1 to AT-rich chromatin sites in promotors of host
defense genes is mediated by the effector ankyrin A (AnkA) resulting in the reduction of histone H3
acetylation and the suppression of target genes such as CYBB that encodes Cytochrome b-245, beta
polypeptide. As this element of the phagocyte NADPH oxidase is involved in the clearance of the
pathogen by neutrophils, it is preferentially targeted [57–60]. Furthermore, AnkA functionally mimics
SATB1, a protein able to bind AT-rich sequences distributed across distinct chromosomes at attachment
regions of the nuclear matrix. Proteins with this ability are involved in nuclear matrix attachment,
spatial organization of chromatin and large-scale transcriptional regulation [59,61–63]. AnkA could
also perform as global organizer of the neutrophil genome, thereby acting locally (cis) and at a distance
(trans) to a target gene. Moreover, pathogens as Chlamydia psittaci secrete nucleomodulins (SinC) that
could act like AnkA and influence anchoring factors and lamins that control the dynamics of chromatin
looping and organization, as the inner nuclear membrane proteins MAN1 and LAP1 [64].
Pseudomonas aeruginosa, an opportunistic pathogen that infects and colonizes inflamed airways
and burn wounds, induces HDAC1 expression in human THP-1 monocytes with the help of a molecule
usually used for quorum sensing, 2-aminoacetophenone [65,66]. This is followed by global histone
H3K18 hypoacetylation and reduced expression of inflammatory cytokines and chemokines (e.g., TNF,
IL-1b and MCP-1) resulting in dampened host defense against the bacterium.
Considering that this effect was also dampened by knockdown or inhibition of class I HDACs and
the evidence that besides A. phagocytophilum and P. aeruginosa also Porphyromonas gingivalis modulates
HDAC1 during infections, HDAC1 family members might play a central role in development of
an epigenetic mediated tolerance against the pathogens [67]. In patients with chronic periodontitis,
mRNA and protein levels of HDAC1 expression were globally increased compared to healthy
individuals and colocalized with TNF expressing cells and tissues. Interestingly, epigenetic regulation
mediated by P. gingivalis seems to be cell-type specific, since HDAC1 and HDAC2 are downregulated
in gingival epithelial cells in vitro, while levels of acetylated histone H3 were increased in murine
epithelial cells of the gingival tissue [68,69]. In addition, the host acetylation system is also often
influenced by short chain fatty acids (SCAFs) produced by commensals or pathogenic bacteria as
P. gingivalis (for recent reviews please refer to References [70] and [71]).
Table 2. Bacteria targeting histone modifying enzymes.
Target Modification Bacterium Effector Cellular function References
HDAC1 induction A. phagocytophilum Ankyrin A
suppression of target genes as
CYBB that encodes cytochrome
b-245, beta polypeptide
[56]





HDAC1 induction M. tuberculosis unknown
Silencing of inteleukin-12β,
suppression of T helper1
response
[55]
HDAC2 repression P. gingivalis SCAFs Activation of genes [68,72–75]
P300 repression E. coli Proteinase NleC decreased IL-8 production [76]
HKMT repression P. gingivalis SCAFs Inhibition of heterochromatinmarks [73–75]
Another strategy followed by bacteria during host infection and manipulation of the epigenetic
regulatory mechanisms is to proteolytically degrade histone acetyl transferase (HAT) family members.
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One example of bacteria using this strategy are enteropathogenic and enterohaemorrhagic Escherichia coli,
which secrete the effector protein NleC, a zinc-dependent metalloproteinase targeting intracellular
signaling to dampen the host inflammatory response [76]. The protein specifically binds and degrades
the host HAT p300 in infected cells leading to decreased IL-8 production, an effect that can be restored
by p300 overexpression. Thus, HATs and HDACs can both be targeted by pathogenic bacteria to
modulate epigenetics and inflammatory gene expression in their benefit.
2.1.2. How to Control Host DNA Methylation
DNA methylation is another way to control gene expression. There are several enzymes called
DNA-(cytosine C5)-methyltransferases (DNMTs), which establish methyl residues to cytosine or
adenosine residues, respectively [71]. In contrast, the removement of DNA methylation patterns is
more complex, as the modified nucleotides or DNA sequences have to be exchanged by DNA-repair
mechanisms or the methylation has to be oxidized to form 5-Hydroxymethylcytosine, which can be
removed by enzymes [77]. DNA methylation patterns at promotors of tumor suppressor genes had
already been discovered, when first hints pointed towards an influence of bacterial inflammation on
mechanisms establishing DNA-methylation patterns after Helicobacter pylori infection. In this context,
among others, genes associated with cell growth (apc, p14 (ARF), p16 (INK4a)), cell adherence (cdh1,
flnc, hand1, lox, hrasis, thbd, p14ARC) and DNA-repair (brca1, mgmt., hMLH1) are influenced [52,78–80].
Similar observations of altered DNA-methylation patterns during inflammation were made following
uropathogenic E. coli, Campylobacter rectus and Mycobacterium leprae infections [81–83]. Still, the
questions if DNA-methylation is directly induced by bacteria or is a secondary reaction by the host
due to persistent inflammations, as well as the underlying mechanisms, are not completely answered
yet [84].
However, several Mycoplasma species to encode mammalian DNMTs like equivalents that target
cytosine-phosphate-guanine (CpG) dinucleotides to establish methylation patterns in the bacterial
genome [85–87]. Moreover, their expression in human cells results in their translocation to the nucleus,
where they set up unusual methylation patterns on the host DNA. This was shown for the DNMTs Mhy1,
Mhy2 and Mhy3 expressed by Mycoplasma hyorhinis in combination with up- and downregulation of
certain genes resulting in activation of proliferation specific pathways, a process that might contribute
to tumor progression [85,88].
Mycobacterium tuberculosis owns an effector called Rv2699 that can enter the nucleus of THP1
cells (a monocytic cell line derived from a patient with acute monocytic leukemia) and methylate
cytosines outside CpG dinucleotides. Notably, Rv2699 prefers cytosine-phosphate-adenine or
cytosine-phosphate-thymine sites to generate a type of methylation that is, with few exceptions,
normally not present in mammalian adult differentiated cells [89,90]. However, non-CpG methylation
could lead to a more stable type of modification that persists longer in the genome of infected
nondividing macrophages, offering an advantage for M tuberculosis by establishing an intracellular
environment for persistence [90]. A follow up study revealed that THP1 macrophages infected
with M. tuberculosis strain H37Rv created genome-wide de novo methylation patterns at non-CpG
dinucleotides that included hyper- and hypomethylated regions [90,91]. Additionally, clinical
isolates infecting THP1 cells may downregulate IL-6 receptor expression by hypermethylation of
CpG-dinucleotides at the promoter of the IL-6 receptor gene. Still, it has to be mentioned, that the
observations of M. tuberculosis induced DNA-methylation patterns depend on the infected cell type.
Another interesting bacterial induced modification of gene expression is represented by
differentiated Swann cells that adapt the phenotype of progenitor stem-like cells after M. leprae
infection. This is probably induced by silencing of the Sox10 gene after bacterial methylation [82].
In contrast to the decreased expression of Sox10, other genes involved in epithelial–mesenchymal
transition (EMT) were demethylated and transcribed leading to the transformation of Swann cells into
myofibers or smooth muscles in vitro and in vivo [92].
196
Int. J. Mol. Sci. 2020, 21, 3730
P. gingivalis was shown to increase the methylation of the TLR-2 promotor in gingival epithelial cells
(GECs) reducing innate immunity activation and causing hyposensibility [69,93]. Besides, coinfection
with Filifactor alocis, another pathogen associated with periodontitis is suggested to influence the whole
cell transcriptome through impact on the nucleosome structure by reduced expression of H1 family
members [73,74]. Other histone modifications induced by LPS or short chain fatty acids (SCFAs)
produced by P. gingivalis are summarized in Tables 1 and 2.
Still, there is not much known about the relation of DNA-methylation and infection and the
underlying causalities [71,84]. Considering that many of these modifications are observed in the
context of cancer initiation and progression, further investigation may contribute to new therapeutic
agents and cancer prophylaxis.
2.1.3. Regulation of Host Gene Expression via lncRNAs
The role of lncRNAs during modulation of gene expression has been discovered in the recent
years. Similar to mRNAs, lncRNAs are transcribed by RNA polymerase II or III, followed by splicing,
5′capping and in some cases polyadenylation at the 3′end. Contrary to mRNAs, the expression of
lncRNAs is much lower and in a cell-, tissue- and developmental stage-specific manner [94].
Dependent on of their position relative to the neighboring protein-coding gene, lncRNAs are
classified as sense, antisense, bidirectional, intronic or intergenic and, despite their enormous number,
they were previously considered as “dark matter” or “junk” in the genome [95]. Au contraire, lncRNAs
are now respected as important physiological regulators during cell homeostasis, growth, differentiation
and anti-viral responses [96–99]. In addition, gene imprinting, regulation of the p53 pathway, stem
cell self-renewal and differentiation and DNA damage response were reported as lncRNA controlled
mechanisms [100–103].
The functionality of lncRNAs is not restricted to the neighbored protein-coding gene (in cis),
in contrast they are also able to act in trans to regulate gene expression across chromosomes.
In this context, lncRNAs regulate different processes as chromatin remodeling, transcription and
post-transcriptional regulation via their capacity as signals, decoys, guides and scaffolds [104,105].
Interestingly, another origin of lncRNAs is the expression of pseudogenes and gaining Influence over the
expression of pseudogenes could, therefore, provide a possibility to control infectious responses [106].
Immune regulation through lncRNAs has already been known after viral infections but recent
research indicates its involvement also whilst fighting bacteria [107]. In that context, 76 enhancer RNAs
(eRNAs), 40 canonical lncRNAs, 65 antisense lncRNAs and 35 regions of bidirectional transcription
are differentially expressed in human monocytes after LPS stimulation [108]. LPS stimulation alone
induces a differential expression of about 27 lncRNAs leading to histone trimethylation or acetylation
of neighboring genes after de-regulation, pointing towards their regulatory influence during the
innate-immune response [109]. The observation, that 44% of total lncRNAs varied in their expression
after Salmonella infection in HeLa cells could foster these results and substantiate them by a function
in the early phase of infection as sensitive markers for pathogen activity [110]. In line with this,
the lncRNA HOTAIR that contributes to transcriptional repression of HOX genes also promotes
inflammation in mice cardiomyocytes by TNF-α production mediated through phosphorylation of p65
protein and NF-κB activation after LPS induced sepsis [111,112].
Long intergenic non-coding RNAs (lincRNAs) are a subtype of lncRNAs, as they are expressed
from intergenic regions. In response to an LPS stimulus, bone-marrow dendritic cells expressed about
20 lincRNAs with the majority being dependent on NF-κB activity, including lincRNA-Cox2, which is
also upregulated in bone marrow-derived macrophages following L. monocytognes infection [113,114].
Additionally, bacteria sabotage lncRNA activity, as BCG (attenuated strain M. bovis bacillus
Calmette-Guérin BCG) infected macrophages repress the expression of 11 lncRNAs that are not
dampened by infection with heat activated bacteria [115]. Still, possible subversion of lncRNA-mediated
inflammatory regulation needs to be further investigated.
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2.2. Bacterial Effectors Manipulating the Host Transcription Machinery
Proper RNA Pol II complex formation is essential for protein expression and tightly controlled by
regulators, who are expressed by approximately 10% of all genes [116]. These are general or specific
TFs, which serve as activators and repressors and determine specificity and efficiency of transcription
at individual promotors [117,118]. Considering the large number of factors involved in transcriptional
regulation, it is not surprising that bacteria target those regulators to drive transcription in their
favor. For example, activator protein-1 (AP-1)–dependent gene transcription is inhibited by NleD,
an effector of E. coli that cleaves and inactivates the MAPKs, JNK and p38. Also, the recently identified
nucleomodulin OrfX secreted by L. monocytogenes that influences host transcription via its interaction
with the Ring1 YY1-binding protein (RYBP), a multifunctional nuclear protein owning a zinc finger
motif to interact with several TF components of the polycomb repressive complex 1 [119,120]. Moreover,
RYBP promotes gene silencing and transcriptional repression of developmental genes, as it is part of
the BCL6 corepressor (BCOR) complex [121,122]. In contrast, it is also involved in the activation of
the Cdc6 promoter and mediates interaction of the TFs E2F and YY1 [123]. Furthermore, the TF p53
(a tumor suppression factor) is assumed to be stabilized by RYBP through binding of MDM2, an E3
ligase, preventing p53 from proteosomal degradation. As p53 controls intracellular levels of reactive
oxygen (ROS) and nitrogen species (RNS) that are part of the immune defense of macrophages, OrfX
targets RYBP for degradation to interrupt P53 activity promoting intracellular bacterial survival. Still,
this model needs to be verified [120,124].
Salmonella Typhimurium inhibits the expression of NF-κB mediated genes by secretion of PipA,
GogA and GtgA via its type II secretion system [125–128]. These proteins belong to the family of
zinc metalloproteases and contain the short metal binding-motif HEXXH, which consists of two
histidine residues coordinating the active-site zinc and a glutamate residue that is essential for catalytic
activity [129]. They can cleave NF-κB TF subunits, including p65, RelB and cRel, thereby suppressing
their ability to control the transcription of innate immune genes [125–128]. In addition, Jennings et al.
predicted suppression of the transcriptional coactivator ribosomal protein S3 (RPS3) by GtgA family
members, as it produces p65 (1–40) after cleavage of p65.
Enteropathogenic and enterohemorrhagic E. coli possess another zinc metalloprotease that also
owns the HEXXH motif and is able to cleave p65, RelB and cRel, as well as NF-κB1 (p105/p50) and
NF-κB2 (p100/p52) [126–128,130]. Following cleavage, the subunits are left inactive except for the
N-terminus of p65, which prevents the nuclear import of the transcriptional coactivator ribosomal
protein S3 (RPS3). This in turn inhibits the expression of a specific subset of NF-κB–dependent genes
requiring RPS3 for their expression.
The non-pathogenic E. coli strain 83972, who is the agent causing persistent asymptomatic
bacteriuria (ABU), suppresses host defense in the urinary tract by inhibition of RNA Pol II dependent
transcription. While infections with pathogenic strains induce urinary tract infections, these bacteria
create an asymptomatic carrier state that reminds of bacterial commensalism and protects patients
against infection with more virulent strains. Therefore, therapeutic urinary tract inoculation with the
ABU strain is a promising alternative to appease symptoms of therapy resistant, recurrent urinary tract
infections [131–133].
Studies with patients and human cells treated with ABU strain 83972 revealed that 24 h after
inoculation, over 60% of all genes were suppressed, including regulatory elements as transcriptional
repressors, transcriptional activators, regulators of translation and chromatin or DNA organizing
factors [134,135]. This phenomenon was observed for many genes of the innate immune response but
about 22.5% of the effected genes are involved in Pol II transcription or in regulating Pol II–dependent
pathways. After Ingenuity Pathway Analysis, a network incorporating FOSB, HSPA6, RN7SK, RGS4
and IFIT1, inversely regulated genes that control Pol II for instance through TATA box–binding proteins
(TBP) [136–138], appeared.
Another fascinating observation revealed that 50% of ABU strains lack virulence genes due to
point mutations or deletions resulting in smaller genome sizes. Considering that ABU strains evolved
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from uropathogenic E. coli, this could be a hint for a reductive evolution creating a niche through
active adaptation to the host environment [139]. Thereby, the ABU strain generates a commensal
like state characterized by a well-balanced immune environment that finally protects the host from
colonialization with more virulent strains and destructive immune activation [134,140–144].
Ambite et al. observed in a follow up study that obtaining one single virulence factor was
enough to induce virulence of a non-virulent strain causing symptoms in the host, in contrast to the
broad repertoire of virulence factors that are normally expressed by pathogens [145]. In this context,
reconstitution of the papG adhesin gene recreated functional P-fimbriae leading to virulence of the
avirulent ABU strain. Considering the high frequency of ABU strains carrying inactive papG genes,
the loss of P-fimbriae might induce development of virulence attenuation and evolution towards
commensalism [96,134].
L. pneumophila is another pathogen that induces global reprogramming of transcription,
by interference with transcriptional elongation by Pol II. Its effector AnkH interacts with LARP7,
a component of the 7SK small nuclear ribonucleoprotein (snRNP) complex involved in Pol II pausing.
Thereby, theβ-hairpin loop of the third ankyrin repeat of AnkH impairs LARP7 interaction with the other
7SK snRNP complex components resulting in promotion of gene wide transcriptional elongation [146].
The nucleomodulin SnlP expressed by Legionella also regulates RNA Pol II mediated transcription
elongation by inhibition of SUPT5H that is part of the 5,6-Dichlorobenzimidazole 1-β-D-ribofuranoside
(DRB, a selective inhibitor of transcriptional elongation by RNA pol II) sensitivity-inducing factor
(DSIF) complex [147].
2.3. RNA Processing as Target during Infections
Following transcription the immature pre-mRNA is processed to mature mRNA, a process that
includes 5′ capping, 3′polyadenylation and splicing and is essential for normal cell function [148].
Splicing of mRNAs can include omitting or retaining of exons to create a protein with altered structure,
function and stability, a process called alternative splicing. In the human genome, more than 90% of
all genes are adjusted by alternative splicing, which enables a variation and dynamism in the static
genome as protein domains can be easily new combined to form isoforms with unique functional
abilities [148,149]. The process is controlled by multi-molecular complexes that assemble at splice
junctions, thereby evaluating splicing enhancer/silencer elements flanking splice junctions, which in
their combination determine inclusion or exclusion of exons. Those elements are divided into cis
elements including splicing enhancers and silencers and trans elements as snRNPs, hnRNPs, SR proteins
(serine-arginine containing proteins) and several other accessory proteins [149,150]. Furthermore,
the rate of transcription has a critical influence on alternative splicing, as a paused or decelerated RNA
Pol II can use newly transcribed splice junctions that could have been skipped at higher translation
speed [151–153].
Recent studies indicate that the host splicing machinery is targeted by pathogens to perturbate
immune response. This has been extensively reported for viral infections but quite less is known about
bacterial interference. Nevertheless, global alterations of splicing patterns were detected after infection
of human macrophages with M. tuberculosis, Salmonella or Listeria [154–157]. More specifically, hnRNP
M interacts with LLO leading to a hampered INF-γ response [158] and co-immunoprecipitation of
splicing factors hnRNP U, hnRNP H, hnRNP A2/B1 isoform A2 and SRSF3 with the bacterial protein
mtrA was shown in macrophages overexpressing specific secreted proteins that are infected with
M. tuberculosis [159]. Another hint for the interaction of mycobacterial proteins and host splicing factors
is the precipitation of host splicing proteins as SRSF2, SRRM2, SF1, HTATSF1, GCN1L1, CPSF6 and
many more by the mycobacterial proteins EsxQ, Apa, Rv1827, LpqN, Rv2074 and Rv1816 [160].
Mycobacterium avium subsp. paratuberculosis, also induces alternative splicing of 46.2% of all genes,
including two genes responsible for monocyte to macrophage differentiation-associated maturation
and lysosome function. Since their splice variants lead to failure of macrophage maturation, bacterial
intracellular persistence is improved in the early phase of infection by hampered clearance [161].
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Furthermore, alternative splicing of RAB8B, a key regulator of phagosome maturation, induced by
M. tuberculosis infected cells leads to the production of a truncated protein. The alternative splicing
event results in nonsense-mediated decay of RAB8B mRNA resulting in lowered protein levels,
that dampens phagosome maturation [156].
Analysis of RNAseq data revealed that specific genes are chosen by pathogens for the manipulation
of alternative splicing. Indeed, most dominant isoforms of protein kinases produced end up with the
loss of critical functional domains including kinase domain or protein–protein interaction domains
like SH2, SH3 and PH domains [162]. Considering nonsense-mediated decay of RAB8B mRNA after
M. tuberculosis infection, it is concluded that this mechanism describes the two strategies host and
bacteria developed during their evolutionary concurrence [156]. In this theory, increase of transcription
after infection represents the host response, whereas splicing into a truncated isoform, which is
destinated for decay, exemplifies bacterial interference. The exact mechanism how bacteria manipulate
alternative splicing is not clear yet. Possibly, they activate cryptic or weak splice sites in the host
genome to alter the splicing pattern but this has still to be proven [149].
However, another aspect that needs to be considered is the high diversity with that individuals
react to the same pathogenic agent. For example, only 5–10% of the individuals in tuberculosis
endemic countries that had contact with M. tuberculosis develop disease, whereas the majority either
eliminates the pathogen or controls it in a metabolically altered latent phase [163,164]. An explanation
are single-nucleotide polymorphisms (SNPs) that disrupt splice-site consensus sequences in 15% of
human disorders induced by inherited point mutations, whose influence induce strongly fluctuating
pathological conditions after varying activation of disease associated genes [165–167]. This was
already reported for diseases as diabetes and seems to be also true for infections, as several SNPs
were identified that change the host susceptibility to M. tuberculosis infections for example, in the
intronic region of human ASAP1 (dendritic cell migration). Another polymorphism in IL-7RA helps
to protect against tuberculosis due to an impaired IL-7Ra splicing [168,169]. Therefore, alternative
splicing gets into focus of possible medical therapy developing splicing inhibitors that are already
tested for cancer [149,170,171]. Nevertheless, the knowledge about alternative splicing during bacterial
infections and their interplay is very limited and deserves more attention, as this could give more
insights in individual susceptibility and immunity.
2.4. The Advantage of Modulating Host RNA Stability and Degradation
The lifetime of mRNAs has a major impact on the amount of proteins that can be produced;
the shorter an mRNA is present, the less it can be transcribed. Since the lifetime of an mRNA is
dependent on its stability, there are mechanisms to increase resistance to degrading RNases [11–13].
First, the 5′m7G cap and the 3′poly-A tail that are established post transcriptionally at all mRNAs but
especially the length of the poly A tail can vary between mRNAs, determining the duration of resistance
against enzymatic degradation [9]. Besides, these structures are involved in virus clearance, as viral
mRNAs lack these structures, what marks them for RNA degradation machinery [172]. In addition,
the structure of the mRNA alone influences its stability, as hairpin-structures and other secondary
structures are formed dependent on the sequence and therefore, increase the stability [11–13]. In the
following paragraphs we want to highlight the regulation of mRNA stability and decay mediated by
miRNAs during infections and how bacteria interfere with this part of the host immune defense.
Manipulation of miRNAs to Favor Bacterial Survival
Their physiological properties enable non-coding RNAs (ncRNAs) to base-pair with their targets
and interfere with a twofold effect on gene expression—one single ncRNA can bind multiple targets,
thereby influencing several pathways at once and one gene can be regulated by several ncRNA fine
tuning gene expression [173]. miRNAs are involved in several cellular processes as cell proliferation
or differentiation and after studies with human monocytes treated with LPS, miR-146 was identified
as anti-inflammatory miRNA proving miRNA involvement in inflammation [174–176]. Indeed,
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subsequent studies revealed specific expression of miRNA sets including miR-155, miR-146, let-7 and
miR-29 (see Table 3) due to infection with different bacterial pathogens regulated in a time dependent
manner [177–181]. Another study with dendritic cells infected with six different bacteria demonstrated
a core infectious response in a temporal manner including 49 miRNAs that were always expressed and
may, therefore, play essential roles in infectious responses. Additionally expressed miRNAs might hint
towards specific variability and signatures arising from the individual pathogens [182]. Interestingly,
following infection, the proportion of miRNA variants, the so called isomiRs, varies, which is supposed
to effect miRNA identity and regulatory potential but has not been proven yet [182].
The induction of miRNAs is often dependent on PRR and NF-κB pathway induction in response
to bacterial stimuli as LPS. Interestingly, there is a dose dependent reaction to the stimulus, as a low
dose activates miR-146 that acts as anti-inflammatory regulator promoting tolerance to low doses
by targeting two members of the NF-κB pathway, TRAF6 (TNF Receptor-associated factor 6) and
IRAK1 (IL-1R-associated kinase 1) [176,183]. In contrast, at high doses of LPS, TNF-α and Interferon β
induce miR-155 via TAB2 to maintain the proinflammatory NF-κB activity fighting pathogens and
exerting a negative feedback on the immune system. Therefore, both mi-RNAs protect the host from
sepsis and overreaction [183,184] but in a dose dependant manner. miR-155 is also involved in T
helper cell development or promoting autophagy by inhibition of the mTOR (mammalian/mechanistic
target of rapamycin) pathway, indicating that it represents an important part of an efficient immune
response [185–187]. Actually, upon Citrobacter rodentium or L. monocytogenes infection, miR-155 null
mice showed slower clearance and an impaired CD8+ T-cell response, respectively and miR-155 was
identified as an essential factor during the vaccination process against S. Typhimurium [188–191].
Table 3. Activity of miRNAs in the host response. The arrows indicate changes of miRNA expression
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let-7C mTOR-pathway ↓Modulation ofT-cell activity several bacteria [194]
let-7I SNAP23 Exosome release
↓ Antimicrobial



































↓ L. monocytogenes [197,198]
Another miRNA family, the let-7 family, is repressed during infection or exposure to LPS, as Lin-28B
expression is induced in a NF-κB dependent manner that blocks let-7 maturation [154,192,193,195,199,200].
Additionally, active repression of these miRNAs by bacteria has been reported in several studies (see
Table 3). Many other bacteria induce miRNA expression and manipulate expression of these immune
regulators in their favor (summarized in Table 4.)
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In addition to H. pylori with miRNAs (see Table 4), there are two more interactions described,
which depend on the effector CagA that activates NF-κB pathway. This effector induces an increased
expression of miR-1289 that in turn leads to a decreased gastric acidity, as miR-1289 targets HKα,
a component of the gastric H+/K+ ATPase [213]. Furthermore, Cag A induces cell cycle arrest at G1/S
transition, which inhibits the renewal of the gastric epithelium, supporting H. pylori colonization [214].
In this context, miR372 and miR-373 expression is suppressed by Cag A, whereas miR-584 and miR-1290
expression is promoted. The latter target FOXA1, a negative regulator of the epithelial-mesenchymal
transition, for inhibition, thereby favoring bacterial persistence and survival within the gastric
epithelium [215]. Moreover, CagA suppresses miR320 and miR370 expression, who induce MCL1
(an anti-apoptotic gene) or downregulate FoxM1 expression, respectively. FoxM1 downregulation in
turn activates p27K1P1 leading to cell cycle inhibition. Together, these factors decrease apoptosis and
favor cell proliferation, which can lead to tumor development.
The M. tuberculosis effector ESAT-6 is also capable of manipulating miRNA expression to the
benefit of the bacterium [212]. ESAT-6 downregulates let-7f expression in macrophages, leading to
an enrichment of the deubiquitinating enzyme A20 that negatively regulates the NF-κB pathway.
Furthermore, miR-155 expression is stimulated, resulting in BACH1 (a transcription regulator protein)
and SHIP1 (SH-2 containing inositol 5′ polyphosphatase 1, a multifunctional protein expressed
predominantly by hematopoietic cells) repression that in turn induces heme oxygenase 1 expression.
Concurrently, serine/threonine kinase AKT is activated fostering bacterial dormancy and survival.
This is subsidized by downregulation of SOCS1 (suppressor of cytokine signaling 1) and targeting of
Rheb (Ras homolog enriched in brain), which is followed by macrophage apoptosis [199,210,211].
Evidence exists that bacteria are able to also produce their own regulatory RNAs that interfere
with the host. In 28 bacterial genomes 68 possible candidate bacterial RNAs were found during an in
silico search, which harbor secondary structures that could form miRNAs after host procession and be
involved in 47 human diseases [216]. As an example, after E. coli ingestion che-2 and F42G9.6 gene
expression was modulated and probably degraded in Caenorhabditis elegans by E. coli OxyS and DsrA
ncRNAs [217]. Furthermore, Mycobacterium marinum expresses a pre-miRNA that associates with the
host RISC complex in its mature, 23 nucleotide long form and could effectively downregulate its target
mRNA when overexpressed [218].
It has been reported that exosomal transfer of host cell miRNAs is used to spread the host response
to other cells and the ratios of miRNAs transported differ in a time and bacterial dependent manner.
Hence, the ratios of miR-146a and miR-155 in exosomes can subsequently modulate host cell responses,
favoring inflammation or recovery, respectively. The use of exosomes containing miRNAs could give
rise for therapeutic possibilities to treat inflammation or to be used during vaccinations [219–226].
Moreover, exosomes containing miRNAs could be used for diagnosis, since they can be detected in
many sample types (blood fluids, saliva, tears, urine, amniotic fluid, colostrum, breast milk, stool, etc.)
and since there are unique patterns for each pathogen [219–221].
Regulation of gene expression through ncRNAs as miRNAs happens more immediately and
flexibly than through transcriptional regulators [33]. The faster response is enabled by the cell and tissue
type specific differentially regulated reservoir of ncRNAs, which also allows a precise fine-tuning of
gene expression to organize immune defense and damage protection [33]. Taken together, investigation
of the host-pathogen crosstalk with a focus on miRNAs and their usage and manipulation by bacteria
provides new perspectives to fight bacterial mediated diseases.
2.5. Controlling Host Translation Improves Bacterial Persistance
Translation is a major regulator of gene expression and immune response. As many factors are
needed to induce Ribosome association, start of translation and ongoing elongation, many ways exist
to regulate or interfere with the translation machinery. Not surprising, inhibition of translation is
a well-known strategy followed by bacteria to circumvent immune defense [227].
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In most cases, eukaryotic translation is controlled during initiation, when ribosomes are recruited
to the mRNA mediated by eukaryotic initiation factor 4F (eIF4F) that recognizes the 5′ cap structure
with the help of its cap-binding subunit eIF4E [228]. The reversible association of this subunit with
4E-binding proteins (4E-BPs) inhibits the assembly of eIF4F and its release and activation are in turn
mediated by the phosphorylation of the 4E-BPs [229–231]. This phosphorylation is induced by the
serine/threonine kinase mTOR complex 1 (mTORC1), thereby requiring the protein Raptor for mTOR
substrate binding whereas rapamycin binding inhibits phosphorylation and dissociation [232,233].
Legionella pneumophila (L. pneumophila) expresses five effectors, Lgt1, Lgt2, Lgt3, SidI and SidL,
involved in global protein translation inhibition by interference with the eukaryotic elongation factors
eELF1A and eELF1Bγ [227,234–236]. Moreover, L. pneumophila was also shown to negatively influence
cap-dependent translation initiation mediated by ubiquitination of the mTOR pathway leading to
suppression of the eukaryotic initiation factor 4E (eIF4E) through decreased eIF4E assembly into the
translation initiation complex eIF4F [237].
Finally, the synthesis of IκB, an inhibitor of the NF-κB TF, is inhibited by L. pneumophila. This leads
to a prolonged NF-κB activation resulting in the so-called effector-triggered response (ETR) including
transcription of target genes, such as Il23a and Csf2 that create a more pro-inflammatory state.
Fascinatingly, mutants lacking effectors or the Dot/Icm type IV secretion system transferring them,
still inhibit host translation via TLRs and NF-κB activation but not sufficient enough to fully induce
ETR [234,235]. In addition, macrophages lacking TLR and Nod signaling still mediated MAPK signaling
after exposure to the five L. pneumophila effectors that leads to inhibition of host translation. Therefore,
translational inhibition does not exclusively rely on ETR but also on effector independent mechanisms
that induce mTOR pathway downregulation and cytokine biasing [237]. In this context it is suggested
that the host immune system senses not only for PAMPs but also for pathogen-encoded enzymatic
activities that disrupt crucial cellular processes [227]. Interestingly, even if host translation is inhibited at
the stage of initiation and elongation by L. pneumophila, there is still an inflammatory response detectable.
The immune response is quite weak compared to its normal potential but few inflammatory cytokines,
as IL-1α and IL-1β, circumvent translational inhibition by L. pneumophila, which is mediated by MyD88
signaling [227]. This demonstrates that the interference with cap-dependent host translation results
in promotion of host defense, as highly abundant transcripts, which often encode proinflammatory
cytokines, are favored for translation. Thereby, the bacterial benefit through blockage of host translation
may consist of increased availability of amino acid nutrients beneath the dampened immune response,
which is impeded by the host [234].
Translational inhibition is also known for P. aeruginosa infections in C. elegans, where Exotoxin A
after its endocytosis into intestinal cells leads to suppression of elongation factor 2 (EF2), followed by
selective translation of ZIP-2 and thus, induction of pathogen clearance [238,239]. As the 5′ UTR of zip-2
contains several untranslated ORFs (uORFs), it was proposed that the uORFs could mediate selective
translation. Moreover, inhibition of translation by pharmacological inhibitors also caused induction of
various stress response genes including Il6, Il23, Il1α and Il1β [240–242]. As these cytokines are still
expressed when the elongation machinery is attacked by P. aeruginosa with Exotoxin A, a consideration
of similar functionalities of the 5′ UTR or the 3′ UTR of cytokine genes to uORFs was raised. However,
the ADP-ribosylation of elongation factor 2 (EF2) in host cells also triggered a strong immune response
that is supposed to be the result of a conserved surveillance mechanism in response to inhibition of
the translation elongation machinery [236,243]. Thus, a set of elongation factors can be considered,
that are resistant to modification by these effectors or are at least not targeted. Therefore, future
research is needed to get more information about the underlying mechanisms and potential therapeutic
targets [227].
204
Int. J. Mol. Sci. 2020, 21, 3730
2.6. Modification of Protein Degradation/Activity as Last Possibility to Evade Host Immune Defense?
2.6.1. Mechanisms to Interfere with Protein Degradation
To maintain cellular homeostasis, the quality of synthesized proteins must be controlled for
a proper folding and products with quality issues must be degraded in a controlled manner. This quality
control is taking place in the cytosol or the ER lumen, where chaperones and heat shock proteins
catalyze and stabilize the protein folding [244]. In the case of physiological stress caused by DNA
damage, chemical stimuli or pathogens, the ratio of misfolded or unfolded proteins in the ER lumen
increases, causing additional stress. Then, the unfolded protein response (UPR), an evolutionary
conserved signaling network, is activated resulting in downregulation of overall protein synthesis,
except for chaperones and induction of ER associated protein degradation (ERAD [245]. The main
kinases controlling the UPR, the inositol-requiring protein 1 (IRE1), PKR like ER kinase (PERK)
and activating TF 6 (ATF6) are located inside the ER membranes. Their luminal domains bind the
ER chaperone immunoglobulin binding protein (BiP) in unstressed conditions but in case of stress,
BiP is released causing activation of the receptor proteins (IRE, PERKI and ATF6) [246]. Following
BiP dissociation, oligomerization and autophosphorylation, the cytosolic RNase domain of IRE1 is
activated targeting X-box-binding protein 1 mRNA (XBP1u) and transfers it into its spliced form
(XPB1s). This enables transcription of the TF responsible for upregulation of UPR target genes fostering
ERAD and enhances overall ER protein folding capacity [240–242]. The ER transmembrane kinase
PERK1 also oligomerizes and autophosphorylates after activation, catalyzing the phosphorylation of
the α-subunit of the eukaryotic initiation factor 2 (eIF2). This is followed by downregulation of global
mRNA translation to reduce ER stress but favoring translation of some mRNAs as ATF4. ATF4 in turn
induces several UPR target genes including C/EBP homologous protein (CHOP) [247,248]. In contrast
to IRE1 and PERK, ATF6 translocates to the Golgi followed by its activation after proteolytical cleavage
and activation of the b-ZIP TF to induce UPR target genes.
Since permanent ER-stress, which cannot be solved by UPR and ERAD, will finally induce
apoptosis, intracellular bacteria have evolved strategies to interfere with those pathways [249–251].
Surprisingly, induction of UPR pathways can also promote bacterial replication, as bacterial effectors
have been detected that induce UPR [19]. As result, it is difficult to refer an upregulation of UPR to
bacteria using the increased ER folding capacity for their benefit or to the defense system of the host.
In the case of L. monocytogenes infection, the effector LLO activates all three UPR pathways leading to
induction of ER stress and reduction of bacterial survival. In contrast, the pharmacological block of
UPR during infection reduced the intracellular replication of Brucella melitensis and Brucella abortus
significantly [252].
B. melitensis and B. abortus both induce the IRE1 branch, a process often mediated by TLRs.
The TLR adapter protein myeloid differentiation primary response gene 88 (MyD88) than mediates
XBP1u splicing. Interestingly, the bacterial effector protein TcpB, secreted by B. melitensis, is able to
induce the UPR target genes BiP, CHOP and ER DnaJ-like 4 (ERdj4) in a MyD88 independent manner;
instead, the TcpB protein itself is required for UPR induction [253].
The induction of IRE1 by B. abortus is mediated by the secreted effector VceC after binding of BiP
inside the ER lumen. This is followed by IRE1 dependent activation of Nod1/Nod2 innate immune
signaling resulting in proinflammatory cytokine expression [254,255]. The ectopic expression of VceC
leads to the structural reorganization of the ER and IL-6 production is stalled after infection with
B. abortus vceC mutants unable to induce UPR. In mice infected with B. abortus vceC mutants necrosis
was reduced and survival of the pups was increased [255]. Following infection with B. abortus WT,
similar effects were observed after treatment with the general UPR inhibitor tauroursodeoxycholic
acid, leading to the assumption that pharmacological UPR inhibition could be a promising treatment
of B. abortus infections.
Several other bacteria are known to inhibit the UPR pathway, as it represents a major host defense
mechanism involved in bacterial sensing mediated by TLR signaling. Some examples are summed up
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in Table 5 but unfortunately, the underlying mechanisms are rarely understood. In some cases, as for
L. pneumophila, it is known that the observed downregulation of UPR is effector dependent, as mutants
lacking functional T4SS were unable to induce those changes but the effectors and its targets have not
been identified yet [256,257].
Table 5. Inhibition of unfolded protein response (UPR) by bacteria.
Effector Bacterium Target Cellular Function Manipulation Reference
glucosyltransferase
effector proteins L. pneumophila unknown IRE1 branch of UPR
Inhibiting splicing of XBP1u
mRNA [256,257]
unknown L. pneumophila unknown UPR inhibit the translation of BiPand CHOP [256–258]
unknown Simkania negevensis unknown UPR BiP induction (early), later oninhibition [259]
unknown Simkania negevensis unknown UPR
blocks the translocation of
preexisting CHOP protein to
the nucleus
[259]
unknown Simkania negevensis unknown PERK branch of UPR Reduced phosphorylated eIF2levels [259]
unknown L. monocytogenes unknown PERK branch of UPR Reduced phosphorylated eIF2levels [260]
unknown C. trachomatis unknown PERK branch of UPR Reduced phosphorylated eIF2levels [260]
Taken together, bacteria follow different strategies of interference with protein folding to ensure
their intracellular survival. Manipulation of UPR is one strategy to achieve the best outcome for
bacteria by either activation or inhibition of UPR. Activation may be induced to take advantage from
increased protein folding capacity and lipid biosynthesis by host cells, whereas UPR blockage should
hamper host defense, such as apoptosis or innate immunity [261]. In this context, further investigations
are needed to understand the underlying mechanisms, how bacterial pathogens manipulate the UPR
and which strategy is favored by the individual pathogens in a spatially and temporally manner.
2.6.2. Control of Protein Activity enables Bacteria to Direct Host Immune Reaction
As already mentioned above, the final level to regulate gene expression, for example, to avoid
prolonged inflammatory response, is to control the activity of proteins followed by their degradation.
The mechanisms to influence protein activity or to mark a protein for degradation are mediated via
attachment of functional groups. To ensure a precise signal transduction, proteins are activated in most
cases by addition of phosphate groups, which must be removed when the inducing stimulus is ending.
The dephosphorylation of MAPKs and the resulting interruption of host signaling cascades, leading to
reduced inflammation and an increase of bacterial replication inside the host, is a common bacterial
strategy, for example, used by S. Typhimurium by secretion of the effector SpvC, a phosphothreonine
lyase [262].
In addition, protein activity, subcellular localization and stability is not only regulated
by ubiquitination or phosphorylation but also by reversible acetylation which is proposed for
approximately 1700 proteins [263]. These include TFs, structural proteins and signal transduction
regulators, indicating that reversible acetylation is critical for cell homeostasis [264]. As there are many
examples for this kind of activation of proteins (e.g., histones) mentioned in the chapters above, the
focus will here lie on the description of the signaling mechanism by ubiquitination. An ATP-dependent
enzymatic cascade establishes covalent ubiquitin attachment to proteins, mediated by enzymes that
activate ubiquitin (E1), conjugate ubiquitin (E2) and ligate ubiquitin (E3). Ubiquitin can be ubiquitinated
at seven distinct lysine residues and is able to form linear or branched chains; the degree and the
linkage determine, whether the substrate is degraded or associated with cell signaling [265]. The
established ubiquitin modifications can be removed and modified by deubiquitinases (DUBs) to change
the linkage pattern and, as consequence, the destination of the substrate.
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Intracellular bacteria are able to mimic enzymes involved in ubiquitination processes, especially
DUBs and E3 ubiquitin ligases, to modulate the ubiquitin pathway [266,267]. The SidE effector
family (SidE, SdeA, SdeB and SdeC), secreted by intracellular bacteria as L. pneumophila, possesses
domains conferring multiple enzymatic functions used for ubiquitination into a single effector
without the requirement of ATP. Thereby, the mono-ADP-ribosyltransferase domain of SidE family
members modifies host ubiquitin posttranslationally by attachment of phosphoribose on arginine
42 to generate ADP-ribosylated ubiquitin (ADPR-Ub) [268–271]. This intermediate is than cleaved
by nucleotidase/phosphohydrolase/phosphodiesterase domains into AMP and phosphoribosylated
ubiquitin (PR-Ub), which in the next step is attached to host proteins via a noncanonical serine-linked
phosphodiester bond. The DUB domain (also found in SidE family members) than removes host
ubiquitin modifications but not the SidE-mediated ubiquitination and reduces the level of ubiquitination
on the surface of the L. pneumophila-containing vacuole (LCV) [271]. In addition, overexpression of
SidE effector family members in mammalian or yeast cells generates a pool of PR-Ub that interfere with
E1 and E2 enzymes hampering conventional host ubiquitination pathways. This results in interruption
of mitophagy, immunity, as shown for TNF-induced NF-κB nuclear translocation, proteasomal
degradation (for example of hypoxia inducing factor 1α) and other ubiquitin-regulated processes in
the host [268,269]. Furthermore, ER structure and host membrane trafficking are modulated by SidE
effector family members to enable LCV biogenesis. To ensure precise temporal control over the signal
transduction mediated by ubiquitination, L. pneumophila secretes another DUB effector, SidJ, that is
able to remove ubiquitin modifications established by the SidE effector family and the mammalian
ubiquitination machinery [268,269,272].
S. flexneri also owns an effector with E3 ubiquitin ligase activity, IpaH9.8, that disrupts the NF-κB
dependent pathway in the cytosol and impairs the activity of U2AF35, an mRNA splicing factor,
leading to host inflammatory responses being suppressed [273–275]. The effector owns an N-terminal
domain containing Leucine-Rich Repeats (LRR), also known as the LPX-domain, that is responsible for
substrate recognition and a C-terminal E3 ubiquitin ligase domain, referred to as NEL domain (novel
E3 ligase). Notably, the original structure of this domain differs from known eukaryotic E3 ligases,
therefore, IpaH9.8 and its orthologues in other bacteria, for example, SspH 1 of Salmonella enterica,
are part of a novel family of bacterial E3 ubiquitin ligases [276–281]. SspH 1 targets the host kinase
PKN1 for proteasomal degradation, thereby functioning as ubiquitin ligase. In this context, it inhibits
NF-κB dependent pro-inflammatory genes and regulates activation and function of neutrophils and
macrophages as part of the androgen receptor pathway [278].
Enterohaemorrhagic E. coli express the T3SS effector protein NleG5-1, which contains a ubiquitin
ligase U-box domain for ubiquitination and degradation of nuclear proteins. One target is a member of
the mediator complex, MED15 that is a master regulator of RNA Pol II- dependent transcription [282].
The Ank-family expressed by Orienta tsutsugamushi (causative reagent of scrub typhus) is another
protein family involved in ubiquitination and degradation, characterized by N-terminal Ank repeats
and a C-terminal F-box-like domain termed as PRANC (pox protein repeats of ankyrin C terminus)
motif. This family includes the proteins 1U5, 1A, 1B, 1E, 1F, 1U4 and 1U9 that interact with two
members of multiprotein E3 ubiquitin ligase complexes, CULLIN-1 and SKP1 [283,284]. These proteins
are supposed to act as mediators, as the ANK domain shall specifically bind target substrates, while the
F-box recruits SKP1 promoting complex formation and finally inducing substrate degradation. This is
also suggested for the degradation of the TF EF1α, probably induced via function of Ank 1U5 [283].
Especially the ubiquitin–proteasome system is a favored target of bacterial pathogens to manipulate
the host cell cycle (summarized in Table 6). Two prominent targets are Skp1–Cullin1–F-Box protein
(SCF, active throughout the cell cycle) and Anaphase-Promoting Complex/Cyclosome (APC/C, only
regulatory active during Mitosis and late G1 phase), two classes of E3 ubiquitin ligase complexes
inducing the degradation of cell cycle key regulators, thereby promoting its progression. A RING
finger protein within both complexes enables binding to a scaffold cullin-like protein, the ubiquitin
conjugating enzyme (E2) and distinct substrate-binding subunits. SCF are rated among the large family
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of Cullin-Ring E3 ubiquitin ligases (CRLs) as they are regulated via conjugation/deconjugation of the
ubiquitin-like protein NEDD8 at the cullin subunit of SCF [285–289].
Table 6. Bacteria manipulating the host cell cycle.



















cell cycle at G1 and
G2 phases
Inhibition of host cell
proliferation [292]
IPAB S. flexneri Mad2L2/MAD2B inhibitorof the APC/Ccdh1 cell cycle arrest [293]
Diverse animal pathogens, such as E. coli, Yersinia pseudotuberculosis, Burkolderia pseudomallei and
Photorhabdus spp., express so-called Cycle inhibiting factors (Cif) that target SCFs and CRLs resulting
in cell cycle arrest [292]. This effector expressed by E. coli, CifEc, induces cell cycle arrest at G1/S and
G2/M transitions by accumulation of cyclin dependent kinase inhibitors p27/Kip1 and p21Waf1/Cip1 and
inhibition of key kinases. The appearing cytopathic effect is accompanied by cell enlargement and
production of actin stress fibers.
Delay of mitotic progression was observed when IpaB, an effector of S. flexneri, induced
unscheduled APC/Ccdh1 activation and degradation of its substrates [293]. IpaB has to localize
to the nucleus during G2/M phase and has to bind Mad2L2/MAD2B, the mitotic spindle assembly
checkpoint protein that inhibits APC/Ccdh1. The benefit of these mechanisms for the bacteria is not
completely clarified yet but it is suggested that delay of cell renewal and cell turnover enables the
bacteria to persist and further colonize the host tissues.
3. Conclusions
During the long coevolution of pathogenic bacteria and their host cells, several strategies developed
on both sides to fight their counterpart and keep predominance. Thus, intracellular bacteria reach for
the establishment of an intracellular niche that allows survival, replication and persistence. This state
is achieved through disarming of the host immune defense while keeping it healthy enough to gain
permanent nutrition excess. Bacterial effectors are crucial tools during the whole process, thereby
targeting the host immune response at each level of gene expression. Even, if there are already
many bacterial effectors reported mimicking host enzymes or featuring novel enzymatic functions,
the complex interaction mechanisms and networks are still not completely understood. Moreover,
it appears, that pathogenic bacteria can target different pathways simultaneously or one pathway with
several effectors, thereby creating a species-specific modification pattern. Therefore, understanding the
individual strategies gain new insights into the complex host-pathogen interactions during infections.
Further investigation might unravel, which bacterial strategies are more efficient or where host
cells already found strategies to circumvent attempts of bacterial manipulation. This highlights the
importance of further research on bacterial subversion of the host immune response considering each
level of gene expression, as new promising targets for successful bacterial clearance during medical
therapy might emerge.
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ATF6 activating transcription factor 6
ATP Adenosine triphosphate
BCG M. bovis bacillus Calmette-Guérin
BiP Immunoglobulin binding protein
CHOP C/EBP homologous protein
Cif Cycle inhibiting factors





eELF Eukaryotic elongation factor
EHEC Enterohaemorrhagic E. coli
eIF Eukaryotic initiation factor
ERAD ER associated protein degradation
ERK Extracellular signal-regulated kinases
ETR effector-triggered response
GECs gingival epithelial cells
HAT Histone acetyl transferase
HDAC Histone deacetylases
HKMT Histone N-lysine methyltransferase
HvgA Hypervirulent GBS adhesin
iagA invasion associated gene A
Inl Internalin
IL Interleukin
IRAK1 IL-1R-associated kinase 1
IRE1 Inositol-requiring protein 1
ISG Interferon-stimulated genes
JNK c-JUN N-terminal kinases
lincRNAs Long intergenic non-coding RNAs
LCV L. pneumophila-containing vacuole
LLO Listeriolysin O
lncRNA Long non-coding RNA
LOS Lipooligosaccharide
LOX 1 Lipoprotein receptor 1
LPS Lipopolysaccharide
LRR Leucine-Rich Repeats
MAPK Mitogen activated protein kinase
MBD1 Methylated DNA-binding protein 1
mRNA Messenger RNA
miRNA MicroRNA
mTOR Mammalian/mechanistic target of rapamycin
mTORC1 mTOR complex 1
NADPH Nicotinamide adenine dinucleotide phosphate
ncRNA Non-coding RNA
NF-κB Nuclear factor κB
NO Nitric oxide
NLR NOD like receptor
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NOD Nucleotide-binding oligomerization domain
NUE Nuclear effector
PAMPs Pathogen-associated molecular patterns
PERK PKR like ER kinase
PTM Posttranslational modifications
PPRs Pattern recognition receptors
PRANC Pox protein repeats of ankyrin C terminus
PR-Ub Phosphoribosylated ubiquitin
Rb retinoblastoma protein
Rheb Ras homolog enriched in brain
RNA Ribonucleidacid
ROS Reactive oxygen species
RPS3 Ribosomal protein S3
RNA Pol II RNA Polymerase II
rRNA Ribosomal RNA
RYBP Ring1 YY1-binding protein
SAM S-adenosyl-l-methionine
SCAFs Short chain fatty acids
SCF Skp1–Cullin1–F-Box protein
SET Suppressor of variegation, Enhancer of zeste and Trithorax
SHIP1 SH-2 containing inositol 5′ polyphosphatase
SIRT 2 Sirtuin 2
SNPs Single-nucleotide polymorphisms
snRNP Small nuclear ribonucleoprotein
SR proteins serine-arginine containing proteins
SOCS1 Suppressor of cytokine signaling 1
SSR Serine-rich repeat
T3SS Type three secretion system
TBP TATA box–binding proteins
TF Transcription factor
TLR Toll like receptors
TNF Tumor necrosis factor




UPR unfolded protein response
XBP1 X-box-binding protein 1
4E-BPs 4E-binding proteins
Pathogens:
A. phagocytophilum Anaplasma phagocytophilum
B. abortus Brucella abortus
B. anthracis Bacillus anthracis
B. melitensis Brucella melitensis
B. thailandensis Burkholderia thailandensis
C. perfringens Clostridium perfringens
C. trachomatis Chlamydia trachomatis
E. coli Escherichia coli
H. pylori Helicobacter pylori
L. monocytogenes Listeria monocytogenes
L. pneumophila Legionella pneumophila
M. leprae Mycobacterium leprae
M. tuberculosis Mycobacterium tuberculosis
P. aeruginosa Pseudomonas aeruginosa
P. gingivialis Porphyromonas gingivalis
S. pneumoniae Streptococcus pneumoniae
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S. flexneri Shigella flexneri
Salmonella Typhimurium Salmonella enterica subsp. enterica serotype Typhimurium
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Abstract: The article reviews the discovery, properties and functional activities of new bacterial
enzymes, proteases grimelysin (ECP 32) of Serratia grimesii and protealysin of Serratia proteamaculans,
characterized by both a highly specific “actinase” activity and their ability to stimulate bacterial
invasion. Grimelysin cleaves the only polypeptide bond Gly42-Val43 in actin. This bond is not cleaved
by any other proteases and leads to a reversible loss of actin polymerization. Similar properties
were characteristic for another bacterial protease, protealysin. These properties made grimelysin
and protealysin a unique tool to study the functional properties of actin. Furthermore, bacteria
Serratia grimesii and Serratia proteamaculans, producing grimelysin and protealysin, invade eukaryotic
cells, and the recombinant Escherichia coli expressing the grimelysin or protealysins gene become
invasive. Participation of the cellular c-Src and RhoA/ROCK signaling pathways in the invasion of
eukaryotic cells by S. grimesii was shown, and involvement of E-cadherin in the invasion has been
suggested. Moreover, membrane vesicles produced by S. grimesii were found to contain grimelysin,
penetrate into eukaryotic cells and increase the invasion of bacteria into eukaryotic cells. These data
indicate that the protease is a virulence factor, and actin can be a target for the protease upon its
translocation into the host cell.
Keywords: actin proteolysis; metalloproteinases; protease ECP 32; grimelysin; protealysin;
bacterial invasion
1. Introduction
Invasion of opportunistic bacterial pathogenic into eukaryotic cells is a process of interaction of
bacteria with eukaryotic cells. [1,2]. To invade host cells, invasive bacteria should initiate the host cell
signaling system by the proteins that interact with cell receptors and modify cytoskeleton through
direct interaction with actin and actin binding proteins. Bacterial effectors can mimic natural activators
of small GTPases or directly stimulate the host signaling pathways [3,4]. On the other hand, efficiency
of bacterial invasion depends on the physiological state of host cells and is determined by the processes
associated with changes in the distribution of cell surface receptors and cytoskeleton rearrangements [5].
This implies the presence of specific bacterial virulence factors capable of interacting with or modifying
eukaryotic cell receptors, as well as components of the signal transduction system and actin cytoskeleton.
Studying the mechanisms of actin polymerization, we discovered and characterized a new
enzyme-bacterial protease that exhibited highly specific “actinase” activity [6]. The protease turned out
to be an intracellular enzyme of bacteria originally identified by standard morphological, biochemical,
and cultural properties as an atypical lactose-negative strain of Escherichia coli A2 [7]. The actin-specific
protease isolated from these bacteria was identified as a single 32 kDa polypeptide, which gave
the protease the name ECP 32 (Escherichia coli protease, 32 kDa) [7,8]. Protease ECP 32 cleaves actin
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at a single site between Gly-42 and Val-43 within the DNase I-binding loop on the top of the actin
monomer [9,10] that is involved in extensive interactions with the neighboring subunits within the actin
filament [11,12]. The high specificity of actin proteolysis made ECP 32 a unique tool to study actin
properties and interactions [13–17]. On the other hand, the enzyme by itself turned out to be not unique.
Although ECP 32 has been described as an E. coli A2 enzyme the N-terminal amino acid sequence of
ECP 32 AKTSSAGVVIRDIF could not be identified in published Escherichia coli genomic sequences [8,18].
Therefore, the systematic position of the ECP 32-producing bacterial strain was reinvestigated. Using
about 50 biochemical reactions of the Vitek-2 system (bioMeґrieux, Marcy l’Etoile, France) and partial
sequencing of the 16S rRNA gene, the former Escherichia coli A2 strain was identified as Serratia grimesii
A2 [18]. Then, the presumptive gene coding for the reference S. grimesii 30063 or Serratia grimesii A2 was
cloned using published sequences of a similar protease protealysin identified in S. proteamaculans [19].
Amino acid sequences of two corresponding proteins from the S. grimesii A2 (former E. coli A2)
and the reference strain of S. grimesii 30,063 were identical and contained the N-terminal 14 amino
acids of protease ECP 32 as previously determined [8,18]. The same specific actin-hydrolyzing activity,
characteristic of protease ECP 32 [9,10], was also revealed in bacterial extracts of the reference S. grimesii
strain and Escherichia coli transformed by the presumptive gene encoding grimelysin (ECP32) in
S. grimesii A2 [18]. Taken together, these data suggested that ECP 32 and grimelysin is the same enzyme
named grimelysin [18], slightly different from protealysin [19]. While S.grimesii and S. proteamaculans
belong to a cluster of bacteria within the Serratia liquefaciens group, a similar protease could be expected
to be synthesized by other members of this group. Our preliminary data indicate that protease with
the actinase activity is present in Serratia marcescens.
Along with the high similarity of the bacteria S. grimesii and S. proteamaculans, their proteases,
grimelysin and protealysin, are highly homologous and differ by only 8 amino acid residues [18,19].
Moreover, similarly to the grimelysin-producing bacteria [20,21], S. proteamaculans 94 turned out to be
one more bacterial strain where the actinase activity of metalloproteinase protealysin is coupled with
bacterial invasion [21,22]. These results are consistent with the idea of the actin-specific metalloproteases
being a factor that can be involved in bacterial invasion of eukaryotic cells. This paper describes
the properties of grimelysin and protealysin in vitro and in vivo in the context of this idea. Our data
indicate that the protease is a virulence factor and actin can be a target for the protease upon its
translocation into the host cell.
2. Basic Properties and Substrate Specificity of Grimelysin and Protealysin
Grimelysin (ECP 32), discovered, purified and initially characterized as protease ECP 32 [6–8],
was later shown to be identical to grimelysin [18]. Therefore, the properties of the enzyme identified
for ECP 32 could be applied to grimelysin. However, here we retain the name grimelysin (ECP 32)
and ECP-cleaved actin to comply with the published data where the protease was named ECP 32.
Grimelysin (ECP 32), purified from a bacterial extract using sequential chromatography steps, is a single
32 kDa polypeptide, whose N-terminal sequence was determined to be AKTSSAGVVIRDIFL [8].
The optimum of the protease activity was observed in the range of pH 7–8 when actin and melittin
were used as substrates [8,23]. The proteolytic activity increased with increasing ionic strength:
in 50–100 mM NaCl the activity of grimelysin (ECP 32) towards melittin was shown to be nearly
twice higher than in a low ionic strength solution [23,24]. It was also enhanced in the presence of
millimolar ATP concentrations, though hydrolysis of melittin was not accompanied by ATP hydrolysis
at a rate comparable with the cleavage rate. This implies that protease grimelysin (ECP 32) is not
an ATP-dependent enzyme [23], which is important for the experiments involving actin because
actin contains ATP as a tightly-bound nucleotide. The protease activity is inhibited by EDTA, EGTA,
o-phenanthroline and zincone, and the EDTA-inactivated enzyme can be reactivated by cobalt, nickel
and zinc ions [2,3]. Based on these data, grimelysin (ECP 32) was classified as a neutral metalloproteinase
(EC 3.4.24) [8].
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Limited proteolysis of skeletal muscle actin between Gly-42 and Val-43 [10] was observed
at enzyme: substrate mass ratios of 1:25 to 1:3000 [8]. Two more sites, between Ala-29 and Val-30
and between Ser-33 and Ile-34, were cleaved by ECP 32 in heat- or EDTA-inactivated actin, apparently
due to conformational changes around residues 28–34 buried in intact actin [8]. Besides actin, only
melittin [18,19], histone H5, bacterial DNA-binding protein HU and chaperone DnaK [25] were
found to be protease substrates. In agreement with this high substrate specificity, ECP 32 did not
hydrolyze tropomyosin, troponin, α-actinin, casein, histone H2B, ovalbumin, bovine serum IgG,
bovine serum albumin, bovine pancreatic ribonuclease A, trypsin, human heat shock protein HSP70,
chicken egg lysozyme [7], insulin [24], DNAse I [9,13], gelsolin [14] and profilin [26]. The amino acid
residues recognized by grimelysin (ECP 32) in actin and melittin are hydrophobic. This specificity is
characteristic for thermolysin-like metalloproteinases [27]. However, high specificity of the enzyme
seems to be determined predominantly by conformation at the actin cleavage site rather than its
primary structure.
Grimelysin was obtained as a recombinant protein. This has been achieved by cloning the putative
gene encoding grimelysin in S. grimesii A2 and in the reference S. grimesii 30063 [18] using published
protealysin sequences identified in S. proteamaculans [19]. Grimelysin shared all properties characteristic
for ECP 32 including a molecular weight of 32 kDa, an N-terminal 14 amino acid sequence, optimum
activity in the range of pH 7–8 and inhibition with o-phenanthroline and EGTA [18].
Protealysin is a neutral zink-containing metalloprotease of Serratia proteamaculans. The protealysin
gene was cloned from a genomic library of S. proteamaculans strain 94 isolated from spoiled meat.
This protein was expressed in Escherichia coli and purified as described earlier [19]. Similarly to other
thermolysin-like proteases [27,28], protealysin is synthesized as a precursor containing a propeptide of
about 50 amino acids that is removed during formation of mature active protein [29]. The propeptide
is much shorter than the propeptides of the thermolysin-like proteases and has no significant structural
similarity to the propeptides of most thermolysin-like proteases [30–32]. A similar propeptide of 50
amino acids was also detected in the primary structure of the recombinant grimelysin. According to
SDS-electrophoresis, recombinant proteins with or without propeptide had an apparent molecular
weight of 37 and 32 kDa, respectively [19].
The molecular weight of the active recombinant protealysin 32 kDa and the N-terminal amino
acid sequence AKTSTGGEVI are identical to those of grimelysin [8,19]. The optimal pH for azocasein
hydrolysis is 7, and protealysin is completely inhibited by o-phenanthroline [19], i.e., has the same
properties as grimelysin [8,18]. Protealysin and grimelysin (ECP 32) are also similar in their unique
property of being able to digest actin specifically [8–10,22,33].
3. Specific Actinase Activity of Grimelysin (ECP 32) and Protealysin
The ECP 32-like limited proteolytic activity towards actin appears in bacterial lysates of S. grimesii
and S. proteamaculans only at the late stationary phase of bacterial growth [7,18,22]. The bacterial
lysates as well as the purified grimelysin (ECP 32) or recombinant grimelysin and protealysin cleave
actin at a single site giving rise to two fragments of 36 and 8 kDa (Figure 1A) [10,13,22]. The fragments
remain associated in the presence of the tightly bound calcium or magnesium cation needed to
maintain the native actin conformation and dissociate after removal of the tightly bound cation with
EDTA [13]. The N-terminal sequence of the 36 kDa actin fragment produced by ECP 32 was determined
as Val-Met-Val-Gly-Met [10]. The same sequence was determined for the 36 kDa N-terminal actin
fragment produced by the lysates of recombinant bacteria expressing the grimelysin or protealysin
gene [18,22]. According to the amino acid sequence of actin [34], this peptide corresponds to the cleavage
site between Gly-42 and Val-43 [10], which is not attacked by any known proteases. However, in
the case of protealysin, this cleavage pattern was observed only at the protealysin/actin mass ratio
of 1:50 or lower. At a higher protealysin to actin ratio, the 36 kDa fragment was further cleaved
yielding two closely situated bands with an apparent molecular weight of 33 kDa [22]. The N-terminal
sequences of these fragments are Leu-Lys-Tyr-Pro-Ile-Glu and Ile-Leu-Thr-Leu-Lys-Tyr, corresponding
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to the cleavage of the bonds Thr66–Leu67 and Gly63–Ile64, respectively [22]. The difference in activity
of the purified bacterial grimelysin and recombinant protealysin may be due to their origin, both in
terms of different bacteria and different purification protocols. Therefore, comparison of the actinase
activities of recombinant grimelysin and protealysin would be of interest.
Figure 1. The actinase activity of grimelysin (ECP 32). (A) Three-dimensional structure of skeletal
muscle actin cleaved with grimelysin (ECP 32) at a single site, Gly42-Val43, within the DNase I-binding
loop [35]. Inset shows SDS electrophoresis of actin (lane 1), with the actin 36 and 8 kDa fragments
produced by the grimelysin (ECP32) cleavage; the upper band is actin not completely cleaved in this
experiment (lane 2) and isolated grimelysin (ECP 32) (lane 3) [8,10]. (B) Polymerization of ECP-cleaved
skeletal muscle actin compared to that of intact actin. (C) Invasion of human larynx carcinoma Hep-2
cells by Serratia grimesii 30063. Intracellular bacteria are marked with arrows. Scale bar, 1 μm. Arrows
indicate intracellular bacteria Reproduced from [13,21,35] with permissions from Elsevier Licences
4820990651384 and 1032953-1, 2020 (A,B) and from Wiley Licence 4821290007049, 2020 (C).
4. Specific Properties of Protease-Cleaved Actin
Although actin cleaved with grimelysin (ECP 32) between Gly42 and Val43 preserves its native
conformation [10,13], the cleaved actin completely loses its ability to polymerize in the presence
of Ca2+ [5,8] (Figure 1B). The ability of the cleaved actin to polymerize is partially restored upon
substitution of the tightly bound Ca2+ with Mg2+ [13]. However, the degree of this polymerization
is lower than that of intact actin, while the critical concentration of polymerization of ECP-Mg-actin
and the exchange of subunits in the ECP-Mg-actin polymer increase 30 and 20–30 times, respectively
(Figure 1B) [13]. This effect is due to a more open conformation of the cleaved actin monomers,
which decreases the monomer nucleation step of cleaved actin polymerization or/and increases
the actin filament dynamics, i.e., the dissociation/association kinetics of actin monomers at the filament
ends [15]. The open conformation of the ECP-cleaved actin monomers is also preserved in
the ECP-actin polymer [15]. Similar properties are inherent to actin cleaved with protealysin [36].
Thus, cleavage in globular actin of the only amino acid bond between Gly-42 and Val-43 causes local
conformational changes that weaken the intermonomer contacts during actin polymerization and lead
to enhanced polymer dynamics. As it turned out later, these properties correlated with the ability of
the protease-producing bacteria to invade eukaryotic cells [20–22] (Figure 1C)
Similar instability arises if the protease cleaves the bond between Gly-42 and Val-43 in the subunits
of the actin polymer. Incubation of filamentous actin (F-actin) with purified S. proteamaculans protealysin
or with the lysates of the recombinant Escherichia coli producing protealysin showed that 20–40%
of F-actin was digested at enzyme/actin mass ratios rising from 1:50 up to 1:5, respectively [33].
This process was accompanied by the increased steady-state ATPase activity (dynamics) of F-actin [33],
which was also shown to be characteristic of the polymers forming from grimelysin (ECP 32)-cleaved
actin [13]. The cleavage-produced increase in the dynamics of the modified filaments can be reversed
with phalloidin [13], aluminium and sodium fluorides [22,36], as well as with actin-binding proteins
gelsolin [14], myosin subfragment 1 [37] and tropomyosin [17], indicating that actin-binding proteins
can restore integrity of actin filaments damaged by proteolysis.
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This assumption was verified in vivo using microinjection of the purified protease grimelysin
(ECP 32) preparation into Amoeba proteus cells, which revealed dynamics of the cytoskeleton structures
by alterations in amoeba locomotion [38]. After injection of the protease solution, pseudopodia
formation was ceased, and the cytoplasm motility slowed down and finally stopped [38]. Injected
amoebae remained spread and immobile until the locomotion was slowly restored to the control level.
No changes in the locomotion were observed when protease grimelysin (ECP 32) was injected in
the presence of ECP 32-specific antibodies [38]. These results indicate that the protease-produced
modifications of actin cytoskeleton can be reversible and might be used by bacteria to regulate their
intracellular activity within eukaryotic and probably bacterial cells. Specifically, actin-like, bacterial
proteins that form the bacterial cytoskeleton could be protease substrates.
5. Actin-Like Proteins of Bacteria
Many functions of bacterial cells are performed by filamentous structures similar to those
of the cytoskeleton filaments of eukaryotic cells [39,40]. These structures are formed by globular
proteins, which are regarded as actin homologues, actin-like proteins or bacterial actins [39] because
three-dimensional structures of their monomers are similar to that of skeletal actin [39,40]. Also similarly
to the eukaryotic globular actin, globular bacterial actin-like proteins assemble into two-stranded
filaments consisting of two protofilaments coming together in various ways [39,40], although this sets
them apart from the eukaryotic actin filaments assembled only in the form of two parallel strands.
The most studied bacterial cytoskeleton proteins, MreB, ParM, MamK and Ftz, perform such functions
as shape determination in rod-shaped bacteria, cell division, plasmid segregation and organelle
positioning [39,40]. It would be tempting, therefore, to suggest that the actin-specific proteases,
grimelysin and protealysin, could regulate these activities. However, all these bacterial proteins,
including MreB, most closely related to actin [40–42] differ from eukaryotic actin due to the absence of
the DNase I-binding loop inserted in eukaryotic actin subdomain 2 [41,42], where eukaryotic actin is
cleaved by grimelysin or protealysin. Thus, in contrast to eukaryotic actin, bacterial actin-like proteins
do not contain any specific cleavage site to be attacked by grimelysin or protealysin. This suggests that
the specific actinase activity of grimelysin and protealysin against eukaryotic actin could be important
if the protease is delivered by bacteria into eukaryotic cells.
6. Invasive Activity of Bacteria Serratia grimesii and Serratia proteamaculans
Capability of the actinase-producing bacteria to invade eukaryotic cells was first found upon
incubation of human larynx carcinoma Hep-2 cells with bacteria Serratia grimesii A2 (E. coli A2) [20,43].
After 2 h of infection, bacteria were detected within the cells, mostly in vacuoles but also free in
cytoplasm (Figure 1C). The invasion was accompanied by a change in the shape of the eukaryotic
cells, disappearance of the actin stress fibers inside the cells and appearance of protrusions on the cell
surface [43]. No changes were observed in the cells infected with the wild-type Escherichia coli CCM
5172 that do not produce actinases [43]. Correlation between synthesis of the specific actin hydrolyzing
protease and the ability of bacteria to invade eukaryotic cells was also detected in Shigella flexneri mutant
obtained by exposure of bacteria to furazolidone [44,45]. This treatment resulted in the formation of
Shigella flexneri L forms whose revertants were not pathogenic but able to invade eukaryotic cells, while
their extracts are capable of cleaving actin as the bacterial extracts containing grimelysin or protealysin
(Figure 2) [44,45].
It was also shown that the transformed cells are more sensitive to invasion by actinase-producing
bacteria than non-transformed or poorly transformed cells [20,46]. Specifically, the grimelysin
(ECP 32)-producing bacteria invaded the transformed epithelial and fibroblasts cells A431, HeLa
and 3T3-SV40, but they were not found in embryonic fibroblasts, primary human keratinocytes and in
cells of poorly transformed 3T3 cell lines [20]. Later, a quantitative analysis of invasion confirmed rather
a low susceptibility of 3T3 cells to Serratia grimesii invasion, compared to that of 3T3-SV40 cells [46].
The higher susceptibility of the immortal CaCo-2 and HeLa cells compared to their untransformed
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counterparts was also shown for invasion of Listeria monocytogenes [47]. Moreover, transfection of
resistant Listeria monocytogenes cells by SV40 large T antigen was shown to induce highly transformed
continuous cell lines with a susceptibility to bacteria phenotypes [48]. This difference may be produced
by the different set of cell surface receptors contacting with bacteria in the “normal” and transformed
cells, as is shown, for example, for the G-protein-coupled receptors [49].
Figure 2. Apathogenic Shigella flexneri 5a2c mutant treated with furazolidone can invade eukaryotic cells.
(A) Detection of the actinase activity in the lysates of Shigella flexneri 5a2c acquired upon the furazolidone
treatment. Numbers indicate the time points of bacteria growth when their extracts were tested for
the actinase activity. A, actin; 36, the 36 kDa actin fragment. (B) Incubation of human larynx carcinoma
Hep-2 cells with the furazolidone-treated non-pathogenic Shigella flexneri 2a 4115. (C) Invasion of
the pathogenic furazolidon-treated Shigella flexneri 5a2c into human larynx carcinoma Hep-2 cells [39].
Arrows indicate extracellular bacterium (B) and intracellular bacteria lying in vacuoles (C). Scale bar,
0.5 μm. Reproduced from [45] with permission from Springer Nature License 4823180887079, 2020.
To find out if grimelysin and protealysin are actively involved in the entry of Serratia grimesii
and Serratia proteamaculans into host cells, human larynx carcinoma Hep-2 cells were infected with
recombinant Escherichia coli expressing grimelysin or protealysin gene [21]. The results of this work
showed that the extracts of the recombinant bacteria cleave actin at the only site corresponding to
the cleavage with grimelysin or protealysin [21]. Recombinant Escherichia coli carrying the grimelysin
or protealysin gene were found in the eukaryotic cells, both in vacuoles (Figure 3) and free in
cytoplasm [21]. At the same time, no invasion was observed if the Hep-2 cells were incubated
with the non-invasive Escherichia coli-carrying plasmids that did not contain the protease gene.
Internalization of the non-invasive Escherichia coli was also not observed if protealysin was added to
the culture medium [21]. These results showed the direct participation of grimelysin and protealysin
in the invasion of the host cells by the protease-producing bacteria [21].
Using electron microscopy, two modes of Serratia grimesii invasion were revealed. In most cases,
interaction of Serratia grimesii with eukaryotic HeLa M cells starts with formation of a tight contact
between bacteria and the host cell, which is followed by bacteria internalization, apparently due
to a specific interaction of bacterial adhesins with a specific cell surface receptor (Figure 4A,B) [50].
This process corresponds to the “zipper” mechanism of invasion involving activation of the signal
system of the host cell followed by moderate cytoskeleton rearrangements [51–53]. However, in
some cases, bacteria looked like they were trapped by filopodia (Figure 4C,D), probably induced by
injected bacterial proteins triggering the bacterial uptake, as described in the “trigger mechanism”
of invasion [54–57]. Recently, coexistence of both the trigger and zipper invasion mechanisms
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was postulated for Salmonella invasion [58–61]. These data provide a frame for revealing bacterial
and cellular factors involved in Serratia grimesii and Serratia proteamaculans invasion.
Figure 3. Actinase activity of recombinant E. coli transformed with the grimelysin or protealysin gene.
(A,B) Detection of the actinase activity in the lysates of the recombinant E. coli expressing grimelysin or
protealysin. Numbers indicate the time points of bacteria culturing when their extracts were tested for
actinase activity [21]. (C,D) Invasion of human larynx carcinoma Hep-2 cells by recombinant E. coli
expressing the grimelysin or protealysin gene, observed by electron (C) and confocal (D) microscopy [21].
Arrows indicate extracellular and internalized bacteria. By electron microscopy, bacteria are in vacuoles
(C) that are not visible with confocal microscopy. Scale bars, 1 μm. (D) The samples were examined
under a Leica TCS SL confocal scanning microscope using a dual argon ion (488 nm; green fluorescence)
and helium/neon (543 nm; red fluorescence) laser system to visualize the FITC-stained bacteria
and rhodamine phalloidin stained cytoskeleton, respectively. Scale bars, 1 μm (C) and 10 μm (D).
Modified from [21] with permission from Wiley license 4827670496420, 2020.
Figure 4. Electron microscopic identification of the initial steps in the invasion of eukaryotic cells by
Serratia grimesii. (A) Tight contact of bacteria with HeLa M cells. (B) Extensive contact of bacteria
with the surface of the host cell followed by the entry of bacteria into the host cell, which corresponds
to the zipper mechanism of invasion. (C,D) Appearance of host cell filopodia, whose fusing traps
bacterium and places it inside the vacuole, which corresponds to the trigger mechanism. (E) Bacteria
live in the vacuoles. (F) Bacteria leave the vacuole to live free in the host cell cytoplasm. Scale bars,
1 μm. (Modified from [50] with permission from Pleiades Publishing, Ltd. 117342, 2020.).
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7. Bacterial Virulence Factors Involved in Serratia Invasion
Transformation of the non-invasive Escherichia coli with the protealysin gene led to the appearance
in the bacteria of the invasive activity [21]. However, inactivation of this gene did not abolish
the ability of Serratia proteamaculans to invade eukaryotic cells [62]. Moreover, invasive activity
of Serratia proteamaculans was five times higher than that of Serratia grimesii [63]. This indicates
involvement of other factors regulating invasion.
Bacteria of Serratia genus are known to be facultative pathogens able to induce nosocomial infections
or infections in immunocompromised patients [64–66]. A most pathogenic strain of Serratia genus is
Serratia marcescens, pathogenicity of which is determined by a secreted pore-forming toxin (hemolysin)
ShlA [67,68] and extracellular proteases [69]. Probing of Serratia grimesii and Serratia proteamaculans for
these factors revealed the presence and high activities of pore-forming hemolysin ShlA and extracellular
metalloprotease serralysin in Serratia proteamaculans. At the same time, in Serratia grimesii, the activity
of the toxin ShlA was not detected, and the serralysin activity of the bacterial growth medium was
very low [63]. It was also shown that iron depletion strongly enhanced the invasive activity of
S. proteamaculans, increasing activities of hemolysin ShlA and serralysin, but did not affect these
properties of Serratia grimesii [63]. These results showed that, along with protealysin, the invasive
activity of S. proteamaculans is also determined by hemolysin and serralysin [63]. At the same time,
grimelysin remains the only known virulent factor of S. grimesii.
The first step in bacterial invasion is the contact of bacteria with the surface of eukaryotic cells,
often performed by bacterial outer membrane protein OmpX [70–72]. Indeed, transformation of
Escherichia coli by a plasmid carrying the OmpX gene of Serratia proteamaculans caused a 3-fold increase
in the adhesion of bacteria to the surface of eukaryotic cells Hep G2 and DF-2, without producing any
effect on Escherichia coli invasion [73]. On the other hand, our preliminary data indicate that OmpX
is a substrate for protealysin capable of enhancing the invasion of Serratia proteamaculans carrying
the inactivated protealysin gene [73]. These data indicate that along with its direct participation in
bacterial adhesion, OmpX could be involved in bacterial invasion, while, in turn, protealysin could
regulate bacterial adhesion.
8. Cellular Factors Involved in Serratia Invasion
The penetration of bacteria into eukaryotic cells includes the contact of bacteria with eukaryotic
cells, activation of the cell signaling system, reorganization of the cytoskeleton leading to bacterial
uptake and spreading of the invaded bacteria within and between the cells [55,74,75]. The efficiency of
this process is determined not only by the activity of bacterial virulent factors, but also by the sensitivity
of eukaryotic cells, which, in turn, correlates with the degree of their transformation [20,47] and depends
on the cell environment [76,77]. These factors were employed to find out whether bacterial invasion is
sensitive to the cell type and the presence of antioxidant N-acethylcysteine (NAC) in the culture medium.
The results of these experiments confirmed different effects of NAC on 3T3, 3T3-SV40 and HeLa
cells [78]. Incubation of HeLa cells with NAC increased penetration of grimelysin-producing bacteria by
1.5–2 times for wild-type Serratia grimesii and by 3–3.5 times for recombinant Escherichia coli expressing
the grimelysin gene [79]. These effects did not correlate with the cytoskeleton rearrangements but
might be due to the NAC-induced upregulation of cell surface receptors playing a primary role in cell
adhesion and cell–cell junctions [79].
Specifically, one of the cell surface receptors whose expression is regulated by N-acethylcysteine
is E-cadherin, a transmembrane receptor known to be upregulated by NAC [77] and one of the two cell
surface proteins that mediate adhesion and internalization of Listeria monocytogenes within epithelial
cells [80,81]. Binding of bacteria internalin InIA to E-cadherin triggers the c-Src kinase-mediated
phosphorylation of E-cadherin, followed by ubiquitination and E-cadherin internalization via
the clathrin-mediated pathway [80–82]. In line with these data, incubation of 3T3 and 3T3-SV40 cells
with NAC led both to increased expression of E-cadherin and increased sensitivity of these cells to
invasion [46]. Co-localization of S. grimesii with E-cadherin of the 3T3 and 3T3-SV40 cells was also
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shown [46]. In addition, inhibitory analysis with the ROCK and c-Src kinase inhibitors revealed
a correlation between c-Src and ROCK protein kinase activities, expression of E-cadherin and invasive
activity of Serratia grimesii [83]. These data allow us to suggest that E-cadherin is at least one of
the receptors involved in Serratia grimesii invasion.
On the other hand, participation of OmpX in Serratia proteamaculans invasion indicates that other
cell surface receptors, including integrins and the epidermal growth factor receptor (EGFR), could be
involved in this process, as it has been recently shown for the invasion of Salmonella [59–61]. In line with
these data, infection of epithelial M-HeLa cells by bacteria Serratia proteamaculans led to the changes in
localization of EGFR and fibronectin receptors α5-, β1-integrins. Accumulation of α5-, β1-integrins
on the cell surface was accompanied by intensive attachment of bacteria to the sites of α5-integrin
localization [84], indicating involvement of the outer membrane protein OmpX–fibronectin–integrin in
the penetration of Serratia proteamaculans into eukaryotic cells.
9. Conclusions
Though Serratia are facultative pathogens able to cause nosocomial infections or infections in
immunocompromised patients, hospital infection by S. grimesii or S. proteamaculans is low [64–66].
Consistent with this, the capability of S. grimesii to invade eukaryotic cells is also rather low, with only
about 10% of the cells being invaded either by the wild-type or recombinant bacteria when cultured
cells are infected in vitro [21]. This implies that production of grimelysin or protealysin does not make
the bacteria pathogenic but rather provides them with an opportunity to be rendered pathogenic under
specific conditions. Therefore, Serratia grimesii and Serratia proteamaculans invasion combines specific
bacterial mechanisms to contact eukaryotic cells and the specificity of the cells to be invaded.
To penetrate eukaryotic cells, invasive bacteria should initiate their uptake by activating the signal
transduction system and cytoskeleton rearrangements [1–4]. Thereby, pathogenic bacteria use
specialized secretion systems to deliver bacterial virulence factors directly into the cytoplasm of the host
cell to manipulate the intracellular pathways, thus following the trigger invasion mechanism [53–57,85].
In contrast, facultative bacterial pathogens use specific surface proteins that interact with the host cell
receptors, according to the zipper invasion mechanism. These interactions activate receptor-mediated
cell signaling cascades and lead to bacterial uptake [2,4,60,61,86]. Recent data showed however that
the virulence components transported via the type III secretion system of pathogenic bacteria can
be also translocated into the eukaryotic cells by the bacterial outer membrane vesicles (OMVs) [87].
Importantly, OMVs can be produced by opportunistic bacteria as well as by pathogenic ones [88–92],
thus smoothing the difference between pathogenic bacteria and facultative bacterial pathogens.
Penetration of opportunistic bacteria Serratia grimesii and S. proteamaculans into eukaryotic
cells [21] correlates with the presence in these bacteria of homologous metalloproteases grimelysin
and protealysin, respectively [18,22]. Protealysin was found in the cytoplasm of 3T3-SV40 cells
infected with S. proteamaculans or recombinant Escherichia coli expressing the protealysin gene [33],
suggesting that protease can be transported into the cytoplasm of eukaryotic cells. Consistent
with this suggestion, our preliminary data showed that the outer membrane vesicles produced by
Serratia grimesii were able to transfer protease grimelysin into the cytoplasm of eukaryotic cells.
This transfer enhanced the penetration of bacteria into eukaryotic cells if these cells were incubated
with the vesicles prior to infection [93,94]. At least a part of this effect could be produced by
the involvement of the OMV-delivered protease in the cytoskeleton dynamics. We have previously
shown that the cleavage of actin with grimelysin (ECP32) enhanced turnover of actin monomers
within actin filaments [15,38]. This, in turn, could contribute to the rearrangements of the actin
cytoskeleton leading to bacteria internalization. The invasive activity of Serratia can also be regulated
by activities of the intracellular factors, being, for example, diminished upon transfection of eukaryotic
cells with anti-RhoA siRNA [83]. The cells transfected with anti-RhoA siRNA exhibited cell rounding,
disassembly of actin cytoskeleton and formation of protrusions at the cell periphery [83], indicating
an active involvement of the cytoskeleton in S. grimesii uptake.
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Thus, the transition of opportunistic bacteria to the status of pathogenic is associated both
with the activity of bacterial virulence factors and the sensitivity of eukaryotic cells to bacteria.
In particular, the sensitivity of eukaryotic cells to bacterial invasion correlates with the degree of
their transformation [20,46,47], the effects of antioxidants [78,79] and the activity of cell signaling
components like c-SRC and ROCK kinases [83]. Further work is needed to integrate these individual
cellular factors and bacterial virulence factors into the Serratia invasion mechanism.
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Abstract: Infections of the central nervous system (CNS) are still a major cause of morbidity and
mortality worldwide. Traversal of the barriers protecting the brain by pathogens is a prerequisite
for the development of meningitis. Bacteria have developed a variety of different strategies to cross
these barriers and reach the CNS. To this end, they use a variety of different virulence factors that
enable them to attach to and traverse these barriers. These virulence factors mediate adhesion to
and invasion into host cells, intracellular survival, induction of host cell signaling and inflammatory
response, and affect barrier function. While some of these mechanisms differ, others are shared
by multiple pathogens. Further understanding of these processes, with special emphasis on the
difference between the blood–brain barrier and the blood–cerebrospinal fluid barrier, as well as
virulence factors used by the pathogens, is still needed.
Keywords: bacteria; blood–brain barrier; blood–cerebrospinal fluid barrier; meningitis;
virulence factor
1. Introduction
Bacterial meningitis, as are bacterial encephalitis and meningoencephalitis, is an inflammatory
disease of the central nervous system (CNS). It can be diagnosed by the presence of bacteria in the
CNS. Despite advances in treatment, it is still a disease of global dimension, which can end fatally or
leave long-term neurological sequelae in survivors [1].
The brain is well protected from invading pathogens by cellular barriers, with the two major
barriers being the blood–brain barrier (BBB) and the blood–cerebrospinal fluid barrier (BCSFB) [2,3].
To reach the CNS, blood-borne bacteria must interact with and cross these barriers of the brain. During
the course of infection attachment to the host cells is initiated, followed by the hijacking of several
host cell pathways by the pathogens. This process can be used by the bacteria to enter host cells with
subsequent intracellular survival and, for some pathogens, multiplication. Finally, after crossing into
the brain, the bacteria elicit an immune response from the cells within the CNS that might contribute
to the inflammatory events leading to disease, with potential disruption of barrier integrity [4].
The traversal or breach of these barriers by meningitis-causing pathogens is defined by a complex
interplay between host cells and the pathogens, which use an array of virulence factors to facilitate this
interaction, resulting in high morbidity and mortality [1]. These virulence factors are involved during
protection in the bloodstream, such as the capsule of both gram-positive and gram-negative bacteria,
mediate adhesion to and invasion into host cells, and are responsible for intracellular survival.
2. Barriers of the Central Nervous System
The barriers protecting the brain are essential for its function and the stability of its internal
microenvironment [5]. Important morphological components found in most of these barriers are
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specialized intercellular tight junctions between the cells, which are the basis for the barrier property.
Various transporters, such as ATP-binding cassette (ABC) transporters, as well as efflux pumps
control the movement of molecules across these interfaces, making them another component of barrier
function [6]. These mechanisms prevent substances such as toxins, pharmacologically active agents
and pathogens from accessing the CNS [4,7,8].
2.1. Blood–Brain Barrier
The BBB is formed by brain microvascular endothelial cells (BMECs), astrocytes and pericytes. It
presents a structural and functional barrier and acts as an interface between the CNS and the peripheral
circulation [2,9]. It has an additional protective function, restricting the free movement of substances
across and inhibiting the entry of pathogens and toxins into the CNS. By regulating the passage of
molecules, it is furthermore responsible for maintaining the CNS homeostasis.
The structure of the BBB is defined by BMECs covering the inner surface of the capillaries by
forming a continuous sheet of cells interconnected by tight junctions (TJs) [10]. Specific TJ proteins,
including occludin and, at the BBB, claudin-5, and claudin-12, but not claudin-3, are responsible for
limiting the paracellular diffusion of ion and solutes across the barrier [11,12]. BMECs are characterized
by less cytoplasmic vesicles, a larger number of mitochondria and a high amount of intercellular
junctions, resulting in a high transendothelial resistance and low paracellular flux [13]. Transporter
systems of the BBB include solute carrier-mediated transport, receptor-mediated transport, as well
as active efflux and ion transport [14]. The BMECs are supported in shaping the BBB by associated
cells such as astrocytes and pericytes [10]. The mechanisms of microbial CNS invasion have been
elucidated by the use of in vivo and in vitro studies. To model infections of the CNS, mice and rats are
most commonly used. To model the BBB in in vitro cell culture systems, primary human, rodent, and
bovine brain microvascular endothelial cells have been used. Extensive studies of the human BBB
have been facilitated by the availability of immortalized brain endothelial cells such as human brain
microvascular endothelial cells (HBMECs) and hCMEC/D3 [1].
2.2. Blood–Cerebrospinal Fluid Barrier
Another major barrier protecting the brain is the BCSFB, which can be separated into a barrier to
the inner CSF in the ventricles at the choroid plexus (CP) and barriers to the outer CSF located at the
arachnoidea and blood vessels present in the subarachnoidal space [15]. Importantly, the choroidal
BCSFB is essential in the trafficking of immune cells into the CNS [3,16]. The epithelial cells displaying
polarity and forming tight junctions, which specifically express claudin-1, -2, -3, and -11, are the
morphological correlates of the BCSFB at the CP [3,11,12]. The presence of specific transporter systems,
such as ABC transporters, and low pinocytotic activity regulating the crossing of substances are key
characteristics of the CP [17,18]. Furthermore, the BCSFB is crucial for the protection of the CNS from
pathogens [19].
To cause diseases of the CNS bacterial pathogens need to overcome these barriers [1,17]. During
this process, several different steps are influenced by bacterial virulence factors. To analyze the role
of the CP during infectious diseases of the CNS, animal models can be utilized. Important tools for
studying the BCSFB in vitro are primary models of CP epithelial cells, such as primary porcine CP
epithelial cells (PCPEC). Another functional model of the BCSFB is a human CP epithelial papilloma
cell line (HIBCPP cells) which displays apical/basolateral polarity and a good barrier function [17].
3. Stages during the Pathogenesis of BACTERIAL Meningitis
Bacterial meningitis can be caused by a variety of different gram-positive and gram-negative
pathogens. There are mechanisms and steps of disease progression that are similar among them as
shown in Figure 1. Colonization of the mucosal surfaces is often the first step of disease progression,
followed by different strategies of dissemination into the bloodstream [4]. Once the pathogens have
entered the bloodstream and successfully counteracted innate and adaptive immune defenses, they
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have to translocate across the barriers of the brain to invade the CNS and cause severe inflammation.
Attachment to the brain endothelium or the epithelial cells of the choroid plexus and subsequent
invasion mark the initial step of translocation into the CNS [4].
Figure 1. CNS entry pathways and stages during the pathogenesis of bacterial meningitis. Bacterial
pathogens can cross the BBB or BCSFB paracellularly between neighboring cells, in a “Trojan horse”
fashion inside infected host macrophages, or transcellularly by invading epithelial or endothelial cells.
Cellular entry can be launched by the zipper mechanism involving binding to host cell receptors or by
the trigger mechanism (see main text for details). During this process, activation of signal transduction
pathways can cause initiation of actin rearrangements. Activation of signal transduction can also be
triggered during the transcellular pathway or the “Trojan horse” mechanism, but is not indicated in the
figure for reasons of clarity. Once in the cytoplasm, the pathogens need to survive inside the cells for
further disease progress. Activation of host genes causes an inflammatory response that can lead to
disruption of tight junctions.
3.1. Attachment and Invasion
To facilitate adhesion and invasion of the barriers protecting the brain, a threshold level of
bacteremia has been shown to be required [20–22], which is correlated with the severity of infection
and likeliness of developing meningitis [23]. However, direct invasion from neighboring infected
tissues can occur as well.
Bacterial adhesion to host cell surfaces is a complex process. It involves multiple adhesion
molecules of the pathogen interacting with a variety of target receptors. These interactions, which
can involve several adhesins of one microbe, can occur in a sequential manner. Hereby, the initial
interactions can trigger the expression of further host receptors, which are then targeted by other
bacterial adhesins [24].
Many pathogens have been shown to bind to extracellular matrix proteins to facilitate initial
attachment to the host cells. Furthermore, binding of bacterial adhesins to specific host cell receptors can
in turn induce different signal transduction pathways, resulting in tight attachment or internalization
of the bacteria into the host cells [4]. The use of pili or fibrils for invasion of HBMECs was observed for
a multitude of meningitis-causing pathogens [8], making them highly important virulence factors for
invasion of the CNS.
Endocytosis of pathogens into non-phagocytotic cells is initiated by one of two mechanisms:
the “zipper” and the “trigger mechanism”. Some pathogens express surface proteins capable of
interacting with transmembrane receptors on the hosts cells which are connected to the cytoskeleton.
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The “zipper mechanism”, in particular, is defined by an interaction of a bacterial ligand and a
host-specific membrane receptor initiating signaling events that lead to internalization of the pathogen
through endocytosis [25]. The “trigger mechanism” is a micropinocytosis-related process that involves
formation of actin-rich membrane ruffles. These are formed by localized changes in actin dynamics
and membrane remodeling triggered by delivery of active effectors, which can be injected by the
needle-like structure of a type three secretion system (T3SS), into the cytosol of host cells initiating
signaling cascades [26,27].
3.1.1. CNS Entry Routes
Meningitis-causing pathogens most commonly cross host barriers in a transcellular or paracellular
manner [2]. These processes are associated with protein interactions between pathogens and the
host’s cells. Transcellular traversal is characterized by pathogens crossing the barrier cells without
evidence of TJ disruption or traversal between cells [2]. This is accomplished by intracellular invasion
of the barrier cells and exploitation of signaling pathways. Paracellular traversal, on the other hand,
involves penetration of pathogens between the host’s cells and can occur with and without permanent
disruption of TJs [2,4]. Furthermore, the release of bacterial toxins can lead to disruption of barrier
function and promote paracellular traversal. Another means of entry is the “Trojan-horse” mechanism,
which describes penetration of the barrier by transmigration within infected phagocytes [2]. It has
been suggested that the infected phagocytes adhere to the luminal side of brain capillaries. This can
occur with and without the activation of BMECs and is followed by either transcellular or paracellular
traversal of the BBB [28].
3.1.2. Signal-Transduction Mechanisms and Cytoskeletal Rearrangements
Meningitis-causing bacterial pathogens have been shown to utilize host cell signaling molecules
to facilitate infection. The mechanisms deployed can vary between the different pathogens, as well as
the host tissues.
To both enter and leave the host cells, several pathogens have developed mechanisms to use the
actin polymerization machinery of the host [29,30]. Pathogens not only use this process to spread
throughout the cells, but have also developed mechanisms to subvert these regulatory mechanisms [31].
Furthermore, meningitis-causing pathogens use different signal-transduction mechanisms that result
in rearrangements of the actin cytoskeleton [2]. This allows the pathogens to initiate attachment and
entry of host cells, movement within and among cells as well as vacuole formation. This complex
process of actin cytoskeletal remodeling can involve many factors, such as Rho-family GTPases and a
variety of actin-binding proteins [30,32].
The innate immune system of the host can be triggered by various molecules which are
characteristic for the bacteria. These pathogen-associated molecular patterns (PAMPs) are then
recognized by eukaryotic pattern recognition receptors (PRRs), which in turn induce signaling cascades
such as the nuclear factor κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways [33,34].
Activation of these signaling cascades triggers pro-inflammatory responses like the up-regulation of
cytokines [35].
3.2. Intracellular Survival
3.2.1. Multiplication and Intracellular Survival
Extracellular multiplication is the most common process for propagation by pathogenic bacteria.
Furthermore, replication and persistence inside host cells has been demonstrated for a variety of
meningitis-causing pathogens as well [36]. Entry into the host´s cells and replication within these
protects the pathogens from clearance by the complement system and circulating antibodies. However,
these pathogens have to overcome several cellular defense mechanisms such as the upregulation and
secretion of neutrophil-specific factors in HBMECs. This response by the BBB is assumed to serve to
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recognize pathogens resulting in their clearance. However, overactivation of the cellular response
through continued exposure to the pathogens could result in increased inflammation and compromised
barrier integrity [8].
3.2.2. Disruption of Barrier Integrity and Inflammatory Response
Characteristically, bacterial meningitis is accompanied by a severe inflammatory response leading
to neuronal damage. Activation of the transcription factor NF-κB upon invasion of the brain
barrier tissues results in high levels of inflammatory cytokines in the blood and CSF [37]. This
proinflammatory response can be triggered by bacterial cell wall components. Examples would include
the lipopolysaccharide (LPS) for gram-negative bacteria, and lipoteichoic acid (LTA) for gram-positive
bacteria. Furthermore, increased permeability of the barriers can be triggered by both bacterial toxins,
as well as the initiation of host inflammatory pathways in response to the infection [38]. Tissue damage
during bacterial meningitis arises from the initiated inflammatory cascade involving cytokines and
chemokines, as well as proteolytic enzymes and oxidants [4]. Consequences of the release of these
inflammatory substances, caused by multiplication of pathogens in the CNS, are damage of neurons
and edema [39]. The hosts’ immune response is therefore unable to embank infection of the CNS, and
may even contribute to adverse events during bacterial meningitis [4].
The release of proinflammatory molecules not only increases permeability of the BBB but also
attracts leukocytes to the CNS [40]. Cell death can be caused by cytokines, reactive oxygen species,
reactive nitrogen species and matrix metalloproteinases [41–45].
4. Roles of Bacterial Virulence Factors During Invasion Through the Barriers of the CNS
To be able to enter the CNS, bacterial pathogens use several virulence factors, which are involved
in the different steps of pathogenesis. Of major importance is the capsule of both gram-positive
and gram-negative bacteria. The capsular polysaccharide has a protective function in bloodstream
survival [46]. However, it was observed to attenuate invasion of the BBB and BCSFB [47–49]. This
could result from electrostatic repulsion or from the masking of bacterial surface structures [8]. The
necessity of the capsule for the pathogens survival in the blood but simultaneous hindrance of invasion
of the host’s tissues indicates a need for the regulation of capsule expression [50].
Besides the capsule, a multitude of further virulence factors are used by gram-positive and
gram-negative bacteria [51]. These include, among others, adhesins and internalins, pore-forming
toxins, and factors involved in intracellular movement as well as cell-to cell spread and are summarized
in Figure 2.
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Figure 2. Multiple virulence factors are involved in the different steps of pathogenesis during bacterial
meningitis. Expression of a capsule can support bloodstream survival of both gram-positive and
gram-negative bacteria. It has been described that down-regulation of capsule expression occurs
during adhesion to and invasion into host cells, which is mediated by adhesins, internalins, pili, and
pore-forming toxins. Pore-forming toxins can also be involved during escape from vacuoles inside of
host cells, as well as intracellular survival. These steps are further supported by pore-forming toxins
and the capsule. Several virulence factors, including internalins and pore-forming toxins, activate host
cell signal transduction and mediate gene activation causing an inflammatory response.
In this review, we will focus particularly on virulence factors, for which evidence for an involvement
during brain entry across the blood–brain barriers has been proposed. A summary of these virulence
factors for gram-positive and gram-negative bacteria is given in Table 1 at the end of this section.
4.1. Gram-Positive Bacteria
4.1.1. Listeria monocytogenes
Listeria monocytogenes (L. monocytogenes) is a facultative intracellular gram-positive bacterium. It
can traverse several physiological barriers and finally enter the brain via the BBB or BCSFB, especially
in immunocompromised individuals [52]. It is ingested through highly contaminated food by the
host. Once ingested, L. monocytogenes traverses the intestinal epithelial barrier into the lamina propria
followed by dissemination of the pathogen via the lymph and blood [53]. L. monocytogenes has
multiple target organs, including the liver and spleen, and can enter the CNS across the barriers
of the brain [53]. In addition to direct traversal of the BBB and BCSFB via the transcellular route,
transportation across the BBB within leukocytes and retrograde migration within axons of cranial
nerves have been described [54,55].
L. monocytogenes can enter non-phagocytotic cells by hijacking the host’s receptor-mediated
endocytosis machinery using the zipper mechanism. The two major invasion proteins of L. monocytogenes
are internalin (InlA) and InlB, which bind to eukaryotic cell membrane members E-cadherin and
tyrosine kinase receptor protein Met, respectively. These interactions induce receptor-mediated
endocytosis of the pathogen. L. monocytogenes has been demonstrated to use one or both internalins
to mediate invasion of the BBB and BCSFB [25,56,57]. A recent study has further demonstrated the
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importance of the bacterial surface protein InlF, showing that interaction with surface vimentin was
required for an optimal colonialization of the brain [58].
The MAPK signaling cascade is activated during the invasion of L. monocytogenes [35,59,60]. In a
model system of the BCSFB consisting of choroid plexus epithelial cells, the requirement of MAPK
activation for listerial entry was demonstrated. Both extracellular signal-regulated kinases (ERK) 1
and 2 and p38 inhibition resulted in decreased bacterial invasion into this model system suggesting
their involvement in the pathogens traversal of the BCSFB [34].
It was previously described that ubiquitination of E-cadherin and Met leads to the recruitment
of the clathrin-mediated endocytosis machinery. This in turn results in the polymerization of the
actin cytoskeleton. During this process, dynamin recruits several factors that result in two waves of
actin rearrangements and subsequently result in the entry of the pathogen inside of vacuoles [61–63].
Accordingly, an in vitro study using a model of the BCSFB based on HIBCPP cells, revealed that
L. monocytogenes invasion is inhibited if dynamin-mediated endocytosis is blocked [34].
Another essential virulence factor of L. monocytogenes is the pore-forming cytolysin Listeriolysin
O (LLO). Activation of the NF-κB signaling pathway by LLO was reported in the human embryonic
kidney HEK-293 cell line [64], as well as MAPK signaling [65,66]. It is secreted by L. monocytogenes
and promotes the pathogens intracellular survival. After entering the host cell, lysis of the vacuole is
initiated through LLO and the bacterial phospholipases PlcA and PlcB, and followed by intracellular
spread in the cytoplasm [61].
Once L. monocytogenes has reached the cytoplasm of the host´s cells, it has been demonstrated
to move around and enter neighboring cells using actin comet tails and membrane protrusions to
facilitate its spread [61,67]. This F-actin-based intracellular motility is dependent on the expression of
another essential listerial virulence factor, ActA [68].
Activation of the NF-κB signaling pathway is, as previously described, achieved through LLO.
Another mechanism involving NF-κB is its activation by InlC, which is secreted intracellularly. It
can directly interact with the subunit of the IκB kinase complex, IKKα. By phosphorylating IκB, this
complex is critical for the activation of NF-κB, a major regulator of innate immune response. InlC was
shown to impair phosphorylation of IκB, thereby scaling down the hosts immune response [69], and is
also involved in cell-to-cell spread [70].
4.1.2. Streptococcus suis
Streptococcus suis (S. suis) is a zoonotic gram-positive bacterium and one of the most important
porcine bacterial pathogens. Serotype 2 of S. suis has been described to be a major cause of meningitis,
especially in South and East Asia [71]. To reach the CNS, S. suis has to colonize the host and
traverse epithelial barriers in order to reach the bloodstream, where it needs to survive. S. suis has
been demonstrated to cross the BBB and the BCFSB in human in vitro models as well as in porcine
models [48,71–73].
The presence of a capsule is essential for survival in the bloodstream. However, it was demonstrated
to attenuate invasion for S. suis in epithelial cells [48,72,74]. A link between capsule expression and
carbohydrate metabolism has been described, indicating adaptation of S. suis to different environments.
High concentrations of nutrients, as found in the bloodstream, coincided with high expression of the
capsule, whereas in the CNS, which is low in nutrients, expression was reduced [50,75]. Attachment
of S. suis to BMECs has been demonstrated in human and porcine in vitro models of the BBB [76,77].
Invasion has been reported in porcine models but at very low rates [73,78]. During the adhesion
process, in these in vitro model systems, the capsule had no effect on adherence [76]. In contrast, in
porcine and human models of the BCSFB, both attachment and significant invasion of S. suis strains
were demonstrated. The use of unencapsulated mutants further increased invasion rates, indicating
a role of the capsule and regulation of its expression [48,72]. Other important virulence factors for
invasion of the barriers of the brain are cell wall components such as lipoteichoic acid, LPXTG-anchored
proteins as well as lipoproteins [79].
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Also, enolase has been identified as a virulence factor of S. suis. Previously thought to act only as a
glycolytic enzyme, this protein, with a highly conserved sequence, has been implicated in the invasion
process of various pathogens. For S. suis, enolase has been shown to increase BBB permeability as well
as promoting the release of interleukin IL-8 [80]. Transmigration might further be promoted by the
thiol-activated cytolysin suilysin, which induces pore formation in membranes. Furthermore, the use
of bacterial mutants lacking suilysin has shown that it is not essential for invasion of the host [81]. It
has, however, been demonstrated to promote association with epithelial cells, making it another major
virulence factor of the pathogen [82].
The upregulation of different cytokines and chemokines in response to S. suis infection in BMECs
has been reported. Exemplary is the induction of IL-6 and IL-8, stimulated by S. suis [83]. An
inflammatory response was also described in a porcine model of the BCSFB. Here, induction of tumor
necrosis factor (TNF) α and matrix metalloproteinase (MMP)-3 gene expression were described. This
was paralleled by rearrangements of the tight junction proteins ZO-1, occludin and claudin-1, and
loss of actin at the apical cell pole as well as the induction of stress fiber formation at the basolateral
side of the barrier [84]. The expression of TNFα after stimulation by S. suis in porcine choroid plexus
epithelial cells further promoted adhesion and transmigration of polymorphonuclear neutrophils
(PMN) through the barrier, which is a critical step during bacterial meningitis. Interestingly, some PMNs
contained internalized S. suis, indicating the possibility of the pathogen exploiting the Trojan-horse
mechanism [85].
4.1.3. Streptococcus pneumoniae
Streptococcus pneumoniae (S. pneumoniae) is a gram-positive pathogen which is the major cause
of bacterial meningitis in the developing world [86]. Close to 30% of individuals carry S. pneumoniae
asymptomatically. Nasopharyngeal colonization is followed by systemic invasion and access to the
bloodstream. Invasion of the CNS via the barriers of the brain is the major cause for meningitis [87].
Furthermore, olfactory neuron invasion was observed to be an entry route for S. pneumoniae [88]. To
facilitate invasion of the CNS, S. pneumoniae utilizes several virulence factors such as the pneumococcal
capsule and surface proteins as well as secreted proteins.
Bacterial interactions with the host and the subsequent development of bacterial meningitis are
promoted by a high level of bacteremia [4]. Accordingly, attachment of S. pneumoniae to the choroid
plexus in an in vivo mouse model was observed only during late stages of infection with high levels of
bacteremia [87]. Further studies of the interaction with the BCSFB would be needed to determine if
S. pneumoniae can use it as entry gate to the CNS.
The capacity of S. pneumoniae to invade host tissues is majorly determined by its capsule. Similar
to other pathogens capable of causing bacterial meningitis, survival in the bloodstream is dependent on
maximum capsule expression [89,90], whereas attachment to host tissues is hindered by its presence [91].
As the binding of various pneumococcal surface proteins is hindered by the capsule, altered expression
of the capsule through quorum sensing and phase variation has been described [92,93].
Pneumococci have been demonstrated to use multiple virulence factors to initiate attachment to
HBMECs in several in vitro studies. The platelet endothelial cell adhesion molecule (PECAM-1) has been
implicated as receptor for neuraminidase A (Nad A) in pneumococcal attachment [94,95]. Importantly,
NadA has been described as an important virulence factor, anchored in the cell wall of S. pneumoniae that
can cleave sialic acid of the host substrates. It has been implicated in triggering the transforming growth
factor-β (TGF-β) signaling cascade during the interaction with the BBB, resulting in decreased barrier
integrity and an increase in invasion [96]. Another important receptor involved in pneumococcal BBB
invasion is the polymeric immunoglobulin receptor (pIgR) as the major adhesin of the pneumococcal
pilus-1, RrgA, was observed to bind to it as well as PECAM-1. Human platelet-activating factor receptor
(PAFR) was demonstrated to be further involved in attachment, together with the before mentioned
PECAM-1 and pIgR [97]. Additionally, a second type of pneumococcal pili has been described to
mediate adhesion to host cells [98]. Furthermore, choline binding protein PspC was shown to bind only
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to pIgR [97], and interaction with the laminin receptor by S. pneumoniae is initiated by choline-binding
protein A (CbpA) [99]. A proteome-based approach in a mouse meningitis model, addressing adaptive
capabilities of the pathogens to a defined host compartment, has highlighted a crucial role for two
highly expressed pneumococcal proteins; ComDE, a regulatory two-component system, and AliB, a
substrate-binding protein of an oligopeptide transporter, in pneumococcal meningitis [100].
A major virulence factor of S. pneumoniae is pneumolysin, a pore-forming toxin which acts in a
cholesterol-dependent manner. Pneumolysin has recently been demonstrated to induce the expression
of CERB-binding protein (CBP), a coactivator of transcription. This results in the release of TNF-α and
IL-6, which in turn lead to increased permeability of the BBB through increased apoptosis of the cells
both in vivo and in vitro [101]. It has furthermore been implicated in paracellular traversal of the BBB
by S. pneumoniae as a result of reduced barrier integrity [102].
In addition to the disruption of the BBB by pneumolysin, generation of H2O2 through
α-glycerophosphate oxidase (GlpO) was observed to have a cytotoxic effect on HBMECs [103].
A study using rat brain tissues investigated the effect of S. pneumoniae infection on nucleotide-binding
oligomerization domain 2 (NOD2) and inflammatory factors, suggesting that NOD2 may hold a role in
the activation of inflammatory pathways and subsequent BBB damage [104].
A study by Coutinho et al. analyzed the CSF of patients with pneumococcal meningitis, detecting
high levels of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 and anti-inflammatory
cytokines IL-10 and TGF-β. Furthermore, chemokines IL-8, MIP-1a and MCP-1 were detected [45].
Furthermore, an in vivo study in neonatal Wistar rats demonstrated an increase in cytokines prior
to BBB breakdown after induction of pneumococcal meningitis [105]. Entry of the CNS by the
pneumococci is followed by rapid multiplication. Components released by the pathogen during this
process are then recognized by PPRs resulting in a strong inflammatory response and subsequent BBB
impairment [4].
4.1.4. Group B streptococcus
Group B streptococcus (GBS, Streptococcus agalactiae) is a β-haemolytic, gram-positive pathogen
and the leading cause of meningitis in human neonates [106]. Classification of GBS strains is done by
sequence type based on an allelic profile of seven loci [107]. The development of GBS meningitis is
dependent on bloodstream survival and development of a high level of bacteremia of the pathogen,
followed by the disruption of the BBB or possibly the BCSFB. This is followed by the multiplication of
GBS in the CNS, culminating in severe inflammation and neural damage [4]. The necessity of high-level
bacteremia indicates that bloodstream survival is an important virulence factor of the pathogen along
with the sialylated GBS capsular polysaccharide [108]. Additionally, reduction of capsule expression
by GBS was demonstrated to increase virulence and intracellular persistence [49]
Direct interaction of GBS with the BBB endothelium has been demonstrated, resulting in traversal
of the barrier and subsequent infection of the CNS [49,109]. Both direct invasion of the BBB and/or brain
invasion as a direct result of increased permeability of the barrier have been observed [4]. The use of
in vitro models has further shown transcellular crossing of the pathogen [109]. To this end, a variety of
virulence factors have been described. One of these factors is a surface anchored novel protein specific
for the GBS ST-17 clone, which is associated with meningitis in infants after the first week of life, called
hypervirulent GBS adhesin (HvgA) and is required for GBS hypervirulence. Increased adherence of
strains expressing HvgA was detected for intestinal epithelial cells, choroid plexus epithelial cells, and
microvascular endothelial cells of the BBB [110]. Another necessary determinant of the GBS interaction
with the BBB is the expression of cell-wall anchored pili [111]. Interestingly, these pili displayed
similar function in adhesion and invasion of GBS, given that the role of pili has been best described for
gram-negative bacteria. Two proteins involved in the formation of the pili, encoded by pilA and pilB,
were shown to facilitate the interaction with the BBB, wherein PilA is promoting attachment of GBS
and PilB is mediating internalization of the bacterium [112]. Interaction of PilA with collagen promotes
its interaction with the α2β1 integrin, initiating the integrin signaling machinery [38]. Interaction
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with HBMECs is further enabled by the GBS fibronectin-binding protein streptococcal fibronectin
binding protein A (SfbA) [113]. Additionally, GBS serine-rich repeat (Srr) glycoprotein was suggested
to both promote bloodstream survival, facilitated by the adherence to fibrinogen, as well as adhesion
to HBMECs [114]. An antigen I/II family adhesin, BspC, was recently demonstrated to interact with
host cell vimentin during the pathogenesis of GBS meningitis, thereby promoting adherence of the
pathogen in vitro as well as contributing to the development of GBS meningitis in vivo [115].
During invasion of type III GBS in HBMECs, tyrosine phosphorylation of the focal adhesion
kinase (FAK) was demonstrated. Not only was the phosphorylation of the FAK required for invasion of
GBS, it further induced association with PI3-kinase and paxillin, an actin filament adaptor protein [116].
BBB penetration of GBS was shown to also involve the invasion associated gene A (iagA). Mice challenged
with a mutant version of this gene, encoding a glycosyltransferase homolog, developed bacteremia
comparable to the wild type (WT) mice but had significantly lower mortality. In addition, the IagA gene
encodes an enzyme, the glycolipid diglucosyldiacylglycerol, which functions as a cell membrane anchor
for LTA, indicating that proper LTA anchoring is necessary for invasion of GBS into the BBB [117].
Similarly to S. pneumoniae, GBS can secrete a pore-forming toxin to disrupt barrier function
in infected BMECs [109]. In addition, a further consequence of the interaction of PilA with α2β1
integrin is the activation of host chemokine expression as well as neutrophil recruitment, which was
correlated with increased permeability of the BBB [38]. Furthermore, GBS hyaluronidase HylB was
demonstrated to induce BBB opening in a dose-dependent manner [118]. Another factor influencing
BBB dysfunction was described during infection of induced pluripotent stem cell-derived brain
endothelial cells with GBS, which resulted in the inhibition of P-glycoprotein, an important efflux
transporter for the maintenance of brain homeostasis [119]. Barrier disruption and subsequent bacterial
passage was further demonstrated to be promoted by reduced expression of tight junction components
ZO-1, Claudin-5 and Occludin in HBMECs. This was facilitated by the induction of transcriptional
repressor Snail1 and sufficient to promote tight junction disruption. This process, which was shown to
be dependent on ERK 1/2 MAPK signaling as well as bacterial cell wall components, marks another
mechanism of BBB disruption by GBS [120].
4.2. Gram-Negative Bacteria
4.2.1. Escherichia coli
E. coli, a gram-negative bacillary organism, is a common cause of meningitis and still an important
cause of mortality and morbidity throughout the world. Circulating E. coli have been shown to traverse
the BBB and the BCSFB as a result of hematogenous spread [22,121]. Expression of the K1 capsule and
O-lipopolysaccharide are critical determinants of E. coli meningitis, especially in neonates [122–124].
Several factors have been demonstrated to influence E. coli invasion of the CNS such as a high level of
bacteremia for the invasion of the blood–brain barrier, as well as a variety of virulence factors that
initiate binding and translocation into the CNS [2].
The first step in E. coli invasion of the CNS is attachment to the cells of the brain barriers. The
two major virulence factors associated with attachment to the blood–brain barrier are type 1 fimbriae
and OmpA [125,126]. The virulence factor IbeA has been associated with the subsequent invasion
process [127], as well as cytotoxic necrotizing factor 1 (CNF1) [128]. Deletion of ompA and ibeA reduced
infection of choroid plexus epithelial cells in a human model of the BCSFB, whereas deletion of fimH
enhanced invasion but simultaneously decreased adhesion of E. coli strains in the same model [121]. In
an in vitro model of the BBB, Ecgp was identified as receptor for OmpA [129].
To promote internalization, E. coli induces rearrangements of the actin cytoskeleton. In HBMECs,
this has been demonstrated to trigger a zipper-like mechanism that envelops the bacterium and
initiates internalization into the cell. This process is dependent on both the actin cytoskeleton as well as
microtubules [4]. Induction of tyrosine phosphorylation of FAK and cytoskeletal proteins by E. coli was
demonstrated in an in vitro model of brain endothelial cells [130]. In addition, phosphatidylinositol
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3-kinase (PI3K) interaction with FAK and PI3-kinase signaling was shown to be necessary for successful
invasion of E. coli in HBMECs [131]. In turn, PI3K activates phospholipase PLCγ, resulting in increased
Ca2+ levels in the cells [132]. The cell adhesion molecule ICAM-1 was selectively upregulated during
invasion of E. coli in brain endothelial cells through the interaction of OmpA and its receptor Ecgp.
This upregulation was dependent on the previously described PI3K signaling pathways, as well as
protein kinase C (PKC)-α and NK-κB signaling [133].
Traversal of E. coli across the BBB has been studied extensively using HBMECs as in vitro
models [22]. Transmission electron microscopy revealed the pathogen crossing the HBMECs in
membrane-bound vacuoles without intracellular replication [134]. Infection of HBMECs by E. coli
K1 was further demonstrated to activate caveolin-1, resulting in the uptake of the pathogen via the
caveolae. Furthermore, caveolin-1 interacts with phosphorylated protein kinase Cα at the site of
E. coli attachment [135]. To promote intracellular survival within the vacuoles, the E. coli K1 capsule is
essential. It can modulate the maturation of the vacuoles and prevent fusion with lysosomes, thereby
enabling traversal of live bacteria to the CNS [136]. There are gene clusters, essential for the production
of the precursors that are the basis of the K1 capsule, called the neuDB genes. They were identified
as an essential virulence factor promoting intracellular survival in HBMEC [122,136]. Furthermore,
neuDB was also shown to be of importance during infection of an in vitro model of the BCSFB [121].
The breakdown of barrier function and neuroinflammation are considered key mechanisms in the
invasion of the brain by pathogenic E. coli. In brain endothelial cells, upregulation of platelet-derived
growth factor-B (PDGF-B) and ICAM-1 was demonstrated after infection with E. coli [137]. Further
in vivo and in vitro studies suggest an involvement of PDGF-B in BBB permeability, mediating
breakdown of tight junction proteins. Upregulation of ICAM-1 on the other hand was shown to
initiate the inflammatory response of the CNS, mediating neutrophils or monocyte recruitment during
infection [138]. The activation of PKC–α and its association with vascular-endothelial cadherins at the
TJs of HBMECs resulted in increased cellular permeability and decrease in transendothelial electrical
resistance by releasing β-catenin from the junctions. Notably, only E. coli strains expressing ompA
could induce this increase in barrier permeability [139]. The infection of HBMECs with E. coli was
further demonstrated to promote the production of nitric oxide (NO) by activating inducible nitric
oxide synthase and, as a result, displayed enhanced invasion rates and increased permeability of
HBMEC monolayers [140]. NO production was hypothesized to additionally be triggered by the
modulation of pterin synthesis, which is involved in cell differentiation, pain modulation as well
as mRNA stability. Infection of HBMECs was demonstrated to induce the rate-limiting enzyme in
pterin synthesis, guanosine triphosphate cyclohydrolase (GCH1), indicating its role in the invasion
process. GCH1 further interacts with Ecgp96, the receptor for OmpA [141]. These findings indicate
an essential role for NO during E. coli invasion of the BBB. The response of HBMECs to meningitic
and non-meningitic E. coli infections highlighted the role for macrophage migration inhibitory factor
(MIF) during infection. MIF, a proinflammatory cytokine that has been described as a major factor
during infection and septic shock, was demonstrated to have a role in BBB damage, as evidenced by
the induction of a significant decrease in ZO-1 and occludin, as well as inflammation [142].
A further study described the role of E. coli K1 virulence factor cglD in polymorphonuclear
leukocyte transendothelial migration [37]. A follow up analysis demonstrated a contribution of cglD to
NF-κB pathway activation in HBMECs, promoting PMN adhesion and transendothelial migration
across the BBB [143].
4.2.2. Neisseria meningitidis
Neisseria meningitidis (N. meningitidis) is a human-specific gram-negative bacterium. It can colonize
the nasopharynx extracellularly and is often non-pathogenic and commensal. Some strains can cause
life-threatening diseases such as meningitis. To reach the barriers protecting the CNS, N. meningitidis
has to overcome the mucosal epithelium and enter the bloodstream. To survive in the bloodstream
and subsequently enter the CNS, N. meningitidis utilizes different virulence factors. These protect the
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bacterium from being killed by the hosts complement system or other effectors. They include the
polysaccharide capsule and other surface structures, such as pili and other adhesins [144]. Factor
H-binding protein is another important factor for bloodstream survival and evading the host innate
immune system by binding factor H, which is a negative regulator of complement activation and
alternative pathway and is bound to the surface of the pathogen [145,146]. N. meningitidis has been
proposed to cross both the BBB and the BCSFB to the inner and the outer CSF [48,147–149].
The polysaccharide capsule of N. meningitidis is a major contributor to meningococcal disease and
has been described as its main virulence factor. It can undergo genetic regulation and has the capability
to mask the function of non-pilus adhesins [150]. While the capsule is essential for bloodstream
survival, adhesion and invasion of host tissues are inhibited by the capsule [151]. Attenuated invasion
was further described for capsulated strains of N. meningitidis in an in vitro model of the BCSFB [48].
The loss of the bacterial capsule for members of group B and group C meningococcal strains lead to
increased uptake into HBMECs [152], and capsule and pili of N. meningitidis are downregulated upon
contact with epithelial cells [153].
Adherence of N. meningitidis to host cells is facilitated by different virulence factors such as pili
and surface exposed proteins like Opa and Opc, which further contribute to meningococcal disease.
The type IV pili are a crucial adhesin expressed by N. meningitidis. They are involved in the attachment
of capsulated virulence strains to host surfaces, extending from the bacterial surface through the
capsule [154]. These long filamentous structures, made up of the major pilin protein and three minor
pilins, promote adhesion of N. meningitidis to human endothelial cells via their interaction with
CD147 [155]. In addition to the major pilin, type IV pili adhesion is also dependent on the expression
of the outer membrane protein PilC [156–158]. Although affinity of pilin monomers to CD147 is
weak, their assembly into the type IV pili as well as high expression of CD147 on the BBB supports
the interaction [155]. Another group of adhesin-like structures, termed minor adhesion proteins, is
expressed at low levels in vitro but may be of importance in in vivo environments which have been
shown to alter the transcriptome of N. meningitidis [159].
While host, as well as tissue specificity, is determined by the pili and Opa proteins, invasion is
facilitated by both Opa and Opc [160]. Opa proteins have been shown to bind to the carcinoembryonic
antigen-related cellular adhesion molecule (CEACAM) receptor family, as well as the extracellular
matrix proteins fibronectin and/or vitronectin [161,162]. An increase in adhesion and entry into
HBMECs has been reported for N. meningitidis expressing Opc. This effect is facilitated by binding of
Opc to serum vitronectin or fibronectin [163]. Also, activation of the acid sphingomyelidase/ceramide
system, which involves clustering of ErbB2, an important receptor involved in bacterial uptake, by
Opc-expressing N. meningitidis played a major role in determining the pathogens invasiveness [164].
Furthermore, the bacterial adhesins PilQ and PorA were shown to bind to the laminin receptor, thereby
initiating contact with the BBB [99].
Attachment and invasion of human cells by three hypervirulent serogroup B strains of
N. meningitidis is furthermore promoted by the Neisseria adhesin A (NadA), a phase-variable,
surface-exposed protein [165–167]. For its interaction with the host, different membrane proteins
have been suggested. NadA was shown to target human β1 integrin subunits [150]. Also, a
genome-wide microarray analysis provided evidence for an interaction between NadA and the
endothelial low-density oxidized lipoprotein receptor 1 (LOX-1) [168]. Following initial binding to the
cell surface, the formation of microcolonies was observed, which in turn promoted the formation of
specific molecular complexes called “cortical plaques”. These structures contain accumulated ezrin,
moesin, tyrosine-phosphorylated proteins, ICAM-1/-2, CD44 and epidermal growth factor receptors
(EGFR) as well as localized polymerized cortical actin, resulting in major reorganization of host cell
morphology. Changes in cell surface morphology are a prerequisite for bacterial uptake and the
formation of microvilli-like cellular projections which protect the microcolonies from shear stress of
the bloodstream [169].
252
Int. J. Mol. Sci. 2019, 20, 5393
Following attachment, N. meningitidis induces host cell signaling events to facilitate invasion
into host tissues. These include the recruitment of ezrin as well as the activation of Src kinase
and cortactin [170–172]. Furthermore, the FAK is essential for integrin-mediated internalization of
N. meningitidis in HBMECs, enabling endocytosis through the interplay between FAK, Src and cortactin.
This is facilitated by N. meningitidis using the integrin signaling pathways to mediate signaling from
activated integrins upon attachment to the cytoskeleton [173]. These events promote the reorganization
of the actin cytoskeleton resulting in the formation of membrane protrusions that take up the pathogens
by surrounding them for internalization [144]. Genes involved in cytoskeletal reorganization were
shown to be differentially expressed after infection of HBMECs [174]. Analysis of whole-cell lysates
of human endothelial and epithelial cells have revealed an interaction of the Opc protein with alpha
actinin, a modulator of various signaling pathways and cytoskeletal functions [175].
Disruption of the BBB integrity was observed in in vitro studies as a consequence of opening
intracellular junctions [176]. Furthermore, cell detachment is initiated through activation of MMP 8,
promoting cleavage of the TJ protein occludin [177]. Alterations of intracellular junctions were observed
in a human brain microvascular endothelial cell line, potentially opening up a paracellular route of
crossing the BBB into the CNS through recruitment of the Par3/Par6/PKCζ polarity complex [178].
Meningococcal disease is accompanied by an acute inflammatory response [179]. The transcription
factor (TF) NF-κB, associated with the release of proinflammatory cytokines and chemokines during the
inflammatory response, was shown to be active in an in vitro CP epithelial model after infection with
N. meningitidis. Its activation was believed to arise from heterodimerization of TLR2 and TLR6 [33]. In
HBMEC the p38 MAPK had an impact on the release of IL-6 and IL-8, whereas the c-JUN N-terminal
kinases 1 and 2 (JNK1 and JNK2) were important for invasion [180].
4.2.3. Haemophilus influenzae
Haemophilus influenzae (H. influenzae) is a gram-negative bacterium capable of colonizing the upper
respiratory tract. The makeup of the polysaccharide capsule determines the pathogens classification
into serotypes a to f, of which H. influenzae serotype b (Hib) is responsible for the most severe infections,
such as meningitis, especially in children under the age of 5 years [181]. Although there is widespread
vaccination against Hib, some populations remain vulnerable and the vaccines do not protect against
other serotypes [182]. Furthermore, in areas where Hib vaccines are used, nontypeable H. influenzae
(NTHi) strains can now be the most common cause of meningitis [183]. Similar to the before described
pathogens, H. influenzae has to cross the epithelial barrier of the upper respiratory tract and, after
dissemination and survival in the bloodstream, cross the barriers of the brain to enter the CNS [184].
Traversal of both the BBB and BCSFB has been demonstrated for H. influenzae [47,51].
Attachment to host cells is enabled by the bacterial capsule and fimbriae which are subject
to reversible phase variation [185]. H. influenzae shares a common strategy to enter endothelial
cells with S. pneumoniae and N. meningitidis, which involves binding to the PAFR, mediated by
phosphorylcholine (ChoP) [186,187]. This interaction results in the entry of the pathogens into the BBB
through activation of β-arrestin–mediated uptake [188]. Binding of PAFR by lipooligosaccharide (LOS)
glycoforms containing ChoP was also demonstrated during invasion NTHi. This binding resulted in
the activation of host cell signaling by coupling with pertussis toxin-sensitive (PTX) heterotrimeric G
protein complexes and invasion of the pathogen. It was further suggested that this mechanism was
more efficient than micropinocytosis [187]. Binding to laminin receptor, another shared mechanism
of these pathogens, is initiated by OmpP2, facilitating the interaction with the brain endothelium by
H. influenzae [99].
In an in vitro model of the BCSFB, Hib as well as clinical isolates of Hib and H. influenzae serotype
f (Hif) were shown to adhere and invade the HIBCPP cells as intracellular bacteria. Both fimbriae and
the capsule lead to attenuated invasion [47]. Also, a study using H. influenzae serotype a (Hia) and a
co-culture of HBMECs and pericytes demonstrated an activation of stimulated A2A and A2B adenosine
receptors after infection. This in turn led to the release of Vascular Endothelial Growth Factor (VEGF)
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by the pericytes leading to pericyte detachment and endothelial cell proliferation resulting in overall
BBB impairment [189].
Using rat models of meningitis, a dose-dependent increase of BBB permeability was observed
after inoculation with Hib LPS [190]. Later studies showed that the permeability of the BBB was also
increased in rats after inoculation with H. influenzae outer membrane vesicles (OMV), suggesting
a role for these vesicles in transporting Hib LPS to the CSF during meningitis [191]. Furthermore,
it was shown that zyxin, a cytoskeletal protein implicated in the protection of TJs in the BBB, is
critical for the integrity of the BBB and, as a consequence, for protecting against invading pathogens
such as H. influenzae [192]. Overall, the inflammatory response of patients during the infection with
H. influenzae is determined by several virulence factors including the capsule, adhesion proteins, pili
and outer membrane proteins as well as LPS and IgA1 protease [193].
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5. Conclusions
A variety of studies have focused on how pathogens cross the blood-CNS barriers, mostly focusing
on the BBB. Although significant progress has been made in identifying mechanisms of host–pathogen
interactions during bacterial meningitis, additional efforts towards identifying bacterial and host cell
targets are needed. The diversity of mechanisms used by these pathogens presents the need for further
research. To this end, the identification of common mechanisms used by multiple pathogens will be
of great significance and further assist the development of effective therapies. Of high importance
is the distinction between the mechanisms the pathogens use for crossing the BCSFB and the BBB.
Pathogens exploiting epitopes of both barriers would present interesting targets for the development
of therapeutics.
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BCSFB Blood–cerebrospinal fluid barrier
BMEC Brain microvascular endothelial cells
CBP CERB-binding protein
CbpA Choline-binding protein A
CECAM Carcinoembryonic antigen-related cellular adhesion molecule
ChoP Phosphorylcholine
CNF1 Cytotoxic necrotizing factor 1
CNS Central nervous system
CP Choroid plexus
EGFR Epidermal growth factor receptors
ERK Extracellular signal-regulated kinases
FAK Focal adhesion kinase
GCH1 Guanosine triphosphate cyclohydrolase
GlpO α-glycerophosphate oxidase
HBMECs Human brain microvascular endothelial cells
HIBCPP Human choroid plexus epithelial papilloma
HvgA Hypervirulent GBS adhesin
iagA invasion associated gene A
Inl Internalin
JNK c-JUN N-terminal kinases
LLO Listeriolysin O
LOS Lipooligosaccharide
LOX 1 Lipoprotein receptor 1
LPS Lipopolysaccharide
LTA Lipoteichoic acid
MAPK Mitogen activated protein kinase
MIF Macrophage migration inhibitory factor
MMP Matrix metalloproteinase
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Nad A Neuraminidase A
NadA Neisseria adhesin A
NF-κB Nuclear factor κB
NO Nitric oxide
NOD2 Nucleotide-binding oligomerization domain 2
OMV Outer membrane vesicles
PAFR Platelet-activating factor receptor
PAMPs Pathogen-associated molecular patterns
PCPEC Primary porcine CP epithelial cells
PDGF-B Platelet-derived growth factor-B
PECAM Platelet endothelial cell adhesion molecule
PI3K Phosphatidylinositol 3-kinase
PKC Protein kinase C
plgR Polymeric immunoglobulin receptor
PMN Polymorphnuclear neutrophils
PPRs Pattern recognition receptors
PTX Pertussis toxin-sensitive
Ssr Serine-rich repeat
T3SS Type three secretion system
TF Transcription factor
TGF-β Transforming growth factor-β
TJs Tight junctions
TNF Tumor necrosis factor
VEGF Vascular Endothelial Growth Factor
GBS Group B streptococcus, Streptococcus agalactiae
E. coli Escherichia coli
H. influenzae Haemophilus influenzae
Hia H. influenzae serotype a
Hib H. influenzae serotype b
Hif H. influenzae serotype f
L. monocytogenes Listeria monocytogenes
N. meningitidis Neisseria meningitidis
NTHi nontypeable H. influenzae
S. pneumoniae Streptococcus pneumoniae
S. suis Streptococcus suis
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Abstract: Coagulase-negative Staphylococci (CoNS) are skin commensal bacteria. Besides their role
in maintaining homeostasis, CoNS have emerged as major pathogens in nosocomial settings. Several
studies have investigated the molecular basis for this emergence and identified multiple putative
virulence factors with regards to Staphylococcus aureus pathogenicity. In the last decade, numerous
CoNS whole-genome sequences have been released, leading to the identification of numerous putative
virulence factors. Koch’s postulates and the molecular rendition of these postulates, established by
Stanley Falkow in 1988, do not explain the microbial pathogenicity of CoNS. However, whole-genome
sequence data has shed new light on CoNS pathogenicity. In this review, we analyzed the contribution
of genomics in defining CoNS virulence, focusing on the most frequent and pathogenic CoNS species:
S. epidermidis, S. haemolyticus, S. saprophyticus, S. capitis, and S. lugdunensis.
Keywords: pathogenomics; coagulase-negative staphylococci; virulence factors; whole
genome sequencing
1. Introduction
Bacterial virulence is a complex concept that must be considered from the clinical, molecular,
and genomic perspectives. Clinically, the virulence of a pathogen, of a specific species or even of
a clonal strain, can refer to its inherent capacity to provoke specific clinical manifestations that can
be linked to the production of a virulence factor, often a protein. Microbiologically, Robert Koch
postulates illustrated bacterial virulence, which Stanley Falkow redefined in the late 1980s to provide
a molecular version of it [1]. Molecularly, the virulence factor is found in the pathogenic strains of a
species and not in non-pathogenic ones. Secondly, the inactivation of the encoding gene in an animal
model should attenuate the virulence of the strain. Thirdly, the reintroduction/reactivation of the gene
should restore virulence. Nevertheless, in the past 20 years, neither Koch’s nor Falkow’s hypotheses
have been able to completely define virulence factors. The development of rapid and cost-effective
genome sequencing technologies has provided the opportunity, among others, to discover a wide
range of genes that could be linked to bacterial pathogenicity. This ability to determine the pathogenic
capacities of a bacterium from its genome is known as pathogenomics [2]. Virulence factor databases
allow for fast and easy identification of putative virulence factors in whole-genome sequence data
based only on sequence homologies. The Virulence Factor Database was released in 2005 and is an
example of a regularly-updated database, of which a fourth version was released in 2018 [3]. Other
updated databases exist, such as PHI-base and Victors [4,5]. Thus, some virulence factors retain
the definition of Stanley Falkow, with a direct causative link with bacterial pathogenicity and some
possible clinical manifestations. Conversely, some other factors, such as those that are produced by
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human commensal bacteria, do not act as virulence factors under normal conditions, but these factors
will take part in bacterial pathogenicity under specific conditions, such as during cutaneous barrier
breach. Staphylococci are examples of such dual characterizations of virulence factors.
Staphylococci comprise Staphylococcus aureus, which is a human commensal bacterium that
colonizes nearly 30% of the human skin and mucosae, and coagulase-negative staphylococci (CoNS),
which include species such as Staphylococcus epidermidis, which colonizes nearly all human skin [6].
S. aureus is usually considered separately from CoNS and as a virulent species. Indeed, it produces a
wide range of toxins which can act as virulence factors leading to specific clinical manifestations with a
direct causative link. For example, the Panton-Valentine leucocidin (LukSF-PV) is a bicomponent toxin
that may lead to necrotizing pneumonia [7]. S. aureus produces other toxins such as epidermolysins
(ETA-B-D) and superantigens, e.g., toxic shock syndrome toxin (TSST-1), that lead to specific
clinical diseases and turn some particular strains into pathogens that fully meet the Koch and
Falkow postulates [8,9]. S. aureus might also produce numerous adhesion factors, capsule, and
biofilm-associated proteins, hemolysins, and immune evasion proteins whose main purpose is to
persist on human skin as a commensal and probably beneficial bacterium [10]. Many of those proteins
are cell wall-anchored and comprise a group of covalently-attached proteins with specific motifs
that bind to the extracellular matrix and are usually identified as microbial surface components
recognizing adhesive matrix molecules (MSCRAMMs) [11]. Many other proteins are cell-wall-attached
but display distinct functions such as iron-regulated surface proteins, and some genes encode for
putative MSCRAMMs but without any molecular and structural confirmation, and can be identified
more generally as surface adhesins, a terminology used in this review. Those adhesion factors play a
crucial role in the pathogenicity of S. aureus. The occurrence of a cutaneous barrier breach will allow its
penetration in a new environment, where those factors will behave as real virulence factors, allowing its
adherence, persistence, and multiplication in a normally sterile environment. Whole-genome sequence
analysis of S. aureus has revealed the existence of a very large repertoire of such toxins, adhesion
molecules, and biofilm-associated genes, sometimes without any molecular confirmation but based on
sequence homologies that lead to the characterization of S. aureus as a major pathogenic species [12].
CoNS are often considered as simple commensal bacteria due to their rarity in clinical pathology
and the absence of virulence factors like those produced by S. aureus. However, the emergence
of nosocomial infections with CoNS has led clinicians and researchers to reconsider the status of
these bacteria [13]. The publication of several CoNS genomes has been an essential tool to better
understand CoNS pathogenicity. The identification of virulence factors, such as toxins with clinical
impacts, remains exceptional or even controversial, and it appears that CoNS have a very large
repertoire of genes that encode for adhesion factors, biofilm production, hemolysins, exoenzymes, and
superantigens. Most CoNS also have similar regulatory systems to S. aureus, e.g., the agr system, for
which homologs have been identified in numerous CoNS species [13]. The cutaneous barrier breach is
a critical step to turning the CoNS species into pathogens, turning factors that are mainly implicated in
the bacterial life cycle on the skin into virulence factors leading to pathological manifestations. In this
situation, once again, the concept of virulence factors does not apply to the definitions provided by
Robert Koch and Stanley Falkow. Considering the great species diversity of CoNS, S. epidermidis is
the most frequent CoNS implicated in clinical diseases, and it remains the best-studied species at a
molecular and genomic level [14]. Nevertheless, none of the virulence factors that were discovered
could clearly categorized a specific strain as pathogenic or commensal, even if the strains belonging
to the clonal type ST2 have been over-represented in the specific context of S. epidermidis neonatal
sepsis [15]. ST2 clonal type always bears the insertion sequence IS256 and ica genes, which are
implicated in biofilm production, but the direct correlation of those loci with S. epidermidis invasiveness
has never been confirmed [16]. Some other species also came up as significant pathogens, such as
S. lugdunensis that has been widely investigated due to the severity and the specificity of clinical
manifestations of infection due to this species [17]. S. haemolyticus, S. saprophyticus, and S. capitis
are three other species for which the rate and the type of infection led to molecular and genomic
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investigations in the search of virulence factors [18,19]. S. caprae is a CoNS that usually belongs to the
animal skin flora, but it can also colonize human skin. This CoNS has been described in veterinary
infections (mastitis principally) and in human osteoarticular infections. Interestingly, this CoNS belongs
to a group of CoNS that is comprised of S. epidermidis, S. capitis, and S. saccharolyticus [13,20–22].
The identification of virulence factors in staphylococci has resulted in the identification of
mobile genetic elements. Indeed, the majority of S. aureus virulence genes are located on mobile
genetic elements such as pathogenicity islands, plasmids, and phages, which represent up to
25% of the S. aureus genome and play crucial roles in host adaptation and the modulation of
virulence [23–25]. Several bioinformatic tools have been developed to identify such genomic regions
based on comparative genomics [26–28]. Thus, the identification of putative virulence factors can be
driven by the identification of these genomic elements, but it has appeared that the presence of such
mobile genetic elements is very common in CoNS, but that they do not bear any virulence factors
which are similar to S. aureus. More generally, this large repertoire of mobile genetic elements in
staphylococci species explains why, despite a limited core genome, those species usually displayed
an open pan genome with a very high number of existing genes, sometimes shared by a very limited
number of clones [29–31]. Worthy of note is the fact that S. lugdunensis has a closed pan genome
which contains several barriers to horizontal gene transfers, which could explain this unique genomic
characteristic amongst CoNS [32].
In this review, we aimed to describe the occurrence of virulence factors, or more accurately, of
pathogenicity factors, based on whole-genome sequence data. We focused this systematic review on
the major CoNS pathogens for which such data have been published: S. epidermidis, S. lugdunensis,
S. saprophyticus, S. haemolyticus, S. caprae, and S. capitis. A comprehensive review of all CoNS
pathogenicity factors has been described elsewhere and is covered in references [13,33–39].
2. Research Method and Results
This systematic review was based on PubMed published articles in the English language.
We used the following MeSH terms: “Virulence”, “Virulence factors”, “Pathogenicity”, “Whole
genome sequencing”, and “Genomics”. In particular, we searched for the following species:
“Staphylococcus epidermidis”, “Staphylococcus lugdunensis”, “Staphylococcus capitis”, “Staphylococcus caprae”,
“Staphylococcus haemolyticus”, and “Staphylococcus saprophyticus”. We excluded studies that were not
based on whole-genome data, and those for which genome sequences were not deposited in public
databases (e.g., GenBank, European Nucleotide Archive).
We identified eight studies for S. epidermidis [29,30,40–45], four for S. capitis [46–49], three for
S. lugdunensis [32,50,51], two for S. haemolyticus [52,53], and one for S. caprae [54] and S. saprophyticus [55].
2.1. Staphylococcus epidermidis
S. epidermidis is by far the most prevalent CoNS in microbiological samples and the primary
cause of CoNS-related infections, particularly in nosocomial settings [56]. This species has been
widely studied at a molecular level and has provided the largest amount of data regarding the
presence of virulence factors that might be identified as pathogenicity factors [16]. Biofilm formation
is the main path by which S. epidermidis colonizes and infects prosthetic and medical devices as
reviewed by Otto et al. [57]. The biofilm life cycle is a complex process which implicates MSCRAMMs,
the proliferation of the exopolysaccharide matrix, and finally, biofilm dispersion, mostly due to
phenol-soluble modulin (PSM) peptides [57].
Nearly 500 genomes have been made available on GenBank, mainly draft genomes, but
also 12 complete genomes. S. epidermidis whole-genome-based studies to determine virulence
determinants are detailed in Table 1. In 2003, Zhang et al. provided the first genome-based analysis of
S. epidermidis virulence [40]. The authors provided the first sequence of the reference strain ATCC 12228,
a non-biofilm forming, non-infection associated strain, and they found several putative pathogenicity
factors, including multiple MSCRAMMs encoding genes and putative exoenzymes and toxins such
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as metalloproteases and Delta/Beta-hemolysins. Interestingly, a revised version of this genome was
released in 2017 which was determined using PacBio (PacBio, Pacific Biosciences, Menlo Park, CA, USA)
long read sequencing; it provided a slightly different genome from the one released by Zhang et al., and
established a new reference genome for comparative genomic studies [58]. In 2005, Gill et al. published
a new complete genome from S. epidermidis strain RP62a and performed comparative genomic analyses
with four S. aureus genomes, and included the genome from S. epidermidis ATCC 12228 [41]. As
expected, the authors found multiple virulence factors in the S. aureus genome. Nearly one-half of those
factors were carried by seven pathogenicity islands that were not found on S. epidermidis. Nevertheless,
some other mobile genetic elements were identified in this species (one genomic island and two
integrated plasmids), some bearing PSM and putative MSCRAMMs. Some other mobile genetic
elements were found in S. epidermidis genomes such as prophages, insertion sequences, and SSCmec-like
cassettes. The authors also identified several other putative virulence factors such as proteases (serine
and cysteine protease), lipases, and hemolysins (Beta/Delta haemolysin) loci. The presence of mobile
genetic elements and virulence factors led the authors to consider that horizontal gene transfer
between staphylococci had to be considered as a source of variability and, in this case, as a cause of
their pathogenicity.
Conlan et al. provided in 2012 the first large comparative genomic analysis of 30 S. epidermidis
whole genomes, showing that S. epidermidis had an open pan genome, as expected, but more
interestingly, that whole-genome-based phylogenetic trees could distinguish between commensal
and pathogenic strains. The presence of the formate dehydrogenase gene (fdh) could explain this
observation [42]. Meric et al. found in a second study based on whole-genome comparative analyses
that S. epidermidis and S. aureus, in hospital settings, share some genes involved in pathogenicity,
suggesting the existence of horizontal gene transfer between these species [29]. The added value of
whole-genome analysis was confirmed by Virginia Post et al., who compared whole-genome sequences
of 104 S. epidermidis isolates from patients with orthopedic-device-related infections. This study
found a correlation between patient outcome and some loci [30]. Patients with multiple surgeries
due to treatment failure were more likely to be infected with the biofilm-associated gene bhp, the
antiseptic resistance gene qacA, the cassette genes ccrA and ccrB, and the IS256-like transposase gene.
This whole-genome-based study identified, for the first time and directly from whole-genome data,
loci that might be involved in S. epidermidis pathogenicity based on well-documented clinical data.
While such studies have yielded novel and sometimes revolutionary insights into S. epidermidis
virulence, the presence of such loci does not provide any information regarding their expression,
regulation, and their impact on clinical implications. Yet, whole-genome data can be used as a
complementary tool when a putative virulence factor is identified, sometimes starting from clinical
considerations. In 2013, Fournier et al. provided observations of a patient with S. epidermidis
endocarditis, and the authors found several clues that could explain the virulence of this strain [43].
Besides known virulence factors such as MSCRAMMs, exoenzymes, and hemolysins, the authors
identified a previously unreported prophage, a new toxin/antitoxin module, and a complete icaABCD
operon, which was usually not observed in non-pathogenic strains. As observed by Conlan et al., this
pathogenic strain also lacked the fdh gene.
The existence of enterotoxins and pathogenicity islands in S. epidermidis has been controversial,
despite observations by Madhusoodanan et al. of such a genetic element in the clinical strain
S. epidermidis FRI909, which carried two functional enterotoxin genes sec3 and sell [59]. This unique
observation was initially considered as a possible genetic “accident”. In 2016, we described two strains
isolated from septic shock patients that produced a staphylococcal enterotoxin C with homology to
S. aureus enterotoxin C3 [60]. By using whole-genome data, we thereafter provided evidence that
the sec3 from our strains was located on a pathogenicity island very similar to the one described
by Madhusoodanan et al., named SePI-1/SeCI-1 [44]. We also identified several plasmids carrying
resistance genes and sharing homologies with S. aureus. This result confirmed that some mobile genetic
elements from S. epidermidis might come from S. aureus, with the transfer of virulence factors.
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Recently, Xu et al. performed a whole-genome analysis of a multi-resistant S. epidermidis strain
isolated in the environment, i.e., in a hotel room, and identified multiple loci dedicated to antibiotic
resistance but also to numerous virulence genes, as described previously [45].
S. epidermidis is a major cause of nosocomial infections within other CoNS. The existence of several
factors that modulate its commensal life cycle on the skin also turns this species into a pathogen when
entering sterile sites. Whole-genome studies have provided specific and unique data regarding the
general evolution of its genome and interactions with other staphylococci, such as S. aureus. However,
whole-genome data also appear as crucial and unique complementary analyses when a specific strain
is isolated clinically, or when a putative virulence factor is molecularly identified.
2.2. Staphylococcus lugdunensis
S. lugdunensis is considered a significant pathogen in human infection [17]. Clinically, its virulence
is most likely lower than that of S. aureus. Clinical observations have emphasized the frequency
and severity of skin and soft tissue infections, endocarditis, and osteoarticular infections [61–63].
Microbiologically, this CoNS produces a coagulase, which is a common feature with S. aureus [64].
Its pathogenicity has been noted by several authors, and multiple virulence factors have been identified
molecularly, including adhesion molecules like a fibrinogen-binding protein; cytotoxins such as
δ-like-hemolysin; a complete biofilm synthesis system, including an agr regulating operon; and as
seen in S. aureus, a large system dedicated to iron metabolism [65–67]. Interestingly, Heilbronner et al.
showed that duplication of the isd locus provided a selective advantage to S. lugdunensis in the case
of iron limitation, possibly improving bacteria survival and pathogenicity. Recently, we identified
and purified a novel metalloprotease named lugdulysin that could be implicated in osteoarticular
infections [61].
S. lugdunensis whole-genome-based studies to determine virulence determinants are listed in
Table 2. The first complete genome of S. lugdunensis was published by Tse et al. in 2010 [68]. Since
then, 17 complete genomes have been published, and eight additional draft genomes are available in
GenBank. Nevertheless, the first exploitation of a complete genome was provided by Heilbronner et al.
in 2011 [50]. The authors published the complete genome of strain N920143 and identified several
putative virulence factors based on comparative genomics and homologies searches. They identified,
for the first time, a complete operon implicated in iron metabolism (isd: isdB-J-C-K-E-F-G), several
genes coding for MSCRAMMs such as fibrinogen and Von Willebrand adhesion factors, a streptolysin
S-like toxin, an IcaABCD operon for biofilm synthesis, agr regulation genes, and even an esx locus with
homology to the esx-ESAT 6 secretion systems that are implicated in the secretion of virulence factors
in Mycobacterium tuberculosis. Due to the frequent localization of virulence genes on mobile genetic
elements in S. aureus, in 2017 we also published the complete genome of seven strains of S. lugdunensis
and identified multiple mobile genetic elements [51]. We identified a very unusual number of plasmids
and prophages by using computational methods, including four new prophages and five plasmids,
in which three were previously described in other CoNS and one in S. aureus. This study suggested
that horizontal gene exchange could occur between staphylococci, including S. aureus. Descriptions of
plasmids and prophages in CoNS remain rare, but, interestingly, they have been performed mainly in
S. epidermidis and S. haemolyticus.
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S. lugdunensis is characterized by its unusual antimicrobial susceptibility, even if some rare strains
are oxacillin-resistant. In 2017, Chang et al. fully characterized, for the first time, two novel variants
of staphylococcal cassette chromosome mec elements in two oxacillin-resistant S. lugdunensis strains
by using whole-genome sequence data [69]. The authors also identified several homologies with
S. aureus, S. haemolyticus, and S. epidermidis cassette chromosome regions. If this result suggested once
again the existence of horizontal gene exchanges between staphylococci, including S. aureus, the very
unusual antimicrobial susceptibly of S. lugdunensis remained unexplained in comparison to other
CoNS, which displayed a very high rate of resistance, particularly in nosocomial settings [19]. We
recently published a comparative genomic analysis of S. lugdunensis whole-genome with S. aureus and
S. epidermidis [32]. S. epidermidis and S. aureus are characterized by an open pan genome, which means
that those species display a virtually unlimited number of new genes when adding different genomes,
even if they conserve a limited number of genes through the strains called the core genome. Conversely,
S. lugdunensis display a closed pan genome, and all published genomes were very similar, with only a
very limited number of new genes among the strains. This unexpected characteristic could explain the
very well conserved antimicrobial susceptibility of S. lugdunensis that rarely acquires resistance genes.
We also found that this observation could rely on the presence of numerous barriers to horizontal gene
transfer in this species, including restriction-modification, CRISPR/Cas, and toxin/antitoxin systems.
S. lugdunensis is a very particular CoNS and might be closer to S. aureus than other CoNS in
terms of virulence. Whole-genome sequence studies have emphasized its originality on a genomic
scale, including the presence of multiple unusual factors implicated in its pathogenicity and that are
uncommon for CoNS, like its iron metabolism system. Overall, its genome encodes for several factors
that take part in its survival on the skin as a commensal bacterium, such as adhesion proteins and
biofilm capacities. Once again, those factors probably act as virulence factors once the cutaneous
barrier is broken. Comparative genomic studies have also revealed that it displays a unique profile in
terms of genomic plasticity, which could explain some of its microbiological characteristics, such as its
highly-conserved antimicrobial susceptibility.
2.3. Staphylococcus capitis
S. capitis is the third CoNS that has been described in clinical infections and for which
whole-genome studies focusing on its virulence are available [13]. S. capitis infections have been
described in various clinical situations implicating biofilm production as endocarditis, catheter-related
bacteremia, and prosthetic joint infections [70,71]. This species also causes neonatal sepsis in neonatal
intensive care units [72,73].
S. capitis whole-genome-based studies to determine virulence determinants are listed in Table 3.
The first draft genome of this species was released in 2009, and the first complete genome was
published in 2015 by Cameron et al. to determine the genetic determinants that could support its
pathogenicity [46]. The authors identified several loci that could encode for virulence factors and
performed a comparative genomic analysis with the S. epidermidis genome. They identified putative
virulence regulators (as agr homologs), biofilm production loci, genes encoding for exoenzymes
(as metalloproteases and hemolysins), PSMs, and MSCRAMMs. This genome-scale analysis led to a
functional analysis of biofilm and PSMs production.
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At a larger scale, it appears that some clonal strains might be implicated in the context of neonatal
sepsis as suggested by Butin et al., who observed the worldwide endemicity in 17 countries of a
multidrug-resistant strain by using pulsed-field gel electrophoresis patterns but also whole-genome
sequence data [74]. Multidrug resistance has emerged as a crucial issue in S. capitis infections, with
nearly half of the strains being oxacillin-resistant in hospital settings; occasionally, some strains
with vancomycin reduced susceptibility have been identified [72,73]. Li et al. provided a complete
whole-genome analysis of a multi-resistant strain causing bacteremia, and found a very high and
unusual number of genes implicated in such a resistant profile [47]. Recently, Simoes et al. published
the first whole-genome sequence of S. capitis strain NRCS-A, which is a multi-resistant clone implicated
in neonatal infections worldwide, by using PacBio (PacBio, Pacific Biosciences, Menlo Park, CA,
USA) long read sequencing, and provided comparative genomic analysis with three other NRCS-A
sequenced clones coming from different countries [48]. The authors identified, as expected, multiple
resistant genes, but interestingly, some of them were located on mobile genetic elements. The authors
identified several virulence genes which had been described previously by Cameron et al., but more
specifically, they identified which of them was clone-specific as a putative restriction-modification
system and a nisin resistance gene, which could explain the persistence of NRCS-A clones in patients’
gut microbiota. In 2017, Kumar et al. used whole-genome sequence data to reveal the existence of
four loci encoding for antimicrobial peptides [49]. The authors were then able to perform a functional
analysis to confirm the functionality (antimicrobial activity against Gram-positive bacteria, including
S. aureus) of those genes, and formulate the hypothesis that such antimicrobial peptides could explain
the adaptation and the persistence of S. capitis on the human skin.
S. capitis is considered a serious pathogen, particularly in neonatal settings, and whole-genome
studies have provided useful and unique data regarding the spread of its antimicrobial resistance, but
have also emphasized its ability to colonize and persist on human skin, which is directly linked to its
pathogenicity regarding catheter-associated infections.
2.4. Staphylococcus caprae
S. caprae is a normal component of the animal skin flora and can cause mastitis, principally in
goats [13]. It also belongs to the human skin flora and is an observed cause of osteoarticular infections
and also material-associated infections and bacteremia [20]. Until recently, only six draft genomes of
S. caprae were available from humans and goats. S. caprae whole-genome-based studies to determine
virulence determinants are listed in Table 4. In 2018, Watanabe et al. published a comparative genomic
analysis of three human strains by performing a whole-genome assembly which leads to three complete
chromosomes [54]. The authors compared the conserved genome parts of S. epidermidis, S. capitis,
and S. caprae, as all previous phylogeny studies found all three species belonged to the same group
(S. epidermidis group) [22]. They found that all three species shared a biofilm- and capsule-associated
loci, and they also shared PSM genes. They also identified several putative MSCRAMMs genes.
We observed that the three species belonged to the S. epidermidis group and shared very common
features for skin resident bacteria. The similarity in clinical presentation of infection caused by these
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2.5. Staphylococcus haemolyticus
S. haemolyticus is a commensal bacterium but is also a frequent nosocomial pathogen that has
been described mainly in catheter-related bacteremia, with one of the highest degrees of methicillin
resistance among CoNS [19,75,76]. S. haemolyticus whole-genome-based studies to determine virulence
determinants are listed in Table 4. S. haemolyticus was one of the first CoNS with a complete genome
published by Takeuchi et al. in 2005 [52]. The authors identified several putative virulence factors
in this pioneering study, such as hemolysins and bacterial capsule. Until now, no publication has
completely explored the presence of virulence genes in this species, warranting future studies. Some
previous studies have described the presence of cytotoxins, enterotoxins, and PSMs at the molecular
level, which is exceptional among CoNS [77,78]. This species is also a biofilm-producing species,
but interestingly, in 2016, Hong et al. published the first complete sequence of S. haemolyticus by
using PacBio (PacBio, Pacific Biosciences, Menlo Park, CA, USA) long read sequencing and found
no ica operon, but an agr regulation system homolog, suggesting that alternative mechanisms were
implicated in biofilm formation [53]. Thus, S. haemolyticus is a significant pathogen in humans, but it
appears that a complete whole-genome analysis of those virulence factors is lacking, whereas, several
complete genomes are already available with this species bearing very unusual virulence factors for
a CoNS.
2.6. Staphylococcus saprophyticus
S. saprophyticus is a commensal CoNS and can lead to lower urinary tract infections in young
women [79,80]. Colonization of the genital area and the gut has been linked to this atypical type of
infection, but most importantly, it was shown in vitro that this CoNS has an unusual capacity to adhere
to urothelial cells and to produce urease. Nevertheless, those characteristics are not unique in CoNS
and do not fully explain the capacity of this CoNS to cause urinary tract infections. S. saprophyticus
whole-genome-based studies to determine virulence determinants are listed in Table 4. In 2005, Kuroda
et al. established the first complete genome of S. saprophyticus, and until now, only six complete
genomes for this species have been made available in GenBank [55]. The authors identified three
factors that could explain the specificity of S. saprophyticus pathogenicity by using whole-genome
data and a comparative genomic approach. They identified a novel—and unique among CoNS—cell
wall-anchored protein, UafA, associated at a molecular level with a high capacity to adhere to cells
from the urinary tract. They also identified a unique uro-adaptative transport system and urease
production as the two other factors that could be linked to the specific pathogenicity of S. saprophyticus.
Since 2005, whole-genome virulence studies have been lacking, but adherence and persistence onto
the urinary tract have been confirmed as the main factors that could be linked to pathogenicity [81–83].
Overall, S. saprophyticus, lacks many of the adhesion proteins and other virulence factors that have
been identified in CoNS from the S. epidermidis group, S. caprae, and S. lugdunensis, which probably
explains the differences that are observed at a clinical level.
2.7. Phylogenetic Relationship among Staphylococcus Species
In 2012, Lamers et al. proposed a refined classification of staphylococci using a combination of
Bayesian and maximum likelihood analysis of multilocus data based on four loci (non coding 16S
rRNA, dnaJ, rpoB, and tuf ) [22]. The authors identified six species groups and 15 cluster groups among
staphylococci, a classification that is considered as a current standard for staphylococci phylogenetic
classification [13]. Interestingly, S. lugdunensis appeared in a unique cluster group, a particularity
that could be link to the very low allelic polymorphism of this species and the existence of a closed
pangenome, a unique characteristic among CoNS [32,84]. In addition, S. epidermidis, S. capare, and
S. capitis which are described here as pathogenic species in nosocomial settings belong to the same
cluster group, along with S. saccharolyticus. S. saprophyticus and S. haemolyticus belong to distinct cluster
groups in this classification. This classification does not clarify the mechanisms by which staphylococci
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acquire genes, including virulence factors, but only emphasize the uniqueness of S. lugdunensis, even if
more generally, all staphylococci have strong barriers preventing horizontal gene transfers, making
their transformation extremely difficult even in vitro [85].
3. Conclusions
The emergence of nosocomial infections with CoNS has illuminated the role of numerous virulence
factors. In the context of infections and breaches of the skin barrier, these factors allow virulent
adherence, persistence, and multiplication of CoNS. The use of whole-genome sequence data has
evidenced the multiplicity of such factors in CoNS. It would be more appropriate to characterize these
elements as pathogenicity factors, even if some of them can appear exceptionally as virulence factors
that may lead to specific clinical conditions, as seen with S. epidermidis-producing strains.
The increasing data that are now available at the clinical, molecular, and genomic levels even make
possible the development of innovative approaches to characterize bacterial pathogenicity. Deneke
et al. proposed such a novel approach by using a machine learning workflow that determines the
pathogenicity of a novel bacterial species based on genomic data only, an eventuality that is not rare
with the increasing use of metagenomic analyses in various environments and microbiota [86].
Nevertheless, if sequencing technologies have become cheaper and whole-genome sequence data
easier to produce, they will remain as complementary tools to molecular and clinical studies that have
to be coordinated in a structured framework [87]. Good practices and quality controls have become
crucial to ensure the quality of the released genomes and the validity of analyses [88,89].
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Abstract: Bacteria from the species Trueperella pyogenes are a part of the biota of skin and mucous
membranes of the upper respiratory, gastrointestinal, or urogenital tracts of animals, but also,
opportunistic pathogens. T. pyogenes causes a variety of purulent infections, such as metritis,
mastitis, pneumonia, and abscesses, which, in livestock breeding, generate significant economic losses.
Although this species has been known for a long time, many questions concerning the mechanisms of
infection pathogenesis, as well as reservoirs and routes of transmission of bacteria, remain poorly
understood. Pyolysin is a major known virulence factor of T. pyogenes that belongs to the family
of cholesterol-dependent cytolysins. Its cytolytic activity is associated with transmembrane pore
formation. Other putative virulence factors, including neuraminidases, extracellular matrix-binding
proteins, fimbriae, and biofilm formation ability, contribute to the adhesion and colonization of
the host tissues. However, data about the pathogen–host interactions that may be involved in the
development of T. pyogenes infection are still limited. The aim of this review is to present the current
knowledge about the pathogenic potential and virulence of T. pyogenes.
Keywords: Trueperella pyogenes; virulence; pyolysin; infection; pathogenicity; immune response;
Actinomycetales
1. Introduction
The species Trueperella pyogenes [1], previously classified as Arcanobacterium pyogenes [2],
Actinomyces pyogenes [3,4], and formerly as Corynebacterium pyogenes [5], belongs to the family
Actinomycetaceae, in the order Actinomycetales of the class Actinobacteria, the so-called actinomycetes [6].
A dendrogram representing the phylogenetic relationship between this bacterium and some other
pathogenic Actinomycetales is shown in Figure 1. T. pyogenes is a Gram-positive, pleomorphic,
non-spore-forming, non-motile, non-capsulated, facultatively anaerobic rod, which is characterized by
a fermentative metabolism and strong proteolytic activity [4]. Its growth requirements are not excessive,
but media enriched with blood or serum need to be used for the culture. The preliminary recognition of
T. pyogenes isolates is based on the cell morphology; the features of colonies, which are surrounded by a
zone of beta-haemolysis on blood agar; and a negative catalase assay. Then, the biochemical properties
can be tested for species determination [7]. Sometimes, additional bacteriological methods other than
the conventional ones are necessary for the differentiation and appropriate identification of isolates.
New techniques, such as loop-mediated isothermal amplification (LAMP) assay, matrix-assisted laser
desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry, Fourier transform infrared
(FT-IR) spectroscopy, or 16S rRNA gene sequencing may be useful for the diagnostics of T. pyogenes
infections [8–13]. Those methods enable the recognition of the closely related taxa of the order
Actinomycetales, and sometimes the reclassification of some of them [14].
Int. J. Mol. Sci. 2019, 20, 2737; doi:10.3390/ijms20112737 www.mdpi.com/journal/ijms289
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Figure 1. Neighbor-joining [15,16] phylogenetic tree based on 16S rRNA gene sequences (a total of 1422
positions in the final dataset) of Trueperella pyogenes, other Trueperella species, and related taxa. Only
bootstrap values of 70%, based on 1000 replicates, are shown next to the branches [17]. The scale bar
represents the number of substitutions per site. The analysis involved 64 nucleotide sequences derived
from the GenBank® database, and the evolutionary relationships were calculated in MEGA X [18].
T. pyogenes is considered to be a part of the biota of skin and mucous membranes of the upper
respiratory and urogenital tracts of animals [19–21]. Moreover, this bacterium was also isolated from
the wall of bovine rumen and swine stomachs, as a gastrointestinal microbiota [22,23], and from
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the udders of clinically healthy cows [24]. However, T. pyogenes is also an important opportunistic
pathogen. This species, like other well-known actinomycetes, such as Corynebacterium pseudotuberculosis
or Rhodococcus equi, is an etiological agent of common suppurative infections in animals. In the case of
C. pseudotuberculosis, the highest susceptibility to the infection is observed in small ruminants, and
abscesses are located mainly in the lymph nodes [25,26]. R. equi is a cause of pyogenic infections,
mostly in horses, and lesions are found mainly in the respiratory tract [27,28]. Whereas T. pyogenes
is pathogenic for a variety of animal species, and purulent or necrotic lesions may occur in different
host tissues. Interestingly, there were no relationships found between the virulence gene profiles of
T. pyogenes strains and their origin, a type of infection and a host [13,21,29–31]. However, Ashrafi
Tamai et al. [32] reported a significant association between the virulence genotypes and clonal types of
T. pyogenes isolates, and the severity of the clinical symptoms in postpartum cows with metritis.
Although T. pyogenes is a bacterium that has been known of for a long time, many questions
concerning the mechanisms of infection pathogenesis, as well as its reservoirs and routes of transmission,
still remain poorly understood. The aim of this review is to present the current knowledge about the
pathogenicity and virulence potential of this opportunistic animal pathogen.
2. Pathogenicity
T. pyogenes infections occur in both domestic and wild animals worldwide, but are rare in humans.
The prevalence of T. pyogenes isolation may differ, depending on a host species and a geographic
region. The majority of published data concerns T. pyogenes infections in food animals and comes
from Europe [21,33–38], China [39–43], Japan [44,45], Brazil [30,46], and the United States [47–50].
In livestock, the diseases caused by T. pyogenes generate significant economic losses, mainly in cattle
and swine breeding, causing a reduction of meat and milk yield, as well as decreased reproductive
efficiency and sometimes the necessity to cull diseased animals. The clinical course of these suppurative
infections may be severe, with different mortality rates, which increase in the case of misdiagnosis or
inappropriate treatment. Beta-lactams, tetracyclines, and macrolides are the antibiotics most often
used to treat T. pyogenes infections. A question of the therapy efficacy is especially important, as the
antimicrobial resistance in T. pyogenes becomes an emerging problem because of the common use of
these drugs in agriculture [29,32,34,39,40,42,44,47,49,51,52].
Generally, the infections caused by T. pyogenes have an opportunistic nature, in which adverse
environmental and host-related factors play a relevant role in the disease establishment [45,50,53,54].
Nevertheless, the risk factors of the infection development are sometimes difficult to estimate. Curiously,
there are no obvious differences observed between the virulence genotypes of commensal and clinical
T. pyogenes isolates, although, in some investigations, a gene encoding one of the virulence determinants,
fimbria A, was found more frequently in the isolates obtained from infected cows than from healthy
ones [49,55]. However, the in vitro study of Ibrahim et al. [56] showed significant differences in the
expression level of eight known virulence genes in T. pyogenes isolated from the uterus of a cow with
clinical endometritis, and the isolate from the uterus of a healthy cow. This indicates the importance
of the regulatory mechanisms of the virulence gene expression in the infection development, which
can be also demonstrated in an example of the pyolysin gene expression [57]. In other study, a
relationship between the clonal types of isolates and their origin, from a diseased or healthy host, was
noted [21]. All of these findings suggest that other unknown bacterial factors may also contribute to
the establishment and development of the T. pyogenes infection.
T. pyogenes may cause infection as a primary etiological agent, but more frequently, this species
is involved in polymicrobial diseases, such as mastitis [45], uterine infections [55], interdigital
phlegmon [58], or liver abscesses [59]. This bacterium may be recovered from a mix infection of various
bacterial species, but especially frequently with Gram-negative anaerobes, such as Fusobacterium
necrophorum, Bacteroides spp., or Peptoniphilus (formerly Peptostreptococcus) indolicus. In these cases,
purulent and necrotic lesions are usually observed, leading to systemic signs and resulting in animal
death. A particularly strong synergistic interaction occurs between T. pyogenes and F. necrophorum [60].
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It consists in the stimulation of F. necrophorum growth by a diffusible and heat-labile product of
T. pyogenes, which probably decreases the oxygen pressure and the oxidation-reduction potential in
a site of infection, generating conditions advantageous for this anaerobe [61]. On the other hand, a
leukotoxin produced by F. necrophorum protects T. pyogenes against phagocytosis, because of its ability
to lysis leukocytes or to induce their apoptosis, depending on its concentration [59]. Moreover, lactic
acid, which is a metabolic product of T. pyogenes, can be used by F. necrophorum as an energy substrate.
Other bacteria, especially Escherichia coli, are also often associated with T. pyogenes co-infections, mostly
postpartum uterine infections [55,62,63]. However, the synergistic effect between both of these bacteria
is not evident. The findings of Zhao et al. [64] indicated that N-acyl homoserine lactones from E. coli
and Pseudomonas aeruginosa, which act as the quorum-sensing (QS) signal molecules, can inhibit the
growth and virulence of T. pyogenes in vitro. The recent in vivo study of Huang et al. [65], conducted
in a mouse model, confirmed these observations.
2.1. T. pyogenes Infections in Animals
In livestock, T. pyogenes infections occur mainly in cattle, swine, sheep, and goats, rarely in horses
or birds, and are often associated with heavy economic losses.
In cattle, T. pyogenes mainly causes infections of the reproductive tract and the mammary gland,
as well as pneumonia and liver abscessation. The most prevalent diseases in dairy cows related
with this bacterium are metritis and endometritis, which may develop in a clinical form in about
23–52% of animals after parturition [29,32,38,39,66]. T. pyogenes together with many other bacteria
comprises a vaginal biota of healthy cows [67], and may also colonize and persist in the uterus of dairy
cows with normal puerperium [21,38]. However, as an opportunistic pathogen, this bacterium can
invade the distant parts of the reproductive tract, especially after parturition, when the protective
epithelium of the endometrium is disrupted, and it can also increase the influx of inflammatory
cells in these tissues [50,68]. The presence of T. pyogenes in the endometrium is correlated with
the damage of the tissue because of the cytolytic activity of the pyolysin against the endometrial
stromal cells, which are particularly sensitive to this cholesterol-dependent toxin [68,69]. The ability of
T. pyogenes to produce inflammatory lesions in the endometrium was confirmed by the findings of
Lima et al. [70]. They noted that after the intrauterine infusion of T. pyogenes suspension containing
109 colony-forming units/mL, moderate to severe endometrial inflammation developed in the studied
cows, and additionally, premature luteolysis was observed in some animals. The uterine inflammation,
usually later postpartum, associated with T. pyogenes, has a form of subclinical or clinical endometritis,
and may reduce the reproductive performance and milk yield [63,71,72]. Bonnett et al. [73] noted
that cows with T. pyogenes infection took significantly longer to conceive. Moreover, the study of
Boer et al. [63] demonstrated that T. pyogenes isolation at day 21 postpartum was associated with the
subsequent diagnosis of purulent vaginal discharge, and this observation was confirmed by Sheldon et
al. [74]. T. pyogenes can also have a lethal impact on the oviductal epithelial cells, as it was demonstrated
by Mesgaran et al. [75] in the in vitro study. In general, in the cows infected by T. pyogenes, an
increased prevalence of clinical endometritis is observed [50]. Frequently, uterine disorders are from
co-infections with T. pyogenes and other bacteria, such as E. coli, Streptococcus spp., Staphylococcus spp.,
Fusobacterium spp., Prevotella spp., and Clostridium spp. [39,55,62,71,76–78]. Such polymicrobial uterine
infections, especially those with anaerobes, result in an increased purulent secretion and higher severity
of lesions [76,79]. The problems regarding parturition, the subsequent negative energy balance, or
hyperketonemia are considered to be important risk factors for these diseases [63,80].
Another important and common T. pyogenes infection in cattle is mastitis, which may affect
lactating and dry cows, as well as heifers [30,37,43,45,46,81–84]. T. pyogenes is well known as one of the
crucial agents of polymicrobial infection, called summer mastitis, which occurs mainly in pastured cows
during the summer, and is associated with pathogen transmission by an insect, Hydrotaea irritans [85,86].
However, Madsen et al. [87] demonstrated no differences in the rates of T. pyogenes isolation from the
mastitis cases in stabled and pastured cattle. Similarly, Ribeiro et al. [46] and Ishiyama et al. [45] did
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not observe a seasonality of the T. pyogenes mastitis occurrence during their long-term survey of the
disease. Moreover, it was reported that T. pyogenes alone can cause clinical mastitis called pyogenes
mastitis, even with a high severity of symptoms [45,85]. The mammary gland inflammation caused by
this bacterium is characterized by severe pyogenic lesions in the mammary tissue, and malodorous
and purulent milk, especially in case of co-infection with anaerobes, decreasing the milk yield and
the low recovery rate [45]. The anaerobes most often involved in mastitis together with T. pyogenes
are P. indolicus, F. necrophorum, and Prevotella melaninogenica (formerly Bacteroides melaninogenicus).
All of these bacteria can colonize the mucous membranes and skin of clinically healthy cattle, but
P. indolicus and T. pyogenes were the most frequently isolated from a teat skin [88]. Regardless of
the many investigations on T. pyogenes mastitis, little is still known about the factors involved in the
establishment and persistence of that infection.
T. pyogenes also contributes to many other disorders in cattle, among them, liver abscesses and
interdigital phlegmon have a more significant economic impact. Those infections are mixed with
anaerobes, mainly F. necrophorum, characterized by the synergistic interaction of both of the bacteria
mentioned previously [59]. Liver abscesses related to T. pyogenes infection occur mostly in feedlot
cattle, with a varying frequency from 2% to 80% [59,89–91]. The infection is associated with T. pyogenes
presence in the rumen wall, in which the primary lesions can form and then bacteria can penetrate by a
hepatic portal venous system to a liver, where abscesses form as secondary infection foci [60]. In the
case of abscesses rupturing, systemic signs can develop, resulting in animal death. The development
of liver abscesses is probably associated with ruminal acute or subacute acidosis, which can induce
primary damage in the protective surface of the rumen wall.
Bovine interdigital phlegmon incidence in dairy cows is usually 2–5% per lactation, but some
cases of outbreaks were also reported [35,58,92,93]. The role of T. pyogenes in the pathogenesis of this
polymicrobial disease is not well defined. Kontturi et al. [58] reported that this bacterium is rather a
secondary pathogen associated with the healing stage of the infection, while Bay et al. [94] did not
detect T. pyogenes at all in the interdigital phlegmon investigation using 16S rRNA gene sequencing.
Moreover, T. pyogenes may cause a variety of other purulent infections in cattle such as pneumonia,
encephalitis, pyelonephritis and kidney abscesses, lymphadenitis, endocarditis, and abscesses of
various localization [30,31,36,44,46,95,96]. This pathogen was also isolated from cases of septicaemia
and abortion [36,44,46,97].
In swine, T. pyogenes is a common agent of pneumonia, pleuritis, endocarditis, osteoarthritis,
polyarthritis, mastitis, reproductive tract infections, and septicaemia [13,29,35,44,98–102].
Abscesses—superficial, muscular, or located in different organs—occur frequently, and may lead to
the development of systemic purulent infection and inflammation of lungs, liver, kidneys, muscles,
bones, joints, or other tissues [13,46,103]. In many cases, these are infection mixed with different
microorganisms, as is observed in T. pyogenes infections in cattle. Diseases of swine associated
with T. pyogenes are an emerging clinical, epidemiological, and economic problem, because they
usually result in the necessity for the elimination of infected animals from a herd, and the discard
of carcasses with suppurative lesions at slaughterhouses [103]. It has been reported that a number
of factors can predispose to the development of these disorders, among other viral infections, that
cause immunosuppression, for example with porcine reproductive and respiratory syndrome virus
(PRRSV) [104].
In small ruminants, T. pyogenes is mostly a cause of abscesses formation in different
tissues and localized in various parts of the body, including bone marrow and foot (footrot)
abscesses [29,31,105–110]. Those lesions differ from that observed in the case of caseous lymphadenitis
caused by C. pseudotuberculosis [111]. Moreover, T. pyogenes can be associated with purulent, mainly
polymicrobial disorders in sheep and goats, such as pneumonia, lymphadenitis, arthritis, osteomyelitis,
reproductive tract infections, mastitis, and septicaemia [30,35,36,46,112–114].
In other domestic animals, infections related to T. pyogenes are rare. It may be connected with the
fact that this bacterium does not belong to their normal biota. Therefore, there are only a few data
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on the occurrence of T. pyogenes infections in companion animals. The first reported cases referred to
otitis externa in a cat and cystitis in a dog [115], lung abscess in a dog [116], and feline pyothorax [117].
Moreover, T. pyogenes was isolated from cases of wound infection, abscesses, vaginitis, pneumonia,
and encephalitis in dogs [30,35,36,46]. Recently, an interesting case of T. pyogenes and Brucella abortus
co-infection in a cat and a dog was described by Wareth et al. [118]. Both animals lived on a dairy cattle
farm, where cases of abortion and mastitis in cows were noted. The bacteria were isolated in a mixed
culture from the uterine discharge of a bitch after abortion and a cat with pyometra.
Infections related to T. pyogenes were noted sporadically in horses, and included single cases
of metritis, orchitis, mastitis, septicaemia, umbilical infection in foals, abscesses, and wound
infection [30,36,46,119].
Furthermore, two cases of suppurative disorders in rabbits caused by T. pyogenes were published.
In the first case, this bacterium was isolated from lung lesions, and in the second one, from necrotic
foci in liver, spleen, lung, and brain [36,120].
The incidence of T. pyogenes infections in birds seems to be very low. Some cases of clinical
lameness and osteomyelitis in turkeys were reported [121,122]. A unique case of liver abscesses in
pigeons was described by Priya et al. [123].
In wildlife, T. pyogenes may be associated with many types of purulent disorders occurring in
free-living and captive animals. T. pyogenes infections were reported the most frequently in ruminants
and other herbivores, in which the bacteria were also found as a resident microbiota of the skin and
mucous membranes of respiratory and urogenital tracts [20,54,124].
In the United States and Canada, T. pyogenes is an emerging pathogen of captive or free-ranging
white-tailed deer (Odocoileus virginianus), which cause intracranial abscessation—suppurative
meningoencephalitis disease complex (the intracranial abscess disease) that occurs with a variable
frequency, depending on animal populations [54,124–127]. T. pyogenes may be also involved in
pneumonia and necrobacillosis occurring in this animal species [128,129].
Furthermore, T. pyogenes was also isolated as an etiological agent of chronic purulent infections,
including keratoconjunctivitis, brain and foot abscesses, in other cervids, such as Key deer (Odocoileus
virginianus clavium) [130], fallow deer (Dama dama) [53], roebuck (Capreolus capreolus) [131], red
deer (Cervus elaphus) [132], and mule deer (Odocoileus hemionus) [133]. T. pyogenes is a prevalent
cause of variably located abscesses in forest musk deer (Moschus berezovskii), noted mainly in farm
animals [40,134].
In European bison (Bison bonasus), T. pyogenes is associated with abscesses of the liver, spleen,
lungs, lymph nodes, skin, and especially with urogenital tract infections [135]. In female bison,
abscesses of various localizations were observed. In male bison, T. pyogenes is considered to be one of
the etiological agents of a chronic necrotizing and ulcerative inflammation of the prepuce and penis
(balanoposthitis) [135].
Additionally, T. pyogenes infections were reported in antelopes [29,136,137], an okapi (Okapia
Johnstoni) [138], bison (Bison bison) [139], Bighorn sheep (Ovis canadensis) [140], a chamois (Rupicapra
pyrenaica) [112], camels [141–144], an elk [36], and reindeer [145,146]. Moreover, some other sporadic
cases of infectious diseases associated with T. pyogenes were described in Grey Slender lorises (Loris
lydekkerianus nordicus) [147,148], macaws, and elephants [48], as well as in reptiles, a bearded dragon,
and a gecko [149].
2.2. T. pyogenes Infections in Humans
Infections caused by T. pyogenes in humans are sporadic, mostly occur in immunosuppressed
patients, and are connected with occupational exposure, especially relating to contact with farm
animals and their environment [150]. Published data concerning T. pyogenes infections in humans are
limited, and include, among others, reports on endocarditis [151–155], endemic leg ulcers [156,157],
pneumonia [158], arthritis [159,160], sepsis [161], and various purulent lesions and abscesses [162].
As T. pyogenes was never demonstrated as a commensal microbiota of humans, those infections should
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be considered as zoonotic diseases [48]. Although, a probability of animal-to-human transmission of
this pathogen has not been well estimated and confirmed.
3. Reservoir, Transmission, and Routes of Infection
Most actinomycetes are widespread in the natural environment, being found in various ecological
niches as saprophytes, but they may also constitute a commensal biota of humans and animals, and some
of them can be opportunistic pathogens [163,164]. Curiously, there is no published characterization of
environmental T. pyogenes isolates, for example from soil, which might be considered non-pathogenic,
as it is known, for instance, in case of environmental strains of R. equi, a typical soil opportunistic
pathogen [165]. Although there are no data on T. pyogenes ability to replicate in soil or water, certainly,
it can persist for some period in such environmental conditions. For example, C. pseudotuberculosis,
the related actinomycete, can survive for several weeks in the environment [166]. Considering the
nutritional requirements of T. pyogenes, it should be assumed that the bacterium can replicate only in the
environment rich in peptides, fermentable carbohydrates, inositol, and hemin, and at the temperature
range of 20 to 40 ◦C [4]. Therefore, it seems that a main reservoir and source of this bacterium are
animals of various species.
Little is known about the dissemination of T. pyogenes infections, and about the transmission
of the pathogen. It is suggested that the majority of infections have an endogenous character, as
the bacteria are a common component of the skin and mucous membrane biota [48]. However, the
possibility of exogenous infections should also be considered, because bacteria may be transmitted, for
instance, by contaminated husbandry utensils and equipment, or directly from animal to animal [30,46].
The natural environment contaminated by T. pyogenes is suggested to be an important source of the
bacteria, especially in the case of mammary or foot disorders in domestic and wild animals [46,53,109].
In addition, climate conditions, such as a high humidity and mild temperature, are factors favouring
the infection occurrence [53]. In the case of summer mastitis, T. pyogenes, exceptionally, may be
transmitted between animals by biting flies [86]. However, a possibility of tissue penetration by these
bacteria through a micro-trauma caused by ectoparasites, such as ticks, should be also considered. The
preliminary results of the study on ticks collected from the skin of European bison indicated a potential
contribution of those arthropods to T. pyogenes transmission [167].
The observations from different studies indicate a potential threat of T. pyogenes transmission from
wild to domestic animals, or the other way around [53,135]. It is very possible, regarding the frequent
co-occurrence of wildlife species and livestock animals on the same agricultural areas, such as pastures
and meadows, which can serve as a reservoir for this pathogen.
The data on the genetic relationship of T. pyogenes isolates occurring in a particular host population,
and on the dissemination of strains amongst animals and the environment are lacking. The results of a
few epidemiological studies on bovine and swine isolates are available [10,13,21,32,148]. In some of
them, an association between the clonal types and the development of clinical infection by a strain was
shown [21,32,148], while in other investigations, such a correlation was not found [10,13]. A variety
of molecular methods, characterized by various discriminatory powers, were used for T. pyogenes
differentiation, which enabled the phylogenetic analysis of strains to be performed, for example
the 16S rRNA gene sequencing [135,149], single enzyme amplified fragments length polymorphism
(SE-AFLP) [13], BOX-PCR [21,32], the superoxide dismutase A gene (sodA) sequencing [36], random
amplification polymorphic DNA (RAPD-PCR), and multilocus sequence analysis (MLSA) [148]. The
usefulness of some of them was proved by Nagib et al. [148] during the study on T. pyogenes isolates
from lorises, which showed a close relationship, indicating their clonal origin. Unfortunately, the gold
standard method used for genomic fingerprinting, pulse field gel electrophoresis (PFGE), was never
reported as a technique applied for T. pyogenes phylogenetic investigation.
The routes of T. pyogenes infections are frequently difficult to establish. The T. pyogenes infections
develop mainly as a consequence of the mechanical injuries of skin and mucous membranes [48].
Wounds and abrasions of skin are common routes of infection, for example, udder injuries in the case
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of T. pyogenes mastitis, or hoof injuries in the case of interdigital phlegmon. In the case of mucous
membranes damage, such as in metritis, the bacteria can invade deeper tissues after endometrial
epithelium, disruption during parturition. Another described route of infection is associated with
improperly performed surgical procedures, such as castration or intramuscular injection [103]. Bacteria
can also invade tissues through micro-injuries of the skin caused by some arthropoda, like flies or
ticks, as it has been mentioned above. In deer, behaviour may influence the pathogen transmission
and susceptibility to cranial/intracranial abscess infection, which occur more frequently in adult
males [125,127]. Interestingly, Belser et al. [54] noted a higher prevalence of T. pyogenes along the
forehead of the males of white-tailed deer than the females, when the rate of the pathogen carriage on
the nasopharyngeal mucosa was the same for both sexes. Therefore, it is suggested that the disease
development may be a result of cuts or abrasions arising from antler rubbing on trees or from sparring
between males.
4. Pathogenesis of T. pyogenes Infection
The pathogenesis of microbial infection is determined by a variety of bacterial and host-related
factors. In the case of T. pyogenes, the pathogenicity is attributed to the determinants, which induce
the formation of abscesses, empyemas, and pyogranulomatous lesions. However, pathogen–host
interactions in T. pyogenes infection are still poorly understood. Some known and putative bacterial
factors contribute to the development of T. pyogenes infection, but their role in the infection pathogenesis
remains insufficiently explained. Moreover, many researchers highlighted a high phenotypic and
genotypic diversity among the studied T. pyogenes isolates of various origins, also taking into
consideration virulence genotypes [13,21,29–31]. This finding indicates the genetic heterogeneity in
the studied T. pyogenes populations. On the other hand, Cohen et al. [124] detected significantly more
virulence genes in T. pyogenes isolates from populations of white-tailed deer males, in which a high
incidence of the intracranial abscess disease was observed, compared with those detected in the isolates
from apparently healthy animals in populations in which the disease was not noted. This finding
suggests that the essential differences in the pathogenic potential may exist among T. pyogenes strains,
depending on their origin.
4.1. T. pyogenes Virulence
Only few virulence factors in T. pyogenes are recognized to date (Figure 2). They include pyolysin
(PLO), the only known toxin of this bacterium; some adhesive factors, such as fimbriae neuraminidases
and extracellular matrix-binding proteins; different exoenzymes, such as serine proteases with gelatinase
and caseinase activity, or DNAses; as well as the ability to invade host cells and to create biofilm
formation [48]. The significance of some of them in the pathogenicity is not clear enough. In general,
profiles of genes encoding particular virulence determinants are not correlated with a type of infection
and host species. However, a few cases of association between the presence of some determinants and
a type of infection were reported [49,55].
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Figure 2. Schematic diagram of known virulence factors of T. pyogenes. Abbreviations:
CpbA—collagen-binding protein; Fbp—fibrinogen-binding protein; Fnbp—fibronectin-binding protein;
NanH—neuraminidase H; NanP—neuraminidase P; PLO—pyolysin.
4.1.1. Pyolysin
PLO is considered to be both a major virulence factor of T. pyogenes and a host-protective
antigen [168–170], and, until now, the gene (plo) encoding this protein was detected in all
wild-type T. pyogenes strains. This is an exotoxin belonging to the cholesterol-dependent
(also called cholesterol-binding) cytolysins (CDCs), which are a family of 51- to 60-kDa
single-chain proteins produced by many species of Gram-positive bacteria, for example Streptococcus
pneumoniae (pneumolysin), Streptococcus suis (suilysin), Streptococcus pyogenes (streptolysin O),
Paenibacillus alvei (alveolysin), Clostridium perfringens (perfringolysin O), or Listeria monocytogenes
(listeriolysin O). [171,172]. PLO is the most divergent protein of this group, presenting only 38% to
45 % identity and 58% to 64% similarity to other toxins from the CDC family, when the conserved
core of the CDCs (corresponding to amino acid fragment 38–500 of perfringolysin O) is taken into
consideration during the analysis [172]. The highest identity of PLO is shown to suilysin, novyilysin,
botulinolysin B, and tetanolysin O, which range from 45% to 44% [172]. This protein was purified and
characterized for the first time by Ding and Lämmler in 1996 [173], however, its toxic and haemolytic
activities were previously reported by Lovell [174]. As a member of the CDC family, PLO displays a
cytotoxic effect on a variety of host cells, for example, erythrocytes, polymorphonuclear neutrophils
(PMNs), macrophages, epithelial cells, fibroblasts, and endometrial stromal cells. [68,168,171,172]. The
cytolytic activity of PLO is associated with its ability to bind to the plasma membrane and to form
transmembrane pores, which is a common feature of CDCs [168,172]. The in vitro study showed that
PLO is able to cause the lysis of human, sheep, horse, rabbit, and guinea pig erythrocytes [4]. Specific
antibodies against PLO completely neutralize its haemolytic activity, suggesting that PLO is the sole
haemolysin produced by T. pyogenes [168].
The significance of PLO as a primary virulence factor of T. pyogenes was confirmed in many in vitro
and in vivo experiments, with use of PLO-deficient mutants or recombinant proteins [168,175,176].
PLO has a lethal effect on mice and rabbits, and a dermonecrotic effect on guinea pigs after intravenous
and intraperitoneal injection [168,174,177–179]. Jost et al. [168] observed a loss of haemolytic activity
in the PLO-1 mutant strain as a result of the insertional inactivation of the plo gene, as well as its
1.8-log10 reduction in virulence for mice in comparison to the wild-type strain. They also, for the first
time, documented the importance of PLO for the in vivo survival of bacteria, studying the effect of
the co-challenge of a wild-type strain, and a mutant strain with the inactivated plo gene in a mouse
model. Similarly, Zhao et al. [179] demonstrated that the T. pyogenes strain with an in vitro higher
expression of the plo gene was more virulent for mice in the in vivo study than the strain with a lower
plo expression, designated as avirulent.
Billington et al. [180] cloned and sequenced the plo gene encoding PLO, which was located in
an open reading frame (ORF) of 1605 bp in the T. pyogenes chromosom. The plo gene sequence was
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also described by Ikegami et al. [181], for which the deduced pyolysin sequence showed a 99.4%
similarity and a 97.6% identity to the PLO sequence previously reported by Billington et al. [180].
A consensus ribosome binding site, two promoter sequences (similar to the E. coli σ70 promoter), and
three direct repeats (DR1 to D3 with sequence ATTTTTG(C)TGG) were found upstream of the plo
gene, and a transcriptional terminator region was found downstream of this gene [180]. Moreover,
Rudnick et al. [170] found that the plo gene, along with the mentioned sequences and ORF (orf121),
encoded a 13.4 kDa protein of an unknown function, form a genomic islet of 2.7 kb, characterized by a
reduced content of G+C (50.2%). This islet, flanked by two housekeeping genes, smc and ftsY (62.5%
G+C), is located in the T. pyogenes chromosome (Figure 3) [170]. Interestingly, the codon usage of plo
and orf121 differ from that of the genes flanking the islet. The genes smc and ftsY are common in many
other bacteria, mainly Gram-positive, and are essential for T. pyogenes viability [170]. Downstream of
the ftsY gene are the ffh gene, and then the ORF, orf353. The ftsY and ffh genes encode the FtsY and
Ffh proteins, respectively, which have a high similarity to the signal recognition particles from the
other bacterial species [170]. The ftsY, ffh, and orf353 genes in T. pyogenes are located in close proximity,
and form an operon-like arrangement that is unusual in most other bacteria. It seems that, as in other
species, these genes are needed for bacterial growth.
Figure 3. Schematic presentation of the T. pyogenes chromosomal region containing the plo gene and the
surrounding genes. P1 and P2 indicate the positions of two promoters; DR 1–3 indicate the positions of
three direct repeats. The scale is not designated.
The differences between the islet and the flanking genes suggest a possibility of horizontal transfer
of the plo gene, though any integrase or transposon sequences were not found in this chromosomal
region. Taking into consideration the fact that the plo gene is present in all wild-type T. pyogenes
strains, including commensal isolates, it seems probable that plo was inserted into the intergenic region
between smc and ftsY by homologous recombination; it has to be retained, as both of these genes are
obligatorily required for bacterial growth. In addition, it was confirmed by Rudnick et al. [170] that
the plo islet is a conserved region of the T. pyogenes chromosome found in all of the studied isolates of
various origins.
T. pyogenes is an opportunistic pathogen that, being a part of the host microbiota, has no damaging
effect on its organism. Therefore, it is suggested that the regulation of the PLO expression may be critical
for the establishment of the status of this bacterium as a pathogen or a commensal. Rudnick et al. [170]
reported that the plo gene expression is not regulated in vitro by orf121 located upstream of this gene.
In their subsequent investigation, two promoters, P1 and P2, located in the plo islet, were identified
as the regulatory sequences controlling the transcription of plo [57]. It was observed that the in vitro
haemolytic activity of T. pyogenes was in growth phase depending on a peak in the early stationary
phase [57,173]. It indicated that plo is up-regulated during that phase, and indeed a significant increase
in the plo specific mRNA was noted. Thus, the suggestion that the PLO expression is controlled at
the transcriptional level was confirmed [57]. It was also shown that the P2 promoter is predominant
and highly active during the stationary phase of the in vitro growth of bacteria, while the P1 activity
is weak. Besides the P1 and P2 promoters, direct repeats (DRs) located in the plo promoter region
may be involved in the regulation of the plo gene transcription. The study of Rudnick et al. [57]
298
Int. J. Mol. Sci. 2019, 20, 2737
showed that DRs, especially DR3, may function as binding sites for a soluble T. pyogenes factor being a
transcriptional regulator. However, regarding AT-rich sequences of DRs, which can easily bend, it was
supposed that DRs may also act as activators of transcription, by promoting RNA polymerase binding
to the promoter.
The predicted, on the basis of the plo gene sequence, length of the PLO molecule is 534 amino
acids (aa), and then, this protein should have a molecular mass of 57.9 kDa [180]. A signal peptidase
cleavage site was found between 27 and 28 aa, indicating that the mature PLO molecule has a weight
of 55.1 kDa. According to the Funk et al. [182] study, PLO is an oxygen-stable protein, heat-labile
(destroyed at 56 and 100 ◦C), destroyed by pH 3 and 11, and id sensitive to treatment of protease,
trypsin, and amylase.
In contrast to the majority of CDCs, the PLO activity is insensitive to thiols or other reducing
agents, in other words, PLO does not require thiol activation [180]. This difference is associated with the
divergence within the amino acid sequence of undecapeptide (491–501 aa) of PLO. The undecapeptide
is a highly conserved region of each CDC, located near the C terminus of the protein. In some CDCs,
including PLO, amino acid substitutions occur in this region [180,183]. In case of PLO undecapeptide
(EATGLAWDPWW), a unique cysteine residue (C491), responsible for the thiol-activated nature of
CDCs, is replaced with an alanine (A492). This substitution has no essential effect on the haemolytic
activity of PLO, but is related to the oxygen stability of this cytotoxin [184]. Moreover, other changes in
the PLO undecapeptide were noted, such as the insertion of a proline residue (P499) and the deletion
of an arginine residue at the end of the CDCs undecapeptide. It seems that these changes have
important effects on the conformation and charge of the undecapeptide [180]. The proline insertion
has the greatest effect on the PLO activity, as the deletion of this amino acid resulted in a lack of
haemolytic activity [183]. The same effect on the PLO haemolytic activity was observed in the case
of the removal or substitution of any of the three tryptophan residues [183]. Therefore, as it was
previously demonstrated by Billington et al. [180], the amino acid sequence of the PLO undecapeptide
is required for full cytolytic activity.
The cytolytic activity of PLO, like other CDCs, is suppressed by free cholesterol in a concentration
of 1μg/mL [180]. However, the presence of cholesterol in the target plasma membrane is absolutely
necessary for pore formation by CDCs. The role of the undecapeptide in the initial plasma membrane
binding seems to be crucial, in particular, the first tryptophan residue (W497) is important. Although,
Billington et al. [183] suggested that other fragments of PLO might also participate in recognition and
binding to the host cell membranes.
The known secondary and tertiary structures of some CDCs shows a significant similarity [172].
A crystal structure of the PLO molecule presumably is homologous to the structure of other CDCs. The
tertiary structure model of PLO, based on the perfringolysin O (PFO)—PLO sequence alignment—was
proposed by Pokrajec et al. [185]. The monomeric PLO molecule is rich in β-sheet elements and consists
of four domains (D1 to D4), of which D2 and D3 are packed against each other, while D1 is located at
the N-terminal and D4 at the C-terminal end of the molecule (Figure 4).
Domain 1 contains a-helix and β-sheet elements. The precise role of D1 in the pore-forming
process remains undefined. Zhang et al. [186], studying an effect of the replacement of aspartic acid
(D238) in this domain with arginine, showed an important role of D1 in maintaining the pore-forming
activity of PLO. The investigation of Imaizumi et al. [177] indicated that domain 1, especially the region
of 55–74 amino acids, is required for the haemolytic activity of PLO. Yan et al. [187] also confirmed
the importance of this region of domain 1, as they demonstrated that the substitution of each amino
acid from 58 to 62 in the PLO molecule, particularly isoleucine 61, resulted in the complete loss of its
haemolytic activity. Moreover, six B-cell linear epitopes in D1 were identified by Yang et al. [188].
Domain 2 of the molecule forms a long, curved single layer of anti-parallel β-sheet, while the
structure of domain 3 is more complex and consists of five strands of anti-parallel β-sheet surrounded
by helical layers and short α-helices at either side of the central β-sheet. Domains 2 and 3 are involved
in the monomer oligomerization and insertion into the plasma membrane. The separation of D2 and
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D3, as well as the structural collapse of D2, are required during these processes [189]. The conversion
of the D3 short α-helices to two transmembrane β-hairpines starts the molecule insertion into the
bilayer, and is a crucial step of the transmembrane β-barrel formation [172].
  
Figure 4. Simplified model of the pyolysin molecule, based on the perfringolysin O-structure.
Domain 4 of the PLO molecule is the only contiguous domain characterized by a β-sandwich
structure, connected by a single peptide with the rest of the protein. As it has been mentioned above, the
conserved undecapeptide sequence, rich in tryptophan residues, is located at the tip of this domain. This
part of the PLO is responsible for host plasma membrane recognition and cholesterol binding [185,190].
However, Pokrajac et al. [185] also demonstrated the ability of D4 to self-oligomerization, but not pore
formation. Their findings indicate a greater functional role of this PLO domain in cytolysin activity,
compared with the previously described CDCs.
The molecular mechanism of pore-forming by PLO and other CDCs seems to be very similar,
and is best described for PFO [172,185]. PLO molecules are secreted to the extracellular environment,
probably via the general secretion system, as in the most CDCs [172]. In a form of water-soluble
monomers, they bind to the cholesterol-containing areas in the plasma membrane of the eukaryotic host
cells [183]. Binding to cholesterol by the PLO domain 4 initiates the oligomerization of the monomers
and the formation of incomplete arc-shaped structures, called th pre-pore. Subsequently, the PLO
oligomers are inserted into the bilayer by the transmembrane β-hairpins of domain 3, which leads to
the formation of a large transmembrane β-barrel pore, which is <50 nm in diameter and protrudes <7
nm above the plasma membrane surface [191]. As a consequence, this process leads to th eleakage of
ions and other cytoplasmatic molecules, and finally to the lysis of the host cell.
It seems that a predominant assignment of the cytolytic activity of PLO is to enable access to
free iron and other growth factors essential for the bacterial replication contained in the host cells.
Furthermore, the ability to lysis phagocytes protects the bacteria against the host immune response.
On the other hand, at lower concentrations, PLO can modulate the host immune response.
Despite a wide knowledge about the molecular structure and function of PLO, the precise role of
this toxin in the pathogenesis of particular T. pyogenes infections, characterized by different course and
clinical manifestations, remains unclear.
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4.1.2. Fimbriae
The occurrence of fimbriae in Gram-positive bacteria is a rarity. T. pyogenes is just one of the
exceptions [48]. T. pyogenes fimbriae have a filamentous structure, at 200–700 nm in length and
2.5–4.5 nm in width, and probably occur in a limited number on bacterial cells (less than 10 per
cell) [48,192]. In T. pyogenes, five fimbriae were described, FimA, FimB, FimC, FimE, and FimG [48,192].
The presence of other fimbrial subunits can be deduced on the base of the T. pyogenes genome sequences,
for example FimJ [192,193]. FimA, 45.7 kDa protein, contains a signal peptide, an E box sequence, and
is encoded by the fimA gene [48]. FimB, 90.5 kDa protein, has a similar structure, but additionally
contains a cell wall-sorting domain and a fibronectin-binding domain, and is encoded by the fimB
gene [48]. Both genes, fimA and fimB, are located in a fimbrial gene operon, together with the srtA gene
encoding a putative sortase. The other fimbriae, FimC, FimE, and FimG, are encoded by the genes
fimC, fimE, and fimG, respectively.
The expression of the fimbriae in vitro is poor; therefore, it is difficult to characterize their
properties, thus only their genes or mRNAs are better known. Liu et al. [192] investigated the in vitro
expression of FimA, FimC, and FimE. However, even though different culture conditions were used,
only the FimE expression could be detected. Zhao et al. [179] studied the expression of the virulence
factors of T. pyogenes, including FimA and FimC, in vitro and in vivo on a mouse model. Their results
showed that in in vivo conditions, the fimA gene was earlier expressed than fimC, which suggests that
FimA is a dominating fimbria in T. pyogenes. This is in accordance with the findings of many studies
on fimbrial genes distribution that demonstrated a high prevalence of fimA among various isolates,
whereas the genes of other fimbriae were detected with different frequencies [13,21,29–31].
A role of fimbriae in the T. pyogenes infection is associated with the bacterial adherence to
host cells, but the precise mechanisms of this interaction are not well understood. Taking into
consideration that T. pyogenes can be a commensal as well as a pathogen, it seems that fimbriae are
equally important for bacteria in both of these forms. Likewise, in the case of infections caused by
many other bacteria, T. pyogenes fimbriae are required for cell adhesion and the colonization of host
tissues [49,55]. Liu et al. [192], based on their study results, speculated that the poor expression of
FimA can limit the formation of other fimbriae, and that the up-regulation of this fimbria production
may be associated with T. pyogenes pathogenicity.
4.1.3. Extracellular Matrix-Binding Proteins
T. pyogenes also expresses other proteins, which determine the adhesive properties, and which
are associated with the cell wall of the bacteria. These proteins probably also promote adhesion and
enhance colonisation through the ability to bind extracellular matrix (ECM) compounds [48]. In the case
of Gram-positive bacteria, these proteins belong to the microbial surface components recognizing the
adhesive matrix molecules (MSCRAMM) family [194]. Firstly, T. pyogenes shows a fibrinogen-binding
activity, however, it was inhibited by proteases [195]. In addition, the 20 kDa fibronectin-binding
protein associated with the T. pyogenes cell wall was also detected, but not well characterized [48].
Collagen-binding protein A (CbpA) represents the MSCRAMM family, and is one of the better
known extracellular matrix-binding proteins produced by T. pyogenes [48,194,196]. This 121.9 kDa
surface protein is encoded by the chromosomal cbpA gene, and displays a 50.4% similarity to Cna, the
collagen adhesin of Staphylococcus aureus. CbpA binds almost all types of collagen, but not other ECM.
However, Pietrocola et al. [194] reported that CbpA can bind fibronectin, but in a distinct subsite than
that recognized by collagen. This protein is involved in the adherence of bacteria to epithelial and
fibroblast cell lines [196]. It may be supposed that the T. pyogenes strain, which produces CbpA, has
higher potential to colonize collagen-rich tissues. Although, the cbpA gene was found in many isolates
of various origins, with different frequencies [13,21,29–31].
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4.1.4. Neuraminidases
Neuraminidases (sialidases) are one of the most important enzymes of the sialic acid catabolism.
Neuraminidases cleave the terminal sialic acid residues from complex glycoproteins, glycolipids,
and carbohydrates from the host cell receptors. Neuraminidases are produced by many species of
Gram-negative and Gram-positive bacteria or viruses [197]. Bacterial neuraminidases are the main
factors for promoting adhesion by exposing the cryptic host cell receptors. In addition, neuraminidases
can promote tissue colonisation by reducing mucus viscosity. These compounds also weaken the
host’s immune response by exposing IgA particles, making them more susceptible to bacterial
proteases [48,197–199]. Bacterial neuraminidases are secreted as extracellular enzymes or are anchored
to the cell wall. While in Gram-negative bacteria, neuraminidases are usually secreted, neuraminidases
of the Gram-positive bacteria are commonly in a cell-associated form [200–204].
The first note about the 50 kDa extracellular neuraminidase of T. pyogenes was reported by
Schaufuss and Lämmler [205]. Afterwards, two neuraminidases expressed by T. pyogenes were
better characterized [206,207]. Neuraminidase H (NanH) and neuraminidase P (NanP) are 107 kDa
and 186,8 kDa proteins, respectively. These neuraminidases are attached to the T. pyogenes cell
wall, which results from the presence of specific anchoring motifs in their molecules (LPxTG—for
NanH; LAWTG—for NanP). NanH and NanP proteins contain the conserved catalytic RIP/RLP motif
(Arg-Ile/Leu-Pro) and five copies of the Asp box motif (Ser-X-Asp-X-Gly-X-Thr-Trp), commonly
occurring in the bacterial neuraminidases [206,207]. NanH is the most similar to the neuraminidase
from Actinomyces viscosus (61.8% similarity and 31.2% identity) [206]. NanP shows a similarity
to the neuraminidase from Micromonospora viridifaciens (61.6% similarity and 45.3% identity) [207].
However, some similarity between NanH and NanP (53.8% similarity and 38.8% identity) was also
demonstrated [48].
T. pyogenes strains can produce neuraminidases H and P, encoded by the nanH and nanP genes,
respectively [206,207]. The occurrence of these genes is characteristic of the majority of T. pyogenes
isolates from cattle [21,29–31,36,206–208] and swine [29,30,36]. However, the nanH and nanP genes
were found at high rates in the bovine isolates studied by Zastempowska and Lassa [37]. The genes
encoding neuraminidases are detected with various frequencies in the T. pyogenes isolates from small
ruminants, such as goats and sheep [29–31,36], and in the forest musk deer isolates [134], while
the presence of these genes among the isolates from European bison is much less common [29,135].
In several studies, the nanP gene was detected more frequently than the nanH gene in the tested
isolates [30,135,208]. However, Rogovskyy et al. [31] reported that most of T. pyogenes isolates from
small ruminants carried mainly the nanH gene.
T. pyogenes neuraminidases play an important role in adhesion to the host cells, as it was shown
in the study with epithelial cells [207]. Moreover, T. pyogenes neuraminidases are probably necessary
for the colonization of host tissues during the early phase of infection, but they are not essential
during further stages of a disease development [48]. The different prevalence of the genes encoding
neuraminidases in the T. pyogenes isolates from various origins, suggests that other adhesion factors
may be also produced by this species.
4.1.5. Biofilm
The ability to perform biofilm formation is a well-known feature of microorganisms, which
promotes their resistance to many disadvantageous factors, for instance antimicrobials, as well as
increases the adherence properties and enables better protection against the immune response of the
host [48]. T. pyogenes, as with many other bacteria that are resident on the mucous membranes of a
host, is able to perform biofilm formation. Biofilm production was noted in a majority of the studied
T. pyogenes isolates from different animal species and various types of infections [43,134]. Biofilm
formation by T. pyogenes is controlled by a two-component regulatory system PloS/PloR, where PloR
up-regulates the expression of biofilm [64,179,209]. In the case of polymicrobial infection, a biofilm
formation by T. pyogenes may be inhibited by the QS molecules produced by other bacteria, for example
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E. coli [64,210]. As in some cases biofilm production may promote the infection development, it seems
important to find a therapeutical option for reducing this bacterial property. Da Silva Duarte et al. [211]
evaluated the use of the E. coli phage UFV13 for the disruption of the T. pyogenes biofilm, and they
obtained a significant decrease of biofilm formation caused by this phage. This finding indicates a
necessity of further studies on this issue.
4.1.6. Regulation of Virulence Factor Expression
Jost and Billington [48] suggested the existence of a two-component system comprising a sensor
histidine kinase (HK) and response regulator (RR) proteins in T. pyogenes. These signalling systems
are common among bacteria, and they enable the detection of an environmental or cellular signal
that leads to an appropriate cellular response [212,213]. Zhao et al. [64] determined a LuxR-type
two-component regulatory system in T. pyogenes, named PloS/PloR, using a comparative transcriptome
analysis between two T. pyogenes isolates from musk deer with different haemolytic activities. The
results of the transcriptome analysis showed the presence of ten typical DNA-binding response
regulators (RRs) in the T. pyogenes genome. However, a protein crystal structure analysis revealed that
only one among the identified DNA-binding RRs had a structure similar to that described previously
by Jost and Billington [48]. This RR, called PloR, had a CheY-type receiver domain and a C-terminal
LuxR-type HTH DNA-binding domain, while a cognate sensor HK was named PloS. Zhao et al. [64]
demonstrated that the expression level of the ploR gene is correlated with the expression level of the plo
gene, indicating PloR as an activator of plo, which up-regulates PLO production. On the other hand, it
was observed that PloR can down-regulate the expression of T. pyogenes proteases [48]. In addition,
it seems that PloR is able to up-regulate the biofilm formation and probably the expression of the
fimbriae in T. pyogenes.
The function of the two-component system in T. pyogenes was also investigated in vitro using the
N-acyl homoserine lactones of P. aeruginosa and E. coli as QS signal molecules, which can bind to the
upstream sensor HK, PloS, and via the PloS/PloR system, may regulate the virulence of bacteria by the
inhibition of their growth and biofilm production [64]. Huang et al. [65], studying an effect of N-acyl
homoserine lactones on the T. pyogenes virulence in a mouse model, confirmed that those QS molecules
inhibited the expression of plo, ploR, and ploS, and increased the survival rate of mice. In conclusion,
the function of the two-component system PloS/PloR and the QS system seems to have the essential
significance for the modulation of the T. pyogenes virulence.
4.2. Induction of Host Defense Mechanisms by T. pyogenes
The pathogenicity of T. pyogenes is assigned mainly to PLO, a cholesterol-dependent cytolysin,
which promotes cell lysis and is responsible for altering the host cytokine profile. This toxin also exerts
cytolytic, dermonecrotic, and lethal effects on numerous types of cells, including immunocompetent
and non-immune cells [176,186]. It is responsible for the complement cascade induction; modulation
of the host cytokine profile; inhibition of respiratory burst; and bactericidal activities in neutrophils,
monocytes, and macrophages. These features lead to the modulation of the immune response and to
evasion from a host’s immune mechanisms. Because of the presence of neuraminidases NanH and
NanP, T. pyogenes is able to adhere to the alimentary and respiratory epithelial mucosa, increasing
the mucus viscosity that facilitates bacterial colonization and diminishes the host immune response,
including damage to a first line of defence—destruction of IgA by bacterial proteases. Those serine
proteases, as it was mentioned above, are involved in the invasion and destruction of tissues [48,196].
For many years, the assessment of PLO involvement in the development of the disease was
conducted using in vitro (established cell lines or primary cell cultures) and in vivo (mouse and large
animal) models [48,68,69,75,168,186].
One of the first antibacterial mechanisms of immune response is inflammation, resulting in the
recruitment of neutrophils, monocytes, and macrophages to a site of infection. The involvement of those
cell populations leads to the phagocytosis and killing of bacteria, clearance of infection, and stimulation
303
Int. J. Mol. Sci. 2019, 20, 2737
of adaptive immune response. Still, T. pyogenes interactions with host phagocytic cells strongly influence
the outcome of the disease. Using macrophage established cell line J774A.1, it was clearly shown
that this pathogen was easily phagocytosed, and could survive within macrophages up to 72 h, with
the survival rate diminishing over time. Probably, this is caused by the presence of antibiotics in a
medium used for culturing infected macrophages. Once bacteria exit the infected cell, they are killed
by the antibiotic present in the medium. Similar results were obtained when the macrophage cell line
RAW264.7 was infected with either T. pyogenes ATCC 19411 strain or T. pyogenes European bison isolate.
In this study, phagosome formation, intracellular bacteria survival, and changes in the mitochondrial
network and distribution were established at 2, 6, and 24 h post infection (pi) [214]. The formation of
phagosomes was noticed as early as 2 h pi, and they were still present within the cells up to 24 h pi,
with bacteria either within the phagosome or in the cytoplasm of the infected cells, and the recovery of
viable bacteria was possible up to 24 h pi (Figure 5). However, the mitochondrial network morphology
and distribution was not visibly altered in the RAW264.7 cells infected with either the ATCC 19411
strain or European bison isolate of T. pyogenes when compared with the uninfected control cells.
Further investigations are required in order to elucidate the mechanism of T. pyogenes pathogenesis.
Nonetheless, these data are in agreement with the observations done on bovine polymorphonuclear
neutrophils (PMNs) infected with T. pyogenes, in which increased phagocytosis was noticed. As this
pathogen can survive within phagocytic cells, increased phagocytosis is strongly connected with
bacterial dissemination throughout the host [195]. Studies done in a mouse model clearly showed that
PLO is responsible for peritonitis [168].
Figure 5. The macrophage of the RAW264.7 cell line infection with T. pyogenes. Staining using the
Giemsa–MayGrünwald method; scale bar = 20 μm (photo courtesy of Anna Hupało-Sikorska, BSc).
One of the common, most recognized infections in dairy and beef cattle are uterine infections
caused by T. pyogenes. They result from the recruitment of neutrophils, from monocytes, and from the
induction of a proinflammatory response, accompanied with formation of mucopurulent discharges
within the infected uterus. This was confirmed on a large animal model. The uterine endometrium of
healthy cows was scratched with a cytobrush (damage to the epithelial layer), and subsequently, an
intrauterine administration of 5× 108 cfu of T. pyogenes was performed. Mucopurulent uterine discharge
was evident in the challenged animals, and was associated with the isolation of this pathogen [68].
However, the ability of cows to defend against T. pyogenes infection depends on the interaction
between the invading pathogen and the host’s innate immunity. An application of bovine endometrial
cell culture in an in vitro model elucidated the PLO involvement in tissue damage and the development
of the endometrium pathology of the postpartum period. Recombinant PLO (rPLO) and bacteria-free
filtrates (BFF) of T. pyogenes had a similar haemolytic activity on the target cells. Still, the stromal
cells and epithelial cells expressed a different level of susceptibility concerning treatment with those
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factors. The endometrial stromal cells were markedly more sensitive than the epithelial cells. This
haemolytic effect was abrogated when the endometrial cells were treated with BFF derived from
T. pyogenes with a deleted plo gene (T. pyogenesΔplo), and when anti-PLO antibodies were applied.
The difference in susceptibility or resistance to PLO between the stromal and epithelial cells can be
explained by a lower level of cholesterol expression in the epithelial cells. It has biological implications
to PLO-mediated uterine tissue damage. The columnar epithelium of the endometrium establishes a
first line of defence by forming a physical barrier between the uterine lumen and the underlying stroma.
As it expresses less sensitivity to PLO, it protects the tissue from colonization by T. pyogenes. Once this
barrier is disrupted, the bacteria can colonize the endometrium, and the development of the disease is
induced. However, PLO did not induce inflammation, as the treatment of bovine endometrial culture
cells with rPLO did not result in increased levels of IL-1β, IL-6, or CXCL8 in the culture supernatant.
Nevertheless, during clinical infection, T. pyogenes often causes tissue damage in association with
other species of bacteria, expressing together with T. pyogenes pathogens, the associated molecular
patterns (PAMPs) and damage associated molecular patterns (DAMPs) responsible for the induction of
inflammatory response.
The described sensitivity of stromal cells to PLO-mediated cytolysis is one of the explanations
for how T. pyogenes acts as an opportunistic pathogen, responsible for endometrial damage once the
protective epithelium is lost after parturition [68].
It has to be remembered that the development of a disease depends on the ability of an infectious
agent to adhere, to colonize a host’s target tissue, and develop mechanism(s) that are responsible for
avoiding a host’s defence and the involvement of its innate immunity. In the case of T. pyogenes, bovine
uterine infections also interplay, as follows: the host–virulent strain of T. pyogenes or host–opportunistic
strain of T. pyogenes, should be considered. The model presented by Ibrahim et al. [56] considers all of
these factors. They focused on in vitro investigating the interactions between a bovine endometrial
epithelial cell culture with either the T. pyogenes strain isolated from the uterus of a postpartum
cow developing clinical endometritis, or T. pyogenes collected from the uterus of a healthy cow. The
assessment of the presence of strain-specific factors participating in the development of the bovine
clinical endometritis was also performed. The outcome of the analysis on a genetic level revealed that
both strains presented genes encoding virulence factors; however, there were differences between the
expression levels of plo, cbpA, nanH, nanP, fimA, fimC, fimE, and fimG genes, favouring the virulent
strain. The proteins encoded by those genes participate in adhesion to the host cells [48,207], so a
virulent strain had a higher ability to attach to the epithelium, because of the elevated level of the
cell-wall associated molecules. Both strains expressed a cytolytic effect on cultured cells, which means
both strains secreted PLO, a major virulence factor. However, this effect was abrogated when the
bovine endometrial epithelial cells were treated with heat inactivated bacteria or bacteria-free filtrates.
These findings are in line with the results obtained by Amos et al. [68], showing that BFF and rPLO
were not responsible for the stimulation of a proinflammatory response in endometrial cells.
To mimic the interplay between the host target tissue and T. pyogenes in the chronic
proinflammatory environment, endometrial endothelial cells treated with bacteria were co-cultured in
the presence/absence of peripheral blood mononuclear cells (PBMCs). The presence of PBMCs did not
influence the viability of the endometrial epithelial cells more than 16 h, upon the treatment with live
bacteria, irrespective of a strain. However, the early detection (4 h) of genes encoding proinflammatory
mediators (PTGS2, CXCL3, IL6, and CXCL8) was noticed in the endometrial endothelial cells treated
with a virulent strain of T. pyogenes, in the presence of PBMCs. This in vitro interaction suggests that
the leukocytes found within the endometrium may be responsible for sensitizing the epithelial cells to
the initial bacterial infection through the enhancement of uterine innate immunity induction (Figure 6).
These data suggest that the development of endometritis in dairy cows after parturition may be caused
by a specific characteristic of certain strains of T. pyogenes. Moreover, the presence of immune cells can
be the reason for the amplification of the proinflammatory response in the endometrial epithelial tissue
towards T. pyogenes pathogenic strains.
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Figure 6. Schematic presentation of the pathogenesis of uterine infection with T. pyogenes. Recruitment
of monocytes (M), neutrophils (N), dendritic cells (DC), and other proinflammatory cells—secretion of
proinflammatory mediators.
The research of Zhang et al. [186] indicated that the inflammation-inducing effect of PLO depends
on its cytolytic activity, but not on PAMPs activity. These findings are in contrast to the results of
Amos et al. [68] and Ibrahim et al. [56].
Studies done on bovine oviductal epithelial cells (BOECs), in an in vitro model, suggested a
specific mechanism employed by T. pyogenes to avoid an immune response. In the course of T. pyogenes
infection, there was no induction of any clear proinflammatory response in the BOECs at either the
transcriptional or protein level. The BOECs co-cultured with T. pyogenes remained viable during the
first 24 h of incubation when treated with MOI 0.01. However, a higher MOI caused the death of those
cells within 24 h of co-culturing. What is interesting, is that the BOECs co-cultured with T. pyogenes
expressed a similar level of IL1A, IL1B, and TNFA mRNA as the control cells did. Similar results were
obtained when the level of mRNA concerning CXCL8, CXCL1/2, and PTGS2 was assessed. Although,
at the same time, the BOECs co-cultured with Bacillus pumilus responded to stimulation, with an
increased level of cytokines and chemokines mRNA. It seems that the lack of responsiveness in the
BOECs induced by T. pyogenes is one of the escape routes from immune surveillance developed by this
pathogen, as the expression of the genes encoding the proinflammatory mediators was similar to the
control levels [75].
5. T. pyogenes Genome
The first complete sequence of the T. pyogenes genome was described in 2014 by Machado and
Bicalho [215]. However, to date, 19 genome assemblies of this species are available in the GenBank
nucleotide database (NCBI). Complete genome sequences were reported for 10 strains, isolated as
follows: four from swine, three from cattle, one from goat, one from forest musk deer, and one from
water buffalo. Additionally, the vast majority of the sequenced genome of T. pyogenes were derived
from strains, which were isolated from animals in China. Other available genome assemblies are
scaffolds (n = 3) and contigs (n = 6). The main features of complete T. pyogenes genomes are summarized
in Table 1.
The T. pyogenes genome was found to consist of a single circular chromosome comprising from
2.25 to 2.43 mega base pairs, depending on the strain. This species is characterized by high G+C%
content. Moreover, the differences in the rate of G+C between the T. pyogenes strains are not significant
(59.4–59.8%). tRNA is the most abundant RNA type in these bacteria. The share of rRNA in the whole
nucleic acid content ranges from three to nine. In addition, there are also several non-coding RNAs
(one or three, depending on the strain). The T. pyogenes genomes are indicated by the relatively high
numbers of pseudogenes (from 27 to 191).
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Table 1. General features of the complete T. pyogenes genomes available in the GenBank nucleotide
database (NCBI).
Strain Designation Strain Origin Size (Mb) GC%
Number of GenBank
Accession nrGenes CDS RNA Pseudogenes
TP4 swine 2.43 59.4 2202 2102 59 41 CP033905.1
TP3 swine 2.38 59.4 2156 2058 58 40 CP033904.1
TP2 cattle 2.25 59.7 2023 1938 58 27 CP033903.1
TP1 cattle 2.33 59.8 2125 1993 58 74 CP033902.1
TP-2849 swine 2.38 59.4 2158 2063 58 37 CP029004.1
TP4479 swine 2.38 59.4 2153 2058 58 37 CP029001.1
Arash114 water buffalo 2.34 59.5 2145 2054 56 35 CP028833.1
2012CQ-ZSH goat 2.30 59.7 2050 1806 53 191 CP012649.1
TP8 forest musk deer 2.27 59.6 2091 2001 50 40 CP007003.1
TP6375 cattle 2.34 59.5 2082 1984 53 45 CP007519.1
The T. pyogenes genome encodes many genes, for which the functions were assigned by the
homologies to known proteins. Apart from the virulence-associated genes, the genome of this species
can contain several antibiotic resistance genes. Furthermore, the luxS gene regulating the formation
of biofilms was also found in the genome sequence [209]. In addition, the presence of a member
of the T4virus (vB_EcoM-UFV13) indicates the efficiency in controlling the biofilm formation by
T. pyogenes [216]. Moreover, the T. pyogenes genome contains four housekeeping genes (metG, tuf, gyrA,
and fusA). The tuf and fusA genes encode the translation elongation factors Tu and G, respectively. Two
other genes confer the DNA gyrase subunit A (gyrA) and methionine—tRNA ligase (metG). These genes
were successfully used in the multilocus sequence analysis (MLSA) of this species [148]. The genetic
analysis showed that T. pyogenes had a more complex system of amino acid and lipid metabolism,
and more genes involved in the pathogenicity than are found in Arcanobacterium hemolyticum. These
differences may affect the ability to cause infections in different host types by T. pyogenes isolates.
Moreover, all of the groups of the family Actinomycetaceae have phosphotransferase systems that
are probably essential for the colonization of a wide range of hosts and for the initiation of abscess
formation. Some genes were lost or acquired as a result of lateral evolution, which helps in the
adaptation of bacteria to a new environment [6]. The T. pyogenes species was reclassified based on
16S rRNA gene sequences, the menaquinone structure, and the phospholipid composition from the
genus Arcanobacterium to the genus Trueperella, together with four other species, such as Trueperella
abortisuis, Trueperella bernardiae, Trueperella bonsai, and Trueperella bialowiezense. Furthermore, 16S rRNA
gene sequence similarities between strains from the genus Trueperella ranged from 95.3% to 98.6% [1].
There was also a draft genome sequence of one human T. bernardiae isolate deposited in the NCBI [217].
The genomes of T. pyogenes also include plasmids. Until now, two plasmids have been described
for this species [178,218]. First, a native pAP1 (U83788) is a circular plasmid of 2439 bp, containing
three open reading frames (ORFs). Plasmid pAP1 encodes the rep gene, which is required for the
initiation of replication. Two other genes, orf 112 and orf 129, encode the hypothetical proteins of an
unknown function. However, pAP1 does not include any antibiotic resistance genes [218]. The other,
pAP2 (AY255627), is a circular plasmid of 9304 bp, and it contains seven ORFs. In pAP2, repA is
probably required for the replication of this plasmid. Moreover, there are other genes, namely: tetR(33),
which encodes the repressor protein and gcrY, and orf 95 with unknown functions. In addition, pAP2
is characterized by the presence of two genes encoding antibiotic resistance determinants—erm(X)
and tetA(33). In T. pyogenes, erm(X) determines the resistance to macrolide antibiotics, while tetA(33)
is associated with low-level tetracycline resistance [178]. Furthermore, plasmid pAP2 contains the
insertion sequence IS6100, which is found either in Gram-positive or in Gram-negative bacteria [219].
The knowledge of the complete genome sequence may allow for the identification of new genes
that may contribute to the pathogenicity and antibiotic resistance of T. pyogenes. In addition, genome
sequencing can help to understand the basics of the metabolism and evolution of the bacterial species.
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6. Immunoprotection and Perspectives
The antimicrobial treatment of T. pyogenes infections is often ineffective, because of the increasing
resistance of bacteria or the limited distribution of drugs to the site of infection, for example, to
abscesses. Hence, vaccination should be considered as a primary method of T. pyogenes infection
prevention. It seems that some of the virulence factors of T. pyogenes could be promising candidates for
vaccine antigens.
Most studies concerning the stimulation of protective immunity against T. pyogenes infection were
done on a mouse model, and only a few were done using a ruminant or swine model. The first trials to
protect ruminants against infection with T. pyogenes were focused on animal treatment with whole
cells of T. pyogenes or a culture supernatant, and were mostly unsuccessful; however, some therapeutic
effects on mastitis development were observed [48,220,221]. In swine, the vaccination of pregnant
sows with an autovaccine was an attempt to control the losses of newborn animals. Studies done by
Kostro et al. [222] revealed that the administration of T. pyogenes cells treated with a phenol solution to
pregnant sows, six and three weeks before anticipated delivery, significantly increased the number
of CD4+ T cells, CD8+ T cells, and CD25+ T cells, as well as enhanced the levels of IFN-γ, TNF-α,
and IL-10 in a colostrum and milk [222]. The recent trials were concentrated on the protection of
heifers against post partum uterine diseases. Pregnant heifers were vaccinated using different routes
of immunization (subcutaneously and intravaginally), and different compositions of the vaccine, as
follows: (i) inactivated bacterial whole cells (E. coli, T. pyogenes, and F. necrophorum) together with
recombinant proteins, FimH, PLO, and leukotoxin (LKT)); (ii) recombinant proteins FimH, PLO, and
LKT only; (iii) inactivated bacterial whole cells (E. coli, T. pyogenes, and F. necrophorum) only [223]. The
obtained results demonstrated that subcutaneous vaccination significantly decreased the incidents of
puerperal metritis, but intravaginal vaccination failed in preventing the disease.
Mice used for the assessment of protective immunity induction against infection with T. pyogenes
provide a reliable model that can serve for further comprehensive studies on other animal species. The
administration of formalin-inactivated recombinant PLO (rPLO) induced the protection of mice against
intraperitoneal challenge with 108 of T. pyogenes cells, and PLO-specific antibodies were detected in the
sera of the immunized mice [168,180].
The current trend in vaccine design is concentrated on the development of such a product that
will induce immunity against multiple pathogens. Using a mouse model, Zhang et al. [224] and
Hu et al. [176] induced specific immunity that protected animals against challenge with T. pyogenes and
C. perfringens. However, their approach to solve the problem concerning the stimulation of protective
immunity was quite different. Hu and colleagues [176] designed a chimeric protein called rPC-PD4,
which was composed of C. perfringens truncated regions of C-domain of phospholipase C (rPLC),
and D4 domain of T. pyogenes PLO (rPLO), and was encoded by chimeric genes incorporated into a
plasmid vector. The production of specific antibodies, and the presence and level of proinflammatory
cytokines (TNF-α, IL-1β), chemokines (CXCL8), and IL-10 in sera of immunized mice were assessed;
however, only partial immunity was observed after challenge with T. pyogenes or C. perfringens. Zhang’s
group [224] concentrated not only on PLC and PLO as major immunogens, but also on the involvement
of formaldehyde inactivated cultures of T. pyogenes and C. perfringens as vaccine antigens, combined
with aluminium hydroxide gel. The outcome of their proposal is promising, as the survival rate of
immunized mice after challenge with T. pyogenes and C. perfringens was 80% and 100%, respectively.
These studies [176,224] present a very interesting approach for the development of a new, safe vaccine
against polymicrobial infections.
Nonetheless, the latest trials to stimulate immunoprotection against T. pyogens infection are the
most promising so far. The studies of Huang’s group [225,226] done on a mouse model, concentrated
on genetic immunization. Two pathways to stimulate protective immunity against T. pyogenes infection
were used. The first one applied the modification of the cytokine environment of immunized animals
together with delivering the gene encoding PLO [225], the second one focused on immunization
308
Int. J. Mol. Sci. 2019, 20, 2737
with a DNA vaccine containing genes encoding four different virulence factors of T. pyogenes, and
simultaneous vaccine protection against destruction by the host environment [226].
In the first study, concurrent immunization with two plasmids carrying the plo gene and the IL1β
gene, respectively, resulted in the protection of mice from intraperitoneal challenge, with 3.7 × 108 cfu
of T. pyogenes [225]. PLO-specific antibodies were detected in the sera of immunized mice with a higher
titer of the IgG2a subtype than the IgG1 subtype. The T-cell profile analysis indicated an increased
level of CD8+ T-cells and CD4+ T-cells. These results correlated with the detection and assessment
of the cytokine levels evaluated in the supernatant collected from the spleen lymphocytes culture
(increased levels of IFN-γ, and IL-2, and slightly diminished IL-4). In this model, IL-1β enhanced the
immunogenicity of the vaccine by influencing the activity of the macrophages, the major population of
the phagocytic cell, as well as antigen presenting cells (APCs), and also the B-cells, which act as APCs
during early phases of immune response development, later transforming into plasma cells secreting
antigen-specific antibodies, hence humoral immunity.
In the second research of Huang’s group [226], the plo, cbpA, fimA, and nanH genes were paralleled
as a single chimeric gene with an attached CpG ODN 1826 motif, so as to overcome low immunogenicity
and susceptibility to host endonucleases. Finally, the chimeric gene was incorporated into the expression
plasmid vector, and then this construct was encapsulated in chitosan nanoparticles to protect the DNA.
The chimeric gene DNA vaccine introduced intramuscularly initiated production of antibodies specific
for the target epitopes of PLO, CbpA, NanH, and FimA in mice. Moreover, the level of IgG2a was
higher than the IgG1 in the sera of immunized mice, suggesting that immunization with this vaccine
mainly primed the Th1 profile.
Compared with the subunit and conventional vaccines, DNA vaccines express some advantages
as future stimulants of immunity. They are easy to manufacture, stable, and confer potential safety.
Moreover, many genes encoding specific antigen proteins can be inserted in a carrier genome, and once
introduced to the host, stimulate protective immunity against a variety of infections. In this context, the
studies done by Huang et al. [225,226] are very important, not only in the induction of effective protection
against T. pyogenes infection. They also proved that the formulated chitosan-CpG ODN nanoparticles
are stable in eukaryotic cells, are able to protect the chimeric gene in the encapsulated plasmid from
degradation, promote its expression, and also participate in the induction and enhancement of the
immune response, so they could serve as a safe and efficient drug release carrier system.
7. Conclusions
T. pyogenes has significant importance as an opportunistic animal pathogen causing a variety of
purulent infections. These infections pose a huge economic problem in livestock breeding. Therefore,
it is crucial to understand the mechanisms of pathogenicity of this bacterium and the routes of its
transmission for the development of an effective prevention strategy.
Although some of virulence determinants in T. pyogenes are well recognized, little is known about
the dissemination of infections. It is interesting, there is still limited data about the pathogen–host
interactions that may be involved in the development of T. pyogenes infection. Especially, the
determination of factors that have a key role in transformation from a commensal to a pathogenic
bacterium is needed. Although it seems that animals are the main reservoir of this bacterium, the
epidemiological relationships between the particular isolates remain unclear.
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Abstract: Candida albicans and Candida glabrata are the two most prevalent etiologic agents of
candidiasis worldwide. Although both are recognized as pathogenic, their choice of virulence traits
is highly divergent. Indeed, it appears that these different approaches to fungal virulence may be
equally successful in causing human candidiasis. In this review, the virulence mechanisms employed
by C. albicans and C. glabrata are analyzed, with emphasis on the differences between the two systems.
Pathogenesis features considered in this paper include dimorphic growth, secreted enzymes and
signaling molecules, and stress resistance mechanisms. The consequences of these traits in tissue
invasion, biofilm formation, immune system evasion, and macrophage escape, in a species dependent
manner, are discussed. This review highlights the observation that C. albicans and C. glabrata follow
different paths leading to a similar outcome. It also highlights the lack of knowledge on some of the
specific mechanisms underlying C. glabrata pathogenesis, which deserve future scrutiny.
Keywords: Candida; host-pathogen interaction; virulence; biofilm formation; morphology;
immune evasion
1. Introduction
Infections caused by fungi affect millions of people worldwide, with the overall mortality
rate estimated to be roughly 1,350,000 deaths per year [1]. Among pathogenic fungi, Candida
species are responsible for the most common invasive fungal disease in developed countries—the
candidiasis [2]. Candida species live as commensals on mucosal surfaces where they are constituents of
the normal microbiota of the oral cavity and gastrointestinal and vaginal tracts. However, they can
opportunistically become pathogenic under suitable conditions, such as host-disrupted microbiota
or immunocompromised hosts, being responsible for clinical manifestations from mucocutaneous
overgrowth to bloodstream infections [3–5]. Of the various Candida species, Candida albicans and
Candida glabrata not only account for 60% of Candida species present in the human body, but also
constitute the most prevalent of the pathogenic Candida species, being responsible for more than 400,000
life-threatening infections worldwide every year [3,6].
C. albicans and C. glabrata are the two most common pathogenic yeasts of humans, yet they are
phylogenetically, genetically, and phenotypically very different. On one hand, C. albicans diploid
genome carries several gene families that are associated with virulence [7]. These include the
ALS (agglutinin-like sequence) adhesins, required for host adhesion, secreted aspartyl proteases
(SAPs) and phospholipases, which allow for the degradation of host barriers and the invasion of
Int. J. Mol. Sci. 2019, 20, 2345; doi:10.3390/ijms20092345 www.mdpi.com/journal/ijms323
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surrounding tissue, and proteins involved in oligopeptide and iron transfer [8–10]. On the other
hand, C. glabrata mechanisms of tissue invasion are mostly unknown, although it is hypothesized to
possibly occur by endocytosis induction of host cells [11]. Its haploid genome encodes a large group of
glycosylphosphatidylinositol (GPI)-anchored cell wall proteins, such as the adhesins from the EPA
gene family, implicated in fungus–host interactions or biofilm formation, and a family of aspartic
proteases (yapsins) which are mainly associated with cell wall remodeling and possible immune
evasion [12,13]. Moreover, key virulence attributes of C. albicans, which are known to be the basis of its
pathogenicity, are absent in C. glabrata [14]. Switching from yeast to hyphal growth not only allows
consistent biofilm production but also enables C. albicans to be highly invasive and escape macrophage
engulfment [15–19]. Nevertheless, both species are known to use biofilms to colonize the surface of
several medical devices based on different materials [20]. Unlike C. albicans, it has been demonstrated
that C. glabrata lets itself be taken up by macrophages, where it persists and divides for long periods
of time eventually leading to cell lysis due to fungal load [21,22]. It has the ability of detoxifying
oxidative radical species and disrupting normal phagosomal maturation, leading to the inhibition of
phagolysosome formation and phagosome acidification [21,23].
The interaction between Candida and its host cells is characterized by a complex interplay between
the expression of fungal virulence factors and the host immune system, and the presence of other
microorganisms affects this interplay. This review aims to explore and compare the remarkably distinct
paths toward virulence trailed by the two most common causative agents of candidiasis worldwide.
On one hand, C. albicans is known for its ability to evade host defenses and form bulk biofilms due
to its ability to undergo filamentous growth, while on the other hand, C. glabrata is an unusually
stress-tolerant organism able to survive and replicate inside the immune system cells. Despite having
such distinct virulence features, C. glabrata and C. albicans are frequently co-isolated [11].
2. Host Damage and Invasion
There is a variety of defense mechanisms through which the human host is able to prevent invasion
by pathogenic microorganisms, such as C. albicans and C. glabrata. These mechanisms consist not only
of physical but also of chemical barriers. For instance, epithelial cells, which in most cases are the first
line of contact between host and pathogen, function as the prime physical barrier restraining Candida
from invasion of the underlying tissue. On one hand, these cells are interconnected through “tight
junctions” preventing the entry of microorganisms into interepithelial space and eventually into the
bloodstream [24,25]. On the other hand, some types of epithelial cells, such as those in the intestinal or
vaginal epithelium, are able to produce a mucus layer by secreting mucins [24,26]. This layer impairs
Candida invasion by preventing contact with the epithelium surface. Likewise, in the oral cavity the
flow of saliva plays an important role as both a physical and a chemical barrier as it not only prevents
the adhesion to mucosa and dental surfaces but also contains several antimicrobial agents that impair
the contact of Candida with the oral epithelium [27,28]. Another chemical barrier against Candida
establishment is the presence of gastric acid and bile in the digestive system which creates a harsh
environment for fungal growth. Nevertheless, these human pathogens are known to have a remarkable
ability to adapt to these adverse conditions and proliferate.
C. albicans relies on two distinct invasion mechanisms to gain entry into host cells: (i) induced
endocytosis and (ii) active penetration of hyphal forms through physical forces of hyphae production
associated with lytic enzyme secretion [29] (Figure 1). Nonetheless, depending on the host cell,
these invasion mechanisms are thought to be exploited to a different extent. For instance, it was
demonstrated that while invasion into oral epithelial cells occurs via both routes, invasion into intestinal
epithelial cells occurs only via active penetration under normal conditions [29,30].
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Figure 1. Schematic representation of C. albicans and C. glabrata host damage and invasion. C. albicans
enter host cells through induced endocytosis or by active penetration (inter- and intra-cellular) of
hyphal forms associated with the release of hydrolytic enzymes, resulting in the damage of cells and
loss of epithelial integrity. Induced endocytosis of host cells is thought to be the mechanism behind
C. glabrata tissue invasion.
Living within host cells is a profitable strategy since it enables cells to deal with the host immune
system and antimicrobial treatment, and there are plenty of nutrients available and an absence of
competition with other commensal microorganisms. Additionally, dissemination into deeper tissues
and ultimately into the bloodstream is easier from within the cell. Fungal invasion via induced
endocytosis is dependent on dynamic microfilaments of the host. In C. albicans, the GPI-anchored
hypha-associated protein Als3 interacts with mammalian cadherins, mimicking the establishment of
adherence junctions. This process leads to rearrangements in the actin cytoskeleton that ultimately
lead to fungal cell internalization [31]. Similarly, Ssa1, a member of the HPS70 heat shock protein
family, was reported to play the same role as Als3, being essential for maximal host cell damage
and subsequently fungal cell endocytosis [32]. However, EED1 was the first fungal gene reported
as being required for epithelial escape and interepithelial dissemination and not for initial invasion
into epithelial cells [33]. Moreover, it is thought that the contact with the epithelium, among several
other stimuli, is a highly potent inducer of C. albicans filamentation. In turn, the contact between
hyphal cells and epithelial cells induces host defense mechanisms such as the formation of epithelial
cell protrusions surrounding the hyphae, and membrane ruffling, which is characteristic for induced
endocytosis [34].
The ability to switch between yeast and hyphal growth forms is one of the most discussed
and best-investigated virulence attributes of C. albicans. This morphology switch is activated
by well-established kinase-based signal transduction pathways and is triggered by diverse host
environmental cues, including temperature, pH, serum, and CO2 and is linked to several steps during
host invasion [35,36]. The extracellular signals are transmitted via Ras to both protein kinase A and the
MAP kinase cascade [37–39], inducing hyphal differentiation through the activation of a number of
transcription factors such as Efg1 [40] and Ume6 [41]. The transcriptional repressor Nrg1 is inactivated
and removed from the hyphal-specific gene promoters, thereby allowing the induction of hyphal
morphogenesis [42,43].
Invasion into epithelial cells via active penetration relies on a combination of physical pressure
employed by the growing hyphae and the secretion of hydrolytic enzymes. Moreover, hyphal cells
are capable of directional growth in response to contact with a solid surface (thigmotropism) which
enables C. albicans to specifically identify and invade intercellular junctions, thereby damaging the
epithelium compact structure [44]. Interestingly, it was very recently discovered that C. albicans
release hydroxyphenylacetic acid (HPA) during hyphal growth [45]. Its production seems to occur
through the same pathway and the same precursors as tyrosol, which is able to stimulate hypha
induction in C. albicans [46], therefore their biological functions are likely to be the same. Additionally,
along with the active penetration by hyphal cells, there is also the secretion of hydrolytic enzymes,
such as SAPs and phospholipases, which can digest epithelial cell surface components enabling the
entrance into or between host cells [47]. SAPs are the best-characterized members of the C. albicans
hydrolytic enzymes, as is well reviewed by Hube and Naglik [48]. Interestingly, these tissue damaging
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enzymes not only have distinct optimal pH requirements but also are growth stage and infection
site related [47]. For instance, SAP1–SAP3 are yeast growth-associated and have optimum activity
at lower pH values, while SAP4–SAP6 are hyphal growth-associated and have optimum activity at
higher pH values [49]. Similarly, it was demonstrated that SAP1, SAP3, and SAP8 are preferentially
expressed in vaginal, rather than oral, C. albicans infections [47]. One possible explanation for the
existence of a significant number of different SAP genes may be the necessity for specific and optimized
proteinases during the different stages of an infection [48]. Additionally, the cytolytic peptide toxin
of C. albicans candidalysin, encoded by the hypha-associated gene ECE1, was recently found to be
essential for damage of enterocytes and is a key factor in subsequent fungal translocation, suggesting
that transcellular translocation of C. albicans through intestinal layers is mediated by candidalysin [25].
Moreover, phytase activity in C. albicans was demonstrated to be important for virulence. Phytate is a
major storage form of phosphorus in plants and is abundant in the human diet and intestinal tract [50].
Recently, it was reported that decreased phytase activity leads to a reduced ability to form hyphae,
attenuated in vitro adhesion, and reduced ability to penetrate human epithelium [51].
While the transition from yeast to hyphae has been extensively studied in C. albicans, the switch
from hyphae to yeast still remains poorly understood [35]. Nevertheless, both yeast and hyphae
forms are found in infection sites, which suggests that both forms are implicit in the infection process.
Interestingly, it was demonstrated that depending on the infected organ, one or the other morphology
predominates [52]. It is thought that the yeast form is important for dissemination upon infection,
whereas hyphae forms are more relevant to attachment, host invasion, and tissue damage [53].
Unlike C. albicans, and despite the existence of some reports demonstrating that C. glabrata
forms pseudohyphae [54,55], the pathogenicity of C. glabrata seems to be independent of morphology.
The most common route for this pathogen to reach the bloodstream is through the iatrogenic breach of
natural barriers, such as the use of catheters, trauma, or surgery.
In 2000, Csank and Haynes [54] reported for the first time that C. glabrata can undergo morphological
change and grow as a pseudohyphae on solid nitrogen starvation media. This invasive growth mode
could be a possible mechanism of host invasion, however, this phenomenon has not yet been reported
in vivo. Despite lacking this prime virulence feature, this opportunistic pathogen is still able to reach
the human bloodstream and cause infection. In some cases, C. glabrata can involuntarily reach the
bloodstream through nosocomial conditions, namely surgery, catheter, parenteral nutrition, and burn
injury [56]. However, even when these external factors are abrogated, C. glabrata is able to invade the
host and colonize different tissues, as shown in an intragastrointestinal mouse model of infection [57]
and in a chorioallantoic membrane chicken embryo model of infection [58]. Thus, C. glabrata must
have other invasion mechanisms.
Co-infection with other microorganisms may be a possible explanation to the invasive capacity
of C. glabrata since this yeast is often co-isolated in infections with C. albicans [59–61] or even other
pathogens such as Clostridium difficile [62]. In the co-infected environment, C. glabrata cells may
exploit the tissue invasion and destruction caused by C. albicans to access nutrients and reach the
bloodstream. In fact, Tati et al. (2016) [63] demonstrated that when mice are infected with C. glabrata
alone, oropharyngeal candidiasis is negligible, however, when co-infected with C. albicans, an increased
colonization by C. glabrata was observed. This effect was attributed to the binding of C. glabrata to
C. albicans hyphae [63] and similar results were reported by Alves et al. (2014) [64] using a reconstituted
human vaginal epithelium. Nonetheless, the intracytoplasmic presence of C. glabrata was detected in
oral epithelial cells [65] and vaginal epithelial cells [66] and it has been shown that when endocytosis is
inhibited, the internalization of C. glabrata is prevented [65]. This suggests that induced endocytosis by
host cells could be the most likely mechanism of C. glabrata internalization (Figure 1).
As referred to before, the tissue/cell damaging ability of C. glabrata is lower compared to C. albicans.
In C. albicans, secreted hydrolytic enzymes are considered to be important destructive factors that
damage host tissues, providing nutrients for its propagation. However, the production of these
hydrolytic enzymes is very low or even null in C. glabrata, wherefore its importance for virulence does
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not seem to be as relevant as it is in C. albicans [67–73]. The proteinase enzyme is responsible for protein
degradation resulting in tissue invasion. Among the proteases, SAPs are considered crucial for the
pathogenicity of C. albicans [74]. Although C. glabrata does not express SAPs [75], its genome contains 11
non-secreted GPI-linked aspartyl proteases (YPS genes), which are surface-exposed aspartic proteases
required for virulence, known as yapsins [13]. These yapsins are important for cell wall maintenance,
remodeling, cell to cell interactions, and resistance to cell wall stress, however, their direct link with
virulence is not very well characterized yet. Otherwise, phospholipases promote the destruction of cell
membrane phospholipids, causing cell damage and lysis which allows a greater invasive capacity [76].
Some of the C. glabrata strains are able to produce these enzymes [67,68,70,71,77], which appear to
play a role in C. glabrata-associated persistent candidemia [9]. However, phospholipase production in
C. glabrata is lower than in C. albicans, and in some cases inexistent [69,72,73], therefore its relation to
C. glabrata virulence is not clear and needs further analysis.
3. Adhesion and Biofilm Formation
The ability to infect and prevail in the human host is related to different pathogenesis factors, of
which biofilm formation excels [19,78–80]. Candida species ability to form biofilms on medical devices
increases mortality rates associated with infections, while often forcing the treatment to include the
removal of the medical device [81]. A lot of efforts have been put into understanding the molecular
basis of Candida species biofilm formation [20].
Adhesion is one of the most relevant and advantageous capacities of the yeast cell wall. It allows
cells to colonize mucosal surfaces and prevail in a nutritional environment, being the first critical
step for biofilm formation, which serves as a shield against adverse conditions, as well as a highly
drug-resistant reservoir of infective cells [82,83]. C. albicans and C. glabrata pathogenesis has been
strongly related to adhesion, which is considered a crucial virulence factor in these yeasts [84–86].
In this regard, both Candida species are able to not only attach to mammalian host cells (epithelial,
endothelial, and immune cells) but also to other microbes (bacteria and other Candida species) and
abiotic surfaces, such as medical devices [85,87]. Several studies have tried to understand the nature of
adherence to plastic surfaces. For instance, cell surface hydrophobicity (CSH) seems to have a positive
correlation with adhesion in both C. albicans and C. glabrata species, thus, adhesion is mediated by van
der Waals forces. Moreover, compared to C. albicans, the relative CSH of C. glabrata has been shown to
be significantly higher [88–90].
Both Candida species have a set of proteins that enable attachment, known as adhesins. The most
important C. albicans adhesins are agglutinin-like sequence (Als) proteins (Als1–7 and Als9) [91]
and hypha-associated GPI-linked protein (Hwp1), known to be required for adhesion and virulence
in vivo, and also being associated to biofilm formation through interaction with Als1 and Als3
adhesins [92–94]. Other adhesins required for adhesion and biofilm formation include Hwp2 [95]
and Eap1 [96–98]. C. glabrata expresses a large group of adhesins, belonging to the epithelial adhesin
(Epa) family, which is encoded by 17 to 23 genes, depending on the strain [78]. Among these, Epa1 is
a major virulence player in C. glabrata, and mediates 95% of in vitro adhesion to epithelial cells [99].
This adhesin is highly heterogeneous among C. glabrata clinical isolates, being an important virulence
factor [100]. Epa6 and Epa7 are involved in kidney and bladder colonization in vivo and boost biofilm
formation [101–104]. Transcriptomic and proteomic studies have revealed that besides EPA genes,
C. glabrata holds other biofilm-related adhesin families, such as Pwp (encoded by seven members
PWP1–7), Aed (AED1 and AED2), and Awp (encoded by 12 members AWP1–6 and AWP8–13), which are
usually found in significantly higher numbers in clinical isolates, consistently with an important role
in pathogenesis [12,105–107].
The successful pathogenicity of these yeasts relies on its flexibility, which allows for adaptation and
proliferation under both nutrient-rich and nutrient-poor conditions. Several studies have reported the
importance of host and antifungal selective pressure on virulence traits as adhesion [108,109]. A recent
study conducted by Vale-Silva et al. (2017) [110] used the PacBio technology to compare the genomes
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of two sequential C. glabrata clinical isolates and observed a significant increase in the number of
adhesin-encoding genes (101 and 107) when compared to the CBS138 genome (63), despite the limited
variation between the two studied isolates. The same authors, along with Ni et al. (2018) [111], further
linked the increased expression of the adhesin gene EPA1 with gain-of-function (GOF) mutations in
the PDR1 gene in drug-resistant clinical isolates [112]. EPA1 has been strongly related to adhesion
of C. glabrata cells to mammalian epithelial cells both in vitro [99] and in vivo [113]. Furthermore,
Salazar et al. (2018) [114] also observed a GOF mutation in the PDR1 gene, which led to changes in the
transcriptome when compared to the CBS138 strain. Among the genes identified as having the highest
number of non-synonymous SNPs, there were several genes encoding adhesins and, agreeing with
Vale-Silva et al. (2013) [115], the number of adhesin-expressed genes varied when compared to other
GOF PDR1 mutations [114]. This reinforces the idea that antifungal treatment deploys a tight selective
pressure which results in changes at the genomic and transcriptional levels, particularly affecting
adhesin-encoding genes [116]. The transcription factor Cst6 was found to also play a role in C. glabrata
adhesion and biofilm formation, negatively regulating the expression of EPA6 [103]. In C. albicans, a
transcriptional regulatory network comprising nine regulators (Bcr1, Brg1, Efg1, Flo8, Gal4, Ndt80,
Rob1, Rfx2, and Tec1) was identified in in vitro and in vivo studies as underlying the biofilm formation
phenomenon in this pathogenic yeast [117–121].
Hyphae formation, which is exclusive to C. albicans, when compared to C. glabrata is also an
important trait in biofilm development. Various studies have described hyphae as exhibiting improved
adhesion to the human epithelium, with these cells displaying increased expression of Als1, Als3, and
Hwp1 [122–125]. Interestingly, Tati et al. (2016) [63] characterized the co-colonization of C. glabrata
and C. albicans in a murine model of oropharyngeal candidiasis (OPC) and demonstrated that this is
driven by specific adhesins in both species. Namely, the C. albicans Als3 and Als1 adhesins are crucial
for in vitro binding of C. glabrata cells to C. albicans hyphae and for further in vivo establishment of
infection. Considering C. glabrata cells, incubation with C. albicans hyphae led to the overexpression of
the adhesins EPA8, EPA19, AWP2, AWP7, and CAGL0F00181 [63].
After adhesion, Candida species are known to be able to form a 3D-structure of cells embedded in
a gel-like matrix [20,126,127]. In order to achieve this, surface-adhered cells begin to adhere to other
Candida cells, initiating the formation of discrete colonies, which correspond to an early phase of biofilm
formation. At this point, the intermediate phase begins with the cellular production and secretion
of important molecules, known as extracellular polymeric substances (EPS), that will constitute the
extracellular matrix of the biofilm, protecting the cells and ensuring a more developed 3D-structure.
The final structure is reached after the maturation phase, where more cells and the matrix are originated.
Mature biofilms might also suffer the detachment of some cells that can spread to form new biofilms
on other niches of the host, a process called the dispersal phase [20,126,128,129]. Although this process
is true for every Candida species, there are differences between C. albicans and C. glabrata biofilms,
regarding their dimensions and structure, cell morphology, EPS produced and secreted, response to
environmental cues, and resistance to antifungal drugs (Figure 2).
A very clear difference between C. albicans and C. glabrata mature biofilms is the dimension and
total biomass of each biofilm. C. glabrata in vivo biofilm formation leads to a thickness of 75–90 ± 5 μm,
which is half of the normal thickness of C. albicans biofilms [130], with much less biomass in the end of
biofilm formation compared to C. albicans [131]. The organization of the biofilm structure also differs
between these two species. C. albicans biofilms are arranged in a three-dimensional structure with
different morphologies and empty spaces between cells [132], where microchannels are formed [133].
On the other hand, C. glabrata biofilms are thinner, but display a higher density of cells, tightly packed
together [132]. Although C. glabrata’s biofilms are composed by yeast cells only [131,132], the same is
not true for C. albicans biofilms, where different morphologies arise. C. albicans mature biofilms are
composed by a dense network of pseudohyphae, hyphae, and yeast cells [134]. This filamentation
process in biofilm formation is controlled by the transcription factor Efg1, without which C. albicans only
forms scarce monolayers of elongated yeast cells on polyurethane catheters and polystyrene [135,136].
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Figure 2. Schematic representation of C. albicans and C. glabrata biofilm formation. C. albicans
forms thicker biofilms, with much more biomass in the end of biofilm formation and produces more
extracellular matrix than C. glabrata. C. albicans mature biofilms are composed by a dense network of
pseudohyphae, hyphae, and yeast cells, whereas C. glabrata biofilms are composed by compact yeast
cells only, forming a thin but dense biofilm.
Although C. albicans produces more extracellular matrix than C. glabrata [137], the main components
of the matrix, proteins, and carbohydrates, are the same in both biofilms [131,138–140]. Interestingly,
C. glabrata has a very high content of proteins and carbohydrates, which is five times higher than
that found on the biofilms of other non-albicans Candida species [131]. C. albicans’ matrix is also
composed by other lipids (mainly neutral glycerolipids, polar glycerolipids, and a small percentage of
sphingolipids) [139], phosphorus, and uronic acid [140]. Biofilms of both species also have a small
content of extracellular DNA [131,138–140].
Interestingly, C. albicans and C. glabrata also behave differently on different surfaces when it comes
to initiating biofilm formation. Cleary, each species has a different propensity to form biofilm on
a given surface. For instance, C. albicans is known to adhere better to latex and silicone elastomer
while showing less biofilm formation on polyvinyl chloride, polyurethane, or 100% silicone [134].
C. albicans also adheres and forms biofilm on different surfaces of denture base materials, having higher
biofilm formation on the surface of alloy and lower biofilm formation on methacrylate-based denture
material [141]. Moreover, polyetherurethane treated with 6% of polyethylene oxide was found to
reduce the metabolic activity of cells and the total biomass of C. albicans biofilms [142]. On the other
hand, while all other pathogenic Candida species have greater biofilm formation on Teflon, C. glabrata
prefers polyvinyl chloride to form biofilm [143]. Interestingly, other components of the environment
might alter the ability of Candida species to adhere to a given surface. For instance, the presence of
saliva has been shown to decrease the ability of C. albicans to form biofilm in vitro [144,145].
Depending on the antifungal drug, C. albicans and C. glabrata biofilms might be able to resist the
therapeutic action of the drug. For instance, Choi and colleagues (2007) [146] measured the in vitro
susceptibilities of biofilms of C. glabrata and C. albicans bloodstream isolates, showing that both biofilms
were resistant to fluconazole and only moderately resistant to amphotericin B, while exposure to
0.25 to 1 μg/mL of caspofungin and micafungin lead to an 80% reduction of the biofilms. Moreover,
voriconazole is also able to reduce C. albicans and C. glabrata biofilms, being present at 0.25 mg/L or
being used as a surface coating at different concentrations [147]. Nevertheless, when growing on an
RPMI 1640 medium, C. glabrata mature biofilms have shown to be less susceptible to caspofungin
and anidulafungin than C. albicans mature biofilms on a polystyrene surface [148], showing that each
species biofilms might resist differently to the same antifungal drug. Although reacting differently
to antifungal drug exposure, the strategy to achieve resistance seems to be very similar between the
two species. The mechanisms known to underlie resistance to antifungal drugs in Candida biofilms
are believed to be related to alterations in the metabolic activity, the role of the extracellular matrix as
a barrier for diffusion, the role of its EPS components, and the presence of persister cells within the
biofilm [20,149]. Both species suffer the upregulation of drug efflux pump-encoding genes [138,150],
as well as seem to rely on the β-1,3-glucans present on the extracellular matrix [151,152].
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Biofilms also allow for the survival of Candida species by protecting them against the host immune
system. The extracellular matrix is essential for the protection against the action of neutrophils by
inhibiting the release of neutrophil extracellular traps (NETs) [153]. Moreover, the β-glucans present
on the matrix avoid the activation of neutrophils, actually inhibiting the reactive oxygen response,
thereby being an important distracting mechanism to evade the innate immune system [154]. Biofilms
are also believed to resist well the action of the innate immune system due to its heterogenicity, given
the different types of cells and different metabolic activity the cells might present on biofilms [155].
The combination of C. albicans and C. glabrata to form biofilm has been well described and the two
species are usually found together in niches of candidiasis patients [60]. A recent study has shown that
a ratio of C. albicans to C. glabrata of 1:3, significantly increases the total biofilm biomass comparatively
to a C. albicans monoculture or ratio of C. albicans to C. glabrata of 1:1. This co-culture biofilm exhibited
a high heterogenicity with C. albicans hyphae and C. glabrata cells clustered together in a 3D-structure.
Interestingly, an upregulation of HWP1 and ALS3 genes is observed in this mixed-species biofilm,
as well as an increased resistance to caspofungin [3]. C. albicans and C. glabrata are also known to form
biofilms with bacteria from different host niches, usually relying on quorum-sensing mechanisms for
the establishment of an interaction [20,155]. All the possible interactions between species increase the
complexity of this vast field, pointing out the big clinical challenge of biofilm formation.
4. Host Immune System Evasion
Throughout infection, when the first line of defense has been breached by invasion into deeper
tissues, Candida pathogens have to cope with cells of the host innate immune system. Interaction
with the host immune system, and the ability to overcome it, is one of the main virulence features for
fungal pathogens.
At early stages of infection, upon an interaction between Candida pathogens and epithelial cells,
the former are recognized as invasive microorganisms by Pattern Recognition Receptors (PRRs) localized
at host epithelial cell surfaces. PRRs interact with Pathogen Associated Molecular Patterns (PAMPs),
such as β-1,3-glucan or chitin, present on microbial cells, thereby inducing a host response [156,157].
Epithelial cells, that are part of the innate immunity, not only secrete antimicrobial peptides, such as
β-defensins and LL-37 [158–160], to try to control fungal infection, but also release proinflammatory
mediators, such as chemokines and cytokines, triggering the recruitment of phagocytic cells, such as
neutrophils, macrophages, and dendritic cells. These innate immune system cells also have PRRs in
their surfaces, such as the C-type lectin receptor Dectin-1 [161], allowing the recognition of the invading
pathogens and thereby inducing phagocytosis [162]. After phagocytosis, dendritic cells are responsible
for the link between innate and adaptative antifungal immunity, presenting the Candida-specific
antigens to naïve T-helper cells [163]. Therefore, in an immunocompetent host, this host–Candida
interaction ultimately leads to the elimination of the pathogen. Otherwise, in immunocompromised
individuals, a persistent infection, such as chronic mucocutaneous candidiasis, candidemia and/or
persistent visceral candidiasis might be established.
Immune interaction can be translated in distinct spectrums, from avoidance of recognition by
host immune cells to escaping or surviving immune attack. Masking PAMPs on the cell wall to avoid
recognition, macrophage activation, and consequent phagocytosis is a common strategy of fungal
pathogens during interaction with immune cells [164]. Generally, yeasts’ cell wall is composed of a
carbohydrate-rich inner layer and a protein-rich outer layer of heavily mannosylated proteins and
phospholipomannan [165]. The outer layer acts as a shield of immunostimulatory components of
the inner layer, such as β-1,3-glucan or chitin, playing a key role in protection and evasion from
immune recognition [166]. β-1,3-glucan is the main polysaccharide present in the cell wall of C. albicans,
C. glabrata, and other pathogenic Candida species, and is a key PAMP recognized by the host immune
system [167]. Recognition of β-1,3-glucan by Dectin-1 receptor prompts phagocytosis by macrophages
and neutrophils [161].
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In order to avoid immune recognition, C. albicans resorts to cell wall remodeling, effectively
masking β-glucan from the cell surface. The first reported case of active PAMP masking by Candida
species was reported by Ballou et al. (2016) [167]. C. albicans was shown to mask β-glucan in
response to lactate [167], which is a relevant physiological metabolite present in Candida niches,
such as the vaginal tract and blood, or produced by the host microbiota [168], with which Candida
interact. Lactate-mediated β-glucan masking is modulated by a signaling pathway associated with
the G-protein coupled receptor Gpr1 and the transcription factor Crz1 [167]. This pathway reduces
C. albicans uptake by macrophages and decreases the inflammatory response (TNFα and MIP1α)
and neutrophil recruitment [167]. The participation of lactate was also observed later in low oxygen
environments [169]. C. albicans was found to mask β-glucan upon oxygen deprivation, hindering
recognition by Dectin-1 of polymorphonuclear leukocytes (PMNs). This was seen to modulate PMN
responses, crippling phagocytosis, action of extracellular DNA traps, and reactive oxygen species (ROS)
production [169]. Interestingly, β-glucan masking was prolonged by the build-up of lactate levels
produced by PMNs [169]. Later, another study reported that hypoxia promotes β-glucan masking in
C. albicans [170]. Hypoxia-induced masking is dependent on mitochondrial function and cAMP-protein
kinase A (PKA) signaling, leading to reduced macrophage phagocytosis and cytokine (IL-10, RANTES,
and TNF-α) production [170].
Changes in carbon source result in cell wall modifications with correspondent changes in virulence
and immune properties [108,171]. As mentioned before, the cell wall is a complex structure with
not only glucan, but also mannans, phosphomannans, and chitin [157], although distinct Candida
species display different glucan exposure and mannan complexity [166]. β-glucans and chitin are
located in the inner-most layer, while mannans are present in the outer layer [172–174]. Because of
such structure, mannan plays an important role in reducing immunogenic exposure of β-glucan [175],
but coordinated chitin and glucan exposure has also been reported to occur in C. albicans [176–178].
Moreover, cell wall structure and mannans affect virulence in different ways in C. albicans and
C. glabrata [179–181]. Recently, mannan structure was found to affect glucan exposure in both C. albicans
and C. glabrata, albeit in distinct ways. Deletion of mannosyltransferase family genes was associated
with loss of negatively-charged acid-labile mannan and less efficient glucan masking in C. albicans
(e.g., Δcgmnn2), while in C. glabrata increased glucan exposure density was associated with mutants
displaying shorter backbones (e.g., Δcgmnn1 and Δcganp1) [166]. Previously, another study had
shown that the β-1,6-mannosyltransferase encoded by C. albicans MNN10 is required for backbone
synthesis and influences immune recognition [182]. Absence of Mnn10 results in reduced C. albicans
virulence, enhanced antifungal immunity by T helper cells, and increased recruitment of monocytes
and neutrophils. Reinforcing the notion of a complex interplay among cell wall polysaccharydes,
mannosyltransferase activity was also associated with β-1,3-glucan masking from Dectin-1 recognition
and modulatory action of cytokine production by macrophages [182]. Another study showed how
C. albicans cell wall responds to immune attacks by NETs [176]. β-glucan exposure and enhanced
Dectin-1 recognition is dependent on fungal-pathogen crosstalk, as this response is dependent on
neutrophil NET-mediated damage and fungal signaling cascades based on the MAP kinase Hog1.
Cell wall structure in response to a neutrophil attack was found to affect more than one component,
as Hog1 signaling leads to chitin deposition via the chitin synthase Chs3 and posterior cell wall
remodeling via Sur7 and Phr1. Accordingly, with the enhanced immune recognition by Dectin-1 after
a NET-mediated attack, macrophage cytokine response was also increased [176].
Much like C. albicans, C. glabrata resorts to cell wall remodeling in order to avoid the host’s
immune system, although the underlying mechanisms are mostly unknown. As indicated by increased
TNFα secretion and increased efficacy of pathogen killing by macrophages, deletion mutants with
disturbed cell wall integrity and altered accessibility of PAMPs caused a stronger inflammatory response.
C. glabrata deletion mutants lacking cell surface-associated proteases (yapsins) or mutants with defective
protein glycosylation were related with a stronger inflammatory response by macrophages [13,181].
Nevertheless, mutations affecting mannan, but not those affecting glucan or chitin, were found to
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reduce the uptake of C. glabrata cells by murine macrophages, suggesting that mannose side chains or
mannosylated proteins are ligands recognized by macrophages [183].
Knowledge regarding the PRRs responsible for C. glabrata recognition by macrophages is limited.
Notwithstanding, as in C. albicans infections, C-type lectin receptors are thought to be involved in
C. glabrata recognition by the host immune system. Specifically, dectin-1 and dectin-2, which recognize
cell wall β-glucan, and mannan and β-glucan respectively, have been reported to be involved in the
recognition of this pathogen [184,185].
Unlike C. albicans that put effort in escaping the immune system, it is hypothesized that
inducing the recruitment of macrophages to the site of infection in vivo is part of the C. glabrata
immune system evasion strategy [21]. C. glabrata infection did not substantially activate any MAPK
pathway, including Erk1/2 (Extracellular signal-regulated kinases), SAPK/JNK (Stress-activated protein
kinases/Jun amino-terminal kinases), and NF-κB signaling. Accordingly, it was found that upon
infection of macrophages, the only cytokine significantly induced is GM-CSF, whereas the induction of
other proinflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8, and IFN-γ) is low [21,65,186]. GM-CSF is a
potent activator of macrophages and induces differentiation of precursor cells as well as the recruitment
of macrophages to sites of infection. This may explain the enhanced tissue infiltration of mononuclear
cells, but not neutrophils, observed in vivo [186]. Considering the ability of C. glabrata to survive
and replicate within macrophages, it is therefore speculated that persistence within macrophages is a
possible strategy of immune evasion in this pathogen [21].
Immune evasion by pathogens also entails escaping from the complement system, another
pathway of the innate immune system that facilitates phagocytosis. To evade immune response, several
pathogens were shown to sequester or bind complement regulators, such as factor H (FH) [187–190].
C. albicans expresses the glucose transporter Hgt1 that binds FH, therefore reducing complement
regulatory activity and limiting phagocytosis and killing by neutrophils [191]. SAP proteases produced
by C. albicans not only cause tissue damage [192], but also contribute to immune evasion, as Sap2 is
able to cleave antimicrobial peptides and complement proteins [193,194]. C. albicans Sap2 also cleaves
FH and its receptors (CR3 and CR4) on macrophages, thus limiting their activation [195]. Additionally,
C. albicans was also seen to bind yet another complement regulator (vitronectin) to modulate the
hosts innate response [196]. The C. albicans pH-regulated protein Pra1 was recently implicated in
the modulation of immune response [197,198]. It was seen to cleave the complement component C3,
blocking the complement effector function and interfering with killing by neutrophils [197]. Pra1 is
also implicated in adaptive immune response, as it binds to mouse CD4+ T cells and reduces cytokine
(IFN and TNF) secretion and antigen stimulation [198].
Ultimately, many yeast cells are engulfed by macrophages, hence survival and replication or
subsequent escape remain important features. Upon phagocytosis, the phagosome carrying the ingested
microorganism, fusion with a lysosome is one central antimicrobial mechanism of macrophages [164].
In the phagolysosome, fungal pathogens have to survive the harsh environment, typically characterized
by carbon source limitation, production of reactive oxygen and nitrogen species, and acidification of
the phagosomal compartment [199–201]. Mature phagolysosomes are normally strongly acidified,
inducing antimicrobial effector mechanisms such as the activity of hydrolytic enzymes. Nonetheless,
both C. albicans and C. glabrata are able to actively limit phagosome maturation in macrophages to
prevent acidification and limit hydrolytic attack [21,202]. Environmental alkalinization by amino acid
use as carbon sources, which results in ammonia extrusion, has been acknowledged as a strategy of these
pathogens to actively raise phagosome pH [199,203,204]. Moreover, extracellular pH-raising triggers
the yeast–hyphal switch in C. albicans [199,204]. Regarding carbon source availability, macrophages
actively deprive pathogens of glucose, and therefore alternative carbon sources must support fungal
growth. Accordingly, genes coding for enzymes of glyoxylate cycle, gluconeogenesis, and β-oxidation
of fatty acids were found to be upregulated in both C. glabrata and C. albicans cells ingested by
macrophages [13,18,205]. Very recently, the glyoxylate cycle gene ICL1 was demonstrated to be crucial
for the survival of C. glabrata in response to macrophage engulfment [206]. Disruption of ICL1 rendered
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C. glabrata cells unable to utilize acetate, ethanol, or oleic acid and conferred a severe attenuation
of virulence in the mouse model of invasive candidiasis [206]. Further, genes of the methylcitrate
cycle, which is important for the degradation of fatty acid chains and which allows the use of lipids as
alternative carbon sources, were also found to be upregulated in C. glabrata [13]. Downregulation of
protein synthesis as well as upregulation of amino acid biosynthetic pathways and amino acid and
ammonium transport genes are features of the nitrogen deprivation faced by fungal cells inside the
macrophages [13].
Although being mainly known by macrophage escape, strategies to counteract oxidative and
nitrosative stress have been described in C. albicans. For instance, flavodoxin-like proteins are part of the
antioxidant response of this species by reducing ubiquinone, which acts as a membrane antioxidant [207].
Expression of four flavodoxin genes (PST1, PST2, PST3, YCP4) is required for C. albicans virulence and
resist neutrophil attack [207]. Other than oxidative burst modulation, C. albicans was also reported to
modulate the nitrosative stress exerted by macrophages [208]. Nitric oxide production is dependent
on the enzyme nitric oxide synthase, which utilizes arginine as a substrate. By increasing chitin
exposure, C. albicans induces the host arginase-1 enzyme, which competes with the nitric oxide synthase
enzyme and prevents the conversion of L-arginine to nitric oxide [208]. Interestingly, the use of
amino acids as carbon source is much more prominent in C. albicans than other fungi [199] and amino
acid metabolism has been associated with more than one mechanism of phagocyte escape/survival.
Arginine was also found to play a role in hyphal development upon phagocytosis by macrophages,
thus contributing to escaping the phagosome [209]. Additionally, in poor glucose conditions, C. albicans
excretes amino acid-derived ammonia that increases external pH and interferes with the acidification
of the phagosome [204,210], as mentioned before. Moreover, the transcription factor Stp2 involved
in amino acid acquisition, is required to prevent phagosome acidification [204,209] based on the SPS
amino acid sensing system [211]. Regarding the contribution of nitrosative stress to macrophage
defense against C. glabrata, it is known that this pathogen induces only low NO production by murine
macrophages [13].
C. glabrata shows increased tolerance to oxidative stress when compared to other yeasts, including
Saccharomyces cerevisiae and C. albicans [212], mostly associated with the activity of the catalase Cta1,
the superoxide dismutases Sod1/Sod2 and the glutathione and thioredoxin pathways [212–214]. Despite
this, it is speculated that ROS play a minor role in killing C. glabrata cells, since experimental inhibition
of ROS production in macrophages did not result in increased fungal survival [215]. In contrast to
C. albicans, mobilization of intracellular resources via autophagy is an important virulence factor
that supports the viability of C. glabrata in the phagosomal compartment of innate immune cells [23].
Phagocytosis induces peroxisome production in C. glabrata cells, which are then degraded via pexophagy,
a specialized form of autophagy [23].
Moreover, besides carbon and nitrogen, trace elements such as iron are important for yeast growth.
Macrophage-engulfed C. albicans upregulate a set of genes involved in iron homeostasis, for example,
the ferric reductase genes FRE3 and FRE7, as well as uptake systems for other trace metals, such as
copper (CTR1) and zinc (ZRT2) [18]. C. glabrata is also able to sense and respond to iron limitation,
although it has not been shown to use host iron-binding proteins as iron sources and is unable to use
heme or hemoglobin. Instead, C. glabrata uses the siderophore-iron transporter Sit1, which is essential
for utilization of ferrichrome as an iron source under iron-deficient conditions, and for iron-dependent
survival in macrophages [216,217]. This iron acquisition system improves the fitness of C. glabrata
when it is subsequently exposed to macrophages [216]. Recently, PI3K-kinase (encoded by VPS34)
signaling was revealed to play a central role in C. glabrata iron metabolism and host colonization.
However, the strategies by which C. glabrata gains iron within macrophages remain unknown [218].
While C. glabrata is most known for a persistence strategy and survival inside macrophages, due
to its high-intrinsic stress tolerance, C. albicans is best known for active escape via hyphal growth and
phagocyte piercing. In 2014, the model of macrophage piercing due to polarized growth of hyphae was
challenged by two studies [17,219]. The study by Wellington et al. (2014) [219] showed that C. albicans
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escape is not exclusively due to disruption by hyphae. The pyroptosis pathway, a proinflammatory
programmed cell-death process that is dependent on caspase-1, leads to interleukin production and
macrophage lysis [220] and occurs concurrently with hyphae-mediated damage. Pyroptosis has been
described to occur in response to intracellular bacteria, and thus is hypothesized to achieve the goal
of destroying macrophages themselves in order to eradicate phagocyted pathogens [221]. C. albicans
yeast-to-hyphae transition induces macrophage pyroptosis, therefore indicating that phagocyte
damage caused by this pathogen is a more complex mechanism than originally postulated [17,219].
Accordingly, the study by Uwamahoro et al. (2014) [17] added more evidence of this escape mechanism.
The triggering of pyroptosis is necessary for full macrophage damage upon hyphal formation and is
activated in early phagocytosis, followed by a more robust hyphal formation that is indeed the main
mechanism of macrophage killing in a later phase [17].
Candida thrives on multiple carbon sources to survive inside macrophages, but these depend
on glucose for viability. Recently, Tucey et al. (2018) [222] demonstrated that C. albicans exploits
this limitation by depleting glucose, and triggering rapid macrophage death, in vitro. Additionally,
they showed that C. albicans infection promotes the disruption of host glucose homeostasis in vivo and
verified that glucose supplementation improves host outcomes under systemic fungal infection [222].
Thus, depriving host immune cells for glucose seems to be one mechanism of C. albicans to induce
phagocyte cell death and actively escape from those. Moreover, it was recently discovered that
candidalysin is both a central trigger for Nlrp3 inflammasome-dependent caspase-1 activation via
potassium efflux, and a key driver of inflammasome-independent cytolysis of macrophages and
dendritic cells upon infection with C. albicans [223]. This study suggests that candidalysin-induced
cell damage is a third mechanism by which C. albicans induces phagocyte cell death in addition to
damage caused by pyroptosis and the growth of glucose-consuming hyphae [223]. C. albicans-induced
activation of the Nlrp3 inflammasome, leading to secretion of IL-1β cytokine, is a crucial myeloid cell
immune response needed for antifungal host defense [224]. Very recently, Rogiers and co-workers
(2019) [225] identified candidalysin as the fungal trigger for Nlrp3 inflammasome-mediated maturation
and secretion of IL-1β from primary macrophages. Therefore, the expression of candidalysin is
speculated to be one of the molecular mechanisms by which hyphal transformation equips C. albicans
with its proinflammatory capacity to prompt the release of bioactive IL-1β from macrophages [225].
A more controversial evasion mechanism, based on quorum-sensing stimulation of immune
recognition, has been reported in both C. albicans and C. glabrata. In the case of C. albicans, white cells
specifically (not opaque cells) secrete E,E-Farnesol, a stimulator of macrophage chemokinesis [226].
Farnesol secretion was found to increase macrophage migration and tissue infiltration [226].
This strategy has been associated with immune evasion by the concealing of the pathogens inside
immune cells themselves, an environment where Candida species can survive.
Conversely to C. albicans, C. glabrata is incapable of hyphal differentiation, failing at this virulence
trait. Although never observed for clinical isolates, interestingly, work by Brunke et al. (2014) [227]
has shown that C. glabrata cells co-incubated during six months with macrophages, were able to
produce pseudohyphae structures and evolve into a hypervirulent phenotype characterized by higher
macrophage damage and faster escape.
Overall, the two more prevalent pathogenic yeasts, C. albicans and C. glabrata, follow two main
different strategies to achieve the same ultimate goal: survive host immune response. On one hand,
C. albicans hyphal forms actively pierce the membrane of macrophages as a mechanism of killing and
escape. On the other hand, C. glabrata, that lacks morphological plasticity, survives and replicates
within macrophages due to its remarkable ability to surpass its harsh environment, ultimately leading
to macrophage lysis after several days due to fungal cells overload [21] (Figure 3).
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Figure 3. Schematic representation of C. albicans and C. glabrata host immune system evasion. C. albicans
actively escape from host immune system cells through hyphal growth and phagocyte piercing.
C. glabrata is most known for a persistence strategy, surviving and thriving inside macrophages,
ultimately leading to immune cells lysis due to fungal load.
5. Conclusion and Perspectives
The pathogenic yeasts C. albicans and C. glabrata are the two most prevalent Candida species isolated
from candidiasis patients worldwide, yet they are phylogenetically, genetically, and phenotypically very
different. Indeed, each species displays divergent virulence traits, indicating differential adaptation to
the human host.
A greater number of virulence mechanisms has been described in C. albicans, most of which are
not known to occur in C. glabrata. Yeast-to-hyphae dimorphism is one of the most striking divergent
features. Hyphal morphology is associated with several key C. albicans traits (tissue invasion, biofilm
formation, immune evasion), but is absent in C. glabrata. The result is that C. glabrata must have
acquired other molecular mechanisms to reach the same goals. While tissue invasion in C. albicans
occurs by proteolytic enzyme secretion and hyphal penetration of host tissues, C. glabrata-induced
tissue damage is quite negligent in comparison and is thought to occur via endocytosis induction by
host cells.
A similar observation can be made regarding biofilm formation, where C. albicans expresses
hyphal-specific adhesins and regulators required for adhesion, while C. glabrata biofilms are much
less “bulky”. Morphological dimorphism also supports noticeable differences in immune evasion, as
hyphal development and phagosome piercing is the main phagocyte escape mechanism employed
by C. albicans, while such a strategy is absent in C. glabrata, which rather survives (and thrives) in
the phagosome.
Dissimilar traits between C. albicans and C. glabrata have been identified, and such attributes have
been extensively studied in C. albicans. However, the molecular mechanisms specific to C. glabrata that
allow such a disparate species to cause human candidiasis demand further scrutiny. Indeed, the up
rise of C. glabrata as a key fungal pathogen can only be prevented with specific therapeutic options that
match its specific virulence traits.
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Abstract: Cystic fibrosis (CF) is the most life-limiting autosomal recessive disorder in Caucasians.
CF is characterized by abnormal viscous secretions that impair the function of several tissues,
with chronic bacterial airway infections representing the major cause of early decease of these
patients. Pseudomonas aeruginosa and bacteria from the Burkholderia cepacia complex (Bcc) are the
leading pathogens of CF patients’ airways. A wide array of virulence factors is responsible for the
success of infections caused by these bacteria, which have tightly regulated responses to the host
environment. Small noncoding RNAs (sRNAs) are major regulatory molecules in these bacteria.
Several approaches have been developed to study P. aeruginosa sRNAs, many of which were
characterized as being involved in the virulence. On the other hand, the knowledge on Bcc sRNAs
remains far behind. The purpose of this review is to update the knowledge on characterized sRNAs
involved in P. aeruginosa virulence, as well as to compile data so far achieved on sRNAs from the Bcc
and their possible roles on bacteria virulence.
Keywords: cystic fibrosis; Pseudomonas aeruginosa; Burkholderia cepacia complex; small noncoding
regulatory RNAs; pathogenicity
1. Introduction: What are Bacterial sRNAs?
Regulation of gene expression in bacteria is achieved by a diversified system of multiple regulators,
from proteins to RNA molecules. Riboswitches, T Boxes, and small noncoding regulatory RNAs
(sRNAs) are among the RNA molecules or sequences that regulate the expression of genes. sRNAs were
first identified in Escherichia coli in the 1960s as part of a large group of transcriptional regulators [1,2].
Since then, sRNAs have been shown as key regulators in bacteria [3], being capable of driving the
fastest responses in the bacterial cell [4]. Ranging from 50 to 400 nucleotides long in size, sRNAs
have been found as encoded widespread in the bacterial genomes, mainly in intergenic regions.
For example, in enterobacterial genomes, sRNAs are estimated to represent approximately 200 to
300 genes, corresponding to ~5% of the number of protein-encoding genes [4,5].
sRNAs can be multipurpose regulators, targeting a wide range of molecular structures such as
DNA/chromatin, proteins, other RNA molecules, and metabolites [6]. These regulatory sRNAs are
therefore involved in the regulation of diverse cellular processes, including DNA assembly, plasmid
replication, phage development, transcription, translation, peptidoglycan synthesis, and bacterial
virulence [1,6]. In addition, sRNAs are also known for playing a role in cellular metabolism, like carbon
and amino acid metabolism, iron homeostasis, quorum sensing (QS), and biofilm formation; stress
responses including acid, osmotic, and oxidative stress responses; adaptation to growth conditions
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like high temperature and changes in molecular oxygen availability; as well as in mechanisms related
to bacterial pathogenesis [7].
Although the vast majority of the so far characterized sRNAs do not encode proteins, a few
can be partially translated originating small peptides, collectively known as dual-function small
regulatory RNAs. These sRNAs can exert their regulation by acting as an RNA molecule or as a peptide.
The peptide can play a similar regulatory role or a distinct one, capable of acting in a distinct metabolic
pathway [8].
The best described sRNAs act by antisense base pairing with a specific target mRNA. These sRNAs
can be cis- or trans-encoded, depending on their genome location in relation to the mRNA target [6].
Cis-encoded antisense RNAs share a full complementarity with their target mRNAs, often leading to
the formation of a near perfect sRNA-mRNA duplex. Distinctly, trans-encoded antisense sRNAs only
establish a partial complementarity with their target mRNAs, forming a partial duplex. Due to their
lower specificity, trans-encoded sRNAs usually have multiple targets, being part of a more complex
regulatory network in the cell. In both cases, the interaction between the antisense sRNA and target
mRNA can affect translation negatively or positively [9].
The base pairing of the sRNAs can occur at different regions of the target mRNA, such as the
3′ untranslated region (3′-UTR), the coding region, or, like most of the cases, at the 5′ untranslated
region (5′-UTR) where the ribosome accommodation usually occurs. The result of the interactions
between the sRNA and the target mRNA can also differ, often leading to the suppression of gene
translation by inhibition of ribosome interactions and/or by the induction of degradation of the target
mRNA. However, activation of gene translation has also been reported. In this case, the interaction
of the sRNA with the translation initiation region of the mRNA leads to a restructure of the mRNA
conformation, exposing the previously occluded ribosome biding site (RBS) [6,10]. sRNAs can also act
as stabilizers of target RNAs, avoiding their degradation. In addition, sRNAs can actually lead to the
cleavage of mRNAs, resulting in one or two stable coding mRNAs [9].
Sometimes a sRNA can also become a target, when another RNA molecule (usually a mRNA)
binds to the sRNA, trapping it. Known cases involve a sRNA that is constitutively expressed, and it
is the expression of the trap-mRNA that will impair the regulatory function of the sRNA on its
target [11,12]. Nevertheless, it has also been observed that some sRNAs bind to other sRNA, like the
SroC of Salmonella that can sequester a given sRNA, impairing its activity [13].
The interaction between sRNAs and proteins usually leads to protein sequestration [9]. One of
the best characterized target protein is CrsA, which has the ability to directly bind to the 5′ regions of
mRNAs, repressing their translation [14]. Some sRNAs act like a sponge, sequestering this protein.
This interaction activates the regulation of multiple pathways, related to carbon starvation and
glycogen biosynthesis, affecting the physiology and virulence of several pathogenic bacteria [14].
Moreover, sRNAs can also bind to proteins in a more complex way, producing more complex outcomes,
such as the modulation of enzymatic activity by inhibiting, activating or modifying the protein activity.
The best known example is E. coli 6S sRNA, which binds to the housekeeping form of RNA polymerase
(σ70-RNAP), modifying its activity [3]. Nevertheless, the best characterized proteins that interact with
sRNAs are the Hfq-like RNA chaperones, which play a major role in the regulatory mechanism of
sRNAs base pair interactions, by stabilizing the RNA molecules and mediating the interaction between
sRNAs and their targets.
Proteins of the Hfq family are conserved among bacterial genomes, being present in approximately
one half of the sequenced organisms, a fact that certainly reflects its importance for the bacterial
cell [15,16]. Hfq is a member of the (L)Sm protein superfamily and is present among the three domains
of life. In bacteria, Hfq assembles as a homohexamer with a donut-like shape containing three distinct
RNA binding sites on its surface, the proximal face, the distal face, and the convex circumferential
rim of the ring. The proximal face of the ring recognizes uridine-rich sequences, a typical feature
of 3′ terminal tails of sRNAs. The distal face preferentially binds adenosine-rich sequences or
repeated ARN motifs (composed of an adenosine, a purine, and any nucleotide), a characteristic
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usually found in mRNAs, allowing the recognition of the sRNA-target regions on the 5′ UTR of
mRNAs [17,18]. The rim, which is rich in arginine residues, seems to promote RNA annealing,
probably by guiding and facilitating the base pairing between the complementary strands of the
sRNA and the target mRNA [19]. The mechanisms underlying the Hfq-mediated sRNA–mRNA
interaction are quite diverse. Hfq increases the chance of the RNA molecules to meet by reducing
their motility and flexibility; the protein can induce changes in RNA secondary structure by exposing
the complementary regions of the RNA molecules, allowing the formation of a stable RNA double
strand by base paring; the chaperone increases the local concentration and proximity of the pairs
sRNA/mRNA by the specificity of its binding sites [20]. Moreover, Hfq is capable of accommodating
multiple RNA molecules and interacting with proteins involved in RNA metabolism and translation,
greatly improving the performance of sRNAs as regulators [17]. Hfq is now recognized as a major
component of post-transcription regulatory mechanisms in bacterial cells. The output of Hfq-mediated
sRNA-mRNA interactions is quite similar to those without mediation, occurring either an activation or
a repression of gene expression, with or without mediated degradation by RNAse E [18,21]. Deletion of
the gene encoding Hfq in several pathogens like Salmonella Typhimurium and Pseudomonas aeruginosa
has resulted in a strong attenuation of virulence [22]. This evidences the major role played by
Hfq-dependent sRNAs in virulence.
A recently characterized RNA chaperone, ProQ, is a RNA-binding protein of the ProQ/FinO
domain superfamily, conserved and abundant among α-, β-, and γ-proteobacteria [23]. A study in
Salmonella Thyphimurium revealed that the sRNAs associated to this chaperone possess extensive
secondary structures, distinct from those that associate to Hfq. In addition, only 2% of the identified
ProQ-interacting sRNAs also bind to Hfq [24]. The only full description of the mechanism of interaction
between ProQ and a sRNA was done by Smirnov et al. [23], who described the ability of ProQ to
stabilize the trans-encoded sRNA RaiZ, as well as the ability of the chaperone to mediate the interaction
of RaiZ with its mRNA target hupA.
2. Cystic Fibrosis Lung Infections
Cystic Fibrosis (CF) is the most common and life-limiting autosomal recessive disorder among
Caucasians, affecting ~70,000 individuals worldwide [25,26]. The CF disease is characterized by
abnormal viscous secretions in several tissues with epithelia, like airways, pancreas, small intestine,
liver, reproductive tract and sweat glands. The disease is due to mutations in the gene encoding
the Cystic Fibrosis transmembrane conductance regulator (CFTR). Despite the potential damaging
effect of cftr gene mutations on the affected organs, nowadays the great concern is centered on chronic
bacterial airway infections that are responsible for 80 to 90% of mortality [26–28]. The expression of
CFTR is much more pronounced in the airway’s tissues, where a dysfunctional CFTR causes deficient
cAMP-dependent chloride and bicarbonate secretion into airway secretions. Mucins are also secreted
to the epithelial surface and then the pH decreases, a factor that impairs the host defense mechanisms.
An inefficient inflammatory response, along with a defective mucus clearance, are the main causes
of microbial infections in the airways of CF patients [29]. A wide array of bacteria can colonize the
airways of CF patients, like Staphylococcus aureus, Haemophilus influenzae, Stenotrophomonas maltophilia,
and Mycobacteria sp other than M. tuberculosis. Fungi like Aspergillus fumigatus have also been found in
patients’ sputum. All these microbes can contribute to the decline of lung functions [30]. However,
the major threats to CF patient’s survival are P. aeruginosa, bacteria of the Burkholderia cepacia complex
(Bcc), and Achromobacter xylosoxidans. These bacteria can persist in the airways and provoke chronic
infections that are the main cause of morbidity and early mortality of CF patients. P. aeruginosa is the
leading cause of CF patients infections, being responsible for chronic infections in approximately 80%
of CF adults [30,31]. Progresses recently achieved in the development of aggressive early eradication of
P. aeruginosa led to an enhancement on prognosis [32]. Bacteria of the Bcc are the second major microbial
threat to CF patients. Despite their lower incidence (only 3%–4% of CF patients are infected by Bcc),
these bacteria are especially feared due to the easy transmission among the patients, the extensive
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antibiotic resistance, and the risk of cepacia syndrome, a fulminating pneumonia that leads to patient
death in a short period of time [33,34].
This review focuses on the current knowledge of sRNAs from the CF major pathogens P. aeruginosa
and Bcc. Since sRNAs are major regulatory molecules involved in bacteria virulence, we review in this
work some sRNAs involved in virulence of P. aeruginosa, as well as the present scarce knowledge on
Bcc sRNAs and their possible roles on bacteria virulence [35].
3. sRNAs of Pseudomonas aeruginosa, the Major CF Pathogen
P. aeruginosa is a Gram-negative species recovered from a wide range of environmental niches.
The species is an opportunistic pathogen to animals and humans and a serious threat to public
health [36]. P. aeruginosa is responsible for severe infections not only among CF patients, but also
in other immunocompromised patients and patients with severe burn injuries [37]. It is still to be
fully elucidated how an environmental species has become a major cause of nosocomial infections
worldwide. However, it is known that the overuse and misuse of antibiotics have led to the selection
of multiple antibiotic resistant strains, against which very few therapeutic options are available [32,36].
In a review, Potron et al. [38] showed that some markers of acquired resistance to antibiotics were
found in strains isolated all over the world. The ability of this bacterium to produce a wide range of
opportunistic infections and to originate strains resistant to various antibiotics can be attributed to its
large genome (typically with more than 6 Mbp), containing a particularly high proportion of regulatory
genes, as well as a large number of genes involved in the catabolism, transport, and efflux of organic
compounds [32]. Although P. aeruginosa infections can be eradicated during acute lung infections
in most of the cases, when a chronic infection is established, its eradication is hardly achieved [39].
The most striking examples of infections by P. aeruginosa are chronic lung infections in CF patients,
which occur in over 60% of adult patients [40]. When invading the CF lung, P. aeruginosa has to surpass
a heterogeneous, hostile, and stressful environment, being exposed to osmotic stress due to the viscous
mucus, oxidative and nitrosative stresses due to host defenses, sublethal concentrations of antibiotics,
and the presence of other microorganisms [32].
Acute infections by P. aeruginosa are among the best characterized; it is known that the expression
of their virulence genes is controlled by extremely complex, interweaving regulatory circuits and
multiple signaling systems. To achieve a successful acute infection, P. aeruginosa produces an impressive
array of virulence factors, such as the Type 3 Secretion Systems (T3SS) to secrete various exotoxins;
the quorum sensing (QS) systems to control numerous important secreted components including
pyocyanin, elastase, cyanide, and rhamnolipids, exhibiting a motile phenotype [32]. On the other
hand, P. aeruginosa virulence factors that are important in chronic infections are still to be fully
elucidated. It is known that in chronic infections, P. aeruginosa strains became less inflammatory and
less cytotoxic, and also lose structures responsible for adherence and motility, like the flagellum and pili.
Other characteristics include the appearance of mucoidy, due to alginate production, the emergence of
highly antibiotic resistant variants, changes in lipopolysaccharide structure including altered lipid A
and loss of O-antigen, and alterations in quorum sensing [39]. The GAC system network was pointed as
controlling the reversible transition from acute to chronic infections, incorporating the two-component
regulatory system GacA/GacS, two other sensor kinases RetS/LadS, the small regulatory protein
RsmA, and sRNAs RsmZ and RsmY [32]
To successfully infect their hosts, P. aeruginosa must achieve fast and precise regulation of its
metabolism. sRNAs are one of the best means to achieve such a fast and tight regulation, and this
is most probably why these bacteria possess a so vast array of those posttranscriptional regulators.
A total of 573 sRNAs are known to be expressed by the strain PAO1 and 233 sRNAs by the strain
PA14 [41]. PAO1 is a moderately virulent strain isolated from a wound, widely used as a reference
strain in comparison to the highly virulent isolate PA14, a representative of the most common clonal
group found worldwide [41]. 126 sRNAs are common to both strains. However, an in silico study
evidenced that the strains share more sRNAs in their genomes than the ones detected [42]. This means
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that, although some sRNAs are encoded in the genome of both strains their expression could be
strain-specific or environmental-dependent [42]. For the PAO1 strains, 149 sRNAs were already
annotated and 117 were experimentally validated, the remaining predicted by similarity searching.
In the case of the PA14 strains, 136 sRNAs are annotated and 66 were experimentally validated
(data obtained from the sRNAs database BSRD [43]).
Although the number of characterized sRNAs is remarkably reduced compared to the total
of predicted sRNAs in P. aeruginosa, it is still a huge number when compared to other organisms.
A boost in the characterization of sRNAs from P. aeruginosa strains PAO1 and PA14 took place in
recent years. At least one half of the characterized sRNAs were found to be dependent or mediated by
the Hfq chaperone (Table 1). Among the sRNAs characterized are the RsmY and RsmZ, both were
involved in the switch from the motile to the sessile modes of living, modulating the expression
of T3SS and T6SS [44]. However, only the role of RsmZ in cell motility and biofilm formation was
proved. Like RsmY and RsmZ, RsmW is also involved in the RsmA regulation, being implied in
the regulation of biofilm formation [45,46]. Moreover, ErsA and SrbA are two sRNAs that also play
a role in the regulation in biofilm formation. ErsA is part of the response to envelope stress and
exerts its regulatory role by modulating the activity of the checkpoint bifunctional enzyme AlgC
with phosphomannomutase/phosphoglucomutase activities and expression of the AmrZ regulon [47].
SrbA has also a role in the pathogenesis of P. aeruginosa PA14, although the mechanisms underlying
such regulation are still to be elucidated [48]. RgsA and NrsZ are both important in swarming motility.
Both are regulated by two-component regulatory systems (TCS). NrsZ is regulated by the TCS NtrB/C
and perform its role through its involvement in the modulation of rhlA expression, and thus controlling
the production of rhamnolipid surfactants [49]. RgsA is regulated by the GacS/GacA TCS, having as
targets fis and acpP, leading to the regulation of pyocyanin synthesis [37].
Las, RhL and PQS are the best known P. aeruginosa quorum sensing systems. The Pseudomonas
quinolone signal (PQS) plays a central role in the quorum sensing network in P. aeruginosa, linking
the three systems. sRNAs PrrF1/2, ReaL, and PhrS are major players in PQS modulation, all of them
playing a role in the expression of virulence genes. PhrS is involved in the regulation of expression of
PqsR, a transcriptional regulator of genes involved in PQS and pyocyanin synthesis [50]. ReaL acts by
positively regulating pqsC expression, in a response modulated by the Las system [51]. PrrF1/2 works
as an iron sensor, leading to an interruption of expression of genes encoding iron-binding proteins in
low iron conditions. The transcription activator antR is also repressed, avoiding the degradation of
anthranilate, a precursor of PQS synthesis. [52,53]. The sRNA PrrH that was not linked to P. aeruginosa
virulence also plays an important role in iron availability, by heme homeostasis [54]. In this context,
the CrcZ sRNA also seems to be involved in iron regulation. Like RsmY/Z/W, CrcZ also sequesters
proteins, in this case the Hfq chaperone. Although it was initially characterized as a regulator of
carbon catabolite repression, recent evidence points out CrcZ as a PrrF regulator, interfering with
the Hfq-mediated repression of antR [53,55]. Two other sRNAs were also characterized recently,
PaiI plays a pivotal role in anaerobic growth conditions and in denitrification, and PesA seems to play
a role in P. aeruginosa pathogenesis, being involved in Pyocin S3 modulation and resistance to UV
radiation [56,57]. Table 1 summarizes the P. aeruginosa sRNAs already characterized according to the
strain from which they were studied. A full description of the best characterized sRNAs playing a role
in P. aeruginosa virulence is described below.
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3.1. RsmY and RsmZ
Chronic infection seems to be the preferred mode of infection by pathogens like P. aeruginosa,
a premise for its survival and persistence as a population. Since the cellular mechanisms involved
in acute or chronic infection are different, the cell is equipped with a complex regulatory network to
switch its state. In the case of P. aeruginosa, the Csr/Rsm system plays a major role in this switch [52].
This system controls a large variety of physiological processes, like carbon metabolism, virulence,
motility, quorum sensing, siderophore production, and stress responses [45]. The system comprises
a major translational regulator, the protein RsmA, which negatively regulates mRNA targets by binding
to sites containing critical GGA motifs present in the 5′-UTR of mRNAs targets [45] This binding
represses the translation of regulons necessary for establishing chronic infections, as the T6SS, quorum
sensing systems, exopolysaccharide production, biofilm formation, and iron homeostasis [70,71].
On the other hand, RsmA exerts a positive and indirect regulation of the mechanisms linked to acute
infection, like the expression of genes associated with surface motility, T3SS, type IV pili, as well as
systems that operate through the cAMP/virulence factor regulator (Vfr) route [72]. RsmA appears to
control T3SS gene expression by increasing exsA translation through an undetermined mechanism.
ExsA is the master transcription factor of all T3SS genes [73]. So, RsmA regulates the switching from
planktonic (acute infection) to biofilm (chronic infection) phenotype. RsmA activity is negatively
regulated by the two-component regulatory system GacA/GacS that induces the expression of sRNAs
antagonist of RsmA, including the RsmY and RsmZ in P. aeruginosa (Figure 1) [74]. These two last
sRNAs have a secondary structure with several unpaired GGA motifs that sequester RsmA proteins,
preventing biding to their targets, and thus enhancing the expression of specific RsmA regulons [45].
Although GacA is a major regulator of rsmY and rsmZ expression, these sRNAs can also be
regulated by alternative regulators, and despite the redundancy, they can have different regulators.
It was observed in P. aeruginosa that rsmY transcription steadly increases during cell growth, whereas
rsmZ is induced harshly during the late exponential phase of growth [45]. Using swarming motility as
a model, Jean-Pierre et al. [61] showed that these sRNAs are differentially regulated depending on the
selected growth conditions (planktonic versus surface–grown cells), and that rsmZ regulation does
not implicate the response regulator GacA in swarming cells. Furthermore, these authors observed
that RsmY/Z expression influences swarming motility via the protein HptB, which acts as a negative
regulator of these sRNAs and that they do not strictly converge to RsmA [61]. Before a biofilm can
be formed, RsmZ is eliminated by the action of ribonuclease G, activated by the TCS BfiSR [45].
Other mechanisms of regulation of RsmY and RsmZ have been discovered recently. AlgR, a TCS
response regulator important for P. aeruginosa pathogenesis in both acute and chronic infections,
seems to affect the antagonizing action of RsmY and RsmZ on RsmA [75]. SuhB regulates the
motile–sessile switch in P. aeruginosa through the Gac/Rsm pathway and c-di-GMP signaling,
regulating multiple virulence factors like the T3SS, swimming motility, T6SS, and biofilm formation [44].
Li et al. [44] reported that this regulation is mediated by the GacA-RsmY/Z-RsmA. MgtE, a magnesium
transporter, was demonstrated to play a role in the inhibition of the T3SS transcriptional activator
ExsA. The negative regulation is mediated by expression of RsmY and RsmZ, most likely though
the TCS GacA/GacS [73]. The polynucleotide phosphorylase (PNPase), which is involved in the
regulation of multiple virulence factors like T3SS, T6SS and pili biosynthesis, plays an important
role in RsmY/Z stability. This stabilizing ability is due to the PNPase KH-S1 domains that bind
to sRNAs stabilizing them, providing a way of pathogenicity regulation by PNPase [76]. Recently,
Miller et al. [45] characterized a new sRNA in P. aeruginosa, the RsmW. Unlike RsmY and RsmZ,
this sRNA is not transcriptionally activated by GacA. RsmW was shown to be upregulated in
nutrient-limiting conditions, biofilms, and at higher temperatures [45].
355
Int. J. Mol. Sci. 2018, 19, 3759
Figure 1. P. aeruginosa functionally characterized sRNAs and their involvement on virulence regulatory
pathways. Grey box—characterized sRNAs (with red border- Hfq biding); Green box—indirect
regulator, Light Blue box—direct regulator; Coral box—direct target; Yellow box—indirect target;
Dark Blue—virulence factors; ↓: positive control; ⊥: negative control; dashed lines: indirect control.
3.2. ReaL
ReaL is a highly conserved P. aeruginosa sRNA recently characterized by Carloni et al. [51]. ReaL
was shown to be a relevant element for P. aeruginosa pathogenesis. In the infection model Galleria
mellonella, deletion of the ReaL encoding gene impaired P. aeruginosa PA14 virulence, while the sRNA
overexpression resulted in a hypervirulent phenotype. ReaL is involved in the quorum sensing
regulatory network architecture, interlinking the Las and PQS QS systems. Both Las and PQS are
part of a major network played at least by two additional systems, the integrated quorum sensing
system (IQS) and the Rhl QS system [77]. This entire network is closely related with the expression of
virulence factors in P. aeruginosa. The Las system is composed by the transcriptional regulator LasR,
its cognate autoinducer molecule N-3-oxo-dodecanoyl-homoserine lactone (3-oxo-C12-HSL), and the
3-oxo-C12-HSL synthase LasI [51]. PQS, positively regulated by the Las QS system, is an essential
mediator of the shaping of the population structure of P. aeruginosa and of its responses and survival
in hostile environmental conditions [78,79]. PQS synthesis proceeds through the condensation of
an anthranilate molecule with a fatty acid to produce the 2-heptyl-4-quinolone (HHQ), which is then
hydroxylated by the PqsH enzyme, whose expression is positively regulated by the LasR3-oxo-C12HSL
to produce PQS [77,80]. It is also known that ReaL plays a role in the interconnection between both
systems. Actually, ReaL is negatively regulated by LasR, and because it is a positive post-transcriptional
regulator of the pqsC gene, a decrease of PQS will occur. ReaL seems to contribute to the fine
co-modulation of HHQ/PQS synthesis [51]. The PQS system plays a vital role in biofilm formation
and production of virulence factors such as pyocyanin, elastase, PA-IL lectin, and rhamnolipids [77].
Therefore, ReaL expression triggers the production of some virulence factors, like biofilm formation
and pyocyanin synthesis, by a Las-independent way. In addition, ReaL plays a negative role in
swarming motility. The upregulation of ReaL expression is observed in the conditions found when
colonizing the human lung, like a temperature of 37 ◦C and low oxygen concentration [51].
3.3. ErsA
ErsA is the first sRNA from P. aeruginosa that appears to be embedded in the envelope
stress response, a critical transduction pathway that impacts pathogenesis in P. aeruginosa. ErsA
expression depends of the envelope stress responsive sigma factor σ22, the major player in the
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envelope stress-signaling pathway like σE in S. Typhimurium and other enterobacteria. ErsA directly
exerts a negative post-transcriptional regulation on the virulence associated algC gene encoding the
bifunctional enzyme AlgC [68]. AlgC plays a central role in exopolysaccharide biosynthesis, generating
the sugar precursors mannose 1-phosphate and glucose 1-phosphate, necessary for the synthesis
of polysaccharides like alginate, Pel, Psl, LPS, and rhamnolipids, key components of the biofilm
matrix [81]. A fine-tuned regulation exerted by ErsA on AlgC is thought to influence the dynamics
of exopolysaccharide biosynthesis, underlying the development of biofilm matrix. This regulation is
crucial when the bacterial cell is under envelope stress. The repressive role of ErsA on algC expression
occurs mainly at the translational level by base pairing with the RBS in a Hfq dependent way [68].
Furthermore, Zhang et al. [82] found that ErsA represses the expression of the OprD porin, the major
channel for the uptake of basic amino acids, peptides, and the carbapenem antibiotic, evidencing a role
played by this sRNA in antibiotic resistance.
3.4. PrrF
PrrF sRNAs are encoded in P. aeruginosa genome by two highly homologous genes, prrf1 and
prrf2. These sRNAs are encoded in tandem sequences, separated by 95 nt, a characteristic exclusive
of this species. The entire prrF region also encodes another sRNA, PrrH, transcribed from the 5′ end
of prrf1 to the 3′ end of prrf2 [83]. Infection experiments in a murine model using a deletion mutant
on the prrF locus showed that this genetic locus plays a pivotal role in P. aeruginosa virulence in acute
murine lung infection. The encoded sRNAs are also important for iron and heme homeostasis [64].
PrrH seems to play a role in heme homeostasis and on the expression of virulence factors. However,
PrrH is not vital for acute murine lung infection, as shown by Reinhart et al. [54]. Iron acquisition
is essential for P. aeruginosa virulence and biofilm formation, highlighting the role of regulatory
systems on the maintenance of iron homeostasis, with this sRNA playing a critical role in bacteria
survival in the host [64]. PrrF is responsible for the iron-sparing response, an effect observed under
conditions of iron limitation. PrrF exerts its regulatory activity by repressing mRNAs encoding
iron-containing proteins like the iron cofactored superoxide dismutase SodB, a putative bacterioferritin,
a heme-cofactored katalase and succinate dehydrogenase. Iron “sparing” is essential when the
intracellular iron concentration is low [54]. Although iron is an essential metallonutrient, when it
accumulates it becomes toxic, due to its ability to catalyze the formation of reactive oxygen species
via Fenton reactions. The regulation of such a homeostasis is mediated by the ferric uptake repressor
protein Fur [84]. Fur has the ability to bind to iron in iron-enriched environments, becoming an active
repressor of PrrFs, leading to a more extensive use of iron by the proteins otherwise downregulated
by PrrFs [64]. PrrF sRNAs also repress the expression of AntR, a transcription activator of genes
involved in the conversion of anthranilate to catechol. By this way, the anthranilate is channeled into
the biosynthetic pathway of the PQS, a system that leads to the expression of several virulence factors
as already mentioned above [64,85]. Furthermore, Sonnleitner et al. [53] added another sRNA to the
already extensive armory of P. aeruginosa, the CrcZ sRNA, which impairs the binding of PrrFs to antR.
Since the riboregulation played by PrrFs is mediated by Hfq, the CrcZ functions like a sponge, binding
to Hfq with a higher affinity compared to antR, inhibiting its binding. This mechanism leads to the
de-repression of antR.
3.5. PesA
PesA, characterized by Ferrara et al. [57], is encoded in the pathogenicity island PAPI-1, being
expressed by the highly virulent strain PA14, as well as by several clinical isolates obtained from CF
patients. The P. aeruginosa strain most commonly used for research, PAO1, does not encode PesA.
The sRNA is expressed under temperature and oxygenation conditions resembling those found in the
CF lung, namely 37 ◦C and low oxygen. PesA was shown to be important for P. aeruginosa pathogenicity
in CF bronchial cells. PesA is involved in the post-transcriptional regulation of genes involved in
S-type pyocin production, like pyocin S3. Pyocin S3, like other soluble pyocins, has a killing activity
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that causes cell death by DNA cleavage. Pyocins are produced by more than 90% of the P. aeruginosa
strains, helping P. aeruginosa in niche establishment, protecting the bacteria from competition [57,86].
By deleting pesA, an increased susceptibility to UV irradiation and to the fluoroquinolone antibiotic
ciprofloxacin was observed, correlated with a decreased level of pyocin expression. A similar effect
was observed when deleting the gene encoding pyocin S3. Although contradictory, PesA seems to
play an important role in the response to DNA damage by promoting the synthesis of pyocin S3 [57].
The mechanism underlying this response is not yet clear.
4. The Burkholderia cepacia Complex and the Emerging Knowledge on Its sRNAs
When compared to P. aeruginosa, respiratory infections caused by Bcc species have a low
prevalence on CF patients. However, bacteria of this complex are still one of the most feared pathogens
and represent a higher risk for those patients.
Burkholderia cepacia complex (Bcc) is a group of opportunistic human pathogens presently
composed of 23 closely-related species [87]. Apart from being a major threat for CF patients,
Bcc bacteria can also cause lethal infections among chronic granulomatous disease (CGD) patients,
immunocompromised patients (e.g., HIV infected), cancer patients, and other chronic patients [88].
B. cenocepacia and B. multivorans remain the predominant Bcc species worldwide that are responsible
for infections in CF patients [89,90]. Bcc species possess genomes larger than those of P. aeruginosa
strains, usually with a length of more than 7 Mbp. This large genome is thought to confer the bacterium
an enormous ability to overcome antimicrobial therapies, as well as the host immune response, being in
constant evolution inside the host lung [91].
The defective mucus clearance of the CF lung is the perfect niche for a persistent infection by
P. aeruginosa, as well as by Bcc bacteria that tends to occur after P. aeruginosa colonization, usually
superseding it [92,93]. Moreover, Bcc infections are easily propagated among CF patients. Bcc bacteria
possess an extraordinary resistance to antibiotics [94,95]. About twenty percent of CF patients infected
with Bcc bacteria develop the cepacia syndrome, a necrotizing pneumonia, often accompanied by
septicemia, leading to a rapid, irreversible and deadly decline of the respiratory function [96,97].
Bcc virulence resembles several traits of P. aeruginosa virulence, due both to the fragility of the
host and to the bacterium extraordinary evolutionary development. Once the colonization of the
respiratory tract is established and the bacteria are attached to epithelial cells, they have to overcome
a strong immunological response [98]. The successful invasion of host internal system is achieved by
mechanisms of penetration like paracytosis and invasion as a biofilm [99,100]. Among the virulence
factors expressed by Bcc species the extracellular lipase, metalloproteases and serine proteases,
and some structures of the bacterial surface such as flagella, pili, and the lipopolysaccharide (LPS)
can be highlighted [96,100]. Exopolysaccharide (EPS) production, namely Cepacian, also represents
a major virulence factor, important for biofilm formation and to protect Bcc from the host defense
machinery, as well as from antimicrobial therapy [101–104].
Like in P. aeruginosa, several noncoding RNAs have been associated with regulatory mechanisms
involved in Bcc virulence, as is the case of the modulation of the adaptation to the host changing
environment, the adherence to, and invasion of host cells, as well as the replication. However, the Bcc
noncoding virulome (sRNAs playing a role in virulence) is still poorly understood compared with
P. aeruginosa.
4.1. Discovering Bcc Noncoding Transcriptome
A pioneer systematic search for sRNAs in Bcc was first described by Coenye et al. in 2007 [105],
who predicted an array of putative noncoding RNAs (ncRNAs) from B. cenocepacia J2315, using
R. solanacearum GMI1000 genome as a reference. Two-hundred-and-thirteen ncRNA genes, ranging in
size from 53 to 1243 nt, were predicted and described. The expression of only four of these sRNAs
was confirmed by microarray experiments using total RNA from cells grown on a 10% (w/v) CF
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sputum [105]. The expression of one sRNA has confirmed by real-time PCR; none of these putative
sRNAs were functionally characterized.
In order to understand the mechanisms underlying the early stage of Bcc infections,
Drevinek et al. [106] performed a microarray-based transcriptomic analysis of B. cenocepacia grown
from sputum recovered from CF patients. The strain was found out to be indistinguishable from
B. cenocepacia J2315, a strain involved in multiple fatalities. The genes found to be upregulated were
mainly involved in antibiotic resistance, the antioxidant response to reactive species, iron metabolism,
and virulence factors such as flagella and metalloproteases. A thorough analysis of transcripts
originating from intergenic regions was carried out, leading to the identification of 88 upregulated and
126 downregulated sequences. However, no further characterization of these regions was performed
to identify putative sRNAs.
In 2009, Yoder-Himes et al. [107] used Illumina RNA-seq techniques to understand the
mechanisms of transcriptional regulation associated to B. cenocepacia environmental adaptation.
Two strains, one isolated from soil (B. cenocepacia HI2424) and another from a CF patient (B. cenocepacia
AU 1054), were grown under conditions mimicking each environment, and their transcriptomes
were analyzed. In both conditions a higher number of genes was transcribed in strain HI2424 than
in strain AU 1054. When grown under CF-like conditions, the strains exhibited differences in the
expression of genes mainly from chromosome 1, while growth under soil conditions led to differences
in the expression of genes mainly encoded in chromosomes 2 and 3. Regarding sRNAs, 13 were
identified (ncRNA1 to ncRNA13), but only one seems to be induced under CF-mimicking conditions.
Those sRNAs have been predicted to be highly structured. The expression of 4 sRNAs was confirmed
by northern blot, allowing the authors to assume that the sequences were indeed expressed in vivo.
The majority of these molecules are conserved among the B. cenocepacia strains and the Bcc (Table S1).
Effective response to reactive oxygen species by bacteria is an important feature regarding
the adoption of disinfection measures, as well as during exposure to oxidative burst by the host
defenses. To evaluate the response to reactive oxygen species (ROS), Peeters et al. [108] used microarray
transcriptomic analysis and qPCR to analyze whole cell responses of B. cenocepacia J2315 sessile cells
exposed to H2O2 and NaOCl. The profile of genes up- and downregulated was found to be similar
to that of planktonic P. aeruginosa PAO1 cells exposed to similar conditions. Many genes involved
in prevention (counteracting or repairing of the damage from oxidative stress) were found to be
upregulated, as well as some genes involved in the synthesis and assembly of flagella. Moreover,
several transcripts from intergenic regions were found, 39 and 56 were upregulated upon exposure to
H2O2 and NaOCl, respectively, whereas 54 and 68 were found to be downregulated. To avoid false
positives, the authors selected as putative noncoding RNAs the regions whose expression pattern
is different from the flanking genes. Eleven and 20 intergenic regions were selected as putative
noncoding RNAs upregulated with H2O2 and NaOCl, respectively. Transcripts from intergenic regions
IG1_2935724 and IG1_3008003 were upregulated in both conditions and their expression was confirmed
by qPCR. The ncRNA4 and ncRNA6, found by Yoder-Himes et al. [107], are located in those intergenic
regions, thus confirming their expression. A match was found between the IG1_2935724 and the
secondary structure of 6S RNA consensus structure. Seven out of the 11 sRNAs upregulated upon
exposure to H2O2 were also found significantly altered in B. cenocepacia J2315 cells of CF sputum [106].
Coenye et al. [109] used microarrays to study transcriptomic differences between planktonic
and sessile cells of B. cenocapacia J2315 exposed to chlorhexidine. The authors found that sessile cells
are more resistant to chlorhexidine (0.015%) than planktonic cells. Furthermore, sessile cells highly
expressed genes encoding efflux systems related to drug resistance, as well as membrane-associated
proteins and regulators. The results suggest that sessile cells engaged a global expression program
to evade the biofilm since an adhesin was downregulated and genes encoding chemotaxis and
motility-related proteins were upregulated. This study also allowed the identification of several
intergenic regions upregulated in the presence of chlorhexidine. After discarding the regions with
an expression level similar to the closest coding sequences (CDS) and the ones whose probes overlapped
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the coding sequences, 19 intergenic regions were suggested as putative sRNAs. As presented
in Supplementary Table S1, these regions are largely conserved among B. cenocepacia strains,
less conserved among the Bcc members, and only one of them is conserved in the B. pseudomallei
group. The majority of the predicted sRNAs seems to have a stable secondary structure, however no
significant match was found in the Rfam database [109].
Previous work from our research group led the experimental identification of 24 sRNAs from
B. cenocepacia, based on co-purification of total RNA and the chaperone Hfq [110]. Expression of these
sRNAs was confirmed by northern blot and characterized in silico. The only consistent results were
related to Bc7, for which the hemB was predicted as mRNA target, and the Salmonella Paratyphi RybB
as homolog. In addition a cis-encoded sRNA, named h2cR, was also previously reported by our
research group as being involved in the regulation of the hfq2 gene that encodes an Hfq-like chaperone
in Bcc [111].
The genome of B. cenocepacia KC-01, a strain isolated from the coastal saline soil, was recently
sequenced by Ghosh et al. [112]. Several potential sRNAs were identified by in silico analysis of
the genome, and the expression of seven putative sRNAs was confirmed (Bc_KC_sr1-7). Bc_KC_sr1
and Bc_KC_sr2 were upregulated in response to iron depletion by 2,2′-bipyridyl. Bc_KC_sr3 and
Bc_KC_sr4 were induced under the presence of 60μM H2O2 in the culture medium. Alterations on the
temperature and incubation time also induced the expression of Bc_KC_sr2, 3, and 4. Searches within
the RFAM and BSRD databases led to the identification of candidate738 of B. pseudomallei D286, tmRNA
and 6S RNA as homologs of Bc_Kc_sr4, 5, and 6, respectively. Interestingly, this group of sRNAs is
extensively conserved among members of the Bcc and B. pseudomallei groups (Supplementary Table S1).
Several targets were predicted for these sRNAs, like Fe-S cluster and siderophore biosynthesis,
ROS homeostasis, porins, transcription, and translation regulators.
4.2. A Deeper Approach: Bcc sRNAs Expressed under Biofilm Formation Conditions
Based on the importance of biofilm formation to antibiotic resistance, Sass et al. [113] analyzed the
transcriptome of B. cenocepacia J2315 grown in biofilms by differential RNA-sequencing (dRNA-seq).
dRNA-seq differs from RNA-seq on a selective sequencing of primary transcripts. The techniques,
used for the first time for a Bcc organism, allow mapping of the transcription start sites (TSS) based on
the difference of primary and processed transcripts ends. Primary transcripts carry a 5′ triphosphate
end, while processed transcripts like tRNA and rRNA, carry a 5′ monophosphate. Using the 5′
P-dependent terminator exonuclease (TEX) to degrade the 5′ monophosphate, it is possible to
distinguish between primary and processed transcripts [114]. As a complementary approach, Sass et al.
also carried out a global RNA-seq (gRNA-seq) to obtain a large coverage of the whole transcript length
and the 3′ end of transcripts, usually lost by dRNA-seq of longer transcripts. The additional use
of 5′ RACE allowed the authors to end up with 2089 genes annotated as expressed under biofilm
conditions and to identify alternative start codons for some genes and novel protein sequences.
A total nine sRNAs with homologs present in the Rfam database and other seven match putative
sRNAs that were experimentally identified in previous studies. The sRNAs with homologs in the
Rfam database were the 6S RNA; two phage-related regulatory RNAs located on genomic island
BcenGI9; two conserved regulatory motifs; the SAH riboswitch located upstream of BCAL0145;
an adenosylhomocysteinase; the sucA RNA motif located upstream of sucA (BCAL1515), an enzyme of
the citric acid cycle; and four sRNAs from the family named “toxic small RNAs”, whose expression in
B. cenocepacia have already been confirmed by northern blot but with unknown functions. From the
transcript sequences containing a TSS in intergenic regions that did not match with a gene and
without a hit in the Rfam database, the authors selected only those obeying to the following criteria:
strong transcription initiation with a coverage >300 reads in dRNA-Seq data, a defined 3′ end in
dRNA-Seq data or a transcript appearing short (<500 nt), and truncated or missing in gRNA-Seq data.
Upon selection, the sequences were compared with the experimentally confirmed sRNAs already
published by other authors. Six putative sRNAs matched those found by Yoder-Himes et al. [107],
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five of them upregulated on soil conditions and one on cystic fibrosis sputum. Another transcript
matched one sRNA previously identified by using co-purification with Hfq [110]. The expression of
these sRNAs in other studies, together with their overexpression under conditions of biofilm formation,
suggests a role for these sRNAs on biofilm regulation.
Sass et al. [115] refined their analysis on putative sRNAs found in association with biofilm
formation. From a total of 148 TSS found in intergenic regions, 41 transcripts were classified
as rho-independent (RIT), and 82 transcripts as derived from 5′ UTR of the downstream gene.
Fifteen sRNAs were selected based on the following criteria, the number of starts at TSS (≥250),
the z-score (<−1), and the conservation on Bcc (≥13 strains). 3′RACE and Northern blot analysis were
used to confirm the length of sRNAs. The expression of 14 sRNAs was quantified by qPCR in different
experimental conditions, all compared with planktonic cultures. Twelve sRNAs were upregulated in
biofilms. Some sRNAs were slightly upregulated by osmotic or pH stress. Nutrient starvation also
induced the expression of 12 sRNAs, as well as the expression of Hfq chaperone. Five of these sRNAs
were also more expressed under glucose-rich medium.
Further work performed by these authors led to the identification of ncS63 as highly expressed
under conditions of low-iron. This sRNA is located upstream of BCAL2297, which encodes for the
hemin-uptake protein HemP, whose expression is under the regulatory control of the Fur repressor.
The predicted targets of ncS63 are related to iron homeostasis like sdhA, a target of RyhB from E. coli.
RyhB is a sRNA involved in iron homeostasis regulated by the Fur repressor, and a possible functional
analogue of ncS63. Recently, RyhB was hypothesized to play an important role as a mediator of
bacterial resistance to multiple antibiotics and stresses [116]. Further investigation is needed to check
if ncS63 is a RyhB functional homolog. The overall prediction of sRNAs targets using CopraRNA
and RNApredator led to similar clues about the mechanisms that can be under regulation of these
sRNAs, like transcriptional regulators, carbon compound transport and metabolism, and cell envelope
components such as outer membrane proteins and porins. The transcriptional regulator BCAL1948
has been predicted to be a target of nine sRNAs, exhibiting particularly extensive complementarity to
ncS11. sRNAs containing double-hairpin were predicted to target genes involved on the metabolism
and transport of amino acids, carbohydrates, and aromatic compounds. The ncS16 has several hits of
genes related to outer membrane and cell envelope components, and genes for transport of inorganic
compounds, whereas the best hits for ncS63 were genes involved in energy production and detoxication
of reactive oxygen species. Regarding the putative sRNAs derived from 5′UTRs, most likely they
have a cis-regulatory function, since some 3′ ends of adjacent genes are homologs of genes that
possess cis-regulatory structures in other species. A possible trans-regulatory function remains to
be investigated.
4.3. ncS35, a Functionally Characterized B. cenocepacia sRNA
While in other organisms sRNAs are being characterized for decades, their characterization
in Bcc is starting. ncS35 was identified by Sass et al. [115] in the course of B. cenocepacia J2315
biofilm transcriptomic analysis, being the first trans-encoded characterized sRNA from B. cenocepacia.
The expression of ncS35 was found to be upregulated in cells grown as biofilm and in minimal
medium compared to planktonic cells grown in rich medium. Increased aggregation, higher cell
metabolic activity, higher growth rate, and increased susceptibility to tobramycin were described for
deletion mutant cells. Moreover, an upregulation of the phenylacetic acid and tryptophan degradation
pathways was observed in the mutant cells, and the first gene of the tryptophan degradation pathway
was predicted to be a putative target of ncS35. This sRNA seems to lead to an attenuation of the
metabolic and growth rates, which can be a way of cells to protect themselves against stress conditions.
A slow growth rate is observed on P. aeruginosa biofilms in CF patient’s sputum, and it is also
known that bacteria on slow growth rate, even in planktonic cultures, have an increased resistance to
antibiotics, including tobramycin [117,118]. Slow growth rates and metabolic activity are characteristics
of persister cells and probably the cause of drug resistance. Since the effect of antibiotics is mainly
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due to the inhibitory action of some metabolic pathways, slow-growing cells are somehow protected
from antibiotics and are more likely to develop drug resistance [119]. The occurrence of persister
cells in Bcc infections is known, and it has also been observed in B. cenocepacia J2315 after treatment
with tobramycin [120]. A better characterization is required to fully understand the roles of ncS35 on
B. cenocepacia pathogenicity, antibiotic resistance, and possibly on the formation of persister cells.
4.4. Compiling the Bcc Predicted sRNAs
Although a few sRNAs from Bcc organisms are functionally characterized, a large number of
putative sRNAs have been described by several research groups. This information was gathered,
and we present on Supplementary Table S1 all predicted and confirmed sRNAs, as well as the intergenic
regions, which can include candidate noncoding RNAs described so far for B. cenocepacia. Predicted
sRNAs for which data is somehow confusing and uncertain, or the methods applied were not accurate
enough, were not considered. B. cenocepacia was chosen because it is the one of the Bcc species with
the noncoding transcriptome better characterized. A total of 167 putative sRNAs were included on
Table S1, seven from B. cenocepacia KC-01, 13 from B. cenocepacia AU 1054, and 147 from B. cenocepacia
J2315, the majority of them identified by Sass et al. [115]. Putative sRNAs are unevenly distributed
throughout the three chromosomes: 67.5% are located on chromosome 1, 28.1% on chromosome 2,
and 4.4% on chromosome 3. The length of the replicons on the J2315 strain is 3,870,082, 3,217,062,
and 875,977 bp, respectively [121]. The chromosomes 1 and 2 are approximately equally sized;
however, chromosome 1 accommodates twice the sRNAs compared with the second chromosome.
This suggests that chromosome 1 sRNAs are more relevant for core functions of bacterial metabolism
(e.g., cell division). On the other hand, since the regulation of the other two replicons encode genes
more related to accessory functions, the regulatory noncoding RNAs encoded in those replicons
are probably expressed in response to specific conditions that may have not been assessed yet [121].
Wong et al. [122] used a transposon mutant pool and identified 383 possible essential genes on J2315
strain, 90% of which was present on chromosome 1. Such a strategy can not only enable the discovery
of crucial coding genes expressed on different conditions, but might also unveil the Bcc noncoding
transcriptome, allowing the discovery of important genes related to some features like virulence and
antibiotic resistance.
Regarding the sequence conservation, 93% of the putative sRNAs listed in Table S1 are conserved
or semiconserved among the species, 70% among the Bcc bacteria and 24% also in the B. pseudomallei
group. Although the B. pseudomallei group is phylogenetically distant and those bacteria display
a distinct pathogenicity and epidemiology, a high level of sequence homology is found in almost 25%
of the putative sRNAs identified so far [123]. It is also interesting to access the conservation of the
putative sRNAs in each chromosome, since a higher conservation can be observed on chromosome 1,
much more extensive than chromosome 2 and 3. A huge difference is observed on the conservation of
sRNAs on the Pseudomallei group, with a conservation (and semiconservation) of ~25% on sRNAs
from chromosome 1, whereas sRNAs from chromosome 2 and 3 exhibited less than 4% conservation.
This is also evidence that Bcc comprises more closely related species than the Pseudomallei group,
mainly regarding the accessory functions.
Several sRNAs were identified by more than one experimental approach and given different
names. For instance, ncRNA4, ncS17, and Bc_KC_sr6 are the same sRNA, which was found on the
intergenic region IG1_2935724. This sRNA shares homology with the 6S RNA, a regulator of RNA
polymerase (RNAP) that is widespread among members of the Bacteria domain. This sRNA was found
as expressed in distinct situations like soil conditions, biofilm formation and response to ROS [124].
Moreover, an upregulation of the 6S RNA was found in response to oxidative stress, further implying
it with a broader role than just on core metabolism, such as on the protection of the cell in the host
environment [108]. The possible role of 6S RNA in pathogenesis or in host survival has been described
for several bacteria [124]. The homologs ncRNA6 and ncRI12 are both located on the intergenic
region IG1_3008003 and are probably the same sRNA. This sRNA was overexpressed during biofilm
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formation and upregulated under soil conditions, exposure to chlorhexidine, and ROS, suggesting
a role on protection against stress conditions. ncS06, homolog of ncRNA7, was found to be expressed
under soil conditions and biofilm formation. Prediction of ncS06 mRNA targets revealed several
peptidase-encoding genes [115]. ncS11 is a homolog of ncRNA13 and was found to be upregulated
on soil conditions, as well as on biofilms, rich medium and starvation conditions [115]. ncS11 has
an extensive complementarity to BCAL1948, whose expression was found to be downregulated
under biofilm formation. BCAL1948 is a protein of the LysR-type transcriptional regulator (LTTR)
family, whose global transcriptional regulators can be found in diverse organisms. The regulated
genes are hypothesized to be involved in a wide range of processes like cell division, metabolism,
nitrogen fixation, oxidative stress responses, motility, quorum sensing, attachment, secretion, virulence,
and toxin production [125].
5. Conclusions
There is a clear contrast between the knowledge currently available about sRNAs characterization,
regulatory pathways and interactome in P. aeruginosa and Bcc bacteria. In P. aeruginosa, fourteen
sRNAs have already been functional characterized. Some P. aeruginosa sRNAs are involved in the
pathogenicity and virulence of the organism, like biofilm formation, iron metabolism, quorum sensing
regulation, response to stress, and host cell invasion. On the other hand, in Bcc bacteria the first
biological function of a sRNA is now being described. This sRNA is ncS35, a growth regulator that
seems to do not interfere with the virulence of Bcc bacteria. Despite the scarce characterization of
sRNAs in Bcc, over the last 10 years at least 167 putative sRNAs were identified in B. cenocepacia
as being expressed on CF sputum, biofilm formation, response to oxidative stress, among others
specific conditions.
In the peculiar environment of the CF lungs, it is interesting to note that both P. aeruginosa and
Bcc bacteria can cause infections presenting a high degree of intrinsic and acquired resistance to
antibiotics. Both opportunistic pathogens have two of the largest genomes known among prokaryotes,
which were predicted to encode a huge number of sRNAs. The functional characterization of these
sRNAs is only beginning in those CF pathogens. However, the already established or predicted roles
of some sRNAs in modulating cellular processes linked to pathogenesis, suggests their yet unexplored
importance for the physiology and pathology of these pathogens, as well as their likely influence
in the outcome of P. aeruginosa and Bcc infections. The assessment of the functional roles of sRNAs
in the host–pathogen interaction is expected to provide additional fundamental knowledge for the
development of next-generation antibiotics inspired by sRNAs and their targets.
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Abstract: The SpyCatcher-SpyTag system was developed seven years ago as a method for protein
ligation. It is based on a modified domain from a Streptococcus pyogenes surface protein (SpyCatcher),
which recognizes a cognate 13-amino-acid peptide (SpyTag). Upon recognition, the two form a covalent
isopeptide bond between the side chains of a lysine in SpyCatcher and an aspartate in SpyTag. This
technology has been used, among other applications, to create covalently stabilized multi-protein
complexes, for modular vaccine production, and to label proteins (e.g., for microscopy). The SpyTag
system is versatile as the tag is a short, unfolded peptide that can be genetically fused to exposed
positions in target proteins; similarly, SpyCatcher can be fused to reporter proteins such as GFP, and to
epitope or purification tags. Additionally, an orthogonal system called SnoopTag-SnoopCatcher has
been developed from an S. pneumoniae pilin that can be combined with SpyCatcher-SpyTag to produce
protein fusions with multiple components. Furthermore, tripartite applications have been produced
from both systems allowing the fusion of two peptides by a separate, catalytically active protein unit,
SpyLigase or SnoopLigase. Here, we review the current state of the SpyCatcher-SpyTag and related
technologies, with a particular emphasis on their use in vaccine development and in determining outer
membrane protein localization and topology of surface proteins in bacteria.
Keywords: autotransporter; covalent labeling; bacterial surface protein; SpyCatcher; topology mapping;
virulence factor
1. Introduction
The peptide bond is essential to biology. This secondary amide bond is produced by the
condensation of the carboxyl group of one amino acid residue with the α-amino group of the following
residue and results in the polymerization of amino acids to produce polypeptides. This central reaction
is catalyzed by the ribosome and the sequence of the polypeptide chain is defined by the genetic code.
In proteins, the peptide bond is sometimes referred to as the eupeptide bond. In addition, peptide
bonds can be found in non-ribosomal peptides, which are secondary metabolites such as antibiotics
produced by non-ribosomal peptide synthases [1]. A minority of proteins contain a second class of
peptide bonds, referred to as isopeptide bonds. This is an amide bond similar to the peptide bond,
but it is produced by the condensation of an amine group with a carboxyl group or a primary amide
group located in amino acid side chains, rather than the main chain-building amino or carboxyl groups
(Figure 1A).
In eukaryotes, the most prevalent example of isopeptide bond formation is the ubiquitination of
proteins targeted for degradation by the 26S proteasome [2]. The isopeptide is formed by the C-terminal
carboxyl group of ubiquitin and the side-chain amine of a lysine residue in the target protein. This reaction
Int. J. Mol. Sci. 2019, 20, 2129; doi:10.3390/ijms20092129 www.mdpi.com/journal/ijms371
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is catalyzed by E3 enzymes, or ubiquitin-protein ligases, which also impart specificity to the system [3].
Similarly, members of the small ubiquitin-like modifiers (SUMO) family, which regulate a number of
cellular processes, are ligated to their target proteins via an isopeptide bond [4].
In bacteria, isopeptides are mostly known from surface proteins of Gram-positive bacteria.
Two classes of proteins have notable isopeptide bonds: the microbial surface components recognizing
adhesive matrix molecules (MSCRAMMs) and pili [5]. In pili, pilin subunits are covalently bound to
each other via an intermolecular isopeptide bond between the carboxyl group of a C-terminal threonine
and the ε-amine of a lysine in the next subunit, a reaction catalyzed by a pilin-specific sortase [6].
In MSCRAMMs and some pilins, isopeptides are formed spontaneously between residues within
the same domain. These domains belong to the immunoglobulin fold superfamily. Isopeptide bond
formation increases the stability of the proteins or pili and may contribute to stronger binding to
ligands by MSCRAMMs, since in some cases the isopeptide only forms upon ligand binding to lock
the protein in a bound conformation [7].
The SpyCatcher-SpyTag system was developed by the Howarth laboratory based on the internal
isopeptide bond of the CnaB2 domain of FbaB, a fibronectin-binding MSCRAMM and virulence factor
of Streptococcus pyogenes [8,9]. An internal isopeptide bond forms spontaneously in this domain between
the ε-amine of lysine K31 and the side chain carboxyl of aspartic acid D117. The reaction is catalyzed by
the spatially adjacent glutamate E77 (Figure 1B). The resulting isopeptide bond confers high stability to
the CnaB2 domain [10]. The CnaB2 domain can be stably split into two components: a larger, incomplete
immunoglobulin-like domain (termed SpyCatcher) of 138 residues (15 kDa) and a shorter peptide
(SpyTag) of 13 residues (see Table 1 for peptide sequences). SpyCatcher contains the reactive lysine
and catalytic glutamate, whereas SpyTag includes the reactive aspartate. The two components can still
recognize each other with high affinity (0.2 μM) and the isopeptide can form between SpyCatcher and
SpyTag to form a covalently bound complex (Figure 1C). Under experimental conditions relevant to life
science research (room temperature, dilute protein concentrations), the reaction rates allow the bonds
to form at high efficiency within minutes [9]. SpyTag in particular is equivalent in size to a number of
epitope tags and can be genetically fused to a number of proteins and is able to react with SpyCatcher
when inserted at the N- or C-termini of target proteins, as well as internal sites [9,11]. SpyCatcher itself
can also be produced as a fusion protein, allowing the formation of covalently bonded protein partners
that might otherwise be difficult to produce as protein fusions [12–14].
A similar system has been developed based on another Gram-positive surface protein, the pilus
adhesin RrgA of S. pneumoniae [15,16]. The D4 domain of this protein is stabilized by an isopeptide
forming between a lysine (K742) and an asparagine (N854), catalyzed by the spatially adjacent E803 [15]
(Figure 1D). This domain was split into a scaffold protein called SnoopCatcher and a 12-residue
peptide termed SnoopTag, which can spontaneously form a covalent isopeptide bond upon mixing [16]
(Figure 1E). In contrast to SpyCatcher-SpyTag, the reactive lysine is present in SnoopTag and the
asparagine in SnoopCatcher. This system is orthogonal to SpyCatcher-SpyTag; that is, SnoopCatcher
does not react with SpyTag and SpyCatcher does not react with SnoopTag. This allows the use of both
systems simultaneously to produce “polyproteams,” programmed modular polyproteins, for use in
biotechnological applications [16].
The Howarth lab further modified these technologies by making tripartite systems, where
the isopeptide-forming lysine and aspartate/asparagine are located on separate peptides, and the
catalytic glutamate is present on a larger scaffold protein [17]. This was first attempted with the
SpyCatcher system to produce SpyLigase. Here, a second peptide containing the reactive lysine (KTag)
was separated from SpyCatcher, which itself was modified to produce the stable SpyLigase protein
containing the catalytic glutamate [18]. When SpyLigase was mixed with two proteins containing one of
the reactive peptides each, SpyLigase was able to catalyze the fusion of the two tags. However, although
SpyLigase could mediate the fusion of KTag and SpyTag located at both N- and C-terminal and even
internal positions, the reactions had a ~50% efficiency at best and were dependent on specific buffer
conditions and low temperature [16]. In contrast, the recently developed SnoopLigase system appears
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more robust and efficient [19]. SnoopLigase was engineered similarly to SpyLigase, and catalyzes the
isopeptide formation between the lysine of a modified SnoopTag (SnoopTagJr) and the asparagine
in a second peptide termed DogTag (Figure 1F). This system can have efficiencies over 95% that are
less sensitive to temperature and reaction conditions than SpyLigase. Furthermore, as SnoopTagJr
and DogTag have relatively high affinity for SnoopLigase, immobilizing SnoopLigase allows washing
away unconjugated reactants followed by elution of essentially pure fusion products [19]. The various
Catcher-Tag systems and their development are summarized in Table 1.
Below, we review the various applications of the SpyCatcher/SnoopCatcher systems in biotechnology.
Our emphasis will be on using this methodology to label surface-exposed proteins, especially for mapping
the topology of outer membrane-embedded virulence factors of Gram-negative bacteria.
Figure 1. The SpyCatcher-SpyTag, SnoopCatcher-SnoopTag, and SnoopLigase systems. (A) Formation
of an isopeptide bond. The primary amine of a lysine side chain condenses with either the side-chain
amide of an asparagine (upper reaction) or the side-chain carboxyl of an aspartate (lower reaction) to
produce the isopeptide bond, releasing either ammonia or water, respectively; (B) the isopeptide bond
between SpyCatcher-SpyTag. The isopeptide formed by the reactive lysine (K31) in SpyCatcher and
aspartate (D117) in SpyTag is shown in green, and the catalytic glutamate (E77) in cyan; (C) crystal
structure of SpyCatcher-SpyTag. SpyCatcher is in blue and SpyTag is in magenta. The structures shown
in panels b and c are based on the Protein Data Bank (PDB) entry 4MLI [20]; (D) the isopeptide bond
between SnoopCatcher-SnoopTag, formed by lysine (K742) in SnoopTag and the asparagine (N854) in
SnoopCatcher, is shown in red, and the catalytic glutamate (E803) is in blue; (E) crystal structure of
SnoopCatcher-SnoopTag. SnoopCatcher is in yellow and SnoopTag in green. The structures shown
in panels d and e are based on the RrgA D4 domain structure (PDB ID: 2WW8) [15]; (F) schematic of
the function of SnoopLigase. A protein (in brown) containing SnoopTagJr (ST, in orange) and another
protein (purple) with DogTag (DT, green) are mixed in the presence of SnoopLigase (yellow). The tags
bind to SnoopLigase, which contains the catalytic glutamate (blue dot) and catalyzes the formation
of an isopeptide between SnoopTagJr and DogTag (red dot). The ligated proteins can then be eluted
from SnoopLigase.
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Table 1. Summary of Catcher-Tag technologies and their development.
Catcher Tag Tag Sequence Description Publication Year Reference











SpyTag AHIVMVDAYKPTK 1 Rationally engineered system
for ligating two peptides. 2014 [18]KTag ATHIKFSKRD
SnoopCatcher SnoopTag KLGDIEFIKVNK 1
Orthogonal technology to
SpyCatcher. 2016 [16]
SpyCatcher002 SpyTag002 VPTIVMVDAYKRYK 1
Improved SpyCatcher-SpyTag
system with faster reaction rate. 2017 [21]
SnoopLigase 2
SnoopTagJr KLGSIEFIKVNK 1 Rationally engineered system
for ligating two peptides. 2018 [19]DogTag DIPATYEFTDGKHYITNEPIPPK
SpyDock SpyTag002 VPTIVMVDAYKRYK 1
Protein affinity purification
system (Spy&Go) based on
SpyCatcher.
2019 [22]
1 The reactive residues are shown in bold. 2 SpyLigase and SnoopLigase have two target peptides.
2. Applications of the SpyCatcher-SpyTag System
Being a quick and reliable coupling tool for irreversible peptide-protein ligation, the SpyTag-SpyCatcher
system is ideal for a wide range of applications, ranging from increasing protein stability to antigen delivery
during vaccination [14,23]. Before focusing on the use of the SpyTag-SpyCatcher system in the investigation
of bacterial virulence factors, we give a short overview of those applications. For more detailed information,
a list of publications and patents using the SpyTag-SpyCatcher and related technologies is accessible at the
SpyInfo web page (available online: https://www.bioch.ox.ac.uk/howarth/info.htm) and the corresponding
sequences and expression routes are listed in the SpyBank database [24].
A major application of the SpyTag-SpyCatcher system is the formation of so-called SpyRings
in order to increase the intrinsic resilience of proteins to denaturation. SpyRings are generated by
circularization of a single protein, which is accomplished by fusing an N-terminal SpyTag with
a C-terminal SpyCatcher, or vice versa (Figure 2A). Enzyme circularization increases resistance to
hyperthermal denaturation and aggregation, as well as alkali tolerance of individual enzymes without
a loss in enzymatic activity [25–29]. Enzymes with a short distance between termini (<15 Å), and
an active site which is not in direct proximity to one of the termini, are considered ideal candidates for
protein circularization [30]. However, efficient SpyRing circularization and increased thermal stability
have been shown for proteins where the termini are even farther apart [28].
Another frequently used application for the SpyCatcher-SpyTag system is the decoration of protein
hydrogels (Figure 2B). Hydrogels have found application, for example as an artificial extracellular
matrix material in medicine [31], tissue engineering [32,33], and cell culturing [34]. Hydrogels are
polymeric materials engineered to resemble the extracellular environment of specific tissues with
defined functional and structural properties. They have been used for decades as molecule delivery
devices and as carriers for cells in tissue engineering due to their ability to mimic aspects of the
native cellular environment [35]. However, hydrogels fail to fully imitate the complexity of biological
systems. Fusing SpyCatcher to the polymeric material used in hydrogel synthesis allows the decoration
with SpyTagged proteins post-hydrogelation to mimic specific microenvironments [36–39]. Thus,
the SpyTag-SpyCatcher system is used as a quick and simple molecular tool for the simultaneous
incorporation and presentation of different target molecules into and on hydrogels, thereby avoiding
an otherwise laborious engineering process.
The SpyTag-SpyCatcher system has also been used for the modular assembly of proteins onto
nanoparticles [40] (Figure 2C) and bacterial outer membrane vesicles [41] (Figure 2D; see also Section 3.3).
The same system can be used for the in vivo encapsulation of enzymes fused to phage capsid proteins
in order to create a protein nanocompartment [42] (Figure 2E) and for the decoration of virus-like
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particles (VLPs) for antigen delivery to the immune system [43,44] (Figure 2F; see also Section 3.3),
while successfully preserving the structure and the function of the assembled proteins.
 
Figure 2. Applications of the SpyCatcher-SpyTag system. (A) SpyRing: SpyCatcher and SpyTag
are fused to the terminal ends of the protein of interest resulting in protein cyclization and thereby
conferring an increased resilience to denaturation; (B) post-hydrogelation decoration of protein
hydrogels: SpyCatcher is fused to the polymeric material used in hydrogel synthesis, which allows
the posthydrogelation decoration with proteins of interest fused to SpyTag; (C–F): (C) bioconjugation
of target proteins to nanoparticles, (D) outer membrane vesicles, (E) phage capsid proteins to create
a proteinaceous nanocompartment, and (F) virus-like particles; (G) SpyCLIP: SpyTagged RNA-binding
protein interacts with RNA and is covalently attached to beads with fused SpyCatcher for use in
pull-down assays; (H) fluorescent protein labeling for use, for example, in microscopy (ST represents
SpyTag sequence); (I) artificial multi-enzyme nanodevices for increased efficiency, stability, and
reusability. Schematic of mesh-like nanodevice is shown on the left and an enzymatic reaction scheme
on the right. S represents substrate; P represents product; A and B represent cofactors.
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Recently, the SpyTag-SpyCatcher system was used for the characterization of protein–RNA
interactions as an alternative for ultraviolet (UV) crosslinking and immunoprecipitation (CLIP) [45].
The CLIP method relies on the limited specificity of antibody–antigen interactions which cannot
withstand harsh washing conditions resulting in insufficient purity of ribonucleoprotein complexes
after immunoprecipitation. Therefore, additional gel purification steps are necessary to further purify
these complexes, which results in loss of protein. The disadvantages of CLIP are the labor-intensive
gel purification steps as well as a high number of false-positive signals due to non-specific interactions.
In comparison, the SpyTag-SpyCatcher technology allows the method to be performed with beads, skips
the gel purification steps altogether, and withstands harsh washing steps, thus reducing non-specific
interactions. The improved method using the Spy technology was termed SpyCLIP and requires
SpyCatcher being fused to beads for immunoprecipitation and fusion proteins of the protein of
interest, in this case the RNA-binding protein, to SpyTag [45] (Figure 2G). UV-crosslinking and affinity
purification (uvCLAP) [46] as well as gel-omitted ligation-dependent CLIP (GoldCLIP) [47], using the
covalent HaloTag-HaloLink purification system for immunoprecipitation [48], are both improvements
to the traditional CLIP protocol, omitting the labor-intensive gel purification steps. The advantage
of the SpyCatcher system over those methods is the ability of SpyTag-SpyCatcher to withstand even
harsher washing conditions than the biotin-streptavidin coupling used during uvCLAP, and the small
size of SpyTag compared to the 33 kDa protein tag used in GoldCLIP.
The system has also found increasing usage in conventional and super-resolution microscopy [49–51]
by providing an easy and reliable way to label a SpyTagged protein with SpyCatcher coupled to
a fluorescent dye (Figure 2H). Additionally, the limited accessibility of large antibodies, classically used
for detection of epitope-tagged molecules, can be avoided by using the relatively small SpyCatcher
protein during the detection of SpyTagged targets.
The Spy technology can also be used for the targeting of chemically synthesized voltage-sensitive
dyes to specific cells for optical measurement of voltage dynamics in living cells. To this end, SpyTag is
linked via a polyethylene linker to voltage-sensitive dyes while expressing SpyCatcher on the target
cells. These SpyTag–dye conjugates, termed Voltage Spy, display improved targeting, good voltage
sensitivity, and fast-response kinetics [52].
The system can also be used for the spatial and functional coordination of enzyme functions,
creating a microenvironment normally associated with biological compartmentalization and conferring
some of the same benefits (e.g., a local increase in enzyme and metabolite concentrations). Linkage
of SpyTag with SpyCatcher is utilized for enzyme organization, allowing construction of artificial
multi-enzyme nanodevices with a controlled spatial arrangement for increased efficiency of enzyme
cascades while maintaining or even increasing stability and reusability of biocatalysts [53] (Figure 2I).
3. Using SpyCatcher-SpyTag to Investigate Bacterial Virulence Factors
The SpyCatcher-SpyTag system has recently been used for investigating bacterial virulence factors.
So far, these have been limited to studying surface proteins of Gram-negative bacteria, especially
autotransporter proteins. Autotransporters, also called type V secretion systems, are a widespread
family of secreted proteins from Gram-negative bacteria, and many of these mediate virulence-related
functions [54]. These proteins, which are divided into several subclasses (type Va through type Ve),
have an outer membrane-embedded β-barrel domain and an extracellular region or passenger, which
harbors the specific activity of each protein. Although SpyCatcher-SpyTag has been used mostly for
studying autotransporters, the methods described below would be applicable to other surface-exposed
proteins, both in Gram-negative and Gram-positive bacteria.
The cell surface of Gram-negative bacteria is represented by the outer membrane (OM), which
is a complex asymmetric lipid bilayer. The extracellular face of the OM is mainly composed of
lipopolysaccharides and outer membrane proteins that include several common virulence factors responsible
for adhesion, mobility, and secretion, such as autotransporter adhesins, flagella, and type I-VIII secretion
systems, among others [55,56]. Studying the expression, secretion, migration, and interactions of OM
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proteins often requires labeling by reporter proteins or other fluorophores. Labeling OM proteins,
however, is challenging. Many fluorescent reporter proteins fail to mature in the periplasm [57]; thus,
genetic fusions with fluorescent proteins are limited to a handful of options [58–61]. An alternative
approach is non-covalent affinity-based labeling by using antibody–reporter protein fusions, affinity tags,
or other high-affinity interactions, for example, colicins ColE9 and ColIa for labeling of the vitamin B12
transporter BtuB [62]. Alternatively, labeling methods using small organic molecules include amine-reactive
fluorescence labeling [63,64], cysteine-reactive labeling [65], or site-specific labeling with unnatural amino
acids, and tag-specific labeling [66,67]. Each of these techniques, however, has shortcomings. Non-covalent
labeling requires high (nM) affinities for the label to remain associated with its target for a significant
amount of time, which often makes such labeling unsuitable for time-resolved imaging on the minute scale.
Small-molecule labeling often requires harsh treatment of the cells with reactive molecules, and site-specific
orthogonal labeling requires co-expression of additional OM proteins that can disturb the system. In this
section, we present a few recent examples showing how the SpyCatcher system can overcome many of
these challenges by covalently labeling OM-bound virulence factors with high specificity, both with the
purpose of studying the virulence factors and of exploiting their properties in vaccine development.
3.1. Using SpyCatcher to Investigate Membrane Protein Topology and Secretion
Trimeric autotransporter adhesins (TAAs), or type Vc secretion systems, constitute a group of
surface-displayed virulence factors in Gram-negative bacteria that are responsible for adhesion to
organic and inorganic surfaces. The prototypical TAA is Yersinia adhesin A (YadA), which consists of
a C-terminal transmembrane β-barrel domain, where three protomers form a 12-stranded β-barrel, and
an N-terminal trimeric passenger that is translocated through the β-barrel to the bacterial surface [68].
Once the passenger is translocated, it adopts a lollipop-like structure, forming a fibrous trimeric
coiled-coil stalk that ends in an N-terminal globular head domain, responsible for adhesion and
autoaggregation (Figure 3A). Autotransporters belonging to the type Va and Ve secretion systems
initiate their translocation process via a hairpin intermediate, meaning that the part of the passenger
most proximal to the β-barrel is initially inserted into the pore and then exported in a hairpin-like loop
from the β-barrel until the entire passenger is outside the cell [69,70].
Figure 3. Using SpyCatcher to determine the surface topology of the Yersinia adhesin YadA. (A) Model
of full-length YadA [71] and solid-state NMR structure of YadAM (PDB ID: 2LME); (B) schematic of
the trimeric SpyTag-YadAMA354P construct with two secreted chains. The secreted chains fused to
SpyTag are located on the bacterial surface and are able to bind to the SpyCatcher-sfGFP, while the
chain located in the periplasm is inaccessible to the SpyCatcher fusion.
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In a recent study, we investigated whether the hairpin model also holds true for TAAs using
YadA as a model system, and aided by the SpyCatcher-SpyTag technology [13]. Earlier studies had
identified a flexible region at the start of the coiled coil embedded within the lumen of the β-barrel,
termed the ASSA region, due to the sequence consisting of alanines and serines. The ASSA region was
hypothesized to be important for the formation of the hairpin [72]. To test this hypothesis, a truncated
YadA construct was used, containing only the β-barrel and a small part of the passenger, termed YadAM
(for YadA membrane anchor; see Figure 3A). Single proline substitutions were introduced to the ASSA
region to probe its importance for translocation. Prolines are known secondary structure disruptors
due to their rigid backbone, and we expected the substitutions to disrupt the flexible ASSA region
sufficiently to stall the autotransporter process and trap the N-termini in the periplasm. To test this,
a representative mutant, YadAMA354P, was chosen for further studies, and a SpyTag was inserted in the
wild-type YadAM and YadAMA354P constructs at the N-terminus of the mature proteins, following the
signal peptide required for secretion. For easy detection, we fused purified SpyCatcher fused to sfGFP
(superfolder green fluorescent protein). Escherichia coli cells expressing the different constructs were
incubated with SpyCatcher-sfGFP (that is too large to penetrate the OM), allowing the SpyCatcher
domain to bind to the exported SpyTags presented on the bacterial surface, but not to any stalled
intermediates where the SpyTags would still be located in the periplasm. Bacterial cells producing the
wild-type construct displayed higher fluorescence compared with cells producing the A354P mutant,
indicating that the mutation was interfering with secretion of the passenger domain [13]. The effect
of the A354P mutation on the surface topology of YadA was further investigated by isolating OM
fractions of the two constructs after SpyCatcher-sfGFP treatment and analyzing them by semi-native
SDS-PAGE (i.e., without heating the samples beforehand) (Figure 4A). GFP is stable in SDS at ambient
temperatures [73], allowing instant visualization of GFP-containing bands by in-gel fluorescence
under blue light. The gel showed a ladder-like pattern of SpyTag-YadAM complexes bound to 1–3
SpyCatcher-GFP molecules, corresponding to the number of strands exported to the bacterial surface
(Figures 3B and 4A). Comparison of the band intensities indicates that the majority of YadAM exports all
three passengers, whereas YadAMA354P mainly exports 1–2 SpyTags. These experiments demonstrated
that the proline substitution is a partially stalled intermediate where one or two passenger strands are
exported, but not a fully blocked autotransport intermediate.
As an alternative to using reporter molecules such as GFP to study the surface topology of OM
proteins, the binding of SpyCatcher alone can be utilized for assessing surface exposure. Because
SpyCatcher forms a covalent bond with SpyTag, the added molecular weight of SpyCatcher causes
a change in electrophoretic mobility, giving a shift of 16 kDa that can be observed either by Coomassie
staining or Western blotting. As an example, we studied the surface exposure of the full-length,
SpyTagged YadA construct. YadA was treated with SpyCatcher alone (i.e., with no fusion partner) and
compared with YadA treated with an inactive SpyCatcher, where the catalytic glutamate was changed
to glutamine (SpyCatcherEQ), by SDS-PAGE. In this example, unlabeled YadA remains trimeric even
when heated to 95 ◦C and is seen as a single band at 200 kDa [74]. By contrast, the sample treated with
active SpyCatcher forms a ladder-like pattern corresponding to YadA alone and YadA plus 1–3 bound
SpyCatchers (Figure 4B). The experiments with truncated and full-length YadA demonstrate how
SpyCatcher can readily bind to SpyTags located in close proximity to the bacterial surface, as shown
for the YadAM constructs, as well as for the more exposed SpyTag protruding far from the surface
located on the full-length protein. Future work will determine whether this technology is also suitable
for detecting OM proteins without protruding domains, for example, where SpyTag is inserted into the
loops of transmembrane β-barrel domains.
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Figure 4. SpyCatcher assays with YadA. (A) Semi-native SDS-PAGE of OM preparations of wild-type
SpyTag-YadAM and SpyTag-YadAMA354P after treatment with SpyCatcher-sfGFP, visualized under
blue light. The ladder-like pattern indicates 1–3 bound SpyCatcher-sfGFP molecules. The gel shown is
based on results from [13]. The wild-type YadAM binds mainly three SpyCatcher-sfGFP molecules,
demonstrating full surface exposure of the N-terminal SpyTags, whereas the A354P mutant mainly binds
to 1–2 SpyCatcher-sfGFP molecules. Note that YadAMA354P migrates anomalously compared with the
wild-type. A schematic of the species visible in the gel is given on the side: SpyCatcher-sfGFP in green
and YadAM monomers in red, blue, and yellow. vc represents vector control; (B) SDS-PAGE of OM
preparations of full-length, trimeric SpyTag-YadA (~200 kDa) treated with the inactive SpyCatcherEQ
and normal SpyCatcher, stained with Coomassie blue. The SpyCatcher-treated SpyTag-YadA shows
a similar ladder-like pattern as in panel a, corresponding to the change in electrophoretic mobility as
1–3 SpyCatchers are bound.
3.2. Using SpyCatcher to Investigate Membrane Dynamics
The OM of Gram-negative bacteria consists of a mixture of OM proteins, lipopolysaccharides,
and phospholipids. Both OM proteins and lipopolysaccharides are inserted into the OM in localized
patches around the cell center where they diffuse to form a uniform distribution across the bacterial
surface [75]. When the bacterium grows in preparation for cell division, the outer membrane proteins
migrate towards the poles as a result of new membrane material and peptidoglycan being incorporated
near the cell center in a process that is still not well understood [62].
In a recent paper, Keeble et al. used the SpyCatcher system to study the OM dynamics in E. coli.
To this end, they used a novel phage display method to develop an improved SpyCatcher-SpyTag pair,
termed SpyTag002 and SpyCatcher002 [21]. The rate constant of the improved 002 pair was increased
by an order of magnitude compared to the original SpyCatcher–SpyTag interaction (2.0 × 104 M−1 s−1
vs. 1.7 × 103 M−1 s−1). The efficiency of the newly developed pair was demonstrated by labeling the
peptidoglycan-binding autotransporter intimin in order to study the membrane dynamics during cell
growth and division. Intimin, a virulence factor of enterohemorrhagic E. coli, is a surface-exposed
protein belonging to the type Ve secretion systems, also called inverse autotransporters [76]. Intimin
consists of three major parts: an N-terminal periplasmic domain that binds to peptidoglycan under acidic
conditions [77], a transmembrane β-barrel anchor [78], and the C-terminal passenger that is translocated
to the bacterial surface through the β-barrel [79]. Keeble et al. prepared an intimin–SpyCatcher002
construct with SpyCatcher002 fused to the C-terminus of a truncated intimin variant (Figure 5). Upon
overexpression in E. coli cells, the SpyCatcher002 domain is secreted together with the truncated passenger
and presented on the bacterial surface, where it can be labeled using SpyTag002 fused to the fluorescent
reporter protein mClover3 [80], in a similar fashion to that described for YadAM in Section 3.1. By imaging
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the cells using wide-field fluorescence microscopy after labeling, the movement of the mClover-tagged
intimins toward the poles could be tracked to study the dynamics of the OM. Intimin was initially
uniformly spread across the bacterial surface, but migrated towards the poles during cell division [21],
suggesting that the polar movement results from incorporation of new peptidoglycan and OM material in
preparation for cell division. This notion was further tested by repeating the experiment in the presence
of cefalexin, a β-lactam antibiotic that prevents bacterial division by inhibiting septum formation and
peptidoglycan synthesis. This time, the cells became elongated in preparation for division but were
unable to divide. After 45 min, the fluorescent signal was localized in patches around the bacterium,
thus demonstrating how inhibited peptidoglycan synthesis prevents the polar migration of OM proteins.
Keeble et al. demonstrated here how an intimin–SpyCatcher fusion can be used to study the effect of
peptidoglycan synthesis during division upon outer membrane dynamics [21]. This method could be
used for tracking the migration of other OM proteins in the membrane during different stages of the
cell cycle.
Figure 5. Intimin–SpyCatcher002 fusion for studying membrane dynamics. Structural model of
the intimin construct used in [21]. The model is based on the crystal structures of the intimin
transmembrane domain (PDB ID: 4E1S) and SpyCatcher (PDB ID: 4MLI), the solution structure of the
peptidoglycan-binding LysM domain (PDB ID: 2MPW), and the homology model structures of the
extracellular D00 and D0 domains [81].
3.3. Exploiting Virulence Factors and Virus-Like Particles for Vaccine Development using SpyCatcher-SpyTag
Outer membrane vesicles (OMVs) are ubiquitously produced by Gram-negative bacteria and
are often responsible for delivering virulence factors to the host cells during infection [82]. Derived
from the outer membrane, OMVs contain many naturally occurring immunogenic components such as
lipopolysaccharides, lipoproteins, outer membrane proteins, peptidoglycan, and other periplasmic
components with intrinsic adjuvant properties [83]. As opposed to live and attenuated bacteria, OMVs
are non-replicating and therefore pose no risk of infection after vaccination of immunocompromised
individuals. Consequently, OMVs are promising candidates for modern vaccine development, both as
adjuvants and as delivery vehicles for antigens. Vaccines utilizing OMVs as adjuvants have already been
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on the market for more than two decades; however, the development of heterologous antigen-presenting
OMV-based vaccines using recombinant technology is still in its infancy [83,84]. Several strategies
have been employed to present antigens on OMV surfaces, most notably as heterologous fusions with
autotransporters [85–87]. The use of autotransporters for heterologous antigen presentation on OMVs
has recently been reviewed in detail elsewhere [88], so we will only provide a short overview here.
The Luirink group has pioneered the use of recombinant OMVs for vaccine development.
As a scaffold, they earlier utilized a classical (type Va) autotransporter, the E. coli hemoglobin protease
(Hbp). Hbp consists of two major parts: a C-terminal transmembrane β-barrel that is inserted into
the outer membrane, and an N-terminal passenger that is translocated through the β-barrel to the
bacterial surface where it is released to the environment through autoproteolysis (Figure 6) [89,90].
The Luirink group developed an Hbp variant suitable for heterologous antigen export and display by
introducing a point mutation that prevents autoproteolysis into a truncated Hbp passenger domain
(HbpD(Δd1); from now referred to only as Hbp) [86]. By combining the new Hbp variant with
a hypervesiculating Salmonella Typhimurium ΔtolRA strain, they developed a method to isolate large
amounts of Hbp-presenting OMVs [87]. To utilize Hbp as an antigen-presenting tool, several loops
in the passenger were identified that allowed the insertion of heterologous protein antigens without
impeding the autotransport process. However, even though the autotransporter accepts substantial
changes to its passenger, there are still considerable limitations to the size and folding properties of
passenger fusions [91].
Figure 6. Hbp constructs used for vaccine display on outer membrane vesicles. (A) Structural model of
full-length HbpD(Δd1) based on the crystal structures of the Hbp transmembrane domain (PDB ID:
3AEH) and passenger (PDB ID: 1WXR); (B) and (C) schematic drawings of Hbp fusions used in [92] to
determine binding efficiencies between the SpyTag-SpyCatcher and SnoopTag-SnoopCatcher pairs on
Hbp-fusion-presenting OMVs.
In a recent paper, this problem was circumvented by using the SpyCatcher-SpyTag technology to
decorate the OMVs after expression of Hbp [92]. In the process, the investigators comprehensively
tested the applicability of the SpyCatcher and SnoopCatcher systems for modular vaccine building, and
we will only cover the highlights here. To fully test the range of the new technology, the authors prepared
OMVs presenting Hbp N-terminal fusions with SpyTag, SpyCatcher, SnoopTag, and SnoopCatcher
(Figure 6). By treating the different constructs with their respective binding partners, and comparing the
changes in electrophoretic mobility upon ligation by SDS-PAGE, they showed that all four Hbp-variants
exported their passenger to the surface and were amenable to ligation. As a proof-of-concept for vaccine
development, they proceeded to treat Hbp-SpyTag-presenting OMVs with a relatively large (24 kDa)
domain of the antigenic S. pneumoniae surface protein, PspAα, fused to both SpyCatcher and SnoopTag
(SpyCatcher–PspAα–SnoopTag) (Figure 7A). Earlier attempts to fuse PspAα with the Hbp passenger
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required the antigen to be divided into two smaller domains, which still resulted in significantly reduced
export and lower antigen presentation on the OMV surface [93]. The SpyCatcher–PspAα—SnoopTag,
on the other hand, was ligated to the Hbp-presenting OMVs with similar efficiency as the earlier
controls, demonstrating that the SpyCatcher system is a robust tool suitable for coating OMVs with
recombinant antigens, completely circumventing the passenger export problem.
Figure 7. Hbp-antigen complexes made through Spy/SnoopCatcher fusions. (A) Schematic of
Hbp bound to SpyCatcher–PspAα–SnoopTag; (B) schematic of Hbp bipartite binding adduct
SpyCatcher–PspAα–SnoopTag and SnoopCatcher–SP1690–SpyTag; (C) schematic of Hbp tripartite
binding adduct with two SpyCatcher–PspAα–SnoopTags flanking SnoopCatcher–SP1690–SpyTag.
The next step was to check whether multiple antigens could be coupled to the OMV surface in
an iterative fashion by using the alternating combinations of the SpyCatcher and SnoopCatcher systems
flanking the antigen proteins. Combinations of antigens to form multivalent OMV-based vaccines can
significantly improve their efficiency, either by eliciting a stronger immune response to a particular
pathogen, or by providing a broader response by combining antigens from multiple pathogens [94,95].
For this approach, they treated the OMVs with PspAα fusion and a SnoopCatcher–SP1690–SpyTag
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fusion with wash steps in between, successfully forming bipartite (Figure 7B) and tripartite (Figure 7C)
coupling adducts. This work demonstrated how various recombinant antigens can be coupled to the
OMV surface using the SpyCatcher system.
A similar application for the SpyCatcher system in vaccine development has been used for VLPs.
VLPs are virus-derived proteins that self-organize into noninfectious virus-like structures that are
capable of eliciting strong immune reactions [96]. Much effort has been put into designing VLP–antigen
fusions; however, this approach has proven to be labor-intensive and time-consuming, since the
fusions often misalign, or are unable to form stable capsids [97]. Brune et al. from the Howarth
group circumvented this problem by using the SpyCatcher technology in an analogous fashion to
the OMV-based vaccines [44]. They were able to create stable SpyCatcher-presenting VLPs by using
a fusion between the bacteriophage AP205-derived capsid and SpyCatcher. They further demonstrated
how the VLPs could be decorated using SpyTag-fused malarial antigens (Figure 2F) in a plug-and-play
fashion, and how this product elicited an antibody response after a single injection in mice. In similar
work, Thrane et al. fused either SpyTag or SpyCatcher to the C- and/or N-termini of the AP205 capsid
protein, and subsequently treated the resulting VLPs with 11 different antigen–SpyCatcher/SpyTag
fusions [43]. In both works, the authors confirmed the immunogenic properties of the novel vaccines
by immunizing mice, thus confirming the functional activity of the novel vaccines. The results from the
OMV and VLP experiments demonstrated the versatility of the SpyCatcher system in a novel approach
for designing vaccines. By presenting one of the binding SpyCatcher/SpyTag partners on the particle
surface, linking antigens in a plug-and-play fashion circumvents the need for designing complicated
fusion constructs, and could soon pave the road for modular vaccines that can easily be tailored for
any need. For further information, Brune and Howarth recently published a more comprehensive
review on the design of VLP-based vaccines, including the use of the SpyCatcher platform for this
purpose [14].
4. Conclusions and Future Perspectives
The SpyCatcher system and its close relatives have been successfully used for protein engineering
purposes, including the cyclic polymerization of enzymes, or the decoration of hydrogels. In our
hands, the system has been extremely useful for showing cell surface localization, and to elucidate
the topology of membrane proteins. Other authors have used the technology for decorating vesicles
and virus particles with antigens. In all cases, the benefits of the system are the same: irreversible,
covalent coupling and the fact that the two partners of the system are relatively small entities that do
not interfere strongly with the native systems that they label.
It is somewhat ironic that the system, derived from a bacterial surface protein, has been widely
used for studying and modifying other bacterial or viral surface proteins. We strongly believe that this
system will have many more applications in basic science, and that this is only limited by the fact that
many researchers are not aware of its existence. This prompted us to write this review.
Some of the approaches related to vaccines will need more testing before they can potentially be
used in patients. For example, it remains unclear whether SpyCatcher (or its relatives) elicits a strong
immune response by itself, and whether that would limit its usefulness in vaccines. The work on VLPs
suggests that this could be problematic for some applications, where the SpyCatcher-VLPs did elicit an
immune response of their own that was then later masked after decorating the particles with the target
antigen [44].
Our own experiments were until now limited to surface-localized proteins in bacteria, but it is
conceivable that the system could also be used to label proteins in other cellular localization (e.g.,
after membrane permeabilization) as an alternative to antibody-based approaches. We also believe
that the system can be used in versatile ways to modify and functionalize artificial or biological
surfaces of almost any kind (e.g., to develop ELISA-like assays that require covalent immobilization),
and possibly to functionalize surfaces used in lab-on-a-chip approaches. Another conceivable use
of the system includes in situ labeling of proteins for added density to identify individual proteins
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(e.g., in cryo-electron micrographs or tomograms). As this review shows, the SpyCatcher-SpyTag
system has proven to be an extremely versatile tool for both basic research and applied science, and it
will undoubtedly spur further innovations in the future.
Author Contributions: Conceptualization, J.C.L. and D.L.; writing—original draft preparation, D.H., T.T., D.L.,
and J.C.L.; writing—review and editing, D.L. and J.C.L.
Funding: This research was funded by the Research Council of Norway, grant numbers 249793 (to J.C.L.) and
240483 (to D.L.).
Acknowledgments: The authors wish to thank Nandini Chauhan for providing the gel image shown in Figure 4B.
They also acknowledge the members of the Leo and Linke groups for fruitful scientific discussions.
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
CLIP UV crosslinking and immunoprecipitation
GoldCLIP Gel-omitted ligation-dependent CLIP
Hbp Hemoglobin protease
MSCRAMMs Microbial surface components recognizing adhesive matrix molecules
OM Outer membrane
OMV Outer membrane vesicle
PDB Protein Data Bank
SDS-PAGE Sodium dodecylsulfate polyacrylamide gel electrophoresis
sfGFP Superfolder green fluorescent protein
SUMO Small ubiquitin-like modifier
TAA Trimeric autotransporter adhesin
UV Ultraviolet
uvCLAP UV-crosslinking and affinity purification
VLP Virus-like particle
YadA Yersinia adhesin A
YadAM YadA membrane anchor
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